Citrus Sinensis ID: 001449
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1075 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.237 | 0.273 | 0.386 | 2e-46 | |
| Q55A09 | 1331 | Probable serine/threonine | yes | no | 0.242 | 0.196 | 0.368 | 1e-45 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.236 | 0.309 | 0.380 | 7e-45 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.245 | 0.109 | 0.393 | 7e-45 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.221 | 0.184 | 0.410 | 2e-44 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.240 | 0.282 | 0.371 | 6e-44 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.224 | 0.369 | 0.384 | 6e-41 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.258 | 0.171 | 0.350 | 3e-40 | |
| Q54U31 | 744 | Dual specificity protein | no | no | 0.263 | 0.380 | 0.362 | 4e-40 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.227 | 0.628 | 0.363 | 4e-40 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 188 bits (478), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 105/272 (38%), Positives = 152/272 (55%), Gaps = 17/272 (6%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+DL +G G+YG VYH W G++VA+K+ F+G +A+F E ++
Sbjct: 667 NDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA------LAEFRSEVRIMRR 720
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNVV F G V P+ L+ VTEF+ GSL + L + ID R+R+ +A+D A GM
Sbjct: 721 LRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGM 778
Query: 920 EYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWM 976
LH IVH DLK NLLV+ K+GD GLS++K T +S GT WM
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLVD----NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L ++ EK DVYSFG+++WEL T P+ M+ ++G + R +IP
Sbjct: 835 APEVL--RNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKEL 892
Query: 1037 DPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
DP ++ CW +DP RPSF++++ L+ +
Sbjct: 893 DPVVGRIILECWQTDPNLRPSFAQLTEVLKPL 924
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 104/282 (36%), Positives = 162/282 (57%), Gaps = 21/282 (7%)
Query: 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD 849
I+ + I D++ +E+G G + V G W+G DVA+K++ ++ K RE +I +
Sbjct: 1061 ISSSVTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSN----KDKAREEMIQE 1116
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL------QKKDRTI 903
F E LL SL HPN+V+ YG + + V EF+ +G+L + + Q++ +
Sbjct: 1117 FKAEVELLGSLQHPNLVTCYGYSLN----PMCIVMEFLPSGNLFELIHSKPSEQQQSIKL 1172
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
D L IA D A GM++LH +NI+H DLK NLL++ + KI DLG+++ T
Sbjct: 1173 DSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMD----KHFNIKIADLGIARETSFT 1228
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI 1023
+ GT+ W APE+L +S+ +K DVYS+ IV++ELLTG+EPY + + +
Sbjct: 1229 QTMTTI-GTVAWTAPEILRHESY--NQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILV 1285
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
+ LRP++P CDP W+ L+ CW+ DP +RPSF EI+ L
Sbjct: 1286 ASKGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 104/273 (38%), Positives = 161/273 (58%), Gaps = 19/273 (6%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
DL ++G+G++G+V+ +W GSDVA+K + F +ER + +F +E ++ L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH---AER---VNEFLREVAIMKRL 603
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFG 918
HPN+V F G V P+ L+ VTE++ GSL + L K +D R+RL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 919 MEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPW 975
M YLH +N IVH DLK NLLV+ ++ K+ D GLS++K T +S GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
MAPE+L + EK DVYSFG+++WEL T +P+ +++ A ++ + R +IP
Sbjct: 718 MAPEVL--RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 775
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+P+ +++E CW ++P +RPSF+ I LR +
Sbjct: 776 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 113/287 (39%), Positives = 158/287 (55%), Gaps = 23/287 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I ++LE + +G G +G V G WR +DVAIK I F K S + F E +
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK--RLIIAMD 914
LS L HPNVV F G G + VTE+M GSL+QFL +++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 915 AAFGMEYLHGKN--IVHFDLKCENLLVNMR-DPQRPV--------CKIGDLGLSKVK--Q 961
A GM YLHG I+H DL N+L++ DP+ PV CKI D GLS++K Q
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021
+ ++ V G +P+MAPE+ G S+ +EK DVYS+G+V++ELLT DEP DM +
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ RP IP +W+ ++ CW S+P RP+F +I L+ M
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLKEM 2388
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 105/256 (41%), Positives = 144/256 (56%), Gaps = 18/256 (7%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G YG V+ G WRG++VA+K + K LI+D KE LL L HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLK------LISDLRKEVDLLCKLRHPNIVL 910
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN- 926
F G + S VTE++ GSL L + +D RL + D A GM YLH +N
Sbjct: 911 FMGACTEP--SSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 927 -IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
I+H DLK +NLLV+ D + K+ D GL+ VK T + + GT W+APE+L+ +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTF-AKTMCGTTGWVAPEVLAEEG 1023
Query: 986 HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLME 1045
+ TEK DVYS+ IV+WELLT PYA + ++ I P +P+WC P++ +LM
Sbjct: 1024 Y--TEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSIDRGERLP-MPAWCPPKYAALMN 1080
Query: 1046 SCWASDPAERPSFSEI 1061
CW +DP RPSF EI
Sbjct: 1081 RCWETDPTHRPSFPEI 1096
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 101/272 (37%), Positives = 153/272 (56%), Gaps = 13/272 (4%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I +L+ +LG GT+G VY G WRGS VAIK+IK + +++ +F KE +
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS L HPN+V P+ L +TE++ GSL L K ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPPN--LCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
GM YLH ++H D+K NLL++ + KI D GLSK+K ++ G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
+PELL G+ + TEK+DVY+FGI++WEL TG+ PY+ + + + +LRP IP+
Sbjct: 826 SPELLMGEDY--TEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAW 883
Query: 1037 DPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ L+++CW DP +RPSF+EI L +
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 103/268 (38%), Positives = 152/268 (56%), Gaps = 27/268 (10%)
Query: 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
+LGSG +GSVY G RG +VAIK++ + F E + +F KE L++ L +P+++
Sbjct: 179 KLGSGAFGSVYKGIVRGKEVAIKKLTQTVF------EENTMNEFKKEVSLMAKLRNPHLL 232
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAAFGMEYLH 923
F G D L+ VTE M GS+ L+ K+ T I ++ ++IA D GM +LH
Sbjct: 233 LFMGACTAPED--LSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTVLGMTWLH 290
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPWMAP 978
NI+H DLK NLLV+ Q V K+ D GLSK K + L G G+ +MAP
Sbjct: 291 ASNILHLDLKPANLLVD----QNWVVKVADFGLSKYMKPDSKDKLL---GQAGSPLYMAP 343
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA--SIIGGIVNNTLRPQIPSWC 1036
E+L + + K+DV+SF I++WELLT EPY ++ + ++ G+VN RP IP +
Sbjct: 344 EMLVNQPY--DGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPIIPDYF 401
Query: 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064
+ L+ CW P+ RPSF+EIS++
Sbjct: 402 PTRLKDLLARCWDHYPSRRPSFAEISKQ 429
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 168 bits (425), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 106/302 (35%), Positives = 167/302 (55%), Gaps = 24/302 (7%)
Query: 766 IEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD 825
I++DY D K E + + + R + I D++ +++G G+YG V++GKW+G D
Sbjct: 1334 IDIDYMADIDK----EDSFLTSANMCRWI--INYDEISIGKQIGLGSYGIVFNGKWKGVD 1387
Query: 826 VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885
VA+K+ K SE + L +F E LS L H N+V+F G P+ + VTE
Sbjct: 1388 VAVKKFVKQ----KLSETQLL--EFRAEMAFLSELKHSNIVTFIGACIKKPN--ICIVTE 1439
Query: 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943
+M G+L+ L+ D I +L + AA G++YLH N IVH D+K N+LV+
Sbjct: 1440 YMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVD--- 1496
Query: 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWE 1003
+ KI D G +++K+ GT W APE++ G+ + EK DV+SFG+VMWE
Sbjct: 1497 -EHFNVKIADFGFARIKEDNTTMTRC-GTPCWTAPEVIRGEKY--CEKADVFSFGVVMWE 1552
Query: 1004 LLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063
+LTG EP+A+ + + I+ RP IPS C E+ L++ CW + +RP+ +E+ +
Sbjct: 1553 VLTGKEPFAECNFMKVSLDILEGG-RPIIPSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQ 1611
Query: 1064 RL 1065
+L
Sbjct: 1612 QL 1613
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (423), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 116/320 (36%), Positives = 166/320 (51%), Gaps = 37/320 (11%)
Query: 760 VNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHG 819
+N + I +D+ + T K +P + A G I ++++ LG G++GSVY G
Sbjct: 240 INPNDYIPLDFVDSTPKVDNNQP-----KRKASGPPEILPEEIDRTDFLGQGSFGSVYKG 294
Query: 820 KWRGSDVAIK---RIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876
K RG +VA+K + K S + + F E ++S + HPNVV F G
Sbjct: 295 KCRGQEVAVKIPRKQKLSLYE---------LTSFRHEVKIMSKIFHPNVVLFLGACTQS- 344
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAAFGMEYLHG-KNIVHFDL 932
G + VTE + L++ L DRT +R+ +A DAA GM +LHG IVH DL
Sbjct: 345 -GKMQIVTE-LCQTDLEKLLHN-DRTKKEFSLFRRMQMAKDAALGMNWLHGITRIVHNDL 401
Query: 933 KCENLLV--NMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVT 989
K NLLV N+R K+ D G S++K+ + +GT WMAPE++ G +
Sbjct: 402 KTANLLVDINLR------VKVTDFGFSQIKEGEEFQDKAAKGTPLWMAPEVMMGNPY--N 453
Query: 990 EKIDVYSFGIVMWELLTGDEPYADMHCASII-GGIVNNTLRPQIPSWCDPEWRSLMESCW 1048
EK DVYSFGI++WE+LT + PY+ I I N RP IP+ P R L+++CW
Sbjct: 454 EKADVYSFGIILWEILTKEAPYSHHKDYDIFFNAICNEKERPPIPADTLPSLRHLIQTCW 513
Query: 1049 ASDPAERPSFSEISRRLRSM 1068
+P RPSFSEI RL +
Sbjct: 514 DHNPQNRPSFSEILFRLNEI 533
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (423), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 93/256 (36%), Positives = 138/256 (53%), Gaps = 11/256 (4%)
Query: 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
+ SG + +Y G ++ VA+K ++ K R +L F E LLS L HPN+V
Sbjct: 91 KFASGAHSRIYRGIYKQRAVAVKMVRIP--THKEETRAKLEQQFKSEVALLSRLFHPNIV 148
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGK 925
F + P +TE+M G+L+ +L KK+ ++ L +A+D + GMEYLH +
Sbjct: 149 QFIAACKKPP--VYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQ 206
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
++H DLK NLL+N D R K+ D G S ++ Q + G GT WMAPE++ K
Sbjct: 207 GVIHRDLKSNNLLLN--DEMR--VKVADFGTSCLETQCREAKGNMGTYRWMAPEMIKEKP 262
Query: 986 HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLME 1045
+ T K+DVYSFGIV+WEL T P+ M + RP +P+ C P L++
Sbjct: 263 Y--TRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIK 320
Query: 1046 SCWASDPAERPSFSEI 1061
CW+ +P++RP FS I
Sbjct: 321 RCWSENPSKRPDFSNI 336
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1075 | ||||||
| 255570521 | 1090 | serine/threonine protein kinase, putativ | 0.96 | 0.946 | 0.656 | 0.0 | |
| 225446134 | 1217 | PREDICTED: uncharacterized protein LOC10 | 0.981 | 0.866 | 0.656 | 0.0 | |
| 297735348 | 978 | unnamed protein product [Vitis vinifera] | 0.889 | 0.977 | 0.625 | 0.0 | |
| 356550754 | 1087 | PREDICTED: uncharacterized protein LOC10 | 0.968 | 0.957 | 0.598 | 0.0 | |
| 449462731 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.949 | 0.588 | 0.0 | |
| 449525772 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.973 | 0.949 | 0.587 | 0.0 | |
| 357479749 | 1113 | Protein kinase-like protein [Medicago tr | 0.963 | 0.930 | 0.595 | 0.0 | |
| 356564856 | 1073 | PREDICTED: uncharacterized protein LOC10 | 0.946 | 0.948 | 0.588 | 0.0 | |
| 297793271 | 1045 | kinase family protein [Arabidopsis lyrat | 0.928 | 0.955 | 0.585 | 0.0 | |
| 15242791 | 1054 | octicosapeptide/Phox/Bem1p domain-contai | 0.922 | 0.941 | 0.573 | 0.0 |
| >gi|255570521|ref|XP_002526218.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223534457|gb|EEF36159.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1444 bits (3739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 724/1102 (65%), Positives = 852/1102 (77%), Gaps = 70/1102 (6%)
Query: 15 AGSNDD-VPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE 73
AGS+D+ PRVK LCSFLG I+PRPQDGKLRYVGGETRIVSLPRD+++EELM++MRELYE
Sbjct: 18 AGSHDENTPRVKLLCSFLGSIMPRPQDGKLRYVGGETRIVSLPRDISFEELMNKMRELYE 77
Query: 74 GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNH 133
GA VLKYQQPDEDLDALVSVVNDDDV NMMEEYEKL SGDGFTRLRIFLFSH DQDGS+H
Sbjct: 78 GASVLKYQQPDEDLDALVSVVNDDDVTNMMEEYEKLDSGDGFTRLRIFLFSHPDQDGSSH 137
Query: 134 YVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMAERFFNTMSLEGGIH 193
YVDGD+RESERRYVDALNN+NDG DFR+ Q DSP+I I+D+H+ E FF+ M+L+ G+H
Sbjct: 138 YVDGDERESERRYVDALNNLNDGADFRR-QQADSPLIGPIEDVHLHEHFFSPMNLDSGLH 196
Query: 194 NQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRP 246
NQ PQYNLH + +P QRYNEMEGPWSPA+YSPRH+GHHDP RP
Sbjct: 197 NQRSGEMLIPQYNLHHVAIP------------QRYNEMEGPWSPAFYSPRHHGHHDP-RP 243
Query: 247 LPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGN 300
L EFP+SP S+R+R FGE +RV EEYAR +NHHP Y+ QP + +N++WMPPG
Sbjct: 244 LTEFPNSPPSSRYRTQFGEFPDRGMDRVSEEYARSQLNHHPAYDHQPPYPDNVVWMPPGT 303
Query: 301 VSGD-KSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGNGLPQVPLSCAECR 359
+SGD K+GFPGNL HG V +G+ CEHCR+ + RNQLHL+QPN+GN + QV SC EC
Sbjct: 304 ISGDNKAGFPGNLLHGPTVVEGSSTCEHCRVAFQRNQLHLEQPNVGNPVHQVANSCTECH 363
Query: 360 QNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLNPRIEEARTHMSGA 417
NRE+ +LNA+ K+ MYPKD ND RS+YNE+H HERGW LQHQL+P +EARTH+SGA
Sbjct: 364 PNREHFMLNADTKVHHAMYPKDQNDPRSIYNEAHSHERGWSLQHQLSPHADEARTHISGA 423
Query: 418 GRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHDPAAAVVPHLHT 477
GR+N+HY+VDGPG+N P GH NL DG H S NH+HHR G E+GN++FHD A A + HLH
Sbjct: 424 GRINEHYIVDGPGINYPLGHSNLADGQHASSNHSHHRAGHELGNDVFHDQAVAAMHHLHI 483
Query: 478 PSAEERVVRYGNFPYGADTI--YPVSHGHATAQNLWRNVQNPIHVTPLEASGPV--INGS 533
P +EER VRYGNF YG T YP+SHGH Q LWRNVQNP+H TP + S +NG+
Sbjct: 484 PPSEERAVRYGNFAYGYGTENPYPISHGHLHPQTLWRNVQNPVHGTPYDTSSATSQVNGT 543
Query: 534 ITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQKMNPQSYNQ 593
+ PA LRG +EG+ R +D+ +S ++ +Q++ GF GT T PEY Y + K+ P Y
Sbjct: 544 VNPALLRGTLEGSQRTGNDLDNMHSRLESAQKILGFDGT-TAPEYSYGHSLKLTPNHYGP 602
Query: 594 QNQ-----------LPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCN 642
+N+ LP + S + +S T+ N L +N+ E + ++
Sbjct: 603 ENKQLFTPETVRPPLPREIRSSSA---------ISGTSGYNPELSSSNIMEVTKMEKPV- 652
Query: 643 LGQEKAANHVVKVEETDVKRS-CLEQNMIPE--------KPIGSTSLLAMEVSGNIEKPG 693
LG EK A + ++E DV+ EQ+M+ + + S S E +G+I K G
Sbjct: 653 LGMEKEAIYAEQIENLDVQNLLSTEQDMVARGNGDAALLETLHSNSSRHTEGAGDIVKGG 712
Query: 694 EKSPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAP 753
E PS E SKL LS LPELIASVK+AALE AEEVKA V E++ S + +KEA
Sbjct: 713 ETDPSAVMETSKLSLDRLSFLPELIASVKKAALEEAEEVKAVVNENEHS----SASKEAT 768
Query: 754 ANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTY 813
+E+E VN H E E+D ++D + T +IEPT AE EAI RGLQTIKNDDLEE+RELGSGTY
Sbjct: 769 PSESEAVNAHEEPELDSESDNINTNEIEPTKAEEEAIERGLQTIKNDDLEEIRELGSGTY 828
Query: 814 GSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873
G+VYHGKW+GSDVAIKRIKASCFAG+PSERERLIADFWKEAL+LSSLHHPNVVSFYGIVR
Sbjct: 829 GAVYHGKWKGSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPNVVSFYGIVR 888
Query: 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLK 933
DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFD+K
Sbjct: 889 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDMK 948
Query: 934 CENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKID 993
CENLLVNMRDPQRPVCKIGDLGLSKVKQ TLVSGGVRGTLPWMAPELLSGKSHMVTEKID
Sbjct: 949 CENLLVNMRDPQRPVCKIGDLGLSKVKQHTLVSGGVRGTLPWMAPELLSGKSHMVTEKID 1008
Query: 994 VYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPA 1053
VYSFGIVMWELLTG+EPYA +HCASIIGGIVNN+LRPQIP+WCDPEW+SLMESCWA+DPA
Sbjct: 1009 VYSFGIVMWELLTGEEPYAGLHCASIIGGIVNNSLRPQIPTWCDPEWKSLMESCWAADPA 1068
Query: 1054 ERPSFSEISRRLRSMAAAINVK 1075
ERPSF+EISR+LRSMAAA+NVK
Sbjct: 1069 ERPSFTEISRKLRSMAAAVNVK 1090
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225446134|ref|XP_002270697.1| PREDICTED: uncharacterized protein LOC100266729 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1441 bits (3729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 739/1125 (65%), Positives = 868/1125 (77%), Gaps = 70/1125 (6%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 105 MDSPSAT---PSSAHGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 161
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 162 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 221
Query: 121 FLFSHSDQDG-SNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQDG S+H+VD DD +ERRYVDALNN+ND +DFRK Q +SP +S+IDDIH+A
Sbjct: 222 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQVGESPTMSAIDDIHLA 279
Query: 180 ERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
E+FFN++SLEGG+HNQ Q+NLH LT+PHM SGQ Q PV+QRYNEME W+PAY
Sbjct: 280 EQFFNSISLEGGLHNQRNCEMPMSQFNLHHLTIPHMGSGQHQ-PVAQRYNEMESQWNPAY 338
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
+SPRH+GHHD RPL E+PSSPSSARFRMPFGE +R+PEEY+RQ VN Y+ Q
Sbjct: 339 FSPRHHGHHDA-RPLAEYPSSPSSARFRMPFGELPDKCIDRLPEEYSRQPVNPQAPYDHQ 397
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
PQ S+N++W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GN
Sbjct: 398 PQASDNVVWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGN 454
Query: 347 GLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLN 404
GLP V CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLN
Sbjct: 455 GLPPVANPCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLN 514
Query: 405 PRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPE 458
PR E+AR +SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTGPE
Sbjct: 515 PRAEDARAQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDPRYIRTGPE 574
Query: 459 MGNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQN 516
+GN +FHD AAA P ++ P EER VRYGN +PYGAD +Y VSHGH A LWRNVQN
Sbjct: 575 LGNGVFHDQAAAAGPAINVPPLEERAVRYGNLPYPYGADNLYQVSHGHVPAHALWRNVQN 634
Query: 517 PIHVTP-LEASGPVI--NGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTA 573
P+H P EAS +GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A
Sbjct: 635 PMHGAPSYEASTSTCQASGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSA 694
Query: 574 TPPEYYYSQTQKMNPQSYNQQNQLP-------------------DPVHQSDSFSALVQDK 614
P +Y Y K+NP ++ Q+ Q P +P+H ++S L+ DK
Sbjct: 695 LP-DYSYGHATKLNPNTHGQEGQHPFTPGPVPSPSDMLKFAAPMEPLHFTNSSPTLMDDK 753
Query: 615 LVSSTTDCNLGLRV-----NNVSEAVRTDENCNLGQEKAANHVVKVEETDVKRSCL-EQN 668
V+S NL NNV++ V + + K H+ KVE+ D+ + L E+N
Sbjct: 754 FVASA---NLSYNPESRNDNNVNQTVIMEAKQAFREGKEEIHMEKVEDNDMPVTSLPEKN 810
Query: 669 MIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAAL 726
+K SL + + N+ KP + ED+KL NLS LPELIASVKRAAL
Sbjct: 811 NNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEEDAKLDVSNLSFLPELIASVKRAAL 870
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAE 786
E AEEVKAKV+E+ D+V ++TKEA +NE E N G++E+D DND V T KIEPT AE
Sbjct: 871 ESAEEVKAKVQENADAVHA-SSTKEA-SNELETANALGDLELDSDNDNVNTFKIEPTKAE 928
Query: 787 AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERL 846
EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSERERL
Sbjct: 929 EEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERERL 988
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
IADFWKEAL+LSSLHHPNVVSFYGIVRDGP GSLATVTEFMVNGSLKQFLQKKDRTIDRR
Sbjct: 989 IADFWKEALILSSLHHPNVVSFYGIVRDGPGGSLATVTEFMVNGSLKQFLQKKDRTIDRR 1048
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
KR IIAMDA+FGMEYLHGKNIVHFDLKCENLLVNMRDP RPVCKIGDLGLSKVKQ TLVS
Sbjct: 1049 KRRIIAMDASFGMEYLHGKNIVHFDLKCENLLVNMRDPHRPVCKIGDLGLSKVKQHTLVS 1108
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026
GGVRGTLPWMAPELLSGK++MVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN
Sbjct: 1109 GGVRGTLPWMAPELLSGKTNMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1168
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
TLRPQIP WC+PEW+ LMESCWASDPAERPSFSEIS++LR+MA A
Sbjct: 1169 TLRPQIPRWCEPEWKYLMESCWASDPAERPSFSEISQKLRNMADA 1213
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735348|emb|CBI17788.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1298 bits (3358), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 681/1089 (62%), Positives = 797/1089 (73%), Gaps = 133/1089 (12%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 1 MDSPSAT---PSSAHGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 57
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 58 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 117
Query: 121 FLFSHSDQDG-SNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQDG S+H+VD DD +ERRYVDALNN+ND +DFRK Q P S
Sbjct: 118 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQMPMS------------ 163
Query: 180 ERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYG 239
Q+NLH LT+PHM SGQ Q PV+QRYNEME W+PAY+SPRH+G
Sbjct: 164 -----------------QFNLHHLTIPHMGSGQHQ-PVAQRYNEMESQWNPAYFSPRHHG 205
Query: 240 HHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENL 293
HHD RPL E+PSSPSSARFRMPFGE +R+PEEY+RQ VN Y+ QPQ S+N+
Sbjct: 206 HHDA-RPLAEYPSSPSSARFRMPFGELPDKCIDRLPEEYSRQPVNPQAPYDHQPQASDNV 264
Query: 294 IWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGNGLPQVPL 353
+W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GNGLP V
Sbjct: 265 VWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGNGLPPVAN 321
Query: 354 SCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLNPRIEEAR 411
CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLNPR E+AR
Sbjct: 322 PCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLNPRAEDAR 381
Query: 412 THMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPEMGNELFH 465
+SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTGPE+GN +FH
Sbjct: 382 AQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDPRYIRTGPELGNGVFH 441
Query: 466 DPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYPVSHGHATAQNLWRNVQNPIHVTPLEA 525
D AAA P ++ P EE +T Q
Sbjct: 442 DQAAAAGPAINVPPLEEPST-------------------STCQ----------------- 465
Query: 526 SGPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQK 585
+GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A P +Y Y K
Sbjct: 466 ----ASGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSALP-DYSYGHATK 520
Query: 586 MNPQSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCNLGQ 645
+NP ++ Q+ Q P F+ ++ + +A R G+
Sbjct: 521 LNPNTHGQEGQHP--------FTPVIME-----------------AKQAFRE------GK 549
Query: 646 EKAANHVVKVEETDVKRSCL-EQNMIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPE 702
E+ H+ KVE+ D+ + L E+N +K SL + + N+ KP + E
Sbjct: 550 EEI--HMEKVEDNDMPVTSLPEKNNNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEE 607
Query: 703 DSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNI 762
D+KL NLS LPELIASVKRAALE AEEVKAKV+E+ D+V ++TKEA +NE E N
Sbjct: 608 DAKLDVSNLSFLPELIASVKRAALESAEEVKAKVQENADAVHA-SSTKEA-SNELETANA 665
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
G++E+D DND V T KIEPT AE EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+
Sbjct: 666 LGDLELDSDNDNVNTFKIEPTKAEEEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWK 725
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVAIKRIKASCFAG+PSERERLIADFWKEAL+LSSLHHPNVVSFYGIVRDGP GSLAT
Sbjct: 726 GSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPNVVSFYGIVRDGPGGSLAT 785
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
VTEFMVNGSLKQFLQKKDRTIDRRKR IIAMDA+FGMEYLHGKNIVHFDLKCENLLVNMR
Sbjct: 786 VTEFMVNGSLKQFLQKKDRTIDRRKRRIIAMDASFGMEYLHGKNIVHFDLKCENLLVNMR 845
Query: 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMW 1002
DP RPVCKIGDLGLSKVKQ TLVSGGVRGTLPWMAPELLSGK++MVTEKIDVYSFGIVMW
Sbjct: 846 DPHRPVCKIGDLGLSKVKQHTLVSGGVRGTLPWMAPELLSGKTNMVTEKIDVYSFGIVMW 905
Query: 1003 ELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062
ELLTGDEPYADMHCASIIGGIVNNTLRPQIP WC+PEW+ LMESCWASDPAERPSFSEIS
Sbjct: 906 ELLTGDEPYADMHCASIIGGIVNNTLRPQIPRWCEPEWKYLMESCWASDPAERPSFSEIS 965
Query: 1063 RRLRSMAAA 1071
++LR+MA A
Sbjct: 966 QKLRNMADA 974
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550754|ref|XP_003543749.1| PREDICTED: uncharacterized protein LOC100779077 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1244 bits (3220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 671/1121 (59%), Positives = 811/1121 (72%), Gaps = 80/1121 (7%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSP P +GS +GS +D RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+ RD++
Sbjct: 1 MDSPI-RSPATGSGSGSGEDNRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVHRDIS 59
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +MRELY+GA VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFTRLRI
Sbjct: 60 YEELMGKMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFTRLRI 119
Query: 121 FLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHM-A 179
FLFS S+QDGS+H++DGDD SERRYVDALN++NDG+DFR+LQ + P++S ++DIH+ A
Sbjct: 120 FLFSQSEQDGSSHFIDGDD--SERRYVDALNSLNDGSDFRRLQQGEFPMMSPVEDIHVVA 177
Query: 180 ERFFNTMSLEGGIHNQPQ-------YNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
++F++ +S+E GIH+Q YN+H LTV H S + QRYNEM+ PW+PAY
Sbjct: 178 DQFYSPISVESGIHSQRSGDLSMSPYNMHHLTVQHPKS------MGQRYNEMDAPWNPAY 231
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
YSPRH+G H EFPSSPS R+R+PF E +RV EEY R HVNHHP Y+ Q
Sbjct: 232 YSPRHHGLH-------EFPSSPSGTRYRVPFPELPDKCIDRVSEEYVRHHVNHHPVYDNQ 284
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
Q+SEN++W+P G G+KS FPGN+ H +V DGN +CE CR+ +HR Q H++ NI N
Sbjct: 285 LQYSENVMWVPTGAAHGEKSAFPGNILHSPHVVDGNSICEQCRMGFHRGQPHMEHSNISN 344
Query: 347 GLPQVPLSCAECRQ-NRENLVLNAEAKL-PGMYPKD--NDSRSVYNESHCHERGWVLQHQ 402
GLPQ CAEC NR+ +NA+AKL P +YP + ND RSVYN++ HERGW LQH
Sbjct: 345 GLPQAANPCAECPPPNRDTFTVNADAKLHPAIYPNEPNNDHRSVYNDTQNHERGWGLQHP 404
Query: 403 LNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNE 462
R+EE+R H+SG+GR+ D P N GHG++ DGH++S N+ H + GPE+G E
Sbjct: 405 -TARVEESRVHVSGSGRM-----FDVPVANFSLGHGSVTDGHNLSSNYVHQQAGPELGPE 458
Query: 463 LFHDPAAAVVPHLHTPSAEERVVRYGNFP--YGADTIYPVSHGHATAQNLWRNVQNPIHV 520
LF D +P + P EE V+YGN P YG D Y V GH WRN P+H+
Sbjct: 459 LFPDQTVTSIPPIQIPPLEECNVQYGNSPSPYGLDCNYAVPRGHPPG--FWRNTPVPVHI 516
Query: 521 TPL--EASGPV-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPE 577
P A+ P +N + +RG EG+ +G DS N W+D SQ++ G GTA P E
Sbjct: 517 GPSYEAATSPQPLNSMMNVGLIRG--EGSTGFFIGPDSQNHWVDSSQKLTGHDGTAIP-E 573
Query: 578 YYYSQTQKMNPQSYNQQNQLPD------PVHQSDSFSALVQDKLVSSTTDCNLGLRV--- 628
Y Y+ +NP Q+NQ PD P ++ + L +L S+ + +V
Sbjct: 574 YPYAHA--LNPVPLGQENQHPDIVDTIHPPQDMNAGTCLEPLQLPKSSFNMVQNQQVLRD 631
Query: 629 -NNVSEAVRTDENCNLGQEKAANHVVKVEET-----DVKRSCLEQNMIPEKPI-GSTSLL 681
+++EA + N LG+ V+K+E+ S EQN I E + S+
Sbjct: 632 DTHLTEAKSFESNSLLGE----GIVIKIEDNVENPGAQTISSSEQNKIAEHACEAAASVE 687
Query: 682 AMEVSG-------NIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKA 734
+ + ++EK +K PS PEDSK L S LPELIASVK+AALE AEE+KA
Sbjct: 688 SNNLKSKPEADCVHVEKLADKDPS-VPEDSKHLVDQFSFLPELIASVKKAALEDAEELKA 746
Query: 735 KVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGL 794
+E +S ++ TK+ NE E N HG++E+D +ND V T KIE T AE EA A GL
Sbjct: 747 AADEPANSQNHNSDTKDETTNEVEPTNAHGDLELDSENDHVDTNKIESTRAEEEAFANGL 806
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
QTI NDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER RLI DFWKEA
Sbjct: 807 QTINNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLITDFWKEA 866
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFM+NGSLKQFL KKDRTIDRRKRLIIAMD
Sbjct: 867 LMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDRTIDRRKRLIIAMD 926
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ TLVSGGVRGTLP
Sbjct: 927 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLVSGGVRGTLP 986
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034
WMAPELLSGKS+MV+EKIDVYSFGIVMWELLTG+EPYADMHCASIIGGIVNN+LRPQIP+
Sbjct: 987 WMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGNEPYADMHCASIIGGIVNNSLRPQIPT 1046
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
WCDPEW+SLMESCWASDP ERPSFSEIS++LRSMAA++N+K
Sbjct: 1047 WCDPEWKSLMESCWASDPVERPSFSEISKKLRSMAASMNLK 1087
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462731|ref|XP_004149094.1| PREDICTED: uncharacterized protein LOC101215475 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1244 bits (3220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/1131 (58%), Positives = 807/1131 (71%), Gaps = 85/1131 (7%)
Query: 1 MDSP--SPNVPGSG--STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP + P S S GS+D+ PRVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+P
Sbjct: 1 MDSPLTRSSTPNSSPISNPGSHDENPRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVP 60
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+TYEELM +MRELY+GA VLKYQQPDED DALVSVVNDDDVINMMEEY+K+GSGDGFT
Sbjct: 61 RDITYEELMVKMRELYDGAAVLKYQQPDEDPDALVSVVNDDDVINMMEEYDKVGSGDGFT 120
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFSH +QD S +VDGD+R++ERRYVDALNN ND NDF + Q +SP +S IDD+
Sbjct: 121 RLRIFLFSHPEQDASLPFVDGDERDTERRYVDALNNSNDMNDFVRQQQQNSPALSGIDDM 180
Query: 177 HMAERFFNTMSLEGGIHNQ------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
H E F N M++EG +H Q QY+LHQLT+PH+ SG QQQ V+QRY+EME PWSP
Sbjct: 181 HGTEHFLNPMNIEGSLHTQRSCEPLSQYHLHQLTIPHVGSGGQQQSVAQRYSEMEAPWSP 240
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
A SPRH+G +D RP+ ++PSSP AR+RMPF + ER+PE+Y RQ +NH YE
Sbjct: 241 ALLSPRHHGPYDS-RPMGDYPSSPF-ARYRMPFPDLPDKYLERMPEDYVRQQMNHQHMYE 298
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ++EN++W+P G ++ ++SGFPGN+ HGH V DGN CEHCR +HR Q H++Q N
Sbjct: 299 HQPQYNENIVWLPNGTIN-EESGFPGNILHGHGVPDGNSSCEHCRANFHRYQAHMEQVNT 357
Query: 345 GNGLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD---NDSRSVYNESHCHERGWVLQ 400
NGLP E QNRE L+ A+ K G++P + ND RS YNE+ HE+GW++Q
Sbjct: 358 LNGLP------LEYTQNREALMQKADTKFHHGIFPNEQNINDHRSAYNETPPHEKGWIMQ 411
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
HQ++ R ++ RTH+SG GRL DHY+VDG G N+P N+ DG+H S N
Sbjct: 412 HQMSVRGDDTRTHVSGTGRLTDHYIVDGSGSNLPSTQSNVADGYHASTN---------FH 462
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP-VSHGHATAQNLWRNVQNPIH 519
+E+F D H+ P E+R V Y + YG + YP ++ H WRNVQNP+H
Sbjct: 463 DEVFRDQVVPSGQHMCVPPPEDRGVGYMPYGYGGEPHYPPMAQRHMPGNASWRNVQNPLH 522
Query: 520 VTP-LEAS--GPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPP 576
V P EAS N SI P Y++ +G+PRI +GVD N W + SQ+V G G AT
Sbjct: 523 VAPPYEASVFHQQGNASINPGYIKAMQDGSPRIHMGVDHQNPWHESSQKVLGVDG-ATGT 581
Query: 577 EYYYSQTQKMNPQSYNQQNQ-----------------LPDPVHQSDSFSALVQDKLVSST 619
E+ + K N + NQ + P+ +SDS SA +Q+K+V+
Sbjct: 582 EHLPAHVLKTNSTTVGHDNQQFTSLEHIQPHLDKINLVASPMQRSDSSSAFIQEKMVAPF 641
Query: 620 TDC-NLGLR-VNNVSEAVRTDENCNLGQEKAANHVVK------VEETDVKRSCLEQN--- 668
N LR V+ V+EA+ + G+ H++K + E + N
Sbjct: 642 HPSQNPQLRAVSAVNEAMMMERKVVHGE--GNGHMIKDMGKPDISEAHTASHPGQNNTDD 699
Query: 669 ----MIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRA 724
+ P + + ST + +G+ KP ++ E KL LS LPELIASVKRA
Sbjct: 700 TYSKVAPLELLNSTCTNSAVENGDGLKPSVETL----EKPKLSVSRLSFLPELIASVKRA 755
Query: 725 ALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTI 784
ALE +EE VEE+ +PD+ K+ NE N H E E++ +++ ++ +IEPT
Sbjct: 756 ALEVSEETM--VEETALR-RPDSIEKKETTNEQHSSNNHVEPELETESEN-QSSRIEPTK 811
Query: 785 AEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERE 844
AE EAI+RGLQTIKNDDLEE+RELGSGTYG+VYHGKWRGSDVAIKRIKASCFAG+PSERE
Sbjct: 812 AEEEAISRGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSERE 871
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
RLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTID
Sbjct: 872 RLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTID 931
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV+Q TL
Sbjct: 932 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQHTL 991
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
VSGGVRGTLPWMAPELLSGKS+MVTEKIDVYSFGIVMWELLTGDEPY+DMHCASIIGGIV
Sbjct: 992 VSGGVRGTLPWMAPELLSGKSNMVTEKIDVYSFGIVMWELLTGDEPYSDMHCASIIGGIV 1051
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
NN LRP+IP+WCDPEW++LM SCW SDPA+RPSFSEIS++LR+MAAA+NVK
Sbjct: 1052 NNCLRPEIPTWCDPEWKALMSSCWDSDPAKRPSFSEISQKLRNMAAAMNVK 1102
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525772|ref|XP_004169890.1| PREDICTED: uncharacterized protein LOC101228819 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1243 bits (3217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/1131 (58%), Positives = 806/1131 (71%), Gaps = 85/1131 (7%)
Query: 1 MDSP--SPNVPGSG--STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP + P S S GS+D+ PRVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+P
Sbjct: 1 MDSPLTRSSTPNSSPISNPGSHDENPRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVP 60
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+TYEELM +MRELY+GA VLKYQQPDED DALVSVVNDDDVINMMEEY+K+GSGDGFT
Sbjct: 61 RDITYEELMVKMRELYDGAAVLKYQQPDEDPDALVSVVNDDDVINMMEEYDKVGSGDGFT 120
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFSH +QD S +VDGD+R++ERRYVDALNN ND NDF + Q +SP +S IDD+
Sbjct: 121 RLRIFLFSHPEQDASLPFVDGDERDTERRYVDALNNSNDMNDFVRQQQQNSPALSGIDDM 180
Query: 177 HMAERFFNTMSLEGGIHNQ------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
H E F N M++EG +H Q QY+LHQLT+PH+ SG QQQ V+QRY+EME PWSP
Sbjct: 181 HGTEHFLNPMNIEGSLHTQRSCEPLSQYHLHQLTIPHVGSGGQQQSVAQRYSEMEAPWSP 240
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
A SPRH+G +D RP+ ++PSSP AR+RMPF + ER+PE+Y RQ +NH YE
Sbjct: 241 ALLSPRHHGPYDS-RPMGDYPSSPF-ARYRMPFPDLPDKYLERMPEDYVRQQMNHQHMYE 298
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ++EN++W+P G ++ ++SGFPGN+ HGH V DGN CEHCR +HR Q H++Q N
Sbjct: 299 HQPQYNENIVWLPNGTIN-EESGFPGNILHGHGVPDGNSSCEHCRANFHRYQAHMEQVNT 357
Query: 345 GNGLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD---NDSRSVYNESHCHERGWVLQ 400
NGLP E QNRE L+ A+ K G++P + ND RS YNE+ HE+GW++Q
Sbjct: 358 LNGLP------LEYTQNREALMQKADTKFHHGIFPNEQNINDHRSAYNETPPHEKGWIMQ 411
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
HQ++ R ++ RTH+SG GRL DHY+VDG G N+P N+ DG+H S N
Sbjct: 412 HQMSVRGDDTRTHVSGTGRLTDHYIVDGSGSNLPSTQSNVADGYHASTN---------FH 462
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP-VSHGHATAQNLWRNVQNPIH 519
+E+F D H+ P E+R V Y + YG + YP ++ H WRNVQNP+H
Sbjct: 463 DEVFRDQVVPSGQHMCVPPPEDRGVGYMPYGYGGEPHYPPMAQRHMPGNASWRNVQNPLH 522
Query: 520 VTP-LEAS--GPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPP 576
V P EAS N SI P Y++ +G+PRI +GVD N W + SQ+ G G AT
Sbjct: 523 VAPPYEASVFHQQGNASINPGYIKAMQDGSPRIHIGVDHQNPWHESSQKALGVDG-ATGT 581
Query: 577 EYYYSQTQKMNPQSYNQQNQ-----------------LPDPVHQSDSFSALVQDKLVSST 619
E+ + K N + NQ + P+ +SDS SA +Q+K+V+
Sbjct: 582 EHLPAHVLKTNSTTVGHDNQQFTSLEHIQPHLDKINLVASPMQRSDSSSAFIQEKMVAPF 641
Query: 620 TDC-NLGLR-VNNVSEAVRTDENCNLGQEKAANHVVK------VEETDVKRSCLEQN--- 668
N LR V+ V+EA+ + G+ H++K + E + N
Sbjct: 642 HPSQNPQLRAVSAVNEAMMMERKVVHGE--GNGHMIKDMGKPDISEAHTASHPGQNNTDD 699
Query: 669 ----MIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRA 724
+ P + + ST + +G+ KP ++ E KL LS LPELIASVKRA
Sbjct: 700 TYSKVAPLELLNSTCTNSAVENGDGLKPSVETL----EKPKLSVSRLSFLPELIASVKRA 755
Query: 725 ALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTI 784
ALE +EE VEE+ +PD+ K+ NE N H E E++ +++ ++ +IEPT
Sbjct: 756 ALEVSEETM--VEETALR-RPDSIEKKETTNEQHSSNNHVEPELETESEN-QSSRIEPTK 811
Query: 785 AEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERE 844
AE EAI+RGLQTIKNDDLEE+RELGSGTYG+VYHGKWRGSDVAIKRIKASCFAG+PSERE
Sbjct: 812 AEEEAISRGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSERE 871
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
RLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTID
Sbjct: 872 RLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTID 931
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV+Q TL
Sbjct: 932 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQHTL 991
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
VSGGVRGTLPWMAPELLSGKS+MVTEKIDVYSFGIVMWELLTGDEPY+DMHCASIIGGIV
Sbjct: 992 VSGGVRGTLPWMAPELLSGKSNMVTEKIDVYSFGIVMWELLTGDEPYSDMHCASIIGGIV 1051
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
NN LRP+IP+WCDPEW++LM SCW SDPA+RPSFSEIS++LR+MAAA+NVK
Sbjct: 1052 NNCLRPEIPTWCDPEWKALMSSCWDSDPAKRPSFSEISQKLRNMAAAMNVK 1102
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479749|ref|XP_003610160.1| Protein kinase-like protein [Medicago truncatula] gi|355511215|gb|AES92357.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1243 bits (3216), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 671/1126 (59%), Positives = 807/1126 (71%), Gaps = 90/1126 (7%)
Query: 1 MDSP----SPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP SP GSG GSNDD RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+
Sbjct: 27 MDSPTAIRSPATTGSG--PGSNDDGRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVS 84
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+++EELM +MRELYEG VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFT
Sbjct: 85 RDISFEELMGKMRELYEGVAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFT 144
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFS S+QDGS H++DGDD ERRYVDALN++ND ++ R+LQ + P+I +++DI
Sbjct: 145 RLRIFLFSQSEQDGSAHFIDGDD--PERRYVDALNSLNDASELRRLQQMEFPLIGTVEDI 202
Query: 177 HMAERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWS 229
H+ +++ + + +E GI +Q QY LH + + Q QQP+ QRYNE++ PW+
Sbjct: 203 HVGDQYISPVGMENGILSQRSGELAMSQYGLHHMPI------QHQQPMGQRYNEIDAPWN 256
Query: 230 PAYYSPRHYG--HHDPPRPLPEFPSSPSSARFRMPF------GEERVPEEYARQHVNHHP 281
YYSPRH+G HHD L E+PSSPS R+RMPF G +RV +EYAR H+NHHP
Sbjct: 257 SGYYSPRHHGQCHHDSRTSLVEYPSSPSGPRYRMPFPEMPDKGIDRVSDEYARHHINHHP 316
Query: 282 TYEPQPQFSENLIWMPPGNV-SGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLD 340
Y+ QP + EN++W+P G GDKSGFPGN+ HG + DGN +CEHCR+++ R Q HL+
Sbjct: 317 VYDNQPPYPENVVWLPTGPAHGGDKSGFPGNVLHGSHALDGNNICEHCRMSFQRPQPHLE 376
Query: 341 QPNIGNGLPQVPLSCAECRQNRENLVLNAEAKL-PGMYPKDNDSRSVYNESHCHERGWVL 399
PN+ LP V + C EC +R+ L++NA+AKL P MYP N++ HERG L
Sbjct: 377 HPNM---LPSVAIPCPECPSSRDALIVNADAKLQPPMYP---------NDTQNHERGCGL 424
Query: 400 QHQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEM 459
QHQ +GR+ DHY+ D P ++ PGHG+++DGH + NH H GPE+
Sbjct: 425 QHQ-------------NSGRVGDHYVGDVPIISFSPGHGSMIDGHALPSNHVHQPVGPEL 471
Query: 460 GNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQNP 517
G ELF D A +PHL P EE V+YGN PYG D Y + G A LWRN P
Sbjct: 472 GVELFPDQTMANIPHLKIPPLEESSVQYGNPPSPYGVDKNYAMPRGQAPGYTLWRNGPTP 531
Query: 518 IHVTPLEASGPV---INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
+H+ P + + ++G I +RG EG+P VG DS + W+D SQ+ G G+AT
Sbjct: 532 VHIGPPHEATTLPQPVDGVINAGIIRG--EGSPGFFVGPDSQSLWVDSSQKFSGHDGSAT 589
Query: 575 PPEYYYSQTQKMNPQSYNQQNQLP---DPVHQSDSFSAL-----VQDKLVSSTTDCNLGL 626
P EY ++ K+NP + Q+N P D +H +A VQ + S N G+
Sbjct: 590 P-EYPHTNAPKLNPMAIGQENPHPIIVDAIHPPQDVNASIYMEPVQLQKSSFHMVHNNGV 648
Query: 627 RVNN--VSEAVRTDENCNLGQEKAANHVVKVEETDVKR-SCLEQNMIPEKPIGSTSLLAM 683
N+ ++E V LG+ + A VE+++V+ S EQN I E + +T+
Sbjct: 649 LKNDAHLTEGVSLQSISLLGERQEAKKEDAVEKSNVQSISFPEQNQIVED-VSNTAASVA 707
Query: 684 EVSGNIEKP------GEK---SPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKA 734
E + + KP GEK PEDSK L +ILPELIASVK+AALE +EVK
Sbjct: 708 ECNDSFLKPASGCEHGEKVADKDCSAPEDSKGLVDQFNILPELIASVKKAALECHDEVKP 767
Query: 735 KVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGL 794
+E+ + ++ TKE ANE E VN+HG++E+D +ND V T KIEPT AEAEAIARGL
Sbjct: 768 TGKENANCQMDNSNTKEEKANEVEPVNVHGDLELDSENDRVDTSKIEPTKAEAEAIARGL 827
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
QTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER RLIADFWKEA
Sbjct: 828 QTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLIADFWKEA 887
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTIDRRKRLIIAMD
Sbjct: 888 LMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTIDRRKRLIIAMD 947
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK-----IGDLGLSKVKQQTLVSGGV 969
AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK IGDLGLSKVKQ TLVSGGV
Sbjct: 948 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKVLASIIGDLGLSKVKQHTLVSGGV 1007
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
RGTLPWMAPELLSGKS+MV+EKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR
Sbjct: 1008 RGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1067
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
PQIP+WCDPEW+SLMES WASDP ERPSFSEIS++LRSMAA++NVK
Sbjct: 1068 PQIPTWCDPEWKSLMESSWASDPVERPSFSEISKKLRSMAASVNVK 1113
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564856|ref|XP_003550663.1| PREDICTED: uncharacterized protein LOC100782903 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1205 bits (3118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/1130 (58%), Positives = 798/1130 (70%), Gaps = 112/1130 (9%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSP P +GS +GS +D RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+PRD++
Sbjct: 1 MDSPI-RSPATGSGSGSGEDNRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVPRDIS 59
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM RMRELY+GA VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFTRLRI
Sbjct: 60 YEELMGRMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFTRLRI 119
Query: 121 FLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGN--DFRKLQHPDSPVISSIDDIHM 178
FLFS S+QDGS+H++DGDD SERRYVDALN++NDG+ DFR+LQ + ++S ++DIH+
Sbjct: 120 FLFSQSEQDGSSHFIDGDD--SERRYVDALNSLNDGSNSDFRRLQQGEFSMMSPVEDIHV 177
Query: 179 A-ERFFNTMSLEGGIHNQPQ-------YNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
A ++F+N +++E GIH+Q YN+H LTV Q Q + QRYNEM+ PW+P
Sbjct: 178 AADQFYNPINVESGIHSQRSGDLSMSPYNMHHLTV------QHPQALGQRYNEMDAPWNP 231
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
AYYSPRH+G HD FPSSPS R+R+PF E +RVPEEYAR HVNHHP Y+
Sbjct: 232 AYYSPRHHGLHD-------FPSSPSGTRYRVPFPELPDKCIDRVPEEYARHHVNHHPVYD 284
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ+SEN++WMP G+KS FPGN+ H +V D N +CE CR+ +HR Q HL+ NI
Sbjct: 285 NQPQYSENVMWMP---AHGEKSAFPGNIIHSPHVVDENSICEQCRMGFHRGQPHLEHSNI 341
Query: 345 GNGLPQVPLSCAECRQ-NRENLVLNAEAKL-PGMYPKD--NDSRSVYNESHCHERGWVLQ 400
NG+ QV CAEC NR+ A+AKL +YP + ND RSV+N++ HERGW LQ
Sbjct: 342 SNGVSQVGNLCAECPPPNRDTFA--ADAKLHSAIYPNEPSNDHRSVFNDTQNHERGWGLQ 399
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
H R+EE+R H+S GHG++ D H++ N+ + GPE+G
Sbjct: 400 HP-TARVEESRVHVS-------------------LGHGSVTDAHNLPSNYVQQQAGPELG 439
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNF--PYGADTIYPVSHGHATAQNLWRNVQNPI 518
ELF + VP + P E+ VRYGN PYG D+ Y V G WRN P+
Sbjct: 440 TELFPEQTVTPVPPIQFPPLEDCNVRYGNSASPYGVDSNYAVPRG--LPPGFWRNTPVPV 497
Query: 519 HVTPL--EASGPV-INGSITPAYL-RGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
H+ P A+ P +NG + A L RG E +P +G DS N W+D SQ++ G GTA
Sbjct: 498 HIGPSYEAATSPQPVNGLMNAAGLIRG--EASPGFFIGPDSQNHWVDSSQKLTGHDGTAI 555
Query: 575 PPEYYYSQTQKMNPQSYNQQNQLP---DPVHQSDSFSA---LVQDKLVSSTTDCNLGLRV 628
P EY Y+ +NP Q+NQ P D +H +A L +L S+ + +V
Sbjct: 556 P-EYPYAHA--LNPLPLGQENQHPVIVDFIHPPQDMNAGTCLKPLQLPKSSFNMVPNQQV 612
Query: 629 ----NNVSEAVRTDENCNLGQE-------------------KAANHVVKVEETDVKRSCL 665
+++EA + N +G+ N + + S +
Sbjct: 613 LRDDTHLTEAKSFESNGLIGEGIVVKIEDNVQNPGTQTISFSVQNKIAENACEAAAASSV 672
Query: 666 EQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAA 725
E N + KP ++EK +K PS PEDSK L S LPELIASVK+AA
Sbjct: 673 ESNNLKSKPEADCV--------HVEKLADKDPS-VPEDSKHLVDQFSFLPELIASVKKAA 723
Query: 726 LEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIA 785
LE A ++KA V+E DS ++ TK+ NE E N HG++E+D +ND V T KIEPT A
Sbjct: 724 LEDAVQLKAAVDEHADSPNHNSDTKDETTNEVEPANAHGDLELDSENDHVDTNKIEPTRA 783
Query: 786 EAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERER 845
E EAIA+GLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER R
Sbjct: 784 EEEAIAKGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERAR 843
Query: 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR 905
LIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFM+NGSLKQFL KKDRTIDR
Sbjct: 844 LIADFWKEALMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDRTIDR 903
Query: 906 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ TLV
Sbjct: 904 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLV 963
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025
SGGVRGTLPWMAPELLSGKS+MV+EKIDVYSFGIVMWELLTG+EPYADMHCASIIGGIVN
Sbjct: 964 SGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGNEPYADMHCASIIGGIVN 1023
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
NTLRPQIP+WCDPEW+SLMESCWASDP ERPSFSEIS++LRSMAA++N+K
Sbjct: 1024 NTLRPQIPTWCDPEWKSLMESCWASDPVERPSFSEISKKLRSMAASMNLK 1073
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793271|ref|XP_002864520.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310355|gb|EFH40779.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1160 bits (3000), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/1087 (58%), Positives = 750/1087 (68%), Gaps = 89/1087 (8%)
Query: 18 NDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGAVV 77
ND+ RVKFLCSFLG ILPRPQDGKLRYVGGETRIVS+ RD+ YEELMS+MRELY+GA V
Sbjct: 19 NDEPHRVKFLCSFLGSILPRPQDGKLRYVGGETRIVSVNRDIRYEELMSKMRELYDGAAV 78
Query: 78 LKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNHYVDG 137
LKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRIFLFS +QDGS HYV+
Sbjct: 79 LKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRIFLFSSPEQDGSLHYVER 138
Query: 138 DD-RESERRYVDALNNMNDGNDFRKLQ-HPDSPVISSIDDIHMAERFFNTMSLEGGIHNQ 195
DD RESERRYVDALNN+ +G DFRKLQ +PDSP + +D+ M E N +S+E G +Q
Sbjct: 139 DDQRESERRYVDALNNLIEGTDFRKLQQYPDSPRFNFVDEFSMVEPMLNQLSIETGGGSQ 198
Query: 196 -------PQY-NLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRPL 247
QY NLHQL +P + SGQ ++QRY E+EG WSP YYSPRH+GHHDP R
Sbjct: 199 RGTEIPTAQYSNLHQLRIPRVGSGQM---LAQRYGEVEGTWSP-YYSPRHHGHHDP-RTF 253
Query: 248 PEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGNV 301
EFPSSPSSAR+RMP+GE +R+PEEY R +HHP YE Q E+++W+P G +
Sbjct: 254 QEFPSSPSSARYRMPYGEIPDKGFDRMPEEYVRPQASHHPLYEHQAHIPESVVWVPAGAM 313
Query: 302 SGD-KSGFPGNLFH-GHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN-GLPQVPLSCAEC 358
+ K GFPGN+ H G ++G +CE+CR+ YHRN L+QPNIGN G P P+ CA C
Sbjct: 314 PPESKGGFPGNVLHSGPGGYEGGNVCENCRVPYHRNHQLLEQPNIGNNGFP--PVHCAHC 371
Query: 359 RQNRENLVLNAEAKLP--GMYPKDNDSRSVYNESHCHERGWVLQHQLN---PRIEEARTH 413
NRE+ +LN + K G YP NE+ HERG ++Q Q+N PRIEE R+H
Sbjct: 372 PPNRESFLLNTDPKPTHHGAYP---------NETFGHERGRMVQQQVNSNPPRIEEGRSH 422
Query: 414 MSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHD-PAAAVV 472
+S GR NDHY D P N P R G E+ NE FHD P +
Sbjct: 423 ISNVGRPNDHYTPDYPVSNYP----------------LAQRAGHEISNEGFHDKPLGGIP 466
Query: 473 PHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHA-TAQNLWRNVQNPIHVTPLEASGPV 529
+ SAEERV YGN +P G ++I H H QN+W+NV NP+ P P+
Sbjct: 467 LNSANRSAEERVFHYGNNLYPPGPESIQSAGHSHMHPQQNIWQNVSNPVAGPP---GLPM 523
Query: 530 -INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQKMNP 588
ING++ +R +E PR ++GV++ + QR+ GF G +P + YY +
Sbjct: 524 QINGTVNQTIIRNPIETAPRYSIGVENQGVLVGSPQRISGFDGMPSPGQPYYPNPHLQDR 583
Query: 589 QSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCNLGQEKA 648
N +P + V++ L NL + ++T E+ K
Sbjct: 584 AFPLDPNWVPSENPTVHNEHLQVREPLSGPLLQTNLNAAPIMQTPVIQTPES------KL 637
Query: 649 ANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLA 708
A K D S + +P+ +EVS PE ++L
Sbjct: 638 AQGGEKFNYVDTGVSNGVPYLDKPQPLAEGKKDMVEVS--------------PEGAELSV 683
Query: 709 HNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEM 768
LS LPEL+ SVKRAALEGA EVKA EES + V+P+ NE+E +N E E+
Sbjct: 684 ERLSFLPELMESVKRAALEGAAEVKAHPEESKNQVRPELVE-----NESEHMNAQDEPEI 738
Query: 769 DYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAI 828
D DND KIE T AEAEA +RGLQ+I+NDDLEE+RELG GTYGSVYHGKW+GSDVAI
Sbjct: 739 DSDNDNPNNFKIEQTKAEAEARSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAI 798
Query: 829 KRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888
KRIKASCFAGKPSERERLI DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV EFMV
Sbjct: 799 KRIKASCFAGKPSERERLIEDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMV 858
Query: 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
NGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+
Sbjct: 859 NGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPI 918
Query: 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008
CKIGDLGLSKVKQ+TLVSGGVRGTLPWMAPELLSGKS+MV+EKIDVYSFGIVMWELLTG+
Sbjct: 919 CKIGDLGLSKVKQKTLVSGGVRGTLPWMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGE 978
Query: 1009 EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
EPYADMHCASIIGGIVNNTLRP+IP WCDPEW+ LMESCWAS+P ERPSF+EIS++LR+M
Sbjct: 979 EPYADMHCASIIGGIVNNTLRPKIPQWCDPEWKGLMESCWASEPTERPSFTEISQKLRTM 1038
Query: 1069 AAAINVK 1075
AAA+N+K
Sbjct: 1039 AAAMNLK 1045
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15242791|ref|NP_200569.1| octicosapeptide/Phox/Bem1p domain-containing protein kinase [Arabidopsis thaliana] gi|9758322|dbj|BAB08796.1| unnamed protein product [Arabidopsis thaliana] gi|332009542|gb|AED96925.1| octicosapeptide/Phox/Bem1p domain-containing protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1131 bits (2925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/1103 (57%), Positives = 753/1103 (68%), Gaps = 111/1103 (10%)
Query: 18 NDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGAVV 77
ND+ RVKFLCSFLG ILPRPQDGKLRYVGGETRIVS+ RD+ YEELMS+MRELY+GA V
Sbjct: 18 NDEPHRVKFLCSFLGSILPRPQDGKLRYVGGETRIVSVNRDIRYEELMSKMRELYDGAAV 77
Query: 78 LKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNHYVDG 137
LKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRIFLFS +QDGS HYV+
Sbjct: 78 LKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRIFLFSTPEQDGSLHYVER 137
Query: 138 DD-RESERRYVDALNNMNDGNDFRKLQ-HPDSPVISSIDDIHMAERFFNTMSLEGGIHNQ 195
DD RESERRYVDALNN+ +G DFRKLQ +PDSP + +DD M E N +S+E G +Q
Sbjct: 138 DDQRESERRYVDALNNLIEGTDFRKLQQYPDSPRFNLVDDFSMVEPMLNQLSIETGGGSQ 197
Query: 196 -------PQY-NLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRPL 247
QY NLHQL +P + SGQ ++QRY E+EG WSP +YSPRH+GHHDP R
Sbjct: 198 RGNEIPTAQYSNLHQLRIPRVGSGQM---LAQRYGEVEGTWSP-FYSPRHHGHHDP-RTF 252
Query: 248 PEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGNV 301
EFPSSPSSAR+RMP+GE +R+PEEY R +HHP YE Q ++++W+P G +
Sbjct: 253 QEFPSSPSSARYRMPYGEIPDKGLDRMPEEYVRPQASHHPFYEHQAHIPDSVVWVPAGAM 312
Query: 302 SGD-KSGFPGNLFHGHNVFDGNGL-CEHCRLTYHRNQLHLDQPNIGN-GLPQVPLSCAEC 358
+ K GFPGN+ HG G CE+CR+ YHRN L+Q NIGN G P P+ CA C
Sbjct: 313 PPESKGGFPGNVLHGGPGGYEGGNGCENCRVPYHRNHQLLEQSNIGNNGFP--PVHCAHC 370
Query: 359 RQNRENLVLNAEAKLP--GMYPKDNDSRSVYNESHCHERGWVLQHQLNP---RIEEARTH 413
NRE+ +LN + K G YP NE+ +RGW++Q Q+NP RIEE R+H
Sbjct: 371 PPNRESFLLNTDPKPTHHGAYP---------NETFGPDRGWMVQQQVNPNPPRIEEGRSH 421
Query: 414 MSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHD-PAAAVV 472
+S GR NDHY D P N P G R G E+ NE FHD P +
Sbjct: 422 ISNVGRPNDHYTPDYPVSNYPLGQ----------------RAGHEISNEGFHDKPLGGIP 465
Query: 473 PHLHTPSAEERVVRYGN--FPYGADTIYPV--SHGHATAQNLWRNVQNPIHVTPLEASGP 528
+ SAEER YGN +P G D+I+ SH H N+W+NV NPI P P
Sbjct: 466 LNSANRSAEERGFHYGNNLYPPGPDSIHSAGHSHMHHPQPNIWQNVSNPIAGPP---GLP 522
Query: 529 V-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT--PPEYYYSQTQK 585
+ ING++ +R +E PR + G+++ + QR+ GF G ++ P Y Q
Sbjct: 523 MQINGTVNQTVIRNPIETAPRYSTGMENQGVLVGSPQRISGFDGMSSLGQPSYPNPHLQD 582
Query: 586 M------------NPQSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSE 633
NP +N+ Q+ +P+ L+Q L ++ ++ + S+
Sbjct: 583 RAFPLDPNWVPSENPTVHNEHLQVREPLP-----GPLLQTNLTAAPIMQTPVMQTSVESK 637
Query: 634 AVRTDENCNLGQEKAANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPG 693
+ E N +N V ++ P+ G + GN+
Sbjct: 638 LAQGGEQFNYVNTGISNGVPYQDK-------------PQPLAGGKKDM-----GNLV--- 676
Query: 694 EKSPSDRP-EDSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEA 752
E +PS E ++L LS LPEL+ SVKRAALEGA EVKA EE+ D V+P+
Sbjct: 677 EVNPSAATLEGAELSVERLSFLPELMESVKRAALEGAAEVKAHPEEAKDQVRPELV---- 732
Query: 753 PANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGT 812
NE+E +N E E+D D+D KIE T AEAEA +RGLQ+I+NDDLEE+RELG GT
Sbjct: 733 -ENESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEAEAKSRGLQSIRNDDLEEIRELGHGT 791
Query: 813 YGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872
YGSVYHGKW+GSDVAIKRIKASCFAGKPSERERLI DFWKEALLLSSLHHPNVVSFYGIV
Sbjct: 792 YGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLIEDFWKEALLLSSLHHPNVVSFYGIV 851
Query: 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932
RDGPDGSLATV EFMVNGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFDL
Sbjct: 852 RDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDL 911
Query: 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKI 992
KCENLLVNMRDPQRP+CKIGDLGLSKVKQ+TLVSGGVRGTLPWMAPELLSGKS+MV+EKI
Sbjct: 912 KCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSGGVRGTLPWMAPELLSGKSNMVSEKI 971
Query: 993 DVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDP 1052
DVYSFGIVMWELLTG+EPYADMHCASIIGGIVNN LRP+IP WCDPEW+ LMESCW S+P
Sbjct: 972 DVYSFGIVMWELLTGEEPYADMHCASIIGGIVNNALRPKIPQWCDPEWKGLMESCWTSEP 1031
Query: 1053 AERPSFSEISRRLRSMAAAINVK 1075
ERPSF+EIS++LR+MAAA+N+K
Sbjct: 1032 TERPSFTEISQKLRTMAAAMNLK 1054
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1075 | ||||||
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.560 | 0.572 | 0.550 | 1.1e-165 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.259 | 0.223 | 0.741 | 3.7e-159 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.309 | 0.290 | 0.635 | 7.7e-158 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.311 | 0.266 | 0.633 | 4.2e-155 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.262 | 0.240 | 0.712 | 3.4e-151 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.263 | 0.253 | 0.727 | 2.2e-147 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.383 | 0.395 | 0.541 | 1.7e-145 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.237 | 0.333 | 0.420 | 9.2e-48 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.237 | 0.467 | 0.368 | 1.8e-46 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.237 | 0.329 | 0.437 | 1.2e-45 |
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1612 (572.5 bits), Expect = 1.1e-165, P = 1.1e-165
Identities = 346/628 (55%), Positives = 411/628 (65%)
Query: 454 RTGPEMGNELFHDPAAAVVP-HLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNL 510
R G E+ NE FHD +P + SAEER YGN +P G D+I+ H H +
Sbjct: 446 RAGHEISNEGFHDKPLGGIPLNSANRSAEERGFHYGNNLYPPGPDSIHSAGHSHM--HHP 503
Query: 511 WRNV-QNPIHVTPLEASGPV-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPG 568
N+ QN + P+ ING++ +R +E PR + G+++ + QR+ G
Sbjct: 504 QPNIWQNVSNPIAGPPGLPMQINGTVNQTVIRNPIETAPRYSTGMENQGVLVGSPQRISG 563
Query: 569 FKGTATPPEYYYSQTQKMNPQSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRV 628
F G ++ + Y + N +P + V++ L NL
Sbjct: 564 FDGMSSLGQPSYPNPHLQDRAFPLDPNWVPSENPTVHNEHLQVREPLPGPLLQTNLTAAP 623
Query: 629 NNVSEAVRTDENCNLGQEKAANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGN 688
+ ++T L Q + V T + Q+ P+ G + GN
Sbjct: 624 IMQTPVMQTSVESKLAQGGEQFNYVN---TGISNGVPYQDK-PQPLAGGKKDM-----GN 674
Query: 689 IEKPGEKSPSDRP-EDSKLLAHNLSILPELIASVKRXXXXXXXXXXXXXXXSDDSVKPDT 747
+ E +PS E ++L LS LPEL+ SVKR + D V+P
Sbjct: 675 LV---EVNPSAATLEGAELSVERLSFLPELMESVKRAALEGAAEVKAHPEEAKDQVRP-- 729
Query: 748 TTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTXXXXXXXXRGLQTIKNDDLEEVRE 807
E NE+E +N E E+D D+D KIE T RGLQ+I+NDDLEE+RE
Sbjct: 730 ---ELVENESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEAEAKSRGLQSIRNDDLEEIRE 786
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
LG GTYGSVYHGKW+GSDVAIKRIKASCFAGKPSERERLI DFWKEALLLSSLHHPNVVS
Sbjct: 787 LGHGTYGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLIEDFWKEALLLSSLHHPNVVS 846
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI 927
FYGIVRDGPDGSLATV EFMVNGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNI
Sbjct: 847 FYGIVRDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNI 906
Query: 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHM 987
VHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ+TLVSGGVRGTLPWMAPELLSGKS+M
Sbjct: 907 VHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSGGVRGTLPWMAPELLSGKSNM 966
Query: 988 VTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESC 1047
V+EKIDVYSFGIVMWELLTG+EPYADMHCASIIGGIVNN LRP+IP WCDPEW+ LMESC
Sbjct: 967 VSEKIDVYSFGIVMWELLTGEEPYADMHCASIIGGIVNNALRPKIPQWCDPEWKGLMESC 1026
Query: 1048 WASDPAERPSFSEISRRLRSMAAAINVK 1075
W S+P ERPSF+EIS++LR+MAAA+N+K
Sbjct: 1027 WTSEPTERPSFTEISQKLRTMAAAMNLK 1054
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 3.7e-159, Sum P(4) = 3.7e-159
Identities = 207/279 (74%), Positives = 247/279 (88%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
GLQ IKN+DLEE+RELGSGT+G+VYHGKWRGSDVAIKRIK SCFAG+ SE+ERL +FW
Sbjct: 955 GLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWG 1014
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +LS LHHPNVV+FYG+V+DGP G+LATVTE+MV+GSL+ L +KDR +DRRKRLIIA
Sbjct: 1015 EAEILSKLHHPNVVAFYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIA 1074
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
MDAAFGMEYLH KN VHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLVSGGVRGT
Sbjct: 1075 MDAAFGMEYLHSKNTVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 1134
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
LPWMAPELL+G S V+EK+DV+SFGIV+WE+LTG+EPYA+MH +IIGGIVNNTLRP I
Sbjct: 1135 LPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTI 1194
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
P +CD EWR+LME CWA +P RPSF+EI+ RLR M++A
Sbjct: 1195 PGFCDDEWRTLMEECWAPNPMARPSFTEIAGRLRVMSSA 1233
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 7.7e-158, Sum P(3) = 7.7e-158
Identities = 213/335 (63%), Positives = 264/335 (78%)
Query: 739 SDDSVKPDTTTKEAPANEAELVNIH-GEIEMDYDNDTVKTLKIEPTX-XXXXXXXRGLQT 796
+++ V P E+ +A + N+ + E + + + + P GLQ
Sbjct: 798 TENRVDPQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNAGLPPVGPSLADYDTSGLQI 857
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I NDDLEE++ELGSGT+G+VYHGKWRGSDVAIKRIK SCFAG+ SE+ERL +FW EA +
Sbjct: 858 IMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEI 917
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS LHHPNVV+FYG+V+DGP +LATVTE+MV+GSL+ L +KDR +DRRKRLIIAMDAA
Sbjct: 918 LSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAA 977
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
FGMEYLH KNIVHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLVSGGVRGTLPWM
Sbjct: 978 FGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 1037
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APELL+G S V+EK+DV+SFGIV+WE+LTG+EPYA+MH +IIGGIVNNTLRP IPS+C
Sbjct: 1038 APELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPSYC 1097
Query: 1037 DPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
D +WR LME CWA +P RPSF+EI+ RLR M+ A
Sbjct: 1098 DSDWRILMEECWAPNPTARPSFTEIAGRLRVMSTA 1132
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 4.2e-155, Sum P(3) = 4.2e-155
Identities = 216/341 (63%), Positives = 270/341 (79%)
Query: 740 DDSVKPDTTTKEAP-ANEAELVNIHGEIEMDYDNDTVKTLKIE-PTXXXXXXXX--RGLQ 795
D ++KPD +T P N + + + ++ T TL P R LQ
Sbjct: 908 DGNIKPDVSTITIPDLNTVDTQEDYSQSQIKGAESTDATLNAGVPLIDFMAADSGMRSLQ 967
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
IKNDDLEE++ELGSGT+G+VYHGKWRG+DVAIKRIK SCF G+ SE+ERL ++FW EA
Sbjct: 968 VIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQERLTSEFWHEAE 1027
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+LS LHHPNV++FYG+V+DGP G+LATVTE+MVNGSL+ L +R +DRRKRLIIAMDA
Sbjct: 1028 ILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLLS-NRHLDRRKRLIIAMDA 1086
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
AFGMEYLH K+IVHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLV+GGVRGTLPW
Sbjct: 1087 AFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1146
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
MAPELLSG S V+EK+DV+SFGIV+WE+LTG+EPYA+MH +IIGGIVNNTLRP +P++
Sbjct: 1147 MAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTVPNY 1206
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA-AINVK 1075
CDPEWR LME CWA DP RP+F EI+RRLR+M++ A++ K
Sbjct: 1207 CDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSSAVHTK 1247
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 3.4e-151, Sum P(3) = 3.4e-151
Identities = 201/282 (71%), Positives = 240/282 (85%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
LQ IK+ DLEE+RELGSGT+G+VYHGKWRG+DVAIKRI CFAGKPSE+ER+I DFW E
Sbjct: 880 LQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERMIDDFWNE 939
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
A L+ LHHPNVV+FYG+V D P GS+ATVTE+MVNGSL+ LQK R DR KR +IAM
Sbjct: 940 AQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRCKRQLIAM 999
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
D AFGMEYLHGK IVHFDLK +NLLVN+RDP RP+CK+GDLGLSKVK QTL+SGGVRGTL
Sbjct: 1000 DIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLISGGVRGTL 1059
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
PWMAPELL+G S +V+EK+DV+SFGIV+WEL TG+EPYAD+H +IIGGIV+NTLRPQIP
Sbjct: 1060 PWMAPELLNGTSSLVSEKVDVFSFGIVLWELFTGEEPYADLHYGAIIGGIVSNTLRPQIP 1119
Query: 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
+CD +W+ LME CW+++P+ERPSF+EI LR+MA + K
Sbjct: 1120 DFCDMDWKLLMERCWSAEPSERPSFTEIVNELRTMATKLPSK 1161
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 2.2e-147, Sum P(4) = 2.2e-147
Identities = 206/283 (72%), Positives = 243/283 (85%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
GLQ IKN DLE++ ELGSGTYG+VYHG WRG+DVAIKRI+ SCFAG+ SE+ERL DFW+
Sbjct: 827 GLQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWR 886
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +LS+LHHPNVV+FYGIV DG G+LATVTEFMVNGSL+ L KKDR +D RK++IIA
Sbjct: 887 EAQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIA 946
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
MDAAFGMEYLH KNIVHFDLKCENLLVN+RDPQRP+CK+GDLGLS++K+ TLVSGGVRGT
Sbjct: 947 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGT 1006
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
LPWMAPELL+G S V+EK+DV+S+GI +WE+LTG+EPYADMHC +IIGGIV NTLRP I
Sbjct: 1007 LPWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPI 1066
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
P C PEW+ LME CW+ DP RP F+EI+ RLRSM+ + K
Sbjct: 1067 PKSCSPEWKKLMEQCWSVDPDSRPPFTEITCRLRSMSMEVVTK 1109
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1137 (405.3 bits), Expect = 1.7e-145, Sum P(3) = 1.7e-145
Identities = 228/421 (54%), Positives = 289/421 (68%)
Query: 657 ETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPE 716
ET+ S ++++ E+ I + L +V SD SKLL L I+ +
Sbjct: 626 ETNSDDSDTQKSLPREESIHYSGLPLRKVGSRETTFMHTQGSDDFFKSKLLGPQL-IVED 684
Query: 717 LIASVKRXXXXXXXXXXXXXXXSDDSVKPDTTTKEAPANEAELVNIHGEIEMDY--DNDT 774
+ V SDD K T KE + E E+E Y +T
Sbjct: 685 VTNEVISDNLLSATIVPQVNRESDDDHKSYTREKEITNADHE-----SEMEEKYKKSRNT 739
Query: 775 VKTLKIEPTXXXXXXXXRGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKAS 834
+ E GLQ IKN DLE++ ELGSGT+G+VY+GKWRG+DVAIKRIK S
Sbjct: 740 DDSFS-EAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNS 798
Query: 835 CFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ 894
CF+G SE+ R DFW+EA +L++LHHPNVV+FYG+V DGP G++ATVTE+MVNGSL+
Sbjct: 799 CFSGGSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRH 858
Query: 895 FLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
LQ+KDR +DRRK+L+I +D+AFGMEYLH KNIVHFDLKC+NLLVN+RDPQRP+CK+GD
Sbjct: 859 VLQRKDRLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 918
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM 1014
GLS++K+ TLVSGGVRGTLPWMAPELL+G S+ V+EK+DV+SFGIVMWE+LTG+EPYA++
Sbjct: 919 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYANL 978
Query: 1015 HCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074
HC +IIGGIVNNTLRP +P C+ EWR LME CW+ DP RPSF+EI RLRSM A+
Sbjct: 979 HCGAIIGGIVNNTLRPPVPERCEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQP 1038
Query: 1075 K 1075
K
Sbjct: 1039 K 1039
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 9.2e-48, Sum P(2) = 9.2e-48
Identities = 114/271 (42%), Positives = 161/271 (59%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+DL ++G G+ G+VYHG W GSDVA+K F+ K E +I F +E L+
Sbjct: 485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVK-----VFS-KQEYSEEIITSFKQEVSLMKR 538
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNV+ F G V P L VTEF+ GSL + LQ+ +D R+R+ +A D A GM
Sbjct: 539 LRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGM 596
Query: 920 EYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
YLH I+H DLK NLLV+ + K+ D GLS++K +T ++ RGT WMA
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVD----RNWTVKVADFGLSRIKHETYLTTNGRGTPQWMA 652
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE+L ++ EK DVYSFG+V+WEL+T P+ +++ +IG + R ++P D
Sbjct: 653 PEVL--RNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVD 710
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P+W +LMESCW S+P RPSF E+ +LR +
Sbjct: 711 PQWIALMESCWHSEPQCRPSFQELMDKLREL 741
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 1.8e-46, Sum P(3) = 1.8e-46
Identities = 99/269 (36%), Positives = 149/269 (55%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+++ SG+YG ++ G + +VAIK +K ++ +F +E ++ + H NV
Sbjct: 290 KKVASGSYGDLHRGTYCSQEVAIKFLKPD------RVNNEMLREFSQEVFIMRKVRHKNV 343
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V F G P +L VTEFM GS+ FL K+ + L +A+D A GM YLH
Sbjct: 344 VQFLGACTRSP--TLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQN 401
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
NI+H DLK NLL++ + + K+ D G+++V+ ++ V GT WMAPE++ K
Sbjct: 402 NIIHRDLKTANLLMD----EHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKP 457
Query: 986 HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLME 1045
+ K DV+S+ IV+WELLTGD PYA + G+V LRP+IP P+ + L+E
Sbjct: 458 Y--NHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLE 515
Query: 1046 SCWASDPAERPSFSEISRRLRSMAAAINV 1074
CW DP +RP F EI L+ + +NV
Sbjct: 516 RCWHQDPEQRPLFEEIIEMLQQIMKEVNV 544
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 1.2e-45, P = 1.2e-45
Identities = 119/272 (43%), Positives = 159/272 (58%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
DDL ++G G+ G+VYHG W GSDVA+K F+ + E +I F +E LL+
Sbjct: 492 DDLTIGEQVGQGSCGTVYHGLWFGSDVAVK-----VFSKQEYSAE-VIESFKQEVLLMKR 545
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNV+ F G V P L V+EF+ GSL + LQK +D R+R+ +A+D A GM
Sbjct: 546 LRHPNVLLFMGAVTS-PQ-RLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIHMALDIARGM 603
Query: 920 EYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-LVSGGVRGTLPWM 976
YLH I+H DLK NLLV D V K+ D GLS++K +T L S +GT WM
Sbjct: 604 NYLHHCSPPIIHRDLKSSNLLV---DKNWTV-KVADFGLSRIKHETYLTSKSGKGTPQWM 659
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L +S EK D+YSFG+V+WEL T P+ ++ +IG + R +IP
Sbjct: 660 APEVLRNES--ADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDI 717
Query: 1037 DPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
DP W SLMESCW SD RP+F E+ +LR +
Sbjct: 718 DPRWISLMESCWHSDTKLRPTFQELMDKLRDL 749
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031430001 | SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (1063 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1075 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-78 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-78 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-77 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-71 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-51 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-49 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-47 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 1e-46 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-45 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-43 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-42 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-42 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-41 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-41 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-40 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-40 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-39 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-39 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-39 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-38 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-37 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-37 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-37 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-36 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-35 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-35 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-35 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-35 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-35 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-34 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-34 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-33 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-33 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-32 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-32 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-32 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-32 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-31 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-31 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-30 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-30 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-30 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-30 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-30 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-28 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-28 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-28 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-28 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-27 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-26 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-23 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-22 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-21 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-21 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-21 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 7e-21 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 5e-20 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-19 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-18 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-16 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 257 bits (660), Expect = 1e-78
Identities = 99/274 (36%), Positives = 135/274 (49%), Gaps = 26/274 (9%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
LE ++LG G +G VY G +G VA+K +K E +F +EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-------SEEEREEFLEEAS 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HPN+V G+ G L VTE+M G L FL+K + + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
A GMEYL KN VH DL N LV + V KI D GLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
+ WMAPE L K T K DV+SFG+++WE+ T G++PY M ++ + + R
Sbjct: 168 IKWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-YRLP 224
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P C E LM CWA DP +RP+FSE+ L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 255 bits (655), Expect = 6e-78
Identities = 98/273 (35%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L ++LG G +G VY GK +G +VA+K +K E+ I +F +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-------EQQIEEFLREAR 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HPNVV G+ + + L V E+M G L +L+K + L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
A GMEYL KN +H DL N LV + V KI D GLS+ G + +
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032
WMAPE L K T K DV+SFG+++WE+ T G++PY M ++ + N R
Sbjct: 168 RWMAPESL--KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQ 224
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P C PE LM CWA DP +RP+FSE+ L
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 3e-77
Identities = 97/274 (35%), Positives = 136/274 (49%), Gaps = 26/274 (9%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L ++LG G +G VY G +G +VA+K +K E+ I +F +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS-------EQQIEEFLREAR 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
++ L HPN+V G+ + + L V E+M G L +L+K + + + L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GMEYL KN +H DL N LV V KI D GLS+ G +
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
+ WMAPE L K T K DV+SFG+++WE+ T G+EPY M A ++ + R
Sbjct: 168 IRWMAPESL--KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLP 224
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P C PE LM CWA DP +RP+FSE+ L
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-71
Identities = 102/278 (36%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 806 RELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++LG G +G VY GK +G +VA+K +K SE ER DF KEA ++ L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEER--KDFLKEARVMKKL 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIA 912
HPNVV G+ + + L V E+M G L +L+K T+ + L A
Sbjct: 54 GHPNVVRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRG 971
+ A GMEYL K VH DL N LV + V KI D GLS+ G
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 972 TLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
LP WMAPE L K + T K DV+SFG+++WE+ T G PY + ++ +
Sbjct: 168 KLPIRWMAPESL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YLRKGY 224
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
R P +C E LM SCW DP +RP+FSE+ RL
Sbjct: 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 1e-60
Identities = 78/263 (29%), Positives = 123/263 (46%), Gaps = 20/263 (7%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E + +LG G++G VY + + + VAIK IK + ++ +E +L L
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIK-------KKKIKKDRERILREIKILKKL 54
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN+V Y + D + L V E+ G L L+K+ R + R + +E
Sbjct: 55 KHPNIVRLYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALE 111
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
YLH K IVH DLK EN+L++ + K+ D GL++ GT +MAPE+
Sbjct: 112 YLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPY-ADMHCASIIGGIVNNTLRPQIPSW-CDP 1038
L GK + + +D++S G++++ELLTG P+ D + I P W P
Sbjct: 168 LLGKGY--GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 1039 EWRSLMESCWASDPAERPSFSEI 1061
E + L+ DP +R + E
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 2e-58
Identities = 78/257 (30%), Positives = 122/257 (47%), Gaps = 49/257 (19%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G+VY + + + VAIK IK + L+ + +E +L L+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-------KEDSSSLLEELLREIEILKKLNHPNI 53
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V YG+ D L V E+ GSLK L++ + + + L I + G+EYLH
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPELLSGK 984
I+H DLK EN+L++ + + K+ D GLSK + + + GT +MAPE+L GK
Sbjct: 112 GIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 985 SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLM 1044
+ +EK D++S G++++EL PE + L+
Sbjct: 169 GY-YSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 1045 ESCWASDPAERPSFSEI 1061
DP +RPS EI
Sbjct: 195 RKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 88/268 (32%), Positives = 137/268 (51%), Gaps = 22/268 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E +R+LGSG++G+VY K +G+ VA+K +K K SE+ + +E +L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK------KRSEKSKKDQTARREIRILRR 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPN+V D L V E+ G L +L + + + IA+ G+
Sbjct: 55 LSHPNIVRLIDAFED--KDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGL 111
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLPWMAP 978
EYLH I+H DLK EN+L++ + V KI D GL+K ++ S GT +MAP
Sbjct: 112 EYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---IIGGIVNNTLRPQIPSW 1035
E+L G + K+DV+S G++++ELLTG P++ + +I I+ L P W
Sbjct: 168 EVLLGGN-GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 1036 CD--PEWRSLMESCWASDPAERPSFSEI 1061
E + L++ C DP++RP+ EI
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 5e-51
Identities = 82/266 (30%), Positives = 128/266 (48%), Gaps = 27/266 (10%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++GSVY K G +A+K ++ S + + E +E +LSSL H
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE------REIRILSSLQH 58
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----TIDRRKRLIIAMDAAFG 918
PN+V +YG RD +L E++ GSL L+K + I + R I+ G
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG---VRGTLPW 975
+ YLH IVH D+K N+LV+ V K+ D G +K G VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-CASIIGGIVNNTLRPQIPS 1034
MAPE++ G+ + D++S G + E+ TG P++++ + + I ++ P+IP
Sbjct: 170 MAPEVIRGEEY--GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSE 1060
E + + C DP +RP+ E
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 95/273 (34%), Positives = 140/273 (51%), Gaps = 26/273 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + +L+ +G G +G V G +RG VA+K +K + F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---------DDSTAAQAFLAEASV 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDA 915
+++L HPN+V G+V G L VTE+M GSL +L+ + R I ++L A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQG--NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP- 974
GMEYL KN VH DL N+LV+ V K+ D GL+K Q S G LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLPV 163
Query: 975 -WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032
W APE L + + K DV+SFGI++WE+ + G PY + ++ + R +
Sbjct: 164 KWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEA 220
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P C PE +M+ CW DPA+RP+F ++ +L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 95/274 (34%), Positives = 140/274 (51%), Gaps = 27/274 (9%)
Query: 805 VRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ +G G +G V G+ + DVAIK +KA S+++RL DF EA ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQ 61
Query: 860 LHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
HPN++ G+V + P + +TE+M NGSL +FL++ D + + + A G
Sbjct: 62 FDHPNIIRLEGVVTKSRP---VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTLPW 975
M+YL N VH DL N+LVN VCK+ D GLS+ + T + G + + W
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034
APE ++ + T DV+SFGIVMWE+++ G+ PY DM +I + + R P
Sbjct: 175 TAPEAIAYRKF--TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPM 231
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
C LM CW D ERP+FS+I L M
Sbjct: 232 DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 62/99 (62%), Positives = 79/99 (79%), Gaps = 4/99 (4%)
Query: 27 LCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPD 84
LCS+ GRILPRP DG+LRYVGGETRIVS+ R ++++EL+S++ EL+ V LKYQ PD
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 85 EDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123
EDLDAL+SV ND+D+ NMMEEY++L G RLR+FLF
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRL--SGGSARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 88/270 (32%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+L ++ELGSG +G V+ GKWRG DVAIK I+ G SE DF +EA ++
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSED-----DFIEEAKVMMK 55
Query: 860 LHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L HPN+V YG+ + P + VTE+M NG L +L+++ + L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWM 976
MEYL +H DL N LV + V K+ D GL++ + Q S G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
PE+ + K DV+SFG++MWE+ + G PY + ++ + + P
Sbjct: 169 PPEVFDYSRF--SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKL 225
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEISRRL 1065
E ++M SCW P +RP+F ++ +L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 89/276 (32%), Positives = 135/276 (48%), Gaps = 27/276 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ R+LG+G +G V+ G W G+ VA+K +K + F +EA
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQ 53
Query: 856 LLSSLHHPNVVSFYGIVRDG-PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
++ L H +V Y + + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRG 971
A GM YL +N +H DL N+LV + VCKI D GL+++ + + G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 972 TLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029
+ W APE G+ T K DV+SFGI++ E++T G PY M ++ +
Sbjct: 167 PIKWTAPEAANYGR---FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM 223
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P+ P C E LM CW DP ERP+F + L
Sbjct: 224 PR-PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-42
Identities = 85/275 (30%), Positives = 134/275 (48%), Gaps = 25/275 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I ++ +R+LG+G +G V+ G W + VA+K +K K DF EA
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---------DFLAEAQ 53
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
++ L HP ++ Y + + P + VTE M GSL ++LQ + +LI +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A GM YL +N +H DL N+LV + +CK+ D GL++V ++ +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGAKF 166
Query: 974 P--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
P W APE + + + K DV+SFGI++ E++T G PY M A ++ + P
Sbjct: 167 PIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP 224
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P C E +M CW DP +RP+F + +L
Sbjct: 225 C-PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 89/291 (30%), Positives = 137/291 (47%), Gaps = 36/291 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIAD 849
+ + + +RELG G++G VY G +G + VAIK + + S RER+ +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-----ASMRERI--E 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRT---- 902
F EA ++ + +VV G+V G V E M G LK +L+ +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 903 --IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+K + +A + A GM YL K VH DL N +V KIGD G+++ +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTRDI 169
Query: 960 KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016
+ G +G LP WMAPE L K + T K DV+SFG+V+WE+ T ++PY +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
++ +++ P C + LM CW +P RP+F EI L+
Sbjct: 228 EEVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 6e-42
Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
E + ++G G +G VY + + G +VAIK IK ++E++I E +L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
HPN+V +YG L V EF GSLK L+ ++T+ + + + G
Sbjct: 53 KCKHPNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+EYLH I+H D+K N+L+ K+ D GLS T + GT WMAP
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---TLRPQIPSW 1035
E+++GK + K D++S GI EL G PY+++ + I N LR P
Sbjct: 167 EVINGKPY--DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR--NPEK 222
Query: 1036 CDPEWRSLMESCWASDPAERPS 1057
E++ ++ C +P +RP+
Sbjct: 223 WSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 88/272 (32%), Positives = 127/272 (46%), Gaps = 30/272 (11%)
Query: 806 RELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ELG G +GSV G + G +VA+K +K A E F +EA +++ L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE-------FLREASVMAQL 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HP +V G+ + G L V E G L ++L+K R I +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GE--PLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMA 109
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPW 975
YL K+ VH DL N+L+ R KI D G+S+ + G R L W
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRH----QAKISDFGMSRALGAGSDYYRATTAG-RWPLKW 164
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034
APE + K DV+S+G+ +WE + G +PY +M A +I ++ + R P
Sbjct: 165 YAPE--CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA-MLESGERLPRPE 221
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
C E S+M SCW P +RP+FSE+ R
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-41
Identities = 101/278 (36%), Positives = 143/278 (51%), Gaps = 43/278 (15%)
Query: 806 RELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G +G VY G +G+ +VA+K +C + P + +R F +EA +L HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKR---KFLQEAEILKQYDHPN 53
Query: 865 VVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+V G+ V+ P + V E + GSL FL+KK + +K L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLP--WMAPE 979
KN +H DL N LV + V KI D G+S+ ++ + VS G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 980 LLS-GKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI----- 1032
L+ G+ T + DV+S+GI++WE + GD PY M N R +I
Sbjct: 166 ALNYGR---YTSESDVWSYGILLWETFSLGDTPYPGMS---------NQQTRERIESGYR 213
Query: 1033 ---PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
P C E LM CWA DP RPSFSEI L+
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 26/269 (9%)
Query: 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG G YG VY G W+ VA+K +K E + +F KEA ++ + HPN
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 865 VVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYL 922
+V G+ R+ P +TEFM G+L +L++ +R ++ L +A + MEYL
Sbjct: 64 LVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPEL 980
KN +H DL N LV + + K+ D GLS++ + G + + W APE
Sbjct: 121 EKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039
L+ + + K DV++FG+++WE+ T G PY + + + ++ R + P C P+
Sbjct: 177 LA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMERPEGCPPK 233
Query: 1040 WRSLMESCWASDPAERPSFSEISRRLRSM 1068
LM +CW +P++RPSF+EI + +M
Sbjct: 234 VYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 8e-40
Identities = 94/304 (30%), Positives = 136/304 (44%), Gaps = 58/304 (19%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIA 848
++ D + RELG G +G V+ G+ VA+K +K + R+
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARK---- 53
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
DF +EA LL++ H N+V FYG+ +G V E+M +G L +FL+ K
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 909 -------------LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
L IA+ A GM YL ++ VH DL N LV V KIGD G
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG----YDLVVKIGDFG 167
Query: 956 LS---------KVKQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWE 1003
+S +V T+ LP WM PE ++ K T + DV+SFG+V+WE
Sbjct: 168 MSRDVYTTDYYRVGGHTM--------LPIRWMPPESIMYRK---FTTESDVWSFGVVLWE 216
Query: 1004 LLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062
+ T G +P+ + +I I L Q P C E +M CW DP +R + +I
Sbjct: 217 IFTYGKQPWYGLSNEEVIECITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
Query: 1063 RRLR 1066
RL+
Sbjct: 276 ERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 88/264 (33%), Positives = 131/264 (49%), Gaps = 21/264 (7%)
Query: 806 RELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
R+LGSG +G V+ G W+ VAIK +K S+ DF KE L L H +
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALKRLRHKH 63
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLH 923
++S + + G + +TE M GSL FL+ + + LI +A A GM YL
Sbjct: 64 LISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPELLS 982
+N +H DL N+LV + VCK+ D GL+++ K+ +S + W APE S
Sbjct: 122 EQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 983 GKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041
+ + K DV+SFGI+++E+ T G PY M+ + I P P+ C E
Sbjct: 178 HGTF--STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQEIY 234
Query: 1042 SLMESCWASDPAERPSFSEISRRL 1065
+M CWA++P +RPSF + L
Sbjct: 235 KIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 86/266 (32%), Positives = 133/266 (50%), Gaps = 27/266 (10%)
Query: 807 ELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+LG G++G V G+W S VA+K +K+ K S+ ++ DF KEA ++ SL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS----DKLSD---IMDDFLKEAAIMHSLD 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGME 920
H N++ YG+V P L VTE GSL L+K L A+ A GM
Sbjct: 55 HENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPWM 976
YL K +H DL N+L+ D KIGD GL + + ++ ++ W
Sbjct: 112 YLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
APE L ++ + DV+ FG+ +WE+ T G+EP+A + + I+ I R + P
Sbjct: 168 APESL--RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
C + ++M CWA +PA+RP+F+ +
Sbjct: 226 CPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 88/287 (30%), Positives = 139/287 (48%), Gaps = 27/287 (9%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLI 847
L+ +K +LE+++ LGSG +G+VY G W VAIK ++ + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
EA +++S+ HP+VV GI + +T+ M G L +++ I +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
L + A GM YL K +VH DL N+LV + PQ KI D GL+K V ++
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDEKEY 166
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023
+ G + + WMA E + + + T K DV+S+G+ +WEL+T G +PY + A I +
Sbjct: 167 HAEGGKVPIKWMALESILHRIY--THKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPDL 223
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070
+ R P C + ++ CW D RP+F E+ MA
Sbjct: 224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 90/279 (32%), Positives = 137/279 (49%), Gaps = 27/279 (9%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADF 850
I+ +D+ R +G G +G VY G + + VA+K K PS RE+ F
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREK----F 54
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+EA ++ HP++V G++ + P + V E G L+ +LQ ++D ++
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLIL 111
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVSGGV 969
+ + + YL K VH D+ N+LV+ P C K+GD GLS+ +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKAS 166
Query: 970 RGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
+G LP WMAPE S T DV+ FG+ MWE+L G +P+ + +IG I N
Sbjct: 167 KGKLPIKWMAPE--SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG 224
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
R +P C P SLM CWA DP++RP F+E+ +L
Sbjct: 225 E-RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 77/260 (29%), Positives = 122/260 (46%), Gaps = 31/260 (11%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G +G VY G G VAIK+I E + +E LL +L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE---KIKEEA---LKSIMQEIDLLKNLKHPN 60
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------G 918
+V + G + SL + E+ NGSL+Q ++K + L+ A + G
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQIIKKFGPF---PESLV----AVYVYQVLQG 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+ YLH + ++H D+K N+L V K+ D G++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++ + D++S G + ELLTG+ PY D++ + + IV + P +P
Sbjct: 168 PEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGIS 224
Query: 1038 PEWRSLMESCWASDPAERPS 1057
PE + + C+ DP RP+
Sbjct: 225 PELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 88/272 (32%), Positives = 135/272 (49%), Gaps = 28/272 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWRG DVAIK IK G SE E F +EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L H +V YG+ + P + VTE+M NG L +L++ + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
GM YL K +H DL N LV+ + K+ D GLS+ + + S G +
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN--TLR 1029
+ W PE+L + K DV++FG++MWE+ + G PY + + + + R
Sbjct: 165 VRWSPPEVLLYSKF--SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR 222
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P + S + ++M SCW ERP+F ++
Sbjct: 223 PHLAS---EKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-38
Identities = 89/274 (32%), Positives = 136/274 (49%), Gaps = 26/274 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ +L+ ++ +G G +G V G +RG+ VA+K IK A F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----------FLAEASV 52
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDA 915
++ L H N+V G++ + G L VTE+M GSL +L+ + R++ L+ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP- 974
MEYL N VH DL N+LV+ + V K+ D GL+K T +G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTG----KLPV 163
Query: 975 -WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032
W APE L K + K DV+SFGI++WE+ + G PY + ++ V +
Sbjct: 164 KWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDA 220
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
P C P +M+ CW D A RPSF ++ +L
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 84/278 (30%), Positives = 130/278 (46%), Gaps = 34/278 (12%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R +G G +G VYHG SD A+K + + ++ E + F KE +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEE-VEQFLKEGIIMKDF 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPNV+S GI +GS V +M +G L+ F++ + + + + A GME
Sbjct: 54 SHPNVLSLLGICLP-SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS---------KVKQQTLVSGGVRG 971
YL K VH DL N +++ + K+ D GL+ V T G +
Sbjct: 113 YLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHT----GAKL 164
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
+ WMA E L ++ T K DV+SFG+++WEL+T G PY D+ I ++
Sbjct: 165 PVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL 222
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
Q P +C +M SCW P RP+FSE+ R+ +
Sbjct: 223 Q-PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 91/276 (32%), Positives = 138/276 (50%), Gaps = 28/276 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L ++ELGSG +G V+ GKWR VAIK I G SE DF +EA
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEE-----DFIEEAK 51
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HP +V YG+ + P L VTEFM NG L +L+++ + + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
GMEYL + +H DL N LV+ V K+ D G+++ + + S G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIV--NNTLR 1029
+ W PE+ + + + K DV+SFG++MWE+ T G P+ ++ I R
Sbjct: 165 VKWSPPEVFNFSKY--SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P++ S E +M SCW P RP+F+E+ R +
Sbjct: 223 PKLASMTVYE---VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 23/269 (8%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E ++++G G++G VY + R SD +K I S ERE + E +L
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNM--SEKEREDAL----NEVKILKK 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLIIAMDAA 916
L+HPN++ +Y + G L V E+ G L Q ++ K+ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG-VRGTLPW 975
++YLH + I+H D+K +N+ + + K+GD G+SKV T+ V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
++PEL K + K D++S G V++EL T P+ + + I+ P IPS
Sbjct: 170 LSPELCQNKPY--NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQ 226
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064
E R+L+ S DP ERPS ++I +
Sbjct: 227 YSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 85/261 (32%), Positives = 134/261 (51%), Gaps = 26/261 (9%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G +G+V G++ G VA+K IK A F +E +++ LHH N+V
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----------FLEETAVMTKLHHKNLVR 63
Query: 868 FYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLHGK 925
G I+ +G L V E M G+L FL+ + R + +L+ ++D A GMEYL K
Sbjct: 64 LLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
+VH DL N+LV+ + V K+ D GL++V + + + + W APE L K
Sbjct: 120 KLVHRDLAARNILVS----EDGVAKVSDFGLARVGSMGVDNS--KLPVKWTAPEAL--KH 171
Query: 986 HMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLM 1044
+ K DV+S+G+++WE+ + G PY M + V R + P C + LM
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-KECVEKGYRMEPPEGCPADVYVLM 230
Query: 1045 ESCWASDPAERPSFSEISRRL 1065
SCW ++P +RPSF ++ +L
Sbjct: 231 TSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 82/290 (28%), Positives = 137/290 (47%), Gaps = 37/290 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L+ +++LG G +G V ++ G VA+K + S E+ +DF +E
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------EEQHRSDFERE 56
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L +L H N+V + G+ SL + E++ +GSL+ +LQ+ I+ ++ L+ +
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--G 971
GM+YL + +H DL N+LV + + V KI D GL+KV + V+ G
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVLPEDKDYYYVKEPG 172
Query: 972 TLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN--- 1025
P W APE L + + DV+SFG+ ++EL T GD + + GI
Sbjct: 173 ESPIFWYAPECLR--TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230
Query: 1026 ------NTLRPQI----PSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
L+ P C E LM+ CW ++P +RPSF+++ +
Sbjct: 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 87/273 (31%), Positives = 134/273 (49%), Gaps = 22/273 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ G SE DF +EA
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEE-----DFIEEAQ 51
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HP +V YG+ + + V EFM +G L +L+ + + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTL 973
GM YL N++H DL N LV + V K+ D G+++ + Q S G + +
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV 165
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032
W +PE+ S + + K DV+SFG++MWE+ + G PY + + ++ I N R
Sbjct: 166 KWSSPEVFSFSKY--SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYK 222
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P LM+ CW P +RPSFS + +L
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-37
Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
L+E+ LG G +G V+ K +G + A + ++ E L ++F +E + L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK--------RLIIAM 913
H NVV G+ R+ + + E+ G LKQFL+ ++ K ++ +
Sbjct: 67 HKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK--------QQTLV 965
A GM++L VH DL N LV+ QR V K+ L LSK + L+
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVS---SQREV-KVSLLSLSKDVYNSEYYKLRNALI 180
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIV 1024
L W+APE + + + K DV+SFG++MWE+ T G+ P+ + ++ +
Sbjct: 181 P------LRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
L +P C LM CWA +P +RPSFSE+
Sbjct: 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 94/280 (33%), Positives = 138/280 (49%), Gaps = 32/280 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+EEV +G+G +G V G+ R VAIK +K+ +E++R DF EA +
Sbjct: 8 IEEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-----TEKQR--RDFLSEASI 58
Query: 857 LSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+ HPN++ G+V + P + +TEFM NG+L FL++ D + + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRP---VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI 115
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGVRG 971
A GM+YL N VH DL N+LVN VCK+ D GLS+ + + + G
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 972 TLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
+P W APE ++ + T DV+S+GIVMWE+++ G+ PY DM +I I +
Sbjct: 172 KIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR 229
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P P C LM CW D RP F +I L M
Sbjct: 230 LPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 31/269 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ + ++G G G VY R G +VAIK+++ + + LI E L++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN+V +Y L V E+M GSL + + ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG----LSKVKQQ--TLVSGGVRGTL 973
EYLH +N++H D+K +N+L++ K+ D G L+K K + ++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQI 1032
WMAPE++ K + K+D++S GI+ E+ G+ PY + I +
Sbjct: 181 YWMAPEVIKRKDY--GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKN 238
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P PE++ + C DP +RPS E+
Sbjct: 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 88/264 (33%), Positives = 131/264 (49%), Gaps = 26/264 (9%)
Query: 808 LGSGTYGSVYHG--KWRG---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+G+G +G V+ G K G VAIK +K +E++R DF EA ++ H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-----TEKQR--QDFLSEASIMGQFSH 65
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
N++ G+V + +TE+M NG+L ++L+ D + + + A GM+YL
Sbjct: 66 HNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPWMAP 978
N VH DL N+LVN CK+ D GLS+V + T + G + + W AP
Sbjct: 124 SDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
E ++ + T DV+SFGIVMWE+++ G+ PY DM ++ I N+ R P C
Sbjct: 180 EAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCP 236
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
LM CW D A RP F +I
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDI 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 99/301 (32%), Positives = 142/301 (47%), Gaps = 58/301 (19%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ + ELG G +G VY G+ G + VAIK +K + +P ++ +F +E
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQ----EFRQE 58
Query: 854 ALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFL-----------QKKDR 901
A L+S L HPN+V G+ ++ P + E++ +G L +FL + D
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 902 TI----DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
T+ D L IA+ A GMEYL + VH DL N LV V KI D GLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGLS 171
Query: 958 K-------VKQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT- 1006
+ + Q+ + LP WM PE +L GK T + D++SFG+V+WE+ +
Sbjct: 172 RDIYSADYYRVQS------KSLLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEIFSY 222
Query: 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
G +PY +I I + L P P C +LM CW PA RP F +I RLR
Sbjct: 223 GLQPYYGFSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
Query: 1067 S 1067
S
Sbjct: 282 S 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 89/268 (33%), Positives = 133/268 (49%), Gaps = 26/268 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V++LG+G +G V+ G + G + VAIK +K + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEAN 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L+ L HP +V Y +V P + +TE+M NGSL FL K I +I M A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAA 109
Query: 916 --AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--LVSGGVRG 971
A GM ++ KN +H DL+ N+LV+ + CKI D GL+++ + G +
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKF 165
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
+ W APE ++ + T K DV+SFGI++ E++T G PY M +I + P
Sbjct: 166 PIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSF 1058
+ P C E LM CW P ERP+F
Sbjct: 224 R-PDNCPEELYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 100/293 (34%), Positives = 144/293 (49%), Gaps = 47/293 (16%)
Query: 802 LEEVRELGSGTYGSV----YH--GKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+ +++LG G +GSV Y G VA+K+++ S E L DF +E
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-------HSTAEHL-RDFEREIE 57
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L SL H N+V + G+ +L V E++ GSL+ +LQK +D RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTL 973
GMEYL K VH DL N+LV KIGD GL+KV Q VR G
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 974 P--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA------SIIGG--- 1022
P W APE L+ V DV+SFG+V++EL T Y+D C+ ++G
Sbjct: 174 PIFWYAPESLTESKFSVAS--DVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQ 227
Query: 1023 ----------IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
++ N R P C E ++M+ CW +DP++RPSFSE++ ++
Sbjct: 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 78/260 (30%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
LGSG++GSVY G D +K A + + +E LLS L HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLH 923
+ G R+ +L E + GSL + L+K + I R I+ G+EYLH
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELL 981
+N VH D+K N+LV D V K+ D G++K V+ S +G+ WMAPE++
Sbjct: 120 DRNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041
+ + D++S G + E+ TG P++ + + + I + P IP E +
Sbjct: 174 A-QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK 232
Query: 1042 SLMESCWASDPAERPSFSEI 1061
+ C DP+ RP+ +E+
Sbjct: 233 DFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 91/267 (34%), Positives = 132/267 (49%), Gaps = 28/267 (10%)
Query: 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G+G +G V G+ R VAIK +KA +E++R DF EA ++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-----TEKQR--RDFLSEASIMGQF 62
Query: 861 HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN++ G+V + P + VTE+M NGSL FL+K D + + + A GM
Sbjct: 63 DHPNIIHLEGVVTKSKP---VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPW 975
+YL VH DL N+LVN VCK+ D GLS+V + + G + + W
Sbjct: 120 KYLSDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034
APE ++ + T DV+S+GIVMWE+++ G+ PY +M +I I P P
Sbjct: 176 TAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PM 232
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEI 1061
C LM CW D ERP F +I
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQI 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 8e-35
Identities = 92/293 (31%), Positives = 138/293 (47%), Gaps = 44/293 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ D + +R LG G +G VY G +RG D VA+K + SC E+ +D
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESD 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT-----VTEFMVNGSLKQFLQKKDRTID 904
F EAL++S +H N+V G+ S + E M G LK FL++ +
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGV-------SFERLPRFILLELMAGGDLKSFLRENRPRPE 108
Query: 905 R------RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R + L A D A G +YL + +H D+ N L+ + P R V KI D G+++
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMAR 167
Query: 959 -VKQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYAD 1013
+ + + G R LP WM PE L G + T K DV+SFG+++WE+ + G PY
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDG---IFTSKTDVWSFGVLLWEIFSLGYMPYPG 224
Query: 1014 MHCASIIGGIVNNTLRPQIPSWC-DPEWRSLMESCWASDPAERPSFSEISRRL 1065
++ V R P C P +R +M CW P +RP+F+ I R+
Sbjct: 225 RTNQEVME-FVTGGGRLDPPKGCPGPVYR-IMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 94/279 (33%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 808 LGSGTYGSVYHGKWRGSD--------VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
LGSG +G VY G VA+K ++ + E F KEA L+S+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-------FLKEAHLMSN 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT------IDRRKRLIIAM 913
+HPN+V G+ + + E M G L +L+ + ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLSK--VKQQTLVSGGVR 970
D A G YL + +H DL N LV+ + V KIGD GL++ K G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-E 172
Query: 971 GTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
G LP WMAPE LL GK T + DV+SFG++MWE+LT G +PY ++ ++ V
Sbjct: 173 GLLPVRWMAPESLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-HVTA 228
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
R Q P C + LM +CWA DP+ERP+F I L
Sbjct: 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-34
Identities = 88/268 (32%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ +++LG+G +G V+ G W G + VA+K +K + + F +EA
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGT 972
A GM Y+ N +H DL+ N+LV VCKI D GL+++ + + G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 973 LPWMAPEL-LSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
+ W APE L G+ T K DV+SFGI++ EL+T G PY M+ ++ V R
Sbjct: 167 IKWTAPEAALYGR---FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRM 222
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSF 1058
P C LM CW DP ERP+F
Sbjct: 223 PCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 86/296 (29%), Positives = 135/296 (45%), Gaps = 47/296 (15%)
Query: 802 LEEVRELGSGTYGSVY------HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+ +R+LG G +G V G G VA+K +K P IAD KE
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L +L+H N+V + GI + + + EF+ +GSLK++L + I+ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRG 971
GM+YL + VH DL N+LV KIGD GL+K K+ V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 972 TLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA------SIIG--- 1021
+ W APE L+ K ++ + DV+SFG+ ++ELLT Y D + +IG
Sbjct: 175 PVFWYAPECLIQSKFYIAS---DVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTH 227
Query: 1022 ---------GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
++ R P C E LM CW P++R +F + ++
Sbjct: 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 85/272 (31%), Positives = 127/272 (46%), Gaps = 37/272 (13%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
DLE V+ LG G+ G VY H K G A+K+I G R++L+ + + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLLREL--KTLR 54
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
P VV YG +G ++ V E+M GSL L KK I IA
Sbjct: 55 SCE--SPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIARQIL 109
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTL 973
G++YLH K +I+H D+K NLL+N + KI D G+SKV + TL + V GT+
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGISKVLENTLDQCNTFV-GTV 164
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY--------ADMHCASIIGGIVN 1025
+M+PE + G+S+ + D++S G+ + E G P+ ++ A I +
Sbjct: 165 TYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----ICD 217
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPS 1057
PE+R + +C DP +RPS
Sbjct: 218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 85/282 (30%), Positives = 124/282 (43%), Gaps = 39/282 (13%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG G +GSV G+ D VA+K +K I +F EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT------YSEIEEFLSEAACMKDF 58
Query: 861 HHPNVVSFYGIVRDGPD-GSLAT---VTEFMVNGSLKQFL-----QKKDRTIDRRKRLII 911
HPNV+ G+ + + + FM +G L FL + + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG---- 967
+D A GMEYL +N +H DL N M VC + D GLSK + SG
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNC---MLREDMTVC-VADFGLSK----KIYSGDYYR 170
Query: 968 -GVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023
G +P W+A E L+ + + T K DV++FG+ MWE+ T G PY + I +
Sbjct: 171 QGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
+ R + P C E LM SCW +DP +RP+F+++ L
Sbjct: 229 RHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 83/275 (30%), Positives = 142/275 (51%), Gaps = 25/275 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + ++ V++LG+G +G V+ G + S VA+K +K + + F +EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---------VQAFLEEAN 53
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
L+ +L H +V Y +V ++ P + +TE+M GSL FL+ + +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRG 971
A GM Y+ KN +H DL+ N+LV+ + +CKI D GL++V + G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
+ W APE ++ S T K DV+SFGI+++E++T G PY M + ++ + P
Sbjct: 167 PIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
++ + C E +M++CW ERP+F + L
Sbjct: 225 RMEN-CPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 85/283 (30%), Positives = 140/283 (49%), Gaps = 28/283 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG---SD----VAIKRIKASCFAGKPSERERLIADFWK 852
++L + LG+G +G V G SD VA+K +K + + SERE L++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMS---- 87
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLI 910
E ++S L +H N+V+ G G G + +TE+ G L FL++K + + L
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQT--LVSG 967
+ A GM +L KN +H DL N+L+ + KI D GL++ + + +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKG 201
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
R + WMAPE S + + T + DV+S+GI++WE+ + G PY M S ++
Sbjct: 202 NARLPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
R P E +M++CW +DP +RP+F +I + +
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 89/273 (32%), Positives = 130/273 (47%), Gaps = 32/273 (11%)
Query: 807 ELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIAD-FWKEALLLSSLH 861
ELGSG +G V G ++ DVAIK +K +E E+ + D +EA ++ L
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK--------NENEKSVRDEMMREAEIMHQLD 53
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+P +V G+ +L V E G L +FL K I + + + GM+Y
Sbjct: 54 NPYIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 922 LHGKNIVHFDLKCEN-LLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPW 975
L GKN VH DL N LLVN + KI D GLSK S G + L W
Sbjct: 111 LEGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKW 164
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034
APE ++ + + DV+S+GI MWE + G +PY M ++ I R P+
Sbjct: 165 YAPECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPA 221
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
C PE +LM+ CW +RP+F+++ R+R+
Sbjct: 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 81/266 (30%), Positives = 121/266 (45%), Gaps = 28/266 (10%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D+ E LG G+YGSVY + G VAIK + P E + + + KE +L
Sbjct: 6 DILEK--LGEGSYGSVYKAIHKETGQVVAIKVV--------PVEED--LQEIIKEISILK 53
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
P +V +YG + L V E+ GS+ ++ ++T+ + I G
Sbjct: 54 QCDSPYIVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMA 977
+EYLH +H D+K N+L+N + K+ D G+S T+ V GT WMA
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---TLRPQIPS 1034
PE++ + K D++S GI E+ G PY+D+H I I N TL P
Sbjct: 168 PEVIQEIGY--NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPE 223
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSE 1060
PE+ ++ C DP ERPS +
Sbjct: 224 KWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 88/271 (32%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 806 RELGSGTYGSVYHG-----KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R LG+G +G + G R VAI ++A C S+++R F EAL L
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-----SDKQRR--GFLAEALTLGQF 63
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H N+V G++ G ++ VTE+M NG+L FL+K + + + + + A GM+
Sbjct: 64 DHSNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--WMAP 978
YL VH L +LVN VCKI + + + + G P W AP
Sbjct: 122 YLSEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
E + + H + DV+SFGIVMWE+++ G+ PY DM +I V + R P C
Sbjct: 178 EAI--QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFRLPAPRNCP 234
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
LM CW + ERP FS+I L M
Sbjct: 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 85/267 (31%), Positives = 134/267 (50%), Gaps = 22/267 (8%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G +G V+ G+ R + VA+K SC P + L A F +EA +L HPN
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPD---LKAKFLQEARILKQYSHPN 54
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V G+ + V E + G FL+ + + ++ + + +AA GMEYL
Sbjct: 55 IVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGT-LPWMAPELL 981
K+ +H DL N LV ++ V KI D G+S+ ++ + +GG++ + W APE L
Sbjct: 113 KHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
+ + + + DV+SFGI++WE + G PYA++ I +R P C
Sbjct: 169 NYGRY--SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAV 225
Query: 1041 RSLMESCWASDPAERPSFSEISRRLRS 1067
LME CW DP +RPSFS + + L+S
Sbjct: 226 YRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 89/266 (33%), Positives = 134/266 (50%), Gaps = 26/266 (9%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K++ F E ++ + E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRR-KRLIIAMDAAFGMEY 921
V +YG +RD D +L+ E+M GS+K L+ T+ R+ R I+ G+EY
Sbjct: 67 VQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GVEY 119
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG----VRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q SG V GT WM+
Sbjct: 120 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++SG+ + K DV+S G + E+LT P+A+ + I I PQ+PS
Sbjct: 176 PEVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233
Query: 1038 PEWRSLMESCWASDPAERPSFSEISR 1063
P+ R+ + + + +RPS E+ R
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 8e-32
Identities = 87/258 (33%), Positives = 127/258 (49%), Gaps = 26/258 (10%)
Query: 807 ELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+LG G +G V+ G W G+ VAIK +K + + F +EA ++ L H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQVMKKLRHEKL 63
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLHG 924
V Y +V + P + VTE+M GSL FL+ + R +L+ +A A GM Y+
Sbjct: 64 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPEL-L 981
N VH DL+ N+LV + VCK+ D GL+++ + + G + + W APE L
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
G+ T K DV+SFGI++ EL T G PY M ++ V R P C
Sbjct: 177 YGR---FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESL 232
Query: 1041 RSLMESCWASDPAERPSF 1058
LM CW +P ERP+F
Sbjct: 233 HDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 92/268 (34%), Positives = 132/268 (49%), Gaps = 27/268 (10%)
Query: 804 EVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+V+ LG G +G V+ G W G+ VAIK +K + F +EA ++ L H
Sbjct: 11 DVK-LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQIMKKLRH 60
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEY 921
+V Y +V + P + VTEFM GSL FL++ D + +L+ +A A GM Y
Sbjct: 61 DKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPE 979
+ N +H DL+ N+LV VCKI D GL+++ + + G + + W APE
Sbjct: 118 IERMNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 980 L-LSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
L G+ T K DV+SFGI++ EL+T G PY M ++ V R P C
Sbjct: 174 AALYGR---FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYRMPCPQGCP 229
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRL 1065
LM+ CW DP ERP+F I L
Sbjct: 230 ESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 90/285 (31%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R LG G +GSV + + D VA+K +KA F+ I +F +EA +
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD------IEEFLREAACMKEF 58
Query: 861 HHPNVVSFYGI-VRDGPDGSLA---TVTEFMVNGSLKQFL-----QKKDRTIDRRKRLII 911
HPNV+ G+ +R G L + FM +G L FL ++ T+ + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG---- 967
+D A GMEYL KN +H DL N M + VC + D GLSK + SG
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNC---MLNENMTVC-VADFGLSK----KIYSGDYYR 170
Query: 968 -GVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023
G LP W+A E L+ ++ T DV++FG+ MWE++T G PYA + + I +
Sbjct: 171 QGCASKLPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ R + P C + LM CW+ +P RPSF + +L +
Sbjct: 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 8e-31
Identities = 84/272 (30%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 808 LGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G +G V+ G + + VA+K +C P E L F EA +L HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK----TCKEDLPQE---LKIKFLSEARILKQYDHPNIV 55
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN 926
G+ + V E + G FL+KK + ++ + A+DAA GM YL KN
Sbjct: 56 KLIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--WMAPELLSGK 984
+H DL N LV + V KI D G+S+ + + S +P W APE L+
Sbjct: 114 CIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 985 SHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI--------PSW 1035
+ + + DV+S+GI++WE + G PY G+ N R Q+ P
Sbjct: 170 RY--SSESDVWSYGILLWETFSLGVCPYP---------GMTNQQAREQVEKGYRMSCPQK 218
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
C + +M+ CW P RP FSE+ + L +
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 84/279 (30%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHP 863
+R+LG G++G VY + VA+K + K + + + F +E +L+SL H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAK-----KLESKSKEVERFLREIQILASLNHPP 58
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEY 921
N+V Y +D +GSL V E++ GSL+ L+K R + + L I +EY
Sbjct: 59 NIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-------KQQTLVSGGVRGTLP 974
LH K I+H D+K EN+L+ D V K+ D GL+K+ + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 975 WMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI---------- 1023
+MAPE+L G S + D++S GI ++ELLTG P+ +S
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 1024 -VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ + L P P L++ A DP R S S
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
|
Length = 384 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 94/284 (33%), Positives = 132/284 (46%), Gaps = 41/284 (14%)
Query: 808 LGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+G G +G V + + D AIKR+K +A K R DF E +L L HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHR-----DFAGELEVLCKLGHH 67
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRK 907
PN+++ G G L E+ +G+L FL+K T+ ++
Sbjct: 68 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
L A D A GM+YL K +H DL N+LV + V KI D GLS+ Q +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSR--GQEVYVK 179
Query: 968 GVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIV 1024
G LP WMA E L+ + T DV+S+G+++WE+++ G PY M CA + +
Sbjct: 180 KTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
R + P CD E LM CW P ERPSF++I L M
Sbjct: 238 QG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 94/298 (31%), Positives = 138/298 (46%), Gaps = 42/298 (14%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADF 850
+ IK +D+ +G G +G V + + AIK +K FA + R DF
Sbjct: 2 EDIKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHR-----DF 49
Query: 851 WKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------- 900
E +L L HHPN+++ G + G L E+ G+L FL+K
Sbjct: 50 AGELEVLCKLGHHPNIINLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 901 ------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
T+ ++ L A D A GM+YL K +H DL N+LV + KI D
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----ENLASKIADF 163
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYAD 1013
GLS+ ++ + R + WMA E L+ + T K DV+SFG+++WE+++ G PY
Sbjct: 164 GLSRGEEVYVKKTMGRLPVRWMAIESLN--YSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221
Query: 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
M CA + + R + P CD E LM CW P ERP F++IS +L M A
Sbjct: 222 MTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 73/259 (28%), Positives = 120/259 (46%), Gaps = 35/259 (13%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
LG G++G V + + + A+K + K + + + E +LS ++HP
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII------KRKEVEHTLTERNILSRINHPF 54
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V + + + L V E+ G L L K+ R + R R A + +EYLH
Sbjct: 55 IVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPE 979
I++ DLK EN+L++ K+ D GL+K L S G R GT ++APE
Sbjct: 112 LGIIYRDLKPENILLD----ADGHIKLTDFGLAKE----LSSEGSRTNTFCGTPEYLAPE 163
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNNTLR--PQIPSWC 1036
+L GK + + +D +S G++++E+LTG P YA+ I L+ + P +
Sbjct: 164 VLLGKGY--GKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-----IYEKILKDPLRFPEFL 216
Query: 1037 DPEWRSLMESCWASDPAER 1055
PE R L+ DP +R
Sbjct: 217 SPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 96/296 (32%), Positives = 138/296 (46%), Gaps = 42/296 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVY----HGKWRGSD---VAIKRIKASCFAGKPSERERLIAD 849
IK D+ ELG G +G V+ H D VA+K +K + SE R D
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-----------QK 898
F +EA LL+ L H ++V FYG+ +G L V E+M +G L +FL
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 899 KDRTIDR---RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
+D + + L IA A GM YL + VH DL N LV Q V KIGD G
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 956 LSK-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011
+S+ + G R LP WM PE + + T + D++SFG+V+WE+ T G +P+
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
+ I I + P C PE ++M+ CW +P +R +I RL++
Sbjct: 226 YQLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 80/281 (28%), Positives = 127/281 (45%), Gaps = 54/281 (19%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERER-LIADFWKEALLLSSLHHPN 864
+GSG++GSVY G G +A+K+++ + +R+R ++ +E LL L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 865 VVSFYGIVRDG----------PDGSLATV-------TEFMVNGSLKQFLQKKDRTIDRRK 907
+V + G D P GS+A + E +V ++Q L+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---------- 117
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
G+ YLH + I+H D+K N+LV+ + KI D G+SK + +S
Sbjct: 118 ----------GLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGISKKLEANSLST 163
Query: 968 GVRGTLP-------WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASII 1020
G P WMAPE++ K T K D++S G ++ E+LTG P+ D I
Sbjct: 164 KTNGARPSLQGSVFWMAPEVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221
Query: 1021 GGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
I N P+IPS E +E + D +RP+ +E+
Sbjct: 222 FKIGEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 87/308 (28%), Positives = 132/308 (42%), Gaps = 61/308 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ D L + LG G +G V + G D VA+K +K +E++ ++D
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 850 FWKEALLLSSL-HHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQ---------K 898
E ++ + H N+++ G+ ++GP L V E+ +G+L+ FL+
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 899 KDRTIDRRKRLI------IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
D + L A A GME+L K +H DL N+LV V KI
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 953 DLGLSK-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GD 1008
D GL++ + G LP WMAPE L + T + DV+SFG+++WE+ T G
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 1009 EPYADMHCASIIGGIVNNTL--------RPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
PY GI L R + P C E LM CW P++RP+F +
Sbjct: 233 SPYP---------GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283
Query: 1061 ISRRLRSM 1068
+ L M
Sbjct: 284 LVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 86/283 (30%), Positives = 139/283 (49%), Gaps = 21/283 (7%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIK-RIKASCFAGKPSERERLIADF 850
L+ +K + ++++ LGSG +G+VY G W G V I IK A P + ++
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL--- 57
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
EA +++S+ +P+V GI ++ +T+ M G L ++++ I + L
Sbjct: 58 -DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 113
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL + +VH DL N+LV + PQ KI D GL+K+ ++ +
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAE 169
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
G + + WMA E + + + T + DV+S+G+ +WEL+T G +PY D AS I I+
Sbjct: 170 GGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEK 226
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
R P C + +M CW D RP F E+ MA
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 83/270 (30%), Positives = 128/270 (47%), Gaps = 26/270 (9%)
Query: 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
ELGSG +G+V G ++ VA+K +K P+ ++ L+ +EA ++ L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELL----REANVMQQLDN 55
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V GI S V E G L +FLQK ++ + + + + GM+YL
Sbjct: 56 PYIVRMIGICEAE---SWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYL 111
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAP 978
N VH DL N+L+ + KI D GLSK + G P W AP
Sbjct: 112 EETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
E ++ + + K DV+SFG++MWE + G +PY M + ++ + R + P C
Sbjct: 168 ECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCP 224
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLRS 1067
PE LM+ CW ERP F+ + RLR+
Sbjct: 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 24/267 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ ++LG+G +G V+ + + + VA+K +K + + F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------VEAFLAEAN 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ +L H +V + +V P + +TEFM GSL FL+ + + +LI +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM ++ +N +H DL+ N+LV+ VCKI D GL++V + G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
+ W APE ++ S T K DV+SFGI++ E++T G PY M +I + P+
Sbjct: 167 IKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 224
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSF 1058
+ C E ++M CW + P ERP+F
Sbjct: 225 PEN-CPEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 39/291 (13%)
Query: 802 LEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+++R LG G +G V + G VA+K +K C KE
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWK----KEIN 58
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L +L+H N+V + G + L + E++ GSL+ +L K ++ + L+ A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQI 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTL 973
GM YLH ++ +H DL N+L+ D R V KIGD GL+K + VR G
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDRLV-KIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 974 P--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-----MHCASIIGGIVN- 1025
P W A E L K + + DV+SFG+ ++ELLT + G +
Sbjct: 173 PVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 1026 --------NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+R P C E LM++CW ++ RP+F + L+ M
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 87/295 (29%), Positives = 139/295 (47%), Gaps = 50/295 (16%)
Query: 808 LGSGTYGSV-----YHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
LG G +G V + K R + VA+K +K + SE L+++F LL +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLKQV 60
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------------------- 899
+HP+V+ YG DG L + E+ GSL+ FL++
Sbjct: 61 NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 900 --DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+R + + A + GM+YL +VH DL N+LV + KI D GLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISDFGLS 174
Query: 958 K-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYAD 1013
+ V ++ +G +P WMA E L H+ T + DV+SFG+++WE++T G PY
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232
Query: 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ + ++ R + P C E +LM +CW +P +RP+F++IS+ L M
Sbjct: 233 IAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 21/269 (7%)
Query: 803 EEVRELGSGTYGS--VYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+R LG G +G +Y S V K + + + SE+ER A E ++LS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT----RLSEKERRDA--LNEIVILSLL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM--DAAFG 918
HPN++++Y D D +L E+ G+L + ++ + + +++
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSA 113
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMA 977
+ Y+H I+H D+K N+ + + K+GD G+SK+ + ++ V GT +M+
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKILGSEYSMAETVVGTPYYMS 169
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PEL G + K D+++ G V++ELLT + + +++ IV P + S
Sbjct: 170 PELCQGVKY--NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYS 226
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLR 1066
E SL+ S DP +RP+ E+ +
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 91/282 (32%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 808 LGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+G G +G V + + D AIKR+K +A K R DF E +L L HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHR-----DFAGELEVLCKLGHH 55
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRK 907
PN+++ G G L E+ +G+L FL+K T+ ++
Sbjct: 56 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
L A D A GM+YL K +H DL N+LV + V KI D GLS+ ++ +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKT 169
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
R + WMA E L+ + T DV+S+G+++WE+++ G PY M CA + +
Sbjct: 170 MGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
R + P CD E LM CW P ERPSF++I L M
Sbjct: 228 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 93/305 (30%), Positives = 128/305 (41%), Gaps = 66/305 (21%)
Query: 802 LEEVRELGSGTYGSVY----------------HGKWRGSD--VAIKRIKASCFAGKPSER 843
L V +LG G +G V+ + VA+K ++ P
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-------PDAS 59
Query: 844 ERLIADFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKD-- 900
+ DF KE +LS L PN+ G+ D P L + E+M NG L QFLQK
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAE 116
Query: 901 --------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
+++ L +A A GM YL N VH DL N LV + KI
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG----KNYTIKIA 172
Query: 953 DLGLSKVKQQTLVSGG---VRGTLP----WMAPE-LLSGKSHMVTEKIDVYSFGIVMWEL 1004
D G+S+ L S V+G P WMA E +L GK T K DV++FG+ +WE+
Sbjct: 173 DFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGK---FTTKSDVWAFGVTLWEI 225
Query: 1005 LT--GDEPYADMHCASII---GGIVNNTLRPQI---PSWCDPEWRSLMESCWASDPAERP 1056
LT ++PY + +I G + R P C + LM CW D +RP
Sbjct: 226 LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP 285
Query: 1057 SFSEI 1061
+F EI
Sbjct: 286 TFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 78/282 (27%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 811 GTYGSVYHGKWRGS------DVAIKRIK--ASCFAGKPSERERLIADFWKEALLLSSLHH 862
GT+G +++G +V +K +K AS + L+ +E+ LL L H
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-----EIQVTLLL----QESCLLYGLSH 67
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-------KDRTIDRRKRLIIAMDA 915
N++ + + + + +M G+LK FLQ+ + + ++ + +A+
Sbjct: 68 QNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGVRG 971
A GM YLH + ++H D+ N ++ D + V KI D LS+ + L R
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVI---DEELQV-KITDNALSRDLFPMDYHCLGDNENR- 181
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
+ WMA E L K + + DV+SFG+++WEL+T G PY ++ + + +
Sbjct: 182 PVKWMALESLVNKEY--SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072
Q P C E ++M CWA DP ERPSFS++ + L A +
Sbjct: 240 Q-PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
DDLE + ELG+G G V H + G +A+K I+ + +++++ +E +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIRLE---INEAIQKQIL----RELDI 52
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG + +G ++ E+M GSL + L++ I R IA+
Sbjct: 53 LHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YLH K I+H D+K N+LVN R K+ D G+S +L V GT +
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQ----IKLCDFGVSGQLVNSLAKTFV-GTSSY 165
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-----------MHCASIIGGIV 1024
MAPE + G + V K D++S G+ + EL TG PY + IV
Sbjct: 166 MAPERIQGNDYSV--KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY------IV 217
Query: 1025 NNTLRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEI 1061
N P++PS + P+++ + C DP ERPS+ E+
Sbjct: 218 NEP-PPRLPSGKF-SPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 92/312 (29%), Positives = 141/312 (45%), Gaps = 59/312 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIA-------- 848
IK D+ RELG G +G V+ A C+ P++ + L+A
Sbjct: 2 IKRRDIVLKRELGEGAFGKVF--------------LAECYNLSPTKDKMLVAVKALKDPT 47
Query: 849 -----DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
DF +EA LL++L H ++V FYG+ DG L V E+M +G L +FL+
Sbjct: 48 LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 898 ---------KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+ + + L IA A GM YL ++ VH DL N LV +
Sbjct: 106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLL 161
Query: 949 CKIGDLGLSK-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
KIGD G+S+ V G LP WM PE + + T + DV+SFG+++WE+
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIF 219
Query: 1006 T-GDEPYADMHCASIIGGIVNNTL--RPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062
T G +P+ + +I I + RP++ C E +M CW +P +R + EI
Sbjct: 220 TYGKQPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIY 276
Query: 1063 RRLRSMAAAINV 1074
+ L ++ A +
Sbjct: 277 KILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 87/304 (28%), Positives = 138/304 (45%), Gaps = 58/304 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
+++E VR++G G +G V+ + G + VA+K +K A + ADF +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQR 57
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---------- 902
EA L++ HPN+V G+ G + + E+M G L +FL+ +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 903 -----------IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ ++L IA A GM YL + VH DL N LV + V KI
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKI 171
Query: 952 GDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-G 1007
D GLS + +P WM PE S + T + DV+++G+V+WE+ + G
Sbjct: 172 ADFGLSRNIYSADYYKASENDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYG 229
Query: 1008 DEPYADMHCASII-----GGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062
+PY M +I G +++ P C E +LM CW+ P++RPSF+ I+
Sbjct: 230 MQPYYGMAHEEVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283
Query: 1063 RRLR 1066
R L+
Sbjct: 284 RILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 77/270 (28%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + +G G++G VY + ++ VAIK I E E I D +E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-------EAEDEIEDIQQEIQFL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S P + +YG G L + E+ GS L K +D I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVRG 971
G+EYLH + +H D+K N+L++ + V K+ D G+S K+ T V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS---EEGDV-KLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031
T WMAPE++ + EK D++S GI EL G+ P +D+H ++ I N P
Sbjct: 161 TPFWMAPEVIKQSGY--DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-PS 217
Query: 1032 IP-SWCDPEWRSLMESCWASDPAERPSFSE 1060
+ + ++ + C DP ERPS E
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 88/290 (30%), Positives = 136/290 (46%), Gaps = 36/290 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIAD 849
+ + + +RELG G++G VY G R + VA+K + S S RER+ +
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----SLRERI--E 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--------KKDR 901
F EA ++ +VV G+V G V E M +G LK +L+ R
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 902 TIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+ +I +A + A GM YL+ K VH DL N +V KIGD G+++ +
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDI 169
Query: 960 KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016
+ G +G LP WMAPE L K + T D++SFG+V+WE+ + ++PY +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
++ +++ Q P C LM CW +P RP+F EI L+
Sbjct: 228 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 77/262 (29%), Positives = 136/262 (51%), Gaps = 17/262 (6%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++R +G G +G V+ K V IK+I + ++ ERL A E +L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE----QMTKDERLAAQ--NECQVLKLL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGM 919
HPN++ +Y + D +L V E+ G+L +++QK+ + +D L + +
Sbjct: 57 SHPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE 979
++H K I+H DLK +N+L++ + V KIGD G+SK+ + V GT +++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039
L GK + +K D+++ G V++EL + + + +++ I++ T P I P+
Sbjct: 172 LCEGKPY--NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRYSPD 228
Query: 1040 WRSLMESCWASDPAERPSFSEI 1061
R L+ S DP++RP S+I
Sbjct: 229 LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 92/296 (31%), Positives = 136/296 (45%), Gaps = 56/296 (18%)
Query: 805 VRELGSGTYGSVYHGKWR--GSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ ELG +G +Y G G D VAIK +K + +F +EA L++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-------DINNPQQWGEFQQEASLMA 62
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL------------QKKDRTI--- 903
LHHPN+V G+V + + + E++ G L +FL +D T+
Sbjct: 63 ELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 904 -DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---- 958
D L IA+ A GMEYL VH DL N+L+ ++ KI DLGLS+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGLSREIYS 176
Query: 959 -----VKQQTLVSGGVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011
V+ ++L+ + WM PE ++ GK + D++SFG+V+WE+ + G +PY
Sbjct: 177 ADYYRVQPKSLLP------IRWMPPEAIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
+I + L P C P SLM CW P+ RP F +I RLRS
Sbjct: 228 YGFSNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 87/276 (31%), Positives = 132/276 (47%), Gaps = 36/276 (13%)
Query: 806 RELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
RELG G++G VY G +G + VAIK + + S RER+ +F EA ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-----SMRERI--EFLNEASVMK 64
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---------RKRL 909
+ +VV G+V G + E M G LK +L+ ++ +K +
Sbjct: 65 EFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGG 968
+A + A GM YL+ VH DL N +V + KIGD G+++ + + G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 969 VRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
+G LP WM+PE L K + T DV+SFG+V+WE+ T ++PY M ++ ++
Sbjct: 179 GKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
L + P C LM CW +P RPSF EI
Sbjct: 237 GGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 74/267 (27%), Positives = 127/267 (47%), Gaps = 18/267 (6%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIK-ASCFAGKPSERERLIADFWK-EALLLSSLHHP 863
+G GTYG VY G +A+K+++ + AG+ R++ + + E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
N+V + G + L+ E++ GS+ L+ R ++ R G+ YLH
Sbjct: 69 NIVQYLGFET-TEE-YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVLEGLAYLH 125
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG---VRGTLPWMAPEL 980
K I+H DLK +NLLV+ +CKI D G+SK + ++G++ WMAPE+
Sbjct: 126 SKGILHRDLKADNLLVD----ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP----SWC 1036
+ S + K+D++S G V+ E+ G P++D + + + N P IP
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 1037 DPEWRSLMESCWASDPAERPSFSEISR 1063
P + +C+ +P RP+ E+ +
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 81/245 (33%), Positives = 112/245 (45%), Gaps = 43/245 (17%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFL----------Q 897
DF KE ++S L PN++ + + P L +TE+M NG L QFL +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
TI + +A A GM+YL N VH DL N LV KI D G+S
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY----TIKIADFGMS 177
Query: 958 KVKQQTLVSGGV-----RGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT--G 1007
+ L SG R LP WM+ E +L GK + DV++FG+ +WE+LT
Sbjct: 178 R----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVTLWEILTLCK 230
Query: 1008 DEPYADMHCASII---GGIVNNTLR----PQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
++PY+ + +I G + R P+ P+ C LM SCW + ERPSF E
Sbjct: 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPK-PALCPDSLYKLMLSCWRRNAKERPSFQE 289
Query: 1061 ISRRL 1065
I L
Sbjct: 290 IHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 28/265 (10%)
Query: 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--- 862
+G G YG+VY GK G VA+K I P + ++D +E LLS L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDD---VSDIQREVALLSQLRQSQP 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PN+ +YG GP L + E+ GS++ + K I + +I + ++Y+
Sbjct: 62 PNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIG---DLGLSKVKQQTLVSGGVRGTLPWMAPE 979
H ++H D+K N+LV +C G L + K+ T V GT WMAPE
Sbjct: 118 HKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFV-----GTPYWMAPE 171
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP-SWCDP 1038
+++ K D++S GI ++E+ TG+ PY+D+ + I + P++ +
Sbjct: 172 VITEGK-YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-PPRLEDNGYSK 229
Query: 1039 EWRSLMESCWASDPAERPSFSEISR 1063
R + +C +P ER S E+ +
Sbjct: 230 LLREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 15/280 (5%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L+ +K +L+ V+ LGSG +G+VY G W +K I + + + +F E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDE 59
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
AL+++S+ HP++V G+ ++ VT+ M +G L ++ + I + L +
Sbjct: 60 ALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV 116
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVR 970
A GM YL + +VH DL N+LV + P KI D GL+++ ++ + G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEYNADGGK 172
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029
+ WMA E + + T + DV+S+G+ +WEL+T G +PY + I +
Sbjct: 173 MPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 230
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
PQ P C + +M CW D RP F E++ MA
Sbjct: 231 PQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 87/266 (32%), Positives = 130/266 (48%), Gaps = 25/266 (9%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A K+++ F + E + ++ E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + +L E+M GS+K L+ + + R I+ GM Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GMSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVR---GTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG G+R GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++SG+ + K DV+S G + E+LT P+A+ + I I PQ+PS
Sbjct: 178 PEVISGEGY--GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS 235
Query: 1038 PEWRSLMESCWASDPAERPSFSEISR 1063
R + C + RPS E+ R
Sbjct: 236 EHARDFL-GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GTYG VY + + + VA+K+I+ +E+E +E LL L
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFM---VNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HPN+V IV GS+ V E+M + G L K T + K + +
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMKQL--LE 111
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL----SKVKQQTLVSGGVRGTL 973
G++YLH I+H D+K N+L+N V K+ D GL +K + + TL
Sbjct: 112 GLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYTNRVI--TL 165
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ PELL G + ++D++S G ++ EL G
Sbjct: 166 WYRPPELLLGATRY-GPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 83/264 (31%), Positives = 135/264 (51%), Gaps = 18/264 (6%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
VR +G G+YG V + R G IK++ S RER A+ +EA LLS L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKH 58
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEY 921
PN+V+ Y +G DG L V F G L L ++K + + + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPEL 980
LH K+I+H DLK +N+ + + + K+GDLG+++V + Q ++ + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
S K + K DV++ G ++E+ T + S++ I+ L P +P PE
Sbjct: 174 FSNKPY--NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPEL 230
Query: 1041 RSLMESCWASDPAERPSFSEISRR 1064
L+ + + P +RPS I R+
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 75/262 (28%), Positives = 124/262 (47%), Gaps = 23/262 (8%)
Query: 801 DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E + ++G G++G V+ K A+K+I S + ERE I EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAI----DEARVLA 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDA 915
L ++ +Y D G L V E+ NG L + L+ + D+ R I
Sbjct: 55 KLDSSYIIRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QI 110
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLP 974
G+ +LH K I+H D+K NL ++ D KIGDLG++K+ T + + GT
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVGTPY 166
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034
+++PEL K + EK DV++ G+V++E TG P+ + ++I I+ P +
Sbjct: 167 YLSPELCEDKPY--NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQ 223
Query: 1035 WCDPEWRSLMESCWASDPAERP 1056
+ L++ C D +RP
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-26
Identities = 91/304 (29%), Positives = 138/304 (45%), Gaps = 52/304 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIA-------- 848
IK ++ RELG G +G V+ A C+ P + + L+A
Sbjct: 2 IKRHNIVLKRELGEGAFGKVF--------------LAECYNLCPEQDKILVAVKTLKDAS 47
Query: 849 -----DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
DF +EA LL++L H ++V FYG+ +G L V E+M +G L +FL+
Sbjct: 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 898 ------KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + L IA A GM YL ++ VH DL N LV + + KI
Sbjct: 106 VLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKI 161
Query: 952 GDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-G 1007
GD G+S+ T V G + WM PE + + T + DV+S G+V+WE+ T G
Sbjct: 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYG 219
Query: 1008 DEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
+P+ + +I I + Q P C E LM CW +P R + EI L++
Sbjct: 220 KQPWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278
Query: 1068 MAAA 1071
+A A
Sbjct: 279 LAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 82/284 (28%), Positives = 136/284 (47%), Gaps = 29/284 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLIADF 850
+K +L +++ LGSG +G+V+ G W G VAIK I+ +G+ + +E I D
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQE--ITD- 58
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + SL H +V GI P SL VT+ GSL +++ ++D ++ L
Sbjct: 59 --HMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL +VH +L N+L ++ + +I D G++ + +
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYFYS 169
Query: 968 GVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
+ + WMA E +L G+ T + DV+S+G+ +WE+++ G EPYA M + +
Sbjct: 170 EHKTPIKWMALESILFGR---YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
Q P C + +M CW D RP+F E++ MA
Sbjct: 227 GERLAQ-PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 81/266 (30%), Positives = 127/266 (47%), Gaps = 25/266 (9%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K+++ F + E + + E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + +L+ E M GS+K L+ + + R I+ G+ Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GVSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG----GVRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++SG+ + K D++S G + E+LT P+A+ + I I P +P
Sbjct: 178 PEVISGEGY--GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235
Query: 1038 PEWRSLMESCWASDPAERPSFSEISR 1063
R ++ + + RPS E+ R
Sbjct: 236 DHCRDFLKRIFV-EAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 93/279 (33%), Positives = 127/279 (45%), Gaps = 34/279 (12%)
Query: 806 RELGSGTYGSVYHGKWRGSD----VAIKRIK-ASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG G +GSV G+ D VA+K +K A C SE E DF EA+ +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSEME----DFLSEAVCMKEF 57
Query: 861 HHPNVVSFYGIVRDGPDG----SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM--- 913
HPNV+ G+ + S + FM +G L FL R D + L M
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDCPQYLPTQMLVK 116
Query: 914 ---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGV 969
D A GMEYL K+ +H DL N ++N VC + D GLSK + G
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSKKIYNGDYYRQGR 172
Query: 970 RGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
+P W+A E L+ + + T K DV+SFG+ MWE+ T G PY + + I +
Sbjct: 173 IAKMPVKWIAIESLADRVY--TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
Q P D + SLM SCW +P +RPSF + L
Sbjct: 231 NRLKQPPDCLDGLY-SLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 37/277 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +GSGTYG VY + + VAIK IK P + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDD---FEIIQQEISML 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HPN+V+++G L V E+ GSL+ Q + + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV------KQQTLVSGGVRG 971
G+ YLH +H D+K N+L+ + K+ D G+S K+++ + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI-----G 163
Query: 972 TLPWMAPELLSGKSHM-VTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030
T WMAPE+ + + K D+++ GI EL P D+H + I + P
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP 223
Query: 1031 QIPS------WCDPEWRSLMESCWASDPAERPSFSEI 1061
P W P + ++ C DP +RP+ +++
Sbjct: 224 --PKLKDKEKWS-PVFHDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 83/248 (33%), Positives = 117/248 (47%), Gaps = 44/248 (17%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKD------- 900
DF KE ++S L +PN++ G+ V D P L +TE+M NG L QFL +++
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 901 ----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
++ L +A+ A GM+YL N VH DL N LV KI D G+
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG----NHYTIKIADFGM 175
Query: 957 SKVKQQTLVSGGV-----RGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWEL--LT 1006
S+ L SG R LP WMA E +L GK T DV++FG+ +WE+ L
Sbjct: 176 SR----NLYSGDYYRIQGRAVLPIRWMAWESILLGK---FTTASDVWAFGVTLWEMFTLC 228
Query: 1007 GDEPYADMHCASII---GGIVNNTLRPQI----PSWCDPEWRSLMESCWASDPAERPSFS 1059
++PY+ + +I G N R QI C LM CW+ D +RP+F+
Sbjct: 229 KEQPYSLLSDEQVIENTGEFFRNQGR-QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287
Query: 1060 EISRRLRS 1067
+I LR
Sbjct: 288 KIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 88/297 (29%), Positives = 136/297 (45%), Gaps = 45/297 (15%)
Query: 806 RELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ LG G +G V + G D VA+K +K + ++ +AD E L
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMEL 70
Query: 857 LSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKR-- 908
+ + H N+++ G+ +G L + E+ G+L++FL+ + D T D K
Sbjct: 71 MKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 909 --------LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+ A A GMEYL + +H DL N+LV + V KI D GL++ V
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARGV 184
Query: 960 KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016
G LP WMAPE L + + T + DV+SFGI+MWE+ T G PY +
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVY--THQSDVWSFGILMWEIFTLGGSPYPGIPV 242
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAIN 1073
+ ++ R PS C E LM CW + P +RP+F ++ L + AA++
Sbjct: 243 EELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 82/276 (29%), Positives = 138/276 (50%), Gaps = 41/276 (14%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +++LG G+YGSVY K R SD A+K + G S++ER D E +L
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDL----GSMSQKER--EDAVNEIRIL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------- 910
+S++HPN++S+ DG L V E+ G L + + K+ + ++LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKK----RKLIPEQEIWR 107
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
I + G++ LH + I+H DLK N+L+ D + KIGDLG+SKV ++ + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI- 162
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY-----ADMHCASIIGGIVN 1025
GT +MAPE+ G+ + + K D++S G +++E+ T P+ D+ + G
Sbjct: 163 GTPHYMAPEVWKGRPY--SYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-YKVQRGKY- 218
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P IP + ++ + S P RP+ +I
Sbjct: 219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 80/266 (30%), Positives = 124/266 (46%), Gaps = 25/266 (9%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K++ F E + + E LL +L H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + L+ E+M GS+K L+ + R R I+ G+ Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GVSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG----GVRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++SG+ + K DV+S + E+LT P+A+ + I I +P +P
Sbjct: 178 PEVISGEGY--GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 1038 PEWRSLMESCWASDPAERPSFSEISR 1063
R ++ + + RP+ + R
Sbjct: 236 DACRDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 27/262 (10%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLI-----ADFWKEALLLSSL 860
R +G G +G V + KR FA K +++ + + E +L L
Sbjct: 6 RVIGKGAFGKVC--------IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+HP +V+ + +D + + V + ++ G L+ L +K + + + + I + +E
Sbjct: 58 NHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALE 114
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPE 979
YLH K I+H D+K +N+L++ ++ I D ++ KV TL + GT +MAPE
Sbjct: 115 YLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTS-GTPGYMAPE 169
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSWCD 1037
+L + + V +D +S G+ +E L G PY H +I I T P+
Sbjct: 170 VLCRQGYSV--AVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYPATWS 226
Query: 1038 PEWRSLMESCWASDPAERPSFS 1059
E + DP +R +
Sbjct: 227 TEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 81/280 (28%), Positives = 120/280 (42%), Gaps = 37/280 (13%)
Query: 800 DDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKAS-CFAGKPSERERLIADFWKEALL 856
DD E + +G G VY VAIKRI C + + L KE
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELR----KEVQA 52
Query: 857 LSSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM- 913
+S +HPNVV +Y +V D L V ++ GSL ++ IIA
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATV 107
Query: 914 --DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVR 970
+ G+EYLH +H D+K N+L+ + KI D G+S + + VR
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 971 ----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026
GT WMAPE++ H K D++SFGI EL TG PY+ ++ + N
Sbjct: 164 KTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222
Query: 1027 TLRPQIPSWCDP-----EWRSLMESCWASDPAERPSFSEI 1061
P + + D +R ++ C DP++RP+ E+
Sbjct: 223 D-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 808 LGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG+G + S Y + G+ +A+K++ SE+E ++ KE L++ L+HP++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
+ G + D E+M GS+ L K K+ I ++ G+ Y
Sbjct: 66 IRMLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-----GLSY 118
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQTLVSGGVRGTLPWM 976
LH I+H D+K NLL+ D +I D G +K G + GT+ +M
Sbjct: 119 LHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY-ADMHCA--SIIGGIVNNTLRPQIP 1033
APE+L G+ + DV+S G V+ E+ T P+ A+ H ++I I + T P IP
Sbjct: 176 APEVLRGEQY--GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 1034 SWCDPEWRSLMESCWASDPAERPSFSEI 1061
P R + C P +RP E+
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 37/218 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFA-GKPSE--RERLIADFWKEALLL 857
E++ +LG GTYG VY + + + VA+K+I+ G PS RE I+ LL
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE--IS-------LL 52
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRL---IIA 912
L HPN+V ++ + L V E+ + LK++L K+ + K + ++
Sbjct: 53 KELKHPNIVKLLDVIHT--ERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGV 969
G+ Y H I+H DLK +N+L+N V K+ D GL++ + +T V
Sbjct: 110 -----GLAYCHSHRILHRDLKPQNILINR----DGVLKLADFGLARAFGIPLRTYTHEVV 160
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
TL + APE+L G S + +D++S G + E++TG
Sbjct: 161 --TLWYRAPEILLG-SKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 81/286 (28%), Positives = 134/286 (46%), Gaps = 27/286 (9%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLI 847
++ +K +L++V+ LGSG +G+VY G W G + VAIK ++ + P + ++
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEIL 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
EA +++ + P V GI ++ VT+ M G L ++++ I +
Sbjct: 58 ----DEAYVMAGVGSPYVCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQD 110
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
L + A GM YL +VH DL N+LV + P KI D GL++ + +
Sbjct: 111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEY 166
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023
+ G + + WMA E + + T + DV+S+G+ +WEL+T G +PY + I +
Sbjct: 167 HADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
PQ P C + +M CW D RP F E+ MA
Sbjct: 225 EKGERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 84/273 (30%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DDLE + ELG G YG V + + +A+KRI+A+ E++RL+ D + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL---DISM 54
Query: 858 SSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAM 913
S+ P V+FYG + R+G + E M + SL +F +K K TI IA+
Sbjct: 55 RSVDCPYTVTFYGALFREG---DVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+EYLH K +++H D+K N+L+N K+ D G+S ++ G
Sbjct: 111 SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ----VKLCDFGISGYLVDSVAKTIDAGC 166
Query: 973 LPWMAPELLSGKSHM--VTEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIVNNTLR 1029
P+MAPE ++ + + K DV+S GI M EL TG PY + +V
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-S 225
Query: 1030 PQIPS-WCDPEWRSLMESCWASDPAERPSFSEI 1061
PQ+P+ PE++ + C + ERP++ E+
Sbjct: 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 78/269 (28%), Positives = 119/269 (44%), Gaps = 33/269 (12%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GTYG VY + + V AIK I P R + +E L S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI--------PERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRKRLIIAMDAAFG 918
V + G + G E + GSL L+ K ++TI + I+ G
Sbjct: 68 VQYLGSDSEN--GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-----G 120
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMA 977
++YLH IVH D+K +N+LVN V KI D G SK + + GTL +MA
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM---HCASIIGGIVNNTLRPQIPS 1034
PE++ D++S G + E+ TG P+ ++ A G+ + P+IP
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--IHPEIPE 235
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063
E ++ + C+ DP +R S ++ +
Sbjct: 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 80/270 (29%), Positives = 128/270 (47%), Gaps = 44/270 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
DD E ++ LG+G++G V + +GS A+K + KA K E E+ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI------ 54
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIA 912
L S+ HP +V+ YG +D D +L V E++ G L L+K R + A
Sbjct: 55 ---LQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR--FYA 107
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGV 969
+EYLH +IV+ DLK ENLL+ D + KI D G +K + TL
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYI-KITDFGFAKRVKGRTYTLC---- 159
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD----MHCASIIGGIVN 1025
GT ++APE++ K + + +D ++ GI+++E+L G P+ D I+ G V
Sbjct: 160 -GTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV- 215
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
+ PS+ P+ + L+ + D +R
Sbjct: 216 -----RFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 48/292 (16%)
Query: 805 VRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ELG +G VY G G+ VAIK +K + RE +F EA++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLRE----EFKHEAMMR 62
Query: 858 SSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK-----------DRTIDR 905
S L HPN+V G+V ++ P L+ + + + L +FL + D+T+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 906 RKR----LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--- 958
+ I A GME+L ++VH DL N+LV + KI DLGL +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDLGLFREVY 175
Query: 959 VKQQTLVSGGVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016
+ G + WM+PE ++ GK + + D++S+G+V+WE+ + G +PY
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS---DIWSYGVVLWEVFSYGLQPYCGYSN 232
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEW-RSLMESCWASDPAERPSFSEISRRLRS 1067
+I I N + P P C P W +LM CW P+ RP F +I RLR+
Sbjct: 233 QDVIEMIRNRQVLP-CPDDC-PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 36/261 (13%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSE---RERLIADFWKEALLLSSLH 861
LG G +G V K + + A+K + K E E+ I L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI---------LEECN 51
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HP +V Y +D + + E+ + G L L+ + + R IA EY
Sbjct: 52 HPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEY 108
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPWM 976
LH + I++ DLK ENLL++ K+ D G +K K T GT ++
Sbjct: 109 LHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYV 159
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYA--DMHCASIIGGIVNNTLRPQIPS 1034
APE++ K + +D +S GI+++ELLTG P+ D I I+ + + P+
Sbjct: 160 APEIILNKGY--DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 1035 WCDPEWRSLMESCWASDPAER 1055
+ D + L++ +P ER
Sbjct: 218 YIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-KPSERERLIADFWKEALLLSS 859
D E + +G G++G+V + R SD I K + E+++L++ E +L
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKEKQQLVS----EVNILRE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAA 916
L HPN+V +Y + D + +L V E+ G L Q +QK + I+ I
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 917 FGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLV 965
+ H G ++H DLK N+ ++ K+GD GL+K+ +T V
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025
GT +M+PE L+ S+ EK D++S G +++EL P+ + + I
Sbjct: 172 -----GTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
R IP E +++S DP +RPS E+
Sbjct: 225 GKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 83/307 (27%), Positives = 137/307 (44%), Gaps = 46/307 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G D VA+K +K+ E+ +
Sbjct: 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDL 67
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------- 899
+D E ++ + H N+++ G DG L + E+ G+L+++L+ +
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + A A GMEYL K +H DL N+LV + V KI
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKI 181
Query: 952 GDLGLSK-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-G 1007
D GL++ + G LP WMAPE L + + T + DV+SFG+++WE+ T G
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLG 239
Query: 1008 DEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL-R 1066
PY + + ++ R PS C E +M CW + P++RP+F ++ L R
Sbjct: 240 GSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298
Query: 1067 SMAAAIN 1073
+A N
Sbjct: 299 ILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 84/254 (33%), Positives = 114/254 (44%), Gaps = 49/254 (19%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDR---- 901
DF KE +LS L PN++ G+ D + L +TE+M NG L QFL D+
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 902 -----------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
I L +A+ A GM+YL N VH DL N LV + K
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG----ENLTIK 178
Query: 951 IGDLGLSKVKQQTLVSGGV-----RGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMW 1002
I D G+S+ L +G R LP WMA E +L GK T DV++FG+ +W
Sbjct: 179 IADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGK---FTTASDVWAFGVTLW 231
Query: 1003 ELLT--GDEPYADMHCASII---GGIVNNTLRPQI----PSWCDPEWRSLMESCWASDPA 1053
E+L ++PY ++ +I G + R Q+ P C LM CW+ D
Sbjct: 232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGR-QVYLFRPPPCPQGLYELMLQCWSRDCR 290
Query: 1054 ERPSFSEISRRLRS 1067
ERPSFS+I L
Sbjct: 291 ERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 33/283 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++N+DLE + +LG+G GSV K + + + K K S R++++ +E +
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAK-KVVHIGAKSSVRKQIL----RELQI 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDA 915
+ P +VSFYG + + + EFM GSL + +K ++ ++ +A+
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMC--MEFMDCGSLDRIYKKGGPIPVEILGKIAVAV-- 112
Query: 916 AFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLG-LSKVKQQTLVSGGVRGTL 973
G+ YL+ + I+H D+K N+LVN R Q +C G G L T V GT
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIADTFV-----GTS 166
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD--------MHCASI---IGG 1022
+M+PE + G + V K DV+S GI + EL G P+A I +
Sbjct: 167 TYMSPERIQGGKYTV--KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224
Query: 1023 IVNNTLRPQIPSWCDPE-WRSLMESCWASDPAERPSFSEISRR 1064
IV P++PS PE R +++C DP ERP+ ++
Sbjct: 225 IVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 63/253 (24%), Positives = 117/253 (46%), Gaps = 21/253 (8%)
Query: 815 SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD-FWKEALLLSSLHHPNVVSFYGIVR 873
S+Y G + +V I+ K K + +++ D E L + N++ YG +
Sbjct: 35 SIYKGIFNNKEVIIRTFK------KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88
Query: 874 DGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHF 930
D D L+ + E+ G L++ L K ++ + + +L +A+D G+ L+ N +
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147
Query: 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTLPWMAPELLSGKSHMV 988
+L + LV + KI GL K L S + + + + ++L+
Sbjct: 148 NLTSVSFLVT----ENYKLKIICHGLEK----ILSSPPFKNVNFMVYFSYKMLNDIFSEY 199
Query: 989 TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCW 1048
T K D+YS G+V+WE+ TG P+ ++ I I+N ++P C E + ++E+C
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259
Query: 1049 ASDPAERPSFSEI 1061
+ D +RP+ EI
Sbjct: 260 SHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 799 NDDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
ND E + ELG G +G VY K G A K I+ E E + DF E +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--------IESEEELEDFMVEIDI 55
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS HPN+V Y + L + EF G+L + + +R + + +
Sbjct: 56 LSECKHPNIVGLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+ +LH ++H DLK N+L+ + K+ D G+S K+ T +
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI----- 164
Query: 971 GTLPWMAPELL---SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN- 1026
GT WMAPE++ + K + K D++S GI + EL + P+ +++ ++ I+ +
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224
Query: 1027 --TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063
TL PS + ++SC DP +RP+ +E+ +
Sbjct: 225 PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-22
Identities = 80/295 (27%), Positives = 129/295 (43%), Gaps = 45/295 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K E+ ++D
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDL 67
Query: 851 WKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------- 899
E ++ + H N+++ G DG L + E+ G+L+++L+ +
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 900 -----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
D + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADF 181
Query: 955 GLSK-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEP 1010
GL++ V G LP WMAPE L + + T + DV+SFG++MWE+ T G P
Sbjct: 182 GLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSP 239
Query: 1011 YADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
Y + + ++ R P+ C E +M CW + P+ RP+F ++ L
Sbjct: 240 YPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 30/269 (11%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+ G YG V+ K + G AIK IK + K + L E +LS P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-----TERDILSQAQSPYV 55
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V Y + +L V E++ G L L+ + R+ IA + +EYLH
Sbjct: 56 VKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSN 112
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGG------VRGTLPWM 976
I+H DLK +N+L++ K+ D GLSK V++Q ++ + GT ++
Sbjct: 113 GIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQIPSW 1035
APE++ G+ H ++ +D +S G +++E L G P+ I I+N + P+
Sbjct: 169 APEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE- 225
Query: 1036 CDPEWRSLMESCWASDPAERP---SFSEI 1061
E L+ DP +R S EI
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADF-WKEALLLSS 859
+++ ++G GTYG VY + + G VAIK+IK I +E LL
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK-------LRFESEGIPKTALREIKLLKE 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L+HPN++ + R G L V EFM + L + ++ + R + G+
Sbjct: 55 LNHPNIIKLLDVFRHK--GDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGL 111
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GTL 973
+ H I+H DLK ENLL+N V K+ D GL++ VR T
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARS-----FGSPVRPYTHYVVTR 162
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APELL G + +D++S G + ELL+
Sbjct: 163 WYRAPELLLG-DKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 82/284 (28%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
E V +G GTYG VY + + G VAIK + E E + E +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKE----EYNI 55
Query: 857 LSSL-HHPNVVSFYGI----VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR--L 909
L +HPN+ +FYG G D L V E GS+ L K R +R +
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEW 114
Query: 910 I--IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
I I + G+ YLH ++H D+K +N+L+ + K+ D G+S TL
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAEVKLVDFGVSAQLDSTL--- 167
Query: 968 GVR----GTLPWMAPELLSGKSHM---VTEKIDVYSFGIVMWELLTGDEPYADMHCASII 1020
G R GT WMAPE+++ + DV+S GI EL G P DMH +
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL 227
Query: 1021 GGIVNN---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
I N TL+ +W ++ + C + +RP E+
Sbjct: 228 FKIPRNPPPTLKSP-ENWSK-KFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY G VA+K+++ R+ + KE LL L HP
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCL----KEIDLLKQLDHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDRTIDRRKRLIIAMDAAFGME 920
NV+ + + + L V E G L + + +K+ R I R + +E
Sbjct: 63 NVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPE 979
++H K I+H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YAD-MHCASIIGGIVNNTLRPQIPSWCD 1037
+ + K D++S G +++E+ P Y D M+ S+ I P
Sbjct: 177 RIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070
E R L+ C DP +RP S + + + M A
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 72/302 (23%), Positives = 128/302 (42%), Gaps = 60/302 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLI-------ADF 850
DD + + +G G++ +V K + ++ AIK + ++ +LI
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL----------DKRQLIKEKKVKYVKI 50
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
KE L + HP ++ Y +D + +L V E+ NG L Q+++K ++ R
Sbjct: 51 EKEVLTRLN-GHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY 107
Query: 911 IA--MDAAFGMEYLHGKNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVKQQTLVS 966
A + A +EYLH K I+H DLK EN+L+ +M KI D G +KV
Sbjct: 108 AAEILLA---LEYLHSKGIIHRDLKPENILLDKDMH------IKITDFGTAKVLDPNSSP 158
Query: 967 GGVR---------------------GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
+ GT +++PELL+ K + D+++ G +++++L
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQML 216
Query: 1006 TGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
TG P+ + I+ P P+ + L+E DP +R +E L
Sbjct: 217 TGKPPFRGSNEYLTFQKILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
Query: 1066 RS 1067
++
Sbjct: 275 KA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 803 EEVRELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
E +G GTYG VY K G + AIK+ K + + +E LL
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-----KEQYTGISQSACREIALLR 57
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATV---TEFMVNGSLKQFLQKKDRTIDRR--KRLIIAM 913
L H NVVS + + D S+ + E + +K Q K +I K L+ +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGV 969
G+ YLH ++H DLK N+LV P+R V KIGDLGL+++ L V
Sbjct: 118 --LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
T+ + APELL G H T+ ID+++ G + ELLT
Sbjct: 176 VVTIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 44/281 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGK-PSERERLIADFWKEALLLSSLHH 862
LG GT+ ++Y G R + + K R F++ A L+S L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 863 PNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
++V YG+ VRD V E++ G L FL ++ + +L +A A + Y
Sbjct: 61 KHLVKLYGVCVRDEN----IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQR---PVCKIGDLGLSKVKQQTLVSGGVR-GTLPWMA 977
L K +VH ++ +N+LV P K+ D G+ T++S R +PW+A
Sbjct: 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERIPWIA 172
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEP------------YADMHCASIIGGIV 1024
PE + +T D +SFG + E+ + G+EP Y D H
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--------- 223
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
R +P E +L+ CW DP +RPSF I R L
Sbjct: 224 ----RLPMPDC--AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 49/277 (17%)
Query: 808 LGSGTYGSVYHGKWRGSDV------AIKRIKASCFAGKPSERE--RLIADFWKEALLLSS 859
+G GT+G VY ++ A+K I+ + ++ + + IAD E +L
Sbjct: 8 IGGGTFGKVY----TAVNLDTGELMAVKEIRI-----QDNDPKTIKEIAD---EMKVLEL 55
Query: 860 LHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRR--KRLIIA 912
L HPN+V +YG+ R+ + E+ G+L++ L+ D + R +L+
Sbjct: 56 LKHPNLVKYYGVEVHRE----KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE- 110
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSG---- 967
G+ YLH IVH D+K N+ ++ V K+GD G + +K T G
Sbjct: 111 -----GLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 968 GVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026
+ GT +MAPE+++G K D++S G V+ E+ TG P++++ I V
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 1027 TLRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEI 1061
+P IP PE + ++ C SDP +RP+ SE+
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-21
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 10/174 (5%)
Query: 896 LQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
L++ + +D L + A GM +L KN +H DL N+L+ + KI D G
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFG 259
Query: 956 LS---KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011
L+ + +V G R + WMAPE S + + T + DV+S+GI++WE+ + G PY
Sbjct: 260 LARDIRNDSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
Query: 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
M S ++ R P E +M+SCW +DP +RP+F +I + +
Sbjct: 318 PGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 63/266 (23%), Positives = 133/266 (50%), Gaps = 18/266 (6%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E ++++G G++G +Y K IK I + K E + KE +LL+ +
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII-AMDAAFGM 919
HPN+V+F+ ++ +G L V E+ G L + + ++ + +++ + + G+
Sbjct: 57 KHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMAP 978
+++H + I+H D+K +N+ ++ V K+GD G+++ ++ ++ GT +++P
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038
E+ + + K D++S G V++EL T P+ + ++ I P P++
Sbjct: 172 EICQNRPY--NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SR 228
Query: 1039 EWRSLMESCWASDPAERPSFSEISRR 1064
+ RSL+ + P +RPS + I +R
Sbjct: 229 DLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-21
Identities = 39/89 (43%), Positives = 59/89 (66%), Gaps = 11/89 (12%)
Query: 38 PQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE---GAVVLKYQQPDEDLDALVSVV 94
D KLRY GGETR +S+PRD+++E+L S++ + + + LKYQ DED D LVS+
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 95 NDDDVINMMEEYEKLGSGDGFTRLRIFLF 123
+D+D+ +EEY+ LGS +LR+ +F
Sbjct: 57 SDEDLEEAIEEYDSLGSK----KLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-20
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 38 PQDGKLRYVGGETRIVSLPRDVTYEELMSRMRE-LYEGAVVLKYQQPDEDLDALVSVVND 96
KLRY GG R +S+ +++EEL S++ + V K + PDED D LVS+ +D
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 97 DDVINMMEEYEKLGSGDGFTRLRIFLF 123
+D+ +EE LGS LR+ +F
Sbjct: 60 EDLEEAIEEARSLGSK----TLRLHVF 82
|
Length = 84 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 32/277 (11%)
Query: 799 NDDLEEV----RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
DD E++ RE+G G++G+VY VAIK++ ++GK S + D K
Sbjct: 10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEK--WQDIIK 64
Query: 853 EALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E L L HPN + + G +R+ + V E+ + GS L+ + + + I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAI 120
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ--QTLVSGGV 969
A G+ YLH +H D+K N+L+ + K+ D G + + + V
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSASLVSPANSFV---- 172
Query: 970 RGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028
GT WMAPE +L+ K+DV+S GI EL P +M+ S + I N
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND- 230
Query: 1029 RPQIPS--WCDPEWRSLMESCWASDPAERPSFSEISR 1063
P + S W D +R+ ++SC P +RPS E+ +
Sbjct: 231 SPTLSSNDWSD-YFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-20
Identities = 30/85 (35%), Positives = 51/85 (60%), Gaps = 6/85 (7%)
Query: 40 DGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDD 98
K++Y G R V + R +++E+L S++ E + AV K + PDED D LV++ +D+D
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 99 VINMMEEYEKLGSGDGFTRLRIFLF 123
+ +EE + GS +LR+F+F
Sbjct: 61 LEEAIEEARRSGSK----KLRLFVF 81
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-20
Identities = 86/337 (25%), Positives = 134/337 (39%), Gaps = 85/337 (25%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L + LG G +G V G D VA+K +K A SE + L+++
Sbjct: 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSE 60
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ--------FLQKKDR 901
+L+ +H NVV+ G P+G L + EF G+L F +++
Sbjct: 61 L---KILIHIGNHLNVVNLLGACTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116
Query: 902 T---------------IDRRKR-------------------------------------- 908
+ +DRR
Sbjct: 117 SPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDL 176
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV- 965
+ + A GME+L + +H DL N+L++ + V KI D GL++ K V
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVR 232
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIV 1024
G R L WMAPE + K + T + DV+SFG+++WE+ + G PY + +
Sbjct: 233 KGSARLPLKWMAPESIFDKVY--TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ R + P PE +M +CW DP ERP+FS +
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-20
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 806 RELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+ LG G +G V + G D K + + K ++ ++D E ++ + H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRK 907
N+++ G DG L + E+ G+L+++L+ + + + +
Sbjct: 78 KNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVS 966
+ A A GMEYL + +H DL N+LV + V KI D GL++ V
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYK 191
Query: 967 GGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023
G LP WMAPE L + + T + DV+SFG+++WE+ T G PY + + +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-L 248
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ R P+ C E +M CW + P++RP+F ++
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 70/260 (26%), Positives = 112/260 (43%), Gaps = 30/260 (11%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ + G +GSVY K R G AIK +K S K ++ + A+++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK----NQVTNVKAERAIMMIQGES 56
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P V Y + L V E++ G ++ + + IA + G+E L
Sbjct: 57 PYVAKLYYSFQSK--DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDL 113
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982
H + I+H D+K ENLL++ Q K+ D GLS+ L + GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETIL 166
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW------- 1035
G + D +S G V++E L G P+ A + +N L +I +W
Sbjct: 167 GVGD--DKMSDWWSLGCVIFEFLFGYPPFH----AETPDAVFDNILSRRI-NWPEEVKEF 219
Query: 1036 CDPEWRSLMESCWASDPAER 1055
C PE L+ DPA+R
Sbjct: 220 CSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 73/258 (28%), Positives = 125/258 (48%), Gaps = 22/258 (8%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E LG+G++G V K +G+ AIK C + + + + +E +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-----CLKKREILKMKQVQHVAQEKSILM 73
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L HP +V+ +D + + + EF+V G L L+K R + + A +
Sbjct: 74 ELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLA 130
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMA 977
EYLH K+I++ DLK ENLL+ D + V K+ D G +K V +T + GT ++A
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL---DNKGHV-KVTDFGFAKKVPDRTFT---LCGTPEYLA 183
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++ K H + +D ++ G++++E + G P+ D I I+ L + P+W D
Sbjct: 184 PEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL--KFPNWFD 239
Query: 1038 PEWRSLMESCWASDPAER 1055
R L++ +D +R
Sbjct: 240 GRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-19
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV-SGGVRGT 972
A GME+L + +H DL N+L++ + V KI D GL++ K V G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
L WMAPE + + + T + DV+SFG+++WE+ + G PY + + R +
Sbjct: 245 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
P + PE M CW +P++RP+FSE+ L ++ A
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 39/218 (17%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +++LG GT+GSVY + + G VAIK++K F E L +E L L
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY-SWEECMNL-----REVKSLRKL 54
Query: 861 -HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRK-RLIIAMDAAF 917
HPN+V + R+ + L V E+M G+L Q ++ + + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--- 974
G+ ++H H DLK ENLLV+ + V KI D GL++ +R P
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR---------EIRSRPPYTD 157
Query: 975 -----WM-APELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
W APE+L +S + +D+++ G +M EL T
Sbjct: 158 YVSTRWYRAPEILL-RSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 29/278 (10%)
Query: 799 NDDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D E + +G GTYG V+ K GS A+K + + E E I L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI--------L 68
Query: 857 LSSLHHPNVVSFYGIV--RDGPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ HPNVV FYG+ +D +G L V E GS+ ++ + +R + IIA
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 914 ---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGV 969
+A G+++LH +H D+K N+L+ K+ D G+S ++ L
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTS 184
Query: 970 RGTLPWMAPELLSGKSHMVT---EKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026
GT WMAPE+++ + + + + DV+S GI EL GD P AD+H + I N
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244
Query: 1027 ---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
TL P E+ + C D +RP+ S++
Sbjct: 245 PPPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 37/282 (13%)
Query: 806 RELGSGTYGSVYHGK----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
E+G+G +G V G+ + V +K ++AS P E+ F +E L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLL----FLQEVQPYRELN 53
Query: 862 HPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI----DRRKRLIIAMDAA 916
HPNV+ G + P V EF G LK +L+ + + +A + A
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD--LGLSKVKQQTLVSGGVRGT-L 973
G+ +LH + +H DL N + KIGD L L + + ++ L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 974 PWMAPELLSG-----KSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027
W+APEL+ T+K +++S G+ MWEL T D+PY D+ ++ +V
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226
Query: 1028 L----RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
+PQ+ W +M+ CW DP RP+ E+ L
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 11/184 (5%)
Query: 891 SLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
K +D +D L + A GM++L KN +H D+ N+L+ V
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVA 251
Query: 950 KIGDLGLSK---VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
KI D GL++ +V G R + WMAPE S + T + DV+S+GI++WE+ +
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFS 309
Query: 1007 -GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
G PY + S +V + P + PE S+M+ CW +P ERP+FS+IS+ +
Sbjct: 310 LGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
Query: 1066 RSMA 1069
+
Sbjct: 370 QRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 30/270 (11%)
Query: 808 LGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G YG+VY G +G +A+K+++ +E+E +E LL SL H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVNIV 65
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYL 922
+ G D D +++ EF+ GS+ L + + + + I+ G+ YL
Sbjct: 66 QYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPV------C--KIGDLGLSKVKQQTLVSGGVRGTLP 974
H +VH D+K N+ M P + C ++ +GL L S + GT
Sbjct: 119 HNNCVVHRDIKGNNV---MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPY 173
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIP 1033
WMAPE+++ + K D++S G ++E+ TG P A M + + I + L P++P
Sbjct: 174 WMAPEVINESGY--GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231
Query: 1034 SWCDPEWRSLMESCWASDPAERPSFSEISR 1063
+ SC D ERPS ++ R
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV-SGGVRGT 972
A GME+L + +H DL N+L++ + V KI D GL++ K V G R
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
L WMAPE + K + T + DV+SFG+++WE+ + G PY + + R +
Sbjct: 239 LKWMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
P + PE S+M CW ++P +RP+FSE+ L
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 84/287 (29%), Positives = 125/287 (43%), Gaps = 33/287 (11%)
Query: 793 GLQTIKN--DDLEEVRELGSGTYGSVYH--GKWRGSDVAIKRIKASCFAGKPSERERLIA 848
GL+++ + D E + +G GTYG VY K GS A+K + + E E I
Sbjct: 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI- 71
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPD---GSLATVTEFMVNGSLKQFLQKKDRTIDR 905
L S +HPNVV FYG+ G L V E GS+ + ++ R
Sbjct: 72 -------LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 906 RKRLIIAM---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQ 961
+I+ A G+++LH I+H D+K N+L+ K+ D G+S ++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTS 180
Query: 962 QTLVSGGVRGTLPWMAPELLSGKS---HMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS 1018
L GT WMAPE+++ + + + DV+S GI EL GD P DMH
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240
Query: 1019 IIGGIVNN---TLR-PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ I N TL P+ WC + + C D RPS + +
Sbjct: 241 TLFKIPRNPPPTLLHPE--KWCR-SFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFW-KEALLLSS 859
+ + +G G +G V+ K R + VA+K++ A + E I + +E L +
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALR--RLEGGIPNQALREIKALQA 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-RLIIAMDAAFG 918
HP VV + G V E+M L + L+ ++R + + + + M G
Sbjct: 56 CQHPYVVKLLDVFPHG--SGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-G 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GT 972
+ Y+H I+H DLK NLL++ V KI D GL+++ R T
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADG----VLKIADFGLARL----FSEEEPRLYSHQVAT 163
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APELL G +D+++ G + ELL G
Sbjct: 164 RWYRAPELLYGARKY-DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 31/266 (11%)
Query: 804 EVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +G G++G V+ G VAIK I E E I D +E +LS
Sbjct: 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P V +YG G L + E++ GS L+ D + + + G++Y
Sbjct: 61 SPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH + +H D+K N+L++ ++ K+ D G+ +++K+ T V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
MAPE++ ++ K D++S GI EL G+ P +DMH ++ I N P +
Sbjct: 168 MAPEVIQQSAY--DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGE 224
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
++ +++C DP+ RP+ E+
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 73/266 (27%), Positives = 122/266 (45%), Gaps = 31/266 (11%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +G G++G VY G + VAIK I E E I D +E +LS
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P + +YG G L + E++ GS L K ++ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH + +H D+K N+L++ ++ K+ D G+ +++K+ T V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
MAPE++ K K D++S GI EL G+ P +D+H ++ I N+ P +
Sbjct: 168 MAPEVI--KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQ 224
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
++ +E+C DP RP+ E+
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 18/268 (6%)
Query: 808 LGSGTYGSVYHGKWR---GSDVAIKRIKAS--CFAGKPSERERLIADFWKE-ALLLSSLH 861
LGSG +G VY + + + +A+K I F ER++ I D E ++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRKRLIIAMDAAFG 918
HPN+V +Y + L V + + L + L++K + + I +
Sbjct: 68 HPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 919 MEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH K IVH DL N+++ D I D GL+K KQ V GT+ +
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++ K+ EK DV++FG +++++ T P+ + S+ IV P
Sbjct: 182 PEIV--KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRL 1065
+ ++ SC D RP ++S +
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 41/279 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + E+ LG G GSV + + G A+K I P +++++ +E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQIL----RELEIN 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL----KQFLQKKDRTIDRRKRLIIAM 913
S P +V +YG D S+ E+ GSL K+ ++ R I + IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAE 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI---GDLGLSKVKQQTLVSGGVR 970
G+ YLH + I+H D+K N+L+ R Q +C G+L S ++G
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNS-------LAGTFT 164
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL--------TGDEPYADMHCASIIGG 1022
GT +MAPE + GK + +T DV+S G+ + E+ G+ P + S I
Sbjct: 165 GTSFYMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222
Query: 1023 IVNNTLRPQIPS----WCDPEWRSLMESCWASDPAERPS 1057
+ N L P W + E++ ++ C DP RP+
Sbjct: 223 MPNPEL-KDEPGNGIKWSE-EFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 811 GTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868
GTYG VY + + + VA+K++K E+E +E +L L HPN+V+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME------KEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKN 926
+V + V E++ + LK ++ + K L++ + + G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS--GVAHLHDNW 126
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGVRGTLPWMAPEL 980
I+H DLK NLL+N R + KI D GL S +K T LV TL + APEL
Sbjct: 127 ILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYRAPEL 177
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGD 1008
L G + ID++S G + ELLT
Sbjct: 178 LLGAKEY-STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 74/259 (28%), Positives = 124/259 (47%), Gaps = 22/259 (8%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++RE+G G++G+VY + + VAIK++ ++GK S + D KE L L
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRFLQKLR 73
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HPN + + G L V E+ + GS L+ + + + + A G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE-L 980
LH N++H D+K N+L++ + + K+GD G + + + GT WMAPE +
Sbjct: 131 LHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVI 183
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS--WCDP 1038
L+ K+DV+S GI EL P +M+ S + I N P + S W +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSE- 241
Query: 1039 EWRSLMESCWASDPAERPS 1057
+R+ ++SC P +RP+
Sbjct: 242 YFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 32/264 (12%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+V+ G +VAIK+I K ++E +I E L++ L +PN
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELII----NEILVMKELKNPN 77
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+F G + L V E++ GSL + + +D + + + +E+LH
Sbjct: 78 IVNFLDSFLVGDE--LFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA 133
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPWMAP 978
++H D+K +N+L+ M K+ D G + K+ T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSWCD 1037
E+++ K++ K+D++S GI+ E++ G+ PY + + + I N T Q P
Sbjct: 185 EVVTRKAY--GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
P +R + C D +R S E+
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKAS-CFAGKPSERERLIADFWKEALL--L 857
EE+ E+G G YG+VY + G VA+K+++ G P R IA LL L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA------LLKQL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDG----SLATVTEFMVNGSLKQFLQK------KDRTIDRRK 907
S HPN+V + GP L V E V+ L +L K TI
Sbjct: 56 ESFEHPNIVRLLDVC-HGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
R ++ G+++LH IVH DLK +N+LV D Q KI D GL+++ +
Sbjct: 114 RQLLR-----GVDFLHSHRIVHRDLKPQNILVT-SDGQ---VKIADFGLARIYSFEMALT 164
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWEL 1004
V TL + APE+L S+ +D++S G + EL
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-18
Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 29/266 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKE 853
+K +D +R LG+G++G V ++ D VAIKR + S +++ + + E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSE 81
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L+ ++HP V+ YG +D + L V EF++ G FL++ R A
Sbjct: 82 RKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAA 138
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
EYL NIV+ DLK ENLL++ + K+ D G +KV + + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YAD---MHCASIIGGIVNNTLR 1029
++APE+L H + D ++ GI ++E+L G P YA+ + I+ GI+
Sbjct: 193 EYIAPEILLNVGH--GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----- 245
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAER 1055
P + D + LM+ + D +R
Sbjct: 246 -YFPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-18
Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 24/268 (8%)
Query: 804 EVRELGSGTYGSVYHGK-WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++RE+G G++G+VY + R ++V IK ++GK S + D KE L + H
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA--IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKH 84
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PN + + G L V E+ + GS L+ + + + I A G+ YL
Sbjct: 85 PNSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE-LL 981
H N++H D+K N+L + +P + K+ D G + + + GT WMAPE +L
Sbjct: 142 HSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASP---ANSFVGTPYWMAPEVIL 194
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW- 1040
+ K+DV+S GI EL P +M+ S + I N + P+ EW
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNEWS 250
Query: 1041 ---RSLMESCWASDPAERPSFSEISRRL 1065
R+ ++SC P +RP+ E+ + +
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+ ++ G R G + + + S R F++ A ++S L H ++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-YSESFFEAASMMSQLSHKHL 61
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V YG+ G + + V E++ GSL +L+K I+ +L +A A+ + +L K
Sbjct: 62 VLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 926 NIVHFDLKCENLLVNMRDPQR-----PVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAP 978
+ H ++ +N+L+ +R+ R P K+ D G+S + ++ L+ +PW+ P
Sbjct: 120 GLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----RIPWVPP 173
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
E + ++ D +SFG +WE+ +G D+P + + + + R Q+P+
Sbjct: 174 ECIENPQNLSLAA-DKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---RHQLPA--- 226
Query: 1038 PEWR---SLMESCWASDPAERPSFSEISRRL 1065
P+W +L+ C +P RPSF I R L
Sbjct: 227 PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-18
Identities = 78/273 (28%), Positives = 127/273 (46%), Gaps = 26/273 (9%)
Query: 800 DDLEEV----RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKE 853
DD EE+ E+G G++G+VY ++ VA+K++ ++GK + + D KE
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEK--WQDIIKE 71
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L L HPN + + G + + V E+ + GS L+ + + + I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLK--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITH 128
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A G+ YLH N++H D+K N+L + +P + K+ D G + + GT
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSP---ANSFVGTP 181
Query: 974 PWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
WMAPE +L+ K+DV+S GI EL P +M+ S + I N P +
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTL 240
Query: 1033 PS--WCDPEWRSLMESCWASDPAERPSFSEISR 1063
S W D +R ++ C P ERP+ +E+ R
Sbjct: 241 QSNEWTD-SFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 32/215 (14%)
Query: 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +LG GTY +VY G+ R G VA+K I G PS R I+ L+ L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-------LMKELK 56
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF---- 917
H N+V + ++ + L V E+M + LK+++ T R L +F
Sbjct: 57 HENIVRLHDVIH--TENKLMLVFEYM-DKDLKKYMD----THGVRGALDPNTVKSFTYQL 109
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
G+ + H ++H DLK +NLL+N +R K+ D GL++ + T + V T
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEVV--T 163
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L + AP++L G S + ID++S G +M E++TG
Sbjct: 164 LWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 72/266 (27%), Positives = 132/266 (49%), Gaps = 23/266 (8%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKA--SCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ LG G++G+VY K + + A +R+K G+ + E + A+ +EA LLS L HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNETVQAN--QEAQLLSKLDHP 62
Query: 864 NVVSFYG--IVRDGPDGSLATVTEFMVNGSLK---QFLQKKDRTIDRRKRLIIAMDAAFG 918
+V F+ + RD + +TE+ L + L+ +T+ + + G
Sbjct: 63 AIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMA 977
+ Y+H + I+H DLK +N+ + + + KIGD G+S++ + ++ GT +M+
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE L + + K D++S G +++E+ + + S++ IV P +P
Sbjct: 174 PEALKHQGY--DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYS 230
Query: 1038 PEWRSLMESCWASDPAERPSFSEISR 1063
+ S+M+S DP+ RPS +EI R
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 77/295 (26%), Positives = 127/295 (43%), Gaps = 63/295 (21%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIK-ASCFAGKPSERERLIADFWKEALLLSS 859
++V ++G GTYG VY + + G VA+K+I+ + G PS R I+ LL
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-------LLKE 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRR--KRLIIAMDAA 916
L+HPN+V +V + L V EF ++ LK+++ T +D K + +
Sbjct: 55 LNHPNIVRLLDVVHS--ENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ- 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQT--LVSGGV 969
G+ Y H ++H DLK +NLL++ + K+ D GL++ V+ T +V
Sbjct: 111 -GIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARAFGVPVRTYTHEVV---- 161
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT------GDEPYADMHCASIIGGI 1023
TL + APE+L G T +D++S G + E++ GD + G
Sbjct: 162 --TLWYRAPEILLGSRQYST-PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT 218
Query: 1024 VNNTLRPQI----------PSW-----------CDPEWRSLMESCWASDPAERPS 1057
+ + P + P W D + L+ DPA+R S
Sbjct: 219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 44/274 (16%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+LE V +GSG G+VY R + A+K I + R I +E +L
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQIC---REIEILR 127
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
++HPNVV + + G + + EFM GSL+ ++ + R I++ G
Sbjct: 128 DVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----G 180
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWM 976
+ YLH ++IVH D+K NLL+N + V KI D G+S++ QT+ + V GT+ +M
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSA---KNV-KIADFGVSRILAQTMDPCNSSV-GTIAYM 235
Query: 977 APE-----LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY--------ADMHCASIIGGI 1023
+PE L G D++S G+ + E G P+ A + CA
Sbjct: 236 SPERINTDLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------ 287
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPS 1057
+ + P+ P+ E+R + C +PA+R S
Sbjct: 288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 72/271 (26%), Positives = 127/271 (46%), Gaps = 23/271 (8%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
N+ E + ELG G +G VY K + G+ A K I+ ++ E + D+ E +
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE--------TKSEEELEDYMVEIEI 62
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L++ +HP +V G DG L + EF G++ + + DR + + +I
Sbjct: 63 LATCNHPYIVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLPW 975
++YLH I+H DLK N+L+ + K+ D G+S +TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 976 MAPELL---SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
MAPE++ + K K D++S GI + E+ + P+ +++ ++ I + P +
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL 235
Query: 1033 --PSWCDPEWRSLMESCWASDPAERPSFSEI 1061
PS E+R +++ P RPS +++
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-17
Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIA-DFWKEALLLSS 859
E+ ++LG GTY VY + + + VAIK+IK G+ E + I +E LL
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQE 58
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI--IAMDAAF 917
L HPN++ + G ++ V EFM L++ + KD++I I +
Sbjct: 59 LKHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--KDKSIVLTPADIKSYMLMTLR 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT----L 973
G+EYLH I+H DLK NLL+ V K+ D GL++ + S + T
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR----SFGSPNRKMTHQVVT 165
Query: 974 PWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
W APELL G H +D++S G + ELL P+
Sbjct: 166 RWYRAPELLFGARHY-GVGVDMWSVGCIFAELLLRV-PF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ ++G G++G V+ G + VAIK I E E I D +E +LS
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P V +YG D L + E++ GS L+ +D + I + G++Y
Sbjct: 61 SPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPEL 980
LH + +H D+K N+L++ + K+ D G++ ++ + GT WMAPE+
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
+ K K D++S GI EL G+ P++++H ++ I N P +
Sbjct: 173 I--KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPL 229
Query: 1041 RSLMESCWASDPAERPSFSEI 1061
+ +E+C +P+ RP+ E+
Sbjct: 230 KEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG GTY +VY G+ + +D VA+K I+ G P R E LL L H N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + I+ + SL V E++ + LKQ+L +I+ + G+ Y H
Sbjct: 66 IVTLHDIIHT--EKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSG 983
+ ++H DLK +NLL+N +R K+ D GL++ K T TL + P++L G
Sbjct: 123 RKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 984 KSHMVTEKIDVYSFGIVMWELLTG 1007
+ T+ ID++ G + +E+ TG
Sbjct: 179 STDYSTQ-IDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 61/266 (22%), Positives = 130/266 (48%), Gaps = 19/266 (7%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+V+++G G++G K + G IK I S + K E R KE +LS++
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL-KQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN+V + + +G+L V ++ G L K+ ++ + L + +
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMAP 978
+++H + I+H D+K +N+ + +D K+GD G+++V T+ ++ GT +++P
Sbjct: 115 KHVHDRKILHRDIKSQNIFL-TKDG---TIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038
E+ + + K D+++ G V++E+ T + + +++ I+ + P + S
Sbjct: 171 EICENRPY--NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSY 227
Query: 1039 EWRSLMESCWASDPAERPSFSEISRR 1064
+ R+L+ + +P +RPS + I +
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 65/304 (21%), Positives = 104/304 (34%), Gaps = 67/304 (22%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+ + K + VA+K+I E +L+ +E + L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSKEDLKLL---QQEIITSRQLQHPNI 61
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---DAAFGMEYL 922
+ + D L V+ M GS + L K + L IA D ++Y+
Sbjct: 62 LPYVTSFIV--DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGT--------- 972
H K +H +K ++L+ V LS ++ +++ G R
Sbjct: 118 HSKGFIHRSVKASHILL---SGDGKVV------LSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 973 ---LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-------------- 1015
LPW++PE+L EK D+YS GI EL G P+ DM
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228
Query: 1016 ----CASI------------IGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPAERPS 1057
++ NN P + +E C DP RPS
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288
Query: 1058 FSEI 1061
S++
Sbjct: 289 ASQL 292
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-16
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +LG GTY +V+ G+ + ++ VA+K I+ G P R E LL L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLK 62
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
H N+V+ + IV D SL V E++ + LKQ++ + I G+ Y
Sbjct: 63 HANIVTLHDIVHT--DKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPEL 980
H + ++H DLK +NLL+N +R K+ D GL++ K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L G S T+ ID++ G + +E+ +G
Sbjct: 176 LLGSSEYSTQ-IDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V +G+GTYG VY G+ G AIK + + E E + + +L
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEI---NMLKKY 59
Query: 860 LHHPNVVSFYG-IVRDGP---DGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG ++ P D L V EF GS+ ++ K T+ I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G+ +LH ++H D+K +N+L+ + K+ D G+S +T+ G R
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTFI 172
Query: 971 GTLPWMAPELLSGKSH---MVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027
GT WMAPE+++ + K D++S GI E+ G P DMH + I N
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232
Query: 1028 LRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEISR 1063
P++ S W +++S +ESC + ++RP+ ++ +
Sbjct: 233 -APRLKSKKW-SKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 21/273 (7%)
Query: 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY G VA+K+++ + AD KE LL L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-----ADCIKEIDLLKQLNHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDRTIDRRKRLIIAMDAAFGME 920
NV+ +Y + D L V E G L + + +K+ R I + + +E
Sbjct: 63 NVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
++H + ++H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YAD-MHCASIIGGIVNNTLRPQIPSWCD 1037
+ + K D++S G +++E+ P Y D M+ S+ I P
Sbjct: 177 RIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070
E R L+ C DP +RP + + + M A
Sbjct: 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 58/295 (19%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D ++ ++G GTYG VY G+ + G VA+K+I+ SE E + + +E LL
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE------SEEEGVPSTAIREISLLK 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAA 916
L HPN+V ++ + L + EF+ + LK++L K + +D
Sbjct: 55 ELQHPNIVCLQDVLMQ--ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------KVKQQTLVSGGV 969
G+ + H + ++H DLK +NLL++ + V K+ D GL+ +V +V
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV---- 163
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT------GDEPYADMHCASIIGGI 1023
TL + APE+L G T +D++S G + E+ T GD + I G
Sbjct: 164 --TLWYRAPEVLLGSPRYST-PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT 220
Query: 1024 VNNTLRPQIPSWCD-----PEWR----------------SLMESCWASDPAERPS 1057
+ P + S D P+W+ L+E DPA+R S
Sbjct: 221 PTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG GTY +V+ G K + VA+K I+ G P R E LL +L H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKNLKHAN 64
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + I+ + L V E++ + LKQ+L + I G+ Y H
Sbjct: 65 IVTLHDIIHT--ERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSG 983
+ I+H DLK +NLL+N ++ K+ D GL++ K T TL + P++L G
Sbjct: 122 RKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 984 KSHMVTEKIDVYSFGIVMWELLTG 1007
+ T ID++ G +++E+ TG
Sbjct: 178 STEYST-PIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 57/158 (36%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTL 973
A GME+L KN VH DL N+L+ Q + KI D GL++ + VS G L
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKG-STFL 301
Query: 974 P--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
P WMAPE S ++ T DV+S+GI++WE+ + G PY M S + + R
Sbjct: 302 PVKWMAPE--SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P E +M CW S+P +RPSF +S + S+
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 69/267 (25%), Positives = 124/267 (46%), Gaps = 32/267 (11%)
Query: 804 EVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++G G G+VY G +VAIK++ + ++E +I E L++
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELII----NEILVMRENK 74
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HPN+V++ G + L V E++ GSL + + +D + + + +E+
Sbjct: 75 HPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 130
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH ++H D+K +N+L+ M K+ D G + K+ T+V GT W
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYW 181
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPS 1034
MAPE+++ K++ K+D++S GI+ E++ G+ PY + + + I N T Q P
Sbjct: 182 MAPEVVTRKAY--GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEI 1061
+R + C D +R S E+
Sbjct: 240 KLSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 68/249 (27%), Positives = 114/249 (45%), Gaps = 46/249 (18%)
Query: 800 DDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + + ++G GTYG VY K G VA+K+++ +E+E +E +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD------NEKEGFPITAIREIKIL 60
Query: 858 SSLHHPNVVSFYGIVRDGPD--------GSLATVTEFM-------VNGSLKQFLQKKDRT 902
L+H N+V+ IV D D G+ V E+M + L F + ++
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--- 959
K+L ++ G+ Y H KN +H D+KC N+L+N + K+ D GL+++
Sbjct: 121 F--MKQL---LE---GLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARLYNS 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT------GDEPYAD 1013
++ + V TL + PELL G+ IDV+S G ++ EL T ++ A
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
Query: 1014 MHCASIIGG 1022
+ S + G
Sbjct: 227 LELISRLCG 235
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSS 859
LG GTYG V G VAIK++K + ++ +L+ +E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ H N++ + +G + V + M LK+ + +K R + + + I+ + G+
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQILNGL 132
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG-------- 971
LH +H DL N+ +N + +CKI D GL++ S +
Sbjct: 133 NVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 972 -------TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
TL + APELL G + +D++S G + ELLTG
Sbjct: 189 EMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 35/277 (12%)
Query: 806 RELGSGTYGSVYHGK----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+E+G+G +G V G+ + + V +K ++ S A + + F +EA SL
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMK-----FLEEAQPYRSLQ 53
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAF 917
H N++ G + L V EF G LK +L+ + T D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLP 974
G+ +LH N +H DL N L+ KIGD GLS K + + + L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 975 WMAPELLSG-KSHMV----TEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
W+APEL+ +++ T++ +V+S G+ +WEL G +PY + ++ V
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 1029 ----RPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+P++ W +M+ CW P +RPS E+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE-----RERLIADFWKEA 854
DDLE ++ +G+GT+G V+ + RI +A K R + E
Sbjct: 1 DDLERIKTVGTGTFGRVH--------LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK 52
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + HP ++ + D L + E++ G L +L+ L A +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASE 109
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTL 973
+EYLH K IV+ DLK EN+L++ ++ K+ D G +K ++ +T + GT
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWT---LCGTP 162
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
++APE++ K H + +D ++ GI+++E+L G P+ D
Sbjct: 163 EYLAPEVIQSKGH--NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 69/254 (27%), Positives = 127/254 (50%), Gaps = 23/254 (9%)
Query: 808 LGSGTYGSVYH-GKWRGSDV----AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++G V+ K G D A+K +K + + R ++ E +L+ ++H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAEVNH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V + + +G L + +F+ G L L K+ + + +A + A +++L
Sbjct: 58 PFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 114
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
H I++ DLK EN+L++ + K+ D GLSK + GT+ +MAPE++
Sbjct: 115 HSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041
+ + H T+ D +SFG++M+E+LTG P+ + I+ L +P + PE +
Sbjct: 171 NRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQ 226
Query: 1042 SLMESCWASDPAER 1055
SL+ + + +PA R
Sbjct: 227 SLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E++ ++G GTYG VY + + G VA+K+ + + E + +E LL
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 858 SSLHH-PNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L +V + SL V E++ + LK+F+ R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 914 DAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQT- 963
+ G+ + H ++H DLK +NLLV D Q+ + KI DLGL + VK T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 964 -LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+V TL + APE+L G +H T +D++S G + E+
Sbjct: 171 EIV------TLWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 4e-15
Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 50/226 (22%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALL 856
++ +GSG YG V K G VAIK+I + D +E L
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------------SNVFDDLIDAKRILREIKL 52
Query: 857 LSSLHHPNVVSFYGIVR-DGPD--GSLATVTEFMVNGS-LKQFLQ-KKDRTIDRRKRLII 911
L L H N++ I+R P+ + VTE M + L + ++ + T D + +
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKV-----KQQTL 964
+ G++YLH N++H DLK N+LVN + C KI D GL++ ++
Sbjct: 111 QI--LRGLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGF 162
Query: 965 VSGGV--RGTLPWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
++ V R W APELL S T+ ID++S G + ELLT
Sbjct: 163 LTEYVVTR----WYRAPELLLSSSRY-TKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-15
Identities = 64/242 (26%), Positives = 102/242 (42%), Gaps = 52/242 (21%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+R +G G G VY + VA+K+I+ SE L F +EA + + L H
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIH 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQ--------KKDRTIDRRKRLIIAM 913
P +V Y I DG T + G +LK L+ K+ K + A
Sbjct: 62 PGIVPVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE---KTSVGAF 115
Query: 914 DAAF-----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ------ 962
+ F +EY+H K ++H DLK +N+L+ + I D G + K+
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLL 171
Query: 963 -------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDE 1009
+ G + GT +MAPE L G +E D+Y+ G++++++LT
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSF 229
Query: 1010 PY 1011
PY
Sbjct: 230 PY 231
|
Length = 932 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
DD E++ ELG+G G V R S + + R K KP+ R ++I +E +L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMAR-KLIHLEIKPAIRNQII----RELKVLHE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ P +V FYG DG ++ E M GSL Q L KK I I++ G+
Sbjct: 56 CNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGL 112
Query: 920 EYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
YL K I+H D+K N+LVN R K+ D G+S ++ + V GT +M+P
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSYMSP 167
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
E L G + V D++S G+ + E+ G P
Sbjct: 168 ERLQGTHYTVQS--DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+K+DD E++ ELG+G G V+ + S + + R K KP+ R ++I +E +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG DG ++ E M GSL Q L+K R I + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVI 113
Query: 917 FGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
M+PE L G + V D++S G+ + E+ G P
Sbjct: 169 MSPERLQGTHYSVQS--DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-15
Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+K+DD E + ELG+G G V + + S + + R K KP+ R ++I +E +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG DG ++ E M GSL Q L K+ + I +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVL 113
Query: 917 FGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
M+PE L G + V D++S G+ + EL G P
Sbjct: 169 MSPERLQGTHYSVQS--DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 57/229 (24%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ +G GTYG VY + S VA+K+++ +ER+ + +E LL +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD------NERDGIPISSLREITLLLNL 63
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF--- 917
HPN+V +V S+ F+V +Q L L+ M F
Sbjct: 64 RHPNIVELKEVVVGKHLDSI-----FLVMEYCEQDL----------ASLLDNMPTPFSES 108
Query: 918 -----------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQ 961
G++YLH I+H DLK NLL+ + KI D GL++ K
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLARTYGLPAKP 164
Query: 962 QT--LVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTG 1007
T +V TL + APELL G ++ T ID+++ G ++ ELL
Sbjct: 165 MTPKVV------TLWYRAPELLLGCTTY--TTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 42/274 (15%)
Query: 746 DTTTKEAP-------ANEAELVNIH-GEIEMDYDNDTVKTLK-----IEPTIAEAEAIAR 792
DTT P A+E +I G++E D+ ++ + PT +A +
Sbjct: 5 DTTPPLPPRSYSGGAADEDLYSDISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVA 64
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFW 851
L ++ L G+ G V+ G D + +I K + LI
Sbjct: 65 SL------GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI-----GQKGTT---LI---- 106
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA+LL +++HP+V+ + G + + + L +L K+ R + + LII
Sbjct: 107 -EAMLLQNVNHPSVIRMKDTLVSGA---ITCMVLPHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
G+ YLH + I+H D+K EN+ +N D VC IGDLG ++ G+ G
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAG 218
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
T+ APE+L+ + K D++S GIV++E+L
Sbjct: 219 TVETNAPEVLARDKY--NSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 72/273 (26%), Positives = 132/273 (48%), Gaps = 38/273 (13%)
Query: 801 DLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELL----FNEVVIMR 71
Query: 859 SLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
HPN+V Y +V D L V EF+ G+L + ++ + + +
Sbjct: 72 DYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVL 125
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG----LSK--VKQQTLVSGGVR 970
+ +LH + ++H D+K +++L+ D + K+ D G +SK ++++LV
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLT-SDGR---VKLSDFGFCAQVSKEVPRRKSLV----- 176
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030
GT WMAPE++S + TE +D++S GI++ E++ G+ PY + + I +N L P
Sbjct: 177 GTPYWMAPEVISRLPYG-TE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP 233
Query: 1031 QI--PSWCDPEWRSLMESCWASDPAERPSFSEI 1061
++ P RS ++ DPA+R + +E+
Sbjct: 234 KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GTYG+V+ K R VA+KR++ + E + + +E LL L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKEL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H N+V Y ++ D L V E+ + LK++ + ID G+
Sbjct: 57 KHKNIVRLYDVLHS--DKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQTLVSGGVRGTLPW 975
+ H N++H DLK +NLL+N + K+ D GL++ V+ S V TL +
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLARAFGIPVRC---YSAEVV-TLWY 165
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
P++L G + + + ID++S G + EL P
Sbjct: 166 RPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 22/269 (8%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIK-ASCFAGKPSERERLIADFWKEALLL 857
+R +G G++G + SD A+K I+ + R KEA+LL
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--------KEAVLL 52
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAA 916
+ + HPN+V+F DG L V E+ G L Q + ++ + L +
Sbjct: 53 AKMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-GTLPW 975
G++++H K ++H D+K +N+ + Q K+GD G +++ GT +
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
+ PE+ + K D++S G +++EL T P+ ++I + + +P +PS
Sbjct: 167 VPPEIWENMPY--NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSH 223
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064
E RSL++ + +P RPS + I R
Sbjct: 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G+Y +VY G+ + + VA+K I+ G P R EA LL L H N+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-------EASLLKDLKHANI 65
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V+ + I+ +L V E++ LKQ++ + + G+ Y H +
Sbjct: 66 VTLHDIIH--TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGTLPWMAPELLS 982
++H DLK +NLL++ +R K+ D GL++ K +T + V TL + P++L
Sbjct: 123 RVLHRDLKPQNLLIS----ERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLL 176
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTG 1007
G + T +D++ G + +E+ TG
Sbjct: 177 GSTEYSTS-LDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-14
Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 823 GSDVAIK--RIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PDG 878
G +VAIK R A E E A F +E L + L+HPN+V+ ++ G P G
Sbjct: 3 GHEVAIKLLRTDAP-------EEEHQRARFRRETALCARLYHPNIVA---LLDSGEAPPG 52
Query: 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936
L V E++ +L++ L + + ++ +DA + H + IVH DLK +N
Sbjct: 53 LLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA---LACAHNQGIVHRDLKPQN 109
Query: 937 LLVNMRDPQRPVCKIGDLGLSKV--------KQQTLVSGGVRGTLPWMAPELLSGKSHMV 988
++V+ RP K+ D G+ + + V GT + APE L G+ V
Sbjct: 110 IMVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--V 166
Query: 989 TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ---IPSW 1035
T D+Y++G++ E LTG + AS + I+ L P +P W
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRV---VQGAS-VAEILYQQLSPVDVSLPPW 212
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 30/214 (14%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASC-FAGKPSERERLIADFWKEALLLSS 859
++V ++G GTYG VY + + G VA+K+I+ G PS R I+ LL
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-------LLKE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF-- 917
L+HPN+V ++ + L V EF+ + LK+F+ D + L + F
Sbjct: 56 LNHPNIVKLLDVIHT--ENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQL 109
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
G+ + H ++H DLK +NLL+N K+ D GL++ V +T V T
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
L + APE+L G + +D++S G + E++T
Sbjct: 164 LWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 74/276 (26%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V +G+GTYG VY G+ G AIK + + E E + + +L
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEI---NMLKKY 69
Query: 860 LHHPNVVSFYG-IVRDGP---DGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG ++ P D L V EF GS+ ++ K + I +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G+ +LH ++H D+K +N+L+ + K+ D G+S +T+ G R
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTFI 182
Query: 971 GTLPWMAPELLSGKSH---MVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027
GT WMAPE+++ + + D++S GI E+ G P DMH + I N
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242
Query: 1028 LRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEI 1061
P++ S W ++ +E C + RPS ++
Sbjct: 243 -PPKLKSKKW-SKKFIDFIEGCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 70/255 (27%), Positives = 120/255 (47%), Gaps = 27/255 (10%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V + R + A+K I+ + + SE +A E +L+ ++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR-SEVTHTLA----ERTVLAQVNCPFI 55
Query: 866 V----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
V SF L V F+ G L LQ++ R R R A + +E
Sbjct: 56 VPLKFSFQS------PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALEN 108
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPEL 980
LH N+++ DLK EN+L++ + +C D GL K+ + + GT ++APEL
Sbjct: 109 LHKFNVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPEL 164
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
L G H T+ +D ++ G++++E+LTG P+ D + + I+ LR P D +
Sbjct: 165 LLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDA 220
Query: 1041 RSLMESCWASDPAER 1055
+ L+ + DP R
Sbjct: 221 KDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 64/259 (24%), Positives = 123/259 (47%), Gaps = 22/259 (8%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+VY G +VAI+++ + ++E +I E L++ +PN
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELII----NEILVMRENKNPN 78
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V++ G + L V E++ GSL + + +D + + + +E+LH
Sbjct: 79 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAPELLSG 983
++H D+K +N+L+ M K+ D G +++ + + GT WMAPE+++
Sbjct: 135 NQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 984 KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSWCDPEWRS 1042
K++ K+D++S GI+ E++ G+ PY + + + I N T Q P +R
Sbjct: 191 KAY--GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 1043 LMESCWASDPAERPSFSEI 1061
+ C D +R S E+
Sbjct: 249 FLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 27/274 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
D++E + ELG G YGSVY R + V A+K I+ K ++ E +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ-------IIMELDIL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDA 915
P +V FYG +G++ E+M GSL + T I I
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 916 AFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++L + NI+H D+K N+LVN K+ D G+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ----VKLCDFGVSGNLVASLAKTNI-GCQS 166
Query: 975 WMAPELLSG----KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI---IGGIVNNT 1027
+MAPE + ++ T + DV+S G+ + E+ G PY A+I + IV+
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P +PS + + + C P RP+++++
Sbjct: 227 -PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 38/263 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E+V ++G GTYG VY + R ++ +A+K+I+ E E + + +E LL
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE------QEDEGVPSTAIREISLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ H N+V +V + L V E++ + LK+ + D + D K + +
Sbjct: 56 KEMQHGNIVRLQDVVHS--EKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRLIKTYLY 109
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVR 970
G+ Y H ++H DLK +NLL++ R K+ D GL++ + +T V
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFGIPVRTFTHEVV- 165
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT------GDEPYADMHCASIIGGIV 1024
TL + APE+L G H T +D++S G + E++ GD ++ I G
Sbjct: 166 -TLWYRAPEILLGSRHYST-PVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP 223
Query: 1025 NNTLRPQIPSWCD-----PEWRS 1042
N P + S D P+W
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPP 246
|
Length = 294 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 34/259 (13%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLH 861
LG G++G V + +G K FA K +++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVLLAELKG--------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+P + Y + L V EF+ G L +Q K R D + A + G+++
Sbjct: 55 NPFLTHLYCTFQT--KEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQF 111
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWM 976
LH K I++ DLK +N++++ RD KI D G+ K V G R GT ++
Sbjct: 112 LHSKGIIYRDLKLDNVMLD-RDGH---IKIADFGMCKEN----VFGDNRASTFCGTPDYI 163
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L G + T +D +SFG++++E+L G P+ + I +T P P W
Sbjct: 164 APEILQGLKY--TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRWI 219
Query: 1037 DPEWRSLMESCWASDPAER 1055
E + ++E + DP R
Sbjct: 220 TKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 76/273 (27%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 808 LGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
LG GT +Y G D K IK PS R+ +A F++ A ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA-FFETASMMRQV 61
Query: 861 HHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H ++V YG+ VRD + V EF+ G L F+ +K + + +A A +
Sbjct: 62 SHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 920 EYLHGKNIVHFDLKCENLLV---NMRDPQRPVCKIGDLG--LSKVKQQTLVSGGVRGTLP 974
YL K++VH ++ +N+L+ + P K+ D G ++ + +Q V +P
Sbjct: 119 SYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RIP 173
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWEL-LTGDEPYADMHCAS---IIGGIVNNTLRP 1030
W+APE + S ++ D +SFG +WE+ G+ P D A G
Sbjct: 174 WIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG----QCML 228
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063
PS C E LM C DP +RP F I R
Sbjct: 229 VTPS-CK-ELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-14
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 10/150 (6%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVS-GGVRGT 972
A GME+L KN VH DL N+L+ + + KI D GL++ ++ +S G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
L WMAPE S +++ T DV+SFGI++WE+ T G PY ++ + R
Sbjct: 305 LKWMAPE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P+ E +M+ CW RP FS++
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 22/253 (8%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G++G V + +G++ AIK +K ++ + L L+ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE---RRVLALAW-EHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
+ + L V E++ G L +Q R + R R A + G+++LH K
Sbjct: 59 THLFCTFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLHKK 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GTLPWMAPELLS 982
I++ DLK +N+L++ +D KI D G+ K + G GT ++APE+L
Sbjct: 116 GIIYRDLKLDNVLLD-KDGH---IKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILK 169
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042
G+ + E +D +SFG++++E+L G P+ + I+N+ RP P W E +
Sbjct: 170 GQKY--NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAKD 225
Query: 1043 LMESCWASDPAER 1055
+ + DP +R
Sbjct: 226 CLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-14
Identities = 67/264 (25%), Positives = 123/264 (46%), Gaps = 32/264 (12%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+VY G +VAIK++ + ++E +I E L++ +PN
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELII----NEILVMRENKNPN 77
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V++ G + L V E++ GSL + + +D + + + +++LH
Sbjct: 78 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHS 133
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPWMAP 978
++H D+K +N+L+ M K+ D G + K+ T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSWCD 1037
E+++ K++ K+D++S GI+ E++ G+ PY + + + I N T Q P
Sbjct: 185 EVVTRKAY--GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
+R + C D R S E+
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 66/269 (24%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
E + ELG G +G VY + + + V + A+ SE E + D+ E +L+S H
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEE--LEDYMVEIDILASCDH 61
Query: 863 PNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
PN+V +FY + +L + EF G++ + + +R + + ++
Sbjct: 62 PNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMA 977
+ YLH I+H DLK N+L + K+ D G+S +T+ GT WMA
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 978 PELL---SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI-- 1032
PE++ + K K DV+S GI + E+ + P+ +++ ++ I + P +
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTLAQ 230
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEI 1061
PS E++ ++ C + R + +++
Sbjct: 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 73/298 (24%), Positives = 115/298 (38%), Gaps = 66/298 (22%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E + +G G YG V + + G VAIK+ K S + E + A +E +L L
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTA--LREVKVLRQL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDAAFG 918
H N+V+ R G L V E+ V +L + L+ + + I + A
Sbjct: 58 RHENIVNLKEAFRR--KGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GT 972
Y H NI+H D+K EN+LV+ + V K+ D G ++ L + T
Sbjct: 115 --YCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFAR----ALRARPASPLTDYVAT 164
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG----------DEPYADMHCASIIGG 1022
+ APELL G + +DV++ G +M ELL G D+ Y C +G
Sbjct: 165 RWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC---LGP 220
Query: 1023 I------------VNNTLR-PQI----------PSWCDPEWRSLMESCWASDPAERPS 1057
+ + P+ P +++C DP ER +
Sbjct: 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 33/271 (12%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E +R LG+G YG V+ G G A+K +K + K + ER + +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+ L +LH+ +F D L + +++ G L L +++ + R+
Sbjct: 61 VRRCPFLVTLHY----AFQ------TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
IA + +++LH I++ D+K EN+L+ D + V + D GLSK + ++ +
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILL---DSEGHV-VLTDFGLSKEFLAEEEERAYS 165
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY----ADMHCASIIGGIV 1024
GT+ +MAPE++ G S + +D +S G++ +ELLTG P+ + I I+
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL 225
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
+ +P P E R ++ DP +R
Sbjct: 226 KS--KPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 73/321 (22%), Positives = 122/321 (38%), Gaps = 79/321 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
++++ LG G G V+ + +G+ A+K + +R ++ E +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM----IKRNKVKRVLT-EQEIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
++L HP + + Y S T V ++ G L + LQ++ K L
Sbjct: 56 ATLDHPFLPTLYA--------SFQTETYLCLVMDYCPGGELFRLLQRQ-----PGKCLSE 102
Query: 912 AMDAAF-------GMEYLHGKNIVHFDLKCENLLV---------------NMRDPQRPVC 949
A F +EYLH IV+ DLK EN+L+ PV
Sbjct: 103 E-VARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 950 KIGDLGLSKVKQQTLV------SGGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFG 998
K G + ++ R GT ++APE++SG H +D ++ G
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLG 219
Query: 999 IVMWELLTGDEPYA----DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAE 1054
I+++E+L G P+ D ++I+ V P + S R L+ DP
Sbjct: 220 ILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSA----RDLIRKLLVKDP-- 273
Query: 1055 RPSFSEISRRLRSMAAAINVK 1075
S+RL S A +K
Sbjct: 274 -------SKRLGSKRGAAEIK 287
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 30/269 (11%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E ++ LG+G YG V+ G G A+K ++ + K + ER + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+++ L +LH+ +F + L + +++ G + L ++D + R
Sbjct: 61 VRQSPFLVTLHY----AFQ------TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
+ +E+LH IV+ D+K EN+L+ D + V + D GLSK + ++ +
Sbjct: 111 SG-EIILALEHLHKLGIVYRDIKLENILL---DSEGHVV-LTDFGLSKEFLSEEKERTYS 165
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028
GT+ +MAPE++ GK + +D +S GI+++ELLTG P+ + + L
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 1029 R--PQIPSWCDPEWRSLMESCWASDPAER 1055
+ P PS+ PE + L+ DP +R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/231 (28%), Positives = 111/231 (48%), Gaps = 16/231 (6%)
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
PS R+ +A F++ A L+S + H ++ +G+ G + + V EF+ +G L L+K+
Sbjct: 54 PSHRDIALA-FFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPLDVCLRKE 110
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPVCKIGDLGL 956
+ ++ +A A + YL KN+VH ++ +N+L+ + P K+ D G+
Sbjct: 111 KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 957 SKVKQQTLVSGGVR-GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWEL-LTGDEPYADM 1014
S T +S R +PW+APE + G + + T D +SFG + E+ G+ P +
Sbjct: 171 S----FTALSREERVERIPWIAPECVPGGNSLST-AADKWSFGTTLLEICFDGEVPLKE- 224
Query: 1015 HCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
S R PS C E +L+ C +P +RPSF I R L
Sbjct: 225 RTPSEKERFYEKKHRLPEPS-C-KELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + + +GSG YG V + VAIK++ +P + ++E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS------RPFQSAIHAKRTYRELRLL 68
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+ H NV+ + P SL VT M L ++ + + D + L+
Sbjct: 69 KHMDHENVIGLLDVFT--PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVY 125
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGV 969
+ G++Y+H I+H DLK N+ VN D C KI D GL++ + G
Sbjct: 126 QI--LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLARHTDDEMT--GY 175
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
T + APE++ H + +D++S G +M ELLTG
Sbjct: 176 VATRWYRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 40/267 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E + +LG GT+G VY + G VA+K+I +E++ +E +L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH------NEKDGFPITALREIKIL 61
Query: 858 SSLHHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
L HPNVV + + PD GS+ VT +M + L L+ + +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGG 968
+ G+ YLH +I+H D+K N+L++ + + KI D GL++ GG
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 969 VRG---------TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD---EPYADMHC 1016
G T + PELL G+ T +D++ G V E+ T + +D+
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSL 1043
+I + P +W P WRSL
Sbjct: 236 LHLIFKLCGT---PTEETW--PGWRSL 257
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 22/264 (8%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G V + + G A K++ + E+ L E +L + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLH 923
VS Y + D L V M G LK + + + + A G+E+LH
Sbjct: 56 VSLAYAF--ETKD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELLS 982
+ IV+ DLK EN+L++ +I DLGL+ ++K + G GT +MAPE+L
Sbjct: 113 QRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQ 167
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI--PSWCDPEW 1040
G+ + +D ++ G ++E++ G P+ + TL + P PE
Sbjct: 168 GEVY--DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEA 225
Query: 1041 RSLMESCWASDPAERPSFSEISRR 1064
+ L E+ DP +R S
Sbjct: 226 KDLCEALLQKDPEKRLGCRGGSAD 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 21/271 (7%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY VA+K+++ + + D KE LL L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-----DCVKEIDLLKQLNHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ---FLQKKDRTIDRRKRLIIAMDAAFGME 920
NV+ + + D L V E G L Q + +K+ R I R + +E
Sbjct: 63 NVIKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
++H + ++H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YAD-MHCASIIGGIVNNTLRPQIPSWCD 1037
+ + K D++S G +++E+ P Y D M+ S+ I P
Sbjct: 177 RIHENGYNF--KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ R L+ C DP +RP + + + M
Sbjct: 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
+DL+++ E+G G +G+V + S A+KRI+ S K E++RL+ D + ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEK--EQKRLLMDL--DVVMR 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ----KKDRTIDRRKRLIIAM 913
SS P +V FYG + +G E M + SL +F + I IA+
Sbjct: 59 SS-DCPYIVKFYGALFR--EGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ YL + I+H D+K N+L++ + K+ D G+S ++ G
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 973 LPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI---IGGIVNN-- 1026
P+MAPE + + DV+S GI ++E+ TG PY + S+ + +V
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDP 228
Query: 1027 -TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
L P + + + C D ++RP + E+
Sbjct: 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 57/223 (25%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E ++ LG+G YG V+ G G A+K +K + K + ER + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+++ L +LH+ +F D L + +++ G L L +++R ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQ------TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
+ +E+LH I++ D+K EN+L+ D V + D GLSK + + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
GT+ +MAP+++ G + +D +S G++M+ELLTG P+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 36/260 (13%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLH 861
LG G++G V+ + +G++ FA K +++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVFLAELKGTN--------QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HP + Y + + L V E++ G L +Q + D + A + G+++
Sbjct: 55 HPFLTHLYCTFQTKEN--LFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQF 111
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------VKQQTLVSGGVRGTLPW 975
LH K IV+ DLK +N+L++ KI D G+ K K T GT +
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKENMLGDAKTCTFC-----GTPDY 162
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
+APE+L G+ + +D +SFG++++E+L G P+ + I P P W
Sbjct: 163 IAPEILLGQKY--NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRW 218
Query: 1036 CDPEWRSLMESCWASDPAER 1055
E + ++ + +P R
Sbjct: 219 LTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 44/278 (15%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+ +LG G+Y +VY G R G VA+K I G P R EA LL L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-------EASLLKGLKH 62
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
N+V + I+ +L V E+M + L Q++ + + + G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGTLPWMAPE 979
HG++I+H DLK +NLL++ K+ D GL++ K QT S V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA--------SIIGGIVNNT---- 1027
+L G + + +D++ G + E+L G + + +++G +T
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232
Query: 1028 -----LRPQIPSWCDPE-----WRSLMESCWASDPAER 1055
+P+ C P+ W+ L A D A +
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQ 270
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 30/269 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +GSGTYG VY + G AIK IK +P E ++ +E +++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQ---QEIIMM 60
Query: 858 SSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
H N+V+++G + RD L EF GSL+ + + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRET 115
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLP 974
G+ YLH K +H D+K N+L+ K+ D G+S T+ GT
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIAKRKSFIGTPY 171
Query: 975 WMAPELLS-GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
WMAPE+ + + + D+++ GI EL P D+H + + + +P P
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP--P 229
Query: 1034 SWCDP-EWRS----LMESCWASDPAERPS 1057
D +W + ++ +P +RP+
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 807 ELGSGTYGSVYHGKWRG----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++G GTYG VY K + D A+K+I+ + + +E LL L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-------MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
PNV+S + D + + ++ ++ KK + R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRG 971
G+ YLH ++H DLK N+LV P+R KI D+G +++ L V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC 1016
T + APELL G H T+ ID+++ G + ELLT EP HC
Sbjct: 178 TFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT-SEPI--FHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 67/281 (23%), Positives = 128/281 (45%), Gaps = 36/281 (12%)
Query: 806 RELGSGTYGSVYHGK-WRGSDVA---IKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+E+G+G +G V + + + VA +K +KA+ E+ +F ++ L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQN----EFLQQGDPYRILQ 53
Query: 862 HPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLI--IAMDAAF 917
HPN++ G V P V E+ G LK +L Q++ + + L+ +A + A
Sbjct: 54 HPNILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD--LGLSKVKQQTLVS-GGVRGTLP 974
G+ ++H N +H DL N + K+GD +G S+ K+ + + L
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 975 WMAPELLSGKSHMV-----TEKIDVYSFGIVMWELL-TGDEPYADMHCASIIGGIVNNT- 1027
W+APEL+ + T+ +V++ G+ +WEL +PY+ + ++ ++ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226
Query: 1028 ---LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
+PQ+ W +++ CW S P +R + E+ R L
Sbjct: 227 VKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 70/260 (26%), Positives = 125/260 (48%), Gaps = 27/260 (10%)
Query: 805 VRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++ LG G YG V+ G G A+K +K + ++ A E +L +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEA 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ HP +V + G G L + E++ G L L+++ ++ ++ + + +
Sbjct: 57 VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLAL 113
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
E+LH + I++ DLK EN+L+ D Q V K+ D GL K +++ G V GT+ +
Sbjct: 114 EHLHQQGIIYRDLKPENILL---DAQGHV-KLTDFGLCK---ESIHEGTVTHTFCGTIEY 166
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
MAPE+L H + +D +S G +M+++LTG P+ + I I+ L +P +
Sbjct: 167 MAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLPPY 222
Query: 1036 CDPEWRSLMESCWASDPAER 1055
PE R L++ +P+ R
Sbjct: 223 LTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+++++GSG YG+V R G+ VAIK++ +P + E ++E LL +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H NV+ + PD SL +F + L + ++ + + DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G++Y+H I+H DLK NL VN + KI D GL++ + G T +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQTDSEMT--GYVVTRWYR 182
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
APE++ H T+ +D++S G +M E+LTG
Sbjct: 183 APEVILNWMHY-TQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864
+G GT+ V + R G AIK +K K E+ + +E L L HPN
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQ----VNNLREIQALRRLSPHPN 59
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
++ ++ D G LA V E M + +L + ++ + R + ++ ++++H
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--------WM 976
I H D+K EN+L+ + K+ D G + G+ P W
Sbjct: 119 NGIFHRDIKPENILIK-----DDILKLADFGSCR---------GIYSKPPYTEYISTRWY 164
Query: 977 -APE-LLSGKSHMVTEKIDVYSFGIVMWELLT 1006
APE LL+ + K+D+++ G V +E+L+
Sbjct: 165 RAPECLLTDGYY--GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 66/265 (24%), Positives = 125/265 (47%), Gaps = 24/265 (9%)
Query: 802 LEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELL----FNEVVIMRD 73
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H NVV Y G + L V EF+ G+L + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
LH + ++H D+K +++L+ K+ D G ++V ++ + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW--C 1036
EL+S + ++D++S GI++ E++ G+ PY + + I +N L P++ +
Sbjct: 186 ELISRLPY--GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKV 242
Query: 1037 DPEWRSLMESCWASDPAERPSFSEI 1061
P + ++ DPA+R + +E+
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 55/289 (19%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-KPSERER--------LIADFWK---- 852
R LGSG G+V K R SD +K G +++ R L DF+
Sbjct: 38 RVLGSGATGTVLCAK-RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 853 -EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKR 908
E +P V +A V ++ G L+Q ++ K +RT +
Sbjct: 97 HEDFAKKDPRNPENVLM-----------IALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
++ + + ++H K+++H D+K N+L+ + K+GD G SK+ T VS
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SNGLVKLGDFGFSKMYAAT-VSDD 200
Query: 969 VR----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY--ADMHCASIIGG 1022
V GT ++APE+ K + ++K D++S G++++ELLT P+ +M
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPY--SKKADMFSLGVLLYELLTLKRPFDGENME------E 252
Query: 1023 IVNNTLRPQ---IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+++ TL + +P PE + ++ + +SDP RPS S +L +M
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPS----SSKLLNM 297
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 22/222 (9%)
Query: 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
K D E++ +LG G+Y +VY GK + G VA+K I+ G P R EA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-------EAS 55
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
LL L H N+V + I+ +L V E+ V+ L Q++ K + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK---QQTLVSGGVRGT 972
G+ Y+H + I+H DLK +NLL++ K+ D GL++ K T + V T
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSNEVV--T 166
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM 1014
L + P++L G + T +D++ G + E++ G + M
Sbjct: 167 LWYRPPDVLLGSTEYST-CLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 9e-12
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 808 LGSGTYG---SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G YG S H K G VAIK+I P E + +E +L H N
Sbjct: 13 IGEGAYGMVCSATH-KPTGVKVAIKKIS-------PFEHQTFCQRTLREIKILRRFKHEN 64
Query: 865 VVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
++ I+R P S + V E M L + ++ + + D + + + G
Sbjct: 65 IIGILDIIR--PP-SFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQI--LRG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR----GT 972
++Y+H N++H DLK NLL+N C KI D GL+++ G T
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTN------CDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 973 LPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE +L+ K + T+ ID++S G ++ E+L+
Sbjct: 173 RWYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 807 ELGSGTYGSVYHGKWR-GSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++G GTYG VY K + G D A+K+I+ + + +E LL L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-------MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
PNV++ + D + + ++ ++ KK + R +
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRG 971
G+ YLH ++H DLK N+LV P+R KI D+G +++ L V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC 1016
T + APELL G H T+ ID+++ G + ELLT EP HC
Sbjct: 178 TFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT-SEPI--FHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 60/289 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+DLE + E+GSGT G VY +++ G +A+K+++ + G E +R++ D ++L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDL---DVVL 68
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------- 910
S P +V YG F+ + + ++ +D+ + I
Sbjct: 69 KSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPED 114
Query: 911 ----IAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKV 959
+ + + YL K ++H D+K N+L++ K+ D G+ SK
Sbjct: 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKLCDFGISGRLVDSKA 170
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKI--DVYSFGIVMWELLTGDEPYADMHCA 1017
K ++ G +MAPE + I DV+S GI + EL TG PY + C
Sbjct: 171 KTRS------AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN--CK 222
Query: 1018 S---IIGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEI 1061
+ ++ I+ P +P P++ S ++ C D +RP + E+
Sbjct: 223 TEFEVLTKILQEEP-PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + +GSG YG V G VAIK+I F + L +E +
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTL-----RELKI 57
Query: 857 LSSLHHPNVVSFYGIVR-DGPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L H N+++ I+R G D + V + M L I + L
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHI-------IHSDQPLTEEHI 109
Query: 915 AAF------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------VKQQ 962
F G++Y+H N++H DLK NLLVN + +IGD G+++ + +
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFGMARGLSSSPTEHK 165
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
++ V T + APELL T ID++S G + E+L
Sbjct: 166 YFMTEYV-ATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 66/264 (25%), Positives = 124/264 (46%), Gaps = 40/264 (15%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIAD-------FWKEALL 856
+ LG G++G V + +G+D A+K +K ++ ++ D K L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK----------KDVILQDDDVECTMTEKRVLA 50
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L+ HP + + + D L V E++ G L +Q+ R + R R A +
Sbjct: 51 LAG-KHPFLTQLHSCFQT-KD-RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY-AAEIV 106
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----G 971
G+++LH + I++ DLK +N+L++ KI D G+ K + GGV G
Sbjct: 107 LGLQFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCG 158
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031
T ++APE+LS + + +D ++ G++++E+L G P+ + I+ + +R
Sbjct: 159 TPDYIAPEILSYQPY--GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-- 214
Query: 1032 IPSWCDPEWRSLMESCWASDPAER 1055
P W E +S+++S +P +R
Sbjct: 215 YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 802 LEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELL----FNEVVIMRD 75
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HH NVV Y G + L V EF+ G+L + ++ + + + +
Sbjct: 76 YHHENVVDMYNSYLVGDE--LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRAL 131
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
YLH + ++H D+K +++L+ K+ D G ++V ++ + GT WMAP
Sbjct: 132 SYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
E++S + ++D++S GI++ E++ G+ PY
Sbjct: 188 EVISRLPY--GTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 25/255 (9%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPN 864
LG G +G V +++ + AIK +K + E E L+ + K +S HP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR-DEVESLMCE--KRIFETANSERHPF 63
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + + + + V E+ G L + + + A G++YLH
Sbjct: 64 LVNLFACFQT--EDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHE 119
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGVRGTLPWMAPEL 980
IV+ DLK +NLL+ D + V KI D GL K +T GT ++APE+
Sbjct: 120 NKIVYRDLKLDNLLL---DTEGFV-KIADFGLCKEGMGFGDRT---STFCGTPEFLAPEV 172
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
L+ S+ T +D + G++++E+L G+ P+ + IVN+ +R P + E
Sbjct: 173 LTETSY--TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRFLSREA 228
Query: 1041 RSLMESCWASDPAER 1055
S+M +P R
Sbjct: 229 ISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 32/269 (11%)
Query: 802 LEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
LE ++G G+ G V K G VA+K + K RE L + E +++
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELL----FNEVVIMRD 74
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H NVV Y G + L + EF+ G+L + + ++ + ++ A +
Sbjct: 75 YQHQNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA--L 130
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
YLH + ++H D+K +++L+ + K+ D G +++ + + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP----- 1033
E++S ++ TE +D++S GI++ E++ G+ PY + LR P
Sbjct: 187 EVIS-RTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKN 239
Query: 1034 -SWCDPEWRSLMESCWASDPAERPSFSEI 1061
P R +E +P ER + E+
Sbjct: 240 AHKISPVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 29/256 (11%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K ++ K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----VAHTVTESRVLQNTRHPFL 57
Query: 866 VSF-YGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+ Y D L V E+ G L L ++ + R R A + +EYLH
Sbjct: 58 TALKYAFQTHD----RLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPE 979
+++V+ D+K ENL+++ +D KI D GL K + + G GT ++APE
Sbjct: 113 SRDVVYRDIKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039
+L + +D + G+VM+E++ G P+ + + I+ +R P PE
Sbjct: 166 VLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPE 221
Query: 1040 WRSLMESCWASDPAER 1055
+SL+ DP +R
Sbjct: 222 AKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 23/261 (8%)
Query: 803 EEVRELGSGTYGSVYHG---KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL--L 857
E V E+G G YG V+ K G VA+KR++ + E ++ + A+L L
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHL 58
Query: 858 SSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAM 913
+ HPNVV + + R + L V E V+ L +L K + + +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+++LH +VH DLK +N+LV K+ D GL+++ + V TL
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----IKLADFGLARIYSFQMALTSVVVTL 173
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
+ APE+L S+ +D++S G + E+ + +G I++ P
Sbjct: 174 WYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231
Query: 1034 SWCDPEWRSLMESCWASDPAE 1054
W P +L + S A+
Sbjct: 232 DW--PRDVALPRQAFHSKSAQ 250
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 72/267 (26%), Positives = 114/267 (42%), Gaps = 32/267 (11%)
Query: 801 DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D++ LG G G+VY +A+K I E ++ I E +L
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIM---SELEILY 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
P ++ FYG + ++ TEFM GSL + + + + R IA+ G
Sbjct: 55 KCDSPYIIGFYGAFF--VENRISICTEFMDGGSLDVYRKIPEHVLGR-----IAVAVVKG 107
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+ YL I+H D+K N+LVN R K+ D G+S ++ V GT +MAP
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRGQ----VKLCDFGVSTQLVNSIAKTYV-GTNAYMAP 162
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM---HCA----SIIGGIVNNTLRPQ 1031
E +SG+ + + DV+S GI EL G PY + + ++ IV+ P
Sbjct: 163 ERISGEQYGIHS--DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPV 219
Query: 1032 IP-SWCDPEWRSLMESCWASDPAERPS 1057
+P ++ + C P ERP+
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPS------ERERLIADFWKEALLLSS 859
+G GT+G VY + + + A+K + K ER L+ E+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L SF D L VT++M G L LQK+ R + R + IA + +
Sbjct: 61 LK----FSFQ------TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLAL 109
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAP 978
E+LH +IV+ DLK EN+L++ +C D GLSK + GT ++AP
Sbjct: 110 EHLHKYDIVYRDLKPENILLDA-TGHIALC---DFGLSKANLTDNKTTNTFCGTTEYLAP 165
Query: 979 E-LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
E LL K + T+ +D +S G++++E+ G P+
Sbjct: 166 EVLLDEKGY--TKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 60/293 (20%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-RLIADFWKEALLLSSLHHPN 864
+G G+YG V K + G VAIK+ F ++ + IA +E +L L H N
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKK-----FLESEDDKMVKKIA--MREIRMLKQLRHEN 61
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + R L V EF+ + L L+K +D + G+E+ H
Sbjct: 62 LVNLIEVFRR--KKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG-----VRGTLPWMAPE 979
NI+H D+K EN+LV+ Q V K+ D G ++ TL + G T + APE
Sbjct: 119 HNIIHRDIKPENILVS----QSGVVKLCDFGFAR----TLAAPGEVYTDYVATRWYRAPE 170
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY----ADM----HCASIIGGIVNN----- 1026
LL G + +D+++ G ++ E+LTG EP +D+ H +G ++
Sbjct: 171 LLVGDTKY-GRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
Query: 1027 ------------------TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
L + P L + C DP +RPS S++
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GT+G V+ + + + VA+K++ +E+E +E +L L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME------NEKEGFPITALREIKILQLL 68
Query: 861 HHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIA 912
H NVV+ I R GS V EF + L L K T+ K+++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVS 966
+ G+ Y+H I+H D+K N+L+ +D + K+ D GL SK + +
Sbjct: 128 LLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRYT 181
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
V TL + PELL G+ ID++ G +M E+ T
Sbjct: 182 NRVV-TLWYRPPELLLGERDYGP-PIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V + + + A+K ++ K E+ + + +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + L V +++ G L LQ++ ++ R R A + A + YLH
Sbjct: 59 VGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGK 984
NIV+ DLK EN+L+ D Q + + D GL K + + GT ++APE+L +
Sbjct: 116 NIVYRDLKPENILL---DSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 985 SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSWCDPEWRS 1042
+ T +D + G V++E+L G P+ + A + I+N L+P I + R
Sbjct: 172 PYDRT--VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITN----SARH 225
Query: 1043 LMESCWASDPAERPSFSE 1060
L+E D +R +
Sbjct: 226 LLEGLLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E V E+G G YG+VY + G VA+K ++ + + L +E LL L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV------QTNEDGLPLSTVREVALLKRL 56
Query: 861 H---HPNVVSFYGI---VRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRK 907
HPN+V + R + + V E V+ L+ +L K + D +
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
+ + G+++LH IVH DLK EN+LV K+ D GL+++ +
Sbjct: 116 QFLR------GLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALT 165
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
V TL + APE+L ++ +D++S G + E+
Sbjct: 166 PVVVTLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 26/255 (10%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E +L + HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-----VAHTLTENRVLQNSRHPFL 57
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG- 924
+ + L V E+ NG F ++R + + ++YLH
Sbjct: 58 TALKYSFQT--HDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 114
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPEL 980
KN+V+ DLK ENL+++ +D KI D GL K + + G GT ++APE+
Sbjct: 115 KNVVYRDLKLENLMLD-KDGH---IKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 167
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
L + +D + G+VM+E++ G P+ + + I+ +R P PE
Sbjct: 168 LEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 223
Query: 1041 RSLMESCWASDPAER 1055
+SL+ DP +R
Sbjct: 224 KSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-10
Identities = 76/295 (25%), Positives = 126/295 (42%), Gaps = 56/295 (18%)
Query: 799 NDDLEEVRE---LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKE 853
ND L ++E + G G+ Y GK + + +K I S IAD K
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADMGK- 739
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L HPN+V G+ R L + E++ +L + L ++ + +RR+++ I +
Sbjct: 740 ------LQHPNIVKLIGLCRSEKGAYL--IHEYIEGKNLSEVL--RNLSWERRRKIAIGI 789
Query: 914 DAAFGMEYLH---GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A + +LH +V +L E ++++ +D P ++ GL + +S
Sbjct: 790 AKA--LRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLRLSLPGLLCTDTKCFISSA-- 843
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN----N 1026
++APE K +TEK D+Y FG+++ ELLTG P AD + G IV
Sbjct: 844 ----YVAPETRETKD--ITEKSDIYGFGLILIELLTGKSP-ADAE-FGVHGSIVEWARYC 895
Query: 1027 TLRPQIPSWCDP--------------EWRSLMESCWASDPAERPSFSEISRRLRS 1067
+ W DP E +L C A+DP RP +++ + L S
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/253 (23%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G++G V + + S A+K +K + + + ++ +L + +HP
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL----QDDDVECTMTEKRILSLARNHP 56
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+ Y + PD L V EF VNG F +K R D + A + + +LH
Sbjct: 57 FLTQLYCCFQT-PD-RLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELLS 982
K I++ DLK +N+L++ + CK+ D G+ K + GT ++APE+L
Sbjct: 114 DKGIIYRDLKLDNVLLD-HEGH---CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL- 168
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042
+ + +D ++ G++++E+L G P+ + + I+N+ + P+W +
Sbjct: 169 -QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAVD 225
Query: 1043 LMESCWASDPAER 1055
++++ +P R
Sbjct: 226 ILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVA-----------IKRIKASCFAGKPSERERLIA 848
+D E ++ +G G +G V K + +D +KR + +CF ER+ L+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR---EERDVLVN 57
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +D + +L V ++ V G L L K +DR +
Sbjct: 58 G---DNQWITTLHYA--------FQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R +A + ++ +H + VH D+K +N+L++M R + D G L ++ T+
Sbjct: 105 RFYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQ 159
Query: 966 SGGVRGTLPWMAPELLS----GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021
S GT +++PE+L GK E D +S G+ M+E+L G+ P+ G
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 1022 GIVNNTLRPQIPS 1034
I+N+ R Q P+
Sbjct: 219 KIMNHKERFQFPA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+GSG YGSV K G VAIK++ +P + E ++E LL + H NV
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 866 VSFYGIVRDGPDGSLATVTEF-MVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEY 921
+ + S +F +V ++ LQK + D+ + L+ M G++Y
Sbjct: 77 IGLLDVFTSAV--SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC--GLKY 132
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELL 981
+H I+H DLK NL VN D + KI D GL++ + G T + APE++
Sbjct: 133 IHSAGIIHRDLKPGNLAVN-EDCE---LKILDFGLARHADAEMT--GYVVTRWYRAPEVI 186
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTG 1007
H + +D++S G +M E+LTG
Sbjct: 187 LNWMHY-NQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 66/230 (28%), Positives = 114/230 (49%), Gaps = 20/230 (8%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + GS A+K ++ K E+ ++A+ +LL +L HP +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + L V +++ G L LQ++ ++ R R A + A + YLH
Sbjct: 59 VGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSG 983
NI++ DLK EN+L+ D Q V + D GL K V+ + S GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHVV-LTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRK 170
Query: 984 KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
+ + T +D + G V++E+L G P+ + + I++ L Q+P
Sbjct: 171 EPYDRT--VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--QLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 27/255 (10%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLQNTRHPFL 57
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+ Y L V E+ NG F ++R + + + YLH
Sbjct: 58 TALKYSF---QTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPEL 980
++V+ DLK ENL+++ +D KI D GL K + + G GT ++APE+
Sbjct: 114 CDVVYRDLKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
L + + +D + G+VM+E++ G P+ + + I+ +R P PE
Sbjct: 167 L--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEA 222
Query: 1041 RSLMESCWASDPAER 1055
+SL+ DP +R
Sbjct: 223 KSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 18/251 (7%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + A+K ++ K E++ ++A+ +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAE---RNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + D L V +++ G L LQ++ + R R A + A + YLH
Sbjct: 59 VGLHYSFQT-AD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFY-AAEIASALGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGK 984
NI++ DLK EN+L+ D Q V + D GL K + + + GT ++APE+L +
Sbjct: 116 NIIYRDLKPENILL---DSQGHV-VLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 985 SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLM 1044
+ T +D + G V++E+L G P+ A + I+N LR + R L+
Sbjct: 172 PYDRT--VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLL 227
Query: 1045 ESCWASDPAER 1055
E D +R
Sbjct: 228 EGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIA--DFWK 852
D+E R +G G +G V W G VA+K++ P+ + L++ ++
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKM--------PNVFQNLVSCKRVFR 48
Query: 853 EALLLSSLHHPNVVSFYGIVRD---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
E +L H NV+S I++ P + VTE M + K + + + D K
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK-- 106
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-------- 961
+ G++YLH I+H D+K NLLVN V KI D GL++V++
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMT 162
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
Q +V+ R APE+L G H T +D++S G + ELL
Sbjct: 163 QEVVTQYYR------APEILMGSRHY-TSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 67/217 (30%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 805 VRELGSGTYGSVYHGKWRGSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++ELG G YG V + + VAIK+I + F+ K + L +E LL
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRAL-----RELKLLRHF 58
Query: 861 H-HPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
H N+ Y IV G L E M L Q ++ D + I
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-YQILC 116
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVRG 971
G++Y+H N++H DLK NLLVN D + KI D GL+ + ++ V
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNA-DCE---LKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 972 TLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
T + APE +LS +S+ T+ IDV+S G ++ ELL
Sbjct: 172 TRWYRAPEIMLSFQSY--TKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 38/252 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-----------VAIKRIKASCFAGKPSERERLIA 848
DD E ++ +G G +G V K + ++ +KR + +CF ER L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR---EERNVLVN 57
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +D + L V ++ V G L L K +DR +
Sbjct: 58 G---DCQWITTLHYA--------FQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R IA + + +H + VH D+K +N+L++M R + D G L + T+
Sbjct: 105 RFYIA-EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQ 159
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTE---KIDVYSFGIVMWELLTGDEPYADMHCASIIGG 1022
S GT +++PE+L + + + D +S G+ M+E+L G+ P+ G
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 1023 IVNNTLRPQIPS 1034
I+N+ R Q PS
Sbjct: 220 IMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 37/237 (15%)
Query: 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKAS--CFAGKPSERERLI-- 847
R LQ +K +D + V+ +G G +G +V + R K+S +A K + +I
Sbjct: 36 RKLQ-MKAEDYDVVKVIGRGAFG----------EVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 848 ---ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
A FW+E +++ + P VV + +D D L V E+M G L + D +
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNYD--VP 140
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+ + ++ +H ++H D+K +N+L++ + K+ D G +T
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDET- 195
Query: 965 VSGGVR-----GTLPWMAPELL--SGKSHMVTEKIDVYSFGIVMWELLTGDEP-YAD 1013
G VR GT +++PE+L G + D +S G+ ++E+L GD P YAD
Sbjct: 196 --GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 45/236 (19%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKAS-CFAGKPSERERLIADFWKEALLLSSL 860
++R LG G+ G V+ D VA+K+I + + K + RE I + L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI---------IRRL 59
Query: 861 HHPNVVSFYGIVRDGPDGS-----LATVTEFMVNGSLKQFLQKKDRTIDRRKRL------ 909
H N+V Y ++ GP GS + ++TE ++++++ + + L
Sbjct: 60 DHDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK--------- 960
+ G++Y+H N++H DLK N+ +N D V KIGD GL+++
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPHYSHKGY 174
Query: 961 -QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015
+ LV+ R +P LL ++ T+ ID+++ G + E+LTG +A H
Sbjct: 175 LSEGLVTKWYR------SPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 7e-10
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+PN + Y V G + + +++ +G L L+K+ + + + II +
Sbjct: 67 DNPNFIKLYYSV-TTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKII-RQLVEALN 123
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
LH NI+H D+K EN+L + + +C D GL K+ GTL + +PE
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYGLCKIIGTPSCY---DGTLDYFSPEK 177
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
+ G H D ++ G++ +ELLTG P+
Sbjct: 178 IKG--HNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 75/299 (25%), Positives = 125/299 (41%), Gaps = 54/299 (18%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V+ + + + A+K ++ S + IA E +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-----IAHVRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAA 916
+ P +V Y +D + L V E+M G L L +KD + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------------------ 958
++ +H +H D+K +N+L++ D K+ D GL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILID-ADGH---IKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 959 ------------VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
KQ+ + + GT ++APE+L G + + D +S G++++E+L
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY--GLECDWWSLGVILYEMLY 225
Query: 1007 GDEPYADMHCASIIGGIVN--NTLR-PQIPSWCDPEWRSLMESCWASDPAER-PSFSEI 1061
G P+ I+N +LR P P PE L+ DP +R SF EI
Sbjct: 226 GFPPFYSDTLQETYNKIINWKESLRFPPDPPV-SPEAIDLICRLLC-DPEDRLGSFEEI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 83/305 (27%), Positives = 128/305 (41%), Gaps = 82/305 (26%)
Query: 804 EVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+++ +G G +G V + G +VAIK+I KP L ++E LL L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIM------KPFSTPVLAKRTYRELKLLKHLR 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFM--------VNGSL-KQFLQKKDRTIDRRKRLIIA 912
H N++S I P + VTE + + L KQF+Q I R
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR------- 119
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR 970
G++Y+H +VH DLK N+L+N C KI D GL+++ Q ++G V
Sbjct: 120 -----GLKYVHSAGVVHRDLKPSNILINEN------CDLKICDFGLARI-QDPQMTGYV- 166
Query: 971 GTLPWMAPELLSGKSHMVT-----EKIDVYSFGIVMWELLTGDE--PYAD-MHCASIIGG 1022
T + APE+ M+T ++D++S G + E+L G P D ++ SII
Sbjct: 167 STRYYRAPEI------MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
Query: 1023 IV-------------NNTLR-----PQ---------IPSWCDPEWRSLMESCWASDPAER 1055
++ NTLR P+ + DP L+E DP +R
Sbjct: 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKR 279
Query: 1056 PSFSE 1060
S +E
Sbjct: 280 ISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 23/253 (9%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLKNTRHPFL 57
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
S + L V E+ VNG F ++R + + ++YLH
Sbjct: 58 TSLKYSFQT--KDRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPELLS 982
IV+ DLK ENL+++ +D KI D GL K T+ + GT ++APE+L
Sbjct: 115 KIVYRDLKLENLMLD-KDGH---IKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLE 168
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042
+ +D + G+VM+E++ G P+ + + I+ ++ P + +S
Sbjct: 169 DNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKS 224
Query: 1043 LMESCWASDPAER 1055
L+ DP +R
Sbjct: 225 LLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G +G V + R G A K+++ + E L E +L ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSR 60
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
VVS + D +L V M G LK + D + + A + G+E L
Sbjct: 61 FVVSL-AYAYETKD-ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELL 981
H + IV+ DLK EN+L++ R I DLGL+ ++ + + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
K+ T D + G +++E++ G P+
Sbjct: 174 --KNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADF-WKEALL 856
+ E++ ++G G+YG V+ + R G VAIK+ S E + +I +E +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-------EDDPVIKKIALREIRM 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L L HPN+V+ + R L V E+ + L + L+K R + I
Sbjct: 54 LKQLKHPNLVNLIEVFRR--KRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTL 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------ 970
+ + H N +H D+K EN+L+ + K+ D G ++ +++G
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFAR-----ILTGPGDDYTDYV 161
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
T + APELL G + +DV++ G V ELLTG
Sbjct: 162 ATRWYRAPELLVGDTQYGP-PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 58/260 (22%), Positives = 122/260 (46%), Gaps = 36/260 (13%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIAD------FWKEALLLSS 859
LG G++G V + +G+D AIK +K ++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK----------KDVILQDDDVDCTMTEKRILALA 52
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HP + + + + D L V E+ VNG F ++ R D + A + +
Sbjct: 53 AKHPFLTALHCCFQT-KD-RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
+LH +++ DLK +N+L++ CK+ D G+ K + +++G GT +
Sbjct: 110 MFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
+APE+L + + +D ++ G++M+E++ G P+ + + I+++ + P W
Sbjct: 163 IAPEILQELEYGPS--VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVW 218
Query: 1036 CDPEWRSLMESCWASDPAER 1055
E S++++ +P +R
Sbjct: 219 LSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 65/267 (24%), Positives = 115/267 (43%), Gaps = 28/267 (10%)
Query: 801 DLEEVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E ++ +GSGTYG VY + G A+K IK +P + LI +E ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-----EPGDDFSLIQ---QEIFMVK 61
Query: 859 SLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H N+V+++G + R+ L E+ GSL Q + + + + +
Sbjct: 62 ECKHCNIVAYFGSYLSRE----KLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETL 116
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPW 975
G+ YLH K +H D+K N+L+ K+ D G+ +K+ GT W
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172
Query: 976 MAPELLS-GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP---- 1030
MAPE+ + K+ + D+++ GI EL P D+H + + + +P
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPS 1057
W + + ++ +P +RP+
Sbjct: 233 DKTKW-SSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ R LG G +G V + R G A KR++ + E L E +L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL-----NEKQILEK 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFG 918
++ VV+ + D +L V M G LK + + + L A + G
Sbjct: 57 VNSQFVVNL-AYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+E LH +N V+ DLK EN+L++ R I DLGL+ K+ + + G V GT+ +MA
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGYMA 169
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
PE+L+ + + ++ D + G +++E++ G P+
Sbjct: 170 PEVLNNQRYTLSP--DYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-09
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA LL L HP V++ + G L + L +L + R + + +A
Sbjct: 210 EARLLRRLSHPAVLALLDV---RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG---LSKVKQQTLVSGGV 969
++Y+HG+ I+H D+K EN+LVN P+ +C +GD G ++ T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVN--GPED-IC-LGDFGAACFARGSWSTPFHYGI 322
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI 1019
GT+ APE+L+G + T +D++S G+V++E A +H AS+
Sbjct: 323 AGTVDTNAPEVLAGDPY--TPSVDIWSAGLVIFE--------AAVHTASL 362
|
Length = 461 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 6e-09
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 59/230 (25%)
Query: 805 VRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFA--GKPSERERLIADFWKEALL 856
+++LG G YG V W+ D VA+K+I F ++ +R ++E +
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKI----FDAFRNATDAQRT----FREIMF 59
Query: 857 LSSL-HHPNVVSFYGIVRDGPDGSLATVTEFM---VNGSLKQFLQKKDRTIDRRKRLII- 911
L L HPN+V +++ D + V E+M ++ ++ + + D KR I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-----DVHKRYIMY 114
Query: 912 ----AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
A ++Y+H N++H DLK N+L+N D + K+ D GL++ +L
Sbjct: 115 QLLKA------LKYIHSGNVIHRDLKPSNILLN-SDCR---VKLADFGLAR----SLSEL 160
Query: 968 GVRGTLPWM----------APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
P + APE+L G S T+ +D++S G ++ E+L G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI- 910
E +L HPN+++ + + G L ++ FM GS L K + LI
Sbjct: 48 NEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFMAYGSANSLL-KTYFPEGMSEALIG 104
Query: 911 -IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGG 968
I A G+ YLH +H ++K ++L++ G + LS + +LV G
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGD---------GLVSLSGLSHLYSLVRNG 155
Query: 969 VR------------GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015
+ LPW++PELL + K D+YS GI EL TG P+ DM
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G YG V+ K + + VA+KR+K S R L E +L++
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL-----TERDILTTTKSEW 62
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAAFGMEYLH 923
+V +D D L E++ G + L + R +A M A ++ LH
Sbjct: 63 LVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALH 118
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983
+H DLK EN L++ K+ D GLSK S V G+ +MAPE+L G
Sbjct: 119 ELGYIHRDLKPENFLID----ASGHIKLTDFGLSKGIVTYANS--VVGSPDYMAPEVLRG 172
Query: 984 KSHMVTEKIDVYSFGIVMWELLTGDEPYA 1012
K + T +D +S G +++E L G P++
Sbjct: 173 KGYDFT--VDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-09
Identities = 78/319 (24%), Positives = 135/319 (42%), Gaps = 51/319 (15%)
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKE-APANEAELVNIHGEI----------EMDYDNDTV 775
E AE+V E D ++ APA E + + ++ D D +
Sbjct: 61 EAAEKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHL 120
Query: 776 KTLKIEPTIAEAEAIARGLQTIKNDD--LEEVRELGS---GTYGSVYHGKWRGS--DVAI 828
+ P A +A+ +K+DD L R + G +G ++ R S +
Sbjct: 121 DFDEAPPDAAGPVPLAQA--KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEA 178
Query: 829 KRIKASCFAGKPSERERLIADFWK-----------EALLLSSLHHPNVVSFYGIVRDGPD 877
+R S GKP + ERLIA K E L L L+H N++ I+R +
Sbjct: 179 RRGVNSTNQGKP-KCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEAN 237
Query: 878 GSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931
+ T + FM + + KDR + ++ R I+ +EY+H K ++H D
Sbjct: 238 TYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQTRAIMKQLLC-AVEYIHDKKLIHRD 292
Query: 932 LKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLPWMAPELLSGKSHMVT 989
+K EN+ +N +GD G + K++ G GT+ +PE+L+G +
Sbjct: 293 IKLENIFLNCDG----KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY--C 346
Query: 990 EKIDVYSFGIVMWELLTGD 1008
E D++S G+++ ++L+ D
Sbjct: 347 EITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 800 DDLEEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + + +GSG YGSV + K G VA+K++ +P + ++E L
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLS------RPFQSIIHAKRTYRELRL 69
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + H NV+ + P SL VT M L ++ + T D + LI
Sbjct: 70 LKHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 126
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ G++Y+H +I+H DLK NL VN + KI D GL++ + G
Sbjct: 127 YQI--LRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMT--GYV 178
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
T + APE++ H + +D++S G +M ELLTG
Sbjct: 179 ATRWYRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G +G V + R G A K+++ + E L E +L ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKRILEKVNSR 60
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
VVS + D +L V M G LK + D ++ + A + G+E L
Sbjct: 61 FVVSL-AYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELL 981
+ IV+ DLK EN+L++ R R I DLGL+ ++ + V G V GT+ +MAPE++
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVI 173
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
+ + + + D + G +++E++ G P+
Sbjct: 174 NNEKYTFSP--DWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 20/260 (7%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + G A+K ++ + E++ ++A+ +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAE---RNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAAFGMEYLHG 924
V + + L V +F+ G L LQ++ + R R A + +A G YLH
Sbjct: 59 VGLHYSFQT--TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS 114
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSG 983
NIV+ DLK EN+L+ D Q V + D GL K Q+ + GT ++APE++
Sbjct: 115 INIVYRDLKPENILL---DSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 984 KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSWCDPEWR 1041
+ + T +D + G V++E+L G P+ A + I++ LRP
Sbjct: 171 QPYDNT--VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228
Query: 1042 SLMESCWASDPAERPSFSEI 1061
L+E + F EI
Sbjct: 229 ELLEKDRQRRLGAKEDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G YG V K VAIK+I A+ F + + L +E LL L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNRIDAKRTL-----REIKLLRHLDHENV 66
Query: 866 VSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
++ I+ P A V E M + L Q ++ D + + G++
Sbjct: 67 IAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLK 122
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKV---KQQTLVSGGVRGTLPW 975
Y+H N++H DLK NLL+N C KI D GL++ K + V T +
Sbjct: 123 YIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLARTTSEKGDFMTEYVV--TRWY 174
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
APELL S T IDV+S G + ELL
Sbjct: 175 RAPELLLNCSEY-TTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWM 976
G+E+LH + I++ DLK EN+L++ R I DLGL+ ++K + G GT +M
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
APELL G+ + + +D ++ G+ ++E++ P+
Sbjct: 165 APELLQGEEYDFS--VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-08
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++ E ++++G+G +G V+ K + + S K E+ +L+ E ++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI----EVNVMRE 68
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAA 916
L H N+V + + + L + EF G L + +QK + I+ + I
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 917 FGMEYLH-------GKNIVHFDLKCENLLVNMRDPQ-------------RPVCKIGDLGL 956
+ Y H G+ ++H DLK +N+ ++ RP+ KIGD GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC 1016
SK ++ GT + +PELL ++ +K D+++ G +++EL +G P+ H
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF---HK 245
Query: 1017 ASIIGGIVNNTLR-PQIP-SWCDPEWRSLMESCWASDPAERPS 1057
A+ +++ R P +P E L+++ ERPS
Sbjct: 246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 69/261 (26%), Positives = 113/261 (43%), Gaps = 22/261 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ R LG G +G V + R G A K+++ + E L E +L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL-----NEKQILEK 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFG 918
++ VVS + D +L V M G LK + + + + A + G
Sbjct: 57 VNSRFVVSL-AYAYETKD-ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+E LH + IV+ DLK EN+L++ R I DLGL+ V + + G V GT+ +MA
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMA 169
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR---PQIPS 1034
PE++ K+ T D ++ G +++E++ G P+ I V ++ +
Sbjct: 170 PEVV--KNERYTFSPDWWALGCLLYEMIAGQSPFQQRK-KKIKREEVERLVKEVQEEYSE 226
Query: 1035 WCDPEWRSLMESCWASDPAER 1055
P+ RSL + DP ER
Sbjct: 227 KFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 26/227 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLI-----ADFW 851
+K +D E V+ +G G +G V + + +A K + +I A FW
Sbjct: 40 MKAEDYEVVKVIGRGAFGEV--------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E +++ + P VV + +D D L V E+M G L + D ++ R
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 148
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVR 970
A + ++ +H +H D+K +N+L++ + K+ D G K+ ++ +V
Sbjct: 149 A-EVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 971 -GTLPWMAPELL--SGKSHMVTEKIDVYSFGIVMWELLTGDEP-YAD 1013
GT +++PE+L G + D +S G+ ++E+L GD P YAD
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 17/226 (7%)
Query: 846 LIADFWKEALLLSSLHHPNVVSFYGIVRD----GPDGSLATVTEFMVNGSL-KQFLQ--K 898
++ D + A S LH +GIV+ D L + E+ G L KQ Q K
Sbjct: 102 MLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 899 KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+ + ++ ++ +H + ++H DLK N+ + + K+GD G SK
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGDFGFSK 217
Query: 959 VKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015
++ V+ GT ++APEL K + ++K D++S G++++ELLT P+
Sbjct: 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRY--SKKADMWSLGVILYELLTLHRPFKGPS 275
Query: 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
I+ ++ P P ++L++ + +PA RP+ ++
Sbjct: 276 QREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 802 LEEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ + +GSG YGSV Y + R VA+K++ +P + ++E LL
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLS------RPFQSLIHARRTYRELRLLK 69
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ H NV+ + P S+ E ++ L ++ + + + + LI +
Sbjct: 70 HMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G++Y+H I+H DLK N+ VN + +I D GL++ + G T
Sbjct: 128 --LRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRILDFGLARQADDEMT--GYVATR 179
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ H + +D++S G +M ELL G
Sbjct: 180 WYRAPEIMLNWMHY-NQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 25/189 (13%)
Query: 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935
PD L + + M G L L + ++ R A + G+E++H + +V+ DLK
Sbjct: 69 PD-KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-ATEIILGLEHMHNRFVVYRDLKPA 126
Query: 936 NLLVNMRDPQRPVCKIGDLGL----SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
N+L++ R I DLGL SK K V GT +MAPE+L K
Sbjct: 127 NILLDEHGHVR----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQ-KGTAYDSS 176
Query: 992 IDVYSFGIVMWELLTGDEPY-----ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMES 1046
D +S G ++++LL G P+ D H + VN ++P PE +SL+E
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN----VELPDSFSPELKSLLEG 232
Query: 1047 CWASDPAER 1055
D ++R
Sbjct: 233 LLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 80/303 (26%), Positives = 124/303 (40%), Gaps = 64/303 (21%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++EV +G G+YG V G VAIK+I F S+ R++ +E LL
Sbjct: 4 IQEV--IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFE-HVSDATRIL----REIKLLRL 55
Query: 860 LHHPNVVSFYGIV-----RDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAM 913
L HP++V I+ R+ D + V E M L Q ++ D T + + + +
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKD--IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQL 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVK-----QQTLVS 966
++Y+H N+ H DLK +N+L N C KI D GL++V +
Sbjct: 113 --LRALKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLARVAFNDTPTAIFWT 164
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD------------EPYADM 1014
V T + APEL T ID++S G + E+LTG + D+
Sbjct: 165 DYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
Query: 1015 ---HCASIIGGIVN-------NTLRPQIP-------SWCDPEWRSLMESCWASDPAERPS 1057
I + N +++R + P DP L+E A DP +RP+
Sbjct: 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
Query: 1058 FSE 1060
E
Sbjct: 284 AEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 30/196 (15%)
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
F + L +S L +HPN+V + D L VT FM GS K + +D
Sbjct: 45 FLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDLICT--HFMDGMSE 100
Query: 909 LIIA---MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-TL 964
L IA ++Y+H VH +K ++L+++ G + LS ++ ++
Sbjct: 101 LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLSGLRSNLSM 151
Query: 965 VSGGVRG------------TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYA 1012
++ G R LPW++PE+L K D+YS GI EL G P+
Sbjct: 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
Query: 1013 DMHCASIIGGIVNNTL 1028
DM ++ +N T+
Sbjct: 212 DMPATQMLLEKLNGTV 227
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 32/230 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ + +G YG+VY + + + A+K+I + ++ +++ E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR-NQIQQVFV----ERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ +P VVS + L V E++ G L+ R+ A +
Sbjct: 56 TFAENPFVVSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----------------KQ 961
+EYLH IVH DLK +NLL+ K+ D GLSK+
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGH----IKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
+ + V GT ++APE++ + + + +D ++ GI+++E L G P+
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGY--GKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 40/176 (22%), Positives = 67/176 (38%), Gaps = 26/176 (14%)
Query: 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
SL L+ + R ++ + + + + LH + L + L+ D
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLK-LD------ 53
Query: 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDE 1009
G V +T R +MAPE++ G+S TEK D+YS GI ++E L +
Sbjct: 54 -----GS--VAFKTPEQS--RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYEL 102
Query: 1010 PYADMHCASIIGGIVNNTLRP-QIPSWCDPE-------WRSLMESCWASDPAERPS 1057
PY + S I I+ N + + E + M C + P R +
Sbjct: 103 PYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 40/253 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVA-----------IKRIKASCFAGKPSERERLIA 848
DD E ++ +G G +G V K + + +KR + +CF ER+ L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR---EERDVLV- 56
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +F +D + +L V ++ V G L L K +DR +
Sbjct: 57 --NGDRRWITNLHY----AF----QD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R +A + ++ +H VH D+K +N+L++ R + D G L + T+
Sbjct: 105 RFYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTVQ 159
Query: 966 SGGVRGTLPWMAPELL----SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021
S GT +++PE+L GK E D +S G+ M+E+L G+ P+ G
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 1022 GIVNNTLRPQIPS 1034
I+N+ Q P
Sbjct: 219 KIMNHKEHFQFPP 231
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++++ +GSG G V G +VA+K++ +P + + ++E +LL +
Sbjct: 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKRAYRELVLLKCV 77
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+H N++S + P SL V E M + +L Q + + +D + +
Sbjct: 78 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQ 131
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V KI D GL++ + T
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ G + E +D++S G +M EL+ G
Sbjct: 188 YRAPEVILGMGY--KENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 19/151 (12%)
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL----SKVKQQTLVSG 967
A + G+E++H + +V+ DLK N+L++ R I DLGL SK K V
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR----ISDLGLACDFSKKKPHASV-- 156
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---IIGGIV 1024
GT +MAPE+L K D +S G ++++LL G P+ I +
Sbjct: 157 ---GTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
T+ ++P PE RSL+E D R
Sbjct: 213 --TMAVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G V K G A K++ K E+ L+ E +L ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
V+ Y L V M G LK +R ++ + + + G+ +LH
Sbjct: 56 VNLAYAF---ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983
+IV+ D+K EN+L++ + C++ DLGL+ + GT +MAPE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 984 KSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+ + + +D ++ G ++E++ G P+ D
Sbjct: 169 EPY--SYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-07
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + G +VAIK++ +P + ++E +L+ +
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS------RPFQNVTHAKRAYRELVLMKLV 72
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+H N++ + P SL V E M + +L Q +Q D +R L+ M
Sbjct: 73 NHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQM-DLDHERMSYLLYQM- 127
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V KI D GL++ + + T
Sbjct: 128 -LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ G + E +D++S G +M E++ G
Sbjct: 183 YRAPEVILGMGY--KENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+HP +V + + + L V E++ G L +Q++ + + R A + + +
Sbjct: 54 NHPFLVGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALN 110
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWM 976
YLH + I++ DLK +N+L++ K+ D G+ K + L G GT ++
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGH----IKLTDYGMCK---EGLRPGDTTSTFCGTPNYI 163
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
APE+L G+ + + +D ++ G++M+E++ G P+
Sbjct: 164 APEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 48/210 (22%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+H N++S + P SL + +++ +L Q +Q + +D + +
Sbjct: 74 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQM 128
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
APE++ G + E +D++S G +M E++
Sbjct: 185 RAPEVILGMGY--KENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSER----ERLIADFWKEA 854
D + LG G++G V + +G+D AIK +K E+ + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L+ LH F + R L V E++ G L +Q+ R + A +
Sbjct: 61 PFLTQLHS----CFQTMDR------LYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAE 109
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTL 973
A G+ +LH K I++ DLK +N+ M D + + KI D G+ K + + GT
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNV---MLDSEGHI-KIADFGMCKENMWDGVTTKTFCGTP 165
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
++APE+++ + + + +D ++FG++++E+L G P+
Sbjct: 166 DYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 45/187 (24%), Positives = 88/187 (47%), Gaps = 23/187 (12%)
Query: 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939
L V E+ VNG F ++ R + A + + +LH + I++ DLK +N+L+
Sbjct: 71 LFLVIEY-VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL 129
Query: 940 NMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPELLSGKSHMVTEKIDVY 995
+ K+ D G+ K + L G GT ++APE+L G+ + + +D +
Sbjct: 130 D----ADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS--VDWW 180
Query: 996 SFGIVMWELLTGDEPY------ADMHCASIIGGIVNNTLRP-QIPSWCDPEWRSLMESCW 1048
+ G++M+E++ G P+ DM+ + ++ +P +IP + + +++
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPRFLSVKASHVLKGFL 238
Query: 1049 ASDPAER 1055
DP ER
Sbjct: 239 NKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 47/210 (22%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+ ++ +GSG G V D ++R A +P + + ++E +L+ ++H
Sbjct: 27 QNLKPIGSGAQGIV----CAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
N++ + P SL + +++ +L Q +Q + +D + +
Sbjct: 83 KNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLC 137
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+++LH I+H DLK N++V KI D GL++ + + T + A
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
PE++ G + E +D++S G +M E++ G
Sbjct: 194 PEVILGMGY--KENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSER----ERLIADFWKEALLLSSLH 861
LG G++G V + +G+D AIK +K E+ + + L+ LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
F + R L V E++ G L +Q+ + + + A + + G+ +
Sbjct: 68 S----CFQTVDR------LYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFF 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMA 977
LH + I++ DLK +N++++ KI D G+ K + +V G GT ++A
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGH----IKIADFGMCK---EHMVDGVTTRTFCGTPDYIA 169
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
PE+++ + + + +D +++G++++E+L G P+
Sbjct: 170 PEIIAYQPY--GKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASC-FAGKPSE----RERLIADFWKEALLLSSL 860
LG G++G V + +G+D AIK +K E +R++A K L + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL-TQL 66
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H F + R L V E++ G L +Q+ + + A + A G+
Sbjct: 67 HS----CFQTMDR------LYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLF 115
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPW 975
+LH K I++ DLK +N++++ KI D G+ K + GG GT +
Sbjct: 116 FLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMCKEN----IFGGKTTRTFCGTPDY 167
Query: 976 MAPELLS----GKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
+APE+++ GKS +D ++FG++++E+L G P+
Sbjct: 168 IAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 56/247 (22%), Positives = 108/247 (43%), Gaps = 30/247 (12%)
Query: 780 IEPTIAEAEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASC 835
I+ ++ E A + +K +D + ++ +G G +G V + + S A+K +
Sbjct: 21 IDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE 80
Query: 836 FAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF 895
+ A FW+E +++ + +V + +D D L V E+M G L
Sbjct: 81 MIKRSDS-----AFFWEERDIMAHANSEWIVQLHYAFQD--DKYLYMVMEYMPGGDLVNL 133
Query: 896 LQKKDRTIDRRK----RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ D + +++A+DA +H +H D+K +N+L++ K+
Sbjct: 134 MSNYDIPEKWARFYTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGH----LKL 183
Query: 952 GDLGLS-KVKQQTLV-SGGVRGTLPWMAPELLSGKSH--MVTEKIDVYSFGIVMWELLTG 1007
D G K+ +V GT +++PE+L + + D +S G+ ++E+L G
Sbjct: 184 ADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
Query: 1008 DEP-YAD 1013
D P YAD
Sbjct: 244 DTPFYAD 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 33/133 (24%), Positives = 70/133 (52%), Gaps = 14/133 (10%)
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
V EF+ G L +Q++ + + R + + + + +LH + I++ DLK +N+L++
Sbjct: 74 VIEFVSGGDLMFHMQRQRKLPEEHARFY-SAEISLALNFLHERGIIYRDLKLDNVLLDAE 132
Query: 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPELLSGKSHMVTEKIDVYSFG 998
K+ D G+ K + + G GT ++APE+L G+ + + +D ++ G
Sbjct: 133 GH----IKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS--VDWWALG 183
Query: 999 IVMWELLTGDEPY 1011
++M+E++ G P+
Sbjct: 184 VLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 57/253 (22%), Positives = 104/253 (41%), Gaps = 55/253 (21%)
Query: 800 DDLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V K G A+K+++ S + E+E++ A E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----EMLEKEQV-AHVRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ +P VV Y +D + L + E++ G + L KKD + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------------------- 958
++ +H +H D+K +NLL++ + K+ D GL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 959 -----VKQQTLVSGG---------------VRGTLPWMAPELLSGKSHMVTEKIDVYSFG 998
+ + S GT ++APE+ + ++ D +S G
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLG 226
Query: 999 IVMWELLTGDEPY 1011
++M+E+L G P+
Sbjct: 227 VIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-05
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G+G++G VY VAIK++ P + R E L++ +L+H N+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNR-------ELLIMKNLNHINI 121
Query: 866 V---SFY---GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---DAA 916
+ +Y ++ + L V EF+ ++ ++++ R ++ +
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG----- 971
+ Y+H K I H DLK +NLL+ DP K+ D G +K + G R
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAKN-----LLAGQRSVSYIC 232
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ + APEL+ G ++ T ID++S G ++ E++ G
Sbjct: 233 SRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-05
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +L +++HP+++ G + L +L K R I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTF---TYNKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIE 188
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP--VCKIGDLGLS--KVKQQTLVSGG 968
++YLH I+H D+K EN+ +N P VC +GD G + V G
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFPVDINANKYYG 242
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
GT+ APELL+ + +D++S GIV++E+ T
Sbjct: 243 WAGTIATNAPELLARDPY--GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G YG V + + + VAIK+ K S E E + +E +L +L N+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDS------EENEEVKETTLRELKMLRTLKQENI 62
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLH 923
V R G L V E+ V ++ + L++ + ++ + I + A + + H
Sbjct: 63 VELKEAFRR--RGKLYLVFEY-VEKNMLELLEEMPNGVPPEKVRSYIYQLIKA--IHWCH 117
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTLPWMAPELL 981
+IVH D+K ENLL++ D V K+ D G ++ + + T + +PELL
Sbjct: 118 KNDIVHRDIKPENLLISHND----VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 982 SGKSHMVTEKIDVYSFGIVMWELLTG 1007
G + + +D++S G ++ EL G
Sbjct: 174 LGAPY--GKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 57/250 (22%), Positives = 102/250 (40%), Gaps = 52/250 (20%)
Query: 800 DDLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V K G A+K ++ + E+E+ +A E +L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML----EKEQ-VAHIRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
VV + +D + L + EF+ G + L KKD + + IA +
Sbjct: 56 VEADGAWVVKMFYSFQDKRN--LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL--------------------- 956
++ +H +H D+K +NLL++ + K+ D GL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGH----VKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 957 ---------SKVKQQTL------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001
SK K +T ++ GT ++APE+ + + D +S G++M
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY--NKLCDWWSLGVIM 226
Query: 1002 WELLTGDEPY 1011
+E+L G P+
Sbjct: 227 YEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 9/88 (10%)
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSG--GVRGTLPWMA 977
YLHG+ I+H D+K EN+ ++ +P+ V +GD G + K+ G GTL +
Sbjct: 200 YLHGRGIIHRDVKTENIFLD--EPENAV--LGDFGAACKLDAHPDTPQCYGWSGTLETNS 255
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELL 1005
PELL+ + K D++S G+V++E+
Sbjct: 256 PELLALDPYCA--KTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-04
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
V+ + G +G VY G K A+K +K + K + ++ A+ ++AL LS
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK-NMVHQVQAE--RDALALSK--S 63
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V Y ++ + L V E+++ G +K L + I+ + A ++YL
Sbjct: 64 PFIVHLYYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYL 120
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
H I+H DLK +N+L++ K+ D GLSKV
Sbjct: 121 HRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 26/274 (9%)
Query: 800 DDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +G G +G V K G A+K +K S + + ++ F +E +L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQET-----VSFFEEERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S + P + +D +L V E+ G L L + + D +
Sbjct: 56 SISNSPWIPQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPW 975
+ +H VH D+K EN+L++ + K+ D G + + + S GT +
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 976 MAPELLSGKS----HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031
+APE+L+ + + D +S G++ +E++ G P+ + A I+N +
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229
Query: 1032 IPSWCDP----EWRSLMESCWASDPAERPSFSEI 1061
P DP ++ L++S ER + +
Sbjct: 230 FPE--DPKVSSDFLDLIQSLLCG-QKERLGYEGL 260
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 26/150 (17%)
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
+++A+DA LH + IV DL N+L++ R G + L+ + + V
Sbjct: 94 MVVALDA------LHREGIVCRDLNPNNILLDDR---------GHIQLTYFSRWSEVEDS 138
Query: 969 VRGTLP---WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025
G + APE+ G TE D +S G +++ELLTG + + H + I N
Sbjct: 139 CDGEAVENMYCAPEV--GGISEETEACDWWSLGAILFELLTG-KTLVECHPSGI-----N 190
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
IP W E RSL++ +P ER
Sbjct: 191 THTTLNIPEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-04
Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 52/250 (20%)
Query: 800 DDLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +G G +G V K G A+K ++ + E+E+ + E +L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML----EKEQ-VGHIRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
VV + +D + L + EF+ G + L KKD + + IA +
Sbjct: 56 VEADSLWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL--------------------- 956
++ +H +H D+K +NLL++ + K+ D GL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGH----VKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 957 ---------SKVKQQTL------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001
SK K +T ++ GT ++APE+ + + D +S G++M
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY--NKLCDWWSLGVIM 226
Query: 1002 WELLTGDEPY 1011
+E+L G P+
Sbjct: 227 YEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 17/112 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
D+L+ + LG+G +G V G VA+K +KAS ERE L++
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS---AHTDEREALMS---- 90
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI 903
E +LS L H N+V+ G G G + +TE+ G L FL+KK T
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHG--GPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1075 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.23 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.22 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.96 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.86 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.64 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.62 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.35 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.29 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.86 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 96.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.65 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 96.65 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 96.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.46 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 96.19 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 95.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.49 | |
| PLN02236 | 344 | choline kinase | 95.46 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.4 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.91 | |
| cd06402 | 87 | PB1_p62 The PB1 domain is an essential part of p62 | 94.79 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.65 | |
| cd06406 | 80 | PB1_P67 A PB1 domain is present in p67 proteins wh | 94.41 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=415.72 Aligned_cols=266 Identities=49% Similarity=0.831 Sum_probs=234.3
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcCcc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kGt~-VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
.++..++.+.+.||.|+||+||+++++|+. ||||++......... .+.|.+|+.+|.+++|||||+++|++.+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES------RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH------HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 444555666677999999999999999999 999999865433221 6789999999999999999999999988
Q ss_pred CCCCceEEEEeeecCCcHHHHHhh-ccccCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCceEeccCCCCCC-eEEE
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRP-VCKI 951 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk-~~~~Lse~~~l~Ia~QIL~AL~yLHs~G-IIHRDIKPeNILId~~d~~~g-~VKL 951 (1075)
.. ..+++||||+++|+|.+++.+ ....+++..++.|+.||++||+|||+++ ||||||||+|||++ ... ++||
T Consensus 111 ~~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~KI 185 (362)
T KOG0192|consen 111 PP-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTLKI 185 (362)
T ss_pred CC-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEEEE
Confidence 42 268999999999999999988 4678999999999999999999999999 99999999999998 564 9999
Q ss_pred eecCCccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 952 GDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 952 iDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
+|||+++..... ...+...||+.|||||++.+....|+.|+||||||++||||+||+.||.......+...+.....++
T Consensus 186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999966554 3444578999999999998533348999999999999999999999999999888888888888899
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHc
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
.++..++..+..||..||+.||.+||++.+++..|+.+...+
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999999999987754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=404.51 Aligned_cols=250 Identities=34% Similarity=0.552 Sum_probs=220.7
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
+..++++.++.||+|..|+|||++++ +..+|+|++... .++...+++.+|+++|++++||+||.+|++|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34467888899999999999999986 778999999543 234456788999999999999999999999998
Q ss_pred CCCC-ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 875 GPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 875 ~~e~-~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
++ .+.|+||||.+|+|+++++..+ .+++...-.|+.++++||.|||+ .+||||||||+||||+ .++.||||
T Consensus 149 --~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKic 221 (364)
T KOG0581|consen 149 --NGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKIC 221 (364)
T ss_pred --CCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEec
Confidence 45 5999999999999999998764 58999999999999999999995 8999999999999998 78899999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHhhhhcc
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM-----HCASIIGGIVNNT 1027 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~-----~~~eil~~Ilk~~ 1027 (1075)
|||.|+..... ...++.||..|||||.+.+.. |+.++||||||++++|+++|+.||... ...+.+..|+.+.
T Consensus 222 DFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 222 DFGVSGILVNS-IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred cccccHHhhhh-hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 99999976655 557788999999999999765 899999999999999999999999874 5667778877765
Q ss_pred CCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1028 LRPQIPSW-CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1028 l~p~ips~-ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+.+|.. +++++++||..||++||.+|||+++|++.
T Consensus 299 -pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 -PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4667775 99999999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=409.54 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=222.3
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..+.|.+.+.||+|+||.|-+|.. +|+.||||++++.....-...... .....+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAK-TRDVQNEIEILKKLSHPNIVRIKDFFEV- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccc-hhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence 346788899999999999999976 588999999998766543221111 2335689999999999999999999998
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
....||||||++||+|.+.+-.++ .+.+...+.+++||+.||.|||++||+||||||+|||+..+. ++-.+||+|||
T Consensus 248 -~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKItDFG 324 (475)
T KOG0615|consen 248 -PDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKITDFG 324 (475)
T ss_pred -CCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEecccc
Confidence 567799999999999999997664 478888899999999999999999999999999999997443 66799999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhhhhccCCCCCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHM-VTEKIDVYSFGIVMWELLTGDEPYADMHCAS-IIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~-yS~KsDIWSLGVILyELLTG~~PF~~~~~~e-il~~Ilk~~l~p~ip 1033 (1075)
+|+.........++|||+.|.|||++.++... +..++|||||||+||-+|+|.+||.+..... +.+.|.++.+...-+
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 99988888888899999999999999865543 4459999999999999999999998765554 777777776654333
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 --SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 --s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++++.++||..||..||++|||+.|+|+.
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 3589999999999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=415.33 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=224.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|+..+.||+|+|+.||++++ +|+.||+|++.+..+.+. ...+...+|++|.+.|+|||||+++++|++ .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFED--S 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeec--C
Confidence 5699999999999999999987 599999999987654432 334567789999999999999999999998 7
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+..|||+|+|..++|..+++ +.+.+++.+++++++||+.||.|||+++|||||||..|||++ ++..|||+|||+|
T Consensus 91 ~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred CceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 78999999999999999998 456799999999999999999999999999999999999998 8889999999999
Q ss_pred cccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
.... +.....+.||||.|.|||++.... .+..+||||+||+||.||+|++||...+..+.+.+|....+ .+|..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~g--HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--~~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSG--HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--SMPSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCC--CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--cccccc
Confidence 9665 435667889999999999998655 68899999999999999999999999999999998887765 577899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.++++||.++|+.||.+|||+++|+..
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=393.79 Aligned_cols=246 Identities=28% Similarity=0.472 Sum_probs=218.9
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.+..++|++++.||+|+||+||.++. +++.+|+|++++..+..+ ..++....|..||.+++||.||.++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 34568999999999999999999976 477899999998765543 23567789999999999999999999999
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ .+.+|||+||+.||+|...|++.+ .+++..++.++.+|+.||.|||++|||||||||+|||++ .+|+++|+|
T Consensus 96 t--~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtD 168 (357)
T KOG0598|consen 96 T--EEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTD 168 (357)
T ss_pred c--CCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEec
Confidence 9 788999999999999999998765 488998888888999999999999999999999999999 889999999
Q ss_pred cCCcccc-ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 954 LGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 954 FGLAk~~-~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
||+++.. .....+.++|||+.|||||++.+.. |+..+|+||||+++|||++|.+||...+...++.+|.+... ...
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g--y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~ 245 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG--YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLP 245 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCC--CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCC
Confidence 9999954 3444556789999999999998765 89999999999999999999999999999999999888763 445
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCC
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERP 1056 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRP 1056 (1075)
+..++.+++++|+++|..||++|.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhc
Confidence 666899999999999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=393.53 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=220.2
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
..+|...+.||.|+||+||+|+++ +..||||.+.+..+. .+..+.+..|+++|+.++|||||.+++++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~------~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-- 80 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN------KKLVELLLSEIKILKELKHPNIVRLLDCIED-- 80 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC------HHHHHHHHHHHHHHHhcCCcceeeEEEEEec--
Confidence 467999999999999999999884 788999999876432 2234567799999999999999999999988
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCC--CeEEEeec
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR--PVCKIGDL 954 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~--g~VKLiDF 954 (1075)
.+.+|||||||.||+|.+||++++ .+++..++.++.||+.||++||+++||||||||+||||+.....+ ..+||+||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 679999999999999999998876 589999999999999999999999999999999999998653333 78999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-CCCCCC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-LRPQIP 1033 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-l~p~ip 1033 (1075)
|+|+...........||++.|||||++... .|+.|+|+||+|+|||+|++|+.||...+..+.+..+.+.. ..+.++
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 999988877777889999999999999743 49999999999999999999999999999998887665543 345666
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..++.++.+|+...|+.++..|-++.+...
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 778888889999999999999977665543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=384.06 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=222.0
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~ 873 (1075)
.....|.+.+.||+|+||+|++|++ ++..||+|++......... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 3457899999999999999999987 5889999987765322111 122344558999999999 999999999999
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCC-CeEEEe
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR-PVCKIG 952 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~-g~VKLi 952 (1075)
. ...+++||||+.||+|.+++.+ .+.+.+..+..+++||++||+|||++||+||||||+|||++ .+ +.+||+
T Consensus 91 t--~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~ 163 (370)
T KOG0583|consen 91 T--PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLS 163 (370)
T ss_pred c--CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEe
Confidence 8 4569999999999999999998 56689999999999999999999999999999999999998 44 899999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 953 DFGLAk~~-~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|||++... .........+||+.|+|||++.++..+...++||||+||+||.|++|+.||.+.+...++..+.+..+ .
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~ 241 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--K 241 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--c
Confidence 99999977 45566778899999999999998664457899999999999999999999999888888888776654 6
Q ss_pred CCCCC-CHHHHHHHHHhhhcCCCCCCCHHHHH
Q 001449 1032 IPSWC-DPEWRSLMESCWASDPAERPSFSEIS 1062 (1075)
Q Consensus 1032 ips~l-s~eL~dLI~kCLq~DPeeRPSa~ELL 1062 (1075)
+|.++ +.++++||.+||..||.+|+++.+|+
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 88888 99999999999999999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=390.95 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=223.0
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVR 873 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~ 873 (1075)
....||.+.+.||+|+|++|++|+. .+..||||++.+..+. ++..++...+|-.+|.+| .||.||+||..|+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-----ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-----KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-----hhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 3457899999999999999999987 4788999999876543 445566677899999999 7999999999999
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ +..+|+|+||+++|+|.++|++.+ .+++..++.++.||+.||+|||++|||||||||+|||++ .++++||+|
T Consensus 145 D--~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikITD 217 (604)
T KOG0592|consen 145 D--EESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKITD 217 (604)
T ss_pred c--ccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEee
Confidence 8 778999999999999999998875 589999999999999999999999999999999999999 889999999
Q ss_pred cCCcccccccc------------cc--CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001449 954 LGLSKVKQQTL------------VS--GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI 1019 (1075)
Q Consensus 954 FGLAk~~~~~~------------~s--ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~ei 1019 (1075)
||.|+...... .. .+++||..|.+||++.... .+..+|||+||||||+|+.|.+||...+..-+
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 99998532211 11 4588999999999998655 78899999999999999999999999999999
Q ss_pred HHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1020 IGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1020 l~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+++|+.-.+ .++...++.+++||+++|..||.+|+++++|.+.
T Consensus 296 FqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 999988665 6788899999999999999999999999888764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=374.52 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=218.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|+++++||.|+||.||++.. +|..||.|.++-.. -.....+....|+.+|++|+|||||+++++-...+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 5688899999999999999876 68899999987332 123345778899999999999999999995544446
Q ss_pred CceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHh--CC--cccccCCCCceEeccCCCCCCeEE
Q 001449 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHG--KN--IVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs--~G--IIHRDIKPeNILId~~d~~~g~VK 950 (1075)
..++||||||..|+|...|+. ..+.+++..+|+++.|+++||.++|. .. |+||||||.||+|+ .++.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gvvK 168 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGVVK 168 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCcee
Confidence 669999999999999999864 45669999999999999999999998 44 99999999999999 889999
Q ss_pred EeecCCccccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 951 IGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 951 LiDFGLAk~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
|+|||+++... ......+++|||.||+||++.+.+ |+.|+|||||||++|||+.-+.||.+.+..++..+|....+.
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP 246 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC
Confidence 99999999644 444556789999999999998766 899999999999999999999999999888888888777654
Q ss_pred CCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1030 PQIP-SWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1030 p~ip-s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
.+| ..+|.+++.||..|+..|++.||+.-.+++.+.+
T Consensus 247 -~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 -PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 344 6789999999999999999999986666665554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=367.81 Aligned_cols=263 Identities=30% Similarity=0.526 Sum_probs=212.8
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIV 866 (1075)
+++..++|++.+.||+|+||.||+|.+. +..||||+++... .......+.+|+.+|+++ +|||||
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCccee
Confidence 4556678999999999999999999742 4569999987431 112235678999999999 899999
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhcc----------------------------------------------
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------------------------------------- 900 (1075)
++++++... .+.+++||||+.+|+|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 999988753 456899999999999999987532
Q ss_pred ---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccc--
Q 001449 901 ---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-- 963 (1075)
Q Consensus 901 ---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~-- 963 (1075)
..+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcc
Confidence 2377888899999999999999999999999999999998 6678999999999853221
Q ss_pred -cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHH
Q 001449 964 -LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041 (1075)
Q Consensus 964 -~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~ 1041 (1075)
.......++..|+|||++.+.. ++.++|||||||+||||++ |..||........+...+........+..++.++.
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred hhcccCCCCCccccCcHHhhcCC--CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1122334667899999997544 7899999999999999997 99999876544433344444444556677899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1042 SLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
+||.+||+.||.+|||+.+|++.|+++..+
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.49 Aligned_cols=241 Identities=27% Similarity=0.487 Sum_probs=220.5
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
...++|++++.||.|+||+|.+++.+ |..+|+|++++.. ..+.+.++...+|..+|+.+.||.++++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-----HHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 55688999999999999999999874 7779999998653 3456677888999999999999999999999988
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
.+.++|||||+.||.|.+++++.++ +++..++.++.||+.||+|||+++|++|||||+||||| .+|.+||+||
T Consensus 116 --~~~lymvmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 --NSNLYMVMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred --CCeEEEEEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 7899999999999999999988754 89999999999999999999999999999999999999 8899999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
|+|+..... +.+.||||.|+|||++..+. |+..+|+|||||++|||+.|.+||...+...++++|+.... .+|+
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCc
Confidence 999976554 45689999999999998776 89999999999999999999999999999999999998876 6899
Q ss_pred CCCHHHHHHHHHhhhcCCCCC
Q 001449 1035 WCDPEWRSLMESCWASDPAER 1055 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeR 1055 (1075)
..+.++++||+++|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 999999999999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=386.41 Aligned_cols=261 Identities=36% Similarity=0.647 Sum_probs=225.4
Q ss_pred ccccccCCCeeEEEEEcccCcEEEEEEEEcCc-ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 793 ~i~~i~~ddYeil~~LGeG~FG~VYkAk~kGt-~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
..+.+....++.++.||+|-||.|+.|+++++ +||+|.++...+. ...|++|+++|++|+|+|||+++++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhHHHHHHHHHHhCcccCeEEEEEE
Confidence 34445555667778899999999999999977 8999999875332 2567899999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhh-ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk-~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
+.. +..++||||||+.|+|.++|+. .+..+.....+.++.|||+|++||+++++|||||..+||||+ ++..+|
T Consensus 270 ~~~--~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~vK 343 (468)
T KOG0197|consen 270 CTK--QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVVK 343 (468)
T ss_pred Eec--CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceEE
Confidence 988 4579999999999999999997 566789999999999999999999999999999999999998 778999
Q ss_pred EeecCCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc
Q 001449 951 IGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 951 LiDFGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
|+|||+|+...+.. ......-...|.|||.+.... ++.|+|||||||+||||+| |+.||..++..+++..+. ..
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~--FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~G 420 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK--FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RG 420 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhCC--cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-cc
Confidence 99999999543322 222233455799999997544 8999999999999999999 999999999999877654 45
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
++...|..||+++.+++..||..+|++|||+..+...|+++...
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 67788999999999999999999999999999999999998653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=355.84 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=216.6
Q ss_pred EEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc--CCCCceEEE
Q 001449 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--GPDGSLATV 883 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d--~~e~~L~LV 883 (1075)
..||+|+++.||+|+++|+.||||+++.... .....++.+.+|+.+|++++|||||++++++.+ .....+++|
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-----GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEecccccc-----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 5799999999999999999999999875421 122345678899999999999999999999876 334578999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
|||+.+|+|.+++.+. ..+++...+.++.|++.||.|||+ .+++||||||+|||++ .++.+||+|||+++....
T Consensus 101 ~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 101 LEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEEEcccchHhhhcc
Confidence 9999999999999765 458999999999999999999998 4999999999999998 678999999999885433
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
.. ....||..|+|||++.+....++.++|||||||++|||++|+.||...+..+....+........++..++.++++
T Consensus 176 ~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 176 PP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred cc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence 21 2345889999999997633458999999999999999999999999888777777776666666677778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1043 LMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
||.+||+.||++|||++++++.|+++..
T Consensus 254 li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 254 IVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=385.20 Aligned_cols=252 Identities=29% Similarity=0.377 Sum_probs=216.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~ 875 (1075)
.++|.++++||.|+||.||+|+. ++..||||.+++.... .+. ..-+||++.|++|+ |||||++.+++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-----~ee--~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-----WEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-----HHH--HHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 46799999999999999999987 4888999999876543 111 23468999999999 99999999999984
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
+ ..+++||||| ..+|.++|+.+++.+++..++.|+.||++||+|+|++|++||||||+||||. ....+||+|||
T Consensus 82 ~-~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaDFG 155 (538)
T KOG0661|consen 82 D-RILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIADFG 155 (538)
T ss_pred C-ceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEecccc
Confidence 3 3899999999 6799999999999999999999999999999999999999999999999997 57899999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-------
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL------- 1028 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l------- 1028 (1075)
+|+........+.++.|.||+|||++... ..|+.++||||+|||++||++-++.|.+.+..+.+.+|+.-.-
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 99977666666778899999999999854 4699999999999999999999999999888777766653100
Q ss_pred ----------CCCC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 ----------RPQI-----------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ----------~p~i-----------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...+ -..++.++.+||.+||.+||.+|||+.+.++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0011 12267899999999999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.70 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=207.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
+.|+.+.++|+|+||+||+|++ +|+.||||++... ..+....+..++|+++|++++|+|+|.++.+|.. .
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--k 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--K 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--c
Confidence 4588899999999999999987 4889999998753 1233444667899999999999999999999988 7
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++|+|||+. ++.+.+.....-++...++.++.|+++|+.|+|++++|||||||+||||+ .++.+||||||+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhh
Confidence 889999999955 66666666666689999999999999999999999999999999999999 8899999999999
Q ss_pred cccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc----------
Q 001449 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---------- 1026 (1075)
Q Consensus 958 k~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~---------- 1026 (1075)
+... .....+.++.|.||+|||++.|.. .|...+||||+||++.||++|.+.|.+....+.+..|.+.
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 9655 555556678999999999999854 3899999999999999999999999987776655444320
Q ss_pred -----cC-----CCC------CC---CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1027 -----TL-----RPQ------IP---SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1027 -----~l-----~p~------ip---s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+ .|. ++ ..++.-+.+|+++||..||.+|++..+++.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 000 01 124557889999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.27 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=215.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.++...+.||+|+||.||++... |...|||.+.... ... .+.+.+|+.+|++++|||||+++|.......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----SPT---SESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----chh---HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 45777888999999999999885 6899999987541 011 4667899999999999999999997554222
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCC-CCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~-~g~VKLiDFGL 956 (1075)
..+++.|||+.+|+|.+++.+.+..+++..+..+++||++||.|||++|||||||||+|||++ . ++.+||+|||+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCcc
Confidence 368999999999999999998776799999999999999999999999999999999999998 5 68999999999
Q ss_pred cccccc----ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHhhhhccCCCC
Q 001449 957 SKVKQQ----TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-MHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 957 Ak~~~~----~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~-~~~~eil~~Ilk~~l~p~ 1031 (1075)
++.... ........||+.|||||++.. ......++|||||||++.||+||+.||.. ......+..+......+.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE 243 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC
Confidence 985542 222345789999999999984 21133589999999999999999999998 455566666666666779
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
+|..++.+.++||.+|+..||++|||+.++|+....
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 999999999999999999999999999999987543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=384.96 Aligned_cols=256 Identities=34% Similarity=0.626 Sum_probs=231.4
Q ss_pred hccccccCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 792 ~~i~~i~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
...|++..+.+..++-||.|+.|.||+|+.+++.||||+++.- -..+++-|++|+|+|||.|.|+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeee
Confidence 3456777777778888999999999999999999999987632 1257889999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
|.. ..++|||||||..|-|..+|+.. ++++......+.++|+.|+.|||.+.|||||||.-||||+ .+..|||
T Consensus 181 Ctq--sPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VKI 253 (904)
T KOG4721|consen 181 CTQ--SPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVKI 253 (904)
T ss_pred ecC--CceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEEe
Confidence 988 67899999999999999999754 4688888889999999999999999999999999999998 6669999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
+|||-++...+.....+++||..|||||+|...+ .+.|+|||||||+|||||||..||.+.+...++..+-.+.+...
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP 331 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc
Confidence 9999999877777778899999999999998766 89999999999999999999999999999988888888888888
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
+|+.+++.|+-||++||+..|..|||+.+|+..|+.+-.+
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 9999999999999999999999999999999999876443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=379.22 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=216.8
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..+.|+.+++||+|+||.||+|++ +|..||+|+++.+.. ++.......+|+.||++|.|||||+|.+++.+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~------~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE------KEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC------CCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 456789999999999999999988 577899999986632 223346677999999999999999999999886
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..+.+|||+|||+ -+|.-++...+-.|++.+++.+++||+.||+|||.+||+|||||.+||||| .++.+||+|||
T Consensus 189 ~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaDFG 263 (560)
T KOG0600|consen 189 LSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIADFG 263 (560)
T ss_pred CCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEecccc
Confidence 5678999999995 599999988877899999999999999999999999999999999999999 88999999999
Q ss_pred Ccccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc------
Q 001449 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT------ 1027 (1075)
Q Consensus 956 LAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~------ 1027 (1075)
||+.+.... ..+..+-|.||+|||++.|... |+..+|+||.||||.||++|++.|.+.+..+.+..|.+-.
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~-Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATS-YGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcc-cccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 999654433 3455668999999999998764 8999999999999999999999999999888887776411
Q ss_pred CCC--CC-------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 LRP--QI-------------------PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 l~p--~i-------------------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+++ .+ ...++....+|+.++|..||.+|.|+.+.|+
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 01 1235778889999999999999999988775
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=372.13 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=220.3
Q ss_pred HHhccccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceee
Q 001449 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1075)
Q Consensus 790 i~~~i~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVk 867 (1075)
+......+..++|+.+..||+|+||.||+|+. +|..+|+|++++..+. ....++....|..+|....+|.||+
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-----~~~Qv~hV~aERdiL~~~ds~~vVK 205 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-----KKNQVEHVRAERDILAEVDSPWVVK 205 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-----hhhhHHHHHHHHHHhhhcCCCcEEE
Confidence 33344466789999999999999999999976 5888999999987543 3345678889999999999999999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g 947 (1075)
||..|++ ...+||||||++||++..+|.+.+ .|++..++.++.+++.||+.||+.|+|||||||+|+||| ..|
T Consensus 206 LyYsFQD--~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~~G 278 (550)
T KOG0605|consen 206 LYYSFQD--KEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----AKG 278 (550)
T ss_pred EEEEecC--CCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----CCC
Confidence 9999999 678999999999999999998764 689998888889999999999999999999999999999 889
Q ss_pred eEEEeecCCcccccc-------------------------cc----c-------------------cCCCCCCCCccCcc
Q 001449 948 VCKIGDLGLSKVKQQ-------------------------TL----V-------------------SGGVRGTLPWMAPE 979 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~-------------------------~~----~-------------------sss~~GT~~YmAPE 979 (1075)
++||+||||++.... .. . ..+++|||-|||||
T Consensus 279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE 358 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE 358 (550)
T ss_pred CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence 999999999862100 00 0 01357999999999
Q ss_pred cccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCC-
Q 001449 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP--SWCDPEWRSLMESCWASDPAERP- 1056 (1075)
Q Consensus 980 vl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip--s~ls~eL~dLI~kCLq~DPeeRP- 1056 (1075)
++.++. |+..+|+||||||+||||.|.+||...++.+...+|++-.....+| ..++.+++|||.+||. ||++|.
T Consensus 359 Vll~kg--Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 359 VLLGKG--YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHhcCC--CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999876 8999999999999999999999999999999999988765434444 4578999999999999 999995
Q ss_pred --CHHHHHH
Q 001449 1057 --SFSEISR 1063 (1075)
Q Consensus 1057 --Sa~ELLq 1063 (1075)
.++||.+
T Consensus 436 ~~G~~EIK~ 444 (550)
T KOG0605|consen 436 SKGAEEIKK 444 (550)
T ss_pred cccHHHHhc
Confidence 5666654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.91 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=210.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+|+++ ++.||+|++...... .......+.+|+.+|++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--Q 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--C
Confidence 46899999999999999999885 788999998753211 12234567789999999999999999998887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcc
Confidence 78999999999999999997654 589999999999999999999999999999999999998 6678999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
+..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ..++..++
T Consensus 149 ~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~ 222 (291)
T cd05612 149 KKLRDR--TWTLCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLD 222 (291)
T ss_pred hhccCC--cccccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCC
Confidence 854332 22356899999999997654 7899999999999999999999999888777777666554 35677789
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPS-----FSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPS-----a~ELLq~ 1064 (1075)
..+++||++||+.||.+|++ ++++++.
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 99999999999999999995 8887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=378.53 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=216.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..|....+||+|+.|.||.++. +++.||||.+.......+ +-+++|+.+|+..+|+|||.+++.|.. .
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--------eLilnEi~Vm~~~~H~NiVnfl~Sylv--~ 342 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--------ELLLNEILVMRDLHHPNIVNFLDSYLV--G 342 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--------hhhHHHHHHHHhccchHHHHHHHHhcc--c
Confidence 3578888999999999999976 477799999987654332 346789999999999999999999988 4
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+|.|||||+||+|.+++.... +++.++..|+++++.||+|||.+||||||||.+|||++ .++.+||+|||++
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFc 416 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFC 416 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeee
Confidence 77999999999999999998764 89999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc-cCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~-~l~p~ips~ 1035 (1075)
....... ......||+.|||||++..+. |+.|+||||||++++||+-|++||...++...+..|..+ ......+..
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 8654443 566788999999999998655 899999999999999999999999987777776666544 445566788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++.++++|+.+||+.|+++|+|+.|||+.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=364.14 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=219.2
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
+.+..++|++..+||.|..++||+|+. +++.||||++..+... ..++.+.+|+..|+.++||||+.++..|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-------~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-------NDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-------hhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 345668899999999999999999987 5888999999876432 1256788999999999999999999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.. +..+|+||.||.+|++.++++... .-+++..+..|++++++||.|||++|.||||||+.||||+ .+|.|||
T Consensus 94 vv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkL 167 (516)
T KOG0582|consen 94 VV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKL 167 (516)
T ss_pred Ee--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEE
Confidence 98 678999999999999999998753 3389999999999999999999999999999999999998 8899999
Q ss_pred eecCCccccccc----ccc-CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc
Q 001449 952 GDLGLSKVKQQT----LVS-GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 952 iDFGLAk~~~~~----~~s-ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~ 1026 (1075)
+|||.+...... ... ..+.||++|||||++...-+.|+.|+||||||++.+||.+|..||...++.+++...+++
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 999987632111 111 567899999999998777788999999999999999999999999999998877766665
Q ss_pred cCCC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1027 TLRP--------QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1027 ~l~p--------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.... ......+..++.+|..||+.||.+|||+.++++.
T Consensus 248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 5421 1123456789999999999999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=376.75 Aligned_cols=247 Identities=27% Similarity=0.495 Sum_probs=217.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|.+.+.||+|+||.||||+.+ .+.||+|.+.+.. ..++.++.+.+|+.|+++++|||||.++++|.+ .
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~ 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG------RNEKELKNLRQEVRILRSLKHPNIVEMLESFET--S 73 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--c
Confidence 46778888999999999999765 5669999987653 233446788899999999999999999999998 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++|+||+.| +|..+|...+ .++++.+..|+.|+++||.|||+++|+|||+||.|||+. ..+.+||||||+|
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLA 147 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhh
Confidence 789999999966 9999998765 489999999999999999999999999999999999998 8899999999999
Q ss_pred cc-cccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KV-KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~-~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
+. .......++..|||.|||||++.+.. |+..+|+||||||+|||++|++||...........|...... .|..+
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~p--yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~ 223 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQP--YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTA 223 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCC--ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--Ccccc
Confidence 94 44445567788999999999998766 899999999999999999999999988888888888776653 45588
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+..+.+|++.+|.+||.+|.++.+++..
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 9999999999999999999999998864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.21 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=213.5
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.+..++|++.+.||+|+||.||+|+++ ++.||||+++..... .......+.+|+.+|++++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 344578999999999999999999884 778999998754221 2233466789999999999999999999988
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ .+.+++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~D 161 (329)
T PTZ00263 89 D--ENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTD 161 (329)
T ss_pred c--CCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEee
Confidence 7 678999999999999999997654 578999999999999999999999999999999999998 678899999
Q ss_pred cCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 954 FGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
||+++...... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........+..+.... ..++
T Consensus 162 fg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p 235 (329)
T PTZ00263 162 FGFAKKVPDRT--FTLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFP 235 (329)
T ss_pred ccCceEcCCCc--ceecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCC
Confidence 99998654322 2356999999999997654 7899999999999999999999998887777766666543 4567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPS-----FSEISRR 1064 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPS-----a~ELLq~ 1064 (1075)
.+++..+++||.+||+.||.+|++ +.++++.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 889999999999999999999986 6777744
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.22 Aligned_cols=256 Identities=32% Similarity=0.577 Sum_probs=213.1
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
+...+|++.+.||+|+||.||+|+++ +..||+|.++.... ......+.+|+.+|++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 34567999999999999999999753 55799999875421 1223568899999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
+.. .+.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred Eec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 886 5689999999999999999987666789999999999999999999999999999999999998 6779999
Q ss_pred eecCCcccccccccc--CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccC
Q 001449 952 GDLGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 952 iDFGLAk~~~~~~~s--ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
+|||.+......... ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||......+.+..+... .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-F 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhCC--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-C
Confidence 999987643222111 1233567899999987544 7899999999999999875 99999888777666655433 3
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
....+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 3456778899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=344.31 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=204.2
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|+..+.||+|+||.||++.+ +++.||+|.+....... ......+.+|+.+|++++|+||+.+++++.+ .+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKRILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----hhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CC
Confidence 378899999999999999987 48889999987543221 1122456789999999999999999999887 56
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 899999999999999888653 33589999999999999999999999999999999999998 6678999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh--ccCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN--NTLRPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk--~~l~p~ips~ 1035 (1075)
.............||..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.. ......++..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEK--YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCC--CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 8654433334567999999999997654 78999999999999999999999986543222221111 1122345667
Q ss_pred CCHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPS-----FSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPS-----a~ELLq~ 1064 (1075)
++.++.+||++||+.||.+|++ +.++++.
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 8999999999999999999997 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=376.97 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=225.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.-|+..+.||.|+.|.|-+|++ +|+.+|||++.+.... .+.....+.+|+.||+.+.||||+++|+++.+ +
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-----s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~ 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-----SSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--K 84 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-----ccccccchhhhhHHHHHhcCCCeeeeeeeecc--C
Confidence 4588889999999999999998 6999999999876322 12223567789999999999999999999988 7
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+|+|+||+++|.|+++|.+++. +++.++.++++||+.|+.|+|..+|+||||||+|+|++ ..+.+||+|||+|
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMA 159 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMA 159 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeecccee
Confidence 889999999999999999988764 78888889999999999999999999999999999998 5566999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
.+........+.||++.|.|||++.|+++ ...++||||-|||||-||||++||.+.+...++.++..+.+ .+|..++
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pY-dG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPY-DGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNIS 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCC-CCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCC
Confidence 99888888888999999999999999874 68899999999999999999999999999999888888776 5789999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++++||.+||..||++|.|..+|++.
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhC
Confidence 999999999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.08 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=204.6
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.||+|+||.||++++ +|+.||||+++..... ....+..+.+|+.+|++++||||+++++++.. .+.+++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~ 74 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVM 74 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEE
Confidence 699999999999987 4788999999864321 12234567789999999999999999999887 67899999
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-cc
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QT 963 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~~ 963 (1075)
||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... ..
T Consensus 75 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 75 EYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccCC
Confidence 999999999998765 4589999999999999999999999999999999999998 67789999999987432 22
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHH
Q 001449 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSL 1043 (1075)
Q Consensus 964 ~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dL 1043 (1075)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.... ..++..++.++++|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l 225 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSL 225 (323)
T ss_pred CcccceecCccccChhhhcCCC--CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHH
Confidence 2234467999999999997654 7899999999999999999999998877776666655443 35677889999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHH
Q 001449 1044 MESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1044 I~kCLq~DPeeRP-----Sa~ELLq 1063 (1075)
|.+||+.||++|| ++.++++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHc
Confidence 9999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=341.56 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=202.8
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||+|+.+ +..||+|+++...... ....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKNLKHANIVTLHDIIHT-- 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-------cchhHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 467999999999999999999874 7789999987542211 11345689999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG~ 149 (288)
T cd07871 75 ERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGL 149 (288)
T ss_pred CCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 567999999996 599999887766789999999999999999999999999999999999998 667899999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-------
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL------- 1028 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l------- 1028 (1075)
++..... .......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGST-EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 8753322 2223456899999999987532 378999999999999999999999987766555443322100
Q ss_pred -------------CC--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 -------------RP--------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 -------------~p--------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+ .....++.++++||.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 011246789999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=375.98 Aligned_cols=246 Identities=24% Similarity=0.445 Sum_probs=216.8
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~ 871 (1075)
..+..++|.++++||+|+||+|+++..+ ++.+|||++++..+..+.. ++..+.|..|+.... ||.++.++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccc
Confidence 4567789999999999999999999875 6679999999887665433 355667777877775 9999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
|++ ...+++||||+.||++..++. .+.+++..+..++..|+.||.|||++|||+||||.+|||+| ..|.+||
T Consensus 438 fQT--~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~ki 509 (694)
T KOG0694|consen 438 FQT--KEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKI 509 (694)
T ss_pred ccc--CCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEe
Confidence 999 789999999999999544433 24589999999999999999999999999999999999999 8899999
Q ss_pred eecCCccccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 952 GDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 952 iDFGLAk~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
+|||+++... ....++++|||+.|||||++.+.. |+..+|+|||||+|||||.|..||.+.+..++...|+... +
T Consensus 510 ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~ 585 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--V 585 (694)
T ss_pred cccccccccCCCCCccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--C
Confidence 9999999654 444667899999999999998765 8999999999999999999999999999999999998865 4
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPS 1057 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPS 1057 (1075)
..|.+++.+..++++++|..+|++|.-
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG 612 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLG 612 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccC
Confidence 689999999999999999999999963
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.57 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=208.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+|++. ++.||||++++.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--D 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--C
Confidence 36999999999999999999884 788999999864321 12234567889999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCC
Confidence 78999999999999999997653 589999999999999999999999999999999999998 6778999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC----
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP---- 1033 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip---- 1033 (1075)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..+....+.........+
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRGKG--YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcCCC--CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 85443 234467999999999998653 7899999999999999999999999887766655544322111112
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 --SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 --s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++.++.+||.+||..+|.+||++.++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2458999999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=363.94 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=217.7
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCch------hHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS------ERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~------ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
.++|++++.||+|.||+|-+|+. +++.||||++.+........ ....-++...+|+.||++|+|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46799999999999999999988 47789999997654322111 11112457789999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
+..++....+|||+|||..|.+...-... ..+++.++++|+++++.||+|||.+|||||||||+|+||+ .+++||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~g~VK 250 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SDGTVK 250 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CCCcEE
Confidence 99998899999999999988877643322 1289999999999999999999999999999999999998 779999
Q ss_pred EeecCCcccccc------ccccCCCCCCCCccCcccccCC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHh
Q 001449 951 IGDLGLSKVKQQ------TLVSGGVRGTLPWMAPELLSGK--SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGG 1022 (1075)
Q Consensus 951 LiDFGLAk~~~~------~~~sss~~GT~~YmAPEvl~g~--~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~ 1022 (1075)
|+|||.+..... ........|||.|+|||++.+. ..+.+.+.|||||||+||.|+.|+.||.+....+.+.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 999999884421 1122346799999999998762 23456789999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1023 Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
|++..+.......+.+++++||.+||.+||++|.++.+|....
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 9988765444445789999999999999999999999886543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=340.54 Aligned_cols=254 Identities=32% Similarity=0.515 Sum_probs=203.7
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k------------------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk 859 (1075)
..++|++.+.||+|+||.||+|.++ +..||+|+++... .......+.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 4568999999999999999999752 2359999887532 12234668899999999
Q ss_pred CCCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc------------------ccCCHHHHHHHHHHHHHHHHH
Q 001449 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------RTIDRRKRLIIAMDAAFGMEY 921 (1075)
Q Consensus 860 L~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~------------------~~Lse~~~l~Ia~QIL~AL~y 921 (1075)
++||||+++++++.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999887 567899999999999999986532 236778899999999999999
Q ss_pred HHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHH
Q 001449 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFG 998 (1075)
Q Consensus 922 LHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLG 998 (1075)
||+.||+||||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.++||||||
T Consensus 154 lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG 227 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFG 227 (304)
T ss_pred HHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC--CCchhhhHHHH
Confidence 9999999999999999998 66789999999997432211 122334578899999987544 78999999999
Q ss_pred HHHHHHHc--CCCCCCCCChHHHHHhhhh------ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 999 IVMWELLT--GDEPYADMHCASIIGGIVN------NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 999 VILyELLT--G~~PF~~~~~~eil~~Ilk------~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+++|+|++ +..||........+..+.. .......+..++..+.+||.+||+.||.+|||+.+|.+.|+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999986 6788887666555443321 11122334567899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=341.32 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=211.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|..++.||+|.||.||+|++ +|+.||||+++.....+ ..-...++|+++|+.++|+||+.++++|.. .
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------Gi~~talREIK~Lqel~h~nIi~LiD~F~~--~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------GINRTALREIKLLQELKHPNIIELIDVFPH--K 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------CccHHHHHHHHHHHHccCcchhhhhhhccC--C
Confidence 4688889999999999999988 48899999999763322 122457799999999999999999999988 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+.||+||| ..+|...|+.+...++...++.++.++++||+|||++.|+||||||.|+||+ .++.+||+|||+|
T Consensus 74 ~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLA 148 (318)
T KOG0659|consen 74 SNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLA 148 (318)
T ss_pred CceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccch
Confidence 7899999999 5699999999999999999999999999999999999999999999999998 7889999999999
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC------
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP------ 1030 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p------ 1030 (1075)
+...... .....+-|.||+|||++.|.. .|+..+||||+|||+.||+.|.+-|.+.+.-+.+..|....-.+
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 9654332 223336899999999998865 48999999999999999999999998887777666665311100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1031 --------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1031 --------------------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+....+.++.+|+.+||..||.+|.++.+.++.
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0122356778999999999999999999998863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=351.77 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=210.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+|++. ++.||||+++...... ......+.+|+.+|..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-----RNQIAHVRAERDILADADSPWIVKLYYSFQD--E 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhcCCCCccchhhheec--C
Confidence 46999999999999999999985 8889999998643221 1234567889999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCC
Confidence 7899999999999999999876 4689999999999999999999999999999999999998 6788999999998
Q ss_pred ccccccc------------------------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcC
Q 001449 958 KVKQQTL------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007 (1075)
Q Consensus 958 k~~~~~~------------------------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG 1007 (1075)
....... ......||+.|+|||++.+.. ++.++|||||||+||+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC--CCCceeeEecchhhhhhccC
Confidence 8543322 223456999999999998664 78999999999999999999
Q ss_pred CCCCCCCChHHHHHhhhhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 001449 1008 DEPYADMHCASIIGGIVNNTLRPQIP--SWCDPEWRSLMESCWASDPAERPS-FSEISRR 1064 (1075)
Q Consensus 1008 ~~PF~~~~~~eil~~Ilk~~l~p~ip--s~ls~eL~dLI~kCLq~DPeeRPS-a~ELLq~ 1064 (1075)
+.||...........+........++ ..++.++++||.+||. ||.+|++ +.++++.
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99999888776666666522222232 3369999999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=357.22 Aligned_cols=260 Identities=32% Similarity=0.549 Sum_probs=212.9
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIV 866 (1075)
+.+..++|++.+.||+|+||.||+|++. +..||||+++.... ......+.+|+.+|+++ +|+|||
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCcee
Confidence 3455678999999999999999998752 24699999875421 11235677899999999 899999
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhcc----------------------------------------------
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------------------------------------- 900 (1075)
++++++.. .+.+++||||+.+|+|.+++....
T Consensus 106 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 106 NLLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eEeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 99999887 567899999999999999986431
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 901 -----------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 901 -----------------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGla 259 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLA 259 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeeceee
Confidence 2367888999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 958 KVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 958 k~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
+...... ......++..|+|||++.+.. ++.++|||||||++|+|++ |+.||........+..+.........+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 337 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP 337 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC
Confidence 8543221 112233566799999986544 8999999999999999997 999998766555555555555555667
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
..++.+++++|.+||+.||.+|||+.+|++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.68 Aligned_cols=254 Identities=34% Similarity=0.609 Sum_probs=211.0
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
..+|++++.||+|+||.||+|...+ ..||+|.++... .......+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 4578899999999999999998743 358999876431 12234567899999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeN 936 (1075)
+.. ....+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 154 (283)
T cd05048 77 CTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154 (283)
T ss_pred EcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence 876 567899999999999999997542 347888999999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 001449 937 LLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYA 1012 (1075)
Q Consensus 937 ILId~~d~~~g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~ 1012 (1075)
||++ .++.+||+|||+++..... .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 155 il~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 155 CLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK--FTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred EEEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc--CchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9998 6678999999998743221 1122345678899999987544 7899999999999999998 999999
Q ss_pred CCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1013 DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1013 ~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.....+....+.... ....+..++.++.+|+.+||+.||.+||++.+|++.|+++
T Consensus 229 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 229 GFSNQEVIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCHHHHHHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 887777666655443 3456778899999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=356.30 Aligned_cols=258 Identities=31% Similarity=0.531 Sum_probs=209.7
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~-------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVk 867 (1075)
.+..++|++.+.||+|+||.||+|++ .+..||||+++.... ....+.+.+|+.+|+.+ +|||||+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCcceee
Confidence 34456799999999999999999974 245699999874321 11235677899999999 8999999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhcc-----------------------------------------------
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~----------------------------------------------- 900 (1075)
+++++.+ .+..++||||+.+|+|.+++....
T Consensus 104 l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 104 LLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 9999987 567899999999999999986432
Q ss_pred ---------------------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 901 ---------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 901 ---------------------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
..+++..++.|+.||++||.|||++||+||||||+|||++ .+..+||+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~D 257 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICD 257 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEec
Confidence 1467888999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCC
Q 001449 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 954 FGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||..................
T Consensus 258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 335 (375)
T cd05104 258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335 (375)
T ss_pred CccceeccCcccccccCCCCCCcceeChhHhcCCC--CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence 99998543221 112233566799999997654 7899999999999999998 99999876655444455555445
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1030 p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
...+...+.++++||.+||+.||++|||+.+|++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 555667889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=328.31 Aligned_cols=249 Identities=34% Similarity=0.616 Sum_probs=208.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.++|++++.||+|+||.||+++++ +..+|+|.++..... ...+.+|+.+|++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--Q 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEcc--C
Confidence 467999999999999999999885 457999987643211 2457789999999999999999999877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~~ 147 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMT 147 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCCc
Confidence 678999999999999999976555689999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 958 k~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
+....... .....++..|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+.+..+.... ....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 224 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPK 224 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccCc--cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCC
Confidence 85322211 12233566899999997554 7889999999999999999 999998887777766665443 334456
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
..+.++.++|.+||+.+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 6788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=351.73 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=207.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++++ ++.||||+++..... .......+.+|+.+|+.++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--E 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--C
Confidence 47999999999999999999884 788999999754221 12334567789999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+|+|.+++.+.+ .+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccc
Confidence 78999999999999999997654 589999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc---------------------------------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHH
Q 001449 958 KVKQQTL---------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFG 998 (1075)
Q Consensus 958 k~~~~~~---------------------------------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLG 998 (1075)
+...... .....+||+.|+|||++.+.. ++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG 226 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG--YNKECDWWSLG 226 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC--CCCeeeeecch
Confidence 7422110 011246999999999997554 78999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 001449 999 IVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPAERPS---FSEISRR 1064 (1075)
Q Consensus 999 VILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips--~ls~eL~dLI~kCLq~DPeeRPS---a~ELLq~ 1064 (1075)
|++|+|++|..||...+....+..+........++. .++.++++||.+||. +|.+|++ +.++++.
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999999999998887776666655333333333 468999999999996 8999987 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.52 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=212.7
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcC---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kG---t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
.+..++|++++.||+|+||.||+|++++ ..||+|++.+.... .......+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 4556789999999999999999998642 46999998754321 122345678899999999999999999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
.+ .+.+++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 101 ~~--~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL~ 173 (340)
T PTZ00426 101 KD--ESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMT 173 (340)
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEe
Confidence 87 678999999999999999997654 589999999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+.... ..+
T Consensus 174 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~ 247 (340)
T PTZ00426 174 DFGFAKVVDTR--TYTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYF 247 (340)
T ss_pred cCCCCeecCCC--cceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCC
Confidence 99999854332 23457999999999997654 7889999999999999999999999887776666666543 346
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
+..++.+++++|++||+.||.+|+ +++++++.
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 777899999999999999999995 88888764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=350.98 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=205.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||+||+++.+ ++.||||++++.... .......+.+|+.++++++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--K 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 47999999999999999999874 778999999754221 22334567789999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCc
Confidence 7899999999999999999765 3589999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc------------------------------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHH
Q 001449 958 KVKQQTL------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001 (1075)
Q Consensus 958 k~~~~~~------------------------------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVIL 1001 (1075)
+...... .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil 226 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIM 226 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC--CCCchhhhhhHHHH
Confidence 7432110 012357999999999997654 78999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC--CCCHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 001449 1002 WELLTGDEPYADMHCASIIGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPA---ERPSFSEISRR 1064 (1075)
Q Consensus 1002 yELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips--~ls~eL~dLI~kCLq~DPe---eRPSa~ELLq~ 1064 (1075)
|||++|+.||...+..+.+..+........++. .++.+++++|.+++. ++. .||++.+|++.
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 999999999998887777777665333333343 368899999998764 444 45899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.51 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=197.9
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||+|++ +++.||||+++....... ...+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-------PFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-------chhHHHHHHHHhhCCCCCcCeEEEEEec--
Confidence 47899999999999999999988 478899999875421111 1345689999999999999999999987
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...+++||||+ .++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 149 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGL 149 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCc
Confidence 56799999999 5788888877666789999999999999999999999999999999999998 677899999999
Q ss_pred cccccc-ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhhhhc---cC---
Q 001449 957 SKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIVNN---TL--- 1028 (1075)
Q Consensus 957 Ak~~~~-~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-eil~~Ilk~---~l--- 1028 (1075)
++.... ........+|+.|+|||++.+.. .++.++|||||||++|+|++|..||...... ..+..+... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGST-EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 874322 22223456899999999987543 3788999999999999999999999865332 222222110 00
Q ss_pred ----------CC-C----CC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 ----------RP-Q----IP---------SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 ----------~p-~----ip---------s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+ . .+ ...+.++++||.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0 00 013467899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=335.26 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=198.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC---CCCceeeeecccc
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVR 873 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL---~HPNIVkL~g~~~ 873 (1075)
++|++++.||+|+||.||+|++. +..||+|+++........ ...+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999873 567999998754322111 12334566666555 6999999999875
Q ss_pred c---CCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 874 D---GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 874 d---~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
. .....+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCE
Confidence 3 23456899999995 69999887543 4489999999999999999999999999999999999998 66789
Q ss_pred EEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
||+|||+++............||+.|+|||++.+.. ++.++|||||||++|||++|++||......+.+..+......
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhCCC--CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 999999998654444445567899999999997544 788999999999999999999999887766665555432100
Q ss_pred C-------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 P-------------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 p-------------------------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+ .+...++..+++||.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 011346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.58 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=202.1
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||+|+||.||++++. +..||+|+++..... .......+.+|+.+|++++||||+++++++.. .+.+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEc
Confidence 699999999999884 677999998754221 12234567789999999999999999999887 678999999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc-cc
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-TL 964 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~-~~ 964 (1075)
|+.+|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ..
T Consensus 74 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 999999999997653 589999999999999999999999999999999999998 677899999999985322 22
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHH
Q 001449 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLM 1044 (1075)
Q Consensus 965 ~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI 1044 (1075)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++++||
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHG--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHcCCC--CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHH
Confidence 234467999999999997654 7899999999999999999999999887777766666543 356678899999999
Q ss_pred HHhhhcCCCCCCC---HHHHHH
Q 001449 1045 ESCWASDPAERPS---FSEISR 1063 (1075)
Q Consensus 1045 ~kCLq~DPeeRPS---a~ELLq 1063 (1075)
.+||+.||.+||+ +.+++.
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHc
Confidence 9999999999975 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=340.66 Aligned_cols=259 Identities=30% Similarity=0.581 Sum_probs=212.5
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE--cCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~--kGt----~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
.+...+|++++.||+|+||.||+|++ .+. .||+|+++... .......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45667899999999999999999986 333 38999876421 112235677899999999999999999
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
+++.. ...++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 76 g~~~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~ 148 (316)
T cd05108 76 GICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHV 148 (316)
T ss_pred EEEcC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcE
Confidence 99876 346899999999999999988766789999999999999999999999999999999999998 66789
Q ss_pred EEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||+++....... .....++..|+|||++.+.. ++.++||||||+++|||++ |..||......+.. .+..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~ 225 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE 225 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHh
Confidence 9999999985432221 12223467899999997544 7899999999999999998 99999877665543 3344
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1026 ~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
.......+..++.++.++|.+||..+|.+||++.+++..|.++..+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 4444455667889999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=371.17 Aligned_cols=264 Identities=33% Similarity=0.572 Sum_probs=223.3
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.|++..+++.+...||+|.||+||+|+|-|. ||||+++..... ...++.|.+|+..|++.+|.||+-+.|++.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt------~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPT------PEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCC------HHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 4555666778889999999999999999875 999999876432 225788999999999999999999999998
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.+ .+.||+.||+|-+|+.+|.-....+...+.+.|++||++|+.|||.++|||||||..|||+. ++++|||+|
T Consensus 459 ~p---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIgD 531 (678)
T KOG0193|consen 459 NP---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIGD 531 (678)
T ss_pred CC---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEec
Confidence 73 34999999999999999988777799999999999999999999999999999999999998 668999999
Q ss_pred cCCccccccc---cccCCCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 954 LGLSKVKQQT---LVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 954 FGLAk~~~~~---~~sss~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
||++...... .......|...|||||+++- ....|++.+||||||+++|||++|.+||...+...++.++-.+...
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM 611 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence 9999854322 12233458889999999962 3345899999999999999999999999977777777666666443
Q ss_pred CC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1030 PQ---IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1030 p~---ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
+. +...++.++++|+..||..++++||.+.+|+..|+.+...
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 33 3457888999999999999999999999999999887653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=356.46 Aligned_cols=251 Identities=24% Similarity=0.434 Sum_probs=226.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++.+.||+|+||+|-+|.. .|+.||||.|+++.+.++ ..+-.+.+|+.||+.|+||||+.+|.+|.. .
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde-----qDlvhIRREIeIMSsLNHPhII~IyEVFEN--k 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE-----QDLVHIRREIEIMSSLNHPHIIQIYEVFEN--K 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH-----HHHHHHHHHHHHHhhcCCCceeehhhhhcC--C
Confidence 5688999999999999999976 489999999998765433 335667899999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+.|||||..+|.|++|+.+++ .+++..+..|++||.+|+.|+|+++++|||||.+|||+| .++.+||+|||++
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGLS 200 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGLS 200 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccchh
Confidence 78999999999999999998876 489999999999999999999999999999999999999 7889999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
..+........+||++.|.+||+++|.++ -...+|-||||++||.|+.|..||.+.+...++..|.++.++.. .-+
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY-~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~P 276 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPY-KGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETP 276 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCC-CCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCC
Confidence 99988888899999999999999998874 57789999999999999999999999999999999888776432 335
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
....-||+.||..||++|.|+.+|...+.
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 67889999999999999999999988764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=346.91 Aligned_cols=242 Identities=24% Similarity=0.390 Sum_probs=204.0
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.||+|+||.||+++. +|..||+|+++..... .......+.+|+.++++++||||+++++++.. .+.+++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~ 74 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVM 74 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEE
Confidence 699999999999987 4788999999865322 12234567789999999999999999999887 67899999
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-cc
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QT 963 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~~ 963 (1075)
||+.+++|..++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... ..
T Consensus 75 E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 75 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCCC
Confidence 9999999998887653 589999999999999999999999999999999999998 67789999999987532 22
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHH
Q 001449 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSL 1043 (1075)
Q Consensus 964 ~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dL 1043 (1075)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++++|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l 225 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSL 225 (323)
T ss_pred CccccccCCcCcCCcccccCCC--CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHH
Confidence 2233467999999999997654 7899999999999999999999998877776666655443 34677889999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1044 MESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1044 I~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
|.+||+.||.+|+ ++.++++.
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 9999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.25 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=205.0
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
+..++|++++.||+|+||.||++++. +..||+|++.... .......+.+|+.+|++++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45688999999999999999999885 7779999987531 12234668899999999999999999999887
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.+.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 --DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred --CCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 568999999999999999997654 589999999999999999999986 699999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhh---------
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV--------- 1024 (1075)
Q Consensus 954 FGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Il--------- 1024 (1075)
||++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9998754332 223456999999999997654 7899999999999999999999997654433211110
Q ss_pred ------------------------------------hccCCCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1025 ------------------------------------NNTLRPQI-PSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1025 ------------------------------------k~~l~p~i-ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
.....+.. ...++.++++||.+||+.||++|||+.+|++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00001111 124678999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=353.02 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=204.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++. +++.||||++.+... .....+..+.+|+.+|++++|||||++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--A 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 4789999999999999999987 477899999875321 122345677889999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeecccc
Confidence 7899999999999999999765 4589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc------------------------------------------------ccCCCCCCCCccCcccccCCCCCCC
Q 001449 958 KVKQQTL------------------------------------------------VSGGVRGTLPWMAPELLSGKSHMVT 989 (1075)
Q Consensus 958 k~~~~~~------------------------------------------------~sss~~GT~~YmAPEvl~g~~~~yS 989 (1075)
+...... .....+||+.|+|||++.+.. ++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~ 226 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--YG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--CC
Confidence 6221100 001246999999999997654 78
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 001449 990 EKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPAER---PSFSEISRR 1064 (1075)
Q Consensus 990 ~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips--~ls~eL~dLI~kCLq~DPeeR---PSa~ELLq~ 1064 (1075)
.++|||||||+||||++|..||......+.+..+........++. .++.++++||.+||. +|.+| +++.++++.
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999999999999988777666666654332333343 478999999999997 67765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=333.35 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=199.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||+++++ +..||+|+++..... +.....+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRR--R 72 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEec--C
Confidence 36999999999999999999885 677999998754211 1223556789999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.++.|..+. .....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~ 147 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFA 147 (287)
T ss_pred CEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCc
Confidence 7899999999887666544 3445689999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc--------
Q 001449 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 958 k~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-------- 1027 (1075)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 8543221 223456899999999997654 7889999999999999999999998765544332221100
Q ss_pred -----------C-CC----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -----------L-RP----------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -----------l-~p----------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. .+ .....++.++++||++||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00 011236788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=352.04 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=202.8
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|++++.||+|+||+||+|++ ++..||||++.+.... ....+..+.+|+.+|++++|+||+++++++.+ .+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CC
Confidence 589999999999999999987 4678999999754221 22334678899999999999999999999987 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+.||+||||||+||||+ ..+.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 8999999999999999997654 588999999999999999999999999999999999998 66799999999975
Q ss_pred ccccc------------------------------------------------cccCCCCCCCCccCcccccCCCCCCCc
Q 001449 959 VKQQT------------------------------------------------LVSGGVRGTLPWMAPELLSGKSHMVTE 990 (1075)
Q Consensus 959 ~~~~~------------------------------------------------~~sss~~GT~~YmAPEvl~g~~~~yS~ 990 (1075)
..... ......+||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ 227 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQ 227 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC--CCC
Confidence 22100 0012356999999999997654 789
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC--CCCCHHHHHHHHHhh--hcCCCCCCCHHHHHHH
Q 001449 991 KIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP--SWCDPEWRSLMESCW--ASDPAERPSFSEISRR 1064 (1075)
Q Consensus 991 KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip--s~ls~eL~dLI~kCL--q~DPeeRPSa~ELLq~ 1064 (1075)
++|||||||++|||++|..||...+.......+........++ ..++.++++||.+|+ ..++..|+++.++++.
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999999999998877666555554322222333 357899999999955 4455569999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.34 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=204.1
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.||+|+||.||+++. +++.||+|++++.... .......+.+|+.+|+.++||||+++++++.. .+.+++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 74 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVM 74 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEE
Confidence 699999999999987 4788999999865322 12234567889999999999999999999887 67899999
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-cc
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QT 963 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~~ 963 (1075)
||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... ..
T Consensus 75 Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 75 EYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCcc
Confidence 999999999988654 3589999999999999999999999999999999999998 67789999999987532 22
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHH
Q 001449 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSL 1043 (1075)
Q Consensus 964 ~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dL 1043 (1075)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++.+|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~l 225 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSL 225 (328)
T ss_pred cccccccCCcCccChhhhcCCC--CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHHH
Confidence 2234467999999999997654 7899999999999999999999998877766665554433 35677889999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1044 MESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1044 I~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
|.+||+.||++|+ ++.++++.
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.02 Aligned_cols=243 Identities=26% Similarity=0.451 Sum_probs=203.9
Q ss_pred EEEcccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~-----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
+.||+|+||.||+++. .++.||||+++...... .......+.+|+.+|+.++||||+++++++.. ++.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeE
Confidence 5799999999999975 46779999998643211 11223556789999999999999999999887 5789
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++||||+.+++|.+++.+.+ .+.+..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 99999999999999987654 578888999999999999999999999999999999998 6789999999998743
Q ss_pred -ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHH
Q 001449 961 -QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039 (1075)
Q Consensus 961 -~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~e 1039 (1075)
..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.... ..++..++.+
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 2222233457999999999997654 6889999999999999999999999888777666666543 3567788999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHH
Q 001449 1040 WRSLMESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1040 L~dLI~kCLq~DPeeRP-----Sa~ELLq 1063 (1075)
+++||.+||+.||++|| ++.++++
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 99999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=343.37 Aligned_cols=246 Identities=25% Similarity=0.450 Sum_probs=202.7
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHH---HHhCCCCceeeeecccccCC
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL---LSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~I---LkkL~HPNIVkL~g~~~d~~ 876 (1075)
|++++.||+|+||.||++.++ ++.||||++++...... .....+.+|+.+ ++.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR-----DEVESLMCEKRIFETANSERHPFLVNLFACFQT-- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----hHHHHHHHHHHHHHhccccCCCChhceeeEEEc--
Confidence 678999999999999999874 77899999986532211 122344455544 467789999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+.+++||||+.+++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 5789999999999999988864 3589999999999999999999999999999999999998 677999999999
Q ss_pred ccccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 957 SKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 957 Ak~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
++... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.... ..++..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCCC--CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCC
Confidence 87432 222234567999999999997654 7889999999999999999999999888777776666543 346677
Q ss_pred CCHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
++.++.++|.+||+.||.+|| ++.++++.
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 899999999999999999999 57777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.44 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=197.2
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC--
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~-- 876 (1075)
+|++.+.||+|+||.||+|++ ++..||||+++..... ......+.+|+.+|++++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 488999999999999999987 4788999998743211 112245778999999999999999999876432
Q ss_pred -CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 877 -e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+++||||+ +++|.+++.... .+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 23589999999 578999887553 589999999999999999999999999999999999998 67899999999
Q ss_pred Cccccccc----cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh------
Q 001449 956 LSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN------ 1025 (1075)
Q Consensus 956 LAk~~~~~----~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk------ 1025 (1075)
+++..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99843221 11234569999999999875334578999999999999999999999976554322211100
Q ss_pred --------------------ccCCCCC---CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 --------------------NTLRPQI---PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 --------------------~~l~p~i---ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
......+ ...++.++.++|.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 12357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.56 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=213.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|+.+..|++|+||.||+|+++ ++.||+|+++-+. .+ +-.--..++|+.+|.+++|||||.+-.++....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek----~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EK----EGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc--cc----CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 367999999999999999999985 6779999998653 11 122234679999999999999999999988777
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
-+.+|||||||+ -+|..+|.+...++...+++.++.|+++||+|||.+.|+|||||++|+|++ ..|.+||+|||+
T Consensus 149 ~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGL 223 (419)
T ss_pred cceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccch
Confidence 778999999995 599999998888899999999999999999999999999999999999998 889999999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc--------
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-------- 1027 (1075)
|+.+... ...+..+-|.||+|||++.|.. .|++.+|+||+|||+.||+++++.|.+....+.+.+|.+..
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~-tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAK-TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCc-ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 9976554 3345567899999999999865 48999999999999999999999999887777766665310
Q ss_pred ---------------------CCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 ---------------------LRPQIPSW-CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 ---------------------l~p~ips~-ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++..++.. +++...+|+..+|..||.+|.|+.+-|+
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 01112211 5678889999999999999999998875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.27 Aligned_cols=255 Identities=32% Similarity=0.649 Sum_probs=212.9
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
++...+|++.+.||+|+||.||+|.++ ++.||+|+++... .....+.+|+.+|++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 345567999999999999999999874 7789999876431 11356788999999999999999999987
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
. .+.++++|||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+
T Consensus 73 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~ 146 (263)
T cd05052 73 R--EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVA 146 (263)
T ss_pred C--CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeC
Confidence 7 668899999999999999997643 4589999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccccccc--CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCC
Q 001449 953 DLGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~s--ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
|||++......... ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||......+....+. ....
T Consensus 147 df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~ 223 (263)
T cd05052 147 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYR 223 (263)
T ss_pred CCccccccccceeeccCCCCCccccCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCC
Confidence 99998854332211 1223456799999987554 7889999999999999998 999998877666554443 3345
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1030 p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
...+..++.++.++|.+||+.||++||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 566778899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=344.50 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=202.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeeccccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~-----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d 874 (1075)
+|++++.||+|+||.||+++. ++..||+|++++..... .......+.+|+.+|++++ |+||+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 588999999999999999875 46789999987543221 2233456778999999995 9999999998877
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
.+.+++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 --EAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 678999999999999999987653 589999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccc--ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHhhhhccC
Q 001449 955 GLSKVKQQ--TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH----CASIIGGIVNNTL 1028 (1075)
Q Consensus 955 GLAk~~~~--~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~----~~eil~~Ilk~~l 1028 (1075)
|+++.... ........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.... .......+.. .
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--C 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCC-CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--C
Confidence 99985322 12223457999999999997543 36889999999999999999999996432 2222222222 2
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
.+.++..++..++++|.+||+.||++|| +++++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 3456677899999999999999999999 77788753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.27 Aligned_cols=255 Identities=31% Similarity=0.608 Sum_probs=211.2
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
.+..++|+++++||+|+||.||+|... +..||+|.+..... ..+.+.+|+.++++++|+||+++++.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456688999999999999999999874 56799998764211 13567889999999999999999998876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.+..+++|||+.+++|.+++.+. ...+++..++.++.||+.||.|||+.+++||||||+||+++ .++.+||+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~d 146 (261)
T cd05072 73 --EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIAD 146 (261)
T ss_pred --CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEECC
Confidence 56789999999999999999754 34588899999999999999999999999999999999998 677899999
Q ss_pred cCCccccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 954 LGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 954 FGLAk~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........+... ...
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~ 223 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRM 223 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhccCC--CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 999985433221 12234567899999987544 7889999999999999998 99999887766665555433 333
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.....++.++.++|.+||+.+|++||+++++++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 34456889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.49 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=209.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||++++ +++.||+|+++..... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQD--K 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--C
Confidence 4689999999999999999987 4788999999864321 12234567789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCC
Confidence 689999999999999999988766799999999999999999999999999999999999998 6789999999999
Q ss_pred ccccccc--ccCCCCCCCCccCcccccCC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 958 KVKQQTL--VSGGVRGTLPWMAPELLSGK----SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 958 k~~~~~~--~sss~~GT~~YmAPEvl~g~----~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
....... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||........+..+........
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 8543222 22334689999999998632 23478899999999999999999999988777766666654432223
Q ss_pred CC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1032 IP--SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1032 ip--s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++ ..++.++++||.+||+ +|.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 33 2578999999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.73 Aligned_cols=251 Identities=33% Similarity=0.617 Sum_probs=208.9
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEcCc-ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~kGt-~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
+.++|++++.||+|+||.||++++.+. .+|+|.++..... ...+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 70 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTK-- 70 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 346799999999999999999988654 5999988743211 2457789999999999999999999876
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...+++||||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||++ .++.+||+|||+
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~ 146 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGL 146 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCcc
Confidence 5678999999999999999987655789999999999999999999999999999999999998 667899999999
Q ss_pred ccccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 957 SKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 957 Ak~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.......+... .....+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 223 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYRP 223 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhcCc--ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CCCCCC
Confidence 875432221 12233567899999997544 7889999999999999998 99999887776666655443 333445
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
...+..+++++.+||+.+|.+||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 667899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.95 Aligned_cols=252 Identities=33% Similarity=0.638 Sum_probs=211.3
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
+...+|++.+.||+|+||.||+++.++..||+|.++... ....+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 71 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE- 71 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-
Confidence 455789999999999999999999999999999876431 124677899999999999999999976542
Q ss_pred CCceEEEEeeecCCcHHHHHhhccc-cCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~-~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
.+..+++|||+.+++|.+++.+... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg 147 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFG 147 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCCc
Confidence 4578999999999999999976543 478999999999999999999999999999999999998 67799999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
++....... ....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||...........+.. ......+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 222 (256)
T cd05082 148 LTKEASSTQ--DTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 222 (256)
T ss_pred cceeccccC--CCCccceeecCHHHHccCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCC
Confidence 988543322 2234566899999987544 7889999999999999997 9999987776665555443 33445667
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.++..++++|.+||+.+|++|||+.++++.|+++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 7899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.43 Aligned_cols=255 Identities=36% Similarity=0.640 Sum_probs=212.2
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
..++|++.+.||+|+||.||+|+++ ...||||+++... .......+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 3467999999999999999999874 3468999886432 122235678899999999999999999998
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
.. .+..++||||+.+++|.+++......+++..++.++.|++.||.|||+++|+|+||||+|||++ .++.+||+
T Consensus 75 ~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~ 148 (266)
T cd05033 75 TK--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVS 148 (266)
T ss_pred ec--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEEC
Confidence 76 5678999999999999999987666789999999999999999999999999999999999998 67789999
Q ss_pred ecCCcccccc---ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccC
Q 001449 953 DLGLSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 953 DFGLAk~~~~---~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
|||++..... ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 225 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-Y 225 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccCC--CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-C
Confidence 9999985431 11112233567899999987544 7889999999999999998 99999877766666555433 3
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
....+..++..+.+|+.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3345667899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.29 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=205.3
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC-ceeeeecccccCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPD 877 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP-NIVkL~g~~~d~~e 877 (1075)
+|++++.||+|+||.||+|+++ ++.||||++++..... ......+..|..++..+.|+ +|+.+++++.+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--M 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--C
Confidence 5889999999999999999885 5679999998653221 22345677899999999765 58888888876 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 68999999999999999987654 489999999999999999999999999999999999998 6678999999998
Q ss_pred cccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
+... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.... ..++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 7422 222233457999999999998654 7889999999999999999999999888777777665543 4567788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSF-----SEISR 1063 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa-----~ELLq 1063 (1075)
+.++.++|.+||..||.+|++. .++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999999999999975 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.42 Aligned_cols=247 Identities=35% Similarity=0.665 Sum_probs=203.1
Q ss_pred eEEEEEcccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 803 EEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~k------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
++.+.||.|.||.||+|.++ +..|+||.++... .......+.+|+.+|++++||||+++++++..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-- 72 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-- 72 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccc--
Confidence 56789999999999999987 6679999985421 12224678899999999999999999999995
Q ss_pred CCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
.+.+++||||+.+|+|.++|... ...+++..++.|+.||++||.|||+++|+|+||+++|||++ .++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 55699999999999999999887 56689999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccc---ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCC
Q 001449 956 LSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 956 LAk~~~~---~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
++..... ............|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.. .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~-~~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ-GQRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT-TEETT
T ss_pred ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-cccce
Confidence 9985421 12223344677899999997654 7999999999999999999 7899999888777777643 34455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
++..++..+.++|.+||..||++|||+.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7778899999999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=350.53 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=203.9
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++.+ ++.||||++.+.... .......+.+|+.+|++++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--K 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 46999999999999999999874 778999998753211 12234567789999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCC
Confidence 78999999999999999997654 578999999999999999999999999999999999998 6778999999997
Q ss_pred ccccc--------------------------------------------ccccCCCCCCCCccCcccccCCCCCCCchhh
Q 001449 958 KVKQQ--------------------------------------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKID 993 (1075)
Q Consensus 958 k~~~~--------------------------------------------~~~sss~~GT~~YmAPEvl~g~~~~yS~KsD 993 (1075)
..... .......+||+.|+|||++.+.. ++.++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~D 226 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--CCccee
Confidence 42110 00112357999999999997654 789999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 001449 994 VYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP--SWCDPEWRSLMESCWASDPAERP---SFSEISRR 1064 (1075)
Q Consensus 994 IWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip--s~ls~eL~dLI~kCLq~DPeeRP---Sa~ELLq~ 1064 (1075)
||||||++|||++|+.||......+....+........++ ..++.++.++|.+|+ .+|.+|+ ++.++++.
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999999999998877666555554332222222 357899999999976 5999999 89998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.17 Aligned_cols=256 Identities=36% Similarity=0.601 Sum_probs=209.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeeccccc
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d 874 (1075)
++|++.+.||+|+||.||+|+.+ +. .+++|.++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 57899999999999999999874 33 36888776321 112235678899999999 69999999999877
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEe
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILI 939 (1075)
.+.+++||||+++++|.+++.+.. ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 --RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred --CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 567899999999999999996532 247889999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001449 940 NMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCAS 1018 (1075)
Q Consensus 940 d~~d~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~e 1018 (1075)
+ .++.+||+|||++..............+..|+|||++.+.. ++.++|||||||++|+|++ |..||.......
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8 66789999999987433222222223355799999987544 7899999999999999997 999998887777
Q ss_pred HHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1019 IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1019 il~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
....+... .....+..++.++++||.+||+.+|.+|||+.++++.|+.+...
T Consensus 227 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 227 LYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 66655443 34456667899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=350.73 Aligned_cols=256 Identities=20% Similarity=0.341 Sum_probs=212.7
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.+..++|++++.||+|+||.||+++++ +..||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678999999999999999999874 778999998753221 1122345778999999999999999999988
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ .+.+++||||+.+|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~D 185 (370)
T cd05596 114 D--DKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (370)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEe
Confidence 7 67899999999999999998654 478889999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc--ccCCCCCCCCccCcccccCCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS--HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 954 FGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~--~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
||++....... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||...+....+..+......
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 99988543221 223457999999999986532 24788999999999999999999999988877777777665433
Q ss_pred CCCCC--CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 001449 1030 PQIPS--WCDPEWRSLMESCWASDPAE--RPSFSEISRR 1064 (1075)
Q Consensus 1030 p~ips--~ls~eL~dLI~kCLq~DPee--RPSa~ELLq~ 1064 (1075)
..++. .++.++++||.+||+.+|.+ |+++.++++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 44444 57999999999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.85 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=208.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||+|+. +++.||||.++..... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--D 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--C
Confidence 5799999999999999999987 5788999987643211 12234567889999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+.+++++||+.+++|.+++.. ....+++..++.++.||++||.|||+++|+|+||||+|||++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 678999999999999988853 234578999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH--CASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~--~~eil~~Ilk~~l~p~ 1031 (1075)
|++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... .......+......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCC--CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9988543221 122346888999999987644 7889999999999999999999996543 2334444333333333
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
....++..++++|.+||+.+|++||++.++++.|+++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 3446788999999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.23 Aligned_cols=242 Identities=21% Similarity=0.369 Sum_probs=203.0
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e 877 (1075)
+|++++.||+|+||.||+|+++ +..||||++++.... .......+..|..++..+ +|++|+.+++++.+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--M 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--C
Confidence 5889999999999999999885 567999999865322 122234566778888777 48899999998877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 68999999999999999987653 589999999999999999999999999999999999998 6778999999998
Q ss_pred cccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
+... .........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+..+.... ..++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCCC--CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcC
Confidence 7432 222334567999999999998654 7899999999999999999999999888777777766543 3467788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH
Q 001449 1037 DPEWRSLMESCWASDPAERPSF 1058 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa 1058 (1075)
+.++.+||.+||+.||.+|++.
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.41 Aligned_cols=259 Identities=34% Similarity=0.589 Sum_probs=214.3
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
++.++|.+.+.||+|+||.||+++.. +..+|+|.+... .......+.+|+.+++++.||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34578999999999999999999752 345888987642 122345688999999999999999999
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhcc------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENL 937 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNI 937 (1075)
+++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 99887 578999999999999999997532 2489999999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 001449 938 LVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYAD 1013 (1075)
Q Consensus 938 LId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~ 1013 (1075)
|++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||..
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998 67789999999988432211 112334577899999987543 7889999999999999998 9999988
Q ss_pred CChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHc
Q 001449 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1014 ~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
....+.+..+..... ...+..++.++.+|+.+||+.||.+|||+.++++.|+++.+..
T Consensus 226 ~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 226 LSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 777766666655443 3445568899999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.18 Aligned_cols=254 Identities=33% Similarity=0.590 Sum_probs=208.0
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
..++|++.+.||+|+||.||+|++ .+..||+|.++... .......+.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 346799999999999999999975 34679999886421 11223567789999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhcc----------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~----------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPe 935 (1075)
+.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred Eec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 877 567899999999999999985321 24788899999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 001449 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011 (1075)
Q Consensus 936 NILId~~d~~~g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF 1011 (1075)
|||++ .++.+||+|||+++..... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||
T Consensus 154 nili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 154 NILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred eEEEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC--CCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99998 5678999999999753221 1123344677899999987544 7899999999999999998 99999
Q ss_pred CCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1012 ~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
...........+.... ....+..++.+++++|.+||+.||.+||++.+|++.|++
T Consensus 228 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 228 YGFSNQEVIEMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 8776655555444333 345667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.13 Aligned_cols=248 Identities=21% Similarity=0.326 Sum_probs=203.5
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|++++.||+|+||.||+|++ +++.||+|++.+... ........+.+|+.+|++++|+|||++++.+.+ .+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CC
Confidence 589999999999999999987 467799999875321 123345678899999999999999999999987 67
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 899999999999999999765 3578999999999999999999999999999999999998 67899999999975
Q ss_pred cccc------------------------------------------------ccccCCCCCCCCccCcccccCCCCCCCc
Q 001449 959 VKQQ------------------------------------------------TLVSGGVRGTLPWMAPELLSGKSHMVTE 990 (1075)
Q Consensus 959 ~~~~------------------------------------------------~~~sss~~GT~~YmAPEvl~g~~~~yS~ 990 (1075)
.... .......+||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ 227 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCC
Confidence 2110 00012346999999999997654 789
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 001449 991 KIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP--SWCDPEWRSLMESCWASDPAERPS---FSEISR 1063 (1075)
Q Consensus 991 KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip--s~ls~eL~dLI~kCLq~DPeeRPS---a~ELLq 1063 (1075)
++|||||||+||||++|+.||...+..+....+........++ ..+++++.++|.+|+ .+|.+|++ +.++++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999999999999877766666655433333333 357899999999976 59999987 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.35 Aligned_cols=262 Identities=29% Similarity=0.538 Sum_probs=212.3
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCcee
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIV 866 (1075)
|.+..++|++.+.||+|+||.||+|.+. ++.||+|+++.... ......+.+|+.+++++ +|+||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchh
Confidence 3455678999999999999999999653 35699998874321 11235567899999999 799999
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhcc----------------------------------------------
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------------------------------------- 900 (1075)
++++++... ...++++|||+.+++|.+++....
T Consensus 75 ~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 999987653 567899999999999999986421
Q ss_pred --------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccc---
Q 001449 901 --------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--- 963 (1075)
Q Consensus 901 --------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~--- 963 (1075)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcch
Confidence 2578999999999999999999999999999999999998 5678999999999853221
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 964 ~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
.......++..|+|||++.+.. ++.++|||||||+||||++ |..||......+.+............+..++.++.+
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred hhccCCCCCccccCcHHhcCCC--CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 1122334567899999987654 8999999999999999997 999997755444444444444455566678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1043 LMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
++.+||+.+|++||++.++++.|++++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=344.33 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=203.2
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.||+|+||.||++++ ++..||+|+++...... ...+..+.+|+.+++.++||||+++++++.. .+.+++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~ 74 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVM 74 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEE
Confidence 699999999999987 47889999998653221 2234567789999999999999999999887 67899999
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
||+.+++|.+++.+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 75 EYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCCC
Confidence 9999999999886543 58999999999999999999997 7999999999999998 67789999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||+.|+|||++.+.. ++.++|||||||+||+|++|+.||...+.......+.... ..++..++.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ 225 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 225 (325)
T ss_pred CcccccccCCcccCCHHHHccCC--CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHH
Confidence 22233456999999999997654 7899999999999999999999998877766666555433 3466778999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1043 LMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1043 LI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
||.+||+.||++|+ ++.++++.
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 99999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.19 Aligned_cols=258 Identities=30% Similarity=0.561 Sum_probs=210.4
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE--cCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~--kGt----~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
.+..++|++++.||+|+||.||+|++ ++. .||+|+++... .......+.+|+.+++.++|+||+.++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 34567899999999999999999986 344 37999886432 122235677899999999999999999
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
+++.. ...++++||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~ 148 (279)
T cd05109 76 GICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHV 148 (279)
T ss_pred EEEcC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcE
Confidence 98865 346899999999999999987666789999999999999999999999999999999999997 56789
Q ss_pred EEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||........... ..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~ 225 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR--FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LE 225 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH
Confidence 9999999985432211 11223567899999987544 7899999999999999998 9999987665554443 33
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1026 ~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
.......+..++.++.++|.+||+.||++||++.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 333344556788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.51 Aligned_cols=242 Identities=22% Similarity=0.425 Sum_probs=202.9
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+|+++ ++.||||++++.... .......+..|..+++.+ +||||+++++++.. .+.+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv 74 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFV 74 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEE
Confidence 5999999999999885 668999999864322 122235566788888866 79999999999987 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 75 MEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceecccC
Confidence 9999999999998765 3589999999999999999999999999999999999998 67899999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.... ..++.+++.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ 225 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELE--YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVS 225 (321)
T ss_pred CccccccccCccccCHHHHcCCC--CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 22234456999999999997654 7889999999999999999999999888877777766544 3456788999999
Q ss_pred HHHHhhhcCCCCCC-------CHHHHHHH
Q 001449 1043 LMESCWASDPAERP-------SFSEISRR 1064 (1075)
Q Consensus 1043 LI~kCLq~DPeeRP-------Sa~ELLq~ 1064 (1075)
+|.+||+.||++|+ ++.++++.
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=319.95 Aligned_cols=253 Identities=32% Similarity=0.508 Sum_probs=211.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|++|.||++.. ++..||+|.+...... ......+..+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--C
Confidence 4688899999999999999976 4788999998754221 1122334678899999999999999999999987 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++|+||+.+++|.+++.+.. .+++..++.++.||+.||.|||+.||+||||||+||+++ .++.++|+|||++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~ 151 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 151 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 68999999999999999987653 588999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccccc----CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 958 KVKQQTLVS----GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 958 k~~~~~~~s----ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
+........ ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+........++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 753322111 2355788999999998654 7899999999999999999999998776666555555555556677
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++.++.++|.+||..+|.+|||+.++++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 7889999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.99 Aligned_cols=254 Identities=32% Similarity=0.637 Sum_probs=210.2
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
++..++|++.+.||+|++|.||+|.+. +..||+|.++..... ...+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---------PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---------HHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 345577999999999999999999874 567999998753211 2457789999999999999999998876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.+.+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d 146 (261)
T cd05068 73 --EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVAD 146 (261)
T ss_pred --CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECC
Confidence 567899999999999999997653 4689999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccccc--CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 954 LGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 954 FGLAk~~~~~~~s--ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
||+++........ .....+..|+|||++.+.. ++.++||||||+++|+|++ |+.||........+..+... ...
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~ 223 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRM 223 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCC--CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 9999854422111 1122345799999987544 7899999999999999999 99999887766666555433 333
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
..+..++..+.++|.+||+.+|.+||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 4556678999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.89 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=204.9
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|++.+.||+|+||.||++.+ +++.||+|++...... .......+.+|+.+++.++||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CC
Confidence 478999999999999999987 4788999998754321 11223456789999999999999999999887 56
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++ +++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 799999999999999888654 34589999999999999999999999999999999999998 6678999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc--cCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~--~l~p~ips~ 1035 (1075)
.............|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+... .....++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNER--YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCCC--CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 8654333334457899999999997544 788999999999999999999999876543332222111 122345566
Q ss_pred CCHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
++..+++||.+||+.||.+|| ++.++++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 899999999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.77 Aligned_cols=236 Identities=24% Similarity=0.443 Sum_probs=199.1
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+|+++ ++.||||++++.... .+.....+..|..+++.+ +||||+++++++.. .+.+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv 74 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFV 74 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEE
Confidence 6999999999999874 678999998764321 122345567888888876 69999999999887 6789999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 75 MEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred EcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCcC
Confidence 99999999999887653 589999999999999999999999999999999999998 67789999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.... ..++.+++.++++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 225 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAVD 225 (320)
T ss_pred CCcccccccCccccCHHHHcCCC--CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHH
Confidence 22334567999999999997554 7889999999999999999999999888877777766543 3467788999999
Q ss_pred HHHHhhhcCCCCCCCH
Q 001449 1043 LMESCWASDPAERPSF 1058 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa 1058 (1075)
||.+||+.||.+|+++
T Consensus 226 li~~~L~~dP~~R~~~ 241 (320)
T cd05590 226 ILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHcccCHHHCCCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=361.00 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=215.4
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
...|+.+++||+|+||.||+|.+. ++.||+|++..+... ..+..+.+|+.+|.+++++||.++|+.|..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-------deIediqqei~~Ls~~~~~~it~yygsyl~-- 82 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-------DEIEDIQQEISVLSQCDSPNITEYYGSYLK-- 82 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc-------hhhHHHHHHHHHHHhcCcchHHhhhhheee--
Confidence 456788899999999999999884 777999999876432 235677899999999999999999999998
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...++++||||.||++.++++... .+++..+..|+++++.||.|||..+.+|||||+.|||+. ..+.|||+|||+
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~DfgV 157 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADFGV 157 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEecce
Confidence 678999999999999999997654 358888888999999999999999999999999999998 668999999999
Q ss_pred cccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 957 Ak~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
+....... ....++||+.|||||++++.. |+.|+||||||++.+||++|.+||.+.++..++..|-+.. +|.+...
T Consensus 158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~~--Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~~ 234 (467)
T KOG0201|consen 158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQSG--YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDGD 234 (467)
T ss_pred eeeeechhhccccccccccccchhhhcccc--ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccccc
Confidence 98654433 336788999999999998544 8999999999999999999999999998877666555544 4555567
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++..+++||..||++||+.|||+.++|+.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 89999999999999999999999999874
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=327.62 Aligned_cols=252 Identities=35% Similarity=0.603 Sum_probs=209.2
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
..+|.+++.||+|+||.||+|+.. +..||||+++... .......+.+|+++|+++.|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheeeE
Confidence 456888999999999999999763 3569999886431 11123577899999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhcc-------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD-------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLL 938 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNIL 938 (1075)
+.. ....++||||+.+++|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nil 154 (280)
T cd05049 77 CTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCL 154 (280)
T ss_pred Eec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEE
Confidence 887 578999999999999999997542 34788899999999999999999999999999999999
Q ss_pred eccCCCCCCeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 001449 939 VNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADM 1014 (1075)
Q Consensus 939 Id~~d~~~g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~ 1014 (1075)
++ .++.+||+|||++...... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...
T Consensus 155 i~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 155 VG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred Ec----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 98 6689999999998743221 1122334678899999997654 7899999999999999998 99999887
Q ss_pred ChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1015 HCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1015 ~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
...+....+.... ....+..++.+++++|.+||+.||++||++.|+++.|+
T Consensus 229 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 229 SNEEVIECITQGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 7777666655433 33455678999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=356.44 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=199.2
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.....+|++.+.||+|+||.||+|.+ +++.||||++.... ....+|+.+|+.++|||||++++++.
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEe
Confidence 34456899999999999999999987 47789999886431 12236999999999999999988764
Q ss_pred cC------CCCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC
Q 001449 874 DG------PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 874 d~------~e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~ 944 (1075)
.. ....+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--- 205 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--- 205 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---
Confidence 31 1234779999996 577776643 3456899999999999999999999999999999999999972
Q ss_pred CCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhh
Q 001449 945 QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024 (1075)
Q Consensus 945 ~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Il 1024 (1075)
....+||+|||+|+............||+.|+|||++.+.. .++.++|||||||+||||++|.+||......+.+..+.
T Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 33579999999998654444444567899999999987543 37899999999999999999999998876655444433
Q ss_pred hcc---------------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1025 NNT---------------------------LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1025 k~~---------------------------l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
... ....++...+.++++||.+||+.||.+|+|+.++++.
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 210 0011344568899999999999999999999999854
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=351.61 Aligned_cols=262 Identities=31% Similarity=0.518 Sum_probs=213.2
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCce
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNV 865 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNI 865 (1075)
.+.+..++|.+.+.||+|+||.||+|++.+ ..||||+++... .....+.+.+|+.+|+++. ||||
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCe
Confidence 345567889999999999999999998632 359999986432 1122356889999999996 9999
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHHHhhcc---------------------------------------------
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------------------------------------------- 900 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~--------------------------------------------- 900 (1075)
|++++++.+ .+.++|||||+.+|+|.++|.++.
T Consensus 104 v~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (400)
T cd05105 104 VNLLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK 181 (400)
T ss_pred eeEEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence 999999987 567999999999999999886531
Q ss_pred --------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 901 --------------------------------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 901 --------------------------------------------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
..+++..++.++.||++||.|||+++|+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~ 261 (400)
T cd05105 182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR 261 (400)
T ss_pred cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 236778889999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 262 dikp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 262 DLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred CCChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC--CCchhhHHHHHHHHHHHHHC
Confidence 9999999998 66789999999998532221 122344678899999987544 7899999999999999997
Q ss_pred CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1007 G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
|..||........+...+........+..++.+++++|.+||+.||++||++.+|.+.|+++..
T Consensus 336 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999987654444444444444555667789999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.74 Aligned_cols=249 Identities=27% Similarity=0.483 Sum_probs=210.2
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|++|.||++++ +++.|++|.+...... ......+.+|+.++++++||||+++++.+.+ .+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLD--KG 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeecc--CC
Confidence 588899999999999999987 4788999998754221 2234667889999999999999999999887 57
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999999775 45689999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
+...... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+.... .+.++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccc
Confidence 8543322 223456889999999997654 7889999999999999999999998877666666555443 34456678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.++.++|.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 8999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.16 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=198.2
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|+.++.||+|+||.||++++. ++.||||++.... .......+.+|+.+|++++|+||+++++++..
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 143 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-- 143 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--
Confidence 356778889999999999999874 7889999986431 12234567899999999999999999999877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+.+++||||+.+++|.+.. ..++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 144 ~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG~ 214 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGV 214 (353)
T ss_pred CCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccccc
Confidence 67899999999999987542 256778889999999999999999999999999999998 678899999999
Q ss_pred cccccccc-ccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhhhhccCC
Q 001449 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---SIIGGIVNNTLR 1029 (1075)
Q Consensus 957 Ak~~~~~~-~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~---eil~~Ilk~~l~ 1029 (1075)
++...... ......||..|+|||++... ....+.++|||||||++|||++|+.||...... .....+. ....
T Consensus 215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 293 (353)
T PLN00034 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQP 293 (353)
T ss_pred ceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCC
Confidence 98543322 22345799999999998532 223567899999999999999999999743222 2222222 2233
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...+..++.++++||.+||+.||++|||+.++++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45566789999999999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=359.31 Aligned_cols=250 Identities=30% Similarity=0.495 Sum_probs=223.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|+.+++||+|+||.+++++++ +..+|+|.+.......+ + .+...+|+.+++++.|||||.+.+.|.+ +
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~----~--r~~A~~E~~lis~~~hP~iv~y~ds~~~--~ 75 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP----E--RRSAIQEMDLLSKLLHPNIVEYKDSFEE--D 75 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch----h--hHHHHHHHHHHHhccCCCeeeeccchhc--C
Confidence 67899999999999999988764 67799999987644322 2 2467799999999999999999999998 5
Q ss_pred Cc-eEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 878 GS-LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 878 ~~-L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
+. ++|||+|++||+|.+.|.+.. ..++++.+..++.||+.||.|||++.|+|||||+.|||++ .+..|||.|||
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDfG 151 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDFG 151 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecchh
Confidence 66 999999999999999998765 6689999999999999999999999999999999999998 66788999999
Q ss_pred Ccccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
+|+...... ...+..||+.||+||++.+.+ |+.|+|||||||++|||++-+.+|...+....+.++..... ..++.
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~ 228 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPS 228 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCc
Confidence 999766654 566788999999999999877 89999999999999999999999999999999888887764 56788
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++.+++.+|+.||..+|+.||++.+||..
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 899999999999999999999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=326.04 Aligned_cols=254 Identities=31% Similarity=0.542 Sum_probs=206.6
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
+..++|++.+.||+|+||.||+|.++ +..||+|+++... . ......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-----~--~~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-----S--MRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-----C--HHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 45577999999999999999998764 3459999875321 1 11234578999999999999999999
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhcc---------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEec
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId 940 (1075)
+++.. .+..++||||+.+++|.+++.+.. ..+++..+..++.|++.||.|||+.|++||||||+|||++
T Consensus 76 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~ 153 (277)
T cd05062 76 GVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc
Confidence 99876 567899999999999999987532 2357788899999999999999999999999999999998
Q ss_pred cCCCCCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001449 941 MRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016 (1075)
Q Consensus 941 ~~d~~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~ 1016 (1075)
.++.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.....
T Consensus 154 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 154 ----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred ----CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 677899999999874322111 11223577899999987544 7899999999999999999 7999988777
Q ss_pred HHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1017 ~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
......+.... ...++..++..++++|.+||+.||++|||+.++++.|+
T Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 EQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 66655544433 24456778899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.42 Aligned_cols=238 Identities=27% Similarity=0.424 Sum_probs=200.4
Q ss_pred EEEcccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~-----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
+.||+|+||.||+++. .|+.||+|+++..... ......+.+|+.+|++++||||+++++++.+ .+.+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEE
Confidence 5799999999999875 4788999999864321 1123456789999999999999999999887 6789
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 9999999999999998654 3589999999999999999999999999999999999998 6678999999998854
Q ss_pred ccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHH
Q 001449 961 QQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039 (1075)
Q Consensus 961 ~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~e 1039 (1075)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+.... ..++..++.+
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCC--CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 332 2234567999999999997654 6889999999999999999999999887777766665543 3467778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHH
Q 001449 1040 WRSLMESCWASDPAERPSFSE 1060 (1075)
Q Consensus 1040 L~dLI~kCLq~DPeeRPSa~E 1060 (1075)
+++||++||+.||++||++.+
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCC
Confidence 999999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.10 Aligned_cols=251 Identities=36% Similarity=0.654 Sum_probs=213.1
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
+...+|++.+.||.|+||.||+++..|+.||+|.++.... ...++.+|+.++++++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-- 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC--
Confidence 3457899999999999999999999999999999875421 24667899999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g 147 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFG 147 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEcccc
Confidence 677899999999999999997654 2589999999999999999999999999999999999998 67789999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
+++....... ....+..|+|||.+.... ++.++||||||+++|+|++ |..||...+.......+.. ......+.
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 222 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPE 222 (256)
T ss_pred cccccccccc--cCCCcccccCchhhcCCc--CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCcc
Confidence 9986533222 233466799999986543 7889999999999999997 9999988776665544433 33445666
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
.++.++.++|.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 789999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=323.57 Aligned_cols=255 Identities=32% Similarity=0.577 Sum_probs=210.0
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL 868 (1075)
.+..++|++.+.||+|+||.||++.+++ ..||+|.+.... .......+.+|+.+|+.+.|+||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 3556789999999999999999998743 569999875431 11223567789999999999999999
Q ss_pred ecccccCCCCceEEEEeeecCCcHHHHHhhcc---------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEe
Q 001449 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (1075)
Q Consensus 869 ~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILI 939 (1075)
++++.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 75 ~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill 152 (277)
T cd05032 75 LGVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE
Confidence 999887 577899999999999999996532 236788999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001449 940 NMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMH 1015 (1075)
Q Consensus 940 d~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~ 1015 (1075)
+ .++.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||....
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 153 A----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred c----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC--CCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 8 67889999999987432221 122334678899999986544 7889999999999999998 999998877
Q ss_pred hHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1016 ~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+....+. ......++..++.++.++|.+||+.+|++|||+.+|++.|+
T Consensus 227 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 NEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 776665555 33345567778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.30 Aligned_cols=249 Identities=33% Similarity=0.633 Sum_probs=206.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..+|++.+.||+|+||.||+++++ +..+|+|++...... ...+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTK--Q 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 356888999999999999999885 446999988643211 1356789999999999999999999876 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+..++||||+++++|.+++......+++..++.|+.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~ 147 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLA 147 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccc
Confidence 678999999999999999987666789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccccc--CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 958 KVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 958 k~~~~~~~s--ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
+........ ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+. .......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPK 224 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCC
Confidence 754322211 1122345799999987544 7889999999999999999 899998776666555443 334445566
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
.++.++.+++.+||+.+|++|||+.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.84 Aligned_cols=253 Identities=33% Similarity=0.607 Sum_probs=211.3
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..+|++.+.||.|+||.||+|++. +..+|+|+++.... .....+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--------LKQQDFQKEVQALKRLRHKHLISLFAVCSV--G 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--------hhHHHHHHHHHHHhcCCCcchhheeeeEec--C
Confidence 356888999999999999999875 67799998875421 113457789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
..+++||||+.+++|.+++.+. +..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEccccc
Confidence 6789999999999999999764 34589999999999999999999999999999999999998 677999999999
Q ss_pred ccccccccc-cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 957 SKVKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 957 Ak~~~~~~~-sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
+........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+.+..+.. ......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 227 (261)
T cd05148 151 ARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPA 227 (261)
T ss_pred hhhcCCccccccCCCCceEecCHHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCC
Confidence 975433221 22334567899999987544 7889999999999999998 8999988776666665553 34455667
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.++.++.++|.+||+.||.+|||+.+|++.|+.+
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 7899999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=339.59 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=197.8
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||++++ .|..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN------QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc------hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 37899999999999999999987 4788999998754211 122355678999999999999999999886532
Q ss_pred ----CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 ----e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
...+++||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 235799999995 567666643 378899999999999999999999999999999999998 67899999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc------
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN------ 1026 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~------ 1026 (1075)
|||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+...
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 999998654444444567899999999997654 788999999999999999999999876544322221110
Q ss_pred ----------------cCC------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1027 ----------------TLR------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1027 ----------------~l~------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
... .......+.++++||.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00112246789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.56 Aligned_cols=258 Identities=31% Similarity=0.601 Sum_probs=212.2
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVk 867 (1075)
.+..++|++.+.||+|+||.||++++.+ ..+|+|.++... .......+.+|+.+++++ +|+||++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4556789999999999999999998642 458999886431 112235678899999999 7999999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhc---------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~---------------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDI 932 (1075)
+++++.. .+.++++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||
T Consensus 81 ~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 81 LLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred EEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999877 56799999999999999999642 345899999999999999999999999999999
Q ss_pred CCCceEeccCCCCCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CC
Q 001449 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GD 1008 (1075)
Q Consensus 933 KPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~ 1008 (1075)
||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |.
T Consensus 159 kp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 159 AARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred ceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC--cCcccceeehhhHHHHHhcCCC
Confidence 99999998 678999999999985432211 11223456799999986544 7899999999999999997 99
Q ss_pred CCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1009 EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1009 ~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
.||......+....+.. ......+..++.++.+|+.+||..||++|||+.++++.|++++
T Consensus 233 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 233 SPYPGIPVEELFKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99988776666554433 3344566778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=331.52 Aligned_cols=259 Identities=34% Similarity=0.592 Sum_probs=208.5
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--Ccc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGI 871 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~--VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~ 871 (1075)
+..++|++.+.||+|+||.||+|.++ +.. +|+|.++... .......+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 45578999999999999999999874 443 5666655321 112235677899999999 89999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeN 936 (1075)
+.. .+.+++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 887 567999999999999999997542 257899999999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001449 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMH 1015 (1075)
Q Consensus 937 ILId~~d~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~ 1015 (1075)
||++ .++.+||+|||++.............++..|+|||.+.+.. ++.++|||||||++|+|+| |..||...+
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC--CcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9998 66789999999987432222222223466799999986544 7889999999999999998 999998777
Q ss_pred hHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1016 ~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
..+....+. .......+..++.++.+||.+||+.+|++||++.++++.|..+...
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 229 CAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 666554443 2333445556789999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.54 Aligned_cols=258 Identities=34% Similarity=0.577 Sum_probs=212.2
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
+..+|.+.+.||+|+||.||++++. +..+++|.++... ......+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4467899999999999999999753 3348888876431 122356778999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPe 935 (1075)
++.. ...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 75 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 75 VCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 9887 567899999999999999997532 24789999999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 001449 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011 (1075)
Q Consensus 936 NILId~~d~~~g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF 1011 (1075)
|||++ .++.+||+|||+++..... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus 153 Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 153 NCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred eEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99998 6779999999999743221 1123345678899999987654 7889999999999999998 99999
Q ss_pred CCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHc
Q 001449 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1012 ~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
...+..+.+..+... .....+..++..+.++|.+||+.+|.+||++.++++.|+++.+..
T Consensus 227 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 227 FQLSNTEVIECITQG-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred CCCCHHHHHHHHhCC-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 887776665554433 333455667899999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.48 Aligned_cols=254 Identities=31% Similarity=0.547 Sum_probs=208.2
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
...+|++++.||+|+||.||+|++. +..||||+++... .......+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 3455777888999999999999863 3569999987431 1123456778999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhc---------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~---------------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPe 935 (1075)
++.. ....++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 76 ~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~ 153 (283)
T cd05091 76 VVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153 (283)
T ss_pred EEcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 9887 56789999999999999998532 234788889999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 001449 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011 (1075)
Q Consensus 936 NILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF 1011 (1075)
|||++ .++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||
T Consensus 154 Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~ 227 (283)
T cd05091 154 NVLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPY 227 (283)
T ss_pred heEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99998 56789999999988532221 122334678899999986544 7889999999999999998 89999
Q ss_pred CCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1012 ~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
......+.+..+.... ...++..++..+.+|+.+||+.+|.+||++++|++.|+.
T Consensus 228 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 228 CGYSNQDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8877777666655544 344567789999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=355.20 Aligned_cols=247 Identities=21% Similarity=0.358 Sum_probs=207.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
..|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+|+.++|||||++++++..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKS-- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--
Confidence 34999999999999999999763 566888876432 11223456789999999999999999999987
Q ss_pred CCceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.+.++|||||+.+|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ ..+.+||+|
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~D 212 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGD 212 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEe
Confidence 67899999999999999988642 34589999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 954 FGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
||+++...... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+..... .
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-~ 289 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-D 289 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCC--CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C
Confidence 99998543321 234567999999999997654 79999999999999999999999988877777776665543 3
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.++..++.++++||.+||..||++||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 456678999999999999999999999999875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=338.00 Aligned_cols=241 Identities=26% Similarity=0.486 Sum_probs=198.5
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-CCCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk-L~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+|+++ ++.||||+++...... ......+..|..++.. ++||||+++++++.. .+.+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv 74 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-----DDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFV 74 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEE
Confidence 6999999999999875 6679999998653221 1122344556666664 479999999999887 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 75 MEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMNG 149 (316)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCCC
Confidence 99999999999987654 589999999999999999999999999999999999998 66789999999998532 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+... .+.++..++.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 225 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAKD 225 (316)
T ss_pred CCccccccCCccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHH
Confidence 22334567999999999997654 789999999999999999999999988877766665543 34567789999999
Q ss_pred HHHHhhhcCCCCCCCHH-HHHH
Q 001449 1043 LMESCWASDPAERPSFS-EISR 1063 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~-ELLq 1063 (1075)
||.+||+.||.+||++. ++++
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999864 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.06 Aligned_cols=256 Identities=34% Similarity=0.579 Sum_probs=204.2
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
..+|++++.||+|+||.||+++. .+..||+|+++... ....+.+.+|+.+|++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 45789999999999999999874 36779999876431 22346678999999999999999999987
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
.......+++||||+.+++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEEC
Confidence 65445678999999999999999987666689999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----------
Q 001449 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---------- 1018 (1075)
Q Consensus 953 DFGLAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e---------- 1018 (1075)
|||++........ .....++..|+|||++.+.. ++.++||||||+++|||++|..++......-
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCC--cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 9999885432211 11122345699999987554 7889999999999999999877754322110
Q ss_pred -----HHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1019 -----IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1019 -----il~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.+...+........+..++.++.+||.+||+.+|++|||+.+|++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01122222333344566889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=331.52 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=201.7
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||+|+++ +..||+|.++....... ...+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-------PCTAIREVSLLKDLKHANIVTLHDIVHT-- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-------chhHHHHHHHHHhCCCCCcceEEEEEee--
Confidence 467999999999999999999874 67799999875432111 1345689999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
++.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 150 (309)
T cd07872 76 DKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (309)
T ss_pred CCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcccc
Confidence 567999999996 589888877766789999999999999999999999999999999999998 667899999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc--------
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-------- 1027 (1075)
+...... .......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+..+.+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSS-EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 8753322 2223346789999999986533 37889999999999999999999998766554433332210
Q ss_pred -------------CCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -------------LRP-------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -------------l~p-------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
... .....++.++++||.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 011246889999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=349.43 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=224.3
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~ 875 (1075)
...|++.+.||.|.||.||+++.+ |+.+|+|++.+....... ....+.+|+.+|+++. |||||.++++|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~- 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFED- 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEc-
Confidence 356888999999999999999874 788999999887654432 2456789999999999 9999999999998
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+++|||++.||.|.+.|... . +++..+..++.||+.++.|||+.||+||||||+|+|+.......+.+|++|||
T Consensus 108 -~~~~~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 -PDSVYLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred -CCeEEEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 56899999999999999999877 3 89999999999999999999999999999999999998665556799999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC-
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS- 1034 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips- 1034 (1075)
+|............+||+.|+|||++.+.. |+..+||||+|+++|.|++|..||...........+....+....+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~--y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRP--YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCC--CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 999877666667789999999999998655 89999999999999999999999999988888888887765433333
Q ss_pred -CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1035 -WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1035 -~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++..++++|+.||..||.+|+++.++|+.
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 468999999999999999999999999985
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.14 Aligned_cols=262 Identities=30% Similarity=0.568 Sum_probs=212.7
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCce
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kG---------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNI 865 (1075)
++..++|.+.+.||+|+||.||++++.+ ..+|+|.++... .......+.+|+.+++++ +|+||
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 3445779999999999999999997632 459999887431 112235677899999999 79999
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
+++++++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 87 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred eeEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999887 568899999999999999997642 247889999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 165 dlkp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 165 DLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cccHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC--CCcHHHHHHHHHHHHHHHcC
Confidence 9999999998 667899999999875432111 11122456899999987544 7899999999999999998
Q ss_pred CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHcC
Q 001449 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAIN 1073 (1075)
Q Consensus 1007 G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~Ln 1073 (1075)
|..||...+..+....+ ........+..++.++++||.+||..+|.+|||+.++++.|++++...+
T Consensus 239 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 239 GGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred CCCCCCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 89999877665554443 3333445667789999999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=352.76 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=224.5
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|...+.||+|-|+.|-+|++ +|.+||||++.+..+. +....++++|+..|+..+|||||++|.+..+ ...
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD------~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTK 91 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTK 91 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cce
Confidence 67778899999999999976 7999999999876432 2234667899999999999999999999887 778
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+|||+|+-.+|+|.+||-+...-+.+..+++++.||+.|+.|+|+..+|||||||+||++. ..-+.|||.|||++..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---eecCceEeeecccccc
Confidence 9999999999999999998887899999999999999999999999999999999999997 3668999999999998
Q ss_pred cccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHH
Q 001449 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039 (1075)
Q Consensus 960 ~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~e 1039 (1075)
..........||+..|.|||++.|..+ ....+||||||||||.|++|++||...+..+.+.+|+.-.+ .+|..++.+
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsY-DAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~e 245 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSY-DAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKE 245 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCcc-CCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHH
Confidence 888888889999999999999998763 56789999999999999999999999999998888887655 578899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1040 WRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1040 L~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+++||..||..||.+|.+.++|..
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhc
Confidence 999999999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.81 Aligned_cols=248 Identities=26% Similarity=0.443 Sum_probs=208.1
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|+||.||++++ ++..+|+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+ .+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 588999999999999999987 477899999874321 1223567789999999999999999999887 67
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.++++|||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 899999999999999988653 44579999999999999999999999999999999999998 6678999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
...... .......++..|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+..... ..++..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHccCC--cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCccc
Confidence 754322 2223456899999999987654 78999999999999999999999988776666555544433 3456678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.++++||.+||+.||++||++.+|+..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.99 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=204.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++.+ ++.||||+++..... .......+.+|+.++..++|+||+++++.+.+ .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQD--K 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 47899999999999999999874 778999998753211 12234667789999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCC
Confidence 78999999999999999997653 589999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc------------------------------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHH
Q 001449 958 KVKQQTL------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001 (1075)
Q Consensus 958 k~~~~~~------------------------------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVIL 1001 (1075)
+...... .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil 226 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIM 226 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC--CCCcceecccccee
Confidence 7322110 012356999999999997654 78999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 001449 1002 WELLTGDEPYADMHCASIIGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPAERPS---FSEISRR 1064 (1075)
Q Consensus 1002 yELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips--~ls~eL~dLI~kCLq~DPeeRPS---a~ELLq~ 1064 (1075)
|||++|+.||...+....+..+........++. .++.++++||.+|+ .||.+|++ +.++++.
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 999999999998887777666664332223333 36899999999977 49999984 6676654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=337.10 Aligned_cols=251 Identities=28% Similarity=0.476 Sum_probs=201.9
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
+..++|++.+.||+|+||.||+++++ +..+|+|+++... .......+.+|+++|++++|+||+++++++.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45678999999999999999999885 6778999887531 11223567899999999999999999999988
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.+.+++||||+.+++|.+++.+.+ .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 --DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred --CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 678999999999999999997654 488999999999999999999975 799999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhh----------
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI---------- 1023 (1075)
Q Consensus 954 FGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~I---------- 1023 (1075)
||++...... ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754322 223456899999999997654 788999999999999999999999754432221100
Q ss_pred ---------------------------------hhccCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1024 ---------------------------------VNNTLRPQIP-SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1024 ---------------------------------lk~~l~p~ip-s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
......+.++ ...+.++++||.+||+.||++|||+.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0011111111 2357899999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.42 Aligned_cols=255 Identities=32% Similarity=0.566 Sum_probs=208.2
Q ss_pred CeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
+|++.+.||+|+||.||+|+... ..+|+|.+.... .......+.+|+.+++.+.||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------SSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788899999999999998642 348888776432 1122366889999999999999999999987
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhc-----------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKK-----------------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~-----------------------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
. .+..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||
T Consensus 74 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 Q--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred c--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 7 56789999999999999998642 1247888999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ +++.+||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|+|++
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC--cchHhHHHHHHHHHHHHHhc
Confidence 9999999998 56789999999987432211 112234567899999986544 7899999999999999998
Q ss_pred CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1007 G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
|..||........... .........+..++.++.++|.+||+.+|++||++.++++.|++++.+
T Consensus 226 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 226 GGNPYPGIAPERLFNL-LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 9999988776665443 344444556778899999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.68 Aligned_cols=253 Identities=29% Similarity=0.504 Sum_probs=201.5
Q ss_pred eeEEEEEcccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 802 LEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
|++++.||+|+||+||++++ .+..||+|.++.... ......+.+|+.+|++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48899999999999988653 366799999875421 11235677899999999999999999988765
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
....+++||||+.+++|.+++... .+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 456789999999999999999764 489999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HH----------
Q 001449 956 LSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA--SI---------- 1019 (1075)
Q Consensus 956 LAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~--ei---------- 1019 (1075)
+++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK--FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccC--CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9885432211 12233566799999987544 788999999999999999999998653321 00
Q ss_pred --HHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1020 --IGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1020 --l~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
.............+..++.++++++.+||+.+|++|||++++++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112223345677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.26 Aligned_cols=244 Identities=32% Similarity=0.618 Sum_probs=200.5
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.||+|+||.||+|++ +++.||+|.+.... .......+.+|+.++++++||||+++++++.. .+.+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEE
Confidence 589999999999987 57889999876321 12223567889999999999999999999887 56789999
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~ 964 (1075)
||+.+++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCccccccc
Confidence 99999999999987666689999999999999999999999999999999999998 66789999999987533221
Q ss_pred cc---CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHH
Q 001449 965 VS---GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040 (1075)
Q Consensus 965 ~s---ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL 1040 (1075)
.. .....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.. ......+..++..+
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 225 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAV 225 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHH
Confidence 11 1112245699999987554 7889999999999999997 9999987666554444333 33445666789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1041 RSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1041 ~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
.+||.+||+.+|++|||+.++++.|.
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.88 Aligned_cols=258 Identities=29% Similarity=0.541 Sum_probs=209.3
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEE--cCcc----eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~--kGt~----VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
+..++|++++.||+|+||.||+|++ .+.. +++|.+... ........+..|+.+++++.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4457899999999999999999988 3443 566665321 11223356778888999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
++.. ...++++||+.+|+|.+++......+++..++.|+.||+.||.|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 8754 457889999999999999987777799999999999999999999999999999999999998 678899
Q ss_pred EeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhc
Q 001449 951 IGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 951 LiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~ 1026 (1075)
|+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||.......... +...
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~ 226 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEK 226 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHC
Confidence 99999998532211 122345677899999987544 7899999999999999998 999998776555433 3333
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1027 ~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
......+..++.++.+++.+||..||++|||+.++++.|..+..+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 334455666788999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.85 Aligned_cols=258 Identities=29% Similarity=0.527 Sum_probs=211.8
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVk 867 (1075)
.+..++|++.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++++ +|+||++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCCcce
Confidence 345567999999999999999999752 3468999876431 112235678999999999 7999999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCC
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~ 946 (1075)
+++++.. .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+++|+|+||||+|||++ .+
T Consensus 104 ~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~ 177 (302)
T cd05055 104 LLGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HG 177 (302)
T ss_pred EEEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----CC
Confidence 9999877 567899999999999999997643 3389999999999999999999999999999999999997 66
Q ss_pred CeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHh
Q 001449 947 PVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGG 1022 (1075)
Q Consensus 947 g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~ 1022 (1075)
+.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 789999999988433221 122334677899999987654 7889999999999999998 9999987766555445
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1023 Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
..........+...+.++.++|.+||+.+|++|||+.++++.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 5544444455667789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.68 Aligned_cols=241 Identities=26% Similarity=0.458 Sum_probs=198.6
Q ss_pred EEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEE
Q 001449 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
+.||+|+||.||+|+++ |+.||+|+++....... .....+..|..++..+ +||||+++++++.+ .+.+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-----DDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-----chHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEE
Confidence 36999999999999884 77899999986532211 1234456677777754 89999999999987 678999
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~- 961 (1075)
||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 99999999999998765 3589999999999999999999999999999999999998 66789999999987422
Q ss_pred cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHH
Q 001449 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041 (1075)
Q Consensus 962 ~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~ 1041 (1075)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+... .+.++.+++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 122234467999999999997654 789999999999999999999999887776666555433 3456778999999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHH
Q 001449 1042 SLMESCWASDPAERPSFS-EIS 1062 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRPSa~-ELL 1062 (1075)
+||.+||+.||++|+++. +++
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999974 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.76 Aligned_cols=244 Identities=39% Similarity=0.682 Sum_probs=208.3
Q ss_pred EEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceE
Q 001449 807 ELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.||+|+||.||++.+. +..||+|+++..... .....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 72 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------EERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLY 72 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------hHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceE
Confidence 5899999999999885 677999998754211 134677899999999999999999999887 67899
Q ss_pred EEEeeecCCcHHHHHhhc--------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 882 TVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~--------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+||||+.+++|.+++... ...+++..++.++.||++||.|||+++|+||||||+||+++ .++.+||+|
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~d 148 (262)
T cd00192 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISD 148 (262)
T ss_pred EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEcc
Confidence 999999999999999876 46789999999999999999999999999999999999998 668999999
Q ss_pred cCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCC
Q 001449 954 LGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 954 FGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
||.+...... .......++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+.. ...
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~ 225 (262)
T cd00192 149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYR 225 (262)
T ss_pred cccccccccccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCC
Confidence 9999854432 223345578899999998765 37899999999999999999 6999998877666666554 344
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1030 p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
...+..++.++.++|.+||+.+|.+|||+.++++.|+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 5667788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.97 Aligned_cols=261 Identities=29% Similarity=0.503 Sum_probs=213.7
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
+..++|++.+.||+|+||.||+|.+. +..|++|+++... .......+.+|+.+|++++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45678999999999999999999874 3668988876321 2233466788999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhcc-------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD-------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d 943 (1075)
++... ....++++||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 87653 456789999999999999987642 3589999999999999999999999999999999999998
Q ss_pred CCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001449 944 PQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASI 1019 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~ei 1019 (1075)
.++.+||+|||+++...... ......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+.
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC--CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 66899999999998432211 112234677899999987544 7899999999999999999 9999988766665
Q ss_pred HHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHc
Q 001449 1020 IGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1020 l~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
...+. .......+..++.++.+++.+||..||++|||+.++++.|+++.+++
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 280 (280)
T cd05043 229 AAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280 (280)
T ss_pred HHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence 44333 33344455677899999999999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=346.11 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=209.9
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
+..++|++++.||+|+||.||+++++ +..||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 44578999999999999999999884 677999998753221 11223457789999999999999999999887
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...+++||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~DF 186 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADF 186 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEec
Confidence 67899999999999999999654 478999999999999999999999999999999999998 6789999999
Q ss_pred CCcccccccc--ccCCCCCCCCccCcccccCCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS--HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 955 GLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~--~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
|++....... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...+....+..+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998543221 223567999999999997543 237889999999999999999999999888777777776544334
Q ss_pred CCCC--CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 001449 1031 QIPS--WCDPEWRSLMESCWASDPAE--RPSFSEISRR 1064 (1075)
Q Consensus 1031 ~ips--~ls~eL~dLI~kCLq~DPee--RPSa~ELLq~ 1064 (1075)
.++. .++..++++|.+||..++.+ |+++.++++.
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 4444 46899999999999855543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.03 Aligned_cols=245 Identities=33% Similarity=0.575 Sum_probs=202.2
Q ss_pred EEcccCcEEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 807 ELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
+||+|+||.||+|.+ ++..+|+|+++... ......+.+.+|+.+++++.|+||+++++++.. ...++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEE
Confidence 589999999999965 36679999886432 122345678899999999999999999998754 45789
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 73 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 99999999999999754 3589999999999999999999999999999999999998 567899999999875332
Q ss_pred ccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 963 TLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 963 ~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
... .....++..|+|||.+.... ++.++|||||||++|||++ |..||...........+.+. ..+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCC
Confidence 211 11223457899999986443 7889999999999999998 99999887766665555443 3456777899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.+++++|.+||+.||++||++.+|...|+..
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.54 Aligned_cols=254 Identities=35% Similarity=0.623 Sum_probs=209.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
..+|++.+.||+|+||.||+|+++ +..+|+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 467899999999999999999863 2358999876432 1122456788999999999999999999987
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
. .+..++||||+.+++|.+++.+....+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~d 149 (267)
T cd05066 76 K--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSD 149 (267)
T ss_pred c--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeCC
Confidence 6 5678999999999999999987766789999999999999999999999999999999999998 677999999
Q ss_pred cCCccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccC
Q 001449 954 LGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 954 FGLAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-Y 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCc--cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-C
Confidence 999885432211 11122356899999997544 7899999999999999886 99999887766655555433 3
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
....+..++..+++++.+||+.+|.+||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 3444556789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.79 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=206.5
Q ss_pred eeEEEEEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 802 LEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
|++.+.||+|+||.||+|+.. +..||+|+++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 467788999999999999863 25699999875321 1223456889999999999999999999876532
Q ss_pred C----CceEEEEeeecCCcHHHHHhhc-----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC
Q 001449 877 D----GSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1075)
Q Consensus 877 e----~~L~LVmEYmeGGSL~d~Lkk~-----~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g 947 (1075)
. ...++++||+.+++|..++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ +++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 1 3478999999999999998543 23589999999999999999999999999999999999998 667
Q ss_pred eEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhh
Q 001449 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~I 1023 (1075)
.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||......+.+..+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999988543221 111223567899999986544 7899999999999999999 99999887776666555
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1024 lk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
... .....+..++.++.++|.+||+.||.+|||+.++++.|+++
T Consensus 229 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 443 34556778899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=338.14 Aligned_cols=262 Identities=29% Similarity=0.545 Sum_probs=210.6
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~-------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVk 867 (1075)
.+..++|++.+.||+|+||.||+|++ .++.||||+++.... ......+.+|+.+|.++ +|+||++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHhh
Confidence 45567899999999999999999974 356799999875321 11235677899999999 6899999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhcc-----------------------------------------------
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~----------------------------------------------- 900 (1075)
+++++... ...++++|||+.+|+|.+++....
T Consensus 76 ~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 76 LLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred hcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 99987653 457899999999999999986431
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 901 -------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 901 -------------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
..+++..+..++.||++||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIY 230 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEecccccccc
Confidence 2367788889999999999999999999999999999998 66789999999987532
Q ss_pred cc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 962 QT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 962 ~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
.. .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+............+..++
T Consensus 231 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (343)
T cd05103 231 KDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308 (343)
T ss_pred cCcchhhcCCCCCCcceECcHHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence 21 1112234567899999987544 7899999999999999996 9999977554433344444444455677788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
+++.+++..||+.||++|||+.+|++.|+.+.++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=335.92 Aligned_cols=242 Identities=23% Similarity=0.436 Sum_probs=201.9
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||+||+++++ +..||||++++..... ......+.+|..+++.+ +||||+++++++.+ .+.+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv 74 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFV 74 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEE
Confidence 6999999999999884 6789999998653221 12235566788888887 69999999999887 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|..++.+.. .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 75 MEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGILG 149 (318)
T ss_pred EcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCcC
Confidence 99999999999887653 589999999999999999999999999999999999998 67789999999987422 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
.......+||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++++
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 225 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAKS 225 (318)
T ss_pred CCcccceecCccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHHH
Confidence 22233456899999999997654 7899999999999999999999998877776666655443 3466778999999
Q ss_pred HHHHhhhcCCCCCCCH-----HHHHHH
Q 001449 1043 LMESCWASDPAERPSF-----SEISRR 1064 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa-----~ELLq~ 1064 (1075)
||.+||+.||.+||++ .++++.
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999998 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=344.73 Aligned_cols=246 Identities=28% Similarity=0.380 Sum_probs=206.3
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|+..+++|.|+||.||+|+.. +..||||++-.+.- -.-+|+.+|+++.|||||++.-+|....++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------------~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------------YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 4788899999999999999874 67899998765421 122699999999999999999888754333
Q ss_pred ---ceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 879 ---SLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 879 ---~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
++.+||||| -.+|..+++. .+..++...++.++.||++||.|||+.||+||||||.|||+| +.++.+|||
T Consensus 93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEec
Confidence 678999999 4589988874 255688889999999999999999999999999999999998 577999999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-----
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT----- 1027 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~----- 1027 (1075)
|||.|+.........++..|..|+|||.+.|... |+.+.||||.||++.||+.|++.|.+.+..+.+..|.+-.
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~-Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccc-cCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999998777766677889999999999998654 8999999999999999999999999988777665554300
Q ss_pred ---------------------C-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 ---------------------L-RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 ---------------------l-~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. ...+...+++++.+|+.++|..+|.+|.++.+++.
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 00134557899999999999999999999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=370.30 Aligned_cols=260 Identities=37% Similarity=0.617 Sum_probs=224.5
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL 868 (1075)
.+...+.+..+.||+|+||+||+|+.. .+.||||.++... .....++|.+|+.+|..++|||||+|
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~nIVrL 554 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPNIVRL 554 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 455567788899999999999999763 3459999988542 22345889999999999999999999
Q ss_pred ecccccCCCCceEEEEeeecCCcHHHHHhhc---------ccc----CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 001449 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------DRT----IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (1075)
Q Consensus 869 ~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~---------~~~----Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPe 935 (1075)
+|+|.+ .+.++||+|||..|||.++|+.. +.+ ++..+.+.||.||+.|+.||-++.+|||||..+
T Consensus 555 lGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 555 LGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 999998 67899999999999999999742 122 888999999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEeecCCcccc-c-ccccc-CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 001449 936 NLLVNMRDPQRPVCKIGDLGLSKVK-Q-QTLVS-GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPY 1011 (1075)
Q Consensus 936 NILId~~d~~~g~VKLiDFGLAk~~-~-~~~~s-ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF 1011 (1075)
|+||. ++..|||+|||+++.. . +.... ....-..+||+||.|.-.. +++++||||+||+|||+++ |+.||
T Consensus 633 NCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 633 NCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred hceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcc
Confidence 99998 8899999999999942 2 11111 1223456899999997544 8999999999999999998 99999
Q ss_pred CCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1012 ~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
.+....+++..+..+.. ...|..+|.++++|+..||+.+|.+||++++|-.+|+++.+.
T Consensus 707 ~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 707 YGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99999999999888877 889999999999999999999999999999999999998653
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.66 Aligned_cols=255 Identities=33% Similarity=0.616 Sum_probs=209.3
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc--Cc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k--Gt---~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
..++|+..+.||+|+||.||+|+.. +. .+|+|.++... .......+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4467889999999999999999874 32 58999876431 112235678899999999999999999998
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
.. .+..++||||+.+++|.+++.+....+++..+..++.|++.||.|||+.||+||||||+||+++ .++.+||+
T Consensus 76 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl~ 149 (268)
T cd05063 76 TK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKVS 149 (268)
T ss_pred cc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEEC
Confidence 87 5678999999999999999987666789999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc
Q 001449 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 953 DFGLAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
|||++........ ......+..|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~- 226 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG- 226 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcCC--cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-
Confidence 9999874322111 11122345799999987543 7899999999999999997 99999877766666555443
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.....+..++.++++++.+||+.+|++||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 33344556789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.21 Aligned_cols=252 Identities=33% Similarity=0.627 Sum_probs=208.4
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
+..++|++++.||+|+||.||++++. +..+|+|.++..... ...+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 45578999999999999999999874 567999988753211 1357789999999999999999998753
Q ss_pred CCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...+++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~df 146 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADF 146 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCCc
Confidence 4578999999999999999764 34589999999999999999999999999999999999998 6779999999
Q ss_pred CCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+... ....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 223 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMP 223 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcCC--CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 9998543321 112233566899999986544 7889999999999999999 99999887776666655433 3445
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
.+...+..+++||.+||..+|++|||+.++++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=336.50 Aligned_cols=241 Identities=26% Similarity=0.453 Sum_probs=198.7
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-CCCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk-L~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+|+++ ++.||||+++....... .....+..|..+++. ++||||+++++++.+ .+.+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv 74 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFV 74 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-----chHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEE
Confidence 6999999999999885 66799999986532211 122445567777776 489999999999887 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 75 MEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENMLG 149 (316)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCCC
Confidence 9999999999999764 3588999999999999999999999999999999999998 66789999999987432 1
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.... +.++.+++.++++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 225 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKD 225 (316)
T ss_pred CCceeeecCCccccCHHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHH
Confidence 22223456999999999997654 7899999999999999999999998887776666554332 4567789999999
Q ss_pred HHHHhhhcCCCCCCCHH-HHHH
Q 001449 1043 LMESCWASDPAERPSFS-EISR 1063 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~-ELLq 1063 (1075)
||.+||+.||.+|+++. ++++
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHc
Confidence 99999999999999986 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.02 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=195.5
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh---CCCCceeeeecccccC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS---LHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk---L~HPNIVkL~g~~~d~ 875 (1075)
+|++++.||+|+||.||+|+++ ++.||+|.++........ ...+.+|+.+++. ++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4889999999999999999874 778999998764322111 1123345555554 4799999999987642
Q ss_pred ---CCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 876 ---PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 876 ---~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 2345899999996 58988887643 3489999999999999999999999999999999999998 6678999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC---
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL--- 1028 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l--- 1028 (1075)
+|||+++............+|..|+|||++.+.. ++.++|||||||++|+|++|++||........+.++.....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCCC--CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 9999998655444444556899999999997554 78999999999999999999999987666554444332100
Q ss_pred ---------------C-------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 ---------------R-------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 ---------------~-------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. ..+...++.++++||.+||+.||++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0111246788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.20 Aligned_cols=254 Identities=34% Similarity=0.617 Sum_probs=209.1
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--C---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--G---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--G---t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
..+|++.+.||+|+||.||+|+++ + ..||||.++... .+.....+..|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 356899999999999999999874 2 259999886431 1223467889999999999999999999987
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ ...+++||||+.+++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~d 149 (269)
T cd05065 76 K--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (269)
T ss_pred C--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECC
Confidence 6 5678999999999999999987666789999999999999999999999999999999999997 667899999
Q ss_pred cCCcccccccccc----CCCC--CCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhc
Q 001449 954 LGLSKVKQQTLVS----GGVR--GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 954 FGLAk~~~~~~~s----ss~~--GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~ 1026 (1075)
||++......... .... .+..|+|||.+.+.. ++.++|||||||++|||++ |..||......+....+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~- 226 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ- 226 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCc--ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-
Confidence 9998743322111 1111 245799999987544 7889999999999999886 9999988777666665543
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1027 ~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
......+..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 233344567789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.03 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=205.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++.+ ++.||+|++.+... ........+.+|+.+++.++|+||+.+++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--C
Confidence 47999999999999999999874 77899999875321 122234567789999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCce
Confidence 789999999999999999987666789999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc--ccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 958 KVKQQTL--VSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 958 k~~~~~~--~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
....... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||......+.+..+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 7433221 12234699999999998631 234688999999999999999999999887766666665543322222
Q ss_pred C---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 001449 1033 P---SWCDPEWRSLMESCWASDPAE--RPSFSEISRR 1064 (1075)
Q Consensus 1033 p---s~ls~eL~dLI~kCLq~DPee--RPSa~ELLq~ 1064 (1075)
+ ..++.++++||++||..++.+ |+++.++++.
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2 347899999999998764433 7899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=338.31 Aligned_cols=241 Identities=23% Similarity=0.407 Sum_probs=196.1
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+++++ +..||||++++.... ....+..+.+|..+++++ +||||+++++++.+ .+.+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv 74 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFV 74 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEE
Confidence 6999999999999874 778999999865322 122345677899999988 69999999999887 6789999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc-cc
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQ 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~-~~ 962 (1075)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. ..
T Consensus 75 ~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 75 IEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCccccccccC
Confidence 9999999999988655 4589999999999999999999999999999999999998 6778999999998742 22
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------hHH-HHHhhhhccCCCCCC
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH--------CAS-IIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~--------~~e-il~~Ilk~~l~p~ip 1033 (1075)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ..+ ....+... ...++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p 225 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIP 225 (329)
T ss_pred CCccccccCCccccCHHHHcCCC--CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCC
Confidence 22334567999999999997654 7889999999999999999999996321 111 22223222 23567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCC------HHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPS------FSEISR 1063 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPS------a~ELLq 1063 (1075)
..++.++.++|.+||+.||.+|++ +.++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 788999999999999999999987 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=337.38 Aligned_cols=237 Identities=25% Similarity=0.389 Sum_probs=195.9
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHHhCCCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~-ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+|++ +|+.||||++....... ......+..|.. +++.++||||+++++++.. .+.+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv 74 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFV 74 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEE
Confidence 699999999999988 47889999987643221 112234445544 5688999999999999887 6789999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 75 LDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred EcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCcccccC
Confidence 9999999999998764 4589999999999999999999999999999999999998 67799999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+..... .++..++.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 225 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSARH 225 (323)
T ss_pred CCccccccCChhhcChhhhcCCC--CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence 22234457999999999997654 78999999999999999999999998887777666665433 345567999999
Q ss_pred HHHHhhhcCCCCCCCHH
Q 001449 1043 LMESCWASDPAERPSFS 1059 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~ 1059 (1075)
+|.+||+.||.+||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 226 LLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHhhcCHHhCCCCC
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.42 Aligned_cols=242 Identities=24% Similarity=0.381 Sum_probs=195.3
Q ss_pred EcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||+|+||+||++++ +++.||+|++...... .......+..|+.+|++++|+||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEe
Confidence 69999999999987 4778999998754221 11223566789999999999999999998877 567999999
Q ss_pred eecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 886 FMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 886 YmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
|+.+|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999988753 234589999999999999999999999999999999999998 667899999999875332
Q ss_pred c-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHhhhhccCCCCCCCCCC
Q 001449 963 T-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA----SIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 963 ~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~----eil~~Ilk~~l~p~ips~ls 1037 (1075)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .....+... ...++..++
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 225 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFS 225 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCC
Confidence 2 2223457899999999998654 788999999999999999999999764332 122222221 234556789
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
.++.+++.+||+.||++|| +++++++.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=327.32 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=194.4
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||+|+||.||+++.+ |+.||+|++........ .....+..|+.++++++||||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-----SGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-----hhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEe
Confidence 699999999999874 78899999875432211 112334569999999999999999999887 568999999
Q ss_pred eecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc
Q 001449 886 FMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~ 964 (1075)
|+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 999999998886543 3588999999999999999999999999999999999998 67789999999988654433
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHhhhhccCCCCCCCCCCHHH
Q 001449 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA----SIIGGIVNNTLRPQIPSWCDPEW 1040 (1075)
Q Consensus 965 ~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~----eil~~Ilk~~l~p~ips~ls~eL 1040 (1075)
......||..|+|||++.+.. ++.++|||||||++|+|++|+.||...... ........... ......++.++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-ccccccCCHHH
Confidence 334456899999999997654 889999999999999999999999764332 22222222221 11224578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1041 RSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1041 ~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
++||.+||+.||++||++.++++.+
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhh
Confidence 9999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.52 Aligned_cols=238 Identities=25% Similarity=0.378 Sum_probs=195.0
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHH-HHHHhCCCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEA-LLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi-~ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||++++. +..||+|++.+..... ......+..|. .+++.++||||+++++++.. .+.+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv 74 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFV 74 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-----hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEE
Confidence 6999999999999884 6679999987543211 11123334444 45788999999999999887 6789999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|.+++.+.. .+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 75 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCcccccC
Confidence 99999999999997653 478888999999999999999999999999999999998 66789999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+..... .++..++..+.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSARH 225 (325)
T ss_pred CCCcccccCCccccCHHHHcCCC--CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHHH
Confidence 22334567999999999997654 78899999999999999999999998887777666655432 345578999999
Q ss_pred HHHHhhhcCCCCCCCHHH
Q 001449 1043 LMESCWASDPAERPSFSE 1060 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~E 1060 (1075)
+|.+||+.||.+|+++.+
T Consensus 226 li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHcccCHHHCCCCCC
Confidence 999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=318.76 Aligned_cols=258 Identities=31% Similarity=0.604 Sum_probs=211.8
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~kG-----t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
+..++|.+.+.||+|+||.||+|.+.. ..||||.+..... ....+.+.+|+.+++++.||||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-------PSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 345678999999999999999998642 3589998764311 1233567889999999999999999998
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
+.+ ...++||||+.+++|.+++.+....+++..++.++.||+.||.|||+.|++||||||+|||++ ..+.+||
T Consensus 76 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l 148 (270)
T cd05056 76 ITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKL 148 (270)
T ss_pred EcC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEE
Confidence 765 356899999999999999987666689999999999999999999999999999999999998 6678999
Q ss_pred eecCCccccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccC
Q 001449 952 GDLGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 952 iDFGLAk~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
+|||+++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.+. .
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~ 225 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-E 225 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhccCC--CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-C
Confidence 99999875432211 11223456799999986544 7899999999999999986 99999887766655544433 3
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
....+..++.++.++|.+||..+|.+|||+.++++.|+++..+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3456677899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.51 Aligned_cols=256 Identities=31% Similarity=0.590 Sum_probs=206.8
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
..++|++.+.||+|+||.||+|++.+ ..||+|.+.... .......+.+|+.++++++|+||+++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34679999999999999999998854 558888775421 1122356788999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhcc------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~ 944 (1075)
++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||++..+
T Consensus 77 ~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~- 153 (277)
T cd05036 77 VSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG- 153 (277)
T ss_pred EEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-
Confidence 8877 567799999999999999997653 2489999999999999999999999999999999999997332
Q ss_pred CCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 001449 945 QRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASII 1020 (1075)
Q Consensus 945 ~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil 1020 (1075)
....+||+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||......+..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 345799999999985422111 11222356799999997544 8999999999999999997 99999887766655
Q ss_pred HhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1021 GGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1021 ~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+.. ......+..++.++.++|.+||+.+|++|||+.++++.|.
T Consensus 232 ~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTG-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 54433 3344566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.59 Aligned_cols=254 Identities=33% Similarity=0.586 Sum_probs=208.6
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
+...+|++.+.||+|+||.||+|++. ...||+|+++..... ...+.+|+.++++++|+||+++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 44567999999999999999999875 346999998753211 1356789999999999999999988653
Q ss_pred CCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...++||||+.+++|.+++.+. ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~df 146 (262)
T cd05071 73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADF 146 (262)
T ss_pred --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEeccC
Confidence 4578999999999999999764 34578999999999999999999999999999999999998 6778999999
Q ss_pred CCccccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|++........ .....++..|+|||++.+.. ++.++||||||+++|+|++ |..||........+..+... ....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~ 223 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 223 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCC
Confidence 99975432221 12334667899999986544 7899999999999999999 89999887766665555433 2233
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
.+..++..+.++|.+||+.+|++||++.++++.|++.+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 45668899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.05 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=202.3
Q ss_pred eEEEEEcccCcEEEEEEEEcCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC--
Q 001449 803 EEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~kGt----~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~-- 876 (1075)
.+.+.||+|+||.||+|+++.. .||+|.++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 4567899999999999987532 589998875321 1223467888999999999999999998764321
Q ss_pred --CCceEEEEeeecCCcHHHHHhh-----ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 877 --DGSLATVTEFMVNGSLKQFLQK-----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 877 --e~~L~LVmEYmeGGSL~d~Lkk-----~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
....+++|||+.+|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCE
Confidence 2356899999999999988743 223478999999999999999999999999999999999997 67789
Q ss_pred EEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||+++....... .....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...........+..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCC--cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999985432211 12234567899999987544 7899999999999999999 8999987766665555444
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1026 ~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.. ....+..++..++++|.+||+.||++|||+.+|++.|+.+
T Consensus 230 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 33 2344556889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.22 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=209.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||.|+||.||+++. ++..+|||.+..... ........+.+|+.+++.+.|+||+++++++.. .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--D 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--C
Confidence 4688889999999999999986 588899998765321 122234678899999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+.++++|||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 150 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcc
Confidence 688999999999999999864 234589999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC--ASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~--~eil~~Ilk~~l~p~ 1031 (1075)
|++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||..... ......+......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 9987543322 223456889999999997654 78899999999999999999999965432 233333333333333
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
....++.+++++|.+||+.||++|||+.+|++.++++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 34567899999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=318.16 Aligned_cols=248 Identities=34% Similarity=0.533 Sum_probs=199.8
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|++.+.||+|+||+||+++.. +..||+|++.... ..........+|+.++++++|+||+++++++.. ...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccc--ccc
Confidence 788999999999999999985 4569999998642 122222334569999999999999999999988 678
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++||||+.+++|.+++. ....+++..++.++.||++||.+||+++|+|+||||+||+++ .++.++|+|||.+..
T Consensus 73 ~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 899999999999999998 334589999999999999999999999999999999999998 778999999999875
Q ss_pred -cccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHhhhhccCCCCCC--
Q 001449 960 -KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---IIGGIVNNTLRPQIP-- 1033 (1075)
Q Consensus 960 -~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e---il~~Ilk~~l~p~ip-- 1033 (1075)
...........+|..|+|||++.. ...++.++||||||+++|+|++|..||......+ .+.............
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 333334456678999999999871 2237899999999999999999999999873222 222222211111111
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.....++.++|.+||+.||++|||+.++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112389999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=356.44 Aligned_cols=271 Identities=36% Similarity=0.636 Sum_probs=235.4
Q ss_pred HHhccccccCCCeeEEEEEcccCcEEEEEEEEc--C---cc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC
Q 001449 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--G---SD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863 (1075)
Q Consensus 790 i~~~i~~i~~ddYeil~~LGeG~FG~VYkAk~k--G---t~-VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP 863 (1075)
+.+..|++..++....++||+|+||.||+|+.+ + .. ||||..+.+.. .....+.+|++|..+|++++||
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-----~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-----LTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-----ccHHHHHHHHHHHHHHHhCCCC
Confidence 445667888888888899999999999999874 1 13 89998875321 2334568899999999999999
Q ss_pred ceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC
Q 001449 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 864 NIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d 943 (1075)
|||++||+... +..+++|||+|.||+|.++|++.+..++..+...++.+.++||+|||++++|||||..+|+|++
T Consensus 222 NVVr~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~--- 296 (474)
T KOG0194|consen 222 NVVRFYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS--- 296 (474)
T ss_pred CEEEEEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---
Confidence 99999999887 6789999999999999999999887899999999999999999999999999999999999998
Q ss_pred CCCCeEEEeecCCccccccccccC-CCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 001449 944 PQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIG 1021 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~~~~~ss-s~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~ 1021 (1075)
.+..+||+|||+++......... ...-...|+|||.+... .++.++|||||||++||+++ |..||.+....++..
T Consensus 297 -~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~ 373 (474)
T KOG0194|consen 297 -KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA 373 (474)
T ss_pred -CCCeEEeCccccccCCcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence 66679999999998654333222 12245689999999754 58999999999999999999 899999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHcC
Q 001449 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAIN 1073 (1075)
Q Consensus 1022 ~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~Ln 1073 (1075)
.+....++...+...+.++..++.+||..+|++||++.++.+.|+.+.....
T Consensus 374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 9988888888999999999999999999999999999999999999877543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=353.93 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=212.0
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
...+|++.+.||+|+||+||++++ +++.||||++...... +.....+.+|+.+|..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 346899999999999999999987 5888999998765321 22345677899999999999999998876542
Q ss_pred CC------CceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCC
Q 001449 876 PD------GSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1075)
Q Consensus 876 ~e------~~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~ 946 (1075)
.. ..+++||||+.+|+|.+++... ...+++..+..|+.||+.||.|||+++|+||||||+|||++ .+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----CC
Confidence 11 1368999999999999998653 34689999999999999999999999999999999999998 67
Q ss_pred CeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhh
Q 001449 947 PVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI 1023 (1075)
Q Consensus 947 g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~I 1023 (1075)
+.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+..+.+..+
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 78999999999854322 1223467999999999997654 789999999999999999999999988877777766
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1024 lk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..... ..++..++.++.+||.+||+.||.+||++.++++.
T Consensus 258 ~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 65543 34667789999999999999999999999999864
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.59 Aligned_cols=253 Identities=34% Similarity=0.616 Sum_probs=209.8
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
.+..++|+++++||+|+||.||+|.. +++.||+|.+...... ...+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEcc
Confidence 34567899999999999999999987 4678999988753211 2457789999999999999999998643
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+.++++|||+.+++|.+++... +..+++..++.++.|++.||.|||+.||+||||||+||+++ .++.++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~d 145 (260)
T cd05067 73 ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEcc
Confidence 4689999999999999998653 34689999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 954 FGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
||++....... ......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+. .....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRM 222 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCC
Confidence 99987543221 112334567899999987544 7889999999999999998 999998877666555443 33444
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
..+..++.+++++|.+||+.+|++||++++|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 5667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.23 Aligned_cols=259 Identities=29% Similarity=0.551 Sum_probs=212.0
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCce
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k---------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNI 865 (1075)
.+..++|++.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 455678999999999999999999752 2358999876431 112245678899999999 79999
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
+++++++.. ...+++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999887 567899999999999999997642 247888899999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.++||||||+++|+|++
T Consensus 162 dlkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 162 DLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred ccccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC--CCchhhHHHHHHHHHHHHcC
Confidence 9999999998 66789999999998543211 112234567899999987544 7899999999999999998
Q ss_pred CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1007 G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
|..||...+..+....+. .......+..++.++++||.+||+.+|.+|||+.++++.|+++..
T Consensus 236 g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 236 GGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 889998877766655543 333445567789999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.19 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=208.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||+|... ++.||+|.++...... ....+.+.+|+.++++++|+||+++++.+.. .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIE--N 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--C
Confidence 57999999999999999999884 8889999987532221 1223567789999999999999999999987 5
Q ss_pred CceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++ .++.++|+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEecc
Confidence 678999999999999999864 234589999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH--CASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~--~~eil~~Ilk~~l~p~ 1031 (1075)
|++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.... ..+....+..... +.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 227 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-PP 227 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCC--CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-CC
Confidence 9987533221 223346888999999987544 7889999999999999999999996543 2233333333322 23
Q ss_pred CCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1032 IPS-WCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1032 ips-~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
.+. .++.+++++|.+||..+|++|||+.+|++.|+++.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 333 67889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.65 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=198.6
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 36899999999999999999987 477899999875421 1122356678999999999999999999876421
Q ss_pred ----CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 ----e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
...+++||||+. ++|.+.+.. .+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEEe
Confidence 235799999995 567776653 378899999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC----
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL---- 1028 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l---- 1028 (1075)
|||+++............||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999998655544445567999999999997654 78999999999999999999999987654433222211000
Q ss_pred ------------------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 ------------------------------------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ------------------------------------~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
........+.++++||.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000112235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.03 Aligned_cols=245 Identities=33% Similarity=0.607 Sum_probs=202.4
Q ss_pred EEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
.||+|+||.||+|+++ +..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ..+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 3899999999999763 4458999886431 12233568899999999999999999998754 46899
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999987666789999999999999999999999999999999999998 667899999999874322
Q ss_pred ccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 963 TLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 963 ~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.. .....++..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCC
Confidence 211 11122357899999987544 7889999999999999996 9999988777666544433 34456777889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.++.++|.+||..+|++||++.+|++.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.47 Aligned_cols=254 Identities=33% Similarity=0.623 Sum_probs=211.3
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
.+..++|++.+.||+|+||.||++..+ +..||||.+...... .+.+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 356688999999999999999999875 466999988753211 2457789999999999999999999876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
...+++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|
T Consensus 73 --~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~d 146 (261)
T cd05034 73 --EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIAD 146 (261)
T ss_pred --CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEECc
Confidence 567899999999999999997653 4689999999999999999999999999999999999998 668999999
Q ss_pred cCCccccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 954 LGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 954 FGLAk~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
||++........ ......+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||........+..+... ...
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~ 223 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRM 223 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 999875432211 11223456899999997554 7889999999999999998 99999887776666665443 334
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
..+...+.++++++.+||+.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 4556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.68 Aligned_cols=242 Identities=21% Similarity=0.367 Sum_probs=201.8
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e 877 (1075)
+|++.+.||+|+||.||+|+++ ++.||+|++++.... .......+..|..+++.+. |++|+++++++.+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--V 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEec--C
Confidence 4788999999999999999874 778999998864321 1222355677888888886 5678888888877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+|+|.+++.+.. .+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 68999999999999999987654 589999999999999999999999999999999999998 6678999999998
Q ss_pred cccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
+... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ..++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccC
Confidence 7432 222234456999999999997654 7899999999999999999999999888777777766544 3466778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH
Q 001449 1037 DPEWRSLMESCWASDPAERPSF 1058 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa 1058 (1075)
+.++.+++.+||+.+|.+|++.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.00 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=207.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++++ +..||+|++.+... ........+.+|+.++..++|++|+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQD--E 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--C
Confidence 47999999999999999999885 56799999865321 122223457789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchh
Confidence 789999999999999999987666789999999999999999999999999999999999998 6678999999998
Q ss_pred cccccc--cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 958 KVKQQT--LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 958 k~~~~~--~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
...... .......||+.|+|||++.+. ...++.++|||||||++|||++|+.||...+..+.+..+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 743221 122345699999999998631 234788999999999999999999999988877777776654433333
Q ss_pred C---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 001449 1033 P---SWCDPEWRSLMESCWASDPAE--RPSFSEISRR 1064 (1075)
Q Consensus 1033 p---s~ls~eL~dLI~kCLq~DPee--RPSa~ELLq~ 1064 (1075)
+ ..++.++++||++||..++.+ |+++.++++.
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 3 357999999999999765444 6889998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.47 Aligned_cols=257 Identities=22% Similarity=0.372 Sum_probs=209.4
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.+..++|++.+.||+|+||.||+++++ ++.||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 445688999999999999999999884 677999998753211 1222355778999999999999999999988
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ .+.+++||||+.+|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 D--DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 7 67899999999999999998754 478889999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccc--ccCCCCCCCCccCcccccCCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS--HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 954 FGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~--~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
||+++...... ......||+.|+|||++.+.. ..++.++|||||||+||||++|..||...+.......+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99998543221 223567999999999997543 23788999999999999999999999988877777776654433
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 001449 1030 PQIP--SWCDPEWRSLMESCWASDPAE--RPSFSEISRRL 1065 (1075)
Q Consensus 1030 p~ip--s~ls~eL~dLI~kCLq~DPee--RPSa~ELLq~L 1065 (1075)
..++ ..++.+++++|.+||..++.+ |+++.++++..
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 3333 358999999999999844433 67999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.68 Aligned_cols=249 Identities=33% Similarity=0.639 Sum_probs=207.6
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..+|++.+.||+|+||.||++.+. +..+|+|+++..... ...+.+|+.+++++.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTE--R 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEcc--C
Confidence 467899999999999999999875 778999988654221 1356789999999999999999999877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
...++||||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 147 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT 147 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence 678999999999999999987666789999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 958 k~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+... .....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPR 224 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccCC--cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCC
Confidence 74432211 12233567899999987544 7889999999999999998 99999887766666554432 2333455
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
..+.++.+|+.+||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=312.33 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=207.1
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++++.||+|++|.||+++.+ ++.||+|++...... ....+.+.+|+.++++++|+||+++++.+... +.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 4889999999999999999874 678999998754221 12235677899999999999999999887542 45
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.++++|||+.+++|.+++... ...+++..++.++.|++.||.+||++||+||||||+||+++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999999764 34589999999999999999999999999999999999998 6789999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+..... +..+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKP--YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCcccc
Confidence 854322 2223456889999999987654 78899999999999999999999987776665555544433 3456678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.++.++|.+||+.||++||++.+++..
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=345.47 Aligned_cols=260 Identities=29% Similarity=0.499 Sum_probs=213.8
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCcee
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVV 866 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIV 866 (1075)
+.+..++|.+.+.||+|+||.||+|++.+ ..||||+++.... ....+.+.+|+.+|.++. |||||
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCCeE
Confidence 45566778899999999999999998643 4699999975321 112346789999999997 99999
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhcc----------------------------------------------
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------------------------------- 900 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------------------------------------- 900 (1075)
++++++.. .+.+++||||+.+|+|.+++....
T Consensus 105 ~~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 105 NLLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred EEEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999987 567899999999999999996532
Q ss_pred ---------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001449 901 ---------------------------------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1075)
Q Consensus 901 ---------------------------------------------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIH 929 (1075)
..+++..++.|+.||+.||.|||+.+|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 13577788899999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc
Q 001449 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006 (1075)
Q Consensus 930 RDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT 1006 (1075)
|||||+|||++ ..+.+||+|||+++..... .......++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 263 rdlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 263 RDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred ccCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHHH
Confidence 99999999998 6678999999999853221 1122345678899999997544 7889999999999999998
Q ss_pred -CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1007 -GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1007 -G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
|..||......+...........+..+..++.++.+||.+||..+|.+||++++|++.|+.++
T Consensus 337 ~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 337 LGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred cCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 899998766555555555555556677788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=316.23 Aligned_cols=252 Identities=35% Similarity=0.622 Sum_probs=207.2
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~kG-t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
+..++|++.+.||+|+||.||++++.+ ..+|+|.+..... ....+.+|+.+++++.|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 344679999999999999999998854 4699998764321 12456789999999999999999988753
Q ss_pred CCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+..+++|||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++ .++.+||+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~df 146 (260)
T cd05069 73 --EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECCC
Confidence 45789999999999999997643 4478999999999999999999999999999999999998 6778999999
Q ss_pred CCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.. .....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMP 223 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccCC--cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 9997543221 112234567899999987544 7899999999999999999 9999988776666555443 33445
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
++..++..++++|.+||..||.+||++++|++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=312.62 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=209.7
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++++.||.|+||.||++.+ ++..||+|+++..... ....+.+..|+.++++++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 588999999999999999987 4778999988754221 22235677899999999999999999987765566
Q ss_pred ceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHH-----hCCcccccCCCCceEeccCCCCCCeEE
Q 001449 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLH-----s~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
.++++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ .++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 789999999999999999754 456899999999999999999999 88999999999999998 678999
Q ss_pred EeecCCccccccccc-cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 951 IGDLGLSKVKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~-sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
|+|||++........ .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+... ..
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KF 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CC
Confidence 999999986544332 33456899999999997644 788999999999999999999999887765555544433 34
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.++..++.++.+++.+||+.+|.+||++.+|++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 5567778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=340.49 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=206.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc---
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--- 874 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d--- 874 (1075)
..|..++.||+|+||.|..+++ +|+.||||++.... ......++..+|+++|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F------~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh------hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3455578999999999999987 48889999887432 223345678899999999999999999999876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
..-+.+|+|+|+| +.+|..+|+.. ..++...+..++.||++||+|+|+.+|+||||||+|||++ .+..+|||||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEeccc
Confidence 2344689999999 77999998765 3489999999999999999999999999999999999998 7778999999
Q ss_pred CCcccccc---ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh------
Q 001449 955 GLSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN------ 1025 (1075)
Q Consensus 955 GLAk~~~~---~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk------ 1025 (1075)
|+|+.... ....+.+..|.||+|||++.. ...|+..+||||+||||.||++|++.|.+.+....+..|+.
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 99997643 334466789999999999864 34599999999999999999999999988776554443332
Q ss_pred ------------------ccCCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 ------------------NTLRPQ-----IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 ------------------~~l~p~-----ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
....+. +-...++.+.+|+++||..||.+|+|++|.|+.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011111 123578899999999999999999999998864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.88 Aligned_cols=258 Identities=31% Similarity=0.543 Sum_probs=207.9
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL 868 (1075)
.+..++|++.+.||+|+||.||+|+.+ +..||+|.++... . ......+.+|+.+++.++|+||+++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~--~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----S--LRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-----C--HHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 455678999999999999999998753 3368999876431 1 1112356789999999999999999
Q ss_pred ecccccCCCCceEEEEeeecCCcHHHHHhhcc---------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEe
Q 001449 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (1075)
Q Consensus 869 ~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILI 939 (1075)
++++.+ ....++||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 75 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili 152 (288)
T cd05061 75 LGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 152 (288)
T ss_pred EEEEcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE
Confidence 999877 567899999999999999997532 234667888999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001449 940 NMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMH 1015 (1075)
Q Consensus 940 d~~d~~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~ 1015 (1075)
+ .++.+||+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||....
T Consensus 153 ~----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 153 A----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred c----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8 667899999999874322111 11223567899999987544 7889999999999999998 899998877
Q ss_pred hHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1016 ~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
..+....+.... ....+..++.+++++|.+||+.||++|||+.++++.|++..
T Consensus 227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 227 NEQVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 777665554433 23455677899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.35 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=202.7
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..++|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~- 77 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS- 77 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe-
Confidence 446799999999999999999987 477899999874311 112346689999999999999999999887
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
.+.+++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++ .++.+||+|||
T Consensus 78 -~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg 151 (267)
T cd06646 78 -REKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFG 151 (267)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcCc
Confidence 56889999999999999998754 3589999999999999999999999999999999999997 66789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccCcccccCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC--
Q 001449 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGK-SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ-- 1031 (1075)
Q Consensus 956 LAk~~~~~~-~sss~~GT~~YmAPEvl~g~-~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~-- 1031 (1075)
++....... ......++..|+|||.+... ...++.++|||||||++|+|++|+.||...........+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 988543221 22345688999999988532 22367899999999999999999999976554433322222222211
Q ss_pred -CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1032 -IPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1032 -ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
....++..+.+||++||+.+|++|||++++++.|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1234678999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=335.85 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=199.4
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~- 875 (1075)
.++|++++.||+|+||.||++.+ .++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC------chhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 46899999999999999999987 4778999998754211 12235567899999999999999999987642
Q ss_pred ---CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 876 ---~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
....+++||||+. ++|.+++.. .+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEE
Confidence 1235799999995 577777753 378899999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC---
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--- 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~--- 1029 (1075)
|||+++............+|..|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..++.....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998655444445567899999999997654 789999999999999999999999877655544433321000
Q ss_pred -----------------C--------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 -----------------P--------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 -----------------p--------------------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+ ......+.++++||.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0011134678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=326.38 Aligned_cols=261 Identities=31% Similarity=0.575 Sum_probs=212.0
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCce
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k---------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNI 865 (1075)
.+..++|.+.+.||+|+||.||+++.. ...+|+|.++... .......+.+|+.+++++ .||||
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 80 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMELMKLIGKHKNI 80 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhccCCCCe
Confidence 344567999999999999999999752 3458999876431 112245678899999999 59999
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
+++++++.. .+.++++|||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||
T Consensus 81 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 81 INLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred eeEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999876 567899999999999999996532 347889999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. ++.++||||||+++|+|++
T Consensus 159 dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 159 DLAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred cccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC--cCccchhhHHHHHHHHHHhC
Confidence 9999999998 667899999999985432111 11223456799999987544 7899999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHc
Q 001449 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1007 G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
|..||...+..+....+... .....+..++.+++++|.+||+.+|++|||+.++++.|.++...+
T Consensus 233 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 233 GGSPYPGIPVEELFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 99999887776665554433 334456678899999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=334.01 Aligned_cols=237 Identities=25% Similarity=0.377 Sum_probs=194.9
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHH-HHHHhCCCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEA-LLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi-~ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+|+++ ++.||+|++.+.... .......+..|. .+++.++||||+++++++.+ .+.+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 74 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFV 74 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEE
Confidence 6999999999999884 778999998754321 112223444554 46788999999999999877 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc-cc
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQ 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~-~~ 962 (1075)
|||+++++|...+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. ..
T Consensus 75 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 75 LDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCCC
Confidence 9999999999888654 4578999999999999999999999999999999999998 6778999999998753 22
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.... ..++...+.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~ 225 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAACD 225 (321)
T ss_pred CCccccccCCcccCCHHHhcCCC--CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHH
Confidence 22334567999999999997654 7889999999999999999999999887776666665543 3456677899999
Q ss_pred HHHHhhhcCCCCCCCHH
Q 001449 1043 LMESCWASDPAERPSFS 1059 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~ 1059 (1075)
+|.+||+.||.+|+++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 226 LLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHccCCHhhcCCCC
Confidence 99999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.90 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=208.1
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCC-chhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGK-PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k-~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
|.+...||+|++|.||+|.+ .+..||+|.+........ ........+.+.+|+.++++++||||+++++++.. ..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence 56778899999999999987 467899998876533322 22233456778899999999999999999999887 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCCc
Confidence 889999999999999999765 4578999999999999999999999999999999999998 67789999999988
Q ss_pred cccccc-------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 959 VKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 959 ~~~~~~-------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
...... ......|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||........+..+.. ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~ 231 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPE 231 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCC--CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCc
Confidence 543211 112345888999999987554 68899999999999999999999987665554444333 33456
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++..++.+++++|.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 67778999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.75 Aligned_cols=254 Identities=33% Similarity=0.533 Sum_probs=205.8
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEcC------------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRG------------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~kG------------------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk 859 (1075)
...+|++++.||+|+||.||++++.. ..||+|.+..... ......+.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------DNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------HHHHHHHHHHHHHHHh
Confidence 34679999999999999999987642 3489998775421 1234678899999999
Q ss_pred CCCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc----------ccCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001449 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1075)
Q Consensus 860 L~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~----------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIH 929 (1075)
++||||+++++++.. +..++++|||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.||+|
T Consensus 76 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 999999999999887 578899999999999999997653 25899999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc
Q 001449 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006 (1075)
Q Consensus 930 RDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT 1006 (1075)
|||||+||+++ ..+.++|+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred cccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC--CCccchhhhhHHHHHHHHh
Confidence 99999999998 66899999999987532221 122344677899999987543 7899999999999999998
Q ss_pred --CCCCCCCCChHHHHHhhhhc------cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1007 --GDEPYADMHCASIIGGIVNN------TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1007 --G~~PF~~~~~~eil~~Ilk~------~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+..||...+....+...... ......+..++.++.++|.+||+.||.+|||+.+|++.|+
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 78899876665554444321 1112234456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.69 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=199.7
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC--
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~-- 876 (1075)
+|++++.||+|+||.||++++ +++.||||++..... .......+.+|+.+|+.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478889999999999999986 588899998864311 1122356779999999999999999999987632
Q ss_pred -CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 877 -e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 126899999995 6888887654 4589999999999999999999999999999999999998 67899999999
Q ss_pred Cccccccc--cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc-------
Q 001449 956 LSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN------- 1026 (1075)
Q Consensus 956 LAk~~~~~--~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~------- 1026 (1075)
+++..... .......+|..|+|||++.+.. .++.++|||||||++|||++|+.||...+....+..+...
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSR-HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCC-CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99854322 1223346789999999997643 3788999999999999999999999877655444333210
Q ss_pred ----------------cCCC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1027 ----------------TLRP-------QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1027 ----------------~l~p-------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...+ .+....+.++.+||.+||+.||++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 1233468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.22 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=203.2
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|+..+.||+|+||+||++++. ++.||+|.+...... .......+.+|+.+|++++|+||+.+++.+.. .+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCE
Confidence 778899999999999999884 778999998754221 11223456789999999999999999998877 568
Q ss_pred eEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
+++||||+.+++|.+++...+ ..+++..+..++.|++.||.|||+.||+||||||+||+++ .++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcce
Confidence 999999999999998886543 3589999999999999999999999999999999999998 56789999999987
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc--cCCCCCCCCC
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSWC 1036 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~--~l~p~ips~l 1036 (1075)
............|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+... .....++..+
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQR--YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccC
Confidence 543333333456899999999997544 788999999999999999999999876554333332221 1123455668
Q ss_pred CHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPS-----FSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPS-----a~ELLq~ 1064 (1075)
+.++.+|+..||+.||++||+ +.+++..
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 899999999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.29 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=206.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++++ +..||+|++.+... ........+.+|..++..++|+||+.+++++.+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 47999999999999999999874 67799999875321 122234557789999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+|+|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEeccce
Confidence 789999999999999999987666789999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc--ccCCCCCCCCccCcccccCCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKS---HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 958 k~~~~~~--~sss~~GT~~YmAPEvl~g~~---~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
+...... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...+..+.+..+........+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 7543322 122356999999999986421 23678999999999999999999999887777766666554333333
Q ss_pred C---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 001449 1033 P---SWCDPEWRSLMESCWASDPAE--RPSFSEISRR 1064 (1075)
Q Consensus 1033 p---s~ls~eL~dLI~kCLq~DPee--RPSa~ELLq~ 1064 (1075)
+ ..++.+++++|.+||..++.+ |++++++++.
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 3 346899999999999876544 4678888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.37 Aligned_cols=252 Identities=35% Similarity=0.601 Sum_probs=207.4
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~-------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
+..+|...++||+|+||.||+++. ++..+|+|.++.. .......+.+|+.+++.+.|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--------CHHHHHHHHHHHHHHhcCCCCCCceEEE
Confidence 456788899999999999999864 2456888887642 1223457889999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhcc--------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~--------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeN 936 (1075)
++.. ....+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 75 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~n 152 (280)
T cd05092 75 VCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRN 152 (280)
T ss_pred EEec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhh
Confidence 9877 567899999999999999997543 247899999999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 001449 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYA 1012 (1075)
Q Consensus 937 ILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~ 1012 (1075)
||++ +++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.
T Consensus 153 il~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 153 CLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9998 67789999999987432211 112233567899999987654 7899999999999999998 999998
Q ss_pred CCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1013 DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1013 ~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
.....+....+.... ....+..++..+++||.+||+.||.+||++.+|++.|+
T Consensus 227 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 227 QLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCHHHHHHHHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 777666665554433 34456678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.37 Aligned_cols=249 Identities=31% Similarity=0.593 Sum_probs=199.8
Q ss_pred EEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceE
Q 001449 807 ELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.||+|+||.||+|++. +..||+|.+.... .......+.+|+.+++.++||||+++++++... ++..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~ 73 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPL 73 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcE
Confidence 5899999999999863 3458999875321 112346677899999999999999999976543 45678
Q ss_pred EEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
+||||+.+++|.+++.+....+++..+..++.||++||.|||+.+|+||||||+|||++ ..+.+||+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCcccccccc
Confidence 99999999999999987666678888899999999999999999999999999999998 66789999999987432
Q ss_pred ccc-----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 962 QTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 962 ~~~-----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
... ......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...........+... .....+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEY 226 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCc--cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCc
Confidence 211 112334577899999987543 7899999999999999999 56777766655554444332 23445566
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 78999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.26 Aligned_cols=256 Identities=30% Similarity=0.538 Sum_probs=203.9
Q ss_pred CCeeEEEEEcccCcEEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~------kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
.-|++++.||+|+||.||++++ .+..||+|.++... .......+.+|+.+|+++.||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3478899999999999999974 36679999986431 1122356889999999999999999999887
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
.......++||||+++++|.+++.+....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7545678999999999999999977655689999999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------------
Q 001449 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-------------- 1015 (1075)
Q Consensus 954 FGLAk~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-------------- 1015 (1075)
||++....... ......++..|+|||++.+.. ++.++||||||+++|+|+++..|+....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK--FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCC--CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99988543221 122345677899999987544 7889999999999999999876643211
Q ss_pred hHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1016 ~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.................+..++..+.+||.+||+.||.+|||++++++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00111112222223344566889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.73 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=202.4
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
+.++|++++.||+|+||.||+++++ +..||+|.++...... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~- 75 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHT- 75 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-------chhHHHHHHHHHHhcCCCCcceEEEEEec-
Confidence 3478999999999999999999874 6789999987543211 11345689999999999999999999987
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
.+.+++||||+. ++|.+++.+....+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||+|||
T Consensus 76 -~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg 149 (301)
T cd07873 76 -EKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFG 149 (301)
T ss_pred -CCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCc
Confidence 568999999996 699999887666789999999999999999999999999999999999998 66789999999
Q ss_pred Cccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC------
Q 001449 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL------ 1028 (1075)
Q Consensus 956 LAk~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l------ 1028 (1075)
++...... .......+++.|+|||++.+.. .++.++|||||||++|+|++|++||...+..+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhCCC-CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 98753322 1223345789999999987543 378899999999999999999999987765544333221100
Q ss_pred -----------C---C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 -----------R---P--------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 -----------~---p--------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. + .....++.++++||.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0 011346888999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.36 Aligned_cols=244 Identities=34% Similarity=0.624 Sum_probs=204.6
Q ss_pred EEcccCcEEEEEEEEc---Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceE
Q 001449 807 ELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k---Gt--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.||+|++|.||+|.+. ++ .||||.+...... ...+.+.+|+.++++++||||+++++.+.+ ..++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 71 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLM 71 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEE
Confidence 5899999999999873 22 5899998764321 345678899999999999999999998876 6789
Q ss_pred EEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 882 TVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
+||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++...
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRAL 147 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEeccccccccc
Confidence 9999999999999998765 5689999999999999999999999999999999999998 6689999999998854
Q ss_pred cccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 961 QQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 961 ~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
.... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.........+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCcc
Confidence 3211 112345678899999987544 7889999999999999998 99999887777766666544444455667
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.80 Aligned_cols=248 Identities=33% Similarity=0.640 Sum_probs=207.6
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..++|++.+.||+|+||.||+++..+..||+|.++... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 70 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILH--- 70 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---
Confidence 34679999999999999999999999999999986431 12457789999999999999999998865
Q ss_pred CceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++ .++.+||+|||+
T Consensus 71 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~ 146 (254)
T cd05083 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGL 146 (254)
T ss_pred CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCcc
Confidence 34799999999999999997653 3579999999999999999999999999999999999998 667899999999
Q ss_pred ccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 957 Ak~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
+....... .....+..|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+.+. .....+..
T Consensus 147 ~~~~~~~~--~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 221 (254)
T cd05083 147 ARVGSMGV--DNSKLPVKWTAPEALKHKK--FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEG 221 (254)
T ss_pred ceeccccC--CCCCCCceecCHHHhccCC--cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCc
Confidence 88543321 2233467899999987544 7889999999999999997 99999887776655554433 34445567
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
++..+.++|.+||+.+|++||++++|++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 88999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=317.35 Aligned_cols=259 Identities=32% Similarity=0.575 Sum_probs=213.4
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt----~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
.++..+|++.+.||+|+||.||+|.++ |. .||+|.++.... ......+.+|+.++++++|+||++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 345578999999999999999999863 32 488888765421 22345678899999999999999999
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
+++.. ...++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~ 148 (279)
T cd05057 76 GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHV 148 (279)
T ss_pred EEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeE
Confidence 98875 568999999999999999988766789999999999999999999999999999999999998 66789
Q ss_pred EEeecCCcccccccccc---CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQTLVS---GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~s---ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||+++........ ....++..|+|||.+.... ++.++||||||+++|||++ |+.||......+....+..
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCC--cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence 99999999854322211 1122356799999986443 7889999999999999998 9999988777666555543
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1026 ~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
. .....+..++.++.+++.+||..||.+||++.++++.|+++.++
T Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 G-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 3 33445667889999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=371.62 Aligned_cols=262 Identities=35% Similarity=0.663 Sum_probs=225.5
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc---Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceee
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR---GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k---Gt----~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVk 867 (1075)
..+..+..+..+.||+|.||.||.|... +. .||||.++... ++..+.+|++|..+|++++|||||+
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv~ 759 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIVS 759 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCcceee
Confidence 3455677888999999999999999874 33 38888877542 3344678999999999999999999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhc------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEecc
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~ 941 (1075)
++|++.+ .+..+|++|||++|+|..+|++. ...++..+.+.|+.||++|++||+++++|||||..+|+|++
T Consensus 760 liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~- 836 (1025)
T KOG1095|consen 760 LIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD- 836 (1025)
T ss_pred EEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec-
Confidence 9999998 67789999999999999999987 66799999999999999999999999999999999999999
Q ss_pred CCCCCCeEEEeecCCccc-cccccccCC-C-CCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001449 942 RDPQRPVCKIGDLGLSKV-KQQTLVSGG-V-RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCA 1017 (1075)
Q Consensus 942 ~d~~~g~VKLiDFGLAk~-~~~~~~sss-~-~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~ 1017 (1075)
....|||+|||+|+. +........ . .-...|||||.+... .++.|+|||||||+|||++| |..||...+..
T Consensus 837 ---~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~--iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 837 ---ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG--IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred ---ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc--ccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 668999999999993 222221111 1 223479999999853 38999999999999999999 99999999999
Q ss_pred HHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHc
Q 001449 1018 SIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1018 eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
+++...+.+. +...|..|+..++++|.+||+.+|++||++..|++++.++...+
T Consensus 912 ~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 912 EVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 9988777776 78889999999999999999999999999999999999887654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=341.24 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=218.7
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEcC--cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~kG--t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
..+..+.|++++.||.|.-|+||++..++ ..+|+|++.+..+.. ...+.+...|.+||+.+.||.++.||..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 34556778899999999999999999976 579999998876543 34456778899999999999999999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
+. +..+|+|||||.||+|..++++. ++.+++..++.++.+++.||+|||-.|||+|||||+||||- ++|++.|
T Consensus 147 et--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIML 220 (459)
T KOG0610|consen 147 ET--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIML 220 (459)
T ss_pred ec--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEe
Confidence 98 78999999999999999998775 45699999999999999999999999999999999999997 8899999
Q ss_pred eecCCcccc-------c---------------------------c-c----------------------cccCCCCCCCC
Q 001449 952 GDLGLSKVK-------Q---------------------------Q-T----------------------LVSGGVRGTLP 974 (1075)
Q Consensus 952 iDFGLAk~~-------~---------------------------~-~----------------------~~sss~~GT~~ 974 (1075)
+||.++..- . . . ..+.+++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 999987410 0 0 0 01234679999
Q ss_pred ccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 001449 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAE 1054 (1075)
Q Consensus 975 YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPee 1054 (1075)
|.|||++.|.. -+..+|+|+|||+|||||.|..||.+.+..+.+..++.+.....-...++..++|||+++|.+||.+
T Consensus 301 YlAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 301 YLAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred cccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999877 4778999999999999999999999999999999998877644333467889999999999999999
Q ss_pred CCC----HHHHHH
Q 001449 1055 RPS----FSEISR 1063 (1075)
Q Consensus 1055 RPS----a~ELLq 1063 (1075)
|.. +.||.+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 986 666644
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=314.16 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=207.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 801 DLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
+|++.+.||.|+||.||+|+. ++..+|+|.++...... .........+.+|+.+|++++|+||+++++++.+ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCe
Confidence 477888999999999999987 57789999987542211 1223445678899999999999999999999987 578
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++++||+.+++|.+++.+.. .+++..+..++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 999999999999999997653 578999999999999999999999999999999999998 667899999999874
Q ss_pred ccc-------ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc-cCCCC
Q 001449 960 KQQ-------TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQ 1031 (1075)
Q Consensus 960 ~~~-------~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~-~l~p~ 1031 (1075)
... ........++..|+|||++.+.. ++.++||||||+++|+|++|..||...........+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 311 11123456899999999997654 788999999999999999999999876655444333332 33455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++..++.++.++|++||+.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 67778999999999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.05 Aligned_cols=247 Identities=36% Similarity=0.612 Sum_probs=199.9
Q ss_pred EEcccCcEEEEEEEEcC--c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceE
Q 001449 807 ELGSGTYGSVYHGKWRG--S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~kG--t--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.||+|+||.||+|++++ . .+|+|.++... .......+.+|+.+++++ +||||+++++++.. .+.++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCce
Confidence 58999999999998743 3 36888776321 112235677899999999 79999999999887 56789
Q ss_pred EEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCC
Q 001449 882 TVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~ 946 (1075)
+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999997532 2478899999999999999999999999999999999998 67
Q ss_pred CeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhh
Q 001449 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk 1025 (1075)
+.+||+|||++..............+..|+|||++.... ++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccCC--CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 899999999986432221122223456799999986544 7899999999999999997 9999987776665555433
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1026 ~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
. .....+..++.++.+|+.+||+.||.+|||+.+++..|+.+.
T Consensus 227 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 G-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2 333455667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=326.58 Aligned_cols=247 Identities=27% Similarity=0.371 Sum_probs=189.0
Q ss_pred EEEEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 805 VRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
..+||+|+||.||+|+++ +..||+|.+..... ...+.+|+.+|++++||||+++++++.......+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 357999999999999863 46799998864321 1235689999999999999999999876556678
Q ss_pred EEEEeeecCCcHHHHHhhc--------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 881 ATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~--------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
+++|||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++..+...+.+||+
T Consensus 76 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 9999998 56888887532 22488999999999999999999999999999999999996544467789999
Q ss_pred ecCCcccccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HH
Q 001449 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---------SI 1019 (1075)
Q Consensus 953 DFGLAk~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~---------ei 1019 (1075)
|||+++...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCC-CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999998543221 223457899999999987643 3788999999999999999999999643210 11
Q ss_pred HHhhhhcc-----------------------C-C------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1020 IGGIVNNT-----------------------L-R------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1020 l~~Ilk~~-----------------------l-~------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+..+.... . . .......+.++.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111000 0 0 0001123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.12 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=208.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++.+.||+|+||.||++++ ++..||||.+...... ......+..+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 5789999999999999999987 4778999988643211 1122345678899999999999999999998877545
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..++++|||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 6788999999999999998765 3478899999999999999999999999999999999998 6778999999998
Q ss_pred cccccc----cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 958 k~~~~~----~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
...... .......++..|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+......+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCC--CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 743221 1122345889999999987644 7889999999999999999999998776555555555444455667
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...+..+.++|.+||. +|++||++++|++.
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 7788899999999995 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.56 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=210.5
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|+.++.||.|+||.||.++. ++..+++|.+...... ......+.+|+.+|++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMD--DN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CC
Confidence 488999999999999988876 4788999988654221 1223567799999999999999999999987 67
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.++++|||+.+++|.+++.+. ...+++..+..++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999999765 45589999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+...... ..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCcccc
Confidence 8543322 233456899999999987654 688999999999999999999999887777766666554443 344667
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
+.++.++|.+||+.+|.+||++.++++.+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 89999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.18 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=206.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.+.|++++.||.|+||.||++++. +..||+|.+... .......+.+|+.++++++|+||+++++.+..
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-- 80 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--
Confidence 466999999999999999999874 678999998643 12234667889999999999999999999877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
++.+++||||+.+++|..++.+....+++..++.++.||+.+|.|||+.+|+||||||+||+++ .++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~dfg~ 156 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADFGV 156 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccCcc
Confidence 5789999999999999998877666789999999999999999999999999999999999997 567899999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCC
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQ 1031 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ 1031 (1075)
+...... .......++..|+|||++.+. ...++.++|||||||++|+|++|..||...+.......+..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 8743222 222345688999999998531 22367899999999999999999999987766555444433222 223
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+..++.++.++|.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 34567889999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.84 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=206.6
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||.|+||.||+++.. ++.+|+|++..... .....+.+|+.++++++||||+++++.+..
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 71 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLR-- 71 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEe--
Confidence 367999999999999999999874 67799999875421 124667889999999999999999999877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...++++|||+.+++|.+++......+++..++.++.|++.||.|||+++|+|+||||+||+++ .++.+||+|||+
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~ 147 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGV 147 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECcccc
Confidence 5689999999999999999987656789999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCCCCCCCccCcccccCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC---C
Q 001449 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGK-SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP---Q 1031 (1075)
Q Consensus 957 Ak~~~~~~-~sss~~GT~~YmAPEvl~g~-~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p---~ 1031 (1075)
+....... ......++..|+|||.+.+. ...++.++||||||+++|+|++|..||...........+......+ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 87543322 22345688899999998654 1237889999999999999999999998776555544444332221 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
....++.+++++|++||..+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23345788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=340.60 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=194.2
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
...+...+|++++.||+|+||.||++.+. ++.||+|.... ..+.+|+.+|++++|||||+++++
T Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~ 151 (391)
T PHA03212 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGT 151 (391)
T ss_pred hcccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEE
Confidence 33456678999999999999999999874 77899996432 235689999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
+.. ....++|+|++ .++|..++.... .+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||
T Consensus 152 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL 223 (391)
T PHA03212 152 FTY--NKFTCLILPRY-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCL 223 (391)
T ss_pred EEE--CCeeEEEEecC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEE
Confidence 987 56789999998 578988886653 589999999999999999999999999999999999998 6678999
Q ss_pred eecCCccccccc--cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHh
Q 001449 952 GDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-------CASIIGG 1022 (1075)
Q Consensus 952 iDFGLAk~~~~~--~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-------~~eil~~ 1022 (1075)
+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.... ....+..
T Consensus 224 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~ 301 (391)
T PHA03212 224 GDFGAACFPVDINANKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301 (391)
T ss_pred EeCCcccccccccccccccccCccCCCChhhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence 999999743221 1223457999999999997654 7999999999999999999998874321 1111111
Q ss_pred hhh--------------------------ccC-C-CCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1023 IVN--------------------------NTL-R-PQIP-----SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1023 Ilk--------------------------~~l-~-p~ip-----s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.. ... . ...+ ..++.++.+||.+||+.||.+|||+.|+++
T Consensus 302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 110 000 0 0001 124668999999999999999999999986
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.58 Aligned_cols=236 Identities=23% Similarity=0.386 Sum_probs=191.6
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+++++ ++.||+|++++..... ...+..+.+|+.++.++ +||||+++++++.+ .+.+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv 74 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFV 74 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEE
Confidence 6999999999999874 6779999998653221 12235567888888776 79999999999887 6789999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|..++.+. ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 75 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccCC
Confidence 9999999999888654 4589999999999999999999999999999999999998 67789999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHhhhhccCCCCCC
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH---------CASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~---------~~eil~~Ilk~~l~p~ip 1033 (1075)
........||..|+|||++.+.. ++.++|||||||++|+|++|+.||.... .......+... ...++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p 225 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIP 225 (329)
T ss_pred CCccccccCCccccCHHHHcCCC--CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCC
Confidence 22234567999999999997654 7889999999999999999999995211 11122222222 33567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSF 1058 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa 1058 (1075)
..++.++++||.+||+.||.+|+++
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 7889999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.71 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=204.8
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|++++.||+|+||.||++++. +..+|+|.+.... ......+.+|+.+++.++|+||+++++++.. .+.
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENN 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCE
Confidence 577788999999999999885 5667888875321 1234667889999999999999999999887 568
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.++|+||+.+++|..++.+....+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEcccccccc
Confidence 8999999999999998876666789999999999999999999999999999999999998 667899999999875
Q ss_pred cccc-cccCCCCCCCCccCcccccC---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCCCCC
Q 001449 960 KQQT-LVSGGVRGTLPWMAPELLSG---KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQIPS 1034 (1075)
Q Consensus 960 ~~~~-~~sss~~GT~~YmAPEvl~g---~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ips 1034 (1075)
.... .......++..|+|||++.. ....++.++|||||||++|+|++|+.||...+.......+..... ....+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd06643 153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232 (282)
T ss_pred ccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcc
Confidence 3222 22234568999999999842 223367899999999999999999999988776665555543322 223455
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++.++++||.+||+.||.+||++.++++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 678999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=335.18 Aligned_cols=238 Identities=26% Similarity=0.368 Sum_probs=195.5
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHHhCCCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~-ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||++++ +|+.||+|++.+..... ......+..|.. +++.++||||+++++++.. .+.+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv 74 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-----RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFV 74 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEE
Confidence 599999999999987 47889999987543211 112234445554 5778999999999999887 6789999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-c
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-Q 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-~ 962 (1075)
|||+.+++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... .
T Consensus 75 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 75 LDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCCC
Confidence 9999999999888654 4589999999999999999999999999999999999998 67789999999987432 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+..... .++...+.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAWS 225 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCC--CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHHH
Confidence 22234567999999999997654 78899999999999999999999998877777666665432 344567899999
Q ss_pred HHHHhhhcCCCCCCCHHH
Q 001449 1043 LMESCWASDPAERPSFSE 1060 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~E 1060 (1075)
+|.+||..+|.+||++.+
T Consensus 226 ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 226 ILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHhccCHHhcCCCCC
Confidence 999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=322.88 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=202.0
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|++.+.||+|+||.||++.+. ++.||+|.+....... ......+.+|+.++++++|++|+.+++.+.+ .+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-----hHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CC
Confidence 3778899999999999999874 7789999987543221 1223456789999999999999999999877 56
Q ss_pred ceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+||+++ ..+.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 8999999999999999886543 3589999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhhhhccCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---SIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~---eil~~Ilk~~l~p~ips 1034 (1075)
.............||..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ......... ....++.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCc
Confidence 7544333333457899999999997654 789999999999999999999999764321 112222111 2233556
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPS-----FSEISR 1063 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPS-----a~ELLq 1063 (1075)
.++.++++||.+||+.||++||| +.++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 68899999999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.30 Aligned_cols=254 Identities=34% Similarity=0.575 Sum_probs=201.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~kG-t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
++|.....||+|+||.||+|...+ +.||||++....... ..+|.+|+.+|.+++|||+|+|+|+|.+ .+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e--~~ 144 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--------EREFLNEVEILSRLRHPNLVKLLGYCLE--GG 144 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--------hhHHHHHHHHHhcCCCcCcccEEEEEec--CC
Confidence 567777889999999999999864 889999776542110 2458999999999999999999999998 44
Q ss_pred -ceEEEEeeecCCcHHHHHhhccc-cCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCceEeccCCCCCCeEEEee
Q 001449 879 -SLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKN---IVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 879 -~L~LVmEYmeGGSL~d~Lkk~~~-~Lse~~~l~Ia~QIL~AL~yLHs~G---IIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
..+||+|||.+|+|.++|..... .++|..+++||.++++||.|||... |||||||++|||+| .+...||+|
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~~aKlsD 220 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDFNAKLSD 220 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCCCEEccC
Confidence 58999999999999999988766 8999999999999999999999853 99999999999999 888999999
Q ss_pred cCCcccccc-ccccCCC-CCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHH---hhhh
Q 001449 954 LGLSKVKQQ-TLVSGGV-RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH---CASIIG---GIVN 1025 (1075)
Q Consensus 954 FGLAk~~~~-~~~sss~-~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~---~~eil~---~Ilk 1025 (1075)
||+|+.... ....... .||..|+|||.+.. ...+.|+||||||++|+||+||+.+..... ...... ..+.
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999986654 3322222 79999999999974 337999999999999999999998876432 111111 1111
Q ss_pred -----ccCCCCCC-CCCC--HH---HHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1026 -----NTLRPQIP-SWCD--PE---WRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1026 -----~~l~p~ip-s~ls--~e---L~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
....+.+. ...+ .+ +..+...|++.++.+||++.++++.|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 11222222 2222 22 556777999999999999999999996654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.89 Aligned_cols=244 Identities=33% Similarity=0.597 Sum_probs=201.5
Q ss_pred EEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 807 ELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
.||+|+||.||+++.. +..+|+|+++.... ......+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-------QELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEE
Confidence 5899999999999864 67799998764321 1122457789999999999999999999877 567899999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccc
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~ 965 (1075)
|+.+++|.+++......+++..++.++.|++.||.|||++|++||||||+||+++ .++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceecccccc
Confidence 9999999999977666689999999999999999999999999999999999998 677899999999875332221
Q ss_pred c--CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHH
Q 001449 966 S--GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 966 s--ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~d 1042 (1075)
. ....++..|+|||++.+.. ++.++||||||+++|+|++ |..||...........+.. ......+..++..+.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYK 225 (250)
T ss_pred ccCCCCCCcccccCHHHhccCC--CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 1 1123456799999987543 7889999999999999998 9999988776665554433 3344556678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1043 LMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1043 LI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
++.+||+.+|++||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.86 Aligned_cols=237 Identities=21% Similarity=0.372 Sum_probs=193.2
Q ss_pred EEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCCCCceEEE
Q 001449 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.||+|+||.||+++.+ ++.||+|++++.... ....+..+.+|+.++.++ +||||+.+++++.+ .+.+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv 74 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLV 74 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEE
Confidence 6999999999999874 677999999865322 223346677899999888 59999999999887 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc-cc
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQ 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~-~~ 962 (1075)
|||+.+++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. ..
T Consensus 75 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 75 IEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccCC
Confidence 9999999999988654 3589999999999999999999999999999999999998 6778999999998742 22
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------ChHHHHHhhhhccCCCCCCCCC
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM------HCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~------~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
.......+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||... .....+....... ...++..+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~ 226 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFL 226 (327)
T ss_pred CCceecccCCcccCCHHHHCCCC--CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCC
Confidence 22334567999999999997654 789999999999999999999999532 1222222222222 33467788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH
Q 001449 1037 DPEWRSLMESCWASDPAERPSF 1058 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa 1058 (1075)
+..+.++|.+||+.||.+|+++
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=315.56 Aligned_cols=253 Identities=30% Similarity=0.563 Sum_probs=208.1
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
.++|++++.||+|+||.||+|+.+ ...|++|.+.... .......+.+|+.+|++++|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-------DENLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-------chHHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 467999999999999999999863 3458888765321 12234678899999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhcc--------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD--------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~--------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d 943 (1075)
+.+ .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~--- 151 (275)
T cd05046 77 CRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS--- 151 (275)
T ss_pred ECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---
Confidence 877 567899999999999999997543 1589999999999999999999999999999999999998
Q ss_pred CCCCeEEEeecCCccccccc--cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 001449 944 PQRPVCKIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASII 1020 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~~~--~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil 1020 (1075)
..+.++|+|||++...... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.........
T Consensus 152 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~ 228 (275)
T cd05046 152 -SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228 (275)
T ss_pred -CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHHH
Confidence 6678999999998743211 1222334677899999987544 6789999999999999998 88999877666666
Q ss_pred HhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1021 GGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1021 ~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+.........+..++..+.++|.+||+.+|.+|||+.++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 6555444444455678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=324.57 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=224.7
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
.+...++|++.+.||+|-||.||.|+.+ +..||+|++.++.+. ....-+++.+|++|-..|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-----~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-----KTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-----HhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3456688999999999999999999875 556999999876432 333346778999999999999999999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.+ ....|+++||...|+|...|... ...+++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||
T Consensus 92 hd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lki 165 (281)
T KOG0580|consen 92 HD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKI 165 (281)
T ss_pred ec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeec
Confidence 98 67899999999999999999743 34589999999999999999999999999999999999998 6778999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
+|||.+-... .......|||.-|.+||+..+.. .+..+|+|++|+++||++.|.+||......+.+..|.+-.+ .
T Consensus 166 AdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~ 240 (281)
T KOG0580|consen 166 ADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--K 240 (281)
T ss_pred cCCCceeecC-CCCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--c
Confidence 9999998655 44456789999999999998766 78999999999999999999999999888888888877554 5
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
+|..++.++++||.+||..+|.+|....++++.-..
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 678999999999999999999999999999886543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=319.42 Aligned_cols=253 Identities=32% Similarity=0.592 Sum_probs=206.7
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k-------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
..++|++++.||+|+||.||++++. +..||+|++.... .......+.+|+.+++++.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 4567999999999999999999863 4679999886431 1122356778999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhcc---------------------ccCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIH 929 (1075)
++.+ ...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++|
T Consensus 76 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H 153 (288)
T cd05050 76 VCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVH 153 (288)
T ss_pred EEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9887 567899999999999999997432 24678889999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc
Q 001449 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006 (1075)
Q Consensus 930 RDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT 1006 (1075)
|||||+|||++ .++.+||+|||++....... .......+..|+|||.+.+.. ++.++|||||||++|+|++
T Consensus 154 ~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 154 RDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred ccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC--CCchhHHHHHHHHHHHHHh
Confidence 99999999997 67789999999987432211 112233466799999987554 7899999999999999997
Q ss_pred -CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1007 -GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1007 -G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
|..||......+....+..... ...+..++.++.+||.+||+.+|.+|||+.|+++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 228 YGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8899987777666655544333 3345678899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=322.01 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=202.9
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEcC----------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRG----------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~kG----------------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~ 861 (1075)
...+|++.+.||+|+||.||++++.+ ..||+|.++... .......+.+|+++|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-------TKTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCC
Confidence 45689999999999999999987632 248999886431 1122356889999999999
Q ss_pred CCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc-----------ccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 862 HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-----------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
|+||+++++++.. .+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 76 h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 76 NPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9999999999887 567899999999999999986532 136888899999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ .++.+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 154 dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 154 DLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred ccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC--cCchhhHHHHHHHHHHHHHc
Confidence 9999999998 56789999999987432211 112234567899999987544 7899999999999999988
Q ss_pred -CCCCCCCCChHHHHHhhhh------ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1007 -GDEPYADMHCASIIGGIVN------NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1007 -G~~PF~~~~~~eil~~Ilk------~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+..||........+..+.. .......+..++..+.+||.+||+.||++|||+.+|++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 228 CKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 7788887666555444322 11122334567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=319.72 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=209.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||.|+||.||+++++ +..||+|+++.. .......+.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--E 74 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--C
Confidence 56888999999999999999874 778999998643 12234668889999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++||||+.+++|.+++.+.+..+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~~ 150 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGVS 150 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCccc
Confidence 688999999999999999988777799999999999999999999999999999999999998 6788999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCCC
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQI 1032 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~i 1032 (1075)
...... .......++..|+|||++... ...++.++||||||+++|+|++|+.||........+..+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence 743222 222345689999999998532 22367899999999999999999999988776665555544322 2233
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+..++.++.++|.+||+.+|.+||++.++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 55678999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.69 Aligned_cols=253 Identities=31% Similarity=0.474 Sum_probs=208.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|+..+.||+|+||.||++.. ++..||+|++....... ........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP---ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc---hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 3688899999999999999986 47889999887543211 122345668899999999999999999998876545
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++++||+.+++|.+++.+.. .+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 67899999999999999997654 478999999999999999999999999999999999998 6678999999998
Q ss_pred cccccc----cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 958 k~~~~~----~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
...... .......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||........+..+......+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCC--CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 743221 1112345888999999997644 7889999999999999999999998776666555555555556777
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..++..++++| .||..+|++||+++++++
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 78899999999 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.86 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=197.3
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++++.||+|++|.||+|+. ++..||||+++..... +.....+.+|+.++++++||||+++++++.. .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ES 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CC
Confidence 588999999999999999987 4788999998754211 1122456689999999999999999999987 67
Q ss_pred ceEEEEeeecCCcHHHHHhhcc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~--~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999996 68988886532 5689999999999999999999999999999999999998 677899999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc--------
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-------- 1027 (1075)
+...... .......+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 8743221 1222345788999999986543 36889999999999999999999998665433222211100
Q ss_pred -------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -------------------LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -------------------l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
........++.+++++|.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000112346889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=315.45 Aligned_cols=251 Identities=28% Similarity=0.440 Sum_probs=202.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~ 876 (1075)
..|++.+.||+|+||.||+|+. .++.||+|++.... . . ...+.+|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~--~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---D--E----EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---c--c----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4577788899999999999987 46789999986431 1 0 13466889999988 6999999999987532
Q ss_pred ----CCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 877 ----e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
...++++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~l 152 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKL 152 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEEE
Confidence 24689999999999999998864 34689999999999999999999999999999999999998 6678999
Q ss_pred eecCCccccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc
Q 001449 952 GDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 952 iDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
+|||++...... .......|+..|+|||++.+. ...++.++|||||||++|+|++|..||...........+....
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 232 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence 999998854322 223345689999999998632 2247889999999999999999999998766554444433333
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
........++.++++||.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 333334567889999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.07 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=220.6
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.+.|++.+.||+|.|+.||++.+ +|+.+|+|+++...+... ..+.+.+|+.|-+.|+|||||++.+.+..
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~-- 81 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQE-- 81 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhcc--
Confidence 46678888899999999999866 588999999987665443 23567789999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+..+||+|+|.|++|..-|-.+ ..+++..+-..++||+.||.|+|.+||||||+||+|+|+-+.+ ..--+||+|||+
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~FGv 159 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADFGL 159 (355)
T ss_pred cceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeecccce
Confidence 78999999999999997666554 3478999999999999999999999999999999999997554 455799999999
Q ss_pred ccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC--
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS-- 1034 (1075)
Q Consensus 957 Ak~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips-- 1034 (1075)
|...........+.|||.|||||++...+ |+..+|||+-|+|||-||.|.+||.+.+...+++.|+...+...-+.
T Consensus 160 Ai~l~~g~~~~G~~GtP~fmaPEvvrkdp--y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~ 237 (355)
T KOG0033|consen 160 AIEVNDGEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD 237 (355)
T ss_pred EEEeCCccccccccCCCcccCHHHhhcCC--CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC
Confidence 99877777777889999999999997555 89999999999999999999999999999999999988776444333
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++++.++||++||..||.+|.|+.|.|..
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 478999999999999999999999988753
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.23 Aligned_cols=246 Identities=34% Similarity=0.585 Sum_probs=201.8
Q ss_pred EEEcccCcEEEEEEEEc--C---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 806 RELGSGTYGSVYHGKWR--G---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~k--G---t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
++||+|+||.||+|++. + ..+|+|.+...... .....+.+|+.+++.+.|+||+++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cce
Confidence 36999999999999863 2 56999988754221 223567889999999999999999998754 457
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||..+|+|+||||+|||++ .++.+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 99999999999999998665 689999999999999999999999999999999999998 6778999999998854
Q ss_pred cccccc----CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 961 QQTLVS----GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 961 ~~~~~s----ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
...... ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.. ......+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCC--CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCC
Confidence 222111 1112346799999987544 7889999999999999998 9999988777665554433 334456677
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
++..++++|.+||+.+|++||++.+|++.|+.+.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.64 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=209.6
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|+..+.||+|+||.||++.. .+..+|+|.+...... ......+.+|+.+|++++||||+++++.+.. .+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLE--DK 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEec--CC
Confidence 488999999999999999877 4778999998754321 1224667899999999999999999998876 56
Q ss_pred ceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++||||+.+++|.+++.... ..+++..++.++.|++.+|.|||++||+|+||||+||+++. .+..+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK---HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccCCCc
Confidence 8999999999999999997653 45899999999999999999999999999999999999972 3457899999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
.............++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+..... ..++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCC--CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcC
Confidence 8655443334456889999999997544 78899999999999999999999988776666555554432 34566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+++++|.+||+.+|.+|||+.++++.
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.75 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=195.7
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC---CCCceeeeecccccCCCCceEE
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL---~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
||+|+||+||+|+++ ++.||||++.+.... ....+..+..|..++..+ .||||+.+++++.+ ...+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEE
Confidence 799999999999874 788999998754221 122234455677777665 69999999999887 568999
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc-c
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-Q 961 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~-~ 961 (1075)
||||+.+++|.+++.+. ..+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 99999999999998765 4589999999999999999999999999999999999998 6678999999998743 2
Q ss_pred cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC-CCCCHHH
Q 001449 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP-SWCDPEW 1040 (1075)
Q Consensus 962 ~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip-s~ls~eL 1040 (1075)
........+||..|+|||++.+.. .++.++|||||||++|+|++|..||...+....+..+...... ++ ..++.++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~ 225 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEK-GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--FPKNVLSDEG 225 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCC-CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHH
Confidence 222334567999999999987543 3788999999999999999999999888777766665544332 23 3478999
Q ss_pred HHHHHHhhhcCCCCCC----CHHHHHH
Q 001449 1041 RSLMESCWASDPAERP----SFSEISR 1063 (1075)
Q Consensus 1041 ~dLI~kCLq~DPeeRP----Sa~ELLq 1063 (1075)
++||.+||+.||.+|| ++.++++
T Consensus 226 ~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 9999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.18 Aligned_cols=253 Identities=32% Similarity=0.579 Sum_probs=208.5
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
++..++|++.+.||+|+||.||++++. +..+|+|.++... .....+.+|+.++++++|+||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 456688999999999999999999874 5679999876421 123567789999999999999999998765
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
...+++|||+.+++|.+++.+. ...+++..++.++.||+.||.|||+.|++|+||||+||+++ ..+.+||+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECC
Confidence 4679999999999999999763 34578889999999999999999999999999999999998 677999999
Q ss_pred cCCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 954 FGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
||++....... ......++..|+|||++.... ++.++|||||||++|+|++ |+.||...+.......+.. ....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRM 222 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhccCC--cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCC
Confidence 99987543221 112233567799999997543 7889999999999999998 9999988776665554433 3334
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
..+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.22 Aligned_cols=260 Identities=28% Similarity=0.537 Sum_probs=212.1
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k---------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPN 864 (1075)
+++...+|++.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++++ +|||
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCC
Confidence 4455678999999999999999999752 2258999876431 122346788999999999 7999
Q ss_pred eeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001449 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1075)
Q Consensus 865 IVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIH 929 (1075)
|+++++++.. .+.++++|||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+|
T Consensus 80 iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999999887 567899999999999999997532 24788889999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEeecCCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc
Q 001449 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006 (1075)
Q Consensus 930 RDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT 1006 (1075)
|||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. ++.++||||||+++|||++
T Consensus 158 ~dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 158 RDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cccccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHh
Confidence 99999999998 667899999999885432211 11223456799999997554 7889999999999999998
Q ss_pred -CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1007 -GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1007 -G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
|..||...+..+....+.. ......+..++.++.+||.+||+.+|.+|||+.++++.|+++..
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred cCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 8999988877766555443 33445566788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.93 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=209.5
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|+..+.||+|+||.||+|.. ++..|++|.+........ .....+.+.+|+.++++++|+||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---GQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---chHHHHHHHHHHHHHHhcCCCCchheeeeEec--CC
Confidence 366778899999999999987 478899999875422111 22334678899999999999999999998876 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++++||+.+++|.+++.+.. .+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 8899999999999999997653 588999999999999999999999999999999999998 66789999999988
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCH
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~ 1038 (1075)
............++..|+|||.+.... .++.++|+||||+++|+|++|+.||...........+......+.++..++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 544333334566899999999986443 3788999999999999999999999887655555555443444566777899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1039 EWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1039 eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+++++|.+||+.+|.+||++.+++.
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhc
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.48 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=196.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|+||.||+|++ +|+.||+|+++...... .....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLYDVLHS--DK 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc------cCccchhHHHHHHHhcCCCCeeeHHHHhcc--CC
Confidence 488899999999999999988 47889999987542211 112446679999999999999999999987 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|+||+. ++|.+++......+++..++.++.||++||.|||+++|+||||||+||+++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 8999999995 688888876666789999999999999999999999999999999999998 66789999999988
Q ss_pred ccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHhhhhcc---------
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-MHCASIIGGIVNNT--------- 1027 (1075)
Q Consensus 959 ~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~-~~~~eil~~Ilk~~--------- 1027 (1075)
..... .......++..|+|||++.+.. .++.++|||||||++|+|++|..||.. .+..+.+..+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCc-ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 54322 1223345789999999987543 368899999999999999999888643 33333222221100
Q ss_pred ---------CCC---------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 ---------LRP---------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 ---------l~p---------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+ .....++.++++||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 111246789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=367.42 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=210.1
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
....+|++++.||+|+||.||++++. +..||+|++...... ......+..|+.+|++|+|||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34578999999999999999999885 667999998754321 2234667889999999999999999999876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhC-------CcccccCCCCceEeccCC-
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGK-------NIVHFDLKCENLLVNMRD- 943 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~-------GIIHRDIKPeNILId~~d- 943 (1075)
.....++|||||+.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+...
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 5567799999999999999999753 34689999999999999999999984 499999999999996321
Q ss_pred ------------CCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 001449 944 ------------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011 (1075)
Q Consensus 944 ------------~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF 1011 (1075)
.....+||+|||++.............||+.|+|||++.+....++.++||||||||||+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 12356999999999865444444456799999999999765555889999999999999999999999
Q ss_pred CCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1012 ~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
........+...+....... ....+.++.+||..||+.+|.+||++.++|.
T Consensus 244 ~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 86655444333333322111 2346889999999999999999999999985
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.97 Aligned_cols=257 Identities=29% Similarity=0.530 Sum_probs=207.9
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
..+|++++.||+|+||.||+++++ +..||||+++..... .....+.+|+.+++++.|+||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------QHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356888899999999999999864 567999998754211 2346788999999999999999999988
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
........++||||+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 76555678999999999999999987766689999999999999999999999999999999999998 66899999
Q ss_pred ecCCccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----------
Q 001449 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---------- 1018 (1075)
Q Consensus 953 DFGLAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e---------- 1018 (1075)
|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK--FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCC--CCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 9999985442211 11223456799999987543 7889999999999999999999986532211
Q ss_pred ----HHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1019 ----IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1019 ----il~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.+...+........+..++.++.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11222233333344556789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.88 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=211.2
Q ss_pred CeeEEEEEcccCcEEEEEEEEc---CcceEEEEeeccccCCC--chhHHHHHHHHHHHHHHHHh-CCCCceeeeeccccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGK--PSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRD 874 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~~~~k--~~ere~~i~~flrEi~ILkk-L~HPNIVkL~g~~~d 874 (1075)
+|++.+.||+|+||.||+++++ +..+|+|.+........ .......+.++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778889999999999999885 46799998875432211 11233445667789988875 789999999999887
Q ss_pred CCCCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEE
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
.+.+++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||++ .++.+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 6789999999999999998743 34568999999999999999999996 7899999999999998 677899
Q ss_pred EeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
|+|||++.............++..|++||++.+.. ++.++||||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC--CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 99999998654443344566899999999997644 7899999999999999999999998877766666655554443
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
.....++.++.++|.+||+.||++||++.++...|+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 334467899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.36 Aligned_cols=244 Identities=37% Similarity=0.650 Sum_probs=202.5
Q ss_pred EEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 807 ELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
+||+|+||.||++.+. ++.||+|+++..... .....+.+|+.+++++.|+||+++++++.. ....++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVME 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEE
Confidence 6899999999999875 788999988754211 223567889999999999999999999887 567899999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccc
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~ 965 (1075)
|+.+++|.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCcc
Confidence 9999999999977666789999999999999999999999999999999999998 667899999999885432111
Q ss_pred c---CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHH
Q 001449 966 S---GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041 (1075)
Q Consensus 966 s---ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~ 1041 (1075)
. .....+..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.. ......+..++.++.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIY 225 (251)
T ss_pred eeccccCcceeccCChHhhccCC--CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHH
Confidence 1 1122356799999987544 7899999999999999999 8999987766555444433 233445667889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1042 SLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
++|.+||+.+|.+||++.++++.|+
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=332.00 Aligned_cols=253 Identities=28% Similarity=0.384 Sum_probs=207.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCc-eeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPN-IVkL~g~~~d~~ 876 (1075)
..|+.+++||+|+||+||+|+. +|+.||+|+++.+... +-.-....+|+.+|+.++|+| ||.+++++.+..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence 3466677799999999999987 5888999999976432 112245678999999999999 999999998732
Q ss_pred ----CCceEEEEeeecCCcHHHHHhhcc---ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 877 ----e~~L~LVmEYmeGGSL~d~Lkk~~---~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
.+.+++|+||+ .-+|..++.... ..++...++.++.||++||.|||+++|+||||||+||||+ ..+.+
T Consensus 85 ~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~l 159 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGVL 159 (323)
T ss_pred cccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCcE
Confidence 23899999999 679999998766 3478889999999999999999999999999999999999 68899
Q ss_pred EEeecCCccccc-cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC
Q 001449 950 KIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 950 KLiDFGLAk~~~-~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
||+|||+|+... ........++|.+|+|||++.|... |+..+||||+|||++||++++..|.+....+.+..|....-
T Consensus 160 KlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~-Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 160 KLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTS-YSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred eeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCc-CCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 999999999654 3333556679999999999998654 89999999999999999999999998887776666653110
Q ss_pred ----------------CCCCCC------------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 ----------------RPQIPS------------WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ----------------~p~ips------------~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...++. ..+.+..+++.+||+.+|.+|.|++..++.
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111 123478899999999999999999999875
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.52 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=187.5
Q ss_pred EEEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceE
Q 001449 806 RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.+||+|+||.||+|+.+ +..||+|.+..... ...+.+|+.+|++++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 57999999999999864 35799998864321 12456899999999999999999998765567889
Q ss_pred EEEeeecCCcHHHHHhhc--------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 882 TVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~--------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+||||+. ++|.+++... ...+++..++.|+.||+.||.|||+.||+||||||+|||+...+...+.+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9999985 5888877521 234789999999999999999999999999999999999965444678999999
Q ss_pred cCCcccccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---------HHH
Q 001449 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---------SII 1020 (1075)
Q Consensus 954 FGLAk~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~---------eil 1020 (1075)
||+++...... ......+|..|+|||++.+.. .++.++|||||||++|||+||++||...... ..+
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCC-ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99998543221 123456899999999987533 3789999999999999999999999643211 000
Q ss_pred Hhhhhc-----------------------cC-------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1021 GGIVNN-----------------------TL-------------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1021 ~~Ilk~-----------------------~l-------------~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+... .. ........+..+++||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 00 00001123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=328.47 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=198.1
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||+|.+ ++..||||++..... .......+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ------SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36799999999999999999987 467799999875321 1122345678999999999999999999886421
Q ss_pred ----CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 ----e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
...++++++++ +++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEc
Confidence 23578999988 8899988764 3589999999999999999999999999999999999998 67789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC----
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL---- 1028 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l---- 1028 (1075)
|||+++..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcCCc-cCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999864432 23457899999999987532 378899999999999999999999987655443333221100
Q ss_pred -----------------CCC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 -----------------RPQ--------IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 -----------------~p~--------ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+. +....++.+.+||.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 112356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.31 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=200.3
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||+|+||.||+|++ +++.||+|+++.... .....+.+|+.+++.++||||+++++.+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-- 77 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-- 77 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Confidence 35688888899999999999987 477899999875411 112456689999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+.+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+.||+|+||||+||+++ ..+.+||+|||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~ 152 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGV 152 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECccee
Confidence 678999999999999999987654 589999999999999999999999999999999999998 667899999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC-C-
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ-I- 1032 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~-i- 1032 (1075)
+...... .......|+..|+|||++.. ....++.++|||||||++|+|++|..||..................+. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc
Confidence 8743322 22234568999999999742 123378899999999999999999999976554443333222222111 1
Q ss_pred -CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1033 -PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1033 -ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
...++..+.++|.+||+.+|++|||+.+|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1246788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.51 Aligned_cols=246 Identities=28% Similarity=0.490 Sum_probs=207.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||++++ .++.||+|+++..... .......+.+|+++|+++.||||+++++++.. .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--D 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--C
Confidence 4689999999999999999987 4788999998754221 22334667899999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 6799999999999999999766 4589999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+... ...++..++
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 222 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILSKG--YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFS 222 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCC
Confidence 865433 33456899999999987553 688999999999999999999999877765555555433 235667789
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRP-----Sa~ELLq 1063 (1075)
..++++|.+||..||.+|+ +++++++
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 9999999999999999998 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.24 Aligned_cols=259 Identities=31% Similarity=0.604 Sum_probs=209.0
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE--cCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~--kGt----~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
.+...+|+.++.||+|+||.||++++ .+. .||+|.+.... .......+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 35567899999999999999999987 344 46888775431 112224577899999999999999999
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
+++.. ...++++||+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~ 148 (303)
T cd05110 76 GVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHV 148 (303)
T ss_pred EEEcC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCce
Confidence 98865 246789999999999999987766789999999999999999999999999999999999997 56789
Q ss_pred EEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||+++...... ......++..|+|||.+.+.. ++.++||||||+++|||++ |..||.......... +..
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~ 225 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLE 225 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCC--CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHH
Confidence 999999998543221 112234567899999987544 7899999999999999997 999998765544433 333
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1026 ~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
.......+..++..+.++|.+||..+|++||++.++++.|+++..+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3333444566789999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=358.00 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=210.1
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~ 871 (1075)
-++...++++.+.|.+|||+.||+|+.. |..||+|++... ++..++.+.+|+.+|++|+ |+|||.+++.
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 3456677899999999999999999985 378999998643 3455677889999999998 9999999993
Q ss_pred -ccc--CCC--CceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceEeccCC
Q 001449 872 -VRD--GPD--GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 872 -~~d--~~e--~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~G--IIHRDIKPeNILId~~d 943 (1075)
... +.. -.+.|.||||.||.|.++|.++. ..|++.++++|+.|+++|+.+||... |||||||-|||||+
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls--- 180 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS--- 180 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---
Confidence 222 111 24678999999999999998642 33999999999999999999999987 99999999999998
Q ss_pred CCCCeEEEeecCCcccccccccc-C---------CCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 001449 944 PQRPVCKIGDLGLSKVKQQTLVS-G---------GVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYA 1012 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~~~~~s-s---------s~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~ 1012 (1075)
.++.+||||||.++........ . ...-|+.|+|||++.- ....+++|+|||+|||+||-|+....||.
T Consensus 181 -~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 181 -ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred -CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 7789999999998742211100 0 1235899999999852 12348999999999999999999999998
Q ss_pred CCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1013 DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1013 ~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
..... .|++..+...-...++..|++||..||+.||.+||++-+++..+-.++.+
T Consensus 260 ~sg~l----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 260 ESGKL----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cCcce----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 76442 44555554333356899999999999999999999999999999988653
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.32 Aligned_cols=247 Identities=30% Similarity=0.526 Sum_probs=206.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||+|+||.||+++++ +..+|+|.++... . ...+.+|+.++++++|+||+++++.+.+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-- 69 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--------D--LQEIIKEISILKQCDSPYIVKYYGSYFK-- 69 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--------H--HHHHHHHHHHHHhCCCCcEeeeeeeeec--
Confidence 367899999999999999999885 6789999886431 1 4678899999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...+++++||+.+++|.+++......+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.+||+|||+
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~ 145 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGV 145 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEccccc
Confidence 5789999999999999999987777799999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCCCCC
Q 001449 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQIPS 1034 (1075)
Q Consensus 957 Ak~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ips 1034 (1075)
+....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+..... ....+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEIG--YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchh
Confidence 88544332 223445888999999987654 78999999999999999999999987665544333322111 122334
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.++.++.++|.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 56789999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.07 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=201.4
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k------------------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL 860 (1075)
.++|++.+.||+|+||.||++.+. ...||+|+++... .......+.+|+.+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhC
Confidence 357999999999999999998543 2358999886431 122345678999999999
Q ss_pred CCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc----------ccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 001449 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (1075)
Q Consensus 861 ~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~----------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHR 930 (1075)
+|+||+++++++.. ....++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.||+||
T Consensus 77 ~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 154 (296)
T cd05095 77 KDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154 (296)
T ss_pred CCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999999999877 567899999999999999987642 236778899999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-
Q 001449 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006 (1075)
Q Consensus 931 DIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT- 1006 (1075)
||||+|||++ .++.+||+|||+++...... ......++..|++||+..+.. ++.++|||||||++|||++
T Consensus 155 dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 155 DLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred cCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC--ccchhhhhHHHHHHHHHHHh
Confidence 9999999998 66789999999987532221 112233467899999876543 7899999999999999998
Q ss_pred -CCCCCCCCChHHHHHhhhh------ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1007 -GDEPYADMHCASIIGGIVN------NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1007 -G~~PF~~~~~~eil~~Ilk------~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
|..||......+.+..... .......+..++..+.+||.+||+.||.+||++.+|++.|++
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 229 CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 7899977665554432211 111122345678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.65 Aligned_cols=248 Identities=38% Similarity=0.678 Sum_probs=205.8
Q ss_pred eeEEEEEcccCcEEEEEEEEcC------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 802 LEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~kG------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
+++.+.||.|+||.||++++.. ..||+|+++..... .....+..|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-------QQIEEFLREARIMRKLDHPNIVKLLGVCTE- 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-------HHHHHHHHHHHHHHhcCCCchheEEEEEcC-
Confidence 3567889999999999998864 77999998654211 134667889999999999999999999887
Q ss_pred CCCceEEEEeeecCCcHHHHHhhcccc-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~-Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
.+..+++|||+.+++|.+++...... +++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.++|+||
T Consensus 73 -~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 73 -EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred -CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 57899999999999999999765544 89999999999999999999999999999999999998 6679999999
Q ss_pred CCccccccccccC--CCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCC
Q 001449 955 GLSKVKQQTLVSG--GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~~~~ss--s~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|++.......... ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.... ...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~--~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 224 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGK--FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLP 224 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCC
Confidence 9998543321111 223678999999985443 7899999999999999998 899998877766666555443 345
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
.+..++.++.+++.+||+.||++|||+.++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 5667899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.88 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=201.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
+.+.....||+|+||.||+|+++ +..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 77 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--N 77 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--C
Confidence 34445568999999999999874 5679999876431 1123567899999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~L--se~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
+.+++|+||+.+++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++. ..+.+||+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg 154 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFG 154 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecch
Confidence 78999999999999999998754445 88888999999999999999999999999999999972 34689999999
Q ss_pred Ccccccc-ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHhhhhccCCCCCC
Q 001449 956 LSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS-IIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 956 LAk~~~~-~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e-il~~Ilk~~l~p~ip 1033 (1075)
++..... ........++..|+|||++.+....++.++||||||+++|+|++|..||....... ...........+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd06624 155 TSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234 (268)
T ss_pred hheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC
Confidence 9874322 12223345889999999986554457889999999999999999999997644322 222222222345567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++.+++++|.+||+.+|.+|||+.++++.
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 7889999999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.88 Aligned_cols=246 Identities=30% Similarity=0.498 Sum_probs=191.9
Q ss_pred EEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
.||+|+||.||+|++. +..+|+|.++.... ......+.+|+.++++++||||+++++++.+ ...+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEE
Confidence 5899999999999864 34589998764421 1112467789999999999999999999877 567899
Q ss_pred EEeeecCCcHHHHHhhcc----ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 883 VTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~----~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
||||+.+++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||+++
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCccccc
Confidence 999999999999997532 2356778888999999999999999999999999999998 66789999999987
Q ss_pred cccccc---ccCCCCCCCCccCcccccCCCC-----CCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc-C
Q 001449 959 VKQQTL---VSGGVRGTLPWMAPELLSGKSH-----MVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT-L 1028 (1075)
Q Consensus 959 ~~~~~~---~sss~~GT~~YmAPEvl~g~~~-----~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~-l 1028 (1075)
...... ......++..|+|||++.+... .++.++||||||+++|||++ |+.||......+......... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC
Confidence 432221 1223457788999999864321 25789999999999999996 999998766555433322221 1
Q ss_pred ---CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1029 ---RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1029 ---~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
.+.+....+..+.++|..|| .+|++|||+++|+..|+
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12233356788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.25 Aligned_cols=246 Identities=29% Similarity=0.464 Sum_probs=206.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||.|+||.||++++ +++.||+|++..... ......+.+|+.++++++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--G 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--C
Confidence 3688889999999999999987 477899999875321 1123457789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++|+||+.+++|.+++... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccc
Confidence 7899999999999999999765 689999999999999999999999999999999999998 6778999999999
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCC-
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW- 1035 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~- 1035 (1075)
+..... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+... ..+.++..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNK 222 (274)
T ss_pred eeecccccccccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCcccc
Confidence 854433 2233456888999999997654 889999999999999999999999877665555444433 33444444
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++.++.++|.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 7899999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.56 Aligned_cols=244 Identities=28% Similarity=0.411 Sum_probs=196.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+|++ ++..||+|++..... ......+.+|+.+|++++||||+++++.+.. .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-------VELQKQIMSELEILYKCDSPYIIGFYGAFFV--E 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--C
Confidence 3678899999999999999987 477899999865321 1123567889999999999999999999987 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+..++||||+.+++|..+. .+++..+..++.||+.||.|||+.||+|+||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence 6789999999999997652 368888999999999999999999999999999999998 6789999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-------HHHHhhhhccCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-------SIIGGIVNNTLRP 1030 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-------eil~~Ilk~~l~p 1030 (1075)
...... ......+|..|+|||++.+.. ++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 143 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (279)
T cd06619 143 TQLVNS-IAKTYVGTNAYMAPERISGEQ--YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV 219 (279)
T ss_pred eecccc-cccCCCCChhhcCceeecCCC--CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence 854332 223457899999999997654 789999999999999999999999653221 1112222221111
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
......+.+++++|.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1233478899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.76 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=204.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||++++. +..||+|.++... .+.....+.+|+.++++++|+||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--E 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--C
Confidence 46888999999999999999885 7889999886431 12223567899999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhc--cccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 878 GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~--~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+.+++||||+.+++|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++ .++.+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence 7899999999999999988764 2358999999999999999999997 5999999999999998 5678999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhh--hccC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKS----HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV--NNTL 1028 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~----~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Il--k~~l 1028 (1075)
|++....... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...........+. ....
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 9987543322 23345888999999985432 235789999999999999999999997654433322211 1222
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+.++..++.++.+||.+||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 345666689999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.64 Aligned_cols=257 Identities=27% Similarity=0.502 Sum_probs=206.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCc--hhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKP--SERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~--~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
+|.+.+.||.|+||.||+|+. +++.||+|.++........ ......++.+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 477888999999999999976 4788999988653222111 1223345678889999999999999999998877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+.+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++++||||||+||+++ .++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 56889999999999999999776 4589999999999999999999999999999999999998 678999999999
Q ss_pred cccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 957 SKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 957 Ak~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
++...... ......++..|+|||++......++.++|+||||+++|+|++|..||........+..+........++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 87543211 123345888999999987554447889999999999999999999997665554444433332222222
Q ss_pred ----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 ----SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 ----s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++.+++++|.+||..+|.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3468899999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.37 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=203.1
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|+||.||+|++ .|+.||+|++...... ......+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPH--GS 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEec--CC
Confidence 588999999999999999987 4788999998764321 1223567789999999999999999999887 67
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|+||+ +++|.+++......+++..++.++.||++||.|||+.||+|+||||+||+++ .++.++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 889999999 9999999987667799999999999999999999999999999999999998 57789999999988
Q ss_pred cccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC-------
Q 001449 959 VKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR------- 1029 (1075)
Q Consensus 959 ~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~------- 1029 (1075)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|.++|........+..+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccc-cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 543322 123456899999999986533 3688999999999999999999888766554433333221000
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 ---------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 ---------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..+....+.++.+||++||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00112457889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.86 Aligned_cols=246 Identities=29% Similarity=0.506 Sum_probs=192.3
Q ss_pred EEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
.||+|+||.||+|+.. ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEE
Confidence 5899999999999752 2357777655321 12223567889999999999999999999887 567899
Q ss_pred EEeeecCCcHHHHHhhccc----cCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 883 VTEFMVNGSLKQFLQKKDR----TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~----~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
||||+.+|+|.+++..... ..++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEecccccc
Confidence 9999999999999976432 246778889999999999999999999999999999998 67789999999987
Q ss_pred cccccc---ccCCCCCCCCccCcccccCC-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc--
Q 001449 959 VKQQTL---VSGGVRGTLPWMAPELLSGK-----SHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT-- 1027 (1075)
Q Consensus 959 ~~~~~~---~sss~~GT~~YmAPEvl~g~-----~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~-- 1027 (1075)
...... ......++..|+|||++... ...++.++|||||||++|||++ |..||......+.+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 432211 11233456789999997531 2246889999999999999999 889998776655554443322
Q ss_pred --CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1028 --LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1028 --l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+.++..++..+.+++..|| .||++|||+++|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 123345568899999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.40 Aligned_cols=244 Identities=26% Similarity=0.353 Sum_probs=191.8
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
...+|++++.||+|+||.||+|++. +..||+|+.... ....|+.+|++++|+||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~- 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS- 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe-
Confidence 3467999999999999999999985 557999975432 12358899999999999999999987
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
....++||||+ .++|.+++.+....+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|||
T Consensus 129 -~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DfG 202 (357)
T PHA03209 129 -GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDLG 202 (357)
T ss_pred -CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecCc
Confidence 56789999999 5789999887777799999999999999999999999999999999999998 67789999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChH---------HHHHhhhh
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCA---------SIIGGIVN 1025 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~P-F~~~~~~---------eil~~Ilk 1025 (1075)
+++............||..|+|||++.+.. ++.++|||||||++|||+++..+ |...... ..+..+..
T Consensus 203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 203 AAQFPVVAPAFLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred cccccccCcccccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 998544333334567999999999997654 78999999999999999985444 4332111 01111111
Q ss_pred c--cCCCCC------------------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 N--TLRPQI------------------------------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 ~--~l~p~i------------------------------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
. .....+ ...++.++.+||.+||+.||.+|||+.++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 000000 11346678889999999999999999999863
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.29 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=193.6
Q ss_pred EEEEEccc--CcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 804 EVRELGSG--TYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 804 il~~LGeG--~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
++++||+| +|++||++++ +|+.||+|+++.... .......+.+|+.+++.++||||+++++++.. ++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCE
Confidence 45679999 6889999987 478899999875422 11223456689999999999999999999987 578
Q ss_pred eEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 880 LATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.++|+||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 99999999999999999754 34589999999999999999999999999999999999998 66789999998654
Q ss_pred cccccc--------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC-
Q 001449 959 VKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR- 1029 (1075)
Q Consensus 959 ~~~~~~--------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~- 1029 (1075)
...... ......++..|+|||++.+....++.++|||||||++|+|++|+.||..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 221110 11223467789999999764445889999999999999999999999865543332222211100
Q ss_pred -------------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 -------------------------------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 -------------------------------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
......+++++++||.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011235678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.48 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=199.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+++++ ++.||+|++....... ...+.+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 72 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------VIKKIALREIRMLKQLKHPNLVNLIEVFRR--K 72 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------cccHHHHHHHHHHHhCCCCCEeeeeeEEee--C
Confidence 46899999999999999999884 7889999987542111 112346789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++||||+++++|..++... ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFA 147 (286)
T ss_pred CEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccc
Confidence 6789999999988888776543 3589999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc---------
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT--------- 1027 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~--------- 1027 (1075)
....... ......++..|+|||++.+.. .++.++||||||+++|+|++|..||......+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDT-QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCC-CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8543322 223456788999999987533 36889999999999999999999998766544333222100
Q ss_pred -----------CCCC---------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -----------LRPQ---------IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -----------l~p~---------ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+. ....++..+.+||.+||+.+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 01235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.71 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=202.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~- 875 (1075)
..|++.+.||.|+||.||+|++ .++.+|+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 5788899999999999999988 46789999876431 1124567889999988 699999999988642
Q ss_pred ---CCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 876 ---PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 876 ---~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
....++++|||+.+++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEE
Confidence 245789999999999999999764 34578888999999999999999999999999999999998 6678999
Q ss_pred eecCCccccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc
Q 001449 952 GDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 952 iDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
+|||++...... .......|+..|+|||++... ...++.++|||||||++|+|++|..||........+..+....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 242 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC
Confidence 999998754321 122345689999999998532 2347889999999999999999999998766555444443333
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
........++.++.+||.+||+.||.+|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 333334567899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.93 Aligned_cols=242 Identities=28% Similarity=0.493 Sum_probs=190.8
Q ss_pred EEcccCcEEEEEEEEcCcc------------eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 807 ELGSGTYGSVYHGKWRGSD------------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~kGt~------------VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
.||+|+||.||+|.+.... +++|.+.... .. ...+.+|+.+|++++||||+++++++..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-------~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-------RD--SLAFFETASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch-------hh--HHHHHHHHHHHHcCCCcchhheeeEEec
Confidence 5899999999999885333 6777665331 11 3567789999999999999999998876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC---CCCCeEEE
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD---PQRPVCKI 951 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d---~~~g~VKL 951 (1075)
...++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+. .....+||
T Consensus 73 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 73 ---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred ---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 346899999999999999987665789999999999999999999999999999999999998322 11237999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
+|||++..... .....++..|+|||++.+....++.++||||||+++|+|++ |..||.............. . .
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~--~ 223 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-Q--H 223 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-C--C
Confidence 99999885433 22345677899999997653358899999999999999999 6888876654333222221 1 1
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+......+.++|.+||..+|.+|||+.++++.|+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 122222478999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.64 Aligned_cols=254 Identities=29% Similarity=0.451 Sum_probs=201.3
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeeccccc-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD- 874 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d- 874 (1075)
.++|++++.||+|+||.||++++ .++.+|+|+++.... ....+.+|+.+++++ +|+||+++++++..
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---------IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---------hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 46899999999999999999987 477899998754210 113466789999999 69999999998743
Q ss_pred --CCCCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 875 --GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 875 --~~e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
...+.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||+++ ..+.+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~ 163 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGGV 163 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCCE
Confidence 224578999999999999998753 234588999999999999999999999999999999999998 56779
Q ss_pred EEeecCCccccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||++...... .......|+..|+|||++... ...++.++|||||||++|+|++|+.||........+..+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 99999998754322 222344689999999998532 23368899999999999999999999987665444433322
Q ss_pred cc-CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1026 NT-LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1026 ~~-l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
.. .....+..++.++.+||.+||+.||++|||+.++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 22 11223455688999999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.76 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=225.2
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e 877 (1075)
.|+..+.||.|..+.|-++.. +|..+|+|++...........-.+.++.-.+|+.||+++. ||+|+.+.++|.. +
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--D 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--c
Confidence 456667799999999998865 4888999999876655444445566777889999999986 9999999999988 7
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++|+|.|..|.|+|++...- .++++....|++||+.|+.|||.++|+||||||+|||++ ++..+||+|||+|
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEecccee
Confidence 78999999999999999997654 589999999999999999999999999999999999998 7889999999999
Q ss_pred cccccccccCCCCCCCCccCccccc----CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLS----GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~----g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
+...........||||.|+|||.+. .....|+..+|+|+.|+|+|.||.|.+||-..-..-++..|+.+.+...-|
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9988888888899999999999885 234458999999999999999999999998777777778888888766666
Q ss_pred CC--CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 SW--CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 s~--ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.| ++...++||.+||+.||.+|.|++|.|..
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 65 67889999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.84 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=206.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||++... +..||+|.+...... .....+.+..|+.+|+.+.|+||+++++.+.. .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--E 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--C
Confidence 36899999999999999999884 688999998764221 12234668899999999999999999999877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...++||||+.+++|.+++.+. ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecch
Confidence 6899999999999999998754 34589999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc------------------------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc
Q 001449 957 SKVKQQTL------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006 (1075)
Q Consensus 957 Ak~~~~~~------------------------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT 1006 (1075)
+....... ......||..|+|||++.+.. ++.++||||||+++|+|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG--HGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC--CCchHHHHHHHHHHHHHhh
Confidence 87432110 112346888999999997654 7889999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 001449 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPS----FSEISR 1063 (1075)
Q Consensus 1007 G~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPS----a~ELLq 1063 (1075)
|+.||...+....+..+............++.+++++|.+||..||++||+ +.+++.
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 999998877766666655444332222337899999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.76 Aligned_cols=243 Identities=27% Similarity=0.504 Sum_probs=193.4
Q ss_pred EEcccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 807 ELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k---------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.||+|+||.||+|.++ ...||+|.+... .....+.+..|+.+++.+.||||+++++++.. .
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 71 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--G 71 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--C
Confidence 5899999999999763 223777776432 12234567789999999999999999999987 4
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC----CCCCeEEEee
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD----PQRPVCKIGD 953 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d----~~~g~VKLiD 953 (1075)
...++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .....+||+|
T Consensus 72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 568999999999999999987766789999999999999999999999999999999999997432 1223589999
Q ss_pred cCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHhhhhccCCCCC
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 954 FGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG-~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
||++...... ....++..|+|||++.+. ..++.++||||||+++|+|++| ..||.......... .... ...+
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~ 224 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQL 224 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccC
Confidence 9998754322 234578899999998753 2378899999999999999998 56666555443322 2222 2345
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+...+.++.+||.+||+.||++|||+++|++.|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 5556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.79 Aligned_cols=243 Identities=26% Similarity=0.445 Sum_probs=192.4
Q ss_pred EEcccCcEEEEEEEEc--------------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC
Q 001449 807 ELGSGTYGSVYHGKWR--------------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--------------------------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL 860 (1075)
.||+|+||.||+|+.. ...||+|++... .......+.+|+.+++++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5999999999998741 124788877532 112235677899999999
Q ss_pred CCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEec
Q 001449 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (1075)
Q Consensus 861 ~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId 940 (1075)
+||||+++++++.. ....++||||+.+++|..++.+....+++..+..|+.||++||.|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 99999999999887 5678999999999999999977666789999999999999999999999999999999999997
Q ss_pred cCC---CCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCh
Q 001449 941 MRD---PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL-TGDEPYADMHC 1016 (1075)
Q Consensus 941 ~~d---~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELL-TG~~PF~~~~~ 1016 (1075)
..+ .....+||+|||++...... ....++..|+|||.+.+. ..++.++||||||+++|||+ +|..||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 422 12346899999988643221 223478889999988653 34789999999999999985 79999987655
Q ss_pred HHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1017 ~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
...... ... ...++...+.++.++|.+||+.+|++|||+.+|++.|+
T Consensus 228 ~~~~~~-~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 SEKERF-YEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH-HHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 443222 221 12344445678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.41 Aligned_cols=243 Identities=26% Similarity=0.448 Sum_probs=190.2
Q ss_pred EEcccCcEEEEEEEEc--------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 807 ELGSGTYGSVYHGKWR--------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k--------------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
.||+|+||.||+|+.. ...||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5899999999999752 224788876532 122335678899999999999999999998
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC---CCCeE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP---QRPVC 949 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~---~~g~V 949 (1075)
.. ....++||||+.+++|..++.+....+++..++.|+.||++||.|||+++|+||||||+|||++..+. ....+
T Consensus 74 ~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 74 VR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred ec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 76 56779999999999999998876667899999999999999999999999999999999999973221 12248
Q ss_pred EEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHhhhhccC
Q 001449 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL-TGDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELL-TG~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
||+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ +|..||......+.. .......
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~ 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQC 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCc
Confidence 99999998744221 234578899999988632 33788999999999999998 589998765543332 2222222
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
......+.++++||.+||+.||.+||++.+|++.|+
T Consensus 227 --~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 --MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 122234678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.90 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=203.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~ 875 (1075)
.++|++.+.||+|++|.||+|+++ ++.+++|++..... ....+.+|+.+++++ .|+||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 367999999999999999999884 67799998875321 125677899999999 699999999998763
Q ss_pred C----CCceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCe
Q 001449 876 P----DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1075)
Q Consensus 876 ~----e~~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~ 948 (1075)
. ...+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+|+||+|+||+++ .++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence 2 34589999999999999998653 35689999999999999999999999999999999999998 6678
Q ss_pred EEEeecCCccccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhh
Q 001449 949 CKIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024 (1075)
Q Consensus 949 VKLiDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Il 1024 (1075)
+||+|||++...... .......++..|+|||++... ...++.++||||||++||+|++|..||........+..+.
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 999999998743322 222345689999999988532 2346789999999999999999999998766555555544
Q ss_pred hccCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1025 NNTLRP-QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1025 k~~l~p-~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
...... ..+..++.++++||.+||..||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 432211 112336789999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=307.34 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=211.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++.+.||+|+||.||++++ ++..||+|.+...... .........+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 4789999999999999999987 4788999987543211 1122345678899999999999999999999877555
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++++||+.+++|.+++.+.. .+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 67899999999999999987654 478999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc----cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCC
Q 001449 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 958 k~~~~~----~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
+..... .......++..|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+......+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCC--CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 853221 1122356889999999997644 7889999999999999999999998877666666666555667788
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++.+++++|.+||+ ++.+||++.+++..
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 8899999999999999 47999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.62 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=193.4
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~ 873 (1075)
...+|++++.||+|+||.||++... +..||+|.+... ....+|+.+|++++|||||++++++.
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence 3467999999999999999998763 456898987542 12347999999999999999999988
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
. ...+++|||++ .++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|
T Consensus 157 ~--~~~~~lv~e~~-~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~D 228 (392)
T PHA03207 157 W--KSTVCMVMPKY-KCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLGD 228 (392)
T ss_pred e--CCEEEEEehhc-CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcc
Confidence 7 56899999998 5789888843 45689999999999999999999999999999999999998 677899999
Q ss_pred cCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhhhhc-
Q 001449 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---SIIGGIVNN- 1026 (1075)
Q Consensus 954 FGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~---eil~~Ilk~- 1026 (1075)
||+++...... ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... ..+..+.+.
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~ 306 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence 99987543221 123457999999999997654 789999999999999999999999654321 111111110
Q ss_pred ------------------------cCCC--CCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1027 ------------------------TLRP--QIP-----SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1027 ------------------------~l~p--~ip-----s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...+ .++ ..++.++++||.+||..||++|||+.+++..
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 011 2346789999999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.24 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=203.8
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..++|++.+.||+|+||.||+|++ +|+.||+|+++....... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------IPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------CcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 347899999999999999999987 478899999875432111 112345799999999999999999998765
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..+.+++||||+. ++|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECccc
Confidence 4567899999995 589988877666789999999999999999999999999999999999998 67789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC-----
Q 001449 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR----- 1029 (1075)
Q Consensus 956 LAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~----- 1029 (1075)
++....... ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLGCT-TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcCCC-CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 998543321 222334678899999986533 3788999999999999999999999887766655544331100
Q ss_pred ------------CCC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 ------------PQI-----------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 ------------p~i-----------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..+ ....+.++.+||.+||+.||++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 12357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.89 Aligned_cols=248 Identities=22% Similarity=0.386 Sum_probs=207.0
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||.|+||.||+++++ +..||+|++.+.... .....+.+.+|+.++++++||||+++++.+.. ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CC
Confidence 4889999999999999999885 788999999754321 11235678899999999999999999999877 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|+||+.+++|.+++.+. ..+++..++.++.||++||.|||+++|+|+||||+||+++ .++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 899999999999999999766 4689999999999999999999999999999999999998 66789999999988
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHhhhhccCCCCCCCCC
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC--ASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~--~eil~~Ilk~~l~p~ips~l 1036 (1075)
............++..|+|||++.+.. ++.++|+||||+++|+|++|..||..... ...+...... ....++..+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATW 225 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccC
Confidence 654443344566889999999997654 78999999999999999999999987663 2222222222 345566778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSF--SEISR 1063 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa--~ELLq 1063 (1075)
+.++.++|.+||+.||.+||++ +++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.97 Aligned_cols=249 Identities=22% Similarity=0.448 Sum_probs=208.5
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++++.||+|+||.||+++. .+..||+|.+...... ......+.+|+.++++++|+||+++++++.. .+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEE--NG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CC
Confidence 488999999999999999987 4788999998754221 1223567889999999999999999999877 67
Q ss_pred ceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|+||+|+|||++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 8999999999999999987643 3578999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
....... ......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+..... +..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccC
Confidence 7543322 122345888999999987654 78899999999999999999999988777776666655443 3456678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.++.++|.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=340.20 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=190.0
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC------CCceeeee
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH------HPNVVSFY 869 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~------HPNIVkL~ 869 (1075)
...+|++++.||+|+||+||+|++ .+..||||+++... .....+..|+.+++.++ |.+|+.++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 357899999999999999999987 46779999986421 01123345666666654 45688898
Q ss_pred cccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCC----
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDP---- 944 (1075)
Q Consensus 870 g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~---- 944 (1075)
+++... ...+++|||++ +++|.+++.+. ..+++..++.|+.||+.||.|||+ .|||||||||+|||++..+.
T Consensus 198 ~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNE-TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcC-CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 888763 45789999988 88999988765 458999999999999999999998 59999999999999974321
Q ss_pred --------CCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001449 945 --------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC 1016 (1075)
Q Consensus 945 --------~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~ 1016 (1075)
....+||+|||.+..... .....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+.
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG--WMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 223699999998864322 234567999999999998654 88999999999999999999999987665
Q ss_pred HHHHHhhhhccC-------------------------CCCC---------------CCCCCHHHHHHHHHhhhcCCCCCC
Q 001449 1017 ASIIGGIVNNTL-------------------------RPQI---------------PSWCDPEWRSLMESCWASDPAERP 1056 (1075)
Q Consensus 1017 ~eil~~Ilk~~l-------------------------~p~i---------------ps~ls~eL~dLI~kCLq~DPeeRP 1056 (1075)
.+.+..+....- .+.. ....+..+.+||.+||++||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 443332211100 0000 001145678999999999999999
Q ss_pred CHHHHHH
Q 001449 1057 SFSEISR 1063 (1075)
Q Consensus 1057 Sa~ELLq 1063 (1075)
|+.|+|+
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999997
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=307.11 Aligned_cols=253 Identities=27% Similarity=0.485 Sum_probs=205.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|+..+.||+|+||.||+++. +++.||+|++.... ............+.+|+.+|++++|+||+++++++.+ .+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR--NTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeeccc--CCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CC
Confidence 477788999999999999986 57889999987542 1222333456788899999999999999999999887 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|+||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+|+||||+||+++. ....+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccccccc
Confidence 889999999999999999764 35899999999999999999999999999999999999972 23479999999987
Q ss_pred cccccc-----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHhhhhccCCC
Q 001449 959 VKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---SIIGGIVNNTLRP 1030 (1075)
Q Consensus 959 ~~~~~~-----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~---eil~~Ilk~~l~p 1030 (1075)
...... ......+|..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ..+..+......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 543221 122346888999999987544 788999999999999999999999754432 2223333333445
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.++..++.+++++|.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 666778899999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=309.16 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=198.0
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCC
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~ 878 (1075)
|++++.||+|+||.||+++. ++..||+|+++...... . .....+|+.+++++. |+||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--E-----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--h-----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 67889999999999999987 47789999987542111 1 123347888888886 99999999999875447
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++||||+. ++|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++ . +.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 8999999995 688888877656789999999999999999999999999999999999998 4 899999999998
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-----------
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT----------- 1027 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~----------- 1027 (1075)
............++..|+|||.+.... .++.++|||||||++|||++|..||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDG-YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCC-CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 654433334456889999999875432 36889999999999999999999998776554433332100
Q ss_pred -----CCCCC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1028 -----LRPQI-----------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1028 -----l~p~i-----------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
....+ ...++.++.+||.+||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00001 12467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=351.20 Aligned_cols=246 Identities=30% Similarity=0.491 Sum_probs=213.4
Q ss_pred EEEcccCcEEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEE
Q 001449 806 RELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~kGt--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
-+||+|+||+||.|++..+ .+|||.+... ..+..+-+..|+.+-+.|+|.|||+++|.+.+ ++.+-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--------cchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 3699999999999998644 4789987643 22334667789999999999999999999877 7889999
Q ss_pred EeeecCCcHHHHHhhccccC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc-
Q 001449 884 TEFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK- 960 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~L--se~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~- 960 (1075)
||-++||+|.++++.+-+++ ++.+.-.+.+||++||.|||++.|||||||-+||||+. -.|.+||+|||-++..
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT---ySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT---YSGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee---ccceEEecccccchhhc
Confidence 99999999999999988887 88899999999999999999999999999999999974 5589999999998843
Q ss_pred ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhhhhccCCCCCCCCCCHH
Q 001449 961 QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC-ASIIGGIVNNTLRPQIPSWCDPE 1039 (1075)
Q Consensus 961 ~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~-~eil~~Ilk~~l~p~ips~ls~e 1039 (1075)
.-+..+..+.||..|||||++......|...+|||||||++.||.||++||..... ...+.+.-.....+.+|..++.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 33334567889999999999988778899999999999999999999999987543 34555666666778999999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1040 WRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1040 L~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++.||.+|+..||.+||+++++|+.
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccC
Confidence 9999999999999999999999864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.47 Aligned_cols=251 Identities=31% Similarity=0.522 Sum_probs=210.7
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|+..+.||+|++|.||+|+.+ +..|++|++...... ......+.+|+.++++++|+||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4788899999999999999885 888999998754321 23346778999999999999999999998873337
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++++||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 8999999999999999998765 689999999999999999999999999999999999998 57889999999998
Q ss_pred ccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhhhhccCCCCCCC
Q 001449 959 VKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-CASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 959 ~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-~~eil~~Ilk~~l~p~ips 1034 (1075)
....... .....++..|+|||.+.+.. .+.++||||||+++|+|++|..||.... .......+........++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6544432 34456889999999987654 7889999999999999999999998765 3333333333334456677
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++..++++|.+||..||++||++.++++.
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 789999999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=315.99 Aligned_cols=247 Identities=24% Similarity=0.420 Sum_probs=203.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++++.||+|+||.||++++ .+..||+|.+...... ....+.+|+.+++.+.|+||+++++.+.. .
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~ 89 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV--G 89 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--C
Confidence 5799999999999999999986 4778999988754221 12456789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
...++||||+.+++|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~~ 163 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECccccc
Confidence 6899999999999999998653 478999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-CCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-LRPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-l~p~ips~ 1035 (1075)
....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+.... .....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 7533221 223346889999999987544 6889999999999999999999998766544333332222 12234556
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++..+.++|.+||..+|++||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 78899999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=347.74 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=217.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~kGt--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
+-|+++..||.|+||+||+|..+.+ ..|.|+|... .+..+..++-|+.||..+.||+||++++.|.. +
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~--e 101 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--E 101 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--c
Confidence 3478889999999999999987644 3577877543 23446788999999999999999999999887 7
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.++|+.|||.||-.+.++-.-++.+++.++..+++|++.||.|||+++|||||||..|||++ .+|.++|+|||++
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVS 177 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVS 177 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeeccccc
Confidence 899999999999999999998889999999999999999999999999999999999999998 7789999999997
Q ss_pred cc-cccccccCCCCCCCCccCcccccC---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC-CCC
Q 001449 958 KV-KQQTLVSGGVRGTLPWMAPELLSG---KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR-PQI 1032 (1075)
Q Consensus 958 k~-~~~~~~sss~~GT~~YmAPEvl~g---~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~-p~i 1032 (1075)
.. ........+++|||.|||||++.. +...|++++||||||++|.||..+.+|....++..++.++.+...+ ...
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC
Confidence 64 333344567899999999998853 2334899999999999999999999999999999988888775432 345
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
|+.++..|.+|++.||.+||..||++.+|++.
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 77889999999999999999999999999864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=317.59 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=200.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||++++. +..+|+|.++... .......+.+|++++++++||||+++++.+.+ +
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--D 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 46899999999999999999874 6678989876431 12234567889999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
+.+++||||+.+++|.+++.+. ..+++..+..++.||++||.|||+ .+|+||||||+|||++ .++.+||+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCC
Confidence 7899999999999999999765 458999999999999999999997 5999999999999998 667899999999
Q ss_pred ccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh-----------
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN----------- 1025 (1075)
Q Consensus 957 Ak~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk----------- 1025 (1075)
+...... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 8754322 223457899999999987544 78899999999999999999999965443222111100
Q ss_pred ------------------------ccCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1026 ------------------------NTLRPQIP-SWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1026 ------------------------~~l~p~ip-s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
....+..+ ..++.++++||.+||..+|++||++.++++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00111122 13678899999999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=343.84 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=208.9
Q ss_pred ccccccCCCeeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeec
Q 001449 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYG 870 (1075)
Q Consensus 793 ~i~~i~~ddYeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g 870 (1075)
.+..++...|+++++||.||.+.||++... .+.+|+|++.... .+...+.-|.+|+.+|.+|+ |.+||++|+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE------ADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh------cCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 455677889999999999999999999874 5668888776432 24456788999999999997 899999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
|-.. ++.+||||||= ..+|..+|+++...+..-.++.+.+||+.|+.++|+.||||.||||.|+|+- .|.+|
T Consensus 428 YEv~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LK 499 (677)
T KOG0596|consen 428 YEVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLK 499 (677)
T ss_pred eecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEE
Confidence 9777 78999999986 6799999998876666457888899999999999999999999999999994 68999
Q ss_pred EeecCCccccccccc---cCCCCCCCCccCcccccCCCC---------CCCchhhHHHHHHHHHHHHcCCCCCCCCC-hH
Q 001449 951 IGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSH---------MVTEKIDVYSFGIVMWELLTGDEPYADMH-CA 1017 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~---------~yS~KsDIWSLGVILyELLTG~~PF~~~~-~~ 1017 (1075)
|+|||+|......+. ..+.+||..|||||.+..... ..++++||||||||||+|+.|+.||.... ..
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~ 579 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI 579 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH
Confidence 999999996544332 356789999999999863222 26789999999999999999999998754 33
Q ss_pred HHHHhhhhccCCCCCCCCCC-HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1018 SIIGGIVNNTLRPQIPSWCD-PEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1018 eil~~Ilk~~l~p~ips~ls-~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..+..|........++..-+ .++.++++.||.+||.+||++.+||+.
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 44444444333334443322 349999999999999999999999874
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.38 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=204.0
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||.|+||.||+++++ ++.||+|++....... ....+.+.+|+.+++.++||||+++++.+.+ ...+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-----TGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEe
Confidence 689999999999986 8889999987543221 1223567899999999999999999999877 568999999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccc
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~ 965 (1075)
|+.+++|.+++.+.. .+++..+..++.||+.||.|||+++++|+||||+||+++ .++.+||+|||++........
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 999999999997653 489999999999999999999999999999999999998 667899999999986544333
Q ss_pred cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHhhhhccCCCCCCCCCCHHHHHH
Q 001449 966 SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH--CASIIGGIVNNTLRPQIPSWCDPEWRSL 1043 (1075)
Q Consensus 966 sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~--~~eil~~Ilk~~l~p~ips~ls~eL~dL 1043 (1075)
.....++..|++||.+.+.. ++.++|+||||+++|+|++|..||.... ....+..+........++..++.+++++
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKG--YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhcCCC--CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 33456899999999987543 7889999999999999999999998766 5555666554444556777779999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHH
Q 001449 1044 MESCWASDPAERPS-----FSEISR 1063 (1075)
Q Consensus 1044 I~kCLq~DPeeRPS-----a~ELLq 1063 (1075)
|.+||+.+|++|++ +.++++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999 888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.31 Aligned_cols=248 Identities=34% Similarity=0.596 Sum_probs=198.2
Q ss_pred EEcccCcEEEEEEEEcC--------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 807 ELGSGTYGSVYHGKWRG--------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~kG--------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.||+|+||.||++++.. ..+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NE 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CC
Confidence 58999999999998742 4689998764311 1223567789999999999999999999877 56
Q ss_pred ceEEEEeeecCCcHHHHHhhc------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC-CCCCeEEE
Q 001449 879 SLATVTEFMVNGSLKQFLQKK------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d-~~~g~VKL 951 (1075)
..++||||+.+++|.+++.+. ...+++..++.++.||+.||.|||+++++|+||||+||+++.++ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999999753 23378899999999999999999999999999999999998322 12338999
Q ss_pred eecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc
Q 001449 952 GDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 952 iDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.. .
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-G 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCC--cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-C
Confidence 9999987432211 112234567899999987544 7899999999999999998 9999987766665544332 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
.....+..++..+.++|.+||+.+|.+||+++++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 334456678899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=345.77 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=204.2
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-C-----Cceeeeeccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-H-----PNVVSFYGIV 872 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-H-----PNIVkL~g~~ 872 (1075)
+|++++.||+|+||.|.+|.+ +++.||||+++.. .....+...|+.||..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 799999999999999999987 4788999999854 233456678999999997 3 3899999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.. .+.+|||+|.+ ..+|.++|+.+. ..++...++.|+.||+.||.+||+.+|||.||||+||||... ....|||
T Consensus 258 ~f--r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r~~vKV 332 (586)
T KOG0667|consen 258 YF--RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KRSRIKV 332 (586)
T ss_pred cc--ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--CcCceeE
Confidence 98 78999999988 789999998764 458999999999999999999999999999999999999743 4458999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh------
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN------ 1025 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk------ 1025 (1075)
+|||.|+....... .++.+..|+|||+|.|.+ |+.+.||||||||++||++|.+.|.+.+..+.+..|+.
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999997655543 677899999999999877 89999999999999999999999988877766544431
Q ss_pred ---------------c-c----------------------------CCCCCC-----------CCCCHHHHHHHHHhhhc
Q 001449 1026 ---------------N-T----------------------------LRPQIP-----------SWCDPEWRSLMESCWAS 1050 (1075)
Q Consensus 1026 ---------------~-~----------------------------l~p~ip-----------s~ls~eL~dLI~kCLq~ 1050 (1075)
. . .....| ..-...+.+||++||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 0 0 000011 01124578999999999
Q ss_pred CCCCCCCHHHHHHH
Q 001449 1051 DPAERPSFSEISRR 1064 (1075)
Q Consensus 1051 DPeeRPSa~ELLq~ 1064 (1075)
||.+|+|..+.|+.
T Consensus 489 dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 489 DPAERITPAQALNH 502 (586)
T ss_pred CchhcCCHHHHhcC
Confidence 99999999988763
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.28 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=203.3
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||.|+||.||+|++. ++.+|+|.++..... +.....+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 57888999999999999999985 778999998754322 1122456689999999999999999999877544
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCce
Confidence 78999999996 599999887666789999999999999999999999999999999999998 6688999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc---------
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT--------- 1027 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~--------- 1027 (1075)
...... .......+++.|+|||.+.+.. .++.++||||||+++|+|++|..||........+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 854332 2223445788999999987543 26889999999999999999999998766554443332110
Q ss_pred --------------------CCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 --------------------LRPQIPSW-CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 --------------------l~p~ips~-ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
....++.. ++..++++|++||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 01122222 5888999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.30 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=204.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||++++. ++.||+|.+..... ........+.+|+.+++.++||||+++++.+.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFET--K 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--C
Confidence 46899999999999999999874 67799998875421 112234567789999999999999999999877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++... ..+++..+..++.|+++||.|||+++|+||||||+||+++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCc
Confidence 6889999999999999999765 4589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccccc----------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001449 958 KVKQQTL----------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021 (1075)
Q Consensus 958 k~~~~~~----------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~ 1021 (1075)
+...... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6321100 111235788899999987543 7899999999999999999999998877776666
Q ss_pred hhhhccCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1022 GIVNNTLR-PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1022 ~Ilk~~l~-p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
.+...... +.....++.+++++|.+||+.||++||+..++++.|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 65544322 2222357899999999999999999998655555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.77 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=204.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++.+.||.|+||.||++.+ .++.||+|.+...... ....+.+|+.+++.++||||+++++++.. .
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 88 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--------KKELIINEILVMKELKNPNIVNFLDSFLV--G 88 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--------hHHHHHHHHHHHHhcCCCceeeeeeeEec--C
Confidence 5699999999999999999986 5788999988643211 12456789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++|+||+.+++|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~~ 162 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGFC 162 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 6899999999999999998654 489999999999999999999999999999999999998 6678999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-CCCCCCCC
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-LRPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-l~p~ips~ 1035 (1075)
...... .......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+.... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 743322 1223456889999999987544 7889999999999999999999998776655444443322 12234566
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++..+.++|.+||..||.+||++.++++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 8899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=308.70 Aligned_cols=249 Identities=32% Similarity=0.505 Sum_probs=195.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHH-HHhCCCCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL-LSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~I-LkkL~HPNIVkL~g~~~d~~ 876 (1075)
++|++++.||+|+||.||+++++ |..||+|+++...... . ...+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~---~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----E---QKRLLMDLDISMRSVDCPYTVTFYGALFR-- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----H---HHHHHHHHHHHHHHcCCCCeeeeeEEEec--
Confidence 47899999999999999999884 7889999987542211 1 1234445554 677789999999999876
Q ss_pred CCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
.+.++++|||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~ 146 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLC 146 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEe
Confidence 567999999995 688887754 234589999999999999999999997 999999999999998 67789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhhhhccCC
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS--HMVTEKIDVYSFGIVMWELLTGDEPYADMH-CASIIGGIVNNTLR 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~--~~yS~KsDIWSLGVILyELLTG~~PF~~~~-~~eil~~Ilk~~l~ 1029 (1075)
|||++.............++..|+|||++.+.. ..++.++|||||||++|+|++|+.||.... ..+.+..+.... .
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 225 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-S 225 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-C
Confidence 999988654333333356889999999886421 336889999999999999999999997532 223333333322 2
Q ss_pred CCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 PQIP-SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 p~ip-s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.++ ..++.++.++|.+||..+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2333 357899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.52 Aligned_cols=248 Identities=34% Similarity=0.551 Sum_probs=204.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||.|+||.||++.++ ++.||+|.+..... ......+.+|+.+++++.||||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYN--N 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeec--C
Confidence 35778889999999999999885 77899998875421 1223567789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
+.+++++||+.+++|.+++......+++..++.++.||+.||.|||+ .|++|+||||+||+++ .++.+||+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~ 147 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGV 147 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeeccc
Confidence 78999999999999999998765678999999999999999999999 9999999999999998 567899999999
Q ss_pred ccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHhhhhccCCCC
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-----CASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 957 Ak~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-----~~eil~~Ilk~~l~p~ 1031 (1075)
+......... ...++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... ....+..+... ..+.
T Consensus 148 ~~~~~~~~~~-~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 223 (265)
T cd06605 148 SGQLVNSLAK-TFVGTSSYMAPERIQGND--YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPR 223 (265)
T ss_pred chhhHHHHhh-cccCChhccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCC
Confidence 8754332222 266889999999997653 7899999999999999999999997542 22333333322 2333
Q ss_pred CCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1032 IPSW-CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1032 ips~-ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++.. ++.+++++|.+||..||++|||+.+++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 4443 78999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.84 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=205.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||.|+||.||+|.. ++..+|+|++...... .....+.+|+.+|+.++|+||+++++.+.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-------TSVDELRKEVQAMSQCNHPNVVKYYTSFVV--G 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-------hHHHHHHHHHHHHHhcCCCCEEEEEEEEee--C
Confidence 4789999999999999999986 4678999998653221 134678899999999999999999998877 5
Q ss_pred CceEEEEeeecCCcHHHHHhhcc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~--~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
+.+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++ +++.+||+|||
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~ 147 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFG 147 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccc
Confidence 68899999999999999997642 4589999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 956 LSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 956 LAk~~~~~~-----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
++....... ......++..|+|||++... ..++.++|+||||+++|+|++|+.||...+....+........ .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 225 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-P 225 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-C
Confidence 987543321 12334688999999998754 2478899999999999999999999988776655555444322 1
Q ss_pred CCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1031 QIP-----SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1031 ~ip-----s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+. ..++.+++++|.+||..||++|||+.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111 256789999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.41 Aligned_cols=246 Identities=30% Similarity=0.540 Sum_probs=206.2
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|+..+.||+|++|.||+++++ +..+++|++..... .....+.+|+.++++++|+||+++++.+.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KD 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CC
Confidence 5788899999999999999985 78899999875421 234667889999999999999999999887 57
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
..++++||+.+++|.+++......+++..+..++.|++.||.+||+.|++||||+|+||+++ .++.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 78999999999999999987656789999999999999999999999999999999999998 67889999999988
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC--CC
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS--WC 1036 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips--~l 1036 (1075)
............++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+....+...... ..+..+. .+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLRNPEKW 223 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCCcCccccc
Confidence 654433234556889999999987554 788999999999999999999999877555544443332 2222332 23
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.++.++|.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.40 Aligned_cols=253 Identities=30% Similarity=0.437 Sum_probs=202.3
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~ 875 (1075)
.++|++.+.||+|+||.||+++. +++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 47799999999999999999987 47789999886421 1123456788899998 799999999988753
Q ss_pred C---CCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 876 P---DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 876 ~---e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
+ .+.+++||||+.+++|.++++. ....+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCE
Confidence 2 2468999999999999998863 345689999999999999999999999999999999999998 56789
Q ss_pred EEeecCCcccccccc-ccCCCCCCCCccCcccccCCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh
Q 001449 950 KIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKS---HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~-~sss~~GT~~YmAPEvl~g~~---~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk 1025 (1075)
||+|||++....... ......++..|+|||++.... ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 999999988543222 223456889999999986432 1257899999999999999999999988766555544433
Q ss_pred ccC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 NTL-RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 ~~l-~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
... ....+...+..+.+||.+||+.+|++||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 322 112244567889999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.17 Aligned_cols=250 Identities=28% Similarity=0.511 Sum_probs=203.2
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|+||.||++.. ++..||+|.++.... .....+.+..|+.++++++|+||+++++.+.. .+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--RE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEec--CC
Confidence 478899999999999999987 477899999875421 13345778899999999999999999998776 57
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|+||+.+++|.+++... ..+++..++.|+.|++.||.|||+.||+|+||||+||+++ ..+.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 899999999999999999765 3478999999999999999999999999999999999998 57789999999988
Q ss_pred ccccccc-----cCCCCCCCCccCcccccCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 959 VKQQTLV-----SGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 959 ~~~~~~~-----sss~~GT~~YmAPEvl~g~~-~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
....... .....++..|+|||++.+.. ...+.++||||||+++|+|++|+.||..................+.+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 5432211 11345788999999987543 33688999999999999999999999765332222222222333445
Q ss_pred CCCC--CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1033 PSWC--DPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1033 ps~l--s~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+... +..+.++|.+||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 5544 899999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.38 Aligned_cols=253 Identities=26% Similarity=0.331 Sum_probs=202.3
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|+||.||+|.++ ++.||||.++....... .......+..|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA---KDGINFTALREIKLLQELKHPNIIGLLDVFGH--KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc---cchhhHHHHHHHHHHhhcCCCCChhhhheeec--CC
Confidence 4788899999999999999874 78899999986543211 11223456689999999999999999999987 67
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++||||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 9999999987655689999999999999999999999999999999999998 66789999999998
Q ss_pred ccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC--------
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR-------- 1029 (1075)
Q Consensus 959 ~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~-------- 1029 (1075)
..... .......++..|+|||.+.+.. .++.++|||||||++|+|++|.++|......+.+..+......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCC-CCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 54332 1222345688899999986433 3788999999999999999998888766654444333221100
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 ------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 ------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.......+.++.++|.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00113346789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.17 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=205.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..|+.++.||.|+||.||+|++ .+..||+|+++... .......+.+|+.+++++.|+||+++++.+.+ .
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--G 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 3477788899999999999987 47789999887431 11234678899999999999999999999887 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++||||+.+++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~ 148 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVA 148 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccc
Confidence 7899999999999999998653 478999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
....... ......++..|+|||++.+.. .+.++|+|||||++|+|++|..||...........+. ....+.++..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 225 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEF 225 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCC--CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhh
Confidence 7543222 223346788999999987554 7889999999999999999999998776655444332 22334555667
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.++.++|.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 8899999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.57 Aligned_cols=248 Identities=32% Similarity=0.545 Sum_probs=207.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|++|.||++++. +..||+|++...... .....+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYK--E 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--C
Confidence 36889999999999999999884 788999998754211 224667899999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
+.+++||||+.+++|.+++... ..+++..++.++.||++||.|||+ .+++||||+|+||+++ .++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~ 146 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGI 146 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 7899999999999999999765 468999999999999999999999 9999999999999998 678899999999
Q ss_pred cccccccccc-CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHhhhhccCCCCC
Q 001449 957 SKVKQQTLVS-GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH---CASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 957 Ak~~~~~~~s-ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~---~~eil~~Ilk~~l~p~i 1032 (1075)
+......... ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... .......+.. ...+.+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 223 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSL 223 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCC
Confidence 8854332222 245688999999998765 37889999999999999999999997763 3344444433 333445
Q ss_pred CCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1033 PSW-CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1033 ps~-ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.. ++..+.++|.+||..+|++||++.++++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 555 88999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.40 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=195.9
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||+|++|.||+++. +++.||||.+........ ...+.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIHT-- 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEec--
Confidence 46899999999999999999987 478899999875432111 1235679999999999999999999887
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
....++||||+. ++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~ 149 (291)
T cd07844 75 KKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGL 149 (291)
T ss_pred CCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcccc
Confidence 678999999996 599999887666789999999999999999999999999999999999998 667899999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhhhhc---cC---
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-CASIIGGIVNN---TL--- 1028 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-~~eil~~Ilk~---~l--- 1028 (1075)
++..... .......++..|+|||++.+.. .++.++||||||+++|+|++|+.||.... ..+.+..+.+. ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGST-EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 8743221 1112234688999999987533 36889999999999999999999997654 22222111110 00
Q ss_pred -------------C------C---CCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 -------------R------P---QIPSWCD--PEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 -------------~------p---~ips~ls--~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. . .....++ .++.++|.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 0001233 78889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.15 Aligned_cols=249 Identities=31% Similarity=0.494 Sum_probs=202.7
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..++|++++.||+|+||.||++.+. ++.||+|++.... .......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 74 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLN- 74 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEec-
Confidence 4467888999999999999999875 7889999886431 12234667899999999999999999999987
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
.+.+++||||+.+++|.+++.+. +.+++..++.++.|++.||.|||+ .+|+||||||+||+++ .++.++|+||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d~ 148 (284)
T cd06620 75 -ENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDF 148 (284)
T ss_pred -CCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEccC
Confidence 57899999999999999998764 458999999999999999999997 5999999999999998 6678999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHhh
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-----------SIIGGI 1023 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-----------eil~~I 1023 (1075)
|++...... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... +....+
T Consensus 149 gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 149 GVSGELINS-IADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred Ccccchhhh-ccCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 998743222 12345689999999998754 3788999999999999999999999765432 222222
Q ss_pred hhccCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1024 VNNTLRPQIPS-WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1024 lk~~l~p~ips-~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.... .+.++. .++.++.+||.+||+.||++|||+.++++.
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 226 VQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 2222 222332 377899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.24 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=201.9
Q ss_pred eeEEEEEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 802 LEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
|++.+.||+|+||.||+|.++ +..||||+++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 566788999999999999763 56799999875421 1223456788999999999999999999876532
Q ss_pred C----CceEEEEeeecCCcHHHHHhhc-----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC
Q 001449 877 D----GSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1075)
Q Consensus 877 e----~~L~LVmEYmeGGSL~d~Lkk~-----~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g 947 (1075)
. ...+++++|+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 1 1347889999999998887432 22478899999999999999999999999999999999997 677
Q ss_pred eEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhh
Q 001449 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~I 1023 (1075)
.+||+|||+++...... ......++..|++||.+.+.. ++.++|||||||++|+|++ |+.||...+..+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 89999999988542211 112233567899999987544 7889999999999999999 99999877766555444
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 001449 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1024 lk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi 1068 (1075)
.... ....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4332 2334456789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.49 Aligned_cols=246 Identities=24% Similarity=0.426 Sum_probs=202.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++++.||+|+||.||+++. .+..||+|.+...... ..+.+.+|+.+++.++|+||+++++++.. .
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 88 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV--G 88 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 6799999999999999999986 4888999998653211 12446789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..+++||||+.+++|.+++.+. .+++..+..++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~~ 162 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCccc
Confidence 6899999999999999998653 478899999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc-cCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~-~l~p~ips~ 1035 (1075)
....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 7533221 223346889999999997644 788999999999999999999999765543332222222 222234556
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++..+++||.+||..+|++||++.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7889999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.89 Aligned_cols=248 Identities=31% Similarity=0.543 Sum_probs=210.7
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||.|+||.||++.+. +..||+|++...... ......+.+|+.++++++|+|++++++.+.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS------EKEREDALNEVKILKKLNHPNIIKYYESFEE--KG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC------hHHHHHHHHHHHHHHhcCCCChhheEEEEec--CC
Confidence 5888999999999999999985 788999998754321 2223567789999999999999999999887 47
Q ss_pred ceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..++|+||+++++|.+++.+. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++ .++.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999999875 36789999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
++....... ......+++.|+|||.+.+.. ++.++|+||||+++++|++|..||......+......... ...++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC
Confidence 988543332 233456889999999987554 7889999999999999999999998877766666655443 445666
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.++.++.++|.+||+.+|++|||+.++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 78999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=323.21 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=221.2
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
..+..++|+.+++||+|.||+|-+++- +++.+|+|+++++.+..+. .++.-+.|-.+|+..+||.+..+-..|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-----EVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-----EVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-----HhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 445568899999999999999999876 4888999999988766442 246677899999999999999998888
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
+. +..+|+||||..||.|...|.+. +.+++...+.+..+|+.||.|||+++||+||||.+|+|+| .++++||+
T Consensus 238 Qt--~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKit 310 (516)
T KOG0690|consen 238 QT--QDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKIT 310 (516)
T ss_pred cc--CceEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEee
Confidence 88 78999999999999999998765 4589999999999999999999999999999999999999 88999999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 953 DFGLAk~~-~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|||+++.. ........+||||.|+|||++.... |...+|+|.+||++|||++|++||...+...+..-|+...+ .
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD--YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--k 386 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND--YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--K 386 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhcccc--ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--c
Confidence 99999953 3344556799999999999997554 89999999999999999999999999999888888877654 6
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRP-----Sa~ELLq 1063 (1075)
+|..++++.+.|+..+|.+||.+|. ++.||.+
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 8999999999999999999999994 4555543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.34 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=198.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||+|.++ ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRR--K 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhccc--C
Confidence 36899999999999999999884 778999987653211 1123456789999999999999999999977 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~ 147 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA 147 (286)
T ss_pred CeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeee
Confidence 7899999999998888876544 3489999999999999999999999999999999999998 6779999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc----------
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---------- 1026 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~---------- 1026 (1075)
...... .......++..|+|||++.+.. .++.++||||||+++|+|++|+.||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhcccc-ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 854322 2223456889999999987533 3678999999999999999999999765543322222110
Q ss_pred ----------cCCC---------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1027 ----------TLRP---------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1027 ----------~l~p---------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
...+ .....++..+.+||.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 012346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.16 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=197.3
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++++.||.|++|.||+|++ ++..||||+++...... .....+.+|+.++++++||||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHT--EN 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------ccchHHHHHHHHHHhcCCCCCcchhhhccc--CC
Confidence 488999999999999999987 47889999887543211 122457789999999999999999999876 67
Q ss_pred ceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8999999995 6898888653 34589999999999999999999999999999999999998 6678999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC-------
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR------- 1029 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~------- 1029 (1075)
...... .......++..|+|||++.+.. .++.++||||||+++|+|+||+.||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEecCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 754322 1222345788999999886543 3688999999999999999999999766544333322211000
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 --------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 --------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+...++.+++++|.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0012246788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.08 Aligned_cols=246 Identities=28% Similarity=0.501 Sum_probs=200.5
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC---CCceeeeecccccC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDG 875 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~---HPNIVkL~g~~~d~ 875 (1075)
.|++++.||.|+||.||+|++ ++..||+|.++.... ......+.+|+.+++++. ||||+++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~- 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK- 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-
Confidence 467788999999999999987 478899999875321 112355778999999987 9999999999876
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+++||||+.+++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++ ..+.++|+|||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 74 -GPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred -CCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 56789999999999999998654 689999999999999999999999999999999999998 57789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
++....... ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+... ..+.++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc
Confidence 988543322 22344689999999998643 23688999999999999999999999877655444333222 2233333
Q ss_pred -CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1035 -WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 -~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.++.++.++|.+||+.||++||++.+++.
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 37889999999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.59 Aligned_cols=246 Identities=24% Similarity=0.476 Sum_probs=191.3
Q ss_pred EEcccCcEEEEEEEEc-Ccc---eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 807 ELGSGTYGSVYHGKWR-GSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~k-Gt~---VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
.||+|+||.||+++.. +.. +++|.++... .......+.+|+.+++.++||||+++++.+.. ....++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEE
Confidence 5999999999999753 333 4555544321 11224678899999999999999999999887 567899
Q ss_pred EEeeecCCcHHHHHhhcc---ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 883 VTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~---~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999997642 3356777888999999999999999999999999999998 667899999999863
Q ss_pred cccc---cccCCCCCCCCccCcccccCCC-----CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc---
Q 001449 960 KQQT---LVSGGVRGTLPWMAPELLSGKS-----HMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT--- 1027 (1075)
Q Consensus 960 ~~~~---~~sss~~GT~~YmAPEvl~g~~-----~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~--- 1027 (1075)
.... .......++..|+|||++.... ..++.++||||||+++|||++ |..||......+.+..+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 2111 1123456788999999985321 235778999999999999997 678888776666555544332
Q ss_pred -CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1028 -LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1028 -l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+.++..++..+++++..|| .+|++||+++++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 234445567889999999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=310.23 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=201.6
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|+.++.||+|+||.||+|.+ .+..||+|.++... .......+.+|+.++++++||||+++++.+.. ...
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 76 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTK 76 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCc
Confidence 55566799999999999987 46789999886431 11234567899999999999999999999887 668
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~~~ 150 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEcccccccc
Confidence 9999999999999999864 3589999999999999999999999999999999999998 667899999999875
Q ss_pred ccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCH
Q 001449 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038 (1075)
Q Consensus 960 ~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~ 1038 (1075)
..... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+. ....+.++..++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 227 (277)
T cd06642 151 LTDTQIKRNTFVGTPFWMAPEVIKQSA--YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSK 227 (277)
T ss_pred ccCcchhhhcccCcccccCHHHhCcCC--CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCH
Confidence 43222 222345888999999997654 7889999999999999999999998665554443332 2233445566788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1039 EWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1039 eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++.++|.+||+.+|++||++.++++.
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.91 Aligned_cols=247 Identities=28% Similarity=0.478 Sum_probs=207.6
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|+||.||++++ ++..+|+|.+...... ......+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLD--GN 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CC
Confidence 488999999999999999987 4678999998754321 1223566789999999999999999999887 57
Q ss_pred ceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..++|+||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999998662 34589999999999999999999999999999999999998 56789999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
++...... ......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+.... .+.++..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCchh
Confidence 99865444 223355889999999997654 7889999999999999999999998887766555544433 3445567
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++.+++++|.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 8899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.87 Aligned_cols=256 Identities=29% Similarity=0.364 Sum_probs=196.7
Q ss_pred CeeEEEEEcccCcEEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.|++.+.||+|+||.||+|++ .+..||+|.+....... ......+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-----TGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc-----cCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 478899999999999999987 45789999988643211 111245668999999999999999999998854
Q ss_pred CCceEEEEeeecCCcHHHHHhhc----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKK----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~----~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
...+++||||+. ++|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++...+.+||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 578999999995 5777776432 23689999999999999999999999999999999999998544458899999
Q ss_pred ecCCcccccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---------H
Q 001449 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---------I 1019 (1075)
Q Consensus 953 DFGLAk~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e---------i 1019 (1075)
|||+++...... ......+|..|+|||++.+.. .++.++||||||+++|+|++|+.||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999988543221 123346789999999886533 36889999999999999999999997543321 0
Q ss_pred HHhhhh------------------------ccCCCCCC-----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1020 IGGIVN------------------------NTLRPQIP-----------SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1020 l~~Ilk------------------------~~l~p~ip-----------s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+..++. ......++ ...+.++.++|.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111000 00001111 145678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.83 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=200.1
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|+||.||+|+++ ++.||+|+++..... ......+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 72 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD------EDVKKTALREVKVLRQLRHENIVNLKEAFRR--K 72 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc------ccchhHHHHHHHHHHhcCCCCeeehhheEEE--C
Confidence 36899999999999999999884 678999988754211 1223567789999999999999999999987 6
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+.+++||||+.++.|..++.+ ...+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~ 147 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFA 147 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeecc
Confidence 689999999987666655544 34589999999999999999999999999999999999998 6789999999998
Q ss_pred ccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc--------
Q 001449 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 958 k~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-------- 1027 (1075)
....... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||......+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 8544332 233456889999999997652 47899999999999999999999998765544332221100
Q ss_pred -------------C---------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -------------L---------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -------------l---------~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. ....+..++.++++||++||..+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00123345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=305.26 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=199.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||.|++|.||++.+ +++.+|+|.+..... ......+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4689999999999999999988 477899998875321 1223567889999999999999999999877556
Q ss_pred CceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+.+++||||+.+++|.+++.. ....+++..+..|+.||+.||.|||+.|++|+||+|+||+++ ..+.++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence 689999999999999988753 334588999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHhhhhccCC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-----CASIIGGIVNNTLR 1029 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-----~~eil~~Ilk~~l~ 1029 (1075)
|++........ ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... ..+....+... ..
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 225 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PN 225 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cc
Confidence 99875432221 2345788999999987554 7889999999999999999999997652 22222222221 11
Q ss_pred CCCC------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 PQIP------SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 p~ip------s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.++ ...+..+++||.+||..+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111 234678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.55 Aligned_cols=250 Identities=24% Similarity=0.488 Sum_probs=204.5
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||.|+||.||+++.+ |..||+|.+....... .....+.+|+.++++++|+||+++++.+.. .+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQE--NG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheecc--CC
Confidence 4788999999999999999884 7789999987542211 112456789999999999999999999877 67
Q ss_pred ceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.+++|+||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.+|+|+||||+||+++. ....+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK---NGMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC---CCCeEEecccccc
Confidence 8999999999999999987643 34799999999999999999999999999999999999972 2346799999998
Q ss_pred ccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
....... ......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+..... ..+...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRP--YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNF 226 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCC
Confidence 7543322 122345889999999986543 78899999999999999999999987766665555444332 3344567
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.+++++|.+||..+|++|||+.+++..
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 8899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.04 Aligned_cols=248 Identities=26% Similarity=0.417 Sum_probs=198.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++++.||.|++|.||+|++ +|..||||+++...... ....+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-------TPSTAIREISLMKELKHENIVRLHDVIHT--EN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-------chHHHHHHHHHHHhhcCCCEeeeeeeEee--CC
Confidence 588999999999999999998 47889999987643211 12445679999999999999999999987 56
Q ss_pred ceEEEEeeecCCcHHHHHhhcc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~--~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 7899999996 58988887644 4589999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc--------
Q 001449 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 957 Ak~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~-------- 1027 (1075)
+....... ......++..|++||++.+.. .++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 87432221 122345788999999986543 36889999999999999999999998766554433332110
Q ss_pred --------CCCC-----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 --------LRPQ-----------IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 --------l~p~-----------ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.... +...++.+++++|.+||+.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 11235778999999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.12 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=193.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|.+++.||+|+||.||+|+. ++..||+|++....... ....+.+|+.+|+.++|+||+++++++.. .
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~ 75 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHT--K 75 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEec--C
Confidence 6799999999999999999976 47889999987542211 11345689999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
...++||||+ .++|.+++......+++..+..++.||+.||.|||+.||+|+||||+|||++ .++.+||+|||++
T Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~~ 150 (291)
T cd07870 76 ETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGLA 150 (291)
T ss_pred CeEEEEEecc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEeccccc
Confidence 6789999999 4788777766555678888999999999999999999999999999999998 6678999999998
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhhhhc---------
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIVNN--------- 1026 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-eil~~Ilk~--------- 1026 (1075)
+..... .......++..|+|||++.+.. .++.++||||||+++|+|++|..||...... +.+..+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 151 RAKSIPSQTYSSEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred cccCCCCCCCCCccccccccCCceeecCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 753222 1223345789999999986532 3678999999999999999999999764432 222211100
Q ss_pred ------------cCCCCCC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1027 ------------TLRPQIP---------SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1027 ------------~l~p~ip---------s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
......+ ...+.++.++|.+||..||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 012568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=319.14 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=197.9
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
..+|++++.||+|+||.||++++ +++.||||++..... .......+.+|+.++++++|+||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46799999999999999999987 578899998864321 1122345668999999999999999999876421
Q ss_pred ----CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 ----e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
....++||||+ .++|.+.+... +++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELM-DANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEecc-CCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEc
Confidence 23579999999 46888887643 78999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC---
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--- 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~--- 1029 (1075)
|||+++............++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+......
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCCC--CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998654443334456889999999997654 789999999999999999999999866544333222210000
Q ss_pred -----------------C---------CC------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 -----------------P---------QI------------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 -----------------p---------~i------------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+ .+ ....+.+++++|.+||+.||++|||+.++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 11346678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.92 Aligned_cols=253 Identities=26% Similarity=0.320 Sum_probs=195.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~ 876 (1075)
++|++.+.||+|+||.||+|.+ +++.||||+++..... ......+.+|+.+++++. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4689999999999999999987 4778999988754211 112245678999999995 699999999887632
Q ss_pred C---CceEEEEeeecCCcHHHHHhhc----cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeE
Q 001449 877 D---GSLATVTEFMVNGSLKQFLQKK----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 877 e---~~L~LVmEYmeGGSL~d~Lkk~----~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
. ..+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. .++.+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~---~~~~~ 150 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK---QKGLL 150 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec---CCCeE
Confidence 1 237999999975 888887653 235899999999999999999999999999999999999982 26789
Q ss_pred EEeecCCccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC
Q 001449 950 KIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 950 KLiDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
||+|||++...... .......+++.|+|||++.+.. .++.++||||||+++|+|++|..||........+..+.....
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhCCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998743222 1122335688999999886533 378899999999999999999999987665544433322100
Q ss_pred C------------------C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 R------------------P--------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 ~------------------p--------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. + .....++.++.+||.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 001246888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.56 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=203.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..|++.+.||+|+||.||+++. .++.||+|++...... .......+.+|+.+++.++||||+++++++.. .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~ 87 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--E 87 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--C
Confidence 4588899999999999999987 4788999988643211 11223567889999999999999999999987 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+..++||||+. |+|.+++......+++..+..++.||+.||.|||+.||+||||+|+||+++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~~ 162 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSA 162 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCcc
Confidence 67899999995 678887766556789999999999999999999999999999999999998 6678999999998
Q ss_pred cccccccccCCCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
...... ....++..|+|||++.+ ....++.++||||||+++|+|++|+.||...+.......+.........+..+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (307)
T cd06607 163 SLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW 239 (307)
T ss_pred eecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence 754332 23468889999998853 12347889999999999999999999998877665544444333222233457
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+.+++++|.+||+.+|++||++.+++..
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 8899999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=334.91 Aligned_cols=243 Identities=27% Similarity=0.359 Sum_probs=192.3
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
...|.+.+.||+|+||.||++++. ++.||||.... ..+.+|+.+|++++|+|||++++++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~-- 231 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVV-- 231 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEE--
Confidence 457999999999999999999885 67799995321 234579999999999999999999877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+..++|||++ .++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ ..+.+||+|||+
T Consensus 232 ~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFGl 306 (461)
T PHA03211 232 GGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFGA 306 (461)
T ss_pred CCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccCC
Confidence 56789999999 5799998877666799999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc---ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHhhhhc
Q 001449 957 SKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH-------CASIIGGIVNN 1026 (1075)
Q Consensus 957 Ak~~~~~~---~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~-------~~eil~~Ilk~ 1026 (1075)
++...... ......||..|+|||++.+.. ++.++|||||||+||||++|..++.... ....+..++..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~ 384 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence 98543221 122456999999999997654 7899999999999999999876543211 11111111111
Q ss_pred -cC-------------------------CCCC--C-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1027 -TL-------------------------RPQI--P-----SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1027 -~l-------------------------~p~i--p-----s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.. .+.. + ..++.++++||.+||+.||.+|||+.|+|+.
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000 0 1245689999999999999999999999974
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.18 Aligned_cols=245 Identities=27% Similarity=0.426 Sum_probs=200.9
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||.|+||.||++++. ++.+|+|++..... ........+.+|+.++++++|+||+++++.+.. ...+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEe
Confidence 689999999999985 88899999875422 122345678899999999999999999998876 678999999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc-
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL- 964 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~- 964 (1075)
|+.+++|.+++.+.. .+++..++.++.||+.||.|||+++|+|+||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 999999999997654 689999999999999999999999999999999999998 66789999999987432221
Q ss_pred --------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 965 --------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 965 --------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+............+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 223455788999999987544 7889999999999999999999998887777666665533322222224
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+..+.++|.+||+.+|.+|||+..+.+.|+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 899999999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=351.59 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=205.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.++||+|+||.||+|++. ++.||||+++..... .+....++.+|+.++++++||||+++++++.+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-----~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-----NPLLKKRFLREAKIAADLIHPGIVPVYSICSD--G 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-----CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--C
Confidence 57999999999999999999874 788999998754221 22334668899999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhc----------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKK----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~----------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g 947 (1075)
+..++||||++|++|.+++... ...+++..++.++.||++||.|||++||+||||||+|||++ ..+
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 6889999999999999998642 12356677889999999999999999999999999999998 667
Q ss_pred eEEEeecCCccccccc-------------------cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCC
Q 001449 948 VCKIGDLGLSKVKQQT-------------------LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~~-------------------~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~ 1008 (1075)
.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCC
Confidence 8999999999754110 0112346999999999997655 789999999999999999999
Q ss_pred CCCCCCChHHHHHhhhh-ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHH
Q 001449 1009 EPYADMHCASIIGGIVN-NTLRPQIPSWCDPEWRSLMESCWASDPAERP-SFSEISRRLRSMAA 1070 (1075)
Q Consensus 1009 ~PF~~~~~~eil~~Ilk-~~l~p~ips~ls~eL~dLI~kCLq~DPeeRP-Sa~ELLq~Lesi~~ 1070 (1075)
.||.............. ..........++..+.+++.+||..||++|+ +++++++.|+.+.+
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99987554433222111 1111111235788999999999999999995 78889898888754
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.65 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=195.5
Q ss_pred EcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||+|+||+||++.+ +|+.||+|++...... .......+.+|+.+|++++||||+++++++.. .+.+++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEe
Confidence 68999999999976 4788999998754221 11123456789999999999999999999877 568999999
Q ss_pred eecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc
Q 001449 886 FMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~ 964 (1075)
|+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999999987654 3589999999999999999999999999999999999998 66789999999987544333
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc--cCCCCCCCCCCHHHHH
Q 001449 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSWCDPEWRS 1042 (1075)
Q Consensus 965 ~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~--~l~p~ips~ls~eL~d 1042 (1075)
......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+... ......+..+++.+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 334456888999999987654 788999999999999999999999765432111111111 1233455667999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q 001449 1043 LMESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1043 LI~kCLq~DPeeRP-----Sa~ELLq 1063 (1075)
+|.+||+.||.+|| ++.++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=302.93 Aligned_cols=246 Identities=27% Similarity=0.465 Sum_probs=204.3
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
-|++++.||+|+||.||++.+ .+..||||++.... .......+.+|+.++++++||||+++++.+.. ..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CC
Confidence 377888999999999999986 46789999876431 11223567889999999999999999999887 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++||||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 789999999999999998653 479999999999999999999999999999999999998 66789999999987
Q ss_pred ccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 959 ~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
..... .......++..|+|||.+.+.. .+.++|+|||||++|+|++|..||...........+.. ...+.++..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccC
Confidence 53322 1223456888999999987543 68899999999999999999999987766555444332 33445666789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++.++|.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=332.86 Aligned_cols=259 Identities=32% Similarity=0.656 Sum_probs=223.2
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
|++...++.+..+||.|.||.||.|.|+ ...||||.++.+.+ .+++|+.|..+|+.++|||+|+|+|+|
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---------eveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---------hHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 4555667888899999999999999996 56799999886532 368899999999999999999999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccc-cCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~-~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.. +-.+|||+|||..|+|.+||+++.+ .++....++++.||..|++||..+++|||||...|.|+. ++..||+
T Consensus 333 T~--EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----EnhiVKv 406 (1157)
T KOG4278|consen 333 TH--EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHIVKV 406 (1157)
T ss_pred cc--CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccceEEe
Confidence 88 6789999999999999999998764 367777889999999999999999999999999999998 7889999
Q ss_pred eecCCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccC
Q 001449 952 GDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 952 iDFGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
+|||++++....+ .........-|.|||-+.-. .++.|+|||+|||+||||.| |-.||.+.+...++. ++...+
T Consensus 407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-LLEkgy 483 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-LLEKGY 483 (1157)
T ss_pred eccchhhhhcCCceecccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-HHhccc
Confidence 9999999643322 22233345679999998633 37889999999999999998 999999988877654 566677
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
+..-|..|++..++|+++||+++|.+||++.||-+.|+.++..
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 8888999999999999999999999999999999999988653
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.57 Aligned_cols=247 Identities=30% Similarity=0.531 Sum_probs=207.7
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|++.+.||+|++|.||++++. +..||+|.+...... +.....+.+|++++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CC
Confidence 4788999999999999999874 678999998765321 2334678899999999999999999999877 57
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.++++|||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999999765 4689999999999999999999999999999999999998 56789999999998
Q ss_pred ccccccc-cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCC
Q 001449 959 VKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 959 ~~~~~~~-sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.............. .....++..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCC
Confidence 5433222 23456889999999987554 78899999999999999999999987665555544443 23345667789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+++++|.+||..+|++|||+.+++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=304.79 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=194.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP- 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~- 876 (1075)
++|++++.||+|+||.||+++.+ +..||||.+........ ....+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC------chhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 57999999999999999999874 78899998865422111 1133457999999999999999999876532
Q ss_pred -----CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 877 -----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 877 -----e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
....++||||+. ++|.+++.+....+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEEE
Confidence 235699999994 689888877666789999999999999999999999999999999999998 6779999
Q ss_pred eecCCccccccccc-----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh-
Q 001449 952 GDLGLSKVKQQTLV-----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN- 1025 (1075)
Q Consensus 952 iDFGLAk~~~~~~~-----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk- 1025 (1075)
+|||++........ .....++..|+|||.+.+.. .++.++||||||+++|+|++|..||...+.......+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER-DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc-ccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999874322211 12345788999999886543 267899999999999999999999977654332221111
Q ss_pred -ccCCC---------------CC-------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1026 -NTLRP---------------QI-------------PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1026 -~~l~p---------------~i-------------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
....+ .+ +...+..+++||.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 00 1123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=309.64 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=207.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..|+..+.||+|+||.||++++ .+..||+|++...... .......+.+|+.++++++|+||+++++++.. .
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 3477888999999999999987 4778999988754221 12234567889999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
...++||||+. |+|.+++......+++..+..++.||+.||.|||+++|+||||||+||+++ .++.+||+|||++
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~ 172 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSA 172 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCc
Confidence 67899999995 588888876666789999999999999999999999999999999999997 5678999999998
Q ss_pred cccccccccCCCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
...... ....++..|+|||++.. ....++.++|||||||++|+|++|..||...........+............+
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence 754332 23468899999999742 12337889999999999999999999998877666666655554433444567
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~Les 1067 (1075)
+..++++|.+||+.+|.+||++.++++.+..
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 8899999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.30 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=197.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++.+.||+|++|.||+++++ ++.||+|.+...... +.....+.+|+.++++++|+||+++++++.. .
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHS--E 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEec--C
Confidence 57999999999999999999874 778999988654221 1122456789999999999999999999987 5
Q ss_pred CceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++. .+..+||+|||+
T Consensus 74 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 74 KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 68999999995 68888776543 33688888999999999999999999999999999999972 345799999999
Q ss_pred ccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC------
Q 001449 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR------ 1029 (1075)
Q Consensus 957 Ak~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~------ 1029 (1075)
+...... .......+++.|+|||++.+.. .++.++||||||+++|+|++|..||......+.+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9753222 1223345788999999986532 3788999999999999999999999876655444433221000
Q ss_pred -------------CC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 -------------PQ--------IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 -------------p~--------ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+. ....++.++.++|.+||+.+|++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 112467889999999999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=328.23 Aligned_cols=245 Identities=27% Similarity=0.471 Sum_probs=215.1
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|.++.+||+|+||.||++.++ |.-+|||.+..+. .++++.+|+.||+++..|++|++||.|.. +..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sD 102 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSD 102 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----------hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCc
Confidence 667788999999999999774 8889999887542 25678899999999999999999998887 678
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++|||||-.|++.++++-+++++++.++..|++..++||+|||...-||||||..|||++ .++..||+|||+|..
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVAGQ 178 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhccccch
Confidence 9999999999999999999999999999999999999999999999999999999999998 778999999999986
Q ss_pred ccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCCCCCCCC
Q 001449 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQIPSWCD 1037 (1075)
Q Consensus 960 ~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ips~ls 1037 (1075)
..++. ......||+.|||||++.... |+.++||||||++..||..|++||.+.++...+..|-.... ....|..++
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhh
Confidence 55443 345678999999999998655 89999999999999999999999999998887776655432 123456678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.++.+||++||.++|++|.|+.+|++.
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999999998875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=302.61 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=197.2
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|++++.||.|++|.||+|++ +|+.||+|++....... .....+.+|+.++++++||||+++++++.+ .+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE------GVPSTAIREISLLKELNHPNIVRLLDVVHS--ENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc------cchhHHHHHHHHHHhcCCCCccCHhheecc--CCe
Confidence 56788999999999999987 48889999987543211 112456689999999999999999999887 578
Q ss_pred eEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|||+ +++|.+++.... ..+++..++.++.||++||.|||+++++||||+|+||+++ .++.++|+|||++.
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 99999999 568999987654 3589999999999999999999999999999999999998 57789999999987
Q ss_pred cccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc----------
Q 001449 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT---------- 1027 (1075)
Q Consensus 959 ~~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~---------- 1027 (1075)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||........+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 532221 122335688999999886533 36889999999999999999999997765544333322210
Q ss_pred -----------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -----------------LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -----------------l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
........++.++.++|.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001112356789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=299.54 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=200.7
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|++.+.||.|+||.||+|++. ++.+|+|+++... . .......+.+|+.++++++|+||+++++++.....+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--E----KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--c----cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999885 6889999998653 1 1112245778999999999999999999988743378
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++|+||+. ++|.+++......+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 999999996 599999877656789999999999999999999999999999999999998 678999999999885
Q ss_pred ccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC--------
Q 001449 960 KQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR-------- 1029 (1075)
Q Consensus 960 ~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~-------- 1029 (1075)
..... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||...+....+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccc-cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 44332 122345688999999876533 3788999999999999999999999877665544433321100
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 ---------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 ---------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+...++.++.++|++||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011123788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=337.93 Aligned_cols=251 Identities=26% Similarity=0.472 Sum_probs=222.8
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
....|.++..||+|.|++|.++++ ++..||||++.+..... ..++.+.+|+++|+.++|||||+++.+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~------~~~~k~~rev~imk~l~HPnIvkl~~v~~t- 126 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP------SKRQKLGREVDIMKSLNHPNIVKLFSVIET- 126 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh------HHHHHHHHHHHHHHhcCCcceeeeeeeeee-
Confidence 346699999999999999999987 58899999998765432 223447799999999999999999999887
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+|+||||+.+|.+++++.+.++ +.+..+..++.|+++|++|||+++|+|||||.+|||++ .+..+||+|||
T Consensus 127 -~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDfg 200 (596)
T KOG0586|consen 127 -EATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADFG 200 (596)
T ss_pred -cceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeeccc
Confidence 6789999999999999999998876 45588888999999999999999999999999999998 77889999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ 1035 (1075)
++..........+++|++.|.|||++.+.. +...++|+||+|++||-|+.|.+||.+.+..+.....+...+ .++..
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--rIp~~ 277 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--RIPFY 277 (596)
T ss_pred cceeecccccccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--cccce
Confidence 999888887888999999999999999877 578899999999999999999999998887777666666555 46778
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++.++.++|+++|.++|.+|++.++|...
T Consensus 278 ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 278 MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 89999999999999999999999998765
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.87 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=202.1
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~ 871 (1075)
..+..++|++.+.||+|+||.||+++++ ++.||||.++..... .....+.+|+.++.++. |+||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-------HHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 3455678999999999999999999986 888999998754211 11244556777666665 9999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCCCCeEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
+.+ ...+++||||+ +++|.+++......+++..+..++.||+.||.|||+ .||+||||||+||+++ .++.+|
T Consensus 83 ~~~--~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~k 155 (296)
T cd06618 83 FIT--DSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVK 155 (296)
T ss_pred eec--CCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEE
Confidence 987 56799999998 568888887766678999999999999999999997 5999999999999998 667899
Q ss_pred EeecCCccccccccccCCCCCCCCccCcccccCCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhhhhcc
Q 001449 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS--HMVTEKIDVYSFGIVMWELLTGDEPYADMHC-ASIIGGIVNNT 1027 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~--~~yS~KsDIWSLGVILyELLTG~~PF~~~~~-~eil~~Ilk~~ 1027 (1075)
|+|||++.............++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||..... .+.+..+....
T Consensus 156 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06618 156 LCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235 (296)
T ss_pred ECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC
Confidence 99999987544333333345788999999987543 3468899999999999999999999976432 23333333332
Q ss_pred CCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1028 LRPQIP--SWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1028 l~p~ip--s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
. ...+ ..++.++.+||.+||+.||.+||++.++++.-
T Consensus 236 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 P-PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1 1222 24688999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.92 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=194.3
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~ 876 (1075)
++|+.++.||+|+||.||++++. ++.||+|.+...... .....+.+|+.++.++. |+||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-- 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-- 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--
Confidence 45667788999999999999884 788999998754211 22356778999999996 9999999998876
Q ss_pred CCceEEEEeeecCCcHHHHHh---h-ccccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeEEE
Q 001449 877 DGSLATVTEFMVNGSLKQFLQ---K-KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lk---k-~~~~Lse~~~l~Ia~QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.+..+++|||+. ++|.++.. . ....+++..+..++.|++.||.|||+. +|+||||||+|||++ ..+.+||
T Consensus 75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 149 (288)
T cd06616 75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKL 149 (288)
T ss_pred CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEE
Confidence 567889999984 45554432 2 235689999999999999999999975 999999999999998 6678999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHhhhhccC-
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHC-ASIIGGIVNNTL- 1028 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~-~~yS~KsDIWSLGVILyELLTG~~PF~~~~~-~eil~~Ilk~~l- 1028 (1075)
+|||++.............|+..|+|||++.+.. ..++.++|||||||++|+|++|+.||..... ...+..+.....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 9999987544333333456889999999987542 2478899999999999999999999976542 122222222111
Q ss_pred --CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 --RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 --~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.......++.++.+||.+||+.+|++|||+.+|+..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223478899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.86 Aligned_cols=244 Identities=23% Similarity=0.444 Sum_probs=198.6
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|.....||+|+||.||++.. ++..||||.+.... ......+.+|+.++++++|+||+++++.+.. .+.
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 93 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDE 93 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCe
Confidence 44456799999999999987 47789999876431 1223557789999999999999999999887 568
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.++||||+.+++|.+++... .+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchhh
Confidence 89999999999999988543 478999999999999999999999999999999999998 567899999999874
Q ss_pred cccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC--CCCCC
Q 001449 960 KQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ--IPSWC 1036 (1075)
Q Consensus 960 ~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~--ips~l 1036 (1075)
.... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||........+..+... .... ....+
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHKV 244 (292)
T ss_pred cccccccCceeecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCcccccccc
Confidence 3222 1223356899999999987544 788999999999999999999999877665554443322 2222 22356
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+..++++|.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 8899999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=303.90 Aligned_cols=248 Identities=28% Similarity=0.513 Sum_probs=205.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
+.|++...||+|++|.||+++++ +..||+|+++.... ....+.+|+.++++++|+||+++++.+.. .
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 87 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLV--G 87 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--C
Confidence 45888889999999999999885 78899999875421 23567789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
...++|+||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~~~ 163 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGFA 163 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccchh
Confidence 789999999999999999987655789999999999999999999999999999999999998 6678999999987
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC-CCCCC
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP-QIPSW 1035 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p-~ips~ 1035 (1075)
...... .......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+....... ..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhh
Confidence 743222 1223345788999999987544 7899999999999999999999998877665544444332221 12233
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++.+++++|.+||+.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 78899999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.59 Aligned_cols=244 Identities=23% Similarity=0.451 Sum_probs=200.4
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|...+.||+|++|.||++.. .++.+|+|+++.... .....+.+|+.+++.++||||+++++++.. .+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--------hHHHHHHHHHHHHHHcCCCChheEEEEEEc--CC
Confidence 466678999999999999986 467899998764211 112456789999999999999999999877 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
..++++||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 78999999999999999876 3589999999999999999999999999999999999998 66799999999887
Q ss_pred ccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC--CCC
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI--PSW 1035 (1075)
Q Consensus 959 ~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i--ps~ 1035 (1075)
..... .......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+....+..+.... .+.. +..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHK 240 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCccccc
Confidence 43222 1223356899999999987644 7889999999999999999999998777665555444332 1222 233
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++..+.++|.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 7889999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=298.12 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=193.6
Q ss_pred EEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHH-HHhCCCCceeeeecccccCCCCceEE
Q 001449 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALL-LSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~I-LkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
+.||+|+||.||+|++ .++.||+|++.+..... ......+..|..+ .....|+||+++++++.. .+.+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-----KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-----HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEE
Confidence 4689999999999987 47889999987542211 1112333445444 445589999999999887 568999
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
|+||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++.....
T Consensus 75 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 999999999999997653 589999999999999999999999999999999999998 667899999999885432
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC--CCCCCCCCCHHH
Q 001449 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL--RPQIPSWCDPEW 1040 (1075)
Q Consensus 963 ~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l--~p~ips~ls~eL 1040 (1075)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+..... .......++.++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 23346888999999987654 78999999999999999999999988777666555544332 223344678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1041 RSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1041 ~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
.++|.+||+.+|++||++..+.+.|
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHH
Confidence 9999999999999999765444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=275.91 Aligned_cols=95 Identities=65% Similarity=1.140 Sum_probs=92.0
Q ss_pred EeecCCeeecCCCCCCeeeecCceeEEEccCCCChHHHHHHHHHHhCCc--eEEEeeCCCCCCCceeeccChhhHHHHHH
Q 001449 27 LCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPDEDLDALVSVVNDDDVINMME 104 (1075)
Q Consensus 27 mcsygG~i~pr~~d~~l~Y~gg~tri~~v~r~~~~~~l~~kl~~~~~~~--~~~kyqlp~edld~Lisv~~dedl~~m~~ 104 (1075)
||||||||+||++||+|+|+||+|||++|+|++||+||++||+++++.. ++||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 8999999999999999999999999999999999999999999999877 49999999999999999999999999999
Q ss_pred HHhhcCCCCCCccEEEEEe
Q 001449 105 EYEKLGSGDGFTRLRIFLF 123 (1075)
Q Consensus 105 eydr~~~~~~~~r~r~flf 123 (1075)
||||+ +.+++|+|||||
T Consensus 81 e~~~~--~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL--SGGSARLRVFLF 97 (97)
T ss_pred hhccc--cCCCceEEEEEC
Confidence 99998 667899999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.18 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=199.1
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||+|+||.||+|+++ ++.||+|+++...... .....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------GFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc------CchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 467999999999999999999884 7889999987542211 11234568999999999999999999887632
Q ss_pred --------CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCe
Q 001449 877 --------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1075)
Q Consensus 877 --------e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~ 948 (1075)
.+.+++|+||+.+ +|..++.+....+++..++.|+.||+.||.|||+.||+||||||+||+++ .++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCc
Confidence 3478999999965 77777776655689999999999999999999999999999999999998 6789
Q ss_pred EEEeecCCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc
Q 001449 949 CKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 949 VKLiDFGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~ 1026 (1075)
+||+|||++....... ......++..|+|||.+.+.. .++.++|||||||++|+|++|+.||........+..+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999999988543322 112234678899999886432 3688999999999999999999999876554443333221
Q ss_pred ---cCCC-------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1027 ---TLRP-------------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1027 ---~l~p-------------------------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.... .....++..+.++|..||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 011236889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.00 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=189.5
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHH---HHHHhCCCCceeeeecccccCCCCceE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEA---LLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi---~ILkkL~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.||+|+||.||++++ +++.+|+|.+.......... + ..+.+|. .++....||||+.+++++.. .+.++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--E---TLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--H---HHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEE
Confidence 389999999999987 47889999987653322211 1 1222333 33444579999999999887 56789
Q ss_pred EEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
+||||+.+++|.+++.... .+++..+..|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 9999999999999987654 589999999999999999999999999999999999998 66789999999987543
Q ss_pred cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH--HHHhhhhccCCCCCCCCCCHH
Q 001449 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS--IIGGIVNNTLRPQIPSWCDPE 1039 (1075)
Q Consensus 962 ~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e--il~~Ilk~~l~p~ips~ls~e 1039 (1075)
... .....||..|+|||.+.+. ..++.++|||||||++|+|++|..||....... .+... .......++..++.+
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHH
Confidence 222 2334689999999998632 237889999999999999999999997543221 11111 122334566678999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1040 WRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1040 L~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
++++|.+||+.||.+|+ +++++++.
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999999999999999 69988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=336.66 Aligned_cols=248 Identities=29% Similarity=0.485 Sum_probs=210.0
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|.-++.||.|+||.||-|++ +.+.||||++.- .++.. .....++++|+..|++++|||+|.+-|+|.. +..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy---SGKQs--~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQS--NEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHT 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccc---ccccc--HHHHHHHHHHHHHHHhccCCCcccccceeec--cch
Confidence 56677899999999999987 466799998863 34432 2345788999999999999999999999987 567
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.|+||||| -|+-.|++.-..+++-+..+..|+.+.+.||.|||+.+.||||||..|||++ +.+.|||+|||.|..
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchhh
Confidence 89999999 5687888776667799999999999999999999999999999999999998 889999999999886
Q ss_pred cccccccCCCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCH
Q 001449 960 KQQTLVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038 (1075)
Q Consensus 960 ~~~~~~sss~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~ 1038 (1075)
..+. .+++|||.|||||+|.. ....|+-|+||||||++++||...++|+..++....+.-|..+..+.-....++.
T Consensus 176 ~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 176 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred cCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 5443 56889999999999853 1234899999999999999999999999999988887776665544333456789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1039 EWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1039 eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.|++||..||++-|.+|||..+++..
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 99999999999999999999887753
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=305.16 Aligned_cols=259 Identities=18% Similarity=0.190 Sum_probs=186.4
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcCc-----ceEEEEeeccccCCCchhHHHH------HHHHHHHHHHHHhCCCCc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERL------IADFWKEALLLSSLHHPN 864 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kGt-----~VAVKvIkk~~~~~k~~ere~~------i~~flrEi~ILkkL~HPN 864 (1075)
.+...+|++.+.||+|+||.||+|++.+. .+|+|+..... .....+.. ......+...+..+.|+|
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34557899999999999999999987543 46666543221 11111111 112234445567778999
Q ss_pred eeeeecccccCCCC--ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccC
Q 001449 865 VVSFYGIVRDGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1075)
Q Consensus 865 IVkL~g~~~d~~e~--~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~ 942 (1075)
|+.+++........ ..+++++++ ..++.+.+... ...++..++.|+.||+.||.|||+++|+||||||+|||++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-- 160 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-- 160 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--
Confidence 99999876542221 236677776 44676666543 2357888899999999999999999999999999999997
Q ss_pred CCCCCeEEEeecCCccccccc--------cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 001449 943 DPQRPVCKIGDLGLSKVKQQT--------LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM 1014 (1075)
Q Consensus 943 d~~~g~VKLiDFGLAk~~~~~--------~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~ 1014 (1075)
..+.+||+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 161 --~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 161 --GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred --CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 5678999999999753211 1112346999999999997655 799999999999999999999999876
Q ss_pred Ch-HHHHHh----hhhccCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1015 HC-ASIIGG----IVNNTLRP-QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1015 ~~-~eil~~----Ilk~~l~p-~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
.. ...+.. ........ .....++.++.++++.||..+|++||++.+|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 32 221111 11111111 12345688999999999999999999999999876
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.12 Aligned_cols=246 Identities=22% Similarity=0.396 Sum_probs=200.5
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
.|+....||+|+||.||+++. .++.||+|++..... .....+.+|+.+++.+.||||+++++.+.. .+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~ 91 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GE 91 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheee--CC
Confidence 345556799999999999987 488899999864311 112456789999999999999999999887 57
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~ 165 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCA 165 (297)
T ss_pred eEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHh
Confidence 89999999999999998765 3479999999999999999999999999999999999998 67899999999987
Q ss_pred ccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCCCCCCC
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQIPSWC 1036 (1075)
Q Consensus 959 ~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ips~l 1036 (1075)
..... .......++..|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+..... .......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06659 166 QISKDVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243 (297)
T ss_pred hcccccccccceecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence 43222 2223456899999999997654 78899999999999999999999987666555544332211 12223457
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+..+.++|.+||+.+|.+||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 8899999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.62 Aligned_cols=248 Identities=28% Similarity=0.471 Sum_probs=206.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~ 876 (1075)
++|.+.+.||.|+||.||+++. ++..||+|++.+.... .+.....+.+|+.+++++. |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-- 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-- 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--
Confidence 4689999999999999999987 4788999998764322 1222356778999999999 9999999999877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+.+++||||+.+++|.+++.+.. .+++..++.|+.||+.||.|||+.|++|+||||+||+++ .++.++|+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~ 148 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGT 148 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCcc
Confidence 568999999999999999997654 589999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc---------------------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 001449 957 SKVKQQTL---------------------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015 (1075)
Q Consensus 957 Ak~~~~~~---------------------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~ 1015 (1075)
+....... ......++..|+|||++.+.. ++.++||||||+++++|++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 87432211 122345788999999987544 7889999999999999999999998876
Q ss_pred hHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 001449 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSF----SEISR 1063 (1075)
Q Consensus 1016 ~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa----~ELLq 1063 (1075)
....+..+.. ....++..++..+.+||.+||+.+|.+||++ .++++
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 227 EYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 5555554442 2334666779999999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.18 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=196.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||+|+||.||+|+++ ++.+|||++......... ...+.+|+.++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF------PITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc------chhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 478999999999999999999874 778999998754322111 124567999999999999999999876532
Q ss_pred ------CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 877 ------e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
...+++||||+. ++|...+......+++..++.++.||++||.|||++||+|+||||+|||++ .++.+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEE
Confidence 235799999995 578777766666799999999999999999999999999999999999998 678999
Q ss_pred EeecCCccccccccc------------cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001449 951 IGDLGLSKVKQQTLV------------SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS 1018 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~------------sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e 1018 (1075)
|+|||++........ .....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC-ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999874322111 12235688899999886532 37889999999999999999999998766554
Q ss_pred HHHhhhhccC---------------------CCCC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1019 IIGGIVNNTL---------------------RPQI-------PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1019 il~~Ilk~~l---------------------~p~i-------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
....+..... .... ...++.++.++|.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 4333221100 0000 0124467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=338.01 Aligned_cols=249 Identities=31% Similarity=0.523 Sum_probs=211.5
Q ss_pred eEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
+...+||+|+|-+||+|-+. |..||=-.++...+. .....+++|..|+.+|+.|+|||||++|+.+.+..+..+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~----q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT----QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhh----cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 34567999999999999874 555653333322222 223445788999999999999999999999998777789
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~--GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+|+|.+..|+|+.|+++.+ .++.+.++.|++||++||.|||++ .|||||||.+||+|+ +..|.|||+|+|+|+
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecchhHHH
Confidence 99999999999999998765 489999999999999999999998 599999999999998 577899999999999
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHhhhhccCCCCCCCCCC
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~-~~~eil~~Ilk~~l~p~ips~ls 1037 (1075)
......... .+|||.|||||++.. .|+..+||||||++++||+|+..||..- +...+++++..+..+..+.+.-+
T Consensus 195 l~r~s~aks-vIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 195 LLRKSHAKS-VIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred Hhhccccce-eccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 877665544 789999999999963 3899999999999999999999999764 56667777777777777777779
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1038 ~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+++++||.+||.. ..+|+|+.|||..
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 9999999999999 9999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.67 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=199.8
Q ss_pred CeeEEEEEcccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeeccccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~-----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d 874 (1075)
+|++.+.||+|+||.||+++. +|..||+|+++...... .....+.+.+|+.+|+++ +|+||+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999976 57889999987542211 112234567899999999 58999999998877
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 --DTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 567899999999999999997653 578999999999999999999999999999999999998 6678999999
Q ss_pred CCccccccc--cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhhhhccC
Q 001449 955 GLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC----ASIIGGIVNNTL 1028 (1075)
Q Consensus 955 GLAk~~~~~--~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~----~eil~~Ilk~~l 1028 (1075)
|++...... .......|+..|+|||.+.+....++.++||||||+++|+|++|..||..... ......+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 998754322 12224568999999999875444468899999999999999999999964322 2222222221
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
.+.++..++..+.++|.+||+.||++|+ ++.+++..
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2345667889999999999999999997 77777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.54 Aligned_cols=247 Identities=25% Similarity=0.425 Sum_probs=200.8
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|++++.||+|+||.||++.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. .
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~ 88 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKHPNIVNYLDSYLV--G 88 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--------hHHHHHHHHHHHHhhcCCCCeeehhheeee--C
Confidence 6799999999999999999976 477899998764311 112557789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
+..++|+||+.+++|.+++.+. .+++..+..++.||+.||.|||++|++||||||+||+++ ..+.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~~ 162 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcce
Confidence 6789999999999999998754 478899999999999999999999999999999999998 5678999999988
Q ss_pred cccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-CCCCCCC
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQIPSW 1035 (1075)
Q Consensus 958 k~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ips~ 1035 (1075)
...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........+..+..... ....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 743322 2223446888999999987543 78899999999999999999999987655443332222211 1122345
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1036 ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
++..++++|.+||..+|++||++.+++..
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67889999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.94 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=200.5
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|++.+.||.|++|.||+++. +++.+|+|.++...... .....+.+|+.+|++++|+||+++++++.. ...
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------GIPKTALREIKLLKELNHPNIIKLLDVFRH--KGD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCC
Confidence 56778999999999999987 47889999887543211 223567789999999999999999999887 578
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++|+||+. ++|.+++......+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 999999996 589988887666789999999999999999999999999999999999998 667899999999875
Q ss_pred ccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC---------
Q 001449 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--------- 1029 (1075)
Q Consensus 960 ~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~--------- 1029 (1075)
..... ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...+..+.+..+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 44332 22334578899999998754 24789999999999999999999999877665544333221000
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 -------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 -------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
......++.++.++|.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0111246789999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.68 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=201.6
Q ss_pred CeeEEEEEcccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeeccccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~-----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d 874 (1075)
+|++.+.||+|+||.||+++. +++.||||++++.... ........+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999875 3577999998754221 1223345677899999999 59999999998876
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...+++||||+.+++|.+++... ..+++..++.++.|+++||.|||+.+++||||||+||+++ .++.++|+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 --DTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred --CCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 56789999999999999998754 3588999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhhhhccC
Q 001449 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC----ASIIGGIVNNTL 1028 (1075)
Q Consensus 955 GLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~----~eil~~Ilk~~l 1028 (1075)
|++....... ......|+..|+|||.+.+.....+.++||||||+++|+|++|..||..... .+....+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence 9987532221 1223468899999999876544468899999999999999999999964321 2222222222
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
....+..++.+++++|.+||+.||++|||+.++.+.|+
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 23456678899999999999999999999877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.66 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=194.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP- 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~- 876 (1075)
++|++.+.||+|+||.||+|++ +|+.||||+++... .......+.+|+.++++++|+||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 6799999999999999999987 47889999986321 1122355678999999999999999998866422
Q ss_pred --CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 877 --DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 877 --e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...+++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~df 150 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDF 150 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECcc
Confidence 235799999995 588888754 3589999999999999999999999999999999999998 6788999999
Q ss_pred CCcccccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh-----
Q 001449 955 GLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN----- 1025 (1075)
Q Consensus 955 GLAk~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk----- 1025 (1075)
|++....... ......||..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9987543221 11234689999999987543 2378899999999999999999999976543322211110
Q ss_pred ----------cc---------CCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 ----------NT---------LRPQ-----IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 ----------~~---------l~p~-----ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.. .... .....+.++.++|.+||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000 112357789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=293.65 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=200.5
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|.+.+.||+|+||.||++++. +..+++|+++........ ......+..|+.++++++||||+++++++.+ ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLE--RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CC
Confidence 4788999999999999999875 345677766543221111 1112345678999999999999999999887 56
Q ss_pred ceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 879 SLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++ .+.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-----~~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-----cCCEeecccC
Confidence 78999999999999998864 335689999999999999999999999999999999999996 2459999999
Q ss_pred Cccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips 1034 (1075)
+++..... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+... ..+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCCcc
Confidence 98754322 2233456889999999986544 688999999999999999999999876665555554433 3345566
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.++.++.++|.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 78899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.69 Aligned_cols=256 Identities=27% Similarity=0.331 Sum_probs=200.3
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP- 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~- 876 (1075)
.+|++++.||+|+||.||++++ ++..||||.++...... .....+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR------IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 5799999999999999999987 47889999987542111 11245568999999999999999999876532
Q ss_pred --CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 877 --DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 877 --e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...+++|+||+ +++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELM-DTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCC-CCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECcC
Confidence 13589999999 57899888755 4589999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh--------
Q 001449 955 GLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN-------- 1025 (1075)
Q Consensus 955 GLAk~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk-------- 1025 (1075)
|++...... .......++..|+|||.+.+.. .++.++|||||||++|+|++|+.||...+.......+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999854332 2223456889999999886432 278899999999999999999999976543322211110
Q ss_pred ---------------ccC---C---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 001449 1026 ---------------NTL---R---PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR--LRSM 1068 (1075)
Q Consensus 1026 ---------------~~l---~---p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~--Lesi 1068 (1075)
... . ......++.++.+||++||+.+|++|||+.++++. |+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 0 01123578899999999999999999999999976 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=303.19 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=202.5
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|..++.||+|+||.||+|++ .+..||+|++...... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCE
Confidence 66678899999999999987 4788999998754221 11234567789999999999999999999887 567
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.++||||+ .++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~-~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecC-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 89999999 4688888877666789999999999999999999999999999999999997 667899999999874
Q ss_pred cccccccCCCCCCCCccCcccccC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCH
Q 001449 960 KQQTLVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038 (1075)
Q Consensus 960 ~~~~~~sss~~GT~~YmAPEvl~g-~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~ 1038 (1075)
... .....|+..|+|||++.. ....++.++|||||||++|+|++|..||...+.......+............++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 322 234568899999999853 1233788999999999999999999999877665555554443333333345678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1039 EWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1039 eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+++||.+||+.+|.+||++.+++..
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=302.76 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=209.3
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
.-.++.++|++.++||+|+|+.||+++. ++..+|+|++.... .+.++..++|++..++++|||+++++++
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence 3456788999999999999999999885 67889999998652 1224667799999999999999999988
Q ss_pred cccC---CCCceEEEEeeecCCcHHHHHhhc---cccCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceEeccCC
Q 001449 872 VRDG---PDGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 872 ~~d~---~e~~L~LVmEYmeGGSL~d~Lkk~---~~~Lse~~~l~Ia~QIL~AL~yLHs~G--IIHRDIKPeNILId~~d 943 (1075)
...+ .....|++++|...|+|.+.+... +..+++.+++.|+.+|++||++||+.. ++||||||.|||++
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls--- 163 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS--- 163 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---
Confidence 6542 133589999999999999998753 446999999999999999999999998 99999999999998
Q ss_pred CCCCeEEEeecCCcccccccc----------ccCCCCCCCCccCcccccCCC-CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 001449 944 PQRPVCKIGDLGLSKVKQQTL----------VSGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYA 1012 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~~~~----------~sss~~GT~~YmAPEvl~g~~-~~yS~KsDIWSLGVILyELLTG~~PF~ 1012 (1075)
+.+..+|.|||.++...-.. .......|..|+|||++.-+. ...+.++|||||||+||.|+.|..||.
T Consensus 164 -~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 164 -DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred -CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 57899999999887321110 111234688999999996433 246889999999999999999999996
Q ss_pred CCChH--HHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1013 DMHCA--SIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1013 ~~~~~--eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
..-.. .+...+.+..+.......+++.+.+||+.||+.||.+||++.+++..+.++.
T Consensus 243 ~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 243 RIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 42211 1112222323322233458999999999999999999999999999998764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.74 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=190.6
Q ss_pred EEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.||+|+||.||++++ +++.||+|.+.+........ +.........+.+++...||+|+.+++++.. ...+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh--HHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEE
Confidence 389999999999976 47789999987653322111 1111111223445556689999999999887 56899999
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~ 964 (1075)
||+.+++|.+++.+. ..+++..++.|+.|+++||.|||+.+|+||||||+||+++ .++.+||+|||++......
T Consensus 77 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCcc-
Confidence 999999999988754 4589999999999999999999999999999999999998 5678999999998744322
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHhhhhccCCCCCCCCCCHHHH
Q 001449 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC---ASIIGGIVNNTLRPQIPSWCDPEWR 1041 (1075)
Q Consensus 965 ~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~---~eil~~Ilk~~l~p~ips~ls~eL~ 1041 (1075)
......|+..|+|||++.+.. .++.++||||||+++|+|++|+.||..... ......+ ......++..++.++.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELR 227 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHH
Confidence 223456899999999986432 378899999999999999999999976532 2221111 1223456666799999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHH
Q 001449 1042 SLMESCWASDPAERP-----SFSEISRR 1064 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRP-----Sa~ELLq~ 1064 (1075)
++|.+||..+|.+|+ ++.++++.
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 999999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=328.51 Aligned_cols=252 Identities=31% Similarity=0.610 Sum_probs=215.1
Q ss_pred eeEEEEEcccCcEEEEEEEEc----Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 802 LEEVRELGSGTYGSVYHGKWR----GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k----Gt--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
.+..+.||+|-||.||+|.+. |. .||||.-+.++..++ .+.|+.|..+|+.+.|||||+++|++.+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 344467999999999999873 33 389998887643322 3668899999999999999999999986
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+||||.+..|.|..|++.+...++......++.||+.||.|||++..|||||..+|||+. ....|||+|||
T Consensus 463 --~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVKLaDFG 536 (974)
T KOG4257|consen 463 --QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVKLADFG 536 (974)
T ss_pred --cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceeeecccc
Confidence 468999999999999999999988899999999999999999999999999999999999998 66799999999
Q ss_pred CccccccccccCC--CCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 956 LSKVKQQTLVSGG--VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 956 LAk~~~~~~~sss--~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
+++...+...... ..-..-|||||.++-+. ++.++|||.|||++||++. |..||......+++..+-+ ..+...
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRr--FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-GeRlP~ 613 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRR--FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-GERLPC 613 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhc--ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-CCCCCC
Confidence 9996544433222 22344699999997544 8999999999999999886 9999999888777665544 456778
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
|..|++.++.|+.+||..+|.+||.+.+|...|.++..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999876
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.04 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=197.1
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCC
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~ 878 (1075)
|++.+.||.|++|.||+|+.. +..||||++...... .. .....+|+..+++++ |+||+++++++.+ .+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WE---ECMNLREVKSLRKLNEHPNIVKLKEVFRE--ND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hh---HHHHHHHHHHHHhccCCCCchhHHHHhhc--CC
Confidence 577889999999999999984 677999998754221 01 123446889999999 9999999999987 67
Q ss_pred ceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
..++||||+ +++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||||+||+++ ..+.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 889999887654 4689999999999999999999999999999999999998 6789999999999
Q ss_pred cccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc----------
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT---------- 1027 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~---------- 1027 (1075)
.............++..|+|||++.+.. .++.++||||||+++++|++|+.||......+.+..+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecCc-CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 8654443334456889999999886433 37889999999999999999999997665544333222100
Q ss_pred -------CCC-----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -------LRP-----------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -------l~p-----------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
... ......+.++.++|++||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 001123678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.80 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=193.4
Q ss_pred EEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEE
Q 001449 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 804 il~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
+.+.+|.|+++.|++++.+++.||||+++.... .......+.+|+.++++++|+||+++++++.. .+.++++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~ 77 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVV 77 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEE
Confidence 344566667777777777899999999875421 11234668899999999999999999999887 5678999
Q ss_pred EeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 884 TEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
|||+.+++|.+++.+. ...+++..+..++.||++||.|||+++|+||||||+|||++ .++.+||+|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceeecc
Confidence 9999999999999764 34588999999999999999999999999999999999998 667899999998863321
Q ss_pred cc--------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC-----
Q 001449 963 TL--------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR----- 1029 (1075)
Q Consensus 963 ~~--------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~----- 1029 (1075)
.. ......++..|+|||++.+....++.++|||||||++|+|++|..||........+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 11 11234577889999999765445788999999999999999999999876544332222111100
Q ss_pred ---------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1030 ---------------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 ---------------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
......++.++.+||.+||+.||++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00111234678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.58 Aligned_cols=249 Identities=26% Similarity=0.336 Sum_probs=194.6
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC---CCCceeeeecccccCC
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL---~HPNIVkL~g~~~d~~ 876 (1075)
|++.+.||+|+||.||+++++ ++.||+|+++..... . .....+.+|+.+++++ .|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~----~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--E----GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--c----hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999984 788999999754321 1 1113344666666555 6999999999988632
Q ss_pred C---CceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 D---GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 e---~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
. ..++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 1 23899999995 58998887643 3589999999999999999999999999999999999998 56899999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC---
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--- 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~--- 1029 (1075)
|||++.............++..|+|||++.+.. ++.++|||||||++|+|++|.+||......+.+..+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 999988654443334455788999999997654 788999999999999999999999877665554444321100
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 ----------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 ----------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
......++..+.++|.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0001134577889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.71 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=198.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC--
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG-- 875 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~-- 875 (1075)
++|++.+.||+|+||.||+++. ++..||+|++...... ......+.+|+.+|++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6799999999999999999986 4888999998754211 11235566899999999999999999987642
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
....+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLM-ESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehh-hhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 235689999999 468999886553 489999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc-----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc----
Q 001449 956 LSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---- 1026 (1075)
Q Consensus 956 LAk~~~~~~-----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~---- 1026 (1075)
++....... ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCc-ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987533221 112346889999999986532 3788999999999999999999999776544332221110
Q ss_pred --------------------cCCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1027 --------------------TLRPQ-----IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1027 --------------------~l~p~-----ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..... +....+.+++++|.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001 113468899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.39 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=203.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
..|+..+.||+|+||.||+|++ ++..+|+|.+...... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 87 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 87 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--C
Confidence 3477778899999999999987 4677999988643211 11223567789999999999999999999887 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
...++||||+. ++|.+++......+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~ 162 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 162 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccc
Confidence 67899999995 688888766666689999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccccCCCCCCCCccCcccccCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCC
Q 001449 958 KVKQQTLVSGGVRGTLPWMAPELLSGK-SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036 (1075)
Q Consensus 958 k~~~~~~~sss~~GT~~YmAPEvl~g~-~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~l 1036 (1075)
...... ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...........+............+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccc
Confidence 754332 234688999999997531 2236889999999999999999999998776655554444443333334467
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1037 DPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1037 s~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+..+++||.+||+.+|.+||++.+++....
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 889999999999999999999999887543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.00 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=198.2
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~~ 876 (1075)
++|++.+.||+|+||.||+|.+ .++.+|+|++...... ......+.+|+.+++++ +||||+++++++....
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc------chhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 5788889999999999999987 4778999988643211 11124566899999999 9999999999987644
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...+++||||+. ++|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g~ 153 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFGL 153 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccc
Confidence 557899999996 6999988765 578999999999999999999999999999999999998 778999999999
Q ss_pred cccccccc------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc---
Q 001449 957 SKVKQQTL------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT--- 1027 (1075)
Q Consensus 957 Ak~~~~~~------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~--- 1027 (1075)
+....... ......||..|+|||.+.+.. .++.++||||||+++|+|++|+.||...........+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccc-cccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 88432221 223356899999999886532 36889999999999999999999997655443322221110
Q ss_pred --------------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1028 --------------------------LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1028 --------------------------l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
........++.++.++|.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0011122368899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.10 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=191.0
Q ss_pred EEccc--CcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 807 ELGSG--TYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeG--~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
.||.| +|++||++++ .|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~ 76 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWV 76 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEE
Confidence 46666 9999999988 588999999875421 11224677889999999999999999999987 567899
Q ss_pred EEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 883 VTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
|+||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++||+.+....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhhh
Confidence 999999999999987643 3489999999999999999999999999999999999998 66789999998643211
Q ss_pred cccc--------cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-----
Q 001449 962 QTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL----- 1028 (1075)
Q Consensus 962 ~~~~--------sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l----- 1028 (1075)
.... .....++..|+|||++.+....++.++|||||||++|+|++|..||.................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 1100 011234667999999976544578999999999999999999999987655443322221100
Q ss_pred ----------------------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 ----------------------------------------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ----------------------------------------~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.......++..+++||.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011122356789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.37 Aligned_cols=251 Identities=24% Similarity=0.441 Sum_probs=209.6
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~ 875 (1075)
.++++.+..||.|+.|.|++++.+ |...|||.+.... + . ...++++..+.++.+.+ +|.||+++|+|..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---N---k-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~- 162 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---N---K-EENKRILMDLDVVLKSHDCPYIVQCFGYFIT- 162 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC---C---H-HHHHHHHHhhhHHhhccCCCeeeeeeeEEee-
Confidence 355677788999999999999885 5889999987642 1 1 12356777888777776 9999999999998
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+...++.||.| ...++.++++-..++++..+-++...+++||.||-++ +|||||+||+|||+| ..+.+|||||
T Consensus 163 -n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKlCDF 236 (391)
T KOG0983|consen 163 -NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKLCDF 236 (391)
T ss_pred -CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEeecc
Confidence 56788899998 6677888887778899999999999999999999975 899999999999999 8889999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHhhhhccCCCCC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGK-SHMVTEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~-~~~yS~KsDIWSLGVILyELLTG~~PF~~~-~~~eil~~Ilk~~l~p~i 1032 (1075)
|++....+....+...|-+.|||||.+.-. ...|+.++||||||++|+||.||+.||... ...+++.++++.. ++.+
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-PP~L 315 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-PPLL 315 (391)
T ss_pred cccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-CCCC
Confidence 999877666666667799999999999643 456899999999999999999999999874 4456667776644 3555
Q ss_pred CC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1033 PS--WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1033 ps--~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+. ..++.+++|+..||.+|+.+||.+.+|++.
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 53 379999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=335.88 Aligned_cols=268 Identities=34% Similarity=0.588 Sum_probs=232.2
Q ss_pred HHHHhccccccCCCeeEEEEEcccCcEEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC
Q 001449 788 EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862 (1075)
Q Consensus 788 e~i~~~i~~i~~ddYeil~~LGeG~FG~VYkAk~k-----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H 862 (1075)
+.+.+..++++....++.++||.|.||.|++|+.+ ...||||.+|.. ..++...+|+.|..||.+..|
T Consensus 617 qAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-------ytekqrrdFL~EAsIMGQFdH 689 (996)
T KOG0196|consen 617 QAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-------YTEKQRRDFLSEASIMGQFDH 689 (996)
T ss_pred HHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-------ccHHHHhhhhhhhhhcccCCC
Confidence 44455567788889999999999999999999874 345999999864 345567899999999999999
Q ss_pred CceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccC
Q 001449 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1075)
Q Consensus 863 PNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~ 942 (1075)
|||++|-|++.. .....||+|||++|+|+.+|+++.+.++..+..-+++.|+.|++||-+.++|||||...|||++
T Consensus 690 PNIIrLEGVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN-- 765 (996)
T KOG0196|consen 690 PNIIRLEGVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN-- 765 (996)
T ss_pred CcEEEEEEEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec--
Confidence 999999999987 5678999999999999999999988899999999999999999999999999999999999998
Q ss_pred CCCCCeEEEeecCCccccccccc-cCCCCC---CCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001449 943 DPQRPVCKIGDLGLSKVKQQTLV-SGGVRG---TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCA 1017 (1075)
Q Consensus 943 d~~~g~VKLiDFGLAk~~~~~~~-sss~~G---T~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~ 1017 (1075)
.+..+|++|||+++..++... ..+..| ..+|.|||.|.-++ ++..+||||+|++|||.++ |..||=++...
T Consensus 766 --snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 766 --SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred --cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcccccchH
Confidence 889999999999996644431 111112 35799999997554 7999999999999999887 99999999999
Q ss_pred HHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1018 SIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1018 eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
+++..+. +.++..-|-.|+..+.+|+..||++|-.+||.+.+|+..|.+++.+
T Consensus 842 dVIkaIe-~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 842 DVIKAIE-QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHH-hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9887765 4456667788999999999999999999999999999999999763
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=287.07 Aligned_cols=237 Identities=27% Similarity=0.436 Sum_probs=199.1
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||.|+||.||+++++ ++.+|+|+++...... ......+..|+.++++++|+||+++++.+.. ....++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-----RKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-----hHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEe
Confidence 689999999999884 7889999987653221 1234567889999999999999999999876 678999999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccc-c
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-L 964 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~-~ 964 (1075)
|+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 999999999997654 589999999999999999999999999999999999998 6678999999998854332 2
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHH
Q 001449 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLM 1044 (1075)
Q Consensus 965 ~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI 1044 (1075)
......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.. ....++..++.++.++|
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 234456889999999987554 68899999999999999999999987776555555544 33457777899999999
Q ss_pred HHhhhcCCCCCCCHHH
Q 001449 1045 ESCWASDPAERPSFSE 1060 (1075)
Q Consensus 1045 ~kCLq~DPeeRPSa~E 1060 (1075)
++||..||++||++.+
T Consensus 225 ~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 225 SGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHhcCCHhhCCCccc
Confidence 9999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=303.66 Aligned_cols=255 Identities=28% Similarity=0.349 Sum_probs=204.5
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC--
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~-- 876 (1075)
+|++.+.||.|++|.||+|+.. +..||||++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 4888999999999999999874 78899998875321 1122356778999999999999999999987732
Q ss_pred -CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 877 -e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+++||||+. ++|.+++.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 236899999996 58998887654 689999999999999999999999999999999999998 66899999999
Q ss_pred Ccccccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC-
Q 001449 956 LSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP- 1030 (1075)
Q Consensus 956 LAk~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p- 1030 (1075)
++....... ......+|..|+|||++.+.. .++.++||||||+++|+|++|..||...+..+.+..+......+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998654332 233456899999999997653 47899999999999999999999998877655444433211000
Q ss_pred ----------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 001449 1031 ----------------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR--LRSM 1068 (1075)
Q Consensus 1031 ----------------------------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~--Lesi 1068 (1075)
.+...++.++.++|.+||+.+|.+||++.+++.. |+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0112357889999999999999999999999984 5444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.54 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=205.3
Q ss_pred CCeeEE-EEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-CCCCceeeeecccccC
Q 001449 800 DDLEEV-RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 800 ddYeil-~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk-L~HPNIVkL~g~~~d~ 875 (1075)
++|++- ++||-|-.|+|..+.+ +++++|+|++... ....+|+++--. -.|||||.++++|...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 456554 4699999999998866 5888999988643 223356665433 4599999999998753
Q ss_pred --CCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 876 --PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 876 --~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
...++.+|||.|+||.|+..|..++ ..+++.++..|++||..|+.|||+.+|.||||||+|+|++... .+-.+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 3457889999999999999998775 4599999999999999999999999999999999999997444 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhhhhccC
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC----ASIIGGIVNNTL 1028 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~----~eil~~Ilk~~l 1028 (1075)
|||+|+.........+.+.|+.|.|||++..+. |+..+|+||||||+|-||+|.+||..... ..+..+|....+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eK--ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchh--cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 999999877666677788999999999996443 89999999999999999999999987654 234455666666
Q ss_pred CCCCCCC--CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 RPQIPSW--CDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ~p~ips~--ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...-++| +|++.+++|+++|..+|.+|.|+.++++.
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 5444544 68899999999999999999999998764
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=304.02 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=197.2
Q ss_pred CCeeE-EEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHH------HHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 800 DDLEE-VRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERE------RLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 800 ddYei-l~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere------~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
++|.. .+.||.|+||.||+|.+ .++.||||+++............ .....+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45554 46799999999999986 47889999987543222110000 01124678999999999999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
++.. ...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++ ..+.+|
T Consensus 88 ~~~~--~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~k 159 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICK 159 (335)
T ss_pred EEec--CCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEE
Confidence 9887 568999999995 6999998654 3589999999999999999999999999999999999998 667899
Q ss_pred EeecCCcccccc---------------ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 001449 951 IGDLGLSKVKQQ---------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015 (1075)
Q Consensus 951 LiDFGLAk~~~~---------------~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~ 1015 (1075)
|+|||++..... ........++..|+|||.+.+.. .++.++|||||||++|+|++|..||...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999874331 11112234688899999987543 36889999999999999999999998777
Q ss_pred hHHHHHhhhhccC---CC-----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1016 CASIIGGIVNNTL---RP-----------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1016 ~~eil~~Ilk~~l---~p-----------------------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+.+..+..... .. ......+.++.++|.+||+.+|++|||+.+++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 6555444332110 00 011245788999999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.40 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=194.9
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
.+|++.+.||.|+||.||+|..+ +..||+|++..... ...+.+.+|+.+|++++||||+++++.+.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 67999999999999999999874 77899999865421 123557789999999999999999987665321
Q ss_pred ------------CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCC
Q 001449 878 ------------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (1075)
Q Consensus 878 ------------~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~ 945 (1075)
..+++||||+. ++|.+++... .+++..++.++.||++||.|||+.||+||||||+||+++. .
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~---~ 150 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT---E 150 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---C
Confidence 35789999995 6898888643 4889999999999999999999999999999999999972 4
Q ss_pred CCeEEEeecCCccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001449 946 RPVCKIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021 (1075)
Q Consensus 946 ~g~VKLiDFGLAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~ 1021 (1075)
+..+||+|||+++....... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||...+......
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 46799999999875322111 1223578899999987542 347889999999999999999999998765544333
Q ss_pred hhhhcc-----------------------CCC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1022 GIVNNT-----------------------LRP-----QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1022 ~Ilk~~-----------------------l~p-----~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.+.... ... .+...++.++++||.+||+.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 322110 000 012346788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=327.93 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=184.8
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc---CcceEEEEeeccc---------cCCCchhHHHHHHHHHHHHHHHHhCCCCcee
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASC---------FAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~---------~~~k~~ere~~i~~flrEi~ILkkL~HPNIV 866 (1075)
.++|++++.||+|+||+||++..+ +..+++|.+.... ..............+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 367999999999999999998763 2222333111100 0000011122345678999999999999999
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhcc----ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccC
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~----~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~ 942 (1075)
++++++.. .+..++|++++ .++|.+++.... .......++.|+.||+.||.|||++|||||||||+|||++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-- 301 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-- 301 (501)
T ss_pred cEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 99999987 56789999998 567777765432 1234566778999999999999999999999999999998
Q ss_pred CCCCCeEEEeecCCcccccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCC--hH
Q 001449 943 DPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMH--CA 1017 (1075)
Q Consensus 943 d~~~g~VKLiDFGLAk~~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~P-F~~~~--~~ 1017 (1075)
.++.+||+|||+++...... ......||..|+|||++.+.. ++.++|||||||+||||++|..+ |.... ..
T Consensus 302 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 --CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred --CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 67789999999998543322 223457999999999998654 78999999999999999998754 43221 11
Q ss_pred HHHHhhhhcc----------------------C---CCCC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1018 SIIGGIVNNT----------------------L---RPQI-----PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1018 eil~~Ilk~~----------------------l---~p~i-----ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..+..++... . ...+ ...++.++.++|.+||+.||.+|||+.|+++.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111100 0 0000 11356678889999999999999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=294.77 Aligned_cols=238 Identities=23% Similarity=0.343 Sum_probs=186.0
Q ss_pred CeeEEEE--EcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-CCCCceeeeecccccC
Q 001449 801 DLEEVRE--LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 801 dYeil~~--LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk-L~HPNIVkL~g~~~d~ 875 (1075)
+|++.+. ||+|+||.||+++. ++..+|+|++....... .|+..... .+|+||+++++.+..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 4555555 59999999999987 47779999987542211 01212221 269999999999987
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC-eEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g-~VKLiDF 954 (1075)
.+.+++||||+++++|.+++.+.. .+++..++.++.||++||.|||+.||+||||||+||+++ ..+ .++|+||
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~df 154 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCDY 154 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEecC
Confidence 568999999999999999997764 689999999999999999999999999999999999998 444 8999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-Hhhh-hccCCCCC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASII-GGIV-NNTLRPQI 1032 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil-~~Il-k~~l~p~i 1032 (1075)
|++...... ....++..|+|||++.+.. ++.++||||||+++|+|++|..||......... .... ........
T Consensus 155 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 155 GLCKIIGTP---SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred ccceecCCC---ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 998754322 2346889999999997654 788999999999999999999999754332211 1111 11222344
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPS-FSEISR 1063 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPS-a~ELLq 1063 (1075)
+..++..++++|.+||+.+|.+|++ ++++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 5578999999999999999999995 688875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=347.67 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=217.8
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
++.++|+++++||+|+||.|.+++++ ++-||+|++++.-+.. ......|+.|..+|.--+.+-||.++.+|++
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-----r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-----RAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-----chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 46689999999999999999999885 6669999998754332 2234679999999999999999999999999
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+.++|||||||+||+|..++.+.. .+++.-+++++.+|+.||..||+.|+|||||||+||||| ..|++||+||
T Consensus 147 --~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLADF 219 (1317)
T KOG0612|consen 147 --ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLADF 219 (1317)
T ss_pred --ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeeccc
Confidence 789999999999999999999887 799999999999999999999999999999999999999 8899999999
Q ss_pred CCccc-ccccc-ccCCCCCCCCccCcccccC---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 955 GLSKV-KQQTL-VSGGVRGTLPWMAPELLSG---KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 955 GLAk~-~~~~~-~sss~~GT~~YmAPEvl~g---~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
|.+-. ..+.. .+...+|||-|.|||++.. ....|+..+|+|||||++|||+.|..||......+.+.+|++..-.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 97653 32333 3445679999999999962 2245899999999999999999999999999999999999987655
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 001449 1030 PQIP--SWCDPEWRSLMESCWASDPAERPS---FSEISR 1063 (1075)
Q Consensus 1030 p~ip--s~ls~eL~dLI~kCLq~DPeeRPS---a~ELLq 1063 (1075)
..+| ..+|.++++||++++. +++.|.. +.+|..
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 6666 5689999999998875 4788876 777654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=303.46 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=198.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++++.||+|+||.||++.+ ++..||||++..... .......+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999986 478899998864311 1222345778999999999999999999887532
Q ss_pred C----CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 e----~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
. ..+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEe
Confidence 1 2468999998 8899988864 3589999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC---
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--- 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~--- 1029 (1075)
|||++...... .....+++.|+|||++.+.. .++.++||||||+++|+|++|+.||...+.......+.+....
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999854332 22346789999999986532 3788999999999999999999999876654433333221100
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 --------------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 --------------------------p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+...++.++.++|.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112356788999999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.26 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=229.6
Q ss_pred HHhccccccCCCeeEEEEEcccCcEEEEEEEEcCcc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceee
Q 001449 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1075)
Q Consensus 790 i~~~i~~i~~ddYeil~~LGeG~FG~VYkAk~kGt~--VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVk 867 (1075)
+.+....+...+++.+..||-|+||.|=+++.+++. +|+|++++..+.+. +..+.+..|..||.+++.|.||+
T Consensus 410 ~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-----kQqeHv~sEr~Im~~~~s~fIvr 484 (732)
T KOG0614|consen 410 FAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-----KQQEHVFSERNIMMECRSDFIVR 484 (732)
T ss_pred HHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-----hHHHHHHhHHHHHHhcCchHHHH
Confidence 344556677788999999999999999999887665 89999987765433 33466778999999999999999
Q ss_pred eecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1075)
Q Consensus 868 L~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g 947 (1075)
+|..|.+ +..+||+||-|-||.|+..|++++. ++..+++.++.-+++|++|||++|||+|||||+|++++ .++
T Consensus 485 LYrTfrd--~kyvYmLmEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~G 557 (732)
T KOG0614|consen 485 LYRTFRD--SKYVYMLMEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NRG 557 (732)
T ss_pred HHHHhcc--chhhhhhHHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cCC
Confidence 9999998 7899999999999999999988764 78888888999999999999999999999999999998 889
Q ss_pred eEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc
Q 001449 948 VCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
-+||.|||+|+.......+.++|||+.|.|||++.++. -+..+|+||||+++||||+|.+||...++...+..|+++.
T Consensus 558 y~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred ceEEeehhhHHHhccCCceeeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 99999999999888888889999999999999998776 5888999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPS 1057 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPS 1057 (1075)
-...+|+.++....+||+++...+|.+|.-
T Consensus 636 d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 DKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 888999999999999999999999999964
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.58 Aligned_cols=248 Identities=29% Similarity=0.435 Sum_probs=198.5
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|+..+.||+|.+|.||+|+.. ++.||+|+++.... .+.....+..|+.++++++|+||+++++++.+ .+.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCc
Confidence 567788999999999999884 78899999886531 11223456689999999999999999999887 578
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++|+||+. ++|.+++.+....+++..++.++.|++.||.|||++||+||||+|+||+++ .++.+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 999999996 699999987655689999999999999999999999999999999999998 678999999999885
Q ss_pred ccccc-ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-----------
Q 001449 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT----------- 1027 (1075)
Q Consensus 960 ~~~~~-~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~----------- 1027 (1075)
..... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||......+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43322 22234567889999998754 247889999999999999999999998766554433332100
Q ss_pred -----CC---C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -----LR---P--------QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -----l~---p--------~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.. + .....++.++.++|.+||..||++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0 001124778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=302.44 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=199.3
Q ss_pred ccccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeec
Q 001449 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 793 ~i~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g 870 (1075)
..+.+ .++|.+...||+|+||.||+|++ +++.||||+++..... +.....+.+|+.++++++|+||+++++
T Consensus 9 ~~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 9 TVWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred hhhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhh
Confidence 33444 35799999999999999999986 4788999998754211 112345678999999999999999999
Q ss_pred ccccCC----CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCC
Q 001449 871 IVRDGP----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (1075)
Q Consensus 871 ~~~d~~----e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~ 946 (1075)
++.... ...+++|+||+. .+|..++. ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~ 153 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----ED 153 (342)
T ss_pred eecccccCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CC
Confidence 886532 134689999995 47776653 3489999999999999999999999999999999999998 67
Q ss_pred CeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc
Q 001449 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~ 1026 (1075)
+.+||+|||+++..... .....++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+...
T Consensus 154 ~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 154 CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred CCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCcc-ccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 78999999998854322 23456788999999986532 3788999999999999999999999876654433332221
Q ss_pred cC---------------------CCCC--------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 001449 1027 TL---------------------RPQI--------PSWCDPEWRSLMESCWASDPAERPSFSEISRR--LRSM 1068 (1075)
Q Consensus 1027 ~l---------------------~p~i--------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~--Lesi 1068 (1075)
.. .+.+ ....+.++.+||.+||+.||.+||++.+++.. ++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00 0001 12357789999999999999999999999954 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.37 Aligned_cols=240 Identities=23% Similarity=0.432 Sum_probs=195.7
Q ss_pred EEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEE
Q 001449 805 VRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~L 882 (1075)
...||+|+||.||+++. ++..||||++.... ......+.+|+.++++++|+||+++++.+.. .+..++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 94 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 94 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEE
Confidence 35699999999999987 47889999875321 1123557789999999999999999999887 568999
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
||||+.+++|.+++... .+++..++.++.|++.||.|||+.||+|+||||+||+++ .++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 95 VMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceeccc
Confidence 99999999999987543 478999999999999999999999999999999999998 567899999998874332
Q ss_pred c-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC--CCCCCCHH
Q 001449 963 T-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ--IPSWCDPE 1039 (1075)
Q Consensus 963 ~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~--ips~ls~e 1039 (1075)
. .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+... .... ....++..
T Consensus 169 ~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 245 (292)
T cd06657 169 EVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSPS 245 (292)
T ss_pred ccccccccccCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCcccCCcccCCHH
Confidence 2 1223456889999999986544 688999999999999999999999876665544443222 2222 22357889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1040 WRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1040 L~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.++|.+||+.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.81 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=199.1
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|++.+.||+|++|.||+|++. +..||||++..... .......+.+|+.+++++.|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 467999999999999999999884 77899998764311 1122355678999999999999999999876532
Q ss_pred C----CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 e----~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
. ..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEc
Confidence 1 3489999998 7899999875 3589999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC---
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--- 1029 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~--- 1029 (1075)
|||++...... .....++..|+|||.+.+.. .++.++|||||||++|+|++|+.||........+..+......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99998854332 23456889999999986432 4788999999999999999999999876655544433221100
Q ss_pred -----------------------C---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1030 -----------------------P---QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 -----------------------p---~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. .....++.++.++|.+||+.||.+|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 011235889999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=299.04 Aligned_cols=250 Identities=27% Similarity=0.328 Sum_probs=192.5
Q ss_pred CeeEEEEEcccCcEEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~ 875 (1075)
+|++.+.||+|+||.||++++. +..||+|++...... ......+.+|+.+++++ .||||+++++.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK------KILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999885 557999998643211 11234567899999999 499999999865431
Q ss_pred --CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 876 --~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
....+++++||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 75 ~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELM-EADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEecc-cCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 234578888988 57899988654 4589999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc-----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-
Q 001449 954 LGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT- 1027 (1075)
Q Consensus 954 FGLAk~~~~~~-----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~- 1027 (1075)
||+++...... ......||..|+|||++.+. ..++.++||||||+++|+|++|..||...+....+..++...
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99997433211 12335689999999987653 237899999999999999999999998765443332222100
Q ss_pred -------------------------CC---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 -------------------------LR---PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -------------------------l~---p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
.. ......++..+.+||.+||+.||.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0111235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=301.77 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=196.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP- 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~- 876 (1075)
++|++.+.||+|+||.||++.+ +++.||+|+++.... .......+.+|+.++++++|+||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 6799999999999999999976 478899998875321 1112345678999999999999999999876421
Q ss_pred ---CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 877 ---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 877 ---e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
....+++++++ +++|.+++... .+++..++.++.||++||.|||+.||+||||||+||+++ .++.+||+|
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~d 163 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 163 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCCCEEEec
Confidence 23477888877 88999887653 489999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC-----
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL----- 1028 (1075)
Q Consensus 954 FGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l----- 1028 (1075)
||++...... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 164 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 164 FGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccccc--ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9998854332 2345688999999998653 2378899999999999999999999976655443332221100
Q ss_pred -------------------CC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 -------------------RP-----QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 -------------------~p-----~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+ ......+.++.+||.+||+.||.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0011357889999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.38 Aligned_cols=245 Identities=23% Similarity=0.386 Sum_probs=211.2
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeeccc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kGt--~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~ 872 (1075)
.+...+|.++.+||+|+||+|.++..+|+ .+|||+++++.+...... +--+.|-.+|.... -|.+++++..|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv-----ectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV-----ECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc-----cceehhhhheecCCCCchHHHHHHHh
Confidence 34567899999999999999999988765 499999998876654332 22334666666554 67899999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
++ -+.+|+||||+.||+|...|++.++ +.+..+..+|.+|+-||-|||++|||+||||.+|||++ ..+++||+
T Consensus 420 QT--mDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi~ 492 (683)
T KOG0696|consen 420 QT--MDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIA 492 (683)
T ss_pred hh--hhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEee
Confidence 98 6789999999999999999987764 78888889999999999999999999999999999999 78999999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC
Q 001449 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 953 DFGLAk~~-~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ 1031 (1075)
|||+++.. .....+..++||+.|+|||++.-++ |+..+|+||+||+|||||.|++||.+.+..++...|+.... .
T Consensus 493 DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP--YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--s 568 (683)
T KOG0696|consen 493 DFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--S 568 (683)
T ss_pred ecccccccccCCcceeeecCCCcccccceEEecc--cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--c
Confidence 99999953 3344556789999999999997444 89999999999999999999999999999999998887654 6
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERP 1056 (1075)
Q Consensus 1032 ips~ls~eL~dLI~kCLq~DPeeRP 1056 (1075)
+|+.++.+..++++..|.+.|.+|.
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCcccc
Confidence 8899999999999999999999994
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=326.74 Aligned_cols=263 Identities=23% Similarity=0.370 Sum_probs=207.9
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP- 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~- 876 (1075)
..|..-+.||+|+||.||+++. +|+.||||.++...... ..+...+|+++|++++|+|||+++++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r-------~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR-------PRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc-------hHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 3466677899999999999986 49999999998765221 1244558999999999999999999866543
Q ss_pred ---CCceEEEEeeecCCcHHHHHhhcc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 877 ---DGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 877 ---e~~L~LVmEYmeGGSL~d~Lkk~~--~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
...-.+|||||.||||+.+|.+.. .-+++.+.+.+..++..||.|||++||+||||||.||++....+.....||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence 445689999999999999998642 348999999999999999999999999999999999999755556678999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH----HHHhhhhcc
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS----IIGGIVNNT 1027 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e----il~~Ilk~~ 1027 (1075)
+|||.|+...+.....++.||..|++||++.. ..+|+..+|.|||||++|+.+||..||....... ++..+....
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 99999998888888889999999999999974 2348999999999999999999999996544332 333222211
Q ss_pred C-------------------CCCCCCCCCHH----HHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHH
Q 001449 1028 L-------------------RPQIPSWCDPE----WRSLMESCWASDPAERP--SFSEISRRLRSMAA 1070 (1075)
Q Consensus 1028 l-------------------~p~ips~ls~e----L~dLI~kCLq~DPeeRP--Sa~ELLq~Lesi~~ 1070 (1075)
. ...++..++.. +-.++..+|.+++++|. .+.+.-..+..+..
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 01123333433 44677788899999998 77777777776644
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=351.54 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=209.1
Q ss_pred CeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
++....+||.|.||.||.|.. +|...|+|.++..... .+.+....+|+++|..|+|||+|++||+-.. ..
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Re 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--RE 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeec--HH
Confidence 355567899999999999976 6888999998754322 3344667789999999999999999998666 56
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
..+|.||||.+|+|.+++... +-.++.....+..|++.||.|||+.|||||||||+|||++ .++.+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeeccccee
Confidence 788999999999999998654 3356666667888999999999999999999999999998 77899999999998
Q ss_pred cccccc-----ccCCCCCCCCccCcccccCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 959 VKQQTL-----VSGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 959 ~~~~~~-----~sss~~GT~~YmAPEvl~g~~-~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
...... ......||+.|||||++.+.. ..-..++|||||||++.||+||+.||...+..=.+...+.....|.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 543332 224567999999999998654 33456899999999999999999999988766555555666667889
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
|..++.+.++||..||..||.+|+++.+|++.
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999999999999888764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.33 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=209.1
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
+-+..+.|+.-++||+|+||.||-++. +|..+|.|.+.+..+..+..+ ...++|-.||++++.+.||.+-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge-----~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGE-----TMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhh-----HHhhHHHHHHHHhccCcEEEEeeee
Confidence 445667899999999999999997754 689999998877654433332 4467899999999999999998888
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.+ ...+|+||..|.||+|.-.|.+.+ .-+++..+..++.+|+.||++||+.+||+|||||+|||+| +.|+++|
T Consensus 255 eT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~GhvRI 328 (591)
T KOG0986|consen 255 ET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHVRI 328 (591)
T ss_pred cC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCeEe
Confidence 88 678999999999999999998765 3489999999999999999999999999999999999999 8899999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH---HHhhhhccC
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI---IGGIVNNTL 1028 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~ei---l~~Ilk~~l 1028 (1075)
+|+|+|............+||..|||||++.+.. |+..+|+|||||+||||+.|+.||...-.... +..... ..
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~ 405 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-ED 405 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cc
Confidence 9999999777766666678999999999998665 89999999999999999999999965432221 122111 12
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPS 1057 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPS 1057 (1075)
...++...++++++|.+.+|.+||.+|.-
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 34567888999999999999999999953
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=296.89 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=195.3
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..++|++++.||.|+||.||++++ ++..||||++.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 346799999999999999999986 47789999886542111 1224566899999999999999999988653
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...+++|+||+ +++|.++++.. .+++..+..++.||++||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 82 -~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg 153 (328)
T cd07856 82 -LEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFG 153 (328)
T ss_pred -CCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCccc
Confidence 45688999998 67899888643 478888889999999999999999999999999999998 67789999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh----------
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN---------- 1025 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk---------- 1025 (1075)
++...... .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........+.+
T Consensus 154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 154 LARIQDPQ--MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccccCCC--cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98854322 2334578899999987642 2378999999999999999999999976554221111100
Q ss_pred --------------ccCCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 --------------NTLRPQ-----IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 --------------~~l~p~-----ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...... ....++.+++++|.+||+.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 112467899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=323.07 Aligned_cols=250 Identities=32% Similarity=0.589 Sum_probs=211.0
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc---C--cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR---G--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k---G--t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
.+.+..++||+|.||.|++|.|+ | -.||||.++..... .....|++|+.+|.+|+|+|+|+|||++.+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 34455678999999999999995 3 34899999865322 145789999999999999999999999986
Q ss_pred CCCCceEEEEeeecCCcHHHHHhh-ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk-~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
..+.||||++.+|+|.+.|++ ....|-......++.||+.||.||..+++|||||...|||+. ....|||||
T Consensus 183 ---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVKI~D 255 (1039)
T KOG0199|consen 183 ---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVKICD 255 (1039)
T ss_pred ---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceeeeec
Confidence 467899999999999999988 444577778888999999999999999999999999999997 567899999
Q ss_pred cCCcccccccccc----CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccC
Q 001449 954 LGLSKVKQQTLVS----GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 954 FGLAk~~~~~~~s----ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l 1028 (1075)
||+.+........ ....-...|+|||.++... ++.++|+|++||+||||++ |+.||.+.....+++.+. ...
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~e 332 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGE 332 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccc
Confidence 9999854332221 1223456799999997554 8999999999999999998 999999999999988877 445
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
+...|+.|+++++++++.||..+|++||++..|.+.+-
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 56778899999999999999999999999999985543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=325.56 Aligned_cols=148 Identities=25% Similarity=0.446 Sum_probs=129.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~ 876 (1075)
.++|.+++.||+|+||.||+|.+. ++.||||+++..... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-- 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQS-- 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--
Confidence 367999999999999999999986 888999998754322 22334667889999999999999999998877
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
...++|||||+.+++|.+++...+ .+++..++.|+.||+.||.|||.++||||||||+||||+ .++.+||+|||+
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGl 150 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGL 150 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCC
Confidence 568999999999999999997643 578999999999999999999999999999999999998 667899999998
Q ss_pred cc
Q 001449 957 SK 958 (1075)
Q Consensus 957 Ak 958 (1075)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=315.86 Aligned_cols=261 Identities=30% Similarity=0.515 Sum_probs=215.4
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~kG-t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
+.++..+.+.+.++||+|.||.|.++...+ ..||||.++... .......|.+|+++|.+|+|||||+++++|
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 345556778889999999999999998876 899999998653 223357899999999999999999999999
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccC-CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTI-DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~L-se~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.. ++.+++|+|||++|+|.+++.....+. .......|+.||+.||+||.+.++|||||.+.|+|++ .+.++||
T Consensus 605 ~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iKi 678 (807)
T KOG1094|consen 605 VQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIKI 678 (807)
T ss_pred ec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEEe
Confidence 88 678999999999999999998775433 5556667999999999999999999999999999998 8899999
Q ss_pred eecCCcccc-c-c-ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHhhhh-
Q 001449 952 GDLGLSKVK-Q-Q-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT--GDEPYADMHCASIIGGIVN- 1025 (1075)
Q Consensus 952 iDFGLAk~~-~-~-~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT--G~~PF~~~~~~eil~~Ilk- 1025 (1075)
+|||+++.. . + ........-..+|||+|.+.-.+ +++++|+|+||+++||+++ ...||...+...+......
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 999999932 1 1 11222334567899999886444 7999999999999999876 8899988877776655432
Q ss_pred --c---cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1026 --N---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1026 --~---~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
. ..-+..|..|+.++.++|..||..+-++||++++|...|.+..
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 1224457789999999999999999999999999999887653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=301.26 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=200.0
Q ss_pred EEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCCceEE
Q 001449 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~~L~L 882 (1075)
+.||+|+|+.|-.++. +|..+|||++.+.. .....+..+|++++..++ |+||++++++|.+ +..+||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEE
Confidence 4599999999998765 68999999997652 123467789999999997 9999999999998 778999
Q ss_pred EEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccccc
Q 001449 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~ 962 (1075)
|||-|.||.|...|.++. .+++.++..+.++|+.||+|||.+||.||||||+|||....+ .-.-||||||.+......
T Consensus 154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeecccccccccc
Confidence 999999999999998764 489999999999999999999999999999999999997443 445699999998763221
Q ss_pred c--------cccCCCCCCCCccCcccc---cCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------------h
Q 001449 963 T--------LVSGGVRGTLPWMAPELL---SGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH---------------C 1016 (1075)
Q Consensus 963 ~--------~~sss~~GT~~YmAPEvl---~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~---------------~ 1016 (1075)
. ....+.+|+..|||||+. .+....|++++|+||||||||-||.|.+||.+.- .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 112345688999999976 3566679999999999999999999999996532 1
Q ss_pred HHHHHhhhhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1017 ASIIGGIVNNTLRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1017 ~eil~~Ilk~~l~p~ips--~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
..+...|..+.+...-.. .++.+.+++|..+|..|+..|.++.++++
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 234455555554322222 37899999999999999999999988876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=314.18 Aligned_cols=245 Identities=29% Similarity=0.452 Sum_probs=206.4
Q ss_pred EEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEE
Q 001449 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
+.||+|.||+||-|++ +|+.||||+|.+..+..+.. ..+.+|+.||+++.||.||.+-..|.+ .+.++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFET--PERVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEE
Confidence 4699999999999987 49999999999887776543 445689999999999999999999988 5689999
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccc
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~ 963 (1075)
||-+.|.=|.-+|....+.+++...+.++.||+.||+|||-++|+|.||||+|||+.+.+ .-..+||||||+|+...+.
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999955555556666667799999999999999999999999999999999999997554 4568999999999999888
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccC--CCCCCCCCCHHHH
Q 001449 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL--RPQIPSWCDPEWR 1041 (1075)
Q Consensus 964 ~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l--~p~ips~ls~eL~ 1041 (1075)
....+..||+.|+|||++..+. |+..-|+||+|+|+|--|+|..||.+.. ++...|.+..+ ++.-=+.++.+..
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHH
Confidence 8888999999999999998665 8999999999999999999999997642 33344444332 1222245899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 001449 1042 SLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+||..+|+..-++|-|.+.-++
T Consensus 797 dlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhcc
Confidence 9999999999999988876543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=320.64 Aligned_cols=260 Identities=34% Similarity=0.581 Sum_probs=217.6
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPN 864 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k---------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPN 864 (1075)
+++..+++++.+.||+|.||.|++|... ...||||.++..... ...+.+..|+++|+.+. |+|
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------~~~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------SEKKDLMSELNVLKELGKHPN 363 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------HHHHHHHHHHHHHHHhcCCcc
Confidence 4445555666678999999999998752 345999998765322 23467889999999996 999
Q ss_pred eeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 001449 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1075)
Q Consensus 865 IVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~---------------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIH 929 (1075)
|+.++|++.. .+.+++|+||+..|+|.++++.+. ..++....+.++.||+.|++||+++.+||
T Consensus 364 iv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vH 441 (609)
T KOG0200|consen 364 IVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVH 441 (609)
T ss_pred hhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 9999999988 788999999999999999998876 34899999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEeecCCccccccc--cccCCCCCC--CCccCcccccCCCCCCCchhhHHHHHHHHHHHH
Q 001449 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--LVSGGVRGT--LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005 (1075)
Q Consensus 930 RDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~--~~sss~~GT--~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELL 1005 (1075)
|||..+|||++ .+..+||+|||+|+..... .......++ ..|||||.+... .|+.|+||||||++||||+
T Consensus 442 RDLAaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 442 RDLAARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred hhhhhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHh
Confidence 99999999998 7789999999999953322 111222232 349999999863 4899999999999999999
Q ss_pred c-CCCCCCCCC-hHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1006 T-GDEPYADMH-CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1006 T-G~~PF~~~~-~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
+ |..||.+.. ..++ ...++...+...|..++.+++++++.||+.+|++||++.++.+.|.....
T Consensus 516 sLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 516 TLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred hCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 9 999999876 4455 44777778889999999999999999999999999999999999998653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=279.88 Aligned_cols=218 Identities=23% Similarity=0.280 Sum_probs=176.6
Q ss_pred cCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEeeec
Q 001449 811 GTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888 (1075)
Q Consensus 811 G~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmEYme 888 (1075)
|.+|.||++++ +++.||+|.++... .+.+|...+....||||+++++++.. ....++||||+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCC
Confidence 89999999988 47889999987542 11234445556679999999999887 568899999999
Q ss_pred CCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccccCC
Q 001449 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968 (1075)
Q Consensus 889 GGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~sss 968 (1075)
+++|.+++.+.. .+++..+..++.||++||.|||++||+||||||+||+++ .++.++|+|||.+...... ...
T Consensus 69 ~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~--~~~ 141 (237)
T cd05576 69 GGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDS--CDG 141 (237)
T ss_pred CCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhccccc--ccc
Confidence 999999987653 489999999999999999999999999999999999998 6678999999987644332 123
Q ss_pred CCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhh
Q 001449 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCW 1048 (1075)
Q Consensus 969 ~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCL 1048 (1075)
..++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ........++..++..++++|.+||
T Consensus 142 ~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGGISE--ETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccCCCC--CCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 44677899999986544 688999999999999999999887643221 1111223466778999999999999
Q ss_pred hcCCCCCCCH
Q 001449 1049 ASDPAERPSF 1058 (1075)
Q Consensus 1049 q~DPeeRPSa 1058 (1075)
+.||++|+++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=330.80 Aligned_cols=250 Identities=30% Similarity=0.483 Sum_probs=191.1
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~- 875 (1075)
..+|++++.||+||||.||+++. +|+.||||+|.... .......+.+|+++|.+|+|||||++|..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 35788899999999999999976 69999999998653 223346678999999999999999997432100
Q ss_pred --------------------------------------------------------------------------------
Q 001449 876 -------------------------------------------------------------------------------- 875 (1075)
Q Consensus 876 -------------------------------------------------------------------------------- 875 (1075)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred ----------------------------CC--------CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHH
Q 001449 876 ----------------------------PD--------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919 (1075)
Q Consensus 876 ----------------------------~e--------~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL 919 (1075)
.+ ..+||-||||+..+|.+++.++...-.....|.+++||+.||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence 00 247889999999888888876643225778899999999999
Q ss_pred HHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc-------------------cccccCCCCCCCCccCccc
Q 001449 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-------------------QTLVSGGVRGTLPWMAPEL 980 (1075)
Q Consensus 920 ~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~-------------------~~~~sss~~GT~~YmAPEv 980 (1075)
.|+|+.|||||||||.||+++ ....|||+|||+|+... .....++.+||..|+|||+
T Consensus 711 aYIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999999 67789999999998511 0112245679999999999
Q ss_pred ccCCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHhhhhccCCCC---CCCCCCHHHHHHHHHhhhcCCCCC
Q 001449 981 LSGKSH-MVTEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNNTLRPQ---IPSWCDPEWRSLMESCWASDPAER 1055 (1075)
Q Consensus 981 l~g~~~-~yS~KsDIWSLGVILyELLTG~~PF~~~-~~~eil~~Ilk~~l~p~---ips~ls~eL~dLI~kCLq~DPeeR 1055 (1075)
+.+... .|+.|+|+|||||||+||+. ||... ....++..+.+..++.. +...++ .-..+|+.||+.||.+|
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~-~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHP-EEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccch-HHHHHHHHHhcCCCccC
Confidence 976542 58999999999999999985 56542 22233333333332222 122233 34589999999999999
Q ss_pred CCHHHHHH
Q 001449 1056 PSFSEISR 1063 (1075)
Q Consensus 1056 PSa~ELLq 1063 (1075)
||+.|||.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999985
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=294.01 Aligned_cols=257 Identities=28% Similarity=0.367 Sum_probs=200.4
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~ 872 (1075)
...|+.+..||+|+||.||+|..+ ...+|||.++.+... .+.. ....+|+.+++.++|||||.+..+|
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS----~SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGIS----MSACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcC----HHHHHHHHHHHHhcCCcchhHHHHH
Confidence 357899999999999999999542 235899998865321 1111 3455899999999999999999998
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhh----ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCe
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk----~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~ 948 (1075)
..- +.+++|++||.+ -+|..+|+- +.+.++...++.|+.||+.|+.|||++-|+||||||.||||..+.++.|.
T Consensus 97 l~~-d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 97 LSH-DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred hcc-CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe
Confidence 874 678999999995 589988853 23468999999999999999999999999999999999999877788899
Q ss_pred EEEeecCCccccccccc----cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--------
Q 001449 949 CKIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC-------- 1016 (1075)
Q Consensus 949 VKLiDFGLAk~~~~~~~----sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~-------- 1016 (1075)
|||+|||+++....... ....+-|.+|+|||++.|..+ ||..+||||+|||+.||+|-++.|.+...
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h-YT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH-YTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhccccc-ccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999999997654432 245668999999999998765 89999999999999999999988854221
Q ss_pred -HHHHHhhhhcc---C---C---------------------CC--CC------CCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 001449 1017 -ASIIGGIVNNT---L---R---------------------PQ--IP------SWCDPEWRSLMESCWASDPAERPSFSE 1060 (1075)
Q Consensus 1017 -~eil~~Ilk~~---l---~---------------------p~--ip------s~ls~eL~dLI~kCLq~DPeeRPSa~E 1060 (1075)
.+.+..|+.-. . . .. +. ..-++...+|+.++|+.||.+|.|+.+
T Consensus 254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 12222222100 0 0 00 00 011334779999999999999999999
Q ss_pred HHHH
Q 001449 1061 ISRR 1064 (1075)
Q Consensus 1061 LLq~ 1064 (1075)
.++.
T Consensus 334 Aleh 337 (438)
T KOG0666|consen 334 ALEH 337 (438)
T ss_pred Hhcc
Confidence 8865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=295.85 Aligned_cols=257 Identities=24% Similarity=0.418 Sum_probs=205.2
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHh-CCCCceeeeec
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYG 870 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkk-L~HPNIVkL~g 870 (1075)
..++..++++.+..||.|+||+|+|-.++ |...|||.|+.... ++..++++.|.....+ -++||||++||
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 44556677888889999999999987764 88899999986432 2233667778776554 46999999999
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhh----ccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCC
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQ 945 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk----~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~ 945 (1075)
++.. ++..||.||+| ..+|+.+.+. ....+++..+-.|+.-++.||.||-+ ..||||||||+|||++ .
T Consensus 131 a~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld----r 203 (361)
T KOG1006|consen 131 ALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD----R 203 (361)
T ss_pred hhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----c
Confidence 9877 67889999999 6677766543 23458899888999999999999996 4899999999999999 8
Q ss_pred CCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhhh
Q 001449 946 RPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIV 1024 (1075)
Q Consensus 946 ~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-eil~~Il 1024 (1075)
.|.|||||||++.........+-..|-..|||||.+......|+.++|+||||++|||+.||+.||...+.. +.+..++
T Consensus 204 ~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred CCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 899999999999876666555666788899999999865556999999999999999999999999876542 3334444
Q ss_pred hccCCC-CCCC---CCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1025 NNTLRP-QIPS---WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1025 k~~l~p-~ips---~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+..+. ..+. ..+..+..+|..||.+|-..||.+.+|+..
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 433221 1222 368899999999999999999999998763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=265.21 Aligned_cols=236 Identities=31% Similarity=0.521 Sum_probs=193.5
Q ss_pred CcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEeeecC
Q 001449 812 TYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVN 889 (1075)
Q Consensus 812 ~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmEYmeG 889 (1075)
+||.||++++. ++.+|+|++........ ...+.+|+.++++++|+||+++++.+.. ....++++||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCC
Confidence 58999999985 58899999875432110 3677899999999999999999999887 5678999999999
Q ss_pred CcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccccCCC
Q 001449 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969 (1075)
Q Consensus 890 GSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~sss~ 969 (1075)
++|.+++..... +++..++.++.+++.+|.+||+.+|+|+||+|+||+++ .++.++|+|||.+............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 999999976543 79999999999999999999999999999999999998 5679999999999866554344456
Q ss_pred CCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHhhhhccCCCCCCCC-CCHHHHHHHHHh
Q 001449 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-MHCASIIGGIVNNTLRPQIPSW-CDPEWRSLMESC 1047 (1075)
Q Consensus 970 ~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~-~~~~eil~~Ilk~~l~p~ips~-ls~eL~dLI~kC 1047 (1075)
.++..|++||.+.+.. ++.++||||||+++++|++|..||.. .........+............ ++.++.+++.+|
T Consensus 147 ~~~~~~~~pE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 147 VGTPEYMAPEVLLGKG--YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cCCcCCCCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 6889999999987444 68899999999999999999999987 4444444433333222222222 789999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 001449 1048 WASDPAERPSFSEISR 1063 (1075)
Q Consensus 1048 Lq~DPeeRPSa~ELLq 1063 (1075)
|..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=316.02 Aligned_cols=252 Identities=28% Similarity=0.437 Sum_probs=212.6
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeeccccc-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD- 874 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d- 874 (1075)
.+.|+++..||.|.+|.||+++. +++.+|+|++......+ .++..|..||+.+. |||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---------eEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---------EEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---------HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 35689999999999999999865 58889999876542211 23446788888775 9999999999864
Q ss_pred --CCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 875 --GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 875 --~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
...+.+|||||||.+|+..|++++- +..+.|..+.+|++.++.||.+||.+.+||||||-.|||++ .++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEEE
Confidence 3466899999999999999999763 56699999999999999999999999999999999999999 8889999
Q ss_pred eecCCccccccc-cccCCCCCCCCccCcccccCC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc
Q 001449 952 GDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 952 iDFGLAk~~~~~-~~sss~~GT~~YmAPEvl~g~---~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
+|||++.....+ ......+||+.|||||++... ...|+.++|+||||++..||.-|.+|+-++.+...+..|-.+.
T Consensus 165 vDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP 244 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence 999999865443 334567899999999999632 2347789999999999999999999999999999888877665
Q ss_pred CCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1028 LRP-QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 l~p-~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
... .-++..+.++.++|..||.+|.++||+..++++
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 432 236678899999999999999999999999885
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=273.72 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=206.3
Q ss_pred CeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+|..+++||+|.||+||+++.+ ++.||+|.++.+... +..-...++|+-+|+.++|.|||+++++... ++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd------egvpssalreicllkelkhknivrl~dvlhs--dk 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHS--DK 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC------CCCcHHHHHHHHHHHHhhhcceeehhhhhcc--Cc
Confidence 4666778999999999999864 778999999865321 1122446789999999999999999999877 78
Q ss_pred ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+.+|+||| ..+|..++...++.++.+.++.++.|+++||.|+|+.++.||||||.|+||+ .++.+||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 899999999 6799999998888899999999999999999999999999999999999998 88999999999999
Q ss_pred ccccc-cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCC------C
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR------P 1030 (1075)
Q Consensus 959 ~~~~~-~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~------p 1030 (1075)
...-. ...+...-|.+|++|.++.|.. .|++..|+||.|||+.||.. |++.|.+.+..+.+..|.+..-. +
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgak-ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeee-hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 54333 2334556799999999998754 58999999999999999997 88889998888877777642111 1
Q ss_pred C------------CC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1031 Q------------IP---------SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1031 ~------------ip---------s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
. ++ ..+...-++|++++|..+|..|.++++.++.
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1 11 1123456799999999999999999988763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.51 Aligned_cols=246 Identities=22% Similarity=0.384 Sum_probs=206.2
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecc
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGI 871 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~ 871 (1075)
+.+..++|..+++||.|+|++|.+++++ .+.+|+|+++++.+.++.. +.....|-.++.+. +||.+|.++.+
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-----idwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-----IDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-----chhHHhhHHHHHhccCCCeEEehhhh
Confidence 3456789999999999999999998774 6679999999886654322 34455666677655 59999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
|++ ++.+++|.||+.||+|.-.+++. +.++++.++.+..+|+.||.|||++|||+||||.+|+|++ ..+++||
T Consensus 320 fqt--esrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghikl 392 (593)
T KOG0695|consen 320 FQT--ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHIKL 392 (593)
T ss_pred hcc--cceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCceee
Confidence 998 78899999999999999888765 4589999999999999999999999999999999999999 8899999
Q ss_pred eecCCcccc-ccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-------CChHHHHHhh
Q 001449 952 GDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-------MHCASIIGGI 1023 (1075)
Q Consensus 952 iDFGLAk~~-~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~-------~~~~eil~~I 1023 (1075)
+|+|+++.. .+...++.++||+.|.|||++.|.. |...+|+|+||++++||+.|+.||.- .+..+.+..+
T Consensus 393 tdygmcke~l~~gd~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred cccchhhcCCCCCcccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 999999953 4455567899999999999999876 78899999999999999999999952 3334444333
Q ss_pred -hhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 001449 1024 -VNNTLRPQIPSWCDPEWRSLMESCWASDPAERP 1056 (1075)
Q Consensus 1024 -lk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRP 1056 (1075)
+... ..+|..++-....+++..|++||.+|.
T Consensus 471 ilekq--iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred Hhhhc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 3333 457888999999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=301.67 Aligned_cols=248 Identities=20% Similarity=0.302 Sum_probs=198.9
Q ss_pred cccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecc
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 794 i~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~ 871 (1075)
....+..-|..++.||-|+||.|.++.. +...+|+|.+++.. ......+.....|..||.....+-||+||..
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-----Vl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-----VLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-----HHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 3445667799999999999999999865 34558999887643 2334456778899999999999999999999
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
|++ ...+|+||||++||++..+|.+.+- +.+..++.++.++.+|+++.|..|+|||||||+||||| .+|++||
T Consensus 698 FQD--kdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKL 770 (1034)
T KOG0608|consen 698 FQD--KDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKL 770 (1034)
T ss_pred ecc--CCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceee
Confidence 998 7789999999999999999987754 78888887888999999999999999999999999999 8899999
Q ss_pred eecCCcccccccc-------------------------------------------ccCCCCCCCCccCcccccCCCCCC
Q 001449 952 GDLGLSKVKQQTL-------------------------------------------VSGGVRGTLPWMAPELLSGKSHMV 988 (1075)
Q Consensus 952 iDFGLAk~~~~~~-------------------------------------------~sss~~GT~~YmAPEvl~g~~~~y 988 (1075)
+||||++-..-+. .....+||+.|+|||++.... |
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--~ 848 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--Y 848 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--c
Confidence 9999986211000 012356999999999998554 8
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh--ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 001449 989 TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN--NTLRPQIPSWCDPEWRSLMESCWASDPAERP 1056 (1075)
Q Consensus 989 S~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk--~~l~p~ips~ls~eL~dLI~kCLq~DPeeRP 1056 (1075)
+..+|+||.|||||||+.|++||....+.+...++.+ ..+.......++.++.+||.++. .++++|.
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999999999999999999987766554444433 22223334578999999998864 4466774
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=326.50 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=183.6
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
++....||+|+||.||+|++ ++..||||+++.... ....|+.++++++|||||++++++.+ ...
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~ 757 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRS--EKG 757 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEc--CCC
Confidence 55667899999999999986 478899998864311 11235788999999999999999987 567
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHH---hCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH---GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLH---s~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.++||||+++|+|.++++. +++..+..|+.||++||.||| +.+|+||||||+||+++ .+...++. ||.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ecc
Confidence 8999999999999999963 789999999999999999999 67999999999999998 44455554 665
Q ss_pred ccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHH---Hhhh-----hc
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA--SII---GGIV-----NN 1026 (1075)
Q Consensus 957 Ak~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~--eil---~~Il-----k~ 1026 (1075)
....... ....+|..|+|||++.+.. ++.++|||||||++|||+||+.||...... ... .... ..
T Consensus 829 ~~~~~~~---~~~~~t~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 829 PGLLCTD---TKCFISSAYVAPETRETKD--ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccccC---CCccccccccCcccccCCC--CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 4432111 2235889999999987654 899999999999999999999998532110 010 0000 00
Q ss_pred cCCCCCC------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1027 TLRPQIP------SWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1027 ~l~p~ip------s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
...+.+. .....++.+++.+||+.||++||++.++++.|+++.+
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0011111 1112357789999999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=307.08 Aligned_cols=238 Identities=25% Similarity=0.346 Sum_probs=194.8
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~d~ 875 (1075)
.+.|++...+|.|+|+.|-.+.+ +++..++|++.+... +..+|+.++... +||||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~- 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------DNQDEIPISLLVRDHPNIVKSHDVYED- 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------------ccccccchhhhhcCCCcceeecceecC-
Confidence 46788888899999999998876 577799999986511 112455444444 69999999999988
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
....++|||++.|+.|.+.+..... +. ..+..|+.+|+.|+.|||++|||||||||+|||++ +..++++|+|||
T Consensus 388 -~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG 461 (612)
T KOG0603|consen 388 -GKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFG 461 (612)
T ss_pred -CceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEec
Confidence 6789999999999988888876543 23 66778999999999999999999999999999995 267899999999
Q ss_pred CccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhhhhccCCCCCCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-eil~~Ilk~~l~p~ips 1034 (1075)
.++..... ....+-|..|.|||++.... |+..+||||||++||+||+|+.||...+.. +++..+ ..+.+..
T Consensus 462 ~a~~~~~~--~~tp~~t~~y~APEvl~~~~--yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~ 533 (612)
T KOG0603|consen 462 FWSELERS--CDTPALTLQYVAPEVLAIQE--YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSE 533 (612)
T ss_pred hhhhCchh--hcccchhhcccChhhhccCC--CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcccc
Confidence 99976655 23345689999999998444 899999999999999999999999876655 333333 3344558
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
++|.++++||++||+.||.+|+++++++.
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 89999999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=306.76 Aligned_cols=254 Identities=32% Similarity=0.564 Sum_probs=215.1
Q ss_pred CeeEEEEEcccCcEEEEEEEE--c----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKW--R----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~--k----Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
+++..++||.|+||+||+|.| + +-+||||++....... .-.+++.|+.+|.++.|||++++++++..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-------~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-------ASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-------hhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 345567899999999999988 3 3458999887543221 12568889999999999999999999987
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+ .+.||++||++|+|.++++.....+-.+..+.|..||++||.|||+++++||||..+||||. .-..+||.||
T Consensus 770 s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvkitdf 842 (1177)
T KOG1025|consen 770 S---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVKITDF 842 (1177)
T ss_pred c---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEEEEec
Confidence 3 37899999999999999999888899999999999999999999999999999999999998 5569999999
Q ss_pred CCccccccccc---cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhccCCC
Q 001449 955 GLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 955 GLAk~~~~~~~---sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
|+++....... .....-.+-|||=|.+.... |+.++|||||||++|||+| |..|+.+....++ .++++...+.
T Consensus 843 gla~ll~~d~~ey~~~~gK~pikwmale~i~~~~--~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~geRL 919 (1177)
T KOG1025|consen 843 GLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRK--YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGERL 919 (1177)
T ss_pred chhhccCcccccccccccccCcHHHHHHHhhccC--CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccccC
Confidence 99996433322 12223455699999987544 8999999999999999998 9999999887765 4556666668
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
..|..++.+++-++.+||..|+..||+++++...+..++++
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 88999999999999999999999999999999999998764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=294.56 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=206.3
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e 877 (1075)
++|-++.+||+|+|+.||+|-+ ..+.||+|+-...... +...++...+...+|..|-+.|.||.||++|++|.-. .
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 4577888999999999999976 4667999986544322 2234556677888999999999999999999999864 5
Q ss_pred CceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~--GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..+|-|+|||+|.+|+.||+... .+++.++..|+.||+.||.||.+. .|||.||||.|||+... ...+.+||+|||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G-tacGeIKITDFG 618 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG-TACGEIKITDFG 618 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC-cccceeEeeecc
Confidence 67899999999999999998664 589999999999999999999986 59999999999999643 367899999999
Q ss_pred Ccccccccc--------ccCCCCCCCCccCcccccC--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHH--h
Q 001449 956 LSKVKQQTL--------VSGGVRGTLPWMAPELLSG--KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS-IIG--G 1022 (1075)
Q Consensus 956 LAk~~~~~~--------~sss~~GT~~YmAPEvl~g--~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e-il~--~ 1022 (1075)
+++...... .++...||.||++||.+.- .+...+.|+||||+|||+|+.+.|+.||....... +++ .
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 999543321 2345679999999998853 35568999999999999999999999998754332 221 1
Q ss_pred hhhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1023 IVNNTLRPQIP--SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1023 Ilk~~l~p~ip--s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
|++.. .-.+| ..++.+.++||+.||..--++|.+..+|..
T Consensus 699 IlkAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 699 ILKAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhcce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22211 12233 347899999999999999999998888754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=290.56 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=198.7
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC--C----ceeeeec
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--P----NVVSFYG 870 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H--P----NIVkL~g 870 (1075)
..+|+++..+|+|.||.|..+.+. +..||||+++.- .+..+..+-|+.+|+++.+ | -+|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 467999999999999999999774 667999998742 2333556679999999942 2 3788888
Q ss_pred ccccCCCCceEEEEeeecCCcHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC------
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD------ 943 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d------ 943 (1075)
||.. .+..|||+|.+ |-++.++|.++ ..+++...+..|+.||++++.|||+.+++|-||||+|||+.+..
T Consensus 159 wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 159 WFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 8887 78999999988 77999999875 45689999999999999999999999999999999999995211
Q ss_pred ----------CCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 001449 944 ----------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013 (1075)
Q Consensus 944 ----------~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~ 1013 (1075)
.....+||+|||.|+...+.. ...+.|..|+|||++.+-. ++.++||||+||||+||+||...|..
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceeccc
Confidence 234579999999999765554 4567899999999999877 89999999999999999999999987
Q ss_pred CChHH---HHHhhhhccC----------------CCCCCC-------------------------CCCHHHHHHHHHhhh
Q 001449 1014 MHCAS---IIGGIVNNTL----------------RPQIPS-------------------------WCDPEWRSLMESCWA 1049 (1075)
Q Consensus 1014 ~~~~e---il~~Ilk~~l----------------~p~ips-------------------------~ls~eL~dLI~kCLq 1049 (1075)
.+..+ +++.++.... ....+. .-..++.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 66555 3333321100 000000 001358899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 001449 1050 SDPAERPSFSEISRR 1064 (1075)
Q Consensus 1050 ~DPeeRPSa~ELLq~ 1064 (1075)
.||.+|+|+.|+|+.
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=279.80 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=197.5
Q ss_pred CCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc---
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--- 874 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d--- 874 (1075)
..|+.+.+||+|.||.||+|+. .|+.||+|++--+ ++++-.-...++|+++|..|+|+|++.++.+|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 4577778899999999999876 4777898865432 1122223456789999999999999999988764
Q ss_pred ---CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 875 ---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 875 ---~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.....+++|+++|+ -+|.-++.+....++..++.+++++++.||.|+|+..|+|||+|++|+||+ .++.+||
T Consensus 91 p~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgilkl 165 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGILKL 165 (376)
T ss_pred CcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceEEe
Confidence 22345999999994 589999988877899999999999999999999999999999999999998 7789999
Q ss_pred eecCCcccccccc-----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh-
Q 001449 952 GDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN- 1025 (1075)
Q Consensus 952 iDFGLAk~~~~~~-----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk- 1025 (1075)
+|||+++...... ..+..+.|.+|++||.+.|... |+.+.|||..|||+.||+|+.+-|........+..|..
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~-yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE-YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccc-cCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999997432111 1223446999999999998664 89999999999999999999999877665444332211
Q ss_pred --c---cCC--------------CCC-------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 --N---TLR--------------PQI-------------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 --~---~l~--------------p~i-------------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
. ..+ +.+ |-.-+++..+|+.++|..||.+|+++++.+..
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 000 001 11225678899999999999999999998864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=295.90 Aligned_cols=252 Identities=17% Similarity=0.202 Sum_probs=168.8
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~ 869 (1075)
.+..++|++.+.||+|+||.||+|++. +..||||+++... ..+. ...| .++...+.++..++
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~----~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEI----WMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHH----HHHH--HHHhhchhhHHHHH
Confidence 345678999999999999999999874 5679999876421 1111 1111 11222222233222
Q ss_pred cccc----cCCCCceEEEEeeecCCcHHHHHhhcccc-------------------CCHHHHHHHHHHHHHHHHHHHhCC
Q 001449 870 GIVR----DGPDGSLATVTEFMVNGSLKQFLQKKDRT-------------------IDRRKRLIIAMDAAFGMEYLHGKN 926 (1075)
Q Consensus 870 g~~~----d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~-------------------Lse~~~l~Ia~QIL~AL~yLHs~G 926 (1075)
..+. ......+++|+||+.+++|.+++...... .....+..|+.||+.||.|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 2211 12356789999999999999998754321 123345678999999999999999
Q ss_pred cccccCCCCceEeccCCCCCCeEEEeecCCcccccc--ccccCCCCCCCCccCcccccCCCC------------------
Q 001449 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ--TLVSGGVRGTLPWMAPELLSGKSH------------------ 986 (1075)
Q Consensus 927 IIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~--~~~sss~~GT~~YmAPEvl~g~~~------------------ 986 (1075)
|+||||||+|||++. ..+.+||+|||+|+.... ......+.+|+.|+|||.+.....
T Consensus 276 IiHRDLKP~NILl~~---~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 276 IVHRDVKPQNIIFSE---GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred EEeCcCCHHHEEEeC---CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 999999999999972 346899999999984322 223345678999999997642211
Q ss_pred --CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhc--------------cCCCC------CCCCCCHHHHHHH
Q 001449 987 --MVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--------------TLRPQ------IPSWCDPEWRSLM 1044 (1075)
Q Consensus 987 --~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~--------------~l~p~------ips~ls~eL~dLI 1044 (1075)
.++.++|||||||+||||+++..++.... ..+...+.. ...+. +....+...++||
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence 13456799999999999999877654321 111111110 00000 0011233456899
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 001449 1045 ESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1045 ~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.+||+.||++|||+.++++.
T Consensus 431 ~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHccCCcccCCCHHHHhCC
Confidence 99999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=288.01 Aligned_cols=261 Identities=19% Similarity=0.182 Sum_probs=183.0
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE------------------cCcceEEEEeeccccCCCchhHHH----------HH
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW------------------RGSDVAIKRIKASCFAGKPSERER----------LI 847 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~------------------kGt~VAVKvIkk~~~~~k~~ere~----------~i 847 (1075)
.+..++|++.++||+|+||+||+|.+ +++.||||+++.... ...+. ..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~----~~~~~fl~e~~~~~~~~ 216 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ----GVRQDFLKTGTLAKGSA 216 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch----hhHHHHHhhhhhhhccc
Confidence 35678999999999999999999863 245699999864321 11111 11
Q ss_pred HHHHHHHHHHHhCCCCce-----eeeecccccC------CCCceEEEEeeecCCcHHHHHhhcc----------------
Q 001449 848 ADFWKEALLLSSLHHPNV-----VSFYGIVRDG------PDGSLATVTEFMVNGSLKQFLQKKD---------------- 900 (1075)
Q Consensus 848 ~~flrEi~ILkkL~HPNI-----VkL~g~~~d~------~e~~L~LVmEYmeGGSL~d~Lkk~~---------------- 900 (1075)
+....|+.++.+++|.++ +.++++|... ..+..++|+||+.+++|.+++....
T Consensus 217 e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 217 ETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred chhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 234457777788876654 5667766531 2356899999999999999986431
Q ss_pred -------ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccccC--CCCC
Q 001449 901 -------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRG 971 (1075)
Q Consensus 901 -------~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~ss--s~~G 971 (1075)
..+++..++.|+.||+.+|.|||+.+|+||||||+|||++ .++.+||+|||++.......... ...+
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~ 372 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGML 372 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCC
Confidence 1235677888999999999999999999999999999998 56789999999997433222212 2235
Q ss_pred CCCccCcccccCCCC--------------------CCCchhhHHHHHHHHHHHHcCCC-CCCCCChHHH-----------
Q 001449 972 TLPWMAPELLSGKSH--------------------MVTEKIDVYSFGIVMWELLTGDE-PYADMHCASI----------- 1019 (1075)
Q Consensus 972 T~~YmAPEvl~g~~~--------------------~yS~KsDIWSLGVILyELLTG~~-PF~~~~~~ei----------- 1019 (1075)
|+.|+|||.+..... ....+.||||+|||+|+|++|.. ||........
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 789999998853211 11235799999999999999886 7653211110
Q ss_pred HHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 001449 1020 IGGIVNNTLRPQIPSWCDPEWRSLMESCWASDP---AERPSFSEISRR 1064 (1075)
Q Consensus 1020 l~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DP---eeRPSa~ELLq~ 1064 (1075)
...+............++...++||.+||..++ .+|+|++|+|+.
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 011111122222234568899999999999866 689999999863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=277.54 Aligned_cols=255 Identities=31% Similarity=0.564 Sum_probs=199.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHH--hCCCCceeeeecccccC-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS--SLHHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILk--kL~HPNIVkL~g~~~d~- 875 (1075)
..+..+++.||+|.||.||+|+|+|+.||||++... .| +...+|.+|.+ .|+|+||+.|++.=..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--------dE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--------DE---RSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc--------ch---hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 356788999999999999999999999999998642 11 23446666665 56899999999874432
Q ss_pred -CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceEeccCCCCC
Q 001449 876 -PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQR 946 (1075)
Q Consensus 876 -~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~--------GIIHRDIKPeNILId~~d~~~ 946 (1075)
.-..++||++|.+.|+|.|+|.+ .+++....++++..++.||.|||.. .|.|||||..||||. .+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn 352 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KN 352 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cC
Confidence 23368999999999999999987 4689999999999999999999952 499999999999998 88
Q ss_pred CeEEEeecCCcccccccc-----ccCCCCCCCCccCcccccCCC---CCCC-chhhHHHHHHHHHHHHc----------C
Q 001449 947 PVCKIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKS---HMVT-EKIDVYSFGIVMWELLT----------G 1007 (1075)
Q Consensus 947 g~VKLiDFGLAk~~~~~~-----~sss~~GT~~YmAPEvl~g~~---~~yS-~KsDIWSLGVILyELLT----------G 1007 (1075)
+.+.|+|+|+|-...... .....+||.+|||||++...- ...+ ..+||||||.++||++. -
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999999997543321 234567999999999996421 1112 35899999999999875 2
Q ss_pred CCCCCCC-----ChHHHHHhhhhccCCCCCCCCC-CH----HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1008 DEPYADM-----HCASIIGGIVNNTLRPQIPSWC-DP----EWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1008 ~~PF~~~-----~~~eil~~Ilk~~l~p~ips~l-s~----eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
++||.+. ..+++.+-+..+.++|.+|... +. .+..+|+.||..||.-|.|+-.|...|.++.+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 4688653 2233444444567778877643 22 46688999999999999999999999998863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=280.45 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=198.4
Q ss_pred CCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHH--hCCCCceeeeecccccCC-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS--SLHHPNVVSFYGIVRDGP- 876 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILk--kL~HPNIVkL~g~~~d~~- 876 (1075)
..++.++.||+|.||.||||+.+++.||||++... ..+.|..|..|.+ .++|+||++|+++-.-+.
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 44566778999999999999999999999998642 1255667777766 457999999998755422
Q ss_pred -CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCceEeccCCCCC
Q 001449 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---------NIVHFDLKCENLLVNMRDPQR 946 (1075)
Q Consensus 877 -e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~---------GIIHRDIKPeNILId~~d~~~ 946 (1075)
...++||++|.+.|+|-+||+.+ .++|....+|+..|++||.|||+. .|+|||||..||||. .+
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK----~D 352 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK----ND 352 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----cC
Confidence 44689999999999999999876 589999999999999999999962 599999999999997 78
Q ss_pred CeEEEeecCCcccccccc---ccCCCCCCCCccCcccccCCCCCC----CchhhHHHHHHHHHHHHcCCC----------
Q 001449 947 PVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMV----TEKIDVYSFGIVMWELLTGDE---------- 1009 (1075)
Q Consensus 947 g~VKLiDFGLAk~~~~~~---~sss~~GT~~YmAPEvl~g~~~~y----S~KsDIWSLGVILyELLTG~~---------- 1009 (1075)
++..|+|||+|....... ..-..+||.+|||||++.+.-..- =.+.||||+|.+||||++.-.
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999998654322 223467999999999998654322 136899999999999998432
Q ss_pred --CCC-----CCChHHHHHhhhhccCCCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1010 --PYA-----DMHCASIIGGIVNNTLRPQIPSW-----CDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1010 --PF~-----~~~~~eil~~Ilk~~l~p~ips~-----ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
||. .....++....+....+|.++.. ...-+++.|..||..|++.|.|+.=+.+++.++.
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 332 11223344444556667777643 2346889999999999999999999999888764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=262.47 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=201.0
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeeccccc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d 874 (1075)
..++|++++++|.|-|+.||.|.. ++++++||+++.-. .+.+.+|++||..|. |||||++++++.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 457899999999999999999974 68889999987531 245668999999998 9999999999999
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
+......+|+||+.+.+...+.. +++...+..++.||++||.|+|+.||+|||+||.|++|+ .....++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeeec
Confidence 87778899999999988888764 367788889999999999999999999999999999998 35678999999
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCChHHHHHhhhh--------
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYA-DMHCASIIGGIVN-------- 1025 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~-~~~~~eil~~Ilk-------- 1025 (1075)
|+|...-......-...+..|--||++..- ..|+..-|+|||||+|..|+..+.||. +.+..+.+.+|.+
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 999987666555555678889999999754 358899999999999999999999974 3333333333221
Q ss_pred -------------------ccC--------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1026 -------------------NTL--------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1026 -------------------~~l--------~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
... ........++++.+|+.++|..|..+|+|++|.+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000 01111234689999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=285.85 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=202.5
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC------Ccee
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH------PNVV 866 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H------PNIV 866 (1075)
.++...+|.+....|+|-|++|.+|++ .|..||||+|...- ..-+.=++|+.||++|.. -|++
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---------~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---------VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---------HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 345668899999999999999999988 48899999998542 223455689999999962 3789
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhcccc--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~--Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~ 944 (1075)
+|+..|.. .+.+|||+|-+ ..+|.++|++.+.. |....+..++.||+.||..|-..||+|.||||+||||+ .
T Consensus 498 rl~r~F~h--knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN---E 571 (752)
T KOG0670|consen 498 RLFRHFKH--KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN---E 571 (752)
T ss_pred HHHHHhhh--cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec---c
Confidence 99998887 78999999988 78999999987643 78889999999999999999999999999999999998 3
Q ss_pred CCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhh
Q 001449 945 QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024 (1075)
Q Consensus 945 ~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Il 1024 (1075)
....+||||||.|........+ .+..+..|.|||++.|.+ |+...|+||+||+||||+||+..|.+.+...++.-.+
T Consensus 572 ~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCcccccccccccc-HHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 5678999999998865554443 344677899999999887 7889999999999999999999999877666543222
Q ss_pred h--ccCCC--------------------------------------CCC-----------CCC-------CHHHHHHHHH
Q 001449 1025 N--NTLRP--------------------------------------QIP-----------SWC-------DPEWRSLMES 1046 (1075)
Q Consensus 1025 k--~~l~p--------------------------------------~ip-----------s~l-------s~eL~dLI~k 1046 (1075)
. +.++. ..| ..+ -..|++|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 1 10000 000 001 1358899999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 001449 1047 CWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1047 CLq~DPeeRPSa~ELLq~ 1064 (1075)
||.+||++|.|..+.|..
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999988753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=234.78 Aligned_cols=211 Identities=38% Similarity=0.658 Sum_probs=180.5
Q ss_pred EcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 808 LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
||+|.+|.||+++.. +..+++|++....... ....+.+|+.+++.+.|++|+++++++.. ....++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEe
Confidence 689999999999986 8889999987542211 23567899999999999999999999887 478899999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCC-CCeEEEeecCCcccccccc
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIGDLGLSKVKQQTL 964 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~-~g~VKLiDFGLAk~~~~~~ 964 (1075)
|+.+++|.+++......+++..++.++.+++++|.+||+.|++|+||+|.||+++ . ...++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9998999999987644689999999999999999999999999999999999998 4 6789999999988554332
Q ss_pred -ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHH
Q 001449 965 -VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSL 1043 (1075)
Q Consensus 965 -~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dL 1043 (1075)
......++..|++||.+... ...+.+.|+|+||+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12334578899999998754 2478899999999999999 678899
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 001449 1044 MESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1044 I~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
+.+|++.+|.+||++.++++.|
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=252.49 Aligned_cols=216 Identities=30% Similarity=0.443 Sum_probs=174.7
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCceeeeecccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVR 873 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNIVkL~g~~~ 873 (1075)
+..+++..+..||+|++|.|-+-++ .|+..|+|.++...- ....++.++|+.+..+. .+|.+|.+||.+.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 3445666778899999999966555 689999999986431 12235677888876655 5999999999887
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeE
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~V 949 (1075)
. ++..++.||.| ..+|..+.++ .+..+++..+-+|+..++.||.|||++ .|||||+||+||||+ ..++|
T Consensus 116 r--egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqV 188 (282)
T KOG0984|consen 116 R--EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQV 188 (282)
T ss_pred c--cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcE
Confidence 7 67899999999 5688777653 567799999999999999999999976 899999999999998 78899
Q ss_pred EEeecCCccccccccccCCCCCCCCccCcccccC--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHhhhhc
Q 001449 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG--KSHMVTEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNN 1026 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g--~~~~yS~KsDIWSLGVILyELLTG~~PF~~~-~~~eil~~Ilk~ 1026 (1075)
|+||||++....+....+...|-..|||||.+.. ....|+.|+||||||++++||.+++.||... ++.+.+..++..
T Consensus 189 KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred EEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9999999987666555555668889999999863 2235899999999999999999999999764 455566665544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=292.38 Aligned_cols=241 Identities=29% Similarity=0.444 Sum_probs=185.6
Q ss_pred EEEEcccCcEE-EEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCCceEE
Q 001449 805 VRELGSGTYGS-VYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 805 l~~LGeG~FG~-VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~~L~L 882 (1075)
.+.+|.|+.|+ ||+|.+.|+.||||++-.++ .....+|+..|+... |||||++|+.-.+ ...+||
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----------~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YI 580 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----------FDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYI 580 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----------HHHHHHHHHHHHhccCCCceEEEEeeccC--CceEEE
Confidence 34589999866 59999999999999876442 234568999999886 9999999887555 788999
Q ss_pred EEeeecCCcHHHHHhhcccc--C-CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC-CCCeEEEeecCCcc
Q 001449 883 VTEFMVNGSLKQFLQKKDRT--I-DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP-QRPVCKIGDLGLSK 958 (1075)
Q Consensus 883 VmEYmeGGSL~d~Lkk~~~~--L-se~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~-~~g~VKLiDFGLAk 958 (1075)
+.|.| ..+|.+++...... . .....+.+..|+++||.+||+.+||||||||.||||+..+. ....++|+|||+++
T Consensus 581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99999 67999999874111 1 11344677889999999999999999999999999986442 34789999999999
Q ss_pred cccccc----ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHhhhhccCCCC-C
Q 001449 959 VKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCASIIGGIVNNTLRPQ-I 1032 (1075)
Q Consensus 959 ~~~~~~----~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG-~~PF~~~~~~eil~~Ilk~~l~p~-i 1032 (1075)
...... ......||..|+|||++.... -+..+|||||||++|+.++| ..||.+.-..+ ..|++...... +
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHL 735 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeee
Confidence 543222 134567999999999998655 46689999999999999985 99998754332 24444433211 1
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
...-+.+..+||.+|++.+|..||++.++|.
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1222238999999999999999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=261.34 Aligned_cols=263 Identities=28% Similarity=0.477 Sum_probs=216.5
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kG-------t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL 868 (1075)
++...+++....+-+|.||.||+|.|+. +.|-+|.++.. ..+..+..++.|..+|..+.|||+..+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 3445667788889999999999997742 23666666543 234556788999999999999999999
Q ss_pred ecccccCCCCceEEEEeeecCCcHHHHHhhc-------cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEecc
Q 001449 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (1075)
Q Consensus 869 ~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~-------~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~ 941 (1075)
.++..+. ....+.++.++.-|+|..++..+ .+.++..+...++.|++.|++|||+.||||.||..+|.+|+
T Consensus 353 ~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId- 430 (563)
T KOG1024|consen 353 LGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID- 430 (563)
T ss_pred eEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh-
Confidence 9988763 44567788999889999999832 24467777888999999999999999999999999999998
Q ss_pred CCCCCCeEEEeecCCccccccc-cc-c-CCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001449 942 RDPQRPVCKIGDLGLSKVKQQT-LV-S-GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCA 1017 (1075)
Q Consensus 942 ~d~~~g~VKLiDFGLAk~~~~~-~~-s-ss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~ 1017 (1075)
+...|||+|=.+++..-+. .. . ........|||+|.+.... |+..+|+||||++||||+| |+.||.+.++.
T Consensus 431 ---d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 431 ---DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred ---hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 7799999999999843211 11 1 1122355799999997554 8999999999999999998 99999999998
Q ss_pred HHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHcC
Q 001449 1018 SIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAIN 1073 (1075)
Q Consensus 1018 eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~Ln 1073 (1075)
++... ++..++...|..|++++..++..||..+|++||+++++...|.++..+|.
T Consensus 506 Em~~y-lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 506 EMEHY-LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHHHH-HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 87554 56667888999999999999999999999999999999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-26 Score=233.25 Aligned_cols=210 Identities=31% Similarity=0.524 Sum_probs=172.9
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~ 879 (1075)
|++.+.||.|++|.||+++.. +..+|+|.+...... .....+.+|+..+++++|+||+++++++.. ...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFED--PEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCc
Confidence 567789999999999999885 588999998764321 234678889999999999999999998876 567
Q ss_pred eEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 880 L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.++++||+.+++|.+++......+++..++.++.+++.+|.+||+.+++|+||+|.||+++ ....++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 8999999999999999976543378999999999999999999999999999999999998 558999999999886
Q ss_pred ccccc--ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChH-HHHHhhhh
Q 001449 960 KQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-MHCA-SIIGGIVN 1025 (1075)
Q Consensus 960 ~~~~~--~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~-~~~~-eil~~Ilk 1025 (1075)
..... ......++..|++||.+. ....++.++|||+||+++++|++|+.||.. .... .+.+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 54432 233456788999999984 233467799999999999999999999977 3444 44444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=263.29 Aligned_cols=252 Identities=26% Similarity=0.349 Sum_probs=193.7
Q ss_pred eeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC-
Q 001449 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG- 878 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~- 878 (1075)
.+-.+.||-|+||.||.+++ +|+.||+|++..- ..+-...+.+.+|+++|...+|.|++..+++.+-..-+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence 33345799999999999987 5899999987532 12223357788999999999999999998876543211
Q ss_pred --ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCC
Q 001449 879 --SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 879 --~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGL 956 (1075)
.+|.++|.| ..+|..+|-.. ..++...++-+..||++||+|||+.+|.||||||.|+|++ .+-.+||||||+
T Consensus 129 FqEiYV~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFGL 202 (449)
T KOG0664|consen 129 FQELYVLTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFGL 202 (449)
T ss_pred HHHHHHHHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEeccccc
Confidence 257788888 45787777543 4688899999999999999999999999999999999998 788999999999
Q ss_pred ccccccccc--cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh---------
Q 001449 957 SKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN--------- 1025 (1075)
Q Consensus 957 Ak~~~~~~~--sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk--------- 1025 (1075)
++..+.... .+...-|-.|+|||++.|..+ |+..+||||+|||+.||+..+..|....+.+.++.|..
T Consensus 203 ARvee~d~~~hMTqEVVTQYYRAPEiLMGaRh-Ys~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 203 ARTWDQRDRLNMTHEVVTQYYRAPELLMGARR-YTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred ccccchhhhhhhHHHHHHHHhccHHHhhcchh-hcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 996544332 233456889999999998765 89999999999999999999999987766555443321
Q ss_pred --------------c-cCCCCCCC--------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1026 --------------N-TLRPQIPS--------WCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1026 --------------~-~l~p~ips--------~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
. ...+.++. .-..+...++.++|..||++|.+..+.+..+.
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1 11122211 12346778999999999999999888776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=262.96 Aligned_cols=134 Identities=23% Similarity=0.315 Sum_probs=113.0
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-----C---Ccee
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----H---PNVV 866 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-----H---PNIV 866 (1075)
+...+|.++++||.|-|++||+|.++ .+.||+|+.+.. +...+..+.|+++|++++ + ..||
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 45578999999999999999999885 667999998843 234466778999999985 2 4699
Q ss_pred eeeccccc--CCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEec
Q 001449 867 SFYGIVRD--GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVN 940 (1075)
Q Consensus 867 kL~g~~~d--~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId 940 (1075)
+|++.|.- .....+|||+|++ |.+|..+|+... +-++...++.|++||+.||.|||+ .||||-||||+|||+.
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99999875 3344689999999 899999998754 458999999999999999999997 4999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-28 Score=277.47 Aligned_cols=207 Identities=26% Similarity=0.414 Sum_probs=175.2
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC---CCceeeeeccc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIV 872 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~---HPNIVkL~g~~ 872 (1075)
+..+|..++.+|+|+||.|++|.++ ...|+||.|.++.+-.+.=-+++.+-..-.|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467999999999999999999885 556999999876544332223344455667999999998 99999999999
Q ss_pred ccCCCCceEEEEeee-cCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 873 RDGPDGSLATVTEFM-VNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYm-eGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
.+ ++.+||+||-- ++.+|+++|..+. .+++..++.|++|++.|+++||+.||||||||-+||.++ .+|.+||
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~kl 711 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVKL 711 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEEE
Confidence 98 78999999976 5669999997664 489999999999999999999999999999999999998 8899999
Q ss_pred eecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~ 1013 (1075)
+|||.|....... ...+.||..|.|||++.|.+ +....-|||+||++||.++...-||..
T Consensus 712 idfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~-y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEK-YLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCCC-cceeeeeccccchhhhCCCc-cCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999988554432 34578999999999998765 468889999999999999999988864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=258.58 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=196.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~- 875 (1075)
..+|.-++.+|.|.- .|-.+-+ .+++||+|++... +..... .++..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~-----akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTH-----AKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCcc-----chhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 356778888999998 6655544 5899999988766 333222 24456899999999999999999988631
Q ss_pred ---CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 876 ---~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
.....|+|||+| ..+|...+.. .++-+.+.+|+.|++.|++|||+.||+||||||+||++. ....+||+
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 123479999999 6789888873 368889999999999999999999999999999999997 77899999
Q ss_pred ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhcc-----
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT----- 1027 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~----- 1027 (1075)
|||+|+........+.++.|..|+|||++.+.. |...+||||+|||+.||++|...|.+.+.-+...++....
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999999776665666788999999999998766 8899999999999999999999998765544333222100
Q ss_pred --------------------CCCC----C-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1028 --------------------LRPQ----I-----------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1028 --------------------l~p~----i-----------ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.... + +..-...+++++.+||..||++|.|++++|+.
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 0 11123458899999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=279.83 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=211.2
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..++|+.+..+|.|+||.|||+++ +++..|+|+++.+.-.. +.-..+|+.+++.++|||||.+++.+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--------~~~iqqei~~~~dc~h~nivay~gsylr- 83 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--------FSGIQQEIGMLRDCRHPNIVAYFGSYLR- 83 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--------ccccccceeeeecCCCcChHHHHhhhhh-
Confidence 357899999999999999999987 48889999999763221 2345579999999999999999999887
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
...++++||||-+|+|.+...-. +.+++.++.+++++.++||+|||+.|-+|||||-.|||++ +.+.+||+|||
T Consensus 84 -~dklwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDfg 157 (829)
T KOG0576|consen 84 -RDKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADFG 157 (829)
T ss_pred -hcCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeecccC
Confidence 67899999999999999876543 4689999999999999999999999999999999999998 78899999999
Q ss_pred Ccccccccc-ccCCCCCCCCccCccccc-CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCC--
Q 001449 956 LSKVKQQTL-VSGGVRGTLPWMAPELLS-GKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ-- 1031 (1075)
Q Consensus 956 LAk~~~~~~-~sss~~GT~~YmAPEvl~-g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~-- 1031 (1075)
.+..+.... ...+++||+.|||||+-. ++...|..++|||++|++..|+-.-++|..+..+...+..+.+..+.+.
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL 237 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc
Confidence 988654443 345789999999999863 3445689999999999999999998998877777777666655544332
Q ss_pred -CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1032 -IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1032 -ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
-+...++.|-+|++.||.++|.+||++..+|+
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22346788999999999999999999988875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=240.20 Aligned_cols=262 Identities=19% Similarity=0.259 Sum_probs=200.3
Q ss_pred CeeEEEEEcccCcEEEEEEEEcCc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC----CCceeeeecccc
Q 001449 801 DLEEVRELGSGTYGSVYHGKWRGS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH----HPNVVSFYGIVR 873 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~kGt---~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~----HPNIVkL~g~~~ 873 (1075)
.|++.+.||+|+||.||++..... .+|+|+......... ..+..|..+|..+. ..++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999998643 589998775422211 12345777777775 357888888774
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC-CCCCeEEE
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d-~~~g~VKL 951 (1075)
......+|||+.+ |.+|.++..... +.++..+++.|+.|++.+|++||+.|++||||||+|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 1256789999987 999999987665 7799999999999999999999999999999999999997433 22357999
Q ss_pred eecCCcc--ccccc---------cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001449 952 GDLGLSK--VKQQT---------LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASII 1020 (1075)
Q Consensus 952 iDFGLAk--~~~~~---------~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil 1020 (1075)
+|||+++ ..... .....+.||..|+++.++.+.. .+.+.|+||+++++.+|+.|.+||.........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 9999998 31111 1123456999999999998766 689999999999999999999999765432222
Q ss_pred Hhhh---hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHcCC
Q 001449 1021 GGIV---NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074 (1075)
Q Consensus 1021 ~~Il---k~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~Lnv 1074 (1075)
..+. ............+.++..+...+-..+..++|++..+...|+++..+.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 2222 22211112344567888888888889999999999999999998776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=218.35 Aligned_cols=164 Identities=24% Similarity=0.353 Sum_probs=130.2
Q ss_pred CcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccccCCC
Q 001449 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969 (1075)
Q Consensus 890 GSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~sss~ 969 (1075)
|+|.+++...+..+++..++.|+.||++||.|||+++ ||+|||++ .++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6899999877777999999999999999999999999 99999998 6678888 99988654322 2
Q ss_pred CCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHhhhhccCCC-----CCCCCCCH--HHH
Q 001449 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIVNNTLRP-----QIPSWCDP--EWR 1041 (1075)
Q Consensus 970 ~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~-eil~~Ilk~~l~p-----~ips~ls~--eL~ 1041 (1075)
.||+.|||||++.+.. ++.++|||||||++|||++|+.||...... ..+..+....... ..+..++. +++
T Consensus 65 ~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 5899999999997655 789999999999999999999999765432 2222322221111 11122333 699
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 001449 1042 SLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~ 1071 (1075)
++|.+||+.+|.+||++.++++.+..+..+
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=274.19 Aligned_cols=200 Identities=23% Similarity=0.290 Sum_probs=145.9
Q ss_pred hCCC-CceeeeecccccC-----CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 001449 859 SLHH-PNVVSFYGIVRDG-----PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (1075)
Q Consensus 859 kL~H-PNIVkL~g~~~d~-----~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDI 932 (1075)
.+.| .||+.++++|..+ ....+++++||+ +++|.++|......+++..++.|+.||++||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5788888877321 134677888987 77999999876667999999999999999999999999999999
Q ss_pred CCCceEeccCC---------------CCCCeEEEeecCCccccccc-----------------cccCCCCCCCCccCccc
Q 001449 933 KCENLLVNMRD---------------PQRPVCKIGDLGLSKVKQQT-----------------LVSGGVRGTLPWMAPEL 980 (1075)
Q Consensus 933 KPeNILId~~d---------------~~~g~VKLiDFGLAk~~~~~-----------------~~sss~~GT~~YmAPEv 980 (1075)
||+||||+..+ .....+||+|||+++..... .......||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996210 13456788888887632110 00012358999999999
Q ss_pred ccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 001449 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060 (1075)
Q Consensus 981 l~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~E 1060 (1075)
+.+.. ++.++|||||||+||||++|..|+.... ..+..+......+... ....+..+++.+||+.+|.+||++.+
T Consensus 187 ~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 187 DNGSS--SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hccCC--CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChHH
Confidence 98655 7999999999999999999998875422 1222222222211111 12456678999999999999999999
Q ss_pred HHHH
Q 001449 1061 ISRR 1064 (1075)
Q Consensus 1061 LLq~ 1064 (1075)
+++.
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=236.42 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=181.9
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecc-cccC
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI-VRDG 875 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~-~~d~ 875 (1075)
+.|.+.+.||+|.||.+.++.++ .+.+|+|.+..... .+++|.+|...--.|. |.|||.-|+. |++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt- 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---------TQADFVREFHYSFFLSPHQHIIDTYEVAFQT- 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---------hHHHHHHHhccceeeccchhhhHHHHHHhhc-
Confidence 56888999999999999999997 55699998875432 2477888876554454 8899988875 444
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
.+.+++++||++.|+|.+-+...+ +-+...++++.|+++||.|||++++||||||.+||||-.. +..+|||||||
T Consensus 94 -~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~rvKlcDFG 168 (378)
T KOG1345|consen 94 -SDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYRVKLCDFG 168 (378)
T ss_pred -CceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccEEEeeecc
Confidence 568899999999999999887654 7888899999999999999999999999999999999633 45699999999
Q ss_pred CccccccccccCCCCCCCCccCcccccC---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHhhhhccCC
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSG---KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---IIGGIVNNTLR 1029 (1075)
Q Consensus 956 LAk~~~~~~~sss~~GT~~YmAPEvl~g---~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e---il~~Ilk~~l~ 1029 (1075)
+++....... ....+..|.+||++.. .....+..+|||.||+++|.+|||++||......+ .......+...
T Consensus 169 ~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 169 LTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 9875433222 1224667999998742 22335667899999999999999999997422111 11111112222
Q ss_pred CCC---CCCCCHHHHHHHHHhhhcCCCCC
Q 001449 1030 PQI---PSWCDPEWRSLMESCWASDPAER 1055 (1075)
Q Consensus 1030 p~i---ps~ls~eL~dLI~kCLq~DPeeR 1055 (1075)
+.. -..+++.+..+.++-|..++++|
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 233 34578899999999999999999
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-23 Score=209.51 Aligned_cols=251 Identities=31% Similarity=0.491 Sum_probs=197.0
Q ss_pred eeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC-ceeeeecccccCCCCce
Q 001449 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP-NIVkL~g~~~d~~e~~L 880 (1075)
|.+.+.||.|+|+.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+.+++.+.. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEE
Confidence 678899999999999999988 7789999876543221 2346788999999999988 79999999855 4557
Q ss_pred EEEEeeecCCcHHHHHhhcc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCC-eEEEeecCCc
Q 001449 881 ATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLS 957 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~--~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g-~VKLiDFGLA 957 (1075)
+++++++.+++|.+++.... ..++......++.|++.++.|+|+.+++||||||+||+++ ... .++++|||++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 99999999999997776654 2589999999999999999999999999999999999998 444 7999999998
Q ss_pred ccccccc-------ccCCCCCCCCccCcccccCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHhhhh
Q 001449 958 KVKQQTL-------VSGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHC----ASIIGGIVN 1025 (1075)
Q Consensus 958 k~~~~~~-------~sss~~GT~~YmAPEvl~g~~-~~yS~KsDIWSLGVILyELLTG~~PF~~~~~----~eil~~Ilk 1025 (1075)
+...... ......||..|++||.+.+.. ..++...|+||+|++++++++|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 8443322 235667999999999997642 3478899999999999999999999877653 333333322
Q ss_pred ccCC---CCCCCCC----CHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1026 NTLR---PQIPSWC----DPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 ~~l~---p~ips~l----s~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
.... ....... ...+.+++..|+..+|..|.+..+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2211 1111111 2578899999999999999887776654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=230.28 Aligned_cols=261 Identities=18% Similarity=0.256 Sum_probs=211.9
Q ss_pred CCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~ 875 (1075)
.-.|++.++||+|+||.++.|+. +++.||||.-.....+ -++.-|....+.|. .++|...|.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----------PQLrdEYr~YKlL~g~~GIP~vYYFGqe- 95 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----------PQLRDEYRTYKLLGGTEGIPQVYYFGQE- 95 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCc----------chHHHHHHHHHHHcCCCCCCceeeeccc-
Confidence 45699999999999999999975 7999999975543211 23345666666665 7888888776655
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC-CCCCeEEEeec
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGDL 954 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d-~~~g~VKLiDF 954 (1075)
...-.||||++ |-+|+|++.-+++.++..++..||+|++.-++|+|++.+|.|||||+|+||...+ .....+.|+||
T Consensus 96 -G~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 96 -GKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred -cchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 33457899988 9999999999999999999999999999999999999999999999999997543 34457999999
Q ss_pred CCccccccccc--------cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---ChHHHHHhh
Q 001449 955 GLSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM---HCASIIGGI 1023 (1075)
Q Consensus 955 GLAk~~~~~~~--------sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~---~~~eil~~I 1023 (1075)
|+|+.+.+... ..+..||.+||+-....|+. .+.+.|+-|||-+++++|-|.+||.+. +..+.+++|
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE--QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccch--hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 99997654432 34567999999999998877 689999999999999999999999763 444555555
Q ss_pred hhccCC---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHcCC
Q 001449 1024 VNNTLR---PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074 (1075)
Q Consensus 1024 lk~~l~---p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~Lnv 1074 (1075)
-..... ..+...+|.++...++..-+++..+-|+++-+...+.++++.++-
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 433221 223456789999999999999999999999999999999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=223.95 Aligned_cols=262 Identities=20% Similarity=0.294 Sum_probs=209.5
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC-Cceeeeecccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGIVR 873 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H-PNIVkL~g~~~ 873 (1075)
+....|.++++||.|+||.+|.|.. .|+.||||+-....-. -++..|.++.+.|++ ..|..+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----------pqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----------PQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----------cchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3457899999999999999999986 5999999987654322 234567788888874 45655555555
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
+ ...-.+||+.+ |-+|.+++.-+.+.++..+++.++-|++.-|+|+|.++.|||||||+|+|+..+. ....+.|+|
T Consensus 82 e--~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LID 157 (341)
T KOG1163|consen 82 E--KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLID 157 (341)
T ss_pred c--cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEEe
Confidence 5 55678999988 9999999998888899999999999999999999999999999999999997443 456899999
Q ss_pred cCCcccccccc--------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHh
Q 001449 954 LGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---IIGG 1022 (1075)
Q Consensus 954 FGLAk~~~~~~--------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~e---il~~ 1022 (1075)
||+|+...+.. ......||.+|.+-..+.+.. .+.+.|+-|+|++|.++..|.+||.+..... ..++
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 99999543322 223467999999998887665 5889999999999999999999998764433 2333
Q ss_pred hhhccC---CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHcCC
Q 001449 1023 IVNNTL---RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074 (1075)
Q Consensus 1023 Ilk~~l---~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~~Lnv 1074 (1075)
|..... ...+.+..|.|+.-.+..|-..-.++-|++.-|-+.++.+...++.
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 333222 2234567899999999999999999999999999999998887753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=242.36 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=187.6
Q ss_pred CCeeEEEEEcccCcEEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccc
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~-----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~ 873 (1075)
..|..+.+||+|+|++||++.+ +...||+|.+...... .++..|+.+|..+. +.||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 5688999999999999999875 3566999998754322 44678999999996 899999999998
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEee
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiD 953 (1075)
. ++..++|+||++..+..+++.. ++...+..+++.++.||.++|.+|||||||||+|+|.+ ...+.-.|+|
T Consensus 106 n--nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n---~~t~rg~LvD 176 (418)
T KOG1167|consen 106 N--NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN---RRTQRGVLVD 176 (418)
T ss_pred c--CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc---cccCCceEEe
Confidence 7 6788999999999999998865 67888999999999999999999999999999999997 4567788999
Q ss_pred cCCccccccc---------------c------------------------------ccCCCCCCCCccCcccccCCCCCC
Q 001449 954 LGLSKVKQQT---------------L------------------------------VSGGVRGTLPWMAPELLSGKSHMV 988 (1075)
Q Consensus 954 FGLAk~~~~~---------------~------------------------------~sss~~GT~~YmAPEvl~g~~~~y 988 (1075)
||+|...+.. . ..-...||++|+|||++..-+ ..
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~Q 255 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQ 255 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-Cc
Confidence 9998611000 0 001135999999999997533 46
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHhhhh--------------cc---------------------C----
Q 001449 989 TEKIDVYSFGIVMWELLTGDEPYADMH-CASIIGGIVN--------------NT---------------------L---- 1028 (1075)
Q Consensus 989 S~KsDIWSLGVILyELLTG~~PF~~~~-~~eil~~Ilk--------------~~---------------------l---- 1028 (1075)
+.++||||.|+|++-+++++.||.... ....+..+.. +. .
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 889999999999999999999984321 1111110000 00 0
Q ss_pred ---------C-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1029 ---------R-PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1029 ---------~-p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
. .......+..+.+|+++||..||.+|.|+++.|.
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 0001123457889999999999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.2e-21 Score=204.29 Aligned_cols=253 Identities=28% Similarity=0.502 Sum_probs=203.8
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
..++.++.+|.+.-.|..|+|+|.|..+++|+++..... .++-+.|..|.-.|+-..||||+.++++|..+ .
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t------~risrdfneefp~lrifshpnilpvlgacnsp--p 260 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT------ARISRDFNEEFPALRIFSHPNILPVLGACNSP--P 260 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc------hhhcchhhhhCcceeeecCCchhhhhhhccCC--C
Confidence 344556778899999999999999999999998865322 23346788888889999999999999999884 5
Q ss_pred ceEEEEeeecCCcHHHHHhhccc-cCCHHHHHHHHHHHHHHHHHHHhCC-cc-cccCCCCceEeccCCCCCCeEEE--ee
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKN-IV-HFDLKCENLLVNMRDPQRPVCKI--GD 953 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~~-~Lse~~~l~Ia~QIL~AL~yLHs~G-II-HRDIKPeNILId~~d~~~g~VKL--iD 953 (1075)
.+.++..||+.|+|+.++..... ..+..++.+++.+|++|+.|||+.. ++ ---|....++|| ++.+.+| +|
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edltarismad 336 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTARISMAD 336 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhhheeccc
Confidence 68999999999999999976532 3677788899999999999999874 33 345788889998 4455444 22
Q ss_pred cCCccccccccccCCCCCCCCccCcccccCCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCC
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV-TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 954 FGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~y-S~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~i 1032 (1075)
--++.. .....-.+.||+||.++.++... -..+|+|||+++||||.|...||.+..+.+.-.++.-+.++..+
T Consensus 337 ~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i 410 (448)
T KOG0195|consen 337 TKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI 410 (448)
T ss_pred ceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC
Confidence 222211 11233578999999998665433 34689999999999999999999998888876777778888999
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1033 ps~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~ 1069 (1075)
|..++..+..|+.-|++.||.+||.++.|+-.|+++.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=213.80 Aligned_cols=165 Identities=18% Similarity=0.126 Sum_probs=124.2
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEE---cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceee-eecccc
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW---RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS-FYGIVR 873 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~---kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVk-L~g~~~ 873 (1075)
..++|++.+.||+|+||+||+|.+ .++.||||++........ .......+.+|+.+|++++|+||+. ++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS---KPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc---cHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 457799999999999999999976 356689998753211000 1123456889999999999999985 4432
Q ss_pred cCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCceEeccCCCCCCeEEEe
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL-KCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 874 d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDI-KPeNILId~~d~~~g~VKLi 952 (1075)
+..++||||+.|++|... ... . ...++.|++++|.|||++||+|||| ||+|||++ .++.+||+
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ikLi 154 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAAVI 154 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEEEE
Confidence 246999999999999732 111 1 1457889999999999999999999 99999997 55689999
Q ss_pred ecCCccccccccc---------cCCCCCCCCccCcccccC
Q 001449 953 DLGLSKVKQQTLV---------SGGVRGTLPWMAPELLSG 983 (1075)
Q Consensus 953 DFGLAk~~~~~~~---------sss~~GT~~YmAPEvl~g 983 (1075)
|||+|+....... .....+++.|+|||.+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999985432211 124567888999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-21 Score=230.92 Aligned_cols=251 Identities=27% Similarity=0.346 Sum_probs=184.7
Q ss_pred eEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
.....+|.|++|.|+.++.. ...++.|.++.. ......+ ......+..|+.+-..++|+||+..+..+.+. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~-~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESE-RKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccH-HHHhhhhhhheeecccccCCchhhhHHHHhhc--ccc
Confidence 34567999999988776542 344555544321 1011111 11222266788888999999999988887763 223
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
.-+||||++ +|..++... ..++...+-.+++||+.||+|||+.||.|||||++|++++ ..+.+||+|||.+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCceEEeecCcceee
Confidence 334999999 999999765 3478888889999999999999999999999999999998 7789999999998843
Q ss_pred ccc-----cccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-Hhhh-hcc-----C
Q 001449 961 QQT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASII-GGIV-NNT-----L 1028 (1075)
Q Consensus 961 ~~~-----~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil-~~Il-k~~-----l 1028 (1075)
.-. .....++|+..|+|||++.+.. +....+||||.|++++.|++|+.||......+.. .... ... -
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~-ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKE-YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccc-cCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 221 3445678999999999998765 3566789999999999999999999654333221 0100 000 0
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
...+...++.+.+.+|..||+.||.+|.|+++|++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 112334578899999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-21 Score=221.88 Aligned_cols=224 Identities=28% Similarity=0.429 Sum_probs=185.8
Q ss_pred EcccCcEEEEEEE-----EcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCCceE
Q 001449 808 LGSGTYGSVYHGK-----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 808 LGeG~FG~VYkAk-----~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~~L~ 881 (1075)
+|+|+||.|++++ +.|.-+|+|+.++.....+... ....|..++..++ ||.+|++...++. ++.++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQT--DGKLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecc--ccchh
Confidence 7999999999753 3477799999887655443221 3446788888888 9999999999988 77899
Q ss_pred EEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
+++++..+|+|...+.+... +++.....+...++.+++++|+.+|+|||+|++||+++ ..|++|+.|||+++...
T Consensus 74 l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHhH
Confidence 99999999999998877654 55666666667999999999999999999999999998 88999999999999654
Q ss_pred cccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHH
Q 001449 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR 1041 (1075)
Q Consensus 962 ~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~ 1041 (1075)
..... |||..|||||++++ ....+|.||||++++||+||..||.. +....|++.. ..+|..++.+++
T Consensus 149 ~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~~l~~~a~ 215 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPRELSAEAR 215 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCchhhhHHHH
Confidence 44333 89999999999972 46679999999999999999999987 5555565533 457888999999
Q ss_pred HHHHHhhhcCCCCCCC
Q 001449 1042 SLMESCWASDPAERPS 1057 (1075)
Q Consensus 1042 dLI~kCLq~DPeeRPS 1057 (1075)
+++.+++..+|.+|.-
T Consensus 216 ~~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLG 231 (612)
T ss_pred HHHHHHHhhCHHHHhc
Confidence 9999999999999953
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=201.35 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=185.0
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEcC--c-----------------------------------ceEEEEeeccccCCC
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWRG--S-----------------------------------DVAIKRIKASCFAGK 839 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~kG--t-----------------------------------~VAVKvIkk~~~~~k 839 (1075)
+..++|++...||+|-.+.||.++... . +.|||.+-.-. -
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~---~ 230 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE---H 230 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc---c
Confidence 455789999999999999999875421 0 23555443211 1
Q ss_pred chhHHHHHHHHHHHHH--------------HHHh--------CCCCceeeeecccccC----------------------
Q 001449 840 PSERERLIADFWKEAL--------------LLSS--------LHHPNVVSFYGIVRDG---------------------- 875 (1075)
Q Consensus 840 ~~ere~~i~~flrEi~--------------ILkk--------L~HPNIVkL~g~~~d~---------------------- 875 (1075)
......+++..-+|.. ..+. -+|||||.++++|.++
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1223444555544432 1122 2599999999887542
Q ss_pred ---CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 876 ---~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
....+|+||.-. ..+|..++..+. .+......|+.|+++|+.|||+.||.|||+|.+||||..++..-..+.|+
T Consensus 311 g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 234578999877 569999987653 57777888889999999999999999999999999998777778899999
Q ss_pred ecCCccccccc-----cc--cCCCCCCCCccCcccccCCCCCC----CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001449 953 DLGLSKVKQQT-----LV--SGGVRGTLPWMAPELLSGKSHMV----TEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021 (1075)
Q Consensus 953 DFGLAk~~~~~-----~~--sss~~GT~~YmAPEvl~g~~~~y----S~KsDIWSLGVILyELLTG~~PF~~~~~~eil~ 1021 (1075)
|||.+-..+.. .. .-..-|...-||||+....+... -.|+|.|+.|.+.||+++..-||......-.-.
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 99976532211 11 11234778899999986433211 138999999999999999999998732211111
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1022 ~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
....+..-+.++..+++.+++|+..+|+.||.||+|..-....|
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 11222334678889999999999999999999998865544443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=226.47 Aligned_cols=247 Identities=20% Similarity=0.218 Sum_probs=178.4
Q ss_pred CeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCce
Q 001449 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L 880 (1075)
++...+.||.+.|=+|.+|+++.-.|+||++-+..-. ..-+...+.+.|++ ...+++||++.+..+... +...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~----~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPT----ISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCC----CCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHH
Confidence 6888899999999999999987555999998764311 11122234455666 677789999999887655 5667
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc-
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV- 959 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~- 959 (1075)
|||-+|. .-+|.|.|..+. .+..-+.+.|+.||++||.-+|+.||+|||||.+||||++ -.-+.|+||..-+-
T Consensus 97 ylvRqyv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS----WNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS----WNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee----echhhhhcccccCCc
Confidence 8888888 569999998765 3677788889999999999999999999999999999984 44688999987662
Q ss_pred --ccc-ccccCCC----CCCCCccCcccccCC--------C-CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHh
Q 001449 960 --KQQ-TLVSGGV----RGTLPWMAPELLSGK--------S-HMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGG 1022 (1075)
Q Consensus 960 --~~~-~~~sss~----~GT~~YmAPEvl~g~--------~-~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~ 1022 (1075)
..+ ......+ ..-.+|.|||.+... . ...+.+.||||+||+++||++ |+++|.-.... .
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~----a 246 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL----A 246 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH----h
Confidence 111 1111111 123479999998531 1 115678899999999999998 89998532111 1
Q ss_pred hhhc-cCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1023 IVNN-TLRP--QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1023 Ilk~-~l~p--~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
+... ...+ .+..--+..+++||..|++.||.+|.|+++.|+.
T Consensus 247 Yr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 0000 0011124579999999999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=217.05 Aligned_cols=211 Identities=27% Similarity=0.471 Sum_probs=156.1
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~ 875 (1075)
..++|+.++.|..|+||.||.++++ .+++|+|+ ++..+ ||+ ||..+-+
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------------------ilR-----nilt~a~----- 130 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------------------ILR-----NILTFAG----- 130 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-------------------hhh-----ccccccC-----
Confidence 3478999999999999999999876 77899854 32211 111 1222211
Q ss_pred CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
..+.| |+...+++.-+ +++. +++.+++|||+.||+|||+||+|+||+ ..+++||.|||
T Consensus 131 ---npfvv------gDc~tllk~~g-~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfg 188 (1205)
T KOG0606|consen 131 ---NPFVV------GDCATLLKNIG-PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFG 188 (1205)
T ss_pred ---Cccee------chhhhhcccCC-CCcc--------hhhHHhHhhccCCeecCCCCCCcceee----ecccccccchh
Confidence 11222 55555555433 2332 337899999999999999999999998 88999999999
Q ss_pred Ccccccc----------------ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001449 956 LSKVKQQ----------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI 1019 (1075)
Q Consensus 956 LAk~~~~----------------~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~ei 1019 (1075)
+++..-. .......+||+.|.|||++..+. |.+.+|+|++|+|+||++.|..||.+.+++++
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg--ygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc--cCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 9874211 11124568999999999998554 89999999999999999999999999999888
Q ss_pred HHhhhhccC-CCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHH
Q 001449 1020 IGGIVNNTL-RPQIPSWCDPEWRSLMESCWASDPAERP-SFSEIS 1062 (1075)
Q Consensus 1020 l~~Ilk~~l-~p~ips~ls~eL~dLI~kCLq~DPeeRP-Sa~ELL 1062 (1075)
+...+.... .++-...++.+++++|.++|+.+|..|. +..++.
T Consensus 267 fg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 267 FGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred HhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 877766433 2333455789999999999999999994 444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=214.91 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=186.0
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC---CCceeeeecc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGI 871 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~---HPNIVkL~g~ 871 (1075)
.+....|.+.+.||+|+||.||+|.. +|+.||||+-+.....+-.. -.+++.+|+ -+.|..+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----------~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----------CLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----------hHHHHHhhchhhhcchHHHHHH
Confidence 45567899999999999999999976 58889999987665433221 122333443 2345555555
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEecc---CCCCCCe
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM---RDPQRPV 948 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~---~d~~~g~ 948 (1075)
+.. .+.-++|+||.+.|+|.+++. ..+.+++..+..|+.||+..|++||..+|||+||||+|+||.. .+.....
T Consensus 763 ~~~--~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVF--QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred Hcc--CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 544 344578999999999999998 4456899999999999999999999999999999999999952 2234567
Q ss_pred EEEeecCCcc---ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhh
Q 001449 949 CKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 949 VKLiDFGLAk---~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk 1025 (1075)
++|+|||.|. ...+.......++|-.+-.+|+..|++ |++++|.|.|+.+++-||.|+.- + ..+
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~y~----------q-~~~ 906 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGKYM----------E-VKN 906 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHHHH----------H-hcC
Confidence 9999999987 344555566778999999999999887 89999999999999999998852 1 111
Q ss_pred ccC---CCCCCCCC-CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1026 NTL---RPQIPSWC-DPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1026 ~~l---~p~ips~l-s~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
+.. ...+++.. -+-|.+|+..+|+.|-..=|.+.+|...|+.++.
T Consensus 907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 111 11123222 2346688889999555555899999998888765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-19 Score=190.30 Aligned_cols=178 Identities=12% Similarity=0.096 Sum_probs=135.2
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHH------HHHHHHHHHhCCCCceeeee
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~------flrEi~ILkkL~HPNIVkL~ 869 (1075)
.+...+|++++.||.|+||.||++..++..+|||++...... .+..+.. +.+|+..+.++.|++|..+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 445789999999999999999998777888999999765321 1222233 57899999999999999988
Q ss_pred cccccCC------CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCC
Q 001449 870 GIVRDGP------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 870 g~~~d~~------e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d 943 (1075)
+++.... .+..+|||||++|.+|.++.. +++ .+..+++.+|..||+.|++||||||+||+++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 8765421 245799999999999988732 233 2456999999999999999999999999997
Q ss_pred CCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHH
Q 001449 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELL 1005 (1075)
.++ ++|+|||............. ++..+. ++.++||||||+++..+.
T Consensus 170 -~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~--y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 -KNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERH--YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -CCC-EEEEECCCcccccchhhHHH-----------HHHHhH--hcccccccceeEeehHHH
Confidence 445 99999998875432221111 233333 567899999999988664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=180.04 Aligned_cols=146 Identities=25% Similarity=0.167 Sum_probs=107.2
Q ss_pred EEEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCch------------------hHHHHHHHHHHHHHHHHhCCCCce
Q 001449 805 VRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS------------------ERERLIADFWKEALLLSSLHHPNV 865 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~~------------------ere~~i~~flrEi~ILkkL~HPNI 865 (1075)
...||+|+||.||+|.. +|+.||||+++......... ..........+|+.+|+++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35699999999999987 58999999998653211110 000111233469999999987765
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCceEeccCCC
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL-HGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yL-Hs~GIIHRDIKPeNILId~~d~ 944 (1075)
.....+... ..+|||||+.+++|...+.+ ...+++..+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 332222111 23899999988777655333 24589999999999999999999 799999999999999997
Q ss_pred CCCeEEEeecCCcccc
Q 001449 945 QRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 945 ~~g~VKLiDFGLAk~~ 960 (1075)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 257999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-18 Score=187.26 Aligned_cols=236 Identities=19% Similarity=0.217 Sum_probs=148.3
Q ss_pred eeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC----------Cceeeee
Q 001449 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH----------PNVVSFY 869 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H----------PNIVkL~ 869 (1075)
+.....||.|+++.||.+++. ++.+|||+........ ...++.+.+|......+.+ -.++-.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~-----~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS-----ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH-----TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccc-----hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 566788999999999999994 6889999987654221 1223445555443333221 1122222
Q ss_pred cccc---------cCC-CC-----ceEEEEeeecCCcHHHHHhh---ccc---cCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001449 870 GIVR---------DGP-DG-----SLATVTEFMVNGSLKQFLQK---KDR---TIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1075)
Q Consensus 870 g~~~---------d~~-e~-----~L~LVmEYmeGGSL~d~Lkk---~~~---~Lse~~~l~Ia~QIL~AL~yLHs~GII 928 (1075)
+... ... .+ ..+++|+-+ .++|.+++.- ... .+....++.+..|+++.+.+||..||+
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 2111 110 11 235677766 6788877642 221 234556667779999999999999999
Q ss_pred cccCCCCceEeccCCCCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCC------CCCCCchhhHHHHHHHHH
Q 001449 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK------SHMVTEKIDVYSFGIVMW 1002 (1075)
Q Consensus 929 HRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~------~~~yS~KsDIWSLGVILy 1002 (1075)
|+||||+|+|++ .+|.++|+||+........... ...+..|.+||..... ...++.+.|.|+||++||
T Consensus 168 Hgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 168 HGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 999999999998 7899999999877654443332 2345789999977431 223788999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 001449 1003 ELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055 (1075)
Q Consensus 1003 ELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeR 1055 (1075)
.|+++..||........... ....+. .+++.++.||..+|+.||.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999986543322111 112233 789999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=176.80 Aligned_cols=189 Identities=15% Similarity=0.048 Sum_probs=138.1
Q ss_pred eEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCCceE
Q 001449 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~~L~ 881 (1075)
.+...|+.|+||+||.+...+.+++.+.+....... +......+.+|+++|++|. +++|++++++ +..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL----RGVAWWLARREALALRQLDGLPRTPRLLHW------DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhh----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEE
Confidence 356789999999999888888888888776442211 1112235778999999996 5789999886 2358
Q ss_pred EEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL-KCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDI-KPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++|||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++ .++.++|+|||+|...
T Consensus 75 lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRG 142 (218)
T ss_pred EEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceec
Confidence 99999999998754321 1 1346789999999999999999999 79999997 5678999999999854
Q ss_pred ccccc--------------cCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 001449 961 QQTLV--------------SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013 (1075)
Q Consensus 961 ~~~~~--------------sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~ 1013 (1075)
..... ..-...++.|++|+...--...--...++++.|+.+|.++|+..++-.
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 33221 011235788888886432211112456888999999999999988643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.5e-17 Score=167.60 Aligned_cols=142 Identities=18% Similarity=0.241 Sum_probs=113.1
Q ss_pred EEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEe
Q 001449 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmE 885 (1075)
+.||+|++|.||+|.+.|..|++|+...................+.+|+.++..+.|++|.....++.+ ....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEE
Confidence 569999999999999999999999876543322222222233567789999999999887665555444 345789999
Q ss_pred eecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 886 YmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
|++|++|.+++.... . .+..++.+|+.+|.+||+.+++|+|++|.|||++ .+.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccC
Confidence 999999999986532 2 7788999999999999999999999999999996 35789999998774
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=171.50 Aligned_cols=146 Identities=22% Similarity=0.149 Sum_probs=108.7
Q ss_pred EEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCc------------------hhHHHHHHHHHHHHHHHHhCCCCce
Q 001449 805 VRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKP------------------SERERLIADFWKEALLLSSLHHPNV 865 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~------------------~ere~~i~~flrEi~ILkkL~HPNI 865 (1075)
...||+|+||.||+|++. |+.||||+++........ .........+.+|...+.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999874 999999999875321000 0111112334578999999998887
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHH-HhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCC
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQF-LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~-Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d 943 (1075)
.....+... ..+|||||+.|+++... +.. ..++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 433332222 13899999988755443 332 347888999999999999999999 9999999999999996
Q ss_pred CCCCeEEEeecCCccccc
Q 001449 944 PQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~ 961 (1075)
++.++|+|||++....
T Consensus 153 --~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 --DGKPYIIDVSQAVELD 168 (190)
T ss_pred --CCCEEEEEcccceecC
Confidence 3579999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=174.32 Aligned_cols=142 Identities=18% Similarity=0.201 Sum_probs=105.6
Q ss_pred eEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-----CCCceeeeecccccCCC
Q 001449 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-----HHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-----~HPNIVkL~g~~~d~~e 877 (1075)
.....||+|+|+.||.-..++. .+||++...... ..+.+.+|+.+++.+ .||||+++++++.+...
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CCcceecCCCceEEEECCCCcC-eEEEEEeccccc--------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 3456799999999996322333 368887653211 124578999999999 57999999999988421
Q ss_pred -Cc-eEEEEee--ecCCcHHHHHhhccccCCHHHHHHHHHHHHHHH-HHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 878 -GS-LATVTEF--MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 878 -~~-L~LVmEY--meGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL-~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
+. +.+|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++..+.....++|+
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 23 3478999 5579999999764 35555 34567888888 899999999999999999997544455689999
Q ss_pred ecCCc
Q 001449 953 DLGLS 957 (1075)
Q Consensus 953 DFGLA 957 (1075)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95533
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.8e-17 Score=164.57 Aligned_cols=139 Identities=22% Similarity=0.236 Sum_probs=107.7
Q ss_pred EEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEee
Q 001449 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmEY 886 (1075)
.||+|+||.||++.+++..|++|+..................++.+|+.+++.+.++++.....++.. ....++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEEE
Confidence 38999999999999999999999976543332222233334667889999999988764433323333 3456899999
Q ss_pred ecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 887 MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 887 meGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++|++|.+++..... .++.+++.+|.+||+.|++|+|+||.||+++ .+.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcCC
Confidence 999999998754321 6889999999999999999999999999996 367999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=184.96 Aligned_cols=142 Identities=23% Similarity=0.210 Sum_probs=112.4
Q ss_pred eeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceE
Q 001449 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~ 881 (1075)
|...+.||+|+||.||++.+.+..+++|+........+..........+.+|+.++++++|++|+....++.+ ....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCCE
Confidence 3556789999999999999988888777654332222211222334568899999999999998876655554 34568
Q ss_pred EEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+||||+++++|.+++. ....++.|++.+|.+||+.||+||||||+|||++ ++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCccccc
Confidence 9999999999999875 3456889999999999999999999999999994 35799999999885
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=183.46 Aligned_cols=208 Identities=35% Similarity=0.549 Sum_probs=165.3
Q ss_pred HHhCCCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCCC
Q 001449 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI-VHFDLKCE 935 (1075)
Q Consensus 857 LkkL~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GI-IHRDIKPe 935 (1075)
|+.+.|.|+.+++|.+.++ ..+++|.+||.-|+|.+.+......+++.....+.++|++||.|||...| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678899999999999984 77899999999999999999877778999999999999999999998766 99999999
Q ss_pred ceEeccCCCCCCeEEEeecCCccccccc---cccCCCCCCCCccCcccccCCC--CC---CCchhhHHHHHHHHHHHHcC
Q 001449 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKS--HM---VTEKIDVYSFGIVMWELLTG 1007 (1075)
Q Consensus 936 NILId~~d~~~g~VKLiDFGLAk~~~~~---~~sss~~GT~~YmAPEvl~g~~--~~---yS~KsDIWSLGVILyELLTG 1007 (1075)
|.+++ ....+||+|||+....... .......-..-|.|||.+.+.. .. .+.+.||||||++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99998 7889999999998765321 1111222455799999997631 11 46789999999999999999
Q ss_pred CCCCCCC----ChHHHHHhhhh---ccCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 001449 1008 DEPYADM----HCASIIGGIVN---NTLRPQIPS--WCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070 (1075)
Q Consensus 1008 ~~PF~~~----~~~eil~~Ilk---~~l~p~ips--~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Lesi~~ 1070 (1075)
..||... ...+++..+.+ ..+++.+.. ...+++..++..||..+|.+||+++.+-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999753 22344444433 123333331 345578999999999999999999999999887754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-16 Score=165.20 Aligned_cols=148 Identities=22% Similarity=0.108 Sum_probs=110.2
Q ss_pred CeeEEEEEcccCcEEEEEEE-E--cCcceEEEEeeccccCCC----------------chhHHHHHHHHHHHHHHHHhCC
Q 001449 801 DLEEVRELGSGTYGSVYHGK-W--RGSDVAIKRIKASCFAGK----------------PSERERLIADFWKEALLLSSLH 861 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk-~--kGt~VAVKvIkk~~~~~k----------------~~ere~~i~~flrEi~ILkkL~ 861 (1075)
-|++.+.||+|+||.||+|. + +|+.||||+++....... ..........+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 3 689999999986432110 0111112234568999999997
Q ss_pred CC--ceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCceE
Q 001449 862 HP--NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN-IVHFDLKCENLL 938 (1075)
Q Consensus 862 HP--NIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~G-IIHRDIKPeNIL 938 (1075)
+. .+..++.+ ...++||||+.+.+|...+... ..+....+..++.||+.+|.+||+.| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 23344432 1248999999988887665333 23566677889999999999999999 999999999999
Q ss_pred eccCCCCCCeEEEeecCCcccc
Q 001449 939 VNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 939 Id~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++ .+.++|+|||.+...
T Consensus 182 i~-----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-----CCCEEEEEChhhhcc
Confidence 96 357999999988753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.8e-17 Score=186.77 Aligned_cols=168 Identities=26% Similarity=0.406 Sum_probs=129.8
Q ss_pred CceEEEEeeecCCcHHHHHhhc--cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecC
Q 001449 878 GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 878 ~~L~LVmEYmeGGSL~d~Lkk~--~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFG 955 (1075)
.+++|.|++|...+|.++|..+ ....++...+.+++|++.|++| +|.+|||+||.||++. .+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhhh
Confidence 3589999999999999999643 3456888889999999999999 9999999999999997 55689999999
Q ss_pred Ccccccccc-------ccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHhhhhcc
Q 001449 956 LSKVKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 956 LAk~~~~~~-------~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLT-G~~PF~~~~~~eil~~Ilk~~ 1027 (1075)
+........ ..+...||.+||+||.+.++. |+.|+||||||+||+||+. -...|... ..+..+..+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ 476 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGI 476 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCC
Confidence 987433322 334567999999999998765 8999999999999999997 44444322 2223333344
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSF 1058 (1075)
Q Consensus 1028 l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa 1058 (1075)
+.+.+-...+. -.+|+.++|...|.+||++
T Consensus 477 ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 477 IPPEFLQDYPE-EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred CChHHhhcCcH-HHHHHHHhcCCCcccCchH
Confidence 43344444443 4489999999999999943
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=155.92 Aligned_cols=141 Identities=18% Similarity=0.020 Sum_probs=106.0
Q ss_pred eeEEEEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCch--------------hHHHHHHHHHHHHHHHHhCCCCc--
Q 001449 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS--------------ERERLIADFWKEALLLSSLHHPN-- 864 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~~--------------ere~~i~~flrEi~ILkkL~HPN-- 864 (1075)
|.+.+.||+|+||.||++.. +|+.||||++.......... ........+.+|..++.++.+.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999987 58899999987543110000 00111233667899999998774
Q ss_pred eeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC
Q 001449 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 865 IVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~ 944 (1075)
+...++. ...++||||+.|++|.++... .....++.+|+.++.++|+.||+||||||+||+++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---- 159 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---- 159 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc----
Confidence 4444432 245899999999998776431 33456888999999999999999999999999998
Q ss_pred CCCeEEEeecCCccc
Q 001449 945 QRPVCKIGDLGLSKV 959 (1075)
Q Consensus 945 ~~g~VKLiDFGLAk~ 959 (1075)
.++.++|+|||++..
T Consensus 160 ~~~~~~liDfg~~~~ 174 (198)
T cd05144 160 DDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCcEEEEECCcccc
Confidence 577999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-14 Score=133.88 Aligned_cols=132 Identities=22% Similarity=0.162 Sum_probs=108.1
Q ss_pred EEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC--CceeeeecccccCCCCceE
Q 001449 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGPDGSLA 881 (1075)
Q Consensus 804 il~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H--PNIVkL~g~~~d~~e~~L~ 881 (1075)
+++.||.|.++.||+++..+..+++|....... ...+.+|+.+++.+.+ .++++++.+... .+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGES--DGWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccE
Confidence 457899999999999999888899998765321 2456788889999876 488888887765 46789
Q ss_pred EEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 882 LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~---GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
++|||+.++.+..+ +......++.+++++|.+||.. +++|+||||+||+++ ..+.++|+|||.+.
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999988877654 4456667888999999999984 799999999999998 46789999999877
Q ss_pred c
Q 001449 959 V 959 (1075)
Q Consensus 959 ~ 959 (1075)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.7e-14 Score=151.41 Aligned_cols=144 Identities=15% Similarity=0.135 Sum_probs=105.6
Q ss_pred EEEc-ccCcEEEEEEEEcCcceEEEEeeccccCCCch-----hHHHHHHHHHHHHHHHHhCCCCce--eeeecccccCCC
Q 001449 806 RELG-SGTYGSVYHGKWRGSDVAIKRIKASCFAGKPS-----ERERLIADFWKEALLLSSLHHPNV--VSFYGIVRDGPD 877 (1075)
Q Consensus 806 ~~LG-eG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~-----ere~~i~~flrEi~ILkkL~HPNI--VkL~g~~~d~~e 877 (1075)
..|| .|+.|+||+++..+..+|||.+.......+-. ........+.+|+.++.+|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3577 88999999998889999999986543211110 111223567789999999998775 666665433211
Q ss_pred C--ceEEEEeeecC-CcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 878 G--SLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 878 ~--~L~LVmEYmeG-GSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
. ..++|||+++| .+|.+++.+. .++.. .+.||+.+|.+||++||+||||||+|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 22599999997 6899888653 34543 356899999999999999999999999997 4568999999
Q ss_pred CCccc
Q 001449 955 GLSKV 959 (1075)
Q Consensus 955 GLAk~ 959 (1075)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=6e-14 Score=142.40 Aligned_cols=142 Identities=21% Similarity=0.078 Sum_probs=95.2
Q ss_pred EEEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhHH----------------HHHHHHHHHHHHHHhCCCCc--e
Q 001449 805 VRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERE----------------RLIADFWKEALLLSSLHHPN--V 865 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~ere----------------~~i~~flrEi~ILkkL~HPN--I 865 (1075)
.+.||+|+||.||+|++. ++.||||+++............ ........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 356999999999999886 8899999987543221111000 00011134555666654332 3
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHH-HHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCC
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQ-FLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d-~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d 943 (1075)
.+.++. ...++||||+.++.+.. .+.... .. ..+..++.+++.++.++|. .+|+||||||+||+++
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 344432 13589999998854321 121111 11 5677889999999999999 9999999999999996
Q ss_pred CCCCeEEEeecCCcccc
Q 001449 944 PQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~ 960 (1075)
++.++|+|||.+...
T Consensus 150 --~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 --DGKVYIIDVPQAVEI 164 (187)
T ss_pred --CCcEEEEECcccccc
Confidence 467999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-15 Score=181.46 Aligned_cols=251 Identities=23% Similarity=0.268 Sum_probs=187.5
Q ss_pred CCCeeEEEEEcccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeeccccc
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1075)
Q Consensus 799 ~ddYeil~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d 874 (1075)
...|.+.+.||+|+|+.|-..... ...+|+|.+...... .........|..+-+.+. |.|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~------~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS------EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc------cchhhhcCccccccccccccccccccCCccCC
Confidence 356778888999999999876552 334677766544211 112234446777777787 9999999998877
Q ss_pred CCCCceEEEEeeecCCcHHHHH-hhccccCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCceEeccCCCCCC-eEEE
Q 001449 875 GPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDPQRP-VCKI 951 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~L-kk~~~~Lse~~~l~Ia~QIL~AL~yLH-s~GIIHRDIKPeNILId~~d~~~g-~VKL 951 (1075)
....+++++|..++++.+-+ ......++...+..++.|+..+|.|+| ..++.||||||+|.+++ ..+ .+|+
T Consensus 93 --~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~ 166 (601)
T KOG0590|consen 93 --PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKI 166 (601)
T ss_pred --CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccC
Confidence 56788999999999999988 433324666777788899999999999 99999999999999998 555 8999
Q ss_pred eecCCcccccc----ccccCCCCC-CCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-Hhhhh
Q 001449 952 GDLGLSKVKQQ----TLVSGGVRG-TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASII-GGIVN 1025 (1075)
Q Consensus 952 iDFGLAk~~~~----~~~sss~~G-T~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil-~~Ilk 1025 (1075)
.|||+|..... .......+| ++.|+|||...+.. +.....|+||.|+++.-+++|..||......... .....
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence 99999985443 222344568 99999999998642 3577899999999999999999999764333211 11111
Q ss_pred cc--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 001449 1026 NT--LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062 (1075)
Q Consensus 1026 ~~--l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELL 1062 (1075)
.. ........++....+++.+++..++.+|.+..++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 11 11233355778888999999999999999887764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.9e-12 Score=148.89 Aligned_cols=245 Identities=23% Similarity=0.233 Sum_probs=181.5
Q ss_pred CCeeEEEEEcc--cCcEEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeeccc
Q 001449 800 DDLEEVRELGS--GTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (1075)
Q Consensus 800 ddYeil~~LGe--G~FG~VYkAk~----kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~ 872 (1075)
..+.+.+.+|. |.+|.||.++. .+..+|+|.-+......... ..-.+|....++++ |+|.++.+..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~------~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS------KRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc------ccccchhhcccccCccccccccCccc
Confidence 34556778999 99999998766 46778988754332211111 22235666666665 89999988888
Q ss_pred ccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHH----HHHHHHhCCcccccCCCCceEeccCCCCC-C
Q 001449 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQR-P 947 (1075)
Q Consensus 873 ~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~----AL~yLHs~GIIHRDIKPeNILId~~d~~~-g 947 (1075)
.. .+.+++-+|++ +.+|..+.......++...++.+..+..+ ||.++|..+|+|-|+||.||++. .+ .
T Consensus 188 e~--~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~~~ 260 (524)
T KOG0601|consen 188 EG--SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SDWT 260 (524)
T ss_pred cc--CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----cccc
Confidence 77 67788888988 68999888877767888899999999999 99999999999999999999997 44 7
Q ss_pred eEEEeecCCccccccccccC------CCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--ChHHH
Q 001449 948 VCKIGDLGLSKVKQQTLVSG------GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM--HCASI 1019 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~ss------s~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~--~~~ei 1019 (1075)
..+++|||+........... ...|...|++||+.++. ++...|||+||.++.+..++..++... .....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 89999999987544333221 12478889999998754 688999999999999998877665432 22211
Q ss_pred HHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 001449 1020 IGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1020 l~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq 1063 (1075)
+.. ......+....+.++..++..+++.++..|++++.+..
T Consensus 338 ~r~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQ---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 11334445556777888999999999999998766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.9e-10 Score=134.78 Aligned_cols=152 Identities=17% Similarity=0.240 Sum_probs=92.7
Q ss_pred CCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccC--------------------CC------chhHHHHHHHH-
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA--------------------GK------PSERERLIADF- 850 (1075)
Q Consensus 800 ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~--------------------~k------~~ere~~i~~f- 850 (1075)
.+|+. +.||.|++|.||+|+.+ |+.||||+++..... .. ....+...+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 78999999999999873 899999999754210 00 00001112223
Q ss_pred -----HHHHHHHHhCC----CCceeeeecccccCCCCceEEEEeeecCCcHHHH--Hhhccc---cCCHHHHHHHHHHHH
Q 001449 851 -----WKEALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF--LQKKDR---TIDRRKRLIIAMDAA 916 (1075)
Q Consensus 851 -----lrEi~ILkkL~----HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~--Lkk~~~---~Lse~~~l~Ia~QIL 916 (1075)
.+|...+.++. +.+.+.+-.++.+- .+..+|||||+.|+.|.++ +...+. .+.+..+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 33443333332 33333333333221 2345799999999999875 222221 1233333333344
Q ss_pred HHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 917 ~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
+...|++|+|+||.||+++.+++..+.++++|||++...
T Consensus 276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 346999999999999999855445569999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.7e-11 Score=138.93 Aligned_cols=148 Identities=17% Similarity=0.151 Sum_probs=97.4
Q ss_pred EEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCc--------------------------hhHHHHH------HHHHH
Q 001449 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP--------------------------SERERLI------ADFWK 852 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~--------------------------~ere~~i------~~flr 852 (1075)
+.||.|++|.||+|+. +|+.||||+.+......-. ..-+... -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999988 5999999998654210000 0000000 12445
Q ss_pred HHHHHHhCC----CCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 001449 853 EALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF-GMEYLHGKNI 927 (1075)
Q Consensus 853 Ei~ILkkL~----HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~-AL~yLHs~GI 927 (1075)
|...+.++. +.+-|.+-.++.+. .+..++||||++|++|.++........ ....++.+++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 555555542 32233333333221 234589999999999998765432222 23456666666 4788999999
Q ss_pred ccccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 928 IHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
+|+|+||.||+++ .++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~----~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVL----KDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEEC----CCCcEEEEeCCCeeECC
Confidence 9999999999997 56789999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.2e-11 Score=118.01 Aligned_cols=128 Identities=15% Similarity=0.056 Sum_probs=93.3
Q ss_pred EEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCcee-eeecccccCCCCceEEE
Q 001449 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIV-kL~g~~~d~~e~~L~LV 883 (1075)
++.|+.|.++.||+++..+..|++|+....... ...+.+|+.+++.+...+++ +++.... ...++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---------LINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---------ccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEE
Confidence 467899999999999999999999987643210 12345678888877654443 4444322 224799
Q ss_pred EeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI-----VHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 884 mEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GI-----IHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
|||++|.++.+.. .. ...++.+++++|..||+.++ +|+|+||.||+++ ++.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~~------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEeccccc
Confidence 9999998876530 11 12356789999999999885 9999999999997 2468999999876
Q ss_pred c
Q 001449 959 V 959 (1075)
Q Consensus 959 ~ 959 (1075)
.
T Consensus 136 ~ 136 (170)
T cd05151 136 M 136 (170)
T ss_pred C
Confidence 3
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=9e-10 Score=116.52 Aligned_cols=142 Identities=18% Similarity=0.099 Sum_probs=98.2
Q ss_pred EEEcccCcEEEEEEEEc--------CcceEEEEeeccccC--CC----------------chhHHHHHHHHHHHHHHHHh
Q 001449 806 RELGSGTYGSVYHGKWR--------GSDVAIKRIKASCFA--GK----------------PSERERLIADFWKEALLLSS 859 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~k--------Gt~VAVKvIkk~~~~--~k----------------~~ere~~i~~flrEi~ILkk 859 (1075)
..||.|--+.||.|... +..+|||+.+..... +. .+.+........+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 45899999999999754 368999998754311 11 11122222234489999988
Q ss_pred CCC--CceeeeecccccCCCCceEEEEeeecCCcHH-HHHhhccccCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCC
Q 001449 860 LHH--PNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL-HGKNIVHFDLKCE 935 (1075)
Q Consensus 860 L~H--PNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~-d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yL-Hs~GIIHRDIKPe 935 (1075)
+.. -++...+++. .-+|||||+.+..+. ..+++. .++......+..+++.+|..| |+.||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 863 3455555542 248999999654332 223221 245556677889999999999 8999999999999
Q ss_pred ceEeccCCCCCCeEEEeecCCcccc
Q 001449 936 NLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 936 NILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
|||+. ++.++|+|||.+-..
T Consensus 155 NIL~~-----~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-----DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-----CCcEEEEECCCceeC
Confidence 99996 257999999987744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.6e-10 Score=115.46 Aligned_cols=136 Identities=20% Similarity=0.231 Sum_probs=99.9
Q ss_pred EEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC--ceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP--NIVkL~g~~~d~~e~~L~LVm 884 (1075)
.|++|+-+.||.+.+.|..+++|.-..+.+..+.........+..+|..+|.+++-- +...++++ + .....|+|
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D--~~~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D--PDNGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c--CCCCEEEE
Confidence 578999999999988888888886554444333222222235567899999888632 33344443 2 23457899
Q ss_pred eeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 885 EYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
||++|..|.+++... ...++..+-.-+.-||..||+|+||.++||++. .+.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-----~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-----CCcEEEEECCcccc
Confidence 999999999888764 244667777788899999999999999999996 33499999999884
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-09 Score=114.69 Aligned_cols=154 Identities=19% Similarity=0.188 Sum_probs=110.2
Q ss_pred EEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEE
Q 001449 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 804 il~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LV 883 (1075)
.+..|-+|+-+.|+++.+.|+...||.-....+.-.........++..+|+.+|.++.--.|.--.-++.+ ...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCeEE
Confidence 56779999999999999999998888654443333323333345667889999998863333221112223 2233789
Q ss_pred EeeecC-CcHHHHHhhccccCCHHHH-HHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 884 TEFMVN-GSLKQFLQKKDRTIDRRKR-LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 884 mEYmeG-GSL~d~Lkk~~~~Lse~~~-l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
|||+.| -++.+++......-..... ..+++.|-+.|.-||.++|||+||..+||++..++ ....+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEeecchhcc
Confidence 999966 3788888765443333333 67889999999999999999999999999997444 5566799999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-10 Score=142.96 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=182.5
Q ss_pred ccCCCeeEEEEEcccCcEEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeeccccc
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~ddYeil~~LGeG~FG~VYkAk~k--Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d 874 (1075)
...+.+.+++-+-.|.++.++.++-. |...++|+..+.-...+.. .+....+-.++-.-++|-++...--+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~-----~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND-----YESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc-----ccccCCccCccccCCCCceecccCCCCC
Confidence 45677888889999999999987654 4445556554332222211 1122233333333445666665554333
Q ss_pred CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
...++++++|+.+++|...+.+.+ ..+.+........+..++++||...+.|||+||.|+|+. ..+..++.||
T Consensus 876 --rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~~ 948 (1205)
T KOG0606|consen 876 --RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTDF 948 (1205)
T ss_pred --CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCcc
Confidence 567899999999999999988765 345555555666889999999999999999999999997 6778899999
Q ss_pred CCcc-cc------cc-------------------------ccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHH
Q 001449 955 GLSK-VK------QQ-------------------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMW 1002 (1075)
Q Consensus 955 GLAk-~~------~~-------------------------~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILy 1002 (1075)
|... .. .. ........||+.|.+||...+..+ ...+|+|++|++++
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h--gs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH--GSAADWWSSGVCLF 1026 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC--CCcchhhhhhhhhh
Confidence 8332 10 00 001223568999999999988774 55689999999999
Q ss_pred HHHcCCCCCCCCChHHHHHhhhhccC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 001449 1003 ELLTGDEPYADMHCASIIGGIVNNTL-RPQIPSWCDPEWRSLMESCWASDPAERPSFS 1059 (1075)
Q Consensus 1003 ELLTG~~PF~~~~~~eil~~Ilk~~l-~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ 1059 (1075)
|.++|.+||.......+...+.+... .+.-+...+.+.++++..+|..++.+|..+.
T Consensus 1027 e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999888888776544 4455677899999999999999999996554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.4e-10 Score=123.18 Aligned_cols=197 Identities=22% Similarity=0.333 Sum_probs=135.9
Q ss_pred HHhCCCCceeeeecccccC---CCCceEEEEeeecCCcHHHHHhh---ccccCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Q 001449 857 LSSLHHPNVVSFYGIVRDG---PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK--NIV 928 (1075)
Q Consensus 857 LkkL~HPNIVkL~g~~~d~---~e~~L~LVmEYmeGGSL~d~Lkk---~~~~Lse~~~l~Ia~QIL~AL~yLHs~--GII 928 (1075)
|-++-|-|||+++.++.+. +.....+++|||..|+|..+|++ +...+......+++.||+.||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455688999999998763 33457899999999999999975 345688888999999999999999987 599
Q ss_pred cccCCCCceEeccCCCCCCeEEEeecCCccc-----cccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHH
Q 001449 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWE 1003 (1075)
Q Consensus 929 HRDIKPeNILId~~d~~~g~VKLiDFGLAk~-----~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyE 1003 (1075)
|+++..+-|++. .++.+|+.----... ...........+-+.|.+||.=. ....+..+|||+||+...+
T Consensus 201 hgnlTc~tifiq----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 201 HGNLTCDTIFIQ----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--TTNTTGASDIYKFGMCALE 274 (458)
T ss_pred cCCcchhheeec----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--ccccccchhhhhhhHHHHH
Confidence 999999999997 667777643221110 01111112234667899999643 2235678999999999999
Q ss_pred HHcCCCCCCCCChHH-HHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1004 LLTGDEPYADMHCAS-IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1004 LLTG~~PF~~~~~~e-il~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
|..+..--......- .-..+.+.... .-..--+++|.+||+..|..||++.+++..
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~-----len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIG-----LENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheee-----ccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 988776433222111 11111111110 011223478999999999999999988754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-10 Score=133.63 Aligned_cols=251 Identities=22% Similarity=0.201 Sum_probs=171.6
Q ss_pred cccCCCeeEEEEEcccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecc
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (1075)
Q Consensus 796 ~i~~ddYeil~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~ 871 (1075)
.....+|.++..||.|.|+.|+.+..+ +..+++|.+.......... ..-+.|+.+...+. |.+++.++..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d------i~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD------IFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh------hcchhhhhHhhHhhcccccCCCCCC
Confidence 345578999999999999999987653 6778999877654322111 11234555555554 7788887776
Q ss_pred cccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEE
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKL 951 (1075)
+.. ....++-.|||+++++...+.. ...+++..++.+..|++.++.++|+..++|+|+||+||++..++ ...++
T Consensus 335 W~~--~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~ 408 (524)
T KOG0601|consen 335 WSQ--LRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKL 408 (524)
T ss_pred ccc--cccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhc
Confidence 665 3455688999999988766532 23478888889999999999999999999999999999997322 77899
Q ss_pred eecCCccccccccccCCCCCCCCcc-CcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCCC
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 952 iDFGLAk~~~~~~~sss~~GT~~Ym-APEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~p 1030 (1075)
.|||..+..... ......+-+++ ..|++... +.+..+.|++|||..+.+.+++...-..... ...+..+. -+
T Consensus 409 ~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~-~p 481 (524)
T KOG0601|consen 409 GDFGCWTRLAFS--SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD-TP 481 (524)
T ss_pred ccccccccccee--cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccc---ceeeeccc-cc
Confidence 999988641111 11122334455 25555433 3367899999999999999987753222111 11222221 22
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066 (1075)
Q Consensus 1031 ~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~Le 1066 (1075)
..+.. ..+++.+.+.++..++..||++.++....+
T Consensus 482 ~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 482 NLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 23333 378889999999999999999887765443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-08 Score=121.26 Aligned_cols=164 Identities=21% Similarity=0.283 Sum_probs=120.4
Q ss_pred EcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhcc
Q 001449 821 WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD 900 (1075)
Q Consensus 821 ~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~ 900 (1075)
..+.+|.|.+++...- .......+-++-|+.++||||+++++.+.. ++.+|+|+|-+ .-|..++++.
T Consensus 35 ~~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV--~Pl~~~lk~l- 101 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERV--RPLETVLKEL- 101 (690)
T ss_pred ccCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecc--ccHHHHHHHh-
Confidence 3577788887765421 112334567788999999999999999887 67899999987 4677777654
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCceEeccCCCCCCeEEEeecCCccccccccc-cCCCCCCCCccCc
Q 001449 901 RTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMAP 978 (1075)
Q Consensus 901 ~~Lse~~~l~Ia~QIL~AL~yLH-s~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~-sss~~GT~~YmAP 978 (1075)
....+...+.||+.||.||| +.+++|++|.-+.|+|+ ..|..||++|.++........ .....---.|..|
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDP 174 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEeccccCCcccccchhhhcccCh
Confidence 35566677889999999998 56899999999999998 889999999998764322211 1111122236677
Q ss_pred ccccCCCCCCCchhhHHHHHHHHHHHHcCC
Q 001449 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008 (1075)
Q Consensus 979 Evl~g~~~~yS~KsDIWSLGVILyELLTG~ 1008 (1075)
+.+.... -..|.|-|||++++++.|.
T Consensus 175 ~~~~~s~----~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 175 EEIDPSE----WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhcCccc----cchhhhhHHHHHHHHhCcc
Confidence 7654221 2469999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=105.28 Aligned_cols=145 Identities=21% Similarity=0.230 Sum_probs=102.7
Q ss_pred EEEEcccCcEEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC--ceeeeecccccCC-CCce
Q 001449 805 VRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVRDGP-DGSL 880 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~kG-t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP--NIVkL~g~~~d~~-e~~L 880 (1075)
++.|+.|.++.||++...+ ..+++|+....... .....+.+|..+++.+.+. ++.+++.+..... .+..
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 3568999999999998765 88999987653211 0123466888899988753 3455665544311 1356
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG------------------------------------ 924 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs------------------------------------ 924 (1075)
++||||++|.+|.+.+.. ..++......++.+++++|..||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred eEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 899999999888776532 235666777777788888877773
Q ss_pred --------------------CCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 925 --------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 925 --------------------~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
..++|+|+++.||+++.+ ..+.+.|+||+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~g 207 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATLG 207 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEeccccccC
Confidence 236999999999999721 1457899999987743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.88 E-value=1e-08 Score=92.78 Aligned_cols=75 Identities=49% Similarity=0.848 Sum_probs=66.2
Q ss_pred CCeeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCcc
Q 001449 41 GKLRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTR 117 (1075)
Q Consensus 41 ~~l~Y~gg~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r 117 (1075)
.+++| ||++|.+.|+++++|.+|+.++++.++. .+.|||+ +||-| +|++++|+||..|++.+.+.. ...
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~----~~~ 75 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG----SKK 75 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC----Cce
Confidence 46677 8999999999999999999999999986 5999999 77777 999999999999999997753 356
Q ss_pred EEEEEe
Q 001449 118 LRIFLF 123 (1075)
Q Consensus 118 ~r~flf 123 (1075)
|||++|
T Consensus 76 l~l~v~ 81 (81)
T smart00666 76 LRLHVF 81 (81)
T ss_pred EEEEeC
Confidence 999886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-07 Score=110.37 Aligned_cols=212 Identities=17% Similarity=0.176 Sum_probs=150.9
Q ss_pred EEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccC--CCCceEEEEeeecC
Q 001449 814 GSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PDGSLATVTEFMVN 889 (1075)
Q Consensus 814 G~VYkAk~--kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~--~e~~L~LVmEYmeG 889 (1075)
.+.||+.. +|..|++|++........ + + ...-+++++++.|+|||++.++|.+. .+..+++|++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-n-k------~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST-N-K------DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc-c-c------chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 56688865 688899999853322111 0 1 11346689999999999999988742 35678999999975
Q ss_pred -CcHHHHHhh--------------ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeec
Q 001449 890 -GSLKQFLQK--------------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 890 -GSL~d~Lkk--------------~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDF 954 (1075)
++|.++.-. .+...++..+|.++.||+.||.++|+.|+..+-|.|.+||++ .+.+++|+..
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS~C 437 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRISGC 437 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEecc
Confidence 578776532 123467899999999999999999999999999999999998 6668999988
Q ss_pred CCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCChHHHHHhhhhccCCCCCC
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 955 GLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~P-F~~~~~~eil~~Ilk~~l~p~ip 1033 (1075)
|+......... |.+.+. .+-|.=.||.+++.|.||..- +......+.... .+.
T Consensus 438 ~i~Dvl~~d~~-------------~~le~~-----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~ 491 (655)
T KOG3741|consen 438 GIMDVLQEDPT-------------EPLESQ-----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RIT 491 (655)
T ss_pred cceeeecCCCC-------------cchhHH-----hhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------Hhh
Confidence 88775543320 222221 256999999999999998643 222111111111 123
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1034 s~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~ 1064 (1075)
..++.+++++|..+...++++ -++.+++..
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 356889999999999999886 567776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.4e-07 Score=104.31 Aligned_cols=144 Identities=15% Similarity=0.086 Sum_probs=95.3
Q ss_pred cEEEEEEEEcCcceEEEEeeccccCCCchhHH-----HHHHHHHHHHHHHHhCC-----CCceeeeecccccCCCCceEE
Q 001449 813 YGSVYHGKWRGSDVAIKRIKASCFAGKPSERE-----RLIADFWKEALLLSSLH-----HPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 813 FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere-----~~i~~flrEi~ILkkL~-----HPNIVkL~g~~~d~~e~~L~L 882 (1075)
...|++....|+.|.||......... ..+. .-...+.+|...+.+|. .|.+|-+...-..+....-+|
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~--~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGE--IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHH--HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 34466777888899999764332100 0000 00113567777776664 344444321111111234689
Q ss_pred EEeeecCC-cHHHHHhhc-cccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccC---CCCCCeEEEeecCCc
Q 001449 883 VTEFMVNG-SLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPVCKIGDLGLS 957 (1075)
Q Consensus 883 VmEYmeGG-SL~d~Lkk~-~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~---d~~~g~VKLiDFGLA 957 (1075)
|||++.+. +|.+++... ....+...+..++.+++..+.-||..||+|+|+++.|||++.+ ..+...+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999875 899998642 2335667777899999999999999999999999999999742 234578999999987
Q ss_pred c
Q 001449 958 K 958 (1075)
Q Consensus 958 k 958 (1075)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.1e-07 Score=105.42 Aligned_cols=252 Identities=18% Similarity=0.218 Sum_probs=162.8
Q ss_pred EEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhC-CCCce----eeeecccccCCCCc
Q 001449 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV----VSFYGIVRDGPDGS 879 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL-~HPNI----VkL~g~~~d~~e~~ 879 (1075)
.+.||+|+-+.+|..-.-+..|| |++....-.. .. +.+..|.+. .||-+ +.-......++.+.
T Consensus 16 gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~----~a-------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAA----QA-------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CccccCCccceeeecchhhchhh-eeecCCCchH----HH-------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 45699999999996433333344 8776542211 11 112223333 35432 21111222222333
Q ss_pred -eEEEEeeecCCc-HHHHHhh-----ccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEe
Q 001449 880 -LATVTEFMVNGS-LKQFLQK-----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 880 -L~LVmEYmeGGS-L~d~Lkk-----~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLi 952 (1075)
+.++|..+.+.. +..+++- ......|...+++++.|+.+...||..|.+-+|+.++|+|++ ++..|.|.
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~LV 159 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVVLV 159 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEEEE
Confidence 778888886653 2333321 122368999999999999999999999999999999999998 77789998
Q ss_pred ecCCccccccccccCCCCCCCCccCccccc-C--CCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChH----HHHH-hh
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLS-G--KSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCA----SIIG-GI 1023 (1075)
Q Consensus 953 DFGLAk~~~~~~~sss~~GT~~YmAPEvl~-g--~~~~yS~KsDIWSLGVILyELLTG-~~PF~~~~~~----eil~-~I 1023 (1075)
|-..--.........+..|...|.+||... + ....-+...|.|.||++|++||.| +.||.+.... .-.+ .|
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 866444434444555677999999999865 1 111235568999999999999986 9999653211 0011 11
Q ss_pred hh----------ccC---CCCCC-CCCCHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHc
Q 001449 1024 VN----------NTL---RPQIP-SWCDPEWRSLMESCWAS--DPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1024 lk----------~~l---~p~ip-s~ls~eL~dLI~kCLq~--DPeeRPSa~ELLq~Lesi~~~L 1072 (1075)
.. ..+ ...+| +-+++.++.|+.+|+.. ++.-|||++..+..|.++.++|
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 10 001 11111 34688899999999965 3568999999999999987765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.2e-08 Score=101.45 Aligned_cols=132 Identities=25% Similarity=0.178 Sum_probs=82.7
Q ss_pred EEEEEEE-cCcceEEEEeeccccC---------C---------CchhHHHHHHHHHHHHHHHHhCCCC--ceeeeecccc
Q 001449 815 SVYHGKW-RGSDVAIKRIKASCFA---------G---------KPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR 873 (1075)
Q Consensus 815 ~VYkAk~-kGt~VAVKvIkk~~~~---------~---------k~~ere~~i~~flrEi~ILkkL~HP--NIVkL~g~~~ 873 (1075)
.||.|.. +|..+|||+.+..... . .............+|...|+++..- ++.+.+++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4899886 6889999998754211 0 0112223345677899999999855 4556665422
Q ss_pred cCCCCceEEEEeeec--CCcHHHHHhhccccCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCCCceEeccCCCCCCeEE
Q 001449 874 DGPDGSLATVTEFMV--NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY-LHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 874 d~~e~~L~LVmEYme--GGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~y-LHs~GIIHRDIKPeNILId~~d~~~g~VK 950 (1075)
.+|||||+. |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++ .+ .+.
T Consensus 81 ------~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~-~~~ 146 (188)
T PF01163_consen 81 ------NVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG-KVY 146 (188)
T ss_dssp ------TEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT-CEE
T ss_pred ------CEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc-eEE
Confidence 389999998 55555443222 1234455677788885555 5799999999999999997 33 899
Q ss_pred EeecCCcccc
Q 001449 951 IGDLGLSKVK 960 (1075)
Q Consensus 951 LiDFGLAk~~ 960 (1075)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.4e-07 Score=95.92 Aligned_cols=108 Identities=24% Similarity=0.227 Sum_probs=78.1
Q ss_pred HHHHHHHHHHhCC-----CCceeeeecccccCCCCceEEEEeeecCC-cHHHHHhhccccCCHHHHHHHHHHHHHHHHHH
Q 001449 849 DFWKEALLLSSLH-----HPNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922 (1075)
Q Consensus 849 ~flrEi~ILkkL~-----HPNIVkL~g~~~d~~e~~L~LVmEYmeGG-SL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yL 922 (1075)
...+|...+..|. -|..|-+...-... ....++|+|++++. +|.+++..... ++......++.+++..+.-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4556666665554 34444433221111 12458999999874 89999876433 56667788999999999999
Q ss_pred HhCCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 923 Hs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
|+.||+|+|+++.|||++.++ ....+.|+||+.++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 999999999999999998443 455899999997774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.7e-06 Score=78.55 Aligned_cols=75 Identities=39% Similarity=0.672 Sum_probs=61.1
Q ss_pred eeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCccEE
Q 001449 43 LRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (1075)
Q Consensus 43 l~Y~gg~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r 119 (1075)
++|.|+..|++.++++++|.+|+.++++.++. .+.|+|+ +||- .+|+|++|+||..|++.+... +..+||
T Consensus 6 ~~~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~dg-D~V~i~sd~Dl~~a~~~~~~~----~~~~lr 78 (84)
T PF00564_consen 6 VRYGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DEDG-DLVTISSDEDLQEAIEQAKES----GSKTLR 78 (84)
T ss_dssp EEETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETTS-SEEEESSHHHHHHHHHHHHHC----TTSCEE
T ss_pred EEECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCCC-CEEEeCCHHHHHHHHHHHHhc----CCCcEE
Confidence 34444334569999999999999999999987 4899998 5444 799999999999999999886 334799
Q ss_pred EEEec
Q 001449 120 IFLFS 124 (1075)
Q Consensus 120 ~flf~ 124 (1075)
||+..
T Consensus 79 l~v~~ 83 (84)
T PF00564_consen 79 LFVQD 83 (84)
T ss_dssp EEEEE
T ss_pred EEEEe
Confidence 99863
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.4e-07 Score=110.28 Aligned_cols=144 Identities=21% Similarity=0.270 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhC-CcccccCCCCceEeccCCCCCCeEEEeecCCcccccccc----------ccCCCCCCCCccCccccc
Q 001449 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL----------VSGGVRGTLPWMAPELLS 982 (1075)
Q Consensus 914 QIL~AL~yLHs~-GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~----------~sss~~GT~~YmAPEvl~ 982 (1075)
+.+.||.|+|+. ++||+.|.|++|.++ .++.+||+.|+++-...... ..........|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455899999964 999999999999998 88899999999865322211 111123466899999998
Q ss_pred CCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHh--hhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 001449 983 GKSHMVTEKIDVYSFGIVMWELL-TGDEPYADMHCASIIGG--IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFS 1059 (1075)
Q Consensus 983 g~~~~yS~KsDIWSLGVILyELL-TG~~PF~~~~~~eil~~--Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ 1059 (1075)
+.. .+.++|+||||+++|.+. .|+.-+........... ...+.........++.++++=|.+++..+...||++.
T Consensus 183 ~~~--~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 183 GTT--NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred ccc--ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 643 688999999999999999 56665544322221111 1111112234467899999999999999999999877
Q ss_pred HHHH
Q 001449 1060 EISR 1063 (1075)
Q Consensus 1060 ELLq 1063 (1075)
.++.
T Consensus 261 ~l~~ 264 (700)
T KOG2137|consen 261 LLLS 264 (700)
T ss_pred hhhc
Confidence 7654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.6e-06 Score=92.27 Aligned_cols=141 Identities=21% Similarity=0.066 Sum_probs=101.8
Q ss_pred eEEEEEcccCcEEEEEEEE-cCcceEEEEeeccccC------------CC--chhHHHHHHHHHHHHHHHHhCCCC--ce
Q 001449 803 EEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFA------------GK--PSERERLIADFWKEALLLSSLHHP--NV 865 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~------------~k--~~ere~~i~~flrEi~ILkkL~HP--NI 865 (1075)
.+...||.|--+.||.|.+ +|.++|||.-+..... ++ .......+....+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457899999999999988 5999999975433211 00 001122234567899999999855 66
Q ss_pred eeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCC
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~ 945 (1075)
.+-+++ +..++||||++|..|...- ++.+....|+..|++-+.-+-..||||+|+.+-||+++ +
T Consensus 174 P~P~~~------nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~----~ 237 (304)
T COG0478 174 PKPIAW------NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT----E 237 (304)
T ss_pred CCcccc------ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe----c
Confidence 777765 4568999999887776542 12334445666677777766799999999999999998 6
Q ss_pred CCeEEEeecCCccc
Q 001449 946 RPVCKIGDLGLSKV 959 (1075)
Q Consensus 946 ~g~VKLiDFGLAk~ 959 (1075)
++.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 77899999986653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=86.64 Aligned_cols=147 Identities=16% Similarity=0.122 Sum_probs=101.4
Q ss_pred EcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCc--eeeee--cccccCCCCceEEE
Q 001449 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN--VVSFY--GIVRDGPDGSLATV 883 (1075)
Q Consensus 808 LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPN--IVkL~--g~~~d~~e~~L~LV 883 (1075)
-|.|+-+-|++....|..+-+|.-.......-. ...-...|.+|...|++|..-+ +.+.. +.-..+..-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR--YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCccccccc--CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467899999998888888888875422111100 0111357888999888886322 33333 22122222346889
Q ss_pred EeeecC-CcHHHHHhhcc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 884 TEFMVN-GSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 884 mEYmeG-GSL~d~Lkk~~-~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
+|-+.+ .+|.+++.+.. .+.+......+..++++.|.-||+.|+.|+|+.+.|||++.. .+..++|+||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~--g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE--GKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC--CCeeEEEEEhhccc
Confidence 998854 58998886532 245777778899999999999999999999999999999732 23469999999766
|
|
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.4e-06 Score=73.92 Aligned_cols=74 Identities=36% Similarity=0.657 Sum_probs=58.8
Q ss_pred CeeeecCceeEEEcc-CCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCcc
Q 001449 42 KLRYVGGETRIVSLP-RDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTR 117 (1075)
Q Consensus 42 ~l~Y~gg~tri~~v~-r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r 117 (1075)
+++|- |++|.+.|+ ++++|.+|++++.+.++. .+.|||. .||- .+|++++|+||..|++.+.+ ....+
T Consensus 4 K~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~----~~~~~ 75 (81)
T cd05992 4 KVKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR----SGSKK 75 (81)
T ss_pred EEEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh----cCCcc
Confidence 34454 566667777 999999999999999987 4677777 5544 78999999999999999977 34467
Q ss_pred EEEEEe
Q 001449 118 LRIFLF 123 (1075)
Q Consensus 118 ~r~flf 123 (1075)
+|++++
T Consensus 76 l~l~v~ 81 (81)
T cd05992 76 LRLFVF 81 (81)
T ss_pred EEEEeC
Confidence 888875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.96 E-value=9e-05 Score=80.38 Aligned_cols=145 Identities=16% Similarity=0.136 Sum_probs=95.8
Q ss_pred ccccCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHH------HHHHHHHHhCC---CCce
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADF------WKEALLLSSLH---HPNV 865 (1075)
Q Consensus 795 ~~i~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~f------lrEi~ILkkL~---HPNI 865 (1075)
..+...+|++++.+-......|.+-..+|..+++|..+... ...++.+..| .+++..+.++. .-.+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 44567889999999999999999988899999999876432 1122222222 12333333332 2222
Q ss_pred eeeeccccc---CCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccC
Q 001449 866 VSFYGIVRD---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (1075)
Q Consensus 866 VkL~g~~~d---~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~ 942 (1075)
..++.+... .-....+|+|||++|..|.++.. +++ .++..|.++|.-||+.|++|+|+.|.|++++
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-- 169 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-- 169 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE--
Confidence 222222111 01234578999999998877632 232 2445677889999999999999999999996
Q ss_pred CCCCCeEEEeecCCcc
Q 001449 943 DPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 943 d~~~g~VKLiDFGLAk 958 (1075)
++.++++||+..+
T Consensus 170 ---~~~i~iID~~~k~ 182 (229)
T PF06176_consen 170 ---NNGIRIIDTQGKR 182 (229)
T ss_pred ---CCcEEEEECcccc
Confidence 3459999998655
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00025 Score=85.37 Aligned_cols=146 Identities=17% Similarity=0.188 Sum_probs=89.1
Q ss_pred EEEcccCcEEEEEEEEc-CcceEEEEeeccccC---------------------C-C----chhHHHHHHH------HHH
Q 001449 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA---------------------G-K----PSERERLIAD------FWK 852 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~---------------------~-k----~~ere~~i~~------flr 852 (1075)
..|+.++-|.||+|+.. |+.||||+.+..... . . ...-+...+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999986 999999997654210 0 0 0000111111 334
Q ss_pred HHHHHHhCC-----CCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHH-HHHHHhCC
Q 001449 853 EALLLSSLH-----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG-MEYLHGKN 926 (1075)
Q Consensus 853 Ei~ILkkL~-----HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~A-L~yLHs~G 926 (1075)
|..-+.++. .++| .+=.++.+- .+.-.|+|||+.|..+.+........++.. .|+..++++ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 444444442 2332 222222221 234589999999999988853333334533 333333332 33444589
Q ss_pred cccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 927 IIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++|.|..|.||++. .++.+.+.|||+....
T Consensus 286 ffHaDpHpGNi~v~----~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVR----SDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEe----cCCcEEEEcCcceecC
Confidence 99999999999998 6689999999987743
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.1e-05 Score=82.76 Aligned_cols=144 Identities=22% Similarity=0.121 Sum_probs=95.8
Q ss_pred EEEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCc----------------hhHHHHHHHHHHHHHHHHhCC--CCce
Q 001449 805 VRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP----------------SERERLIADFWKEALLLSSLH--HPNV 865 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~----------------~ere~~i~~flrEi~ILkkL~--HPNI 865 (1075)
...|..|--+.||+|.. .+..+|+|+++.....-+. +.+........+|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34788999999999875 5888999998865432211 111222233456777777764 3344
Q ss_pred eeeecccccCCCCceEEEEeeecCC-cHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCC
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (1075)
Q Consensus 866 VkL~g~~~d~~e~~L~LVmEYmeGG-SL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d 943 (1075)
.+-+.+... .|||||+... .-.-.|+.. .+.......+..++++.+.-|-. .++||+||..=|||+.
T Consensus 133 P~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--- 201 (268)
T COG1718 133 PEPIAFRNN------VLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--- 201 (268)
T ss_pred CCceeecCC------eEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE---
Confidence 455554332 7899999332 111112221 13333566778889999988887 8999999999999995
Q ss_pred CCCCeEEEeecCCccccc
Q 001449 944 PQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 944 ~~~g~VKLiDFGLAk~~~ 961 (1075)
++.+.|+|||.|....
T Consensus 202 --~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 --DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CCeEEEEECccccccC
Confidence 4679999999887543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.86 E-value=9.3e-05 Score=79.84 Aligned_cols=72 Identities=17% Similarity=0.231 Sum_probs=46.8
Q ss_pred EEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCc--eeeeecccccCCCCceEEE
Q 001449 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN--VVSFYGIVRDGPDGSLATV 883 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPN--IVkL~g~~~d~~e~~L~LV 883 (1075)
..||+|..+.||+. .+..+++|...... . .....+|.++++.+..-. +.+.+.+... .+...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-------~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-------D---KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-------C---HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeee
Confidence 57899999999984 35678889876421 0 123456888887765322 2444444433 4457889
Q ss_pred EeeecCCc
Q 001449 884 TEFMVNGS 891 (1075)
Q Consensus 884 mEYmeGGS 891 (1075)
||++.|.+
T Consensus 73 ~e~i~G~~ 80 (226)
T TIGR02172 73 YELIVGKR 80 (226)
T ss_pred eeecCCcc
Confidence 99998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00011 Score=68.15 Aligned_cols=71 Identities=25% Similarity=0.419 Sum_probs=61.0
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCccEEEE
Q 001449 46 VGGETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIF 121 (1075)
Q Consensus 46 ~gg~tri~~v~r~~~~~~l~~kl~~~~~~----~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~f 121 (1075)
.||+++.+.++.+++|.+|..++++.++. .++|||. .|| .-.|+++||+||+.=++-|... ...++|||
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~~----~~~~v~l~ 79 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRSS----GSHTIRLL 79 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHHC----CCCeEEEE
Confidence 38899999999999999999999999874 5999999 766 8899999999999888877553 44678888
Q ss_pred Ee
Q 001449 122 LF 123 (1075)
Q Consensus 122 lf 123 (1075)
+.
T Consensus 80 v~ 81 (82)
T cd06407 80 VH 81 (82)
T ss_pred ee
Confidence 74
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.83 E-value=8.8e-05 Score=79.50 Aligned_cols=135 Identities=23% Similarity=0.225 Sum_probs=93.1
Q ss_pred CCeeEEEEEcccCc-EEEEEEEEcCcceEEEEeeccccCCCc------hhH-------HHHHHHHHHHHHHHHhCC---C
Q 001449 800 DDLEEVRELGSGTY-GSVYHGKWRGSDVAIKRIKASCFAGKP------SER-------ERLIADFWKEALLLSSLH---H 862 (1075)
Q Consensus 800 ddYeil~~LGeG~F-G~VYkAk~kGt~VAVKvIkk~~~~~k~------~er-------e~~i~~flrEi~ILkkL~---H 862 (1075)
.+++.++.||.|.- |.||+++..|..+|||+++.-.+.... ... .....-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 999999999999999994332111110 000 122345667766665554 5
Q ss_pred Cce--eeeecccccC----------------CCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh
Q 001449 863 PNV--VSFYGIVRDG----------------PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924 (1075)
Q Consensus 863 PNI--VkL~g~~~d~----------------~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs 924 (1075)
.++ |+++||+.-. ......||-||+.... .++.. -+.+|++-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 566 9999987432 1123467888775433 11222 24578888999999
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEeecCCc
Q 001449 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 925 ~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLA 957 (1075)
.||+-+|+|+.|..= -||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~---------G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRG---------GKLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccC---------CEEEecccC
Confidence 999999999999962 379999964
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00035 Score=72.13 Aligned_cols=80 Identities=18% Similarity=0.205 Sum_probs=53.3
Q ss_pred EEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC--ceeeeeccccc-CCCCceE
Q 001449 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVRD-GPDGSLA 881 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP--NIVkL~g~~~d-~~e~~L~ 881 (1075)
++.|+.|..+.||++...+..+++|+.... .....+.+|..+++.+... .+..++..... ......+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 578999999999999988889999986532 1123455677777666422 23445543222 1133478
Q ss_pred EEEeeecCCcHHH
Q 001449 882 TVTEFMVNGSLKQ 894 (1075)
Q Consensus 882 LVmEYmeGGSL~d 894 (1075)
++|+++.|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=6.5e-06 Score=98.76 Aligned_cols=184 Identities=16% Similarity=0.143 Sum_probs=131.2
Q ss_pred eeEEEEEcccCcEEEEEEEEcCcc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCc-eeeeecccccCCCCc
Q 001449 802 LEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGPDGS 879 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~kGt~-VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPN-IVkL~g~~~d~~e~~ 879 (1075)
+.....++++++++++|.+...+. ...|++... ....-++++|.+++||| .+..++-+.. +..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCc--ccc
Confidence 344556889999999998764332 334544332 11224778999999999 5555554444 678
Q ss_pred eEEEEeeecCC-cHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 880 LATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 880 L~LVmEYmeGG-SL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++++++.++ +-...+......+...+...+.+.-+++|.+||+.--+|+| ||+.. ....|+.||+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCc
Confidence 89999999766 33322222222234444455666778899999998779999 88875 3678999999988
Q ss_pred ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011 (1075)
Q Consensus 959 ~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF 1011 (1075)
............+|+.|+|||+..+.. +..+.|.|+++.-..+|.-|.+|-
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccc--cccCCCccCCCcchhhcCCCCCCC
Confidence 776666667788999999999887554 788999999999877887777764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0003 Score=74.17 Aligned_cols=98 Identities=24% Similarity=0.166 Sum_probs=77.8
Q ss_pred HHHHHHHhCCC-CceeeeecccccCCCCceEEEEeeecCCcHHHHHh--hccccCCHHHHHHHHHHHHHHHHHHHh---C
Q 001449 852 KEALLLSSLHH-PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAAFGMEYLHG---K 925 (1075)
Q Consensus 852 rEi~ILkkL~H-PNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lk--k~~~~Lse~~~l~Ia~QIL~AL~yLHs---~ 925 (1075)
.|..+|+.+.+ +++.+++|+|-. .+++||...+++..... ..-...+|..+.+||.++++.+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57888888886 689999999865 77999997776642110 011135899999999999999999997 3
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 926 GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.+.-.|++++|+.++ +++.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN----DDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEe----CCCcEEEEechhcch
Confidence 578899999999998 667899999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=9.9e-05 Score=77.71 Aligned_cols=130 Identities=28% Similarity=0.291 Sum_probs=92.5
Q ss_pred eeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCcee-eeecccccCCCCce
Q 001449 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDGPDGSL 880 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIV-kL~g~~~d~~e~~L 880 (1075)
..+.+.|++|.+|.||++.++|..+|+|+-+.+.. ...+..|.++|..+.-.++- ++|.+-. .
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~------~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGE------D 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEech------h
Confidence 34556799999999999999999999998765421 25567899999998866654 3444322 2
Q ss_pred EEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCC-C-CceEeccCCCCCCeEEEeecCCcc
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLK-C-ENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 881 ~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIK-P-eNILId~~d~~~g~VKLiDFGLAk 958 (1075)
++.|||+.|-.|.+.-... +... ...++..-.-|-..||-|+.|. | .||++. +..+.|+||..|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-----~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-----DRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEec-----CCcEEEEEccchh
Confidence 5669999988888765421 2222 2355666666777899999986 3 455553 4479999999888
Q ss_pred cc
Q 001449 959 VK 960 (1075)
Q Consensus 959 ~~ 960 (1075)
..
T Consensus 155 ~k 156 (201)
T COG2112 155 FK 156 (201)
T ss_pred hc
Confidence 43
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.1e-05 Score=103.26 Aligned_cols=247 Identities=15% Similarity=0.031 Sum_probs=163.1
Q ss_pred eeEEEEEcccCcEEEEEEEEcCc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCceeeeecccccCCCC
Q 001449 802 LEEVRELGSGTYGSVYHGKWRGS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~kGt---~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~e~ 878 (1075)
+++.--|+.+.+ +++++-+. -+.+|+.+...+. ...+...+..+.|...++...|+++...+.-.......
T Consensus 1231 ~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e---~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1231 SEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFE---NLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hheeeeccccee---eccchHhhhhceeEEEeehhhhHH---HHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 444434554444 45555222 2456665543221 22334445566677777788999998887766655556
Q ss_pred ceEEEEeeecCCcHHHHHhhcc---ccCCHHHHHHHHHHHHHHHHHHHhC-C----cccccCCCCceEeccCCCCCCeEE
Q 001449 879 SLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGK-N----IVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~d~Lkk~~---~~Lse~~~l~Ia~QIL~AL~yLHs~-G----IIHRDIKPeNILId~~d~~~g~VK 950 (1075)
..+.+++|+.+|.+.+.|.+.- ..+...-+....++.+.+..-+|+. + .+|+++|+-|.+|. .+..+|
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV----tny~v~ 1380 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV----TNYNVK 1380 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee----cCCccc
Confidence 6788999999999999997642 2344445555555557777887764 2 69999999999998 677899
Q ss_pred EeecCCcc-ccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHhhhhccCC
Q 001449 951 IGDLGLSK-VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 951 LiDFGLAk-~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~~PF~~~~~~eil~~Ilk~~l~ 1029 (1075)
+.++|+.+ ........+...+++.|+++++.+.-. ++.++|||..|+.+|.+-.|..+|...... ++..+..+...
T Consensus 1381 ~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik--~t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf 1457 (2724)
T KOG1826|consen 1381 LGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK--FTKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTF 1457 (2724)
T ss_pred ccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh--hhhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCccccccc
Confidence 99999999 434444445667888999999887544 677899999999999999899887653322 23344444444
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 001449 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061 (1075)
Q Consensus 1030 p~ips~ls~eL~dLI~kCLq~DPeeRPSa~EL 1061 (1075)
..++...|.+.-.....+|-+.-.+||.-...
T Consensus 1458 ~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1458 FSIEKLKPGDANVEALHRLLWKYMERPGQYIS 1489 (2724)
T ss_pred ccccccCCCcccHHHHHHHHHHhhhcchhhhh
Confidence 45555545554445555555555667654443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00035 Score=74.79 Aligned_cols=76 Identities=17% Similarity=0.110 Sum_probs=49.0
Q ss_pred EEcccCc-EEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCceeeeecccccCCCCceEEEE
Q 001449 807 ELGSGTY-GSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 807 ~LGeG~F-G~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNIVkL~g~~~d~~e~~L~LVm 884 (1075)
.|-.|.. +.||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++... .+..++||
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEE
Confidence 3445555 8899988777788888765321 123346777777664 2234456665544 34568999
Q ss_pred eeecCCcHHHH
Q 001449 885 EFMVNGSLKQF 895 (1075)
Q Consensus 885 EYmeGGSL~d~ 895 (1075)
|+++|.+|...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99998877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00022 Score=66.71 Aligned_cols=72 Identities=15% Similarity=0.394 Sum_probs=59.3
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCc--eEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcC--CCCCCccEEEEE
Q 001449 47 GGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLG--SGDGFTRLRIFL 122 (1075)
Q Consensus 47 gg~tri~~v~r~~~~~~l~~kl~~~~~~~--~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~--~~~~~~r~r~fl 122 (1075)
+|++|++.|+.+|+|.+|..|+.+.|+.. ++|||+ .| ...|++++++||+-.+.-+.... ..+.-+|+-+.+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~~~~~~~~~~~e~w~ 85 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEARKQGSDMGKLEIWV 85 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHHHhhcccccceeeec
Confidence 78999999999999999999999999864 999999 54 89999999999999998876432 223346766654
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00037 Score=88.71 Aligned_cols=207 Identities=19% Similarity=0.174 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHHHhCCCCceeeeecccccCC-CC-ceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHH
Q 001449 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGP-DG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923 (1075)
Q Consensus 846 ~i~~flrEi~ILkkL~HPNIVkL~g~~~d~~-e~-~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLH 923 (1075)
.+.....|...+.++.|+|++.++.|-.... .+ .+.+..+++...++...+...+ .++....+.+..++++||.++|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH
Confidence 3455567888899999999999988755421 22 2334457788888888887654 4788888889999999999999
Q ss_pred hCCcccccCCCCceEeccCCCCCCeEEEe--ecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHH
Q 001449 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIG--DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001 (1075)
Q Consensus 924 s~GIIHRDIKPeNILId~~d~~~g~VKLi--DFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVIL 1001 (1075)
+..+.|.-+..+-..-.. ....+.+.++ ||+.++............-+..|.++|.............|+|.+|..+
T Consensus 304 ~~~l~~v~L~~s~~~~~~-~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKEST-VDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred HhccceeEEecccccccc-cCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 985444433333111111 1134556666 8888876555444444455677888998876554344457999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHhhhhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 001449 1002 WELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065 (1075)
Q Consensus 1002 yELLTG~~PF~~~~~~eil~~Ilk~~l~p~ips~ls~eL~dLI~kCLq~DPeeRPSa~ELLq~L 1065 (1075)
..+..|..+-.... ....+ .+.....++.+++.+|+..+.++|+++.+++...
T Consensus 383 ~~~~~~~~i~~~~~---~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCccccccc---chhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99988765422111 11111 1122222778899999999999999999988754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.001 Score=84.34 Aligned_cols=82 Identities=15% Similarity=0.234 Sum_probs=54.7
Q ss_pred EEEEEcccCcEEEEEEEEcC----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC-CCce--eeeecccccC-
Q 001449 804 EVRELGSGTYGSVYHGKWRG----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNV--VSFYGIVRDG- 875 (1075)
Q Consensus 804 il~~LGeG~FG~VYkAk~kG----t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~-HPNI--VkL~g~~~d~- 875 (1075)
.++.|+.|.+..+|+....+ ..+++|+......... ...+.+|..+|+.+. |.+| .+++.++.+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 46788999999999987754 3677787543211111 134668999999885 5554 6777766542
Q ss_pred CCCceEEEEeeecCCcH
Q 001449 876 PDGSLATVTEFMVNGSL 892 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL 892 (1075)
..+..++||||+.|..+
T Consensus 115 v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 115 VIGTAFYIMEYLEGRIF 131 (822)
T ss_pred cCCCceEEEEecCCccc
Confidence 12457899999987643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0006 Score=82.23 Aligned_cols=147 Identities=18% Similarity=0.132 Sum_probs=88.5
Q ss_pred EEEcccCcEEEEEEEEc-CcceEEEEeeccccCCCchhH------------------------HHHHH------HHHHHH
Q 001449 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSER------------------------ERLIA------DFWKEA 854 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~~k~~er------------------------e~~i~------~flrEi 854 (1075)
+.|+.-+.|.||+|+.+ |+.||||+-+...... -..+ +...+ +|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~-~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKL-IMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHH-HHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46999999999999885 8889999976542110 0000 00011 133333
Q ss_pred HHH----HhCCCCc------eeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHH-HHH
Q 001449 855 LLL----SSLHHPN------VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME-YLH 923 (1075)
Q Consensus 855 ~IL----kkL~HPN------IVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~-yLH 923 (1075)
+-. +.+.|-+ |.++|-.+. ..-.|+||||.|..+.|+-.-....++...+.. .+.++.. -|=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~---~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRGISPHDILN---KLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcCCCHHHHHH---HHHHHHHHHHH
Confidence 322 2223434 334433332 245899999999877655433333355554333 3333222 222
Q ss_pred hCCcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 924 s~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
..|++|.|=.|.||++......+..+.|.|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 4689999999999999855456789999999998744
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0013 Score=70.34 Aligned_cols=143 Identities=20% Similarity=0.243 Sum_probs=93.8
Q ss_pred EEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchh--------HHHHHHHHHHHHHHHHhCC------CCceeeeec
Q 001449 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE--------RERLIADFWKEALLLSSLH------HPNVVSFYG 870 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~e--------re~~i~~flrEi~ILkkL~------HPNIVkL~g 870 (1075)
...||+|+.=.||.--. .....||+.+.......... ......+..+|+.....+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 34699999999996433 34467788876541000000 0011244555666555554 788999999
Q ss_pred ccccCCCCceEEEEeeecC------CcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC
Q 001449 871 IVRDGPDGSLATVTEFMVN------GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 871 ~~~d~~e~~L~LVmEYmeG------GSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~ 944 (1075)
+..+ +--+.+|+|.+.. -+|.+++.+.. ++. . +...+-+-..+|-+.+|+.+||+|.||++...+.
T Consensus 85 ~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 85 FVET--NLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEec--CCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 9988 5567889998742 37888885543 444 2 3333444556888999999999999999986654
Q ss_pred CCCeEEEee-cCC
Q 001449 945 QRPVCKIGD-LGL 956 (1075)
Q Consensus 945 ~~g~VKLiD-FGL 956 (1075)
....+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 444777777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0012 Score=70.80 Aligned_cols=30 Identities=33% Similarity=0.316 Sum_probs=24.8
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 926 GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
+++|+|+.+.|||++ .....-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~----~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQ----DGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEE----CCCEEEEEeCcccCc
Confidence 589999999999997 444567999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0012 Score=59.96 Aligned_cols=70 Identities=26% Similarity=0.542 Sum_probs=60.3
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCccEEEEEe
Q 001449 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1075)
Q Consensus 47 gg~tri~~v~r~~~~~~l~~kl~~~~~~~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~flf 123 (1075)
-||-||+.++|.+.|.||..|+.+.||..+.+-|-.=. -||-+.|.|||+.-|+-.|+ .+ ....||+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~e----L~iPl~~Q~DLDkAie~ld~-s~--~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNNE----LLIPLKNQEDLDRAIELLDR-SP--HMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEeccc----EEEeccCHHHHHHHHHHHcc-Cc--cccceeEeEe
Confidence 48999999999999999999999999999999997422 79999999999999999998 22 3345888774
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.003 Score=67.09 Aligned_cols=73 Identities=12% Similarity=0.149 Sum_probs=45.3
Q ss_pred EEEEcccCcEEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCc-eeeeecccccCCCCce
Q 001449 805 VRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~k---Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPN-IVkL~g~~~d~~e~~L 880 (1075)
++.|..|-...+|++... +..|++|+....... . ....+|+.+++.+...+ ..+++..+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~--------~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-I--------IDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-e--------ecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 467888889999998765 467889976532111 0 11225777777775333 3344433221
Q ss_pred EEEEeeecCCcH
Q 001449 881 ATVTEFMVNGSL 892 (1075)
Q Consensus 881 ~LVmEYmeGGSL 892 (1075)
.++|||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 479999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0032 Score=68.27 Aligned_cols=135 Identities=14% Similarity=0.104 Sum_probs=74.2
Q ss_pred EcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCce-eeeecccccCCCCceEEEEee
Q 001449 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDGPDGSLATVTEF 886 (1075)
Q Consensus 808 LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNI-VkL~g~~~d~~e~~L~LVmEY 886 (1075)
+..|-...+|+....+..+++|+.......-. ....+|..+++.+..-.+ .+++.... -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~--------~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG--------VDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc--------CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 55688889999888888899997543211100 012457777777753222 22333221 2689999
Q ss_pred ecCCcHHHH--------------Hhh---c---cccCCHHHH-HHHHHH---------HHHHHHHHHh--------CCcc
Q 001449 887 MVNGSLKQF--------------LQK---K---DRTIDRRKR-LIIAMD---------AAFGMEYLHG--------KNIV 928 (1075)
Q Consensus 887 meGGSL~d~--------------Lkk---~---~~~Lse~~~-l~Ia~Q---------IL~AL~yLHs--------~GII 928 (1075)
++|..+... +.+ . ...++.... ..+..+ +...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 988665321 110 0 111121111 111111 1112222221 2589
Q ss_pred cccCCCCceEeccCCCCCCeEEEeecCCccccc
Q 001449 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (1075)
Q Consensus 929 HRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~ 961 (1075)
|+|+.|.||+++ +++ ++|+||+.+....
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCcCC
Confidence 999999999997 333 7899999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0055 Score=56.82 Aligned_cols=53 Identities=26% Similarity=0.621 Sum_probs=44.2
Q ss_pred cCceeEEEccC-CCChHHHHHHHHHHhC------CceEEEeeCCCCCCCceeeccChhhHHHH
Q 001449 47 GGETRIVSLPR-DVTYEELMSRMRELYE------GAVVLKYQQPDEDLDALVSVVNDDDVINM 102 (1075)
Q Consensus 47 gg~tri~~v~r-~~~~~~l~~kl~~~~~------~~~~~kyqlp~edld~Lisv~~dedl~~m 102 (1075)
|||.|.+.++. .++|.+|+..+..++. .+|.|||.=+ | ..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYkD~--d-GDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYKDE--D-GDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEECC--C-CCEEEeccHHHHHHH
Confidence 99999999998 5999999999987775 2589999822 2 368999999999754
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0071 Score=67.03 Aligned_cols=74 Identities=22% Similarity=0.359 Sum_probs=44.4
Q ss_pred EEEEcccCcEEEEEEEEc--------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCCce-eeeecccccC
Q 001449 805 VRELGSGTYGSVYHGKWR--------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDG 875 (1075)
Q Consensus 805 l~~LGeG~FG~VYkAk~k--------Gt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HPNI-VkL~g~~~d~ 875 (1075)
++.|..|-...||+.+.. +..+++|+....... .....+|..+++.+....+ .+++..+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 456777888899998764 367899986643211 1123356666666653222 344444332
Q ss_pred CCCceEEEEeeecCCcHH
Q 001449 876 PDGSLATVTEFMVNGSLK 893 (1075)
Q Consensus 876 ~e~~L~LVmEYmeGGSL~ 893 (1075)
.+|+||++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 3589998887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.011 Score=66.08 Aligned_cols=147 Identities=16% Similarity=0.117 Sum_probs=80.7
Q ss_pred cCCCeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC--ceeeeecccc--
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR-- 873 (1075)
Q Consensus 798 ~~ddYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP--NIVkL~g~~~-- 873 (1075)
.......++.|+.|....+|+.+..+..+++|+..... . . .....|..++..|... .+.+++....
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~---~-~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~ 89 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV---K-A------EELPFFLALTTHLAARGLPVPKPVKSRDGR 89 (307)
T ss_pred CCCCceeccccCCccccceEEEEeCCCcEEEEEecCCC---C-H------HHHHHHHHHHHHHHHCCCCCCccccCCCCC
Confidence 33445567778888889999987766678899765321 0 0 1122344555554311 1333333211
Q ss_pred --cCCCCceEEEEeeecCCcHH----H-------HHh---hccccC-----------CHHHHH------------HHHHH
Q 001449 874 --DGPDGSLATVTEFMVNGSLK----Q-------FLQ---KKDRTI-----------DRRKRL------------IIAMD 914 (1075)
Q Consensus 874 --d~~e~~L~LVmEYmeGGSL~----d-------~Lk---k~~~~L-----------se~~~l------------~Ia~Q 914 (1075)
....+..+++++|++|..+. . .+. .....+ .|.... .....
T Consensus 90 ~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~ 169 (307)
T TIGR00938 90 QLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAE 169 (307)
T ss_pred eehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHH
Confidence 11245678999999875431 1 110 000000 000000 00112
Q ss_pred HHHHHHHHHh-------CCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 915 AAFGMEYLHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 915 IL~AL~yLHs-------~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
+.+.++++.. .+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 170 LDKELDYLDKFWPRDLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEE----CCceEEEeeccccc
Confidence 3344555542 5899999999999997 44567899999776
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.027 Score=62.94 Aligned_cols=31 Identities=19% Similarity=0.275 Sum_probs=25.6
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 925 ~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.++||+|+.+.|||++ .+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~----~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE----GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE----CCceEEEEecccccC
Confidence 4899999999999997 344557999998763
|
|
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.014 Score=54.34 Aligned_cols=72 Identities=22% Similarity=0.345 Sum_probs=58.1
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCccEEEE
Q 001449 46 VGGETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIF 121 (1075)
Q Consensus 46 ~gg~tri~~v~r~~~~~~l~~kl~~~~~~----~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~f 121 (1075)
-+|+-+|..++.+++|.+|..|+.++|.. .+++||- +||= -+|++++|++|+.-+..|... +.+-|-+-
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~--DEEG-Dp~tiSS~~EL~EA~rl~~~n----~~~~l~ih 79 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI--DEEG-DPCTISSQMELEEAFRLYELN----KDSELNIH 79 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE--CCCC-CceeecCHHHHHHHHHHHHhc----CcccEEEE
Confidence 46777899999999999999999999964 5999998 4443 479999999998887777654 23457777
Q ss_pred Eec
Q 001449 122 LFS 124 (1075)
Q Consensus 122 lf~ 124 (1075)
+||
T Consensus 80 vfp 82 (83)
T cd06404 80 VFP 82 (83)
T ss_pred ecC
Confidence 776
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.012 Score=55.69 Aligned_cols=74 Identities=28% Similarity=0.560 Sum_probs=56.9
Q ss_pred eeeecCceeEEEccC-----CCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCC
Q 001449 43 LRYVGGETRIVSLPR-----DVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGD 113 (1075)
Q Consensus 43 l~Y~gg~tri~~v~r-----~~~~~~l~~kl~~~~~~----~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~ 113 (1075)
..| ||++|-++++. +++|.+|..|+++++.. .+.|||. .| =..+|.++||+||+.-|+...+ .+
T Consensus 5 v~y-~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~--De-dgd~V~l~~D~DL~~a~~~~~~---~~ 77 (91)
T cd06398 5 VKY-GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT--DE-DGDVVTLVDDNDLTDAIQYFCS---GS 77 (91)
T ss_pred EEe-CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE--CC-CCCEEEEccHHHHHHHHHHHhc---cC
Confidence 344 88889999995 79999999999999864 4899998 43 3479999999999988876433 33
Q ss_pred CCccEEEEEe
Q 001449 114 GFTRLRIFLF 123 (1075)
Q Consensus 114 ~~~r~r~flf 123 (1075)
+..-||+++-
T Consensus 78 ~~~~lrl~v~ 87 (91)
T cd06398 78 RLNPLRIDVT 87 (91)
T ss_pred CCceEEEEEE
Confidence 4455787764
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.022 Score=62.75 Aligned_cols=144 Identities=14% Similarity=0.108 Sum_probs=81.5
Q ss_pred CeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCCC--ceeeeecccc----c
Q 001449 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR----D 874 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~HP--NIVkL~g~~~----d 874 (1075)
+...++.|..|....+|+....+..+++|+.... . . ..+..|+.++..+..- .+.+++.... .
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~----~---~----~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~ 83 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTTDSGRYVLTLFEKV----S---A----EELPFFLALLDHLAERGLPVPRPIADRDGEYLS 83 (296)
T ss_pred chhheecccCccccceEEEEeCCCcEEEEEcCCC----C---h----HhccHHHHHHHHHHHCCCCCCccccCCCCcEee
Confidence 3444677888888999998877778999987531 0 0 2233456666655422 2334333210 0
Q ss_pred CCCCceEEEEeeecCCcHHH----HHh----------hc--c--c------cCCHHHHH----------HHHHHHHHHHH
Q 001449 875 GPDGSLATVTEFMVNGSLKQ----FLQ----------KK--D--R------TIDRRKRL----------IIAMDAAFGME 920 (1075)
Q Consensus 875 ~~e~~L~LVmEYmeGGSL~d----~Lk----------k~--~--~------~Lse~~~l----------~Ia~QIL~AL~ 920 (1075)
...+..++|++|++|..+.. .+. .. . . ...+.... .....+..++.
T Consensus 84 ~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 163 (296)
T cd05153 84 ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELA 163 (296)
T ss_pred eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence 11345689999998876432 110 00 0 0 00111100 01111233444
Q ss_pred HHHh-------CCcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 921 YLHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 921 yLHs-------~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
++.+ .+++|+|+.|.|||++ .+..+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~~ 205 (296)
T cd05153 164 RQDAFDPSDLPRGVIHADLFRDNVLFD----GDELSGVIDFYFACT 205 (296)
T ss_pred HHHhhhhhcCCCcCCccCcCcccEEEe----CCceEEEeehhhhcC
Confidence 5443 4799999999999997 445668999997763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.013 Score=67.98 Aligned_cols=145 Identities=25% Similarity=0.155 Sum_probs=96.0
Q ss_pred EEEcccCcEEEEEEEE-cCcceEEEEeeccccCCCch------------------hHHHHHHHHHHHHHHHHhCCCCcee
Q 001449 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS------------------ERERLIADFWKEALLLSSLHHPNVV 866 (1075)
Q Consensus 806 ~~LGeG~FG~VYkAk~-kGt~VAVKvIkk~~~~~k~~------------------ere~~i~~flrEi~ILkkL~HPNIV 866 (1075)
..|..|--+.||.|.- +|..+|||+++.+.+.=+.. .+.-..-....|+.-|++|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4688899999999976 58889999998665321111 1111222344677778877643322
Q ss_pred eeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceEeccCCCC
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQ 945 (1075)
Q Consensus 867 kL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs-~GIIHRDIKPeNILId~~d~~ 945 (1075)
----+.. ....|||+|+ |.+=+-.-+-+...++...+..+-.|++.-+.-|-+ .++||.||.-=|+|+.
T Consensus 230 ~PePIlL----k~hVLVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh----- 299 (520)
T KOG2270|consen 230 CPEPILL----KNHVLVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH----- 299 (520)
T ss_pred CCCceee----ecceEeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-----
Confidence 1111111 1247899999 443222222222347777888888899998888875 5899999999999994
Q ss_pred CCeEEEeecCCcccc
Q 001449 946 RPVCKIGDLGLSKVK 960 (1075)
Q Consensus 946 ~g~VKLiDFGLAk~~ 960 (1075)
.+.+.|+|.+.+-..
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 679999999987643
|
|
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.03 Score=52.19 Aligned_cols=69 Identities=16% Similarity=0.282 Sum_probs=56.0
Q ss_pred cCceeEEEccC--CCChHHHHHHHHHHhCCc-eEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCccEEEEEe
Q 001449 47 GGETRIVSLPR--DVTYEELMSRMRELYEGA-VVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1075)
Q Consensus 47 gg~tri~~v~r--~~~~~~l~~kl~~~~~~~-~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~flf 123 (1075)
||+++.+.++. +++|.+|.+.+++.|+.. |.|||= +|| .--|+++||.||+.-++-|.|- +..||+++.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl--Dde-~e~v~lssd~eLeE~~rl~~~~-----~~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV--DEE-NEEVSVNSQGEYEEALKSAVRQ-----GNLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE--cCC-CCEEEEEchhhHHHHHHHHHhC-----CCEEEEEEe
Confidence 67788899988 789999999999999865 899997 433 4689999999998877777662 256888864
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.035 Score=51.44 Aligned_cols=57 Identities=25% Similarity=0.404 Sum_probs=46.7
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeccChhhHHHHHHHH
Q 001449 47 GGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEY 106 (1075)
Q Consensus 47 gg~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~dedl~~m~~ey 106 (1075)
||+||=+++++.-+|++|.+||..++.. ++.|+|- .||= -+|++++|+||+.-+.-.
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi--DeD~-D~ITlssd~eL~d~~~~~ 67 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI--DNDN-DEITLSSNKELQDFYRLS 67 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE--cCCC-CEEEecchHHHHHHHHhc
Confidence 5677777799999999999999999875 4899997 4432 689999999998776543
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.077 Score=59.73 Aligned_cols=109 Identities=14% Similarity=0.074 Sum_probs=73.0
Q ss_pred CeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC---CceeeeecccccC-C
Q 001449 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH---PNVVSFYGIVRDG-P 876 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H---PNIVkL~g~~~d~-~ 876 (1075)
.....+.||+|..+.||+....+..+.+|..+... . ...+..|...|+.|.- ..+.++++++..+ .
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccc-c---------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 45567789999999999987765567778754310 0 1345678888877752 3466677665432 2
Q ss_pred CCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhC
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925 (1075)
Q Consensus 877 e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~ 925 (1075)
.+.-+||||++++.++.+. . .+......+..+++++|.-||+.
T Consensus 85 ~g~~~LVmE~i~G~~~~~~-~-----~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 85 PGPDVLLLERLRGVSVEAP-A-----RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CCCeEEEEeccCCEecCCC-C-----CCHHHHHHHHHHHHHHHHHHhCC
Confidence 3557999999999887652 1 23334445667778888888874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.2 Score=59.15 Aligned_cols=83 Identities=19% Similarity=0.079 Sum_probs=50.2
Q ss_pred eEEEEEcccCcEEEEEEEEcC--cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCC---CCceeeeecccccCCC
Q 001449 803 EEVRELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 803 eil~~LGeG~FG~VYkAk~kG--t~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~---HPNIVkL~g~~~d~~e 877 (1075)
...+.||.|.+..||++...+ +.|+||.-.......... ......++..|...|+.+. ...+.+++.+- .
T Consensus 29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~-wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~ 103 (401)
T PRK09550 29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGES-WPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----E 103 (401)
T ss_pred ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCccccccccc-ccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----C
Confidence 345789999999999998864 379999754211000000 0011234556777777653 23566666652 2
Q ss_pred CceEEEEeeecCC
Q 001449 878 GSLATVTEFMVNG 890 (1075)
Q Consensus 878 ~~L~LVmEYmeGG 890 (1075)
...++||||+.+.
T Consensus 104 ~~~~lVME~L~~~ 116 (401)
T PRK09550 104 ELAVTVMEDLSDH 116 (401)
T ss_pred CCCEEEEecCCCc
Confidence 3468999998764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.065 Score=61.59 Aligned_cols=31 Identities=19% Similarity=0.314 Sum_probs=26.0
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEeecCCccc
Q 001449 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 926 GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~ 959 (1075)
.++|+|+++.|||++. .++.++|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDE---ETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeC---CCCcEEEEeehhccc
Confidence 5899999999999972 236799999998874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.029 Score=67.33 Aligned_cols=155 Identities=23% Similarity=0.296 Sum_probs=97.3
Q ss_pred HHHHHHHHHHhCCCCceeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 001449 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1075)
Q Consensus 849 ~flrEi~ILkkL~HPNIVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GII 928 (1075)
.++....+++.+.|+|...++++.... .....+|||++ +.+|++++.... +- + .+++ .
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~-~~Sled~~~~~~--l~------~-~s~~-----------~ 85 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHY-TMSLEDILKTGN--LK------D-ESLL-----------A 85 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhh-ccchHHHHHhcc--cc------h-hhhc-----------c
Confidence 345667789999999999999876653 44588999998 889999887643 11 1 1111 2
Q ss_pred cccCCCCceEeccCCCCCCeEEEeecCCccccccccccCCCCCCCCccCcccccCCCCCCCchhhHHHHHHHHHHHHcCC
Q 001449 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008 (1075)
Q Consensus 929 HRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~~~sss~~GT~~YmAPEvl~g~~~~yS~KsDIWSLGVILyELLTG~ 1008 (1075)
||=+ +-|| ++.+| -++.. | |-. ...|+||||+|.++.++..|.
T Consensus 86 ~~~~-~~~~-----------~~~td-~~~t~---------------~--~~~-------~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 86 HGVL-HLNI-----------IYITD-HFLTK---------------Y--PSP-------IGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred cccc-eehh-----------hhccc-ccccc---------------C--CCC-------CCcchhhhhHHHHHHHHHHhh
Confidence 2211 1122 22333 00000 0 111 113899999999999999999
Q ss_pred CCCCCCChHHHHHhhhhccCCCC----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 001449 1009 EPYADMHCASIIGGIVNNTLRPQ----------IPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062 (1075)
Q Consensus 1009 ~PF~~~~~~eil~~Ilk~~l~p~----------ips~ls~eL~dLI~kCLq~DPeeRPSa~ELL 1062 (1075)
..|......+....+.+-...+. +--.++..+.++..+|+-..|..||...++.
T Consensus 129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 88877666666555544322111 1123566778889999999999888655543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.01 Score=67.90 Aligned_cols=140 Identities=16% Similarity=0.043 Sum_probs=93.8
Q ss_pred eeEEEEEcccCcEEEEEEEEc-CcceEEEEeeccccC--CCc------------hhHHHHHHHHHHHHHHHHhCCC-C-c
Q 001449 802 LEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA--GKP------------SERERLIADFWKEALLLSSLHH-P-N 864 (1075)
Q Consensus 802 Yeil~~LGeG~FG~VYkAk~k-Gt~VAVKvIkk~~~~--~k~------------~ere~~i~~flrEi~ILkkL~H-P-N 864 (1075)
+.+.+.||-|--+.||.+-+. |++.++|+-+..... .-. .+.....-...+|...|+.|.. - -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567788999999999998774 999999864432111 000 0001112234578888887752 2 1
Q ss_pred eeeeecccccCCCCceEEEEeeecCCcHHHHHhhccccCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceEeccCCC
Q 001449 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (1075)
Q Consensus 865 IVkL~g~~~d~~e~~L~LVmEYmeGGSL~d~Lkk~~~~Lse~~~l~Ia~QIL~AL~yLHs~GIIHRDIKPeNILId~~d~ 944 (1075)
+.+.++ .+..++|||++.|..|...-.- .+. -.|...++.-+.-|-..|+||+|+.-=||+|+
T Consensus 174 VPkpiD------~~RH~Vvmelv~g~Pl~~v~~v----~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---- 236 (465)
T KOG2268|consen 174 VPKPID------HNRHCVVMELVDGYPLRQVRHV----EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---- 236 (465)
T ss_pred CCCccc------ccceeeHHHhhcccceeeeeec----CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEe----
Confidence 344444 3456899999988877765321 122 23455666677788899999999999999998
Q ss_pred CCCeEEEeecCCcc
Q 001449 945 QRPVCKIGDLGLSK 958 (1075)
Q Consensus 945 ~~g~VKLiDFGLAk 958 (1075)
++..++++||-...
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 56789999997543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.12 Score=57.71 Aligned_cols=32 Identities=28% Similarity=0.290 Sum_probs=25.2
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 926 GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
.++|+|+++.|||++. .....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~---~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDE---DARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeC---CCCEEEEECcHhcccC
Confidence 4899999999999971 1334679999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.12 Score=59.14 Aligned_cols=31 Identities=23% Similarity=0.221 Sum_probs=25.8
Q ss_pred cccccCCCCceEeccCCCCCCeEEEeecCCcccc
Q 001449 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 927 IIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~ 960 (1075)
++|+|+.+.|||++. .++.++|+||..|...
T Consensus 184 ~CHnDl~~~NiL~~~---~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNE---DEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeC---CCCcEEEEcccccCCC
Confidence 799999999999962 3457999999988743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.25 Score=54.63 Aligned_cols=29 Identities=17% Similarity=0.306 Sum_probs=24.5
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEeecCCcc
Q 001449 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 925 ~GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk 958 (1075)
.+++|+|+.+.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence 4789999999999997 3 457899999665
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd06402 PB1_p62 The PB1 domain is an essential part of p62 scaffold protein (alias sequestosome 1,SQSTM) involved in cell signaling, receptor internalization, and protein turnover | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.11 Score=49.01 Aligned_cols=64 Identities=20% Similarity=0.457 Sum_probs=49.6
Q ss_pred ceeEEEccC--CCChHHHHHHHHHHhC----CceEEEeeCCCCCCCceeeccChhhHHHHHHHHhhcCCCCCCccEEEEE
Q 001449 49 ETRIVSLPR--DVTYEELMSRMRELYE----GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFL 122 (1075)
Q Consensus 49 ~tri~~v~r--~~~~~~l~~kl~~~~~----~~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~fl 122 (1075)
|-|-.+++. +++|.+|+.++.++|. ..|+|||. .|| .-||+++|||||.--+.... .+-||||+
T Consensus 15 EIRRf~l~~~~~~s~~~L~~~V~~~f~~l~~~~ftlky~--Dee-GDlvtIssdeEL~~A~~~~~-------~~~~RlyI 84 (87)
T cd06402 15 EIRRFAIDEDVSTSYEYLVEKVAAVFPSLRGKNFQLFWK--DEE-GDLVAFSSDEELVMALGSLN-------DDTFRIYI 84 (87)
T ss_pred ceEEEEecCCCCcCHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEeecCHHHHHHHHHcCC-------CCcEEEEE
Confidence 667788865 5699999999999983 46999998 433 35899999999987765543 25589887
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.3 Score=56.20 Aligned_cols=152 Identities=18% Similarity=0.206 Sum_probs=82.8
Q ss_pred CeeEEEEEcccCcEEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHHhCCC--CceeeeecccccCCCC
Q 001449 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeil~~LGeG~FG~VYkAk~kGt~VAVKvIkk~~~~~k~~ere~~i~~flrEi~ILkkL~H--PNIVkL~g~~~d~~e~ 878 (1075)
...+++.+-.|..-.+|....+++++++. ..... ... .......+|+.+|+.+.- .-+...++++.++.-+
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~---~~~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g 98 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRG---DPV---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLG 98 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCcc---ccc---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCC
Confidence 44556666555555666666667888888 22100 111 112344567777777653 2234455666554335
Q ss_pred ceEEEEeeecCCcHH------------------HHHhh------------------ccccC-CHHHHHHHH--------H
Q 001449 879 SLATVTEFMVNGSLK------------------QFLQK------------------KDRTI-DRRKRLIIA--------M 913 (1075)
Q Consensus 879 ~L~LVmEYmeGGSL~------------------d~Lkk------------------~~~~L-se~~~l~Ia--------~ 913 (1075)
..++||+|++|..+. +.|.. ..+.+ .+......+ -
T Consensus 99 ~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 99 TPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred CceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 679999999873222 11110 00000 011111000 0
Q ss_pred HHHHHHHHHHhC--------CcccccCCCCceEeccCCCCCCeEEEeecCCccccccc
Q 001449 914 DAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (1075)
Q Consensus 914 QIL~AL~yLHs~--------GIIHRDIKPeNILId~~d~~~g~VKLiDFGLAk~~~~~ 963 (1075)
.+..-..+|+.+ .++|+|+.+.||+|+ ...-+=|+||+++......
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID----PGRPTGVLDWELATLGDPL 232 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe----CCCeeEEEeccccccCCcH
Confidence 222334555543 489999999999998 3334889999999876544
|
|
| >cd06406 PB1_P67 A PB1 domain is present in p67 proteins which forms a signaling complex with p40, a crucial step for activation of NADPH oxidase during phagocytosis | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.12 Score=48.02 Aligned_cols=59 Identities=19% Similarity=0.360 Sum_probs=48.0
Q ss_pred CeeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeccChhhHHHHHHH
Q 001449 42 KLRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEE 105 (1075)
Q Consensus 42 ~l~Y~gg~tri~~v~r~~~~~~l~~kl~~~~~~---~~~~kyqlp~edld~Lisv~~dedl~~m~~e 105 (1075)
+++|-+ |-+|.|+++++|++|..|+++-.+. .+.|.|. .|+=..++.+ +|+||+.++.-
T Consensus 6 KV~f~~--tIaIrvp~~~~y~~L~~ki~~kLkl~~e~i~LsYk--de~s~~~v~l-~d~dle~aws~ 67 (80)
T cd06406 6 KVHFKY--TVAIQVARGLSYATLLQKISSKLELPAEHITLSYK--SEASGEDVIL-SDTNMEDVWSQ 67 (80)
T ss_pred EEEEEE--EEEEEcCCCCCHHHHHHHHHHHhCCCchhcEEEec--cCCCCCccCc-ChHHHHHHHHh
Confidence 356665 9999999999999999999998765 3889998 5555567777 89999988753
|
PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes . A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. The p67 proteins contain |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1075 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-45 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-45 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-40 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-40 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-40 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-33 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-33 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-32 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-32 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-32 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-32 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-32 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-32 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-32 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-32 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-32 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-32 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-32 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-31 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-30 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-30 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-30 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-30 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-30 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-30 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-30 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-30 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-30 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-30 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-30 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-30 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-30 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-30 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-30 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-30 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-30 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-30 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-30 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-30 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-30 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-30 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-30 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-29 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-29 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-29 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-29 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-29 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-29 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-29 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-29 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-29 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-29 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-28 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-28 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-28 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-28 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-28 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-28 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-28 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-28 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-28 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-28 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-28 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-28 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-28 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-28 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-28 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-27 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-27 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-27 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-27 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-27 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-27 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-27 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-27 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-27 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-27 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-27 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-27 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-27 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-27 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-27 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-27 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-27 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-27 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-27 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-27 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-27 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-27 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-27 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-27 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-27 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-27 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-27 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-27 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-27 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-27 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-27 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-27 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-27 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-27 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-27 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-27 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-27 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-27 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-26 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-26 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-26 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-26 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-26 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-26 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-26 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-26 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-26 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-26 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-26 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-26 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-26 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-26 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-26 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-26 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-26 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-26 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-26 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-26 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-26 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-26 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-26 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-25 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-25 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-25 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-25 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-25 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-25 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-25 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-25 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-25 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-25 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-25 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-25 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-25 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-25 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-25 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-25 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-24 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-24 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-24 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-24 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-24 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-24 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-24 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-24 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-24 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-24 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-24 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-24 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-24 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-24 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-24 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-24 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-24 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-24 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-24 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-24 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-24 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-24 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-24 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-24 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-24 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-24 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-24 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-24 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-24 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-24 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-24 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-24 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-24 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-24 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-23 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-23 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-23 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-23 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-23 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-23 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-23 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-23 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-23 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-23 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-23 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-22 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-22 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-22 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-22 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-22 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-22 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-22 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-22 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-22 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-22 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-22 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-22 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-22 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-22 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-22 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-22 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-22 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-22 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-22 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-21 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-21 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-21 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-21 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-21 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-21 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-20 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-20 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-20 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-19 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-18 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-18 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-18 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-18 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-18 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-18 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-16 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-16 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-16 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-122
Identities = 96/292 (32%), Positives = 153/292 (52%), Gaps = 14/292 (4%)
Query: 784 IAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS 841
+ +E L T+ ++++E +++G G +G V+ G+ S VAIK + G+
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
E+ +F +E ++S+L+HPN+V YG++ + P V EF+ G L L K
Sbjct: 63 MIEKF-QEFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAH 117
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSK 958
I +L + +D A G+EY+ +N IVH DL+ N+ + D PVC K+ D GLS+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC-- 1016
+ G+ G WMAPE + + TEK D YSF ++++ +LTG+ P+ +
Sbjct: 178 QSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
I I LRP IP C P R+++E CW+ DP +RP FS I + L +
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-120
Identities = 89/279 (31%), Positives = 137/279 (49%), Gaps = 18/279 (6%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I +L +G G +G VY W G +VA+K + + + I + +EA L
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ L HPN+++ G+ P+ L V EF G L + L K I + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIA 115
Query: 917 FGMEYLHGKN---IVHFDLKCENLLVNMR----DPQRPVCKIGDLGLSKVKQQTLVSGGV 969
GM YLH + I+H DLK N+L+ + D + KI D GL++ +T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
G WMAPE++ ++ DV+S+G+++WELLTG+ P+ + ++ G+ N L
Sbjct: 176 -GAYAWMAPEVIRASM--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
IPS C + LME CW DP RPSF+ I +L ++
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-119
Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 18/276 (6%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I L + +L G ++ G+W+G+D+ +K +K ++ R DF +E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS------TRKSRDFNEECPR 60
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDA 915
L HPNV+ G + P +T +M GSL L + + +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 916 AFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A GM +LH I L +++++ +I + Q G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDM----TARISMADVKFSFQSP----GRMYAP 172
Query: 974 PWMAPELLSGK-SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
W+APE L K D++SF +++WEL+T + P+AD+ I + LRP I
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P P LM+ C DPA+RP F I L M
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-119
Identities = 108/314 (34%), Positives = 170/314 (54%), Gaps = 25/314 (7%)
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
H DYD T + L + + + I DL ++G+G++G+V+ +W
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDD------MDIPWCDLNIKEKIGAGSFGTVHRAEWH 59
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVA+K + F + +F +E ++ L HPN+V F G V P+ L+
Sbjct: 60 GSDVAVKILMEQDFH------AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LSI 111
Query: 883 VTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLL 938
VTE++ GSL + L K +D R+RL +A D A GM YLH +N IVH +LK NLL
Sbjct: 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171
Query: 939 VNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGKSHMVTEKIDVYSF 997
V+ ++ K+ D GLS++K T +S GT WMAPE+L + EK DVYSF
Sbjct: 172 VD----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSF 225
Query: 998 GIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPS 1057
G+++WEL T +P+ +++ A ++ + R +IP +P+ +++E CW ++P +RPS
Sbjct: 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPS 285
Query: 1058 FSEISRRLRSMAAA 1071
F+ I LR + +
Sbjct: 286 FATIMDLLRPLIKS 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 351 bits (904), Expect = e-113
Identities = 88/281 (31%), Positives = 141/281 (50%), Gaps = 22/281 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + + + +GSG++G+VY GKW G DVA+K + + + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN------VTAPTPQQLQAFKNEVGV 73
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L H N++ F G LA VT++ SL L + + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS---GGVRGTL 973
GM+YLH K+I+H DLK N+ ++ + KIGD GL+ K + S + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 974 PWMAPELLSGKSH-MVTEKIDVYSFGIVMWELLTGDEPYADMHCAS-IIGGIVNNTLRP- 1030
WMAPE++ + + + DVY+FGIV++EL+TG PY++++ II + +L P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 1031 --QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
++ S C + LM C ERPSF I + +A
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-111
Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 27/281 (9%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L I ++E +G G +G V KWR DVAIK+I++ E F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----------ESERKAFIVE 51
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLII 911
LS ++HPN+V YG + + V E+ GSL L + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 912 AMDAAFGMEYLHG---KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
+ + G+ YLH K ++H DLK NLL+ V KI D G + Q + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT---VLKICDFGTACDIQTHMTNN- 163
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI-IGGIVNNT 1027
+G+ WMAPE+ G ++ +EK DV+S+GI++WE++T +P+ ++ + I V+N
Sbjct: 164 -KGSAAWMAPEVFEGSNY--SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
RP + SLM CW+ DP++RPS EI + + +
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-110
Identities = 73/287 (25%), Positives = 115/287 (40%), Gaps = 27/287 (9%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + LE +G G +G VYHG+W G +VAI+ I + E + F +E +
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLID------IERDNEDQLKAFKREVM 81
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
H NVV F G P LA +T +L ++ +D K IA +
Sbjct: 82 AYRQTRHENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG------GV 969
GM YLH K I+H DLK +N+ + I D GL +
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYDNG-----KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 970 RGTLPWMAPELLSGKSHMV-------TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGG 1022
G L +APE++ S ++ DV++ G + +EL + P+ +II
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
+ E ++ CWA + ERP+F+++ L +
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = 5e-97
Identities = 82/321 (25%), Positives = 132/321 (41%), Gaps = 54/321 (16%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+Q ++ V+++G G YG V+ GKWRG VA+K + A E E
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---------TE 81
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+ H N++ F G L +T++ NGSL +L+ T+D + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKL 139
Query: 912 AMDAAFGMEYLHGKN--------IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
A + G+ +LH + I H DLK +N+LV + C I DLGL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFISD 195
Query: 964 -----LVSGGVRGTLPWMAPELLSGKSHMV----TEKIDVYSFGIVMWELLTGDE----- 1009
+ GT +M PE+L + D+YSFG+++WE+
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
Query: 1010 -----PYADM-----HCASIIGGIVNNTLRPQIPSW-----CDPEWRSLMESCWASDPAE 1054
PY D+ + + LRP P+ C + LM CWA +PA
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 1055 RPSFSEISRRLRSMAAAINVK 1075
R + + + L M+ + ++K
Sbjct: 316 RLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 2e-93
Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
+ DL LG G +G R + + +K + + E + F KE
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI------RFDEETQ--RTFLKEV 58
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HPNV+ F G++ L +TE++ G+L+ ++ D +R+ A D
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----------- 963
A GM YLH NI+H DL N LV + + D GL+++
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 964 ----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI 1019
V G WMAPE+++G+S+ EK+DV+SFGIV+ E++ D ++
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSY--DEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 1020 IGGI-VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
G+ V L P C P + + C DP +RPSF ++ L ++
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 6e-85
Identities = 75/322 (23%), Positives = 125/322 (38%), Gaps = 58/322 (18%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
Q + +G G +G V+ GKWRG +VA+K R +++EA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF-----------SSREERSWFREA 85
Query: 855 --LLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L H N++ F L V+++ +GSL +L + T+ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIK 143
Query: 911 IAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+A+ A G+ +LH + I H DLK +N+LV + C I DLGL+
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDS 199
Query: 963 T-----LVSGGVRGTLPWMAPELLSGKSHM----VTEKIDVYSFGIVMWELLTG------ 1007
+ GT +MAPE+L +M ++ D+Y+ G+V WE+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 1008 ---------DEPYADMHCASIIGGIVNNTLRPQIPS-----WCDPEWRSLMESCWASDPA 1053
D +D + + LRP IP+ +M CW ++ A
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 1054 ERPSFSEISRRLRSMAAAINVK 1075
R + I + L ++ +K
Sbjct: 320 ARLTALRIKKTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 6e-83
Identities = 77/316 (24%), Positives = 129/316 (40%), Gaps = 58/316 (18%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+Q D+ + +G G YG V+ G W+G +VA+K R +++E
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF-----------SSRDEKSWFRE 50
Query: 854 A--LLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
L H N++ F S L +T + GSL +LQ T+D L
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCL 108
Query: 910 IIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
I + A G+ +LH + I H DLK +N+LV C I DLGL+ +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMHS 164
Query: 962 QT-----LVSGGVRGTLPWMAPELLSGKSHMV----TEKIDVYSFGIVMWELLTGDE--- 1009
Q+ + + GT +MAPE+L + +++D+++FG+V+WE+
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
Query: 1010 -------PYADMHC-----ASIIGGIVNNTLRPQIPSW-----CDPEWRSLMESCWASDP 1052
P+ D+ + + + RP IP+ LM+ CW +P
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284
Query: 1053 AERPSFSEISRRLRSM 1068
+ R + I + L +
Sbjct: 285 SARLTALRIKKTLTKI 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 9e-71
Identities = 70/319 (21%), Positives = 113/319 (35%), Gaps = 58/319 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++ L+ + G +G V+ + VA+K + E E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW--QNE-------YEVYS 71
Query: 857 LSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L + H N++ F G + G L +T F GSL FL+ + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 915 AAFGMEYLHGK----------NIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVK-- 960
A G+ YLH I H D+K +N+L+ N+ I D GL+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL------TACIADFGLALKFEA 183
Query: 961 -QQTLVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPY----- 1011
+ + G GT +MAPE+L G +ID+Y+ G+V+WEL +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 1012 -----------ADMHCASIIGGIVNNTLRPQIPSWCDPE-----WRSLMESCWASDPAER 1055
+ +V+ RP + + +E CW D R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 1056 PSFSEISRRLRSMAAAINV 1074
S + R+ M N+
Sbjct: 304 LSAGCVGERITQMQRLTNI 322
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-69
Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 22/278 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
+ ++DL ++G G +G V+ G+ R VA+K + + + A F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----PPDLK--AKFLQEA 163
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L HPN+V G+ + V E + G FL+ + + + L + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTL 973
AA GMEYL K +H DL N LV ++ V KI D G+S+ + G +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQV 277
Query: 974 P--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
P W APE L + + DV+SFGI++WE + G PY ++ + R
Sbjct: 278 PVKWTAPEAL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRL 334
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C LME CWA +P +RPSFS I + L+S+
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-68
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 29/287 (10%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKAN-- 61
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI + +T+ M G L ++++ I +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 965 VSGGVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGG 1022
+ G + + WMA E +L T + DV+S+G+ +WEL+T G +PY + + I
Sbjct: 175 HAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-S 230
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
I+ R P C + +M CW D RP F E+ MA
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-67
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 27/281 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I +D+ R LG G +G VY G + VA+K K C + + F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-----TLDNK--EKFM 61
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA+++ +L HP++V GI+ + P + E G L +L++ ++ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
++ M YL N VH D+ N+LV + K+GD GLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 972 TLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027
LP WM+PE + + T DV+ F + MWE+L+ G +P+ + +IG +
Sbjct: 175 RLPIKWMSPESINFRR---FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P+ P C P +LM CW DP++RP F+E+ L +
Sbjct: 232 RLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-67
Identities = 82/284 (28%), Positives = 123/284 (43%), Gaps = 26/284 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I DL + +LG G++G V G+W VA+K +K + + DF
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFI 69
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E + SL H N++ YG+V P + VTE GSL L+K
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
A+ A GM YL K +H DL NLL+ RD + KIGD GL + ++
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 182
Query: 968 GVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
+ W APE L + + D + FG+ +WE+ T G EP+ ++ + I+ I
Sbjct: 183 HRKVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
R P C + ++M CWA P +RP+F + L
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 7e-67
Identities = 88/284 (30%), Positives = 137/284 (48%), Gaps = 27/284 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K S+ R F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-----SDSVR--EKFL 64
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
A + + YL K VH D+ N+LV+ D K+GD GLS+ + + +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 972 TLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNT 1027
LP WMAPE + + T DV+ FG+ MWE+L G +P+ + +IG I N
Sbjct: 178 KLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
P P C P SLM CWA DP+ RP F+E+ +L ++
Sbjct: 235 RLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 9e-67
Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 26/283 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
+ + +G G +G VYHG +D A+K + E + F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 74
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +++ HPNV+S GI +GS V +M +G L+ F++ + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGG 968
+ A GM+YL K VH DL N +++ ++ K+ D GL++ V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 969 VRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
LP WMA E S ++ T K DV+SFG+++WEL+T G PY D++ I ++
Sbjct: 190 TGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
Q P +C +M CW RPSFSE+ R+ ++
Sbjct: 248 GRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 7e-66
Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 26/281 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ E DF +EA
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEE----DFIEEAE 55
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HP +V YG+ P + VTEFM +G L +L+ + L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
GM YL ++H DL N LV + V K+ D G+++ + P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 975 --WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
W +PE + + K DV+SFG++MWE+ + G PY + + ++ I
Sbjct: 169 VKWASPEVFSFSRY---SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 225
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
+ P +M CW P +RP+FS + R+L +A +
Sbjct: 226 K-PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-65
Identities = 66/323 (20%), Positives = 108/323 (33%), Gaps = 65/323 (20%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
++ D+L+ + +G G YG+VY G VA+K + +E K
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINE---------KNIY 59
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGS---LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
+ + H N+ F V E+ NGSL ++L T D +A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLA 117
Query: 913 MDAAFGMEYLHG---------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
G+ YLH I H DL N+LV C I D GLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----TCVISDFGLSMRLTGN 173
Query: 964 LVSG---------GVRGTLPWMAPELLSGKSHM-----VTEKIDVYSFGIVMWELLTGDE 1009
+ GT+ +MAPE+L G ++ +++D+Y+ G++ WE+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 1010 -------------PYADM-----HCASIIGGIVNNTLRPQIPSWCDP------EWRSLME 1045
+ + + RP+ P + +E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 1046 SCWASDPAERPSFSEISRRLRSM 1068
CW D R + R+ +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAEL 316
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-65
Identities = 72/287 (25%), Positives = 127/287 (44%), Gaps = 33/287 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
I+N+DL LG GT+ ++ G R V +K + + E
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSE--- 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
F++ A ++S L H ++V YG+ G V EF+ GSL +L+K I+
Sbjct: 58 -SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR----PVCKIGDLGLSKVKQQT 963
+L +A A M +L ++H ++ +N+L+ + ++ P K+ D G+S
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP- 173
Query: 964 LVSGGVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIG 1021
++ +PW+ PE + + K+ D +SFG +WE+ + GD+P + + +
Sbjct: 174 --KDILQERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ P P E +L+ +C +P RPSF I R L S+
Sbjct: 230 FYEDRHQLPA-PKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 3e-65
Identities = 84/278 (30%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWRG DVAIK IK + +F +EA
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSED----EFIEEAK 71
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ +L H +V YG+ + P + +TE+M NG L +L++ ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
MEYL K +H DL N LVN + V K+ D GLS+ + V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 975 --WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
W PE L+ K + K D+++FG++MWE+ + G PY + I
Sbjct: 185 VRWSPPEVLMYSKF---SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY 241
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ P + ++M SCW ERP+F + + +
Sbjct: 242 R-PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-65
Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ +++LG G +GSV ++ VA+K+++ DF
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLR----DF 58
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L SL H N+V + G+ +L + E++ GSL+ +LQK ID K L
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVS 966
GMEYL K +H DL N+LV + KIGD GL+KV K+ V
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKVK 174
Query: 967 GGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT----------------G 1007
G P W APE L K + DV+SFG+V++EL T G
Sbjct: 175 EP--GESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 1008 DEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
++ M +I + NN P+ P C E +M CW ++ +RPSF +++ R+
Sbjct: 230 NDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 1068 M 1068
+
Sbjct: 289 I 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-65
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 26/283 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
+ + +G G +G VYHG +D A+K + E + F
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 138
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +++ HPNV+S GI +GS V +M +G L+ F++ + + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGG 968
+ A GM++L K VH DL N +++ ++ K+ D GL++ V
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 969 VRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
LP WMA E S ++ T K DV+SFG+++WEL+T G PY D++ I ++
Sbjct: 254 TGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
Q P +C +M CW RPSFSE+ R+ ++
Sbjct: 312 GRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-65
Identities = 89/294 (30%), Positives = 145/294 (49%), Gaps = 28/294 (9%)
Query: 780 IEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGK 839
+ ++A + R + +L+ ++ +G G +G V G +RG+ VA+K IK
Sbjct: 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----- 55
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
+ + F EA +++ L H N+V G++ + G L VTE+M GSL +L+ +
Sbjct: 56 -ATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSR 109
Query: 900 DRTIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R++ L+ ++D MEYL G N VH DL N+LV+ + V K+ D GL+
Sbjct: 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT- 164
Query: 959 VKQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADM 1014
K+ + G LP W APE L K + K DV+SFGI++WE+ + G PY +
Sbjct: 165 -KEASSTQDT--GKLPVKWTAPEALREKKF---STKSDVWSFGILLWEIYSFGRVPYPRI 218
Query: 1015 HCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
++ + P C P +M++CW D A RPSF ++ +L +
Sbjct: 219 PLKDVVPRVEKGYKMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 6e-65
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 26/284 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEA 854
R +G G +G VYHG++ AIK + ++ F +E
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQV--EAFLREG 73
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
LL+ L+HPNV++ GI+ +G + +M +G L QF++ R + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVRG 971
A GMEYL + VH DL N +++ + K+ D GL++ ++ V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 972 TLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
LP W A E S +++ T K DV+SFG+++WELLT G PY + + +
Sbjct: 189 RLPVKWTALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072
PQ P +C +M+ CW +DPA RP+F + + + +A+
Sbjct: 247 LPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 218 bits (559), Expect = 1e-64
Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 26/278 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+K +++ ++ELGSG +G V GKW+G DVA+K IK + +F++EA
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSED----EFFQEAQ 55
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+ L HP +V FYG+ ++ P + VTE++ NG L +L+ + ++ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
GM +L +H DL N LV+ K+ D G+++ V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 975 --WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
W APE K + K DV++FGI+MWE+ + G PY + ++ V+ R
Sbjct: 169 VKWSAPEVFHYFKY---SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHRL 224
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P +M SCW P +RP+F ++ + +
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-64
Identities = 96/339 (28%), Positives = 146/339 (43%), Gaps = 48/339 (14%)
Query: 759 LVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYH 818
+ H DYD T + L + + A Q + L+ +++LG G +GSV
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEM 59
Query: 819 GKWRGSD------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872
++ VA+K+++ DF +E +L SL H N+V + G+
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH----STEEHLR----DFEREIEILKSLQHDNIVKYKGVC 111
Query: 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932
+L + E++ GSL+ +LQK ID K L GMEYL K +H DL
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171
Query: 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGVRGTLP--WMAPE-LLSGKS 985
N+LV + KIGD GL+KV Q V G P W APE L K
Sbjct: 172 ATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKVKEP--GESPIFWYAPESLTESK- 224
Query: 986 HMVTEKIDVYSFGIVMWELLT----------------GDEPYADMHCASIIGGIVNNTLR 1029
+ DV+SFG+V++EL T G++ M +I + NN
Sbjct: 225 --FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P+ P C E +M CW ++ +RPSF +++ R+ +
Sbjct: 283 PR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-64
Identities = 86/288 (29%), Positives = 127/288 (44%), Gaps = 29/288 (10%)
Query: 797 IKNDDLEEVR-ELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFW 851
+K D+L ELG G +GSV G +R DVAIK +K + + +
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----EKADT--EEMM 58
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EA ++ L +P +V G+ + L V E G L +FL K I +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
+ GM+YL KN VH DL N+L+ R KI D GLSK + +
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 970 RGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
G P W APE + K + + DV+S+G+ MWE L+ G +PY M ++ I
Sbjct: 172 AGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAIN 1073
P C PE +LM CW +RP F + +R+R+ ++
Sbjct: 229 GKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-63
Identities = 82/300 (27%), Positives = 125/300 (41%), Gaps = 45/300 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ +R+LG G +G V ++ VA+K +K AD
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-----GGNHI--ADL 70
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
KE +L +L+H N+V + GI + + + EF+ +GSLK++L K I+ +++L
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVS 966
A+ GM+YL + VH DL N+LV KIGD GL+K + V
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTVK 186
Query: 967 GGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDE------------- 1009
P W APE L+ K DV+SFG+ + ELLT D
Sbjct: 187 DD--RDSPVFWYAPECLMQSK---FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 1010 -PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ M ++ + P P C E LM CW P+ R SF + ++
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 30/293 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I + L + LG G +GSV G + D VA+K +K S+RE +F
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS----SQREI--EEFL 84
Query: 852 KEALLLSSLHHPNVVSFYGIV-RDGPDGSLAT--VTEFMVNGSLKQFLQK-----KDRTI 903
EA + HPNV+ G+ G + FM G L +L + I
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQ 962
+ L +D A GMEYL +N +H DL N ++ + D GLSK +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYSG 200
Query: 963 TLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASI 1019
G +P W+A E L + T K DV++FG+ MWE+ T G PY + +
Sbjct: 201 DYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 1020 IGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072
+++ R + P C E +M SCW +DP +RP+FS + +L + ++
Sbjct: 259 YDYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 84/303 (27%), Positives = 133/303 (43%), Gaps = 46/303 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ + +LG G +GSV ++ VA+K+++ S +++R DF
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-----PDQQR---DF 71
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +LH +V + G+ SL V E++ +G L+ FLQ+ +D + L+
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVS 966
+ GMEYL + VH DL N+LV KI D GL+K+ +V
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVVR 187
Query: 967 GGVRGTLP--WMAPE-LLSGK-SHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC----- 1016
G P W APE L S + DV+SFG+V++EL T D+ +
Sbjct: 188 EP--GQSPIFWYAPESLSDNIFSR----QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 1017 ASIIGGIVNNTLRPQI--------PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ L + P C E LM+ CWA P +RPSFS + +L +
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
Query: 1069 AAA 1071
+
Sbjct: 302 WSG 304
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 85/296 (28%), Positives = 131/296 (44%), Gaps = 31/296 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I R LG G +GSV + + D VA+K +KA + + +F
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII----ASSDI--EEFL 73
Query: 852 KEALLLSSLHHPNVVSFYGIV-RDGPDGSLAT---VTEFMVNGSLKQFLQK-----KDRT 902
+EA + HP+V G+ R G L + FM +G L FL
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQ 961
+ + + +D A GMEYL +N +H DL N ++ + + D GLS K+
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIYS 189
Query: 962 QTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCAS 1018
G LP W+A E L ++ T DV++FG+ MWE++T G PYA + A
Sbjct: 190 GDYYRQGCASKLPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 1019 IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074
I ++ R + P C E LM CW++DP +RPSF+ + L ++ ++V
Sbjct: 248 IYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-63
Identities = 93/286 (32%), Positives = 131/286 (45%), Gaps = 28/286 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFW 851
I+ + + +GSG G V +G+ R VAIK +KA +ER+R DF
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----TERQR--RDFL 98
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA ++ HPN++ G+V G VTE+M NGSL FL+ D + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
GM YL VH DL N+LV+ VCK+ D GLS+V
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 970 RGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
G +P W APE + + DV+SFG+VMWE+L G+ PY +M +I +
Sbjct: 213 GGKIPIRWTAPEAIAFRT---FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
P P C LM CW D A+RP FS+I L ++ +
Sbjct: 270 GYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-63
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 29/287 (10%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKAN-- 61
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI + +T+ M G L ++++ I +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 965 VSGGVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGG 1022
+ G + + WMA E +L T + DV+S+G+ +WEL+T G +PY + + I
Sbjct: 175 HAEGGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-S 230
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
I+ R P C + +M CW D RP F E+ MA
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-63
Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 26/278 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V LG+G +G V+ G + G VA+K +K + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPD----AFLAEAN 60
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
L+ L H +V Y +V P + +TE+M NGSL FL+ +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM ++ +N +H DL+ N+LV+ CKI D GL+++ + + P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 975 --WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRP 1030
W APE + G T K DV+SFGI++ E++T G PY M +I + R
Sbjct: 174 IKWTAPEAINYGTF---TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRM 229
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C E LM CW P +RP+F + L
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 3e-63
Identities = 86/280 (30%), Positives = 136/280 (48%), Gaps = 28/280 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E E +F KEA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVE----EFLKEA 60
Query: 855 LLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IA 912
++ + HPN+V G+ R+ P +TEFM G+L +L++ +R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ MEYL KN +H DL N LV + K+ D GLS++ +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 973 LP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
P W APE L K + K DV++FG+++WE+ T G PY + + + + +
Sbjct: 174 FPIKWTAPESLAYNKF---SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ P C + LM +CW +P++RPSF+EI + +M
Sbjct: 231 MER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 4e-63
Identities = 87/293 (29%), Positives = 145/293 (49%), Gaps = 28/293 (9%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKP 840
E T+A + R + +L+ ++ +G G +G V G +RG+ VA+K IK
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDAT 229
Query: 841 SERERLIADFWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK 899
++ F EA +++ L H N+V G++ + L VTE+M GSL +L+ +
Sbjct: 230 AQ------AFLAEASVMTQLRHSNLVQLLGVIVEEKGG--LYIVTEYMAKGSLVDYLRSR 281
Query: 900 DRTIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R++ L+ ++D MEYL G N VH DL N+LV+ + V K+ D GL+
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT- 336
Query: 959 VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMH 1015
K+ + + LP W APE L + + K DV+SFGI++WE+ + G PY +
Sbjct: 337 -KEASSTQDTGK--LPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391
Query: 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
++ + + P C P +M++CW D A RP+F ++ +L +
Sbjct: 392 LKDVVPRVEKG-YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 4e-63
Identities = 98/317 (30%), Positives = 151/317 (47%), Gaps = 31/317 (9%)
Query: 769 DYDNDTVKTLKIEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-- 824
DYD T + L + + +A+ + I + + +G+G +G VY G + S
Sbjct: 11 DYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG 70
Query: 825 ----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880
VAIK +KA +E++R DF EA ++ H N++ G++ +
Sbjct: 71 KKEVPVAIKTLKAGY-----TEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYK--PM 121
Query: 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940
+TE+M NG+L +FL++KD + + + A GM+YL N VH DL N+LVN
Sbjct: 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 941 MRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTLP--WMAPE-LLSGKSHMVTEKIDVY 995
VCK+ D GLS+V + + G +P W APE + K T DV+
Sbjct: 182 ----SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK---FTSASDVW 234
Query: 996 SFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAE 1054
SFGIVMWE++T G+ PY ++ ++ I + P P C LM CW + A
Sbjct: 235 SFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERAR 293
Query: 1055 RPSFSEISRRLRSMAAA 1071
RP F++I L + A
Sbjct: 294 RPKFADIVSILDKLIRA 310
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-63
Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 36/293 (12%)
Query: 794 LQTIKNDDLE--------EVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPS 841
L+ I+ ++ E +ELGSG +G+V G ++ VA+K +K A P+
Sbjct: 3 LEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPA 60
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
++ + EA ++ L +P +V GI V E G L ++LQ+ +R
Sbjct: 61 LKD----ELLAEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQ-NR 112
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-- 959
+ + + + + GM+YL N VH DL N+L+ + KI D GLSK
Sbjct: 113 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALR 168
Query: 960 KQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMH 1015
+ G P W APE + K + K DV+SFG++MWE + G +PY M
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ + + P+ C E LM CW D RP F+ + RLR+
Sbjct: 226 GSEVTAMLEKGERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-63
Identities = 88/277 (31%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K E F +EA
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPE----AFLQEAQ 231
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM Y+ N VH DL+ N+LV VCK+ D GL+++ + + P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 975 --WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
W APE T K DV+SFGI++ EL T G PY M ++ + R
Sbjct: 345 IKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C LM CW +P ERP+F + L
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-62
Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 31/309 (10%)
Query: 774 TVKTLKIEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----V 826
++T ++P E + + + + ++ + +G+G +G V G+ + V
Sbjct: 18 GLRTF-VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 827 AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886
AIK +K +E++R DF EA ++ HPN++ G+V + VTE+
Sbjct: 77 AIKTLKVGY-----TEKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEY 127
Query: 887 MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
M NGSL FL+K D + + + A GM+YL VH DL N+L+N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--- 184
Query: 947 PVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVM 1001
VCK+ D GL +V G +P W +PE + K T DV+S+GIV+
Sbjct: 185 -VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK---FTSASDVWSYGIVL 240
Query: 1002 WELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
WE+++ G+ PY +M +I + P P C LM CW D RP F +
Sbjct: 241 WEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 1061 ISRRLRSMA 1069
I L +
Sbjct: 300 IVSILDKLI 308
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 34/297 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ ++ +R LG G +G VY G+ G VA+K + C SE++ D
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 79
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK------KDRTI 903
F EAL++S +H N+V G+ + E M G LK FL++ + ++
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQ 961
L +A D A G +YL + +H D+ N L+ P R V KIGD G+++ +
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRA 196
Query: 962 QTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCA 1017
GG LP WM PE + G T K D +SFG+++WE+ + G PY
Sbjct: 197 SYYRKGG-CAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
Query: 1018 SIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074
++ + + R P C +M CW P +RP+F+ I R+ +V
Sbjct: 253 EVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 29/284 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
K +L +++ LGSG +G+V+ G W V IK I+ +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSF--QAV 62
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + SL H ++V G+ L VT+++ GSL +++ + + L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL +VH +L N+L+ ++ D G++ + + L+
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLYS 175
Query: 968 GVRGTLPWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025
+ + WMA E + GK T + DV+S+G+ +WEL+T G EPYA + A + ++
Sbjct: 176 EAKTPIKWMALESIHFGK---YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLE 231
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
R P C + +M CW D RP+F E++ MA
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-62
Identities = 88/280 (31%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K S+ R F
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-----SDSVR--EKFL 439
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
A + + YL K VH D+ N+LV+ D K+GD GLS+ + + +G
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 552
Query: 972 TLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
LP WMAPE + T DV+ FG+ MWE+L G +P+ + +IG I N
Sbjct: 553 KLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P P C P SLM CWA DP+ RP F+E+ +L ++
Sbjct: 611 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 8e-62
Identities = 84/293 (28%), Positives = 132/293 (45%), Gaps = 36/293 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ ++ +R LG G +G VY G+ G VA+K + C SE++ D
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 120
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK------KDRT 902
F EAL++S +H N+V G+ + P + E M G LK FL++ + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--K 960
+ L +A D A G +YL + +H D+ N L+ P R V KIGD G+++ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 236
Query: 961 QQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016
GG LP WM PE + G T K D +SFG+++WE+ + G PY
Sbjct: 237 AGYYRKGG-CAMLPVKWMPPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
++ + + R P C +M CW P +RP+F+ I R+
Sbjct: 293 QEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-61
Identities = 89/301 (29%), Positives = 131/301 (43%), Gaps = 48/301 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
I + + ELG +G VY G G VAIK +K R +
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLR--EE 58
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
F EA+L + L HPNVV G+V +D P L+ + + +G L +FL +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
++ + + A GMEYL ++VH DL N+LV + KI D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISD 171
Query: 954 LGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-G 1007
LGL + G LP WMAPE ++ GK + D++S+G+V+WE+ + G
Sbjct: 172 LGLFREVYAADYYKLLG-NSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYG 227
Query: 1008 DEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067
+PY ++ I N + P P C +LM CW P+ RP F +I RLR+
Sbjct: 228 LQPYCGYSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
Query: 1068 M 1068
Sbjct: 287 W 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 4e-61
Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 36/292 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ + + RELG G++G VY G +G VAIK + + S RER +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRER--IE 74
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------D 900
F EA ++ + +VV G+V G + E M G LK +L+
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 901 RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KV 959
K + +A + A GM YL+ VH DL N +V + KIGD G++ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 188
Query: 960 KQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHC 1016
+ G +G LP WM+PE L K + T DV+SFG+V+WE+ T ++PY +
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
++ ++ P C LM CW +P RPSF EI ++
Sbjct: 247 EQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-61
Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
L+++R+LG G +G V + ++ VA+K +KA + R + +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-----GPQHR--SGW 80
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +L+H +++ + G D SL V E++ GSL+ +L + +I + L+
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLL 138
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL----VS 966
A GM YLH ++ +H DL N+L++ + KIGD GL+K + V
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRVR 194
Query: 967 GGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASII-- 1020
G P W APE L K DV+SFG+ ++ELLT D + +
Sbjct: 195 ED--GDSPVFWYAPECLKEYK---FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 1021 ---GGIVNNTLRPQI--------PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
G + L + P C E LM++CW ++ + RP+F + L+++
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 6e-61
Identities = 85/279 (30%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E E +F KEA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVE----EFLKEA 267
Query: 855 LLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IA 912
++ + HPN+V G+ R+ P +TEFM G+L +L++ +R L+ +A
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ MEYL KN +H +L N LV + K+ D GLS++ +
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 973 LP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029
P W APE L + + K DV++FG+++WE+ T G PY + + + + + R
Sbjct: 381 FPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR 437
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ P C + LM +CW +P++RPSF+EI + +M
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 7e-61
Identities = 91/303 (30%), Positives = 135/303 (44%), Gaps = 47/303 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
IK D+ RELG G +G V+ + VA+K +K + R D
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAAR--KD 63
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK---------- 898
F +EA LL++L H ++V FYG+ P L V E+M +G L +FL+
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 899 -----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + L IA A GM YL ++ VH DL N LV + KIGD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGD 176
Query: 954 LGLSK-VKQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GD 1008
G+S+ V G LP WM PE ++ K T + DV+SFG+++WE+ T G
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGK 233
Query: 1009 EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+P+ + +I I + P C E +M CW +P +R + EI + L ++
Sbjct: 234 QPWFQLSNTEVIECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
Query: 1069 AAA 1071
A
Sbjct: 293 GKA 295
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-60
Identities = 79/261 (30%), Positives = 128/261 (49%), Gaps = 21/261 (8%)
Query: 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
E+G G++ +VY G +VA ++ SER+R +EA +L L HPN
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFK----EEAEMLKGLQHPN 86
Query: 865 VVSFYGIVRDGP--DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+V FY + VTE M +G+LK +L K+ + + + G+++L
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 923 HGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
H + I+H DLKC+N+ + KIGDLGL+ +K+ + V GT +MAPE+
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMAPEM 201
Query: 981 LSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ-IPSWCDPE 1039
K E +DVY+FG+ M E+ T + PY++ A+ I V + ++P PE
Sbjct: 202 YEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 1040 WRSLMESCWASDPAERPSFSE 1060
+ ++E C + ER S +
Sbjct: 259 VKEIIEGCIRQNKDERYSIKD 279
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-60
Identities = 90/296 (30%), Positives = 134/296 (45%), Gaps = 43/296 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD----VAIKRIKASCFAGKPSERERLIADFWK 852
+ +D++ +G G +G V + + AIKR+K S+ + DF
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDDH--RDFAG 74
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +L L HHPN+++ G G L E+ +G+L FL+K
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 900 ----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
T+ ++ L A D A GM+YL K +H DL N+LV + V KI D G
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFG 187
Query: 956 LSKVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYA 1012
LS+ ++ + G LP WMA E L + T DV+S+G+++WE+++ G PY
Sbjct: 188 LSRGQEVYVKKTM--GRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 1013 DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
M CA + + + P CD E LM CW P ERPSF++I L M
Sbjct: 244 GMTCAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-60
Identities = 88/277 (31%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K E F +EA
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPE----AFLQEAQ 314
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM Y+ N VH DL+ N+LV VCK+ D GL+++ + + P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 975 --WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
W APE T K DV+SFGI++ EL T G PY M ++ + R
Sbjct: 428 IKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C LM CW +P ERP+F + L
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-60
Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 24/277 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ ++LG+G +G V+ + VA+K +K E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVE----AFLAEAN 235
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ +L H +V + +V P + +TEFM GSL FL+ + + +LI +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM ++ +N +H DL+ N+LV+ VCKI D GL++V + + P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 975 --WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031
W APE + T K DV+SFGI++ E++T G PY M +I + R
Sbjct: 349 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C E ++M CW + P ERP+F I L
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 9e-60
Identities = 87/312 (27%), Positives = 135/312 (43%), Gaps = 56/312 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+++E VR++G G +G V+ + G VA+K +K S + AD
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQ--AD 96
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK---------- 898
F +EA L++ +PN+V G+ P + + E+M G L +FL+
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 899 -------------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945
+ ++L IA A GM YL + VH DL N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----E 209
Query: 946 RPVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIV 1000
V KI D GLS+ + G +P WM PE + + T + DV+++G+V
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADG-NDAIPIRWMPPESIFYNR---YTTESDVWAYGVV 265
Query: 1001 MWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFS 1059
+WE+ + G +PY M +I + + P C E +LM CW+ PA+RPSF
Sbjct: 266 LWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 1060 EISRRLRSMAAA 1071
I R L+ M
Sbjct: 325 SIHRILQRMCER 336
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-59
Identities = 97/302 (32%), Positives = 140/302 (46%), Gaps = 46/302 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
IK D+ ELG G +G V+ + VA+K +K + SE R D
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESAR--QD 89
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR-- 906
F +EA LL+ L H ++V F+G+ P L V E+M +G L +FL+
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 907 -----------KRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+L+ +A A GM YL G + VH DL N LV Q V KIGD
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKIGDF 202
Query: 955 GLSK-VKQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLT-GDE 1009
G+S+ + G R LP WM PE +L K T + DV+SFG+V+WE+ T G +
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQ 259
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
P+ + I I + P C PE ++M CW +P +R S ++ RL+++A
Sbjct: 260 PWYQLSNTEAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 1070 AA 1071
A
Sbjct: 319 QA 320
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 1e-59
Identities = 88/306 (28%), Positives = 132/306 (43%), Gaps = 29/306 (9%)
Query: 774 TVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVR-ELGSGTYGSVYHGKWRGS----DVAI 828
+ T E ++ E + +K D+L ELG G +GSV G +R DVAI
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 829 KRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888
K +K + + + +EA ++ L +P +V G+ + L V E
Sbjct: 369 KVLKQGT-----EKADT--EEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAG 418
Query: 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
G L +FL K I + + GM+YL KN VH +L N+L+ R
Sbjct: 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----Y 474
Query: 949 CKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGKSHMVTEKIDVYSFGIVMWE 1003
KI D GLSK + + G P W APE + K + + DV+S+G+ MWE
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWE 531
Query: 1004 LLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062
L+ G +PY M ++ I P C PE +LM CW +RP F +
Sbjct: 532 ALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVE 590
Query: 1063 RRLRSM 1068
+R+R+
Sbjct: 591 QRMRAC 596
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-58
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K +E++ +D
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDL 87
Query: 851 WKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E ++ + H N+++ G +DGP L + E+ G+L+++L+ +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 200
Query: 954 LGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDE 1009
GL+ + G LP WMAPE L + T + DV+SFG++MWE+ T G
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
PY + + + R P+ C E +M CW + P++RP+F ++ L +
Sbjct: 259 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-58
Identities = 86/304 (28%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWK 852
+L + LG G +G V VA+K +K + S E D
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSEL--RDLLS 75
Query: 853 EALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK------------ 899
E +L ++HP+V+ YG +DGP L + E+ GSL+ FL++
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 900 -----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+R + + A + GM+YL +VH DL N+LV +
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRK 188
Query: 949 CKIGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
KI D GLS V ++ +G +P WMA E L H+ T + DV+SFG+++WE++
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIV 246
Query: 1006 T-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064
T G PY + + + R + P C E LM CW +P +RP F++IS+
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
Query: 1065 LRSM 1068
L M
Sbjct: 306 LEKM 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-58
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K +E++ +D
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDL 133
Query: 851 WKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E ++ + H N+++ G +DGP L + E+ G+L+++L+ +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 246
Query: 954 LGLSKVKQQTLV-SGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDE 1009
GL++ G LP WMAPE L + T + DV+SFG++MWE+ T G
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
PY + + + R P+ C E +M CW + P++RP+F ++ L +
Sbjct: 305 PYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-57
Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 41/299 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L+ + LG G +G V G D VA+K +K + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEH--RA 76
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E +L + HH NVV+ G P G L + EF G+L +L+ K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + A GME+L + +H DL N+L++ ++ V KI D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICD 191
Query: 954 LGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDE 1009
GL+ + + LP WMAPE + + T + DV+SFG+++WE+ + G
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
PY + + R + P + PE M CW +P++RP+FSE+ L ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 7e-57
Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
+ L + LG+G +G V G VA+K +K S ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-----HLTER--EALMS 75
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +LS L +H N+V+ G GP +TE+ G L FL++K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ +D L + A GM +L KN +H DL N+L+ + KI D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 954 LGLSKVKQQTLV-SGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDE 1009
GL++ + LP WMAPE + + + T + DV+S+GI +WEL + G
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
PY M S ++ R P E +M++CW +DP +RP+F +I + +
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-56
Identities = 79/295 (26%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
++L+ + LG+G +G V G VA+K +K++ E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEK--EALMS 98
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR---- 906
E ++S L H N+V+ G GP + +TE+ G L FL++K R ++
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 907 --------KRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+ L+ + A GM +L KN +H D+ N+L+ V KIGD GL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLA 211
Query: 958 -KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYAD 1013
+ + LP WMAPE + + T + DV+S+GI++WE+ + G PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ S +V + + P++ S+M++CWA +P RP+F +I L+
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-56
Identities = 80/302 (26%), Positives = 134/302 (44%), Gaps = 47/302 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G + VA+K +K+ +E++
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----TEKDL-- 118
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK------ 899
+D E ++ + H N+++ G +DGP L + E+ G+L+++LQ +
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 900 ---------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
+ + + + A A GMEYL K +H DL N+LV + V K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMK 231
Query: 951 IGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT- 1006
I D GL+ + G LP WMAPE L + T + DV+SFG+++WE+ T
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTL 289
Query: 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
G PY + + + + PS C E +M CW + P++RP+F ++ L
Sbjct: 290 GGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 1067 SM 1068
+
Sbjct: 349 RI 350
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-56
Identities = 83/304 (27%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
++LE + LGSG +G V + G VA+K +K ER
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSER--EALMS 97
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +++ L H N+V+ G GP + + E+ G L +L+ K
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 900 -----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+ L A A GME+L K+ VH DL N+LV V
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKV 210
Query: 949 CKIGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
KI D GL+ + + LP WMAPE L + T K DV+S+GI++WE+
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIF 268
Query: 1006 T-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064
+ G PY + + ++ N + P + E +M+SCWA D +RPSF ++
Sbjct: 269 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
Query: 1065 LRSM 1068
L
Sbjct: 329 LGCQ 332
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 41/279 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D +E+ +GSG +G V+ K R G IKR+K E+ +E L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAE----REVKAL 58
Query: 858 SSLHHPNVVSFYG--------------IVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRT 902
+ L H N+V + G L EF G+L+Q+++K +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+D+ L + G++Y+H K +++ DLK N+ + KIGD GL +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKN 174
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGG 1022
+GTL +M+PE +S + + +++D+Y+ G+++ ELL + +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDY--GKEVDLYALGLILAELLHVCDTAFETS------K 226
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ I D + ++L++ + P +RP+ SEI
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-50
Identities = 71/256 (27%), Positives = 112/256 (43%), Gaps = 19/256 (7%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GTYG VY G +AIK I P R +E L L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI--------PERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI--IAMDAAFGMEYLH 923
V + G + +G + E + GSL L+ K + ++ I G++YLH
Sbjct: 82 VQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPELLS 982
IVH D+K +N+L+N V KI D G SK + + GTL +MAPE++
Sbjct: 140 DNQIVHRDIKGDNVLINTYSG---VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 983 GKSHMVTEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNNTLRPQIPSWCDPEWR 1041
+ D++S G + E+ TG P+ ++ + + + + P+IP E +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 1042 SLMESCWASDPAERPS 1057
+ + C+ DP +R
Sbjct: 257 AFILKCFEPDPDKRAC 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-48
Identities = 62/265 (23%), Positives = 99/265 (37%), Gaps = 22/265 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + LG G+YG V+ + + G A+KR + P +R R + E
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRARKL----AEVGSH 110
Query: 858 SSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ HP V + G L TE SL+Q + ++ + D
Sbjct: 111 EKVGQHPCCVRLEQAWEE--GGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
+ +LH + +VH D+K N+ + R CK+GD GL G +M
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APELL G DV+S G+ + E+ E H + L P+ +
Sbjct: 224 APELLQGSY---GTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGL 277
Query: 1037 DPEWRSLMESCWASDPAERPSFSEI 1061
E RS++ DP R + +
Sbjct: 278 SSELRSVLVMMLEPDPKLRATAEAL 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-48
Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 43/289 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E ++ LG G +G V+ K + + AIKRI+ + RE+++ +E L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVM----REVKAL 57
Query: 858 SSLHHPNVVSFYG----------IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ L HP +V ++ + P L + +LK ++ + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 908 RLI--IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
+ I + A +E+LH K ++H DLK N+ M D V K+GD GL Q
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEE 173
Query: 966 SGGVR-------------GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYA 1012
V GT +M+PE + G S+ + K+D++S G++++ELL
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY--SHKVDIFSLGLILFELLYP--FST 229
Query: 1013 DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
M + + N P + + P +++ + P ERP I
Sbjct: 230 QMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-48
Identities = 58/271 (21%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ++++G G++G K G IK I S ERE +E +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESR----REVAVL 77
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
+++ HPN+V + + +GSL V ++ G L + + K + L +
Sbjct: 78 ANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLVSGGVR 970
++++H + I+H D+K +N+ + ++GD G+++V + +
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIARVLNSTVELARACI----- 186
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030
GT +++PE+ K + K D+++ G V++EL T + +++ I++ + P
Sbjct: 187 GTPYYLSPEICENKPY--NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP 244
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ + RSL+ + +P +RPS + I
Sbjct: 245 -VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 21/289 (7%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAG 838
P +A+ + + +++G G + VY G VA+K+++
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFD 69
Query: 839 KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ- 897
+ R AD KE LL L+HPNV+ +Y + D L V E G L + ++
Sbjct: 70 LMDAKAR--ADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKH 125
Query: 898 --KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
K+ R I R + +E++H + ++H D+K N+ + V K+GDLG
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLG 181
Query: 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYA-- 1012
L + + + GT +M+PE + + K D++S G +++E+ P+
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGY--NFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 1013 DMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
M+ S+ I P E R L+ C DP +RP + +
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 34/278 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E + +G+G+YG + + G + K + +E++ L+ E LL
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLV----SEVNLL 59
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMD 914
L HPN+V +Y + D + +L V E+ G L + K + + +D L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 915 AAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QT 963
++ H ++ ++H DLK N+ ++ + K+GD GL+++ +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFAKT 175
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI 1023
V GT +M+PE ++ S+ EK D++S G +++EL P+ + G I
Sbjct: 176 FV-----GTPYYMSPEQMNRMSY--NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
R IP E ++ RPS EI
Sbjct: 229 REGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-46
Identities = 66/263 (25%), Positives = 109/263 (41%), Gaps = 30/263 (11%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G++G V+ K G A+K++ RL +E + + L P
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKV-------------RLEVFRVEELVACAGLSSPR 111
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V YG VR+GP + E + GSL Q + K+ + + L A G+EYLH
Sbjct: 112 IVPLYGAVREGP--WVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG------VRGTLPWMAP 978
+ I+H D+K +N+L+ + D G + Q + + GT MAP
Sbjct: 169 RRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-LRPQIPSWCD 1037
E++ GK K+D++S +M +L G P+ + I + +IP C
Sbjct: 226 EVVMGKPC--DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283
Query: 1038 PEWRSLMESCWASDPAERPSFSE 1060
P ++ +P R S E
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAME 306
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D EE+ LG G +G V + AIK+I+ + + ++ E +LL
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT-----------VTEFMVNGSLKQFLQKKDRTIDRR 906
+SL+H VV +Y + + E+ NG+L + ++ R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
+ + + Y+H + I+H DLK N+ + D R V KIGD GL+K ++L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLDI 172
Query: 967 GGVR---------------GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
+ GT ++A E+L G H EKID+YS GI+ +E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-NEKIDMYSLGIIFFEMIYP--FS 229
Query: 1012 ADMHCASIIGGIVNNTLR--PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
M +I+ + + ++ P + ++ DP +RP +
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 39/293 (13%)
Query: 791 ARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIA 848
A G+++ + E+ ++GSG +GSV+ R G AIKR K + + +
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNAL- 58
Query: 849 DFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---ID 904
+E + L H +VV ++ + D + E+ GSL + + R
Sbjct: 59 ---REVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFK 113
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---------------DPQRPVC 949
+ + + G+ Y+H ++VH D+K N+ ++ + +
Sbjct: 114 EAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGD 1008
KIGDLG V G ++A E+L +H K D+++ + + +
Sbjct: 174 KIGDLGHVTRISSPQV---EEGDSRFLANEVLQENYTH--LPKADIFALALTVVCAAGAE 228
Query: 1009 EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ I P+IP E+ L++ DP RPS +
Sbjct: 229 PLPRNGDQWHEI----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 4e-44
Identities = 85/290 (29%), Positives = 131/290 (45%), Gaps = 42/290 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
++ + +G G +G VY G R G+ VA+KR G E F E LS
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEE-----FETEIETLS 90
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---RKRLIIAMDA 915
HP++VS G + + + ++M NG+LK+ L D +RL I + A
Sbjct: 91 FCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
A G+ YLH + I+H D+K N+L++ + V KI D G+SK QT +S V+GT
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG------DEPYADMHCA--------- 1017
L ++ PE +TEK DVYSFG+V++E+L P ++ A
Sbjct: 205 LGYIDPEYFI--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 1018 SIIGGIVNNTLRPQIPSWCDPEWR--SLMESCWASDPAERPSFSEISRRL 1065
+ IV+ L +I + C A +RPS ++ +L
Sbjct: 263 GQLEQIVDPNLADKIRPES--LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-42
Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYH-GKWRGSDVAIKRIKASCFAGKPSERERLIADFW 851
+ + LG G G++ + G + DVA+KRI CF ++RE
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADRE------- 67
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
LL S HPNV+ ++ +D E +L++++++KD + + +
Sbjct: 68 -VQLLRESDEHPNVIRYFCTEKD--RQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITL 123
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVSGGVR 970
G+ +LH NIVH DLK N+L++M + + I D GL K S R
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 971 ----GTLPWMAPELLSGKSHM-VTEKIDVYSFGIVMWELLT-GDEPYADMHC--ASIIGG 1022
GT W+APE+LS T +D++S G V + +++ G P+ A+I+ G
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ D R L+E A DP +RPS +
Sbjct: 244 ACSLDC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 8e-42
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 33/283 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 58
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 115
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 116 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 969 VRGTLPWMAPELLSGKSHM---------VTEKIDVYSFGIVMWELLTGDEPYADM-HCAS 1018
GT+ +M PE + S ++ K DV+S G +++ + G P+ + + S
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228
Query: 1019 IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ I++ + P + + + +++ C DP +R S E+
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 31/295 (10%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE 853
I N +++LG G + V + G A+KRI + +RE +E
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQ----RE 76
Query: 854 ALLLSSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---RKR 908
A + +HPN++ + G + F G+L +++ + +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-- 966
L + + G+E +H K H DLK N+L+ + DLG +
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSR 192
Query: 967 --------GGVRGTLPWMAPELLSGKSHM-VTEKIDVYSFGIVMWELLTGDEPY-ADMHC 1016
R T+ + APEL S +SH + E+ DV+S G V++ ++ G+ PY
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
+ V N L L+ S DP +RP + +L ++
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 63/298 (21%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASC-FAGKPSERERLIADFWKEALLLSSLHHPNVV 866
+G G +G VY G + VA+K++ A + +++ F +E +++ H N+V
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ-----FDQEIKVMAKCQHENLV 93
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFL--QKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
G DG D L V +M NGSL L + R IA AA G+ +LH
Sbjct: 94 ELLGFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 925 KNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPE 979
+ +H D+K N+L+ KI D GL++ QT+++ + GT +MAPE
Sbjct: 152 NHHIHRDIKSANILLDEAFT-A-----KISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ-IPSWCDP 1038
L G+ +T K D+YSFG+V+ E++TG V+ PQ + +
Sbjct: 206 ALRGE---ITPKSDIYSFGVVLLEIITGLPA-------------VDEHREPQLLLDIKEE 249
Query: 1039 EW---RSLME----------------------SCWASDPAERPSFSEISRRLRSMAAA 1071
+++ + C +RP ++ + L+ M A+
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 33/283 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 77
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 78 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 135 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 969 VRGTLPWMAPELLSGKSHM---------VTEKIDVYSFGIVMWELLTGDEPYADM-HCAS 1018
GT+ +M PE + S ++ K DV+S G +++ + G P+ + + S
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247
Query: 1019 IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ I++ + P + + + +++ C DP +R S E+
Sbjct: 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 71/211 (33%), Positives = 112/211 (53%), Gaps = 28/211 (13%)
Query: 808 LGSGTYGSVYHGK-WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G +G VY G+ G+ VA+KR+K G E + F E ++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQ-----FQTEVEMISMAVHRNLL 90
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDAAFGMEYLH 923
G + L V +M NGS+ L+++ +D KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 924 GK---NIVHFDLKCENLLVNMR-DPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLPWMA 977
I+H D+K N+L++ + +GD GL+K+ + T V+ VRGT+ +A
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 978 PE-LLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
PE L +GKS +EK DV+ +G+++ EL+TG
Sbjct: 204 PEYLSTGKS---SEKTDVFGYGVMLLELITG 231
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 58/283 (20%), Positives = 108/283 (38%), Gaps = 33/283 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 105
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 162
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 163 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 969 VRGTLPWMAPELLSGKSHM---------VTEKIDVYSFGIVMWELLTGDEPYADM-HCAS 1018
G + +M PE + S ++ K DV+S G +++ + G P+ + + S
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 1019 IIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ I++ + P + + + +++ C DP +R S E+
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 21/288 (7%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIAD 849
G Q+ N LG G +V+ G+ + G AIK S +P + +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQM---- 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRK 907
+E +L L+H N+V + I + + EF GSL L++ + +
Sbjct: 56 --REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
LI+ D GM +L IVH ++K N++ + + + V K+ D G ++ +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 968 GVRGTLPWMAPELLSGKSHMV------TEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021
+ GT ++ P++ +D++S G+ + TG P+
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
++ + + E+ + P +SR L+ +
Sbjct: 234 EVMYKIITGKPSGA--ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 35/272 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
+D E R LG G +G+VY + + S +A+K + KA RE I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI------ 62
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
S L HPN++ YG D + + E+ G++ + LQK + ++R I
Sbjct: 63 ---QSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGV 969
A + Y H K ++H D+K ENLL+ KI D G S ++ L
Sbjct: 118 LAN-ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSRRTDLC---- 168
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
GTL ++ PE++ G+ H EK+D++S G++ +E L G P+ I
Sbjct: 169 -GTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P + R L+ +P++RP E+
Sbjct: 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
+K DDLE + ELG G YG V G +A+KRI+A+ E++RL+ D
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDL---D 57
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLII 911
+ + ++ P V+FYG + +G + E M + SL +F + K +TI I
Sbjct: 58 ISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 912 AMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A+ +E+LH K +++H D+K N+L+N K+ D G+S +
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 971 GTLPWMAPELLSGKSHMV--TEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNN- 1026
G P+MAPE ++ + + + K D++S GI M EL PY + +V
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230
Query: 1027 --TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
L S E+ C + ERP++ E
Sbjct: 231 SPQLPADKFS---AEFVDFTSQCLKKNSKERPTYPE 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-37
Identities = 73/286 (25%), Positives = 118/286 (41%), Gaps = 43/286 (15%)
Query: 806 RELGSGTYGSVYH-GKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+ LG G+ G+V G ++G VA+KR+ + E LL S HPN
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALME--------IKLLTESDDHPN 70
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------IAMDAAFG 918
V+ +Y D L E N +L+ ++ K+ + + K + A G
Sbjct: 71 VIRYYCSETT--DRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC---------KIGDLGLSKVKQQTLVSGGV 969
+ +LH I+H DLK +N+LV+ I D GL K S
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 970 R-----GTLPWMAPELLSGKSHMV-----TEKIDVYSFGIVMWELLT-GDEPYADMHC-- 1016
GT W APELL +++ T ID++S G V + +L+ G P+ D +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 1017 ASIIGGIVN-NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
++II GI + + ++ E L+ DP +RP+ ++
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 35/272 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
DD + R LG G +G+VY + + + +A+K + K+ RE I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI------ 67
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
S L HPN++ Y D + + EF G L + LQK R ++R +
Sbjct: 68 ---QSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGV 969
A + Y H + ++H D+K ENLL+ + KI D G S ++++T+
Sbjct: 123 LAD-ALHYCHERKVIHRDIKPENLLMGYKG----ELKIADFGWSVHAPSLRRRTMC---- 173
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
GTL ++ PE++ GK+H EK+D++ G++ +E L G P+ IVN L+
Sbjct: 174 -GTLDYLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P + + L+ P +R +
Sbjct: 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+DL+++ E+G G YGSV K G +A+KRI+++ E+++L+ D
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDL--- 71
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL----KQFLQKKDRTIDRRKRL 909
+++ S P +V FYG + +G E M + S K D I
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 910 IIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
I + + +L I+H D+K N+L++ + K+ D G+S ++
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 969 VRGTLPWMAPELLSGKSHMV--TEKIDVYSFGIVMWELLTGDEPYADMHC-ASIIGGIVN 1025
G P+MAPE + + + DV+S GI ++EL TG PY + + +V
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 1026 NTLRPQIPSWCDPEW----RSLMESCWASDPAERPSFSE 1060
PQ+ + + E+ + + C D ++RP + E
Sbjct: 245 GDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 21/288 (7%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIAD 849
G Q+ N LG G +V+ G+ + G AIK S +P + +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQM---- 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRK 907
+E +L L+H N+V + I + + EF GSL L++ + +
Sbjct: 56 --REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
LI+ D GM +L IVH ++K N++ + + + V K+ D G ++ +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 968 GVRGTLPWMAPELLSGKSHMV------TEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021
+ GT ++ P++ +D++S G+ + TG P+
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
++ + + E+ + P +SR L+ +
Sbjct: 234 EVMYKIITGKPSGA--ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 35/276 (12%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
N+ E V ELG G +G VY K G+ A K I ++ E + D+ E +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--------ETKSEEELEDYIVEIEI 69
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L++ HP +V G DG L + EF G++ + + DR + + ++
Sbjct: 70 LATCDHPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+ +LH K I+H DLK N+L+ + ++ D G+S K+ + +
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRDSFI----- 178
Query: 971 GTLPWMAPELLSGKSHMVT---EKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN- 1026
GT WMAPE++ ++ T K D++S GI + E+ + P+ +++ ++ I +
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238
Query: 1027 --TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
TL PS E+R ++ +P RPS ++
Sbjct: 239 PPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-36
Identities = 69/288 (23%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG+G +G V + G VAIK+ + P RER E ++ L+HP
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWC----LEIQIMKKLNHP 72
Query: 864 NVVSFYGIVRDGPDGSLAT----VTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDAAF 917
NVVS + + E+ G L+++L + + + + D +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH I+H DLK EN+++ + KI DLG +K Q + GTL ++A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW-- 1035
PELL K + T +D +SFG + +E +TG P+ G V I +
Sbjct: 192 PELLEQKKY--TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 1036 -----------CDPEWRSLMESC----WAS-----DPAERPSFSEISR 1063
P S + + W +R + +
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 77/309 (24%), Positives = 123/309 (39%), Gaps = 62/309 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
+K+DD E++ ELG+G G V+ K G +A K I KP+ R ++I +E
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQII----REL 82
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + P +V FYG DG ++ E M GSL Q L KK I + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139
Query: 915 AAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+ YL K I+H D+K N+LVN R K+ D G+S ++ + V GT
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 194
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT------ 1027
+M+PE L G + + + D++S G+ + E+ G P +
Sbjct: 195 SYMSPERLQGTHY--SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 1028 ---------------------------LRPQIPSWCDPEW---------RSLMESCWASD 1051
L I + P+ + + C +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 1052 PAERPSFSE 1060
PAER +
Sbjct: 313 PAERADLKQ 321
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 73/287 (25%), Positives = 131/287 (45%), Gaps = 34/287 (11%)
Query: 785 AEAEAIARGLQTIKND---DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGK 839
+ ++ G+Q +K D ++ ++G G++G V+ G VAIK I +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----E 58
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
+E E I D +E +LS P V +YG L + E++ GS L +
Sbjct: 59 EAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--E 112
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-- 957
+D + I + G++YLH + +H D+K N+L++ K+ D G++
Sbjct: 113 PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH----GEVKLADFGVAGQ 168
Query: 958 ----KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
++K+ T V GT WMAPE++ ++ K D++S GI EL G+ P+++
Sbjct: 169 LTDTQIKRNTFV-----GTPFWMAPEVIKQSAY--DSKADIWSLGITAIELARGEPPHSE 221
Query: 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
+H ++ I N P + + +E+C +P+ RP+ E
Sbjct: 222 LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-35
Identities = 76/339 (22%), Positives = 123/339 (36%), Gaps = 77/339 (22%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAG-------------- 838
D L+ + LG G +G V G D VA+K +K
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 839 ---------------KPSERERLIADFWKEALLLSSLH---------------HPNVVSF 868
KP +I +F K L + L +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQK--------------KDRTIDRRKRLIIAMD 914
G + L ++T + S +K + + +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
A GME+L + +H DL N+L++ ++ V KI D GL++ K V G
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKG-DAR 256
Query: 973 LP--WMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLR 1029
LP WMAPE + + T + DV+SFG+++WE+ + G PY + + R
Sbjct: 257 LPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+ P + PE M CW +P++RP+FSE+ L ++
Sbjct: 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 25/275 (9%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ +DLE + E+GSGT G V+ + G +A+K+++ S G E +R++ D
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDL--- 74
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
++L S P +V +G + + E M ++ ++ I R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ YL K ++H D+K N+L++ +R K+ D G+S G
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 973 LPWMAPELLSGKSHMV---TEKIDVYSFGIVMWELLTGDEPYADMHCA-SIIGGIVNN-- 1026
+MAPE + + DV+S GI + EL TG PY + ++ ++
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247
Query: 1027 -TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
L +++S ++ C D +RP +++
Sbjct: 248 PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 66/272 (24%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++G G G+VY G +VAI+++ + ++ LI E L+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELII---NEILV 70
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ +PN+V++ G + L V E++ GSL + + +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+E+LH ++H D+K +N+L+ M K+ D G + K+ T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMV----- 177
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030
GT WMAPE+++ K++ K+D++S GI+ E++ G+ PY + + + I N P
Sbjct: 178 GTPYWMAPEVVTRKAY--GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP 234
Query: 1031 QI--PSWCDPEWRSLMESCWASDPAERPSFSE 1060
++ P +R + C D +R S E
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 66/264 (25%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++ VY + G +VAIK I K + + K +R+ E + L H
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--KAGMVQRVQ----NEVKIHCQLKH 70
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEY 921
P+++ Y D + V E NG + ++L+ + + R + GM Y
Sbjct: 71 PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-GMLY 127
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMA 977
LH I+H DL NLL+ KI D GL+ + GT +++
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNM----NIKIADFGLATQLKM---PHEKHYTLCGTPNYIS 180
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE+ + +H + DV+S G + + LL G P+ + + +V +PS+
Sbjct: 181 PEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLS 236
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
E + L+ +PA+R S S +
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSV 260
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 53/297 (17%), Positives = 104/297 (35%), Gaps = 42/297 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL--- 856
+D +R L G + + + A+K+ + S K + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 857 ------LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
++ + + ++ GI+ + + + E+M N S+ +F + I
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 911 IAMDAAF-------GMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
Y+H KNI H D+K N+L+ D V K+ D G S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRV-KLSDFGESEYMVD 204
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP------------ 1010
+ G RGT +M PE S +S K+D++S GI ++ + P
Sbjct: 205 KKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 1011 ---YADMHC---ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
++ + + N ++ E ++ +PAER + +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 74/264 (28%), Positives = 115/264 (43%), Gaps = 29/264 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
R LG G + + A K + K+ KP +RE++ E + SL H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMS----MEISIHRSLAH 74
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+VV F+G D + + V E SL + +++ + R + G +YL
Sbjct: 75 QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYL 131
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMA 977
H ++H DLK NL +N KIGD GL+ + G R GT ++A
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATKVEY----DGERKKVLCGTPNYIA 183
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE+LS K H + ++DV+S G +M+ LL G P+ I N IP +
Sbjct: 184 PEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHIN 239
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
P SL++ +DP RP+ +E+
Sbjct: 240 PVAASLIQKMLQTDPTARPTINEL 263
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 30/271 (11%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++RE+G G++G+VY VAIK++ ++GK S + D KE
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRF 107
Query: 857 LSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L L HPN + + G +R+ + V E+ GS L+ + + + + A
Sbjct: 108 LQKLRHPNTIQYRGCYLREH---TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS--KVKQQTLVSGGVRGTL 973
G+ YLH N++H D+K N+L++ + K+GD G + + V GT
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPANSFV-----GTP 214
Query: 974 PWMAPELLSG-KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---TLR 1029
WMAPE++ K+DV+S GI EL P +M+ S + I N L+
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 274
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
W +R+ ++SC P +RP+
Sbjct: 275 S--GHW-SEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 64/334 (19%), Positives = 114/334 (34%), Gaps = 88/334 (26%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E ++ +G G +G V+ K + + AIKRI+ + RE++ +E L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKV----MREVKAL 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR------------ 905
+ L HP +V ++ + P + + +
Sbjct: 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 906 RKRLIIAMDAAFG--------MEY------------------------------------ 921
+ + M+
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 922 -LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---------- 970
LH K ++H DLK N+ M D V K+GD GL Q V
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 971 ---GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027
GT +M+PE + G ++ + K+D++S G++++ELL M II + N
Sbjct: 235 GQVGTKLYMSPEQIHGNNY--SHKVDIFSLGLILFELLYSFST--QMERVRIITDVRNLK 290
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P + + P+ +++ + P ERP ++I
Sbjct: 291 F-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 65/305 (21%), Positives = 123/305 (40%), Gaps = 36/305 (11%)
Query: 769 DYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDD----LEEVRELGSGTYGSVYHG--KWR 822
D T + + A + D L+ ++G G+ G V K
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
G VA+K + + +R L+ E +++ H NVV Y G + L
Sbjct: 70 GRQVAVKMMDL-----RKQQRRELLF---NEVVIMRDYQHFNVVEMYKSYLVGEE--LWV 119
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
+ EF+ G+L + ++ + + + YLH + ++H D+K +++L+ +
Sbjct: 120 LMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 943 DPQRPVCKIGDLGLS------KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYS 996
K+ D G K+++LV GT WMAPE++S + ++D++S
Sbjct: 178 G----RVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLY--ATEVDIWS 226
Query: 997 FGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSWCDPEWRSLMESCWASDPAER 1055
GI++ E++ G+ PY + + ++ + + P R +E DP ER
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
Query: 1056 PSFSE 1060
+ E
Sbjct: 287 ATAQE 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 74/264 (28%), Positives = 115/264 (43%), Gaps = 29/264 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
R LG G + + A K + K+ KP +RE++ E + SL H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMS----MEISIHRSLAH 100
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+VV F+G D + + V E SL + +++ + R + G +YL
Sbjct: 101 QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYL 157
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMA 977
H ++H DLK NL +N KIGD GL+ + G R GT ++A
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIA 209
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE+LS K H + ++DV+S G +M+ LL G P+ I N IP +
Sbjct: 210 PEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHIN 265
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
P SL++ +DP RP+ +E+
Sbjct: 266 PVAASLIQKMLQTDPTARPTINEL 289
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 42/298 (14%)
Query: 779 KIEPTIAEAEAIARGLQTIKNDDLEEVRE----LGSGTYGSVYHG--KWRGSDVAIKRIK 832
++ + + + EEV + LG G+YGSVY K G VAIK++
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGS 891
E + + KE ++ P+VV +YG ++ L V E+ GS
Sbjct: 64 V----------ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT---DLWIVMEYCGAGS 110
Query: 892 LKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ ++ +++T+ + I G+EYLH +H D+K N+L+N K+
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG----HAKL 166
Query: 952 GDLGLS------KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
D G++ K+ T++ GT WMAPE++ + D++S GI E+
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIGY--NCVADIWSLGITAIEMA 219
Query: 1006 TGDEPYADMHCASIIGGIVNN---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
G PYAD+H I I N T + P + ++ C P +R + ++
Sbjct: 220 EGKPPYADIHPMRAIFMIPTNPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 41/279 (14%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E V +G+GTYG VY G G AIK + E E + +E +L
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIK----QEINMLKKY 77
Query: 861 -HHPNVVSFYG----IVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG G D L V EF GS+ ++ K T+ I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGG 968
G+ +LH ++H D+K +N+L+ K+ D G+S ++ T +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 969 VRGTLPWMAPELLSGKSHMVT---EKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025
GT WMAPE+++ + K D++S GI E+ G P DMH + I
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 1026 N---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
N L+ W +++S +ESC + ++RP+ ++
Sbjct: 249 NPAPRLKS--KKWS-KKFQSFIESCLVKNHSQRPATEQL 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 49/294 (16%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+I DD E +GSG V + VAIKRI + + + + KE
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-----EKCQTS--MDELLKE 63
Query: 854 ALLLSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL--- 909
+S HHPN+VS+Y V L V + + GS+ ++ + + +
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKD---ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 910 ----IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------- 957
I + G+EYLH +H D+K N+L+ +I D G+S
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG----SVQIADFGVSAFLATGGD 176
Query: 958 ---KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM 1014
++T V GT WMAPE++ + K D++SFGI EL TG PY
Sbjct: 177 ITRNKVRKTFV-----GTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKY 230
Query: 1015 HCASIIGGIVNN---TLRPQIPSWCD-----PEWRSLMESCWASDPAERPSFSE 1060
++ + N +L + +R ++ C DP +RP+ +E
Sbjct: 231 PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 42/294 (14%), Positives = 84/294 (28%), Gaps = 45/294 (15%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIA 848
+ + + LG G + VY + +K K + E I
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK------PANPWEFYIG 114
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK----DRTID 904
+ L + FY V E G+L + ++ +
Sbjct: 115 T--QLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-------KIGDLGLS 957
+ + AM + +E +H I+H D+K +N ++ ++ + DLG S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 958 ---KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM 1014
K+ + + T + E+LS K +ID + ++ +L G
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYMKVKN 288
Query: 1015 HCASIIGGIVNNTLRPQIP---SWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
+P+ W ++ R+
Sbjct: 289 E---------GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 29/231 (12%)
Query: 800 DDLEEVRELGSG--TYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
E + +G G +V K G V ++RI + ++ E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE------ACSNEMVTFLQGELH 78
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM-- 913
+ +HPN+V + + L VT FM GS K + +D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 914 -DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVS 966
++Y+H VH +K ++L+++ + L + +Q+ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDG----KVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 967 GGVR--GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015
LPW++PE+L K D+YS GI EL G P+ DM
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 67/277 (24%), Positives = 112/277 (40%), Gaps = 15/277 (5%)
Query: 795 QTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIA 848
Q++ L + + LGSG G V R VAI+ I FA +
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
+ E +L L+HP ++ D D + V E M G L + R + +
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFF-DAEDYYI--VLELMEGGELFDKVVGNKRLKEATCK 242
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
L ++YLH I+H DLK EN+L++ ++ + KI D G SK+ +T +
Sbjct: 243 LYF-YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRT 300
Query: 969 VRGTLPWMAPELLSGKSHMV-TEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNN 1026
+ GT ++APE+L +D +S G++++ L+G P S+ I +
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 1027 TLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
W + + L++ DP R + E
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 70/307 (22%), Positives = 124/307 (40%), Gaps = 46/307 (14%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ L R L G + VY + G + A+KR+ + + + +I +E
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAII----QE 75
Query: 854 ALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMV-----NGSLKQFLQKKDRT--IDR 905
+ L HPN+V F G + S EF++ G L +FL+K + +
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 906 RKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
L I ++++H + I+H DLK ENLL++ + K+ D G +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHY 191
Query: 964 LVSGG-------------VRGTLPWMAPELLSGKSHM-VTEKIDVYSFGIVMWELLTGDE 1009
T + PE++ S+ + EK D+++ G +++ L
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEISRRLRS 1067
P+ D I+ G + IP + SL+ + +P ER S +E+ +L+
Sbjct: 252 PFEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305
Query: 1068 MAAAINV 1074
+AAA NV
Sbjct: 306 IAAARNV 312
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 79/275 (28%), Positives = 116/275 (42%), Gaps = 35/275 (12%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
K L E+ ++LGSG YG V + + + AIK I+ K S +
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR------KTSVSTSSNSKLL 84
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---- 907
+E +L L HPN++ Y D + V E G L F D I R K
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFED--KRNYYLVMECYKGGEL--F----DEIIHRMKFNEV 136
Query: 908 ---RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+I + + + YLH NIVH DLK ENLL+ ++ + KI D GLS V +
Sbjct: 137 DAAVIIKQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQK 193
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
GT ++APE+L K EK DV+S G++++ LL G P+ I+ +
Sbjct: 194 KMKERLGTAYYIAPEVLRKK---YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
Query: 1025 NNTLRPQIPSWCD--PEWRSLMESCWASDPAERPS 1057
P W + + L++ D R S
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 34/294 (11%), Positives = 70/294 (23%), Gaps = 49/294 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
L G V+ + D A+K F + + + L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALK-----VFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 864 NVVSFYG------------------IVRDGPDGSLATVTEFMV-----NGSLKQFLQKKD 900
+ + P V +++ + L+ D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 901 RTIDRRK------RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
R I+ L K +VH +NL + P + +GD+
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRL-MLGDV 238
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM 1014
+ + + E L+ + T ++ + G+ ++ + P+ +
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 1015 HCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCW-------ASDPAERPSFSEI 1061
+ P S L + D R E
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 43/280 (15%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+++ ++ + LGSG + V+ K R G A+K IK K +
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK------KSPAFRD--SS 52
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-- 907
E +L + H N+V+ I V + + G L F DR ++R
Sbjct: 53 LENEIAVLKKIKHENIVTLEDIYES--TTHYYLVMQLVSGGEL--F----DRILERGVYT 104
Query: 908 -RLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ DA+ ++YLH IVH DLK ENLL + + I D GLSK+
Sbjct: 105 EK-----DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKM 158
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI 1019
+Q ++S GT ++APE+L+ K + ++ +D +S G++ + LL G P+ + + +
Sbjct: 159 EQNGIMSTAC-GTPGYVAPEVLAQKPY--SKAVDCWSIGVITYILLCGYPPFYEETESKL 215
Query: 1020 IGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPS 1057
I + P W D + + DP ER +
Sbjct: 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT 255
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 70/269 (26%), Positives = 110/269 (40%), Gaps = 25/269 (9%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ LGSG G V R VAIK I FA + + E +L L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------ 917
++ D D + V E M G L F D+ + KRL A
Sbjct: 76 CIIKIKNFF-DAEDYYI--VLELMEGGEL--F----DK-VVGNKRLKEA-TCKLYFYQML 124
Query: 918 -GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH I+H DLK EN+L++ ++ + KI D G SK+ +T + + GT ++
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 977 APELLSGKSHMV-TEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNNTLRPQIPS 1034
APE+L +D +S G++++ L+G P S+ I +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 1035 WCD--PEWRSLMESCWASDPAERPSFSEI 1061
W + + L++ DP R + E
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 57/234 (24%), Positives = 107/234 (45%), Gaps = 27/234 (11%)
Query: 793 GLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
G++ K +E+ ELGSG + V + + G + A K IK + S R
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVS 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ +E +L + H NV++ + + + + + E + G L F D +
Sbjct: 59 REEIEREVSILRQVLHHNVITLHDVYEN--RTDVVLILELVSGGEL--F----DFLAQKE 110
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ +A G+ YLH K I HFDLK EN+++ ++ P K+ D GL+
Sbjct: 111 S--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+ + + GT ++APE+++ + + + D++S G++ + LL+G P+
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLG 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 27/234 (11%)
Query: 793 GLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
G++T K +E+ ELGSG + V + + G + A K IK + S R
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVC 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ +E +L + HPN+++ + + + + + E + G L F D +
Sbjct: 59 REEIEREVSILRQVLHPNIITLHDVYEN--RTDVVLILELVSGGEL--F----DFLAQKE 110
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ +A G+ YLH K I HFDLK EN+++ ++ P K+ D GL+
Sbjct: 111 S--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+ + + GT ++APE+++ + + + D++S G++ + LL+G P+
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLG 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 73/279 (26%), Positives = 114/279 (40%), Gaps = 34/279 (12%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
+ R LG G++G V K + G + A+K I K
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLL 74
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---- 907
+E LL L HPN++ Y D G V E G L F D I R++
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGEL--F----DEIISRKRFSEV 126
Query: 908 ---RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
R+I + + + Y+H IVH DLK ENLL+ + + +I D GLS + +
Sbjct: 127 DAARIIRQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASK 183
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
GT ++APE+L G EK DV+S G++++ LL+G P+ + I+ +
Sbjct: 184 KMKDKIGTAYYIAPEVLHGT---YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 1025 NNTLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
++P W + L+ P+ R S +
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 33/265 (12%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
V +LG G +VY + VAIK I K +R F +E S L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
N+VS + + L V E+ + G +L ++++ + + G+++
Sbjct: 71 QNIVSMIDVDEEDDCYYL--VMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKH 126
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTLPWMAPE 979
H IVH D+K +N+L+ D + + KI D G++K +T + + V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILI---DSNKTL-KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY--------ADMHCASIIGGIVNNTLRPQ 1031
G+ E D+YS GIV++E+L G+ P+ A H + V +R
Sbjct: 183 QAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKD 239
Query: 1032 IPSWCDPEWRSLMESCWASDPAERP 1056
IP +++ D A R
Sbjct: 240 IP----QSLSNVILRATEKDKANRY 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 84/284 (29%), Positives = 124/284 (43%), Gaps = 34/284 (11%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIK-----ASCFAGKPSERERL 846
K + E R+LGSG YG V K + S+ AIK IK ++ E+
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ + E LL SL HPN++ + + D VTEF G L F ++ I R
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGEL--F----EQ-IINR 140
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ DAA G+ YLH NIVH D+K EN+L+ ++ + KI D GLS
Sbjct: 141 HKFD-ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSF 198
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI 1019
+ GT ++APE+L K EK DV+S G++M+ LL G P+ + I
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKKKY---NEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
Query: 1020 IGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
I + W + E + L++ D +R + E
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 62/304 (20%), Positives = 105/304 (34%), Gaps = 55/304 (18%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G G+YG V + AIK + + + E L+ LHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---------- 913
N+ Y + D + + V E G L L + + +
Sbjct: 89 NIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 914 ----------------------DAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDP 944
+ + YLH + I H D+K EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 945 QRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFGI 999
+ K+ D GLSK + GT ++APE+L+ + K D +S G+
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 1000 VMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPS 1057
++ LL G P+ ++ A I ++N L + P++ P R L+ + + ER
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 1058 FSEI 1061
Sbjct: 325 AMRA 328
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 34/280 (12%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G G VY + R VA+K + + + P R R +EA L
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAGRLQE 93
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P+VV + DG L +NG L L+++ + + + I ++
Sbjct: 94 PHVVPIHDFGEI--DGQLYVDMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDA 149
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTLPWMAPE 979
H H D+K EN+LV+ D + D G++ + G GTL +MAPE
Sbjct: 150 AHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY-ADMHCASIIGGIVNN------TLRPQI 1032
S T + D+Y+ V++E LTG PY D S++G +N T+RP I
Sbjct: 206 RFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPRPSTVRPGI 261
Query: 1033 PSWCDPEWRSLMESCWASDPAER-PSFSEISRRLRSMAAA 1071
P + +++ A +P +R + ++S + A
Sbjct: 262 P----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 77/267 (28%), Positives = 115/267 (43%), Gaps = 41/267 (15%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELG G VY K +G+ A+K +K + E +L L HP
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK----------KTVDKKIVRTEIGVLLRLSHP 108
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N++ I ++ V E + G L F DR +++ R DAA
Sbjct: 109 NIIKLKEIFET--PTEISLVLELVTGGEL--F----DRIVEKGYYSER-----DAADAVK 155
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ YLH IVH DLK ENLL P P+ KI D GLSK+ + ++ V GT
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVCGTP 214
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNNTLRPQI 1032
+ APE+L G ++ ++D++S GI+ + LL G EP Y + + I+N
Sbjct: 215 GYCAPEILRGCAY--GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS 272
Query: 1033 PSWCD--PEWRSLMESCWASDPAERPS 1057
P W + + L+ DP +R +
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLT 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 78/267 (29%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V K R + A+K I K S + + + +E LL L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLKKLDHP 81
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
N++ + I+ D S V E G L F D I +RKR DAA +
Sbjct: 82 NIMKLFEILED--SSSFYIVGELYTGGEL--F----DE-IIKRKRFS-EHDAARIIKQVF 131
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
Y+H NIVH DLK EN+L+ ++ + KI D GLS QQ GT ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L G EK DV+S G++++ LL+G P+ + I+ + +P W
Sbjct: 191 APEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247
Query: 1037 D--PEWRSLMESCWASDPAERPSFSEI 1061
+ + L+ P+ R + ++
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 37/285 (12%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G V+ + DVA+K ++A A PS R F +EA ++L+H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLR----FRREAQNAAALNH 71
Query: 863 PNVVSFYGIVRD-GPDGSLA-TVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
P +V+ Y P G L V E+ V+G +L+ + + + ++ + + DA +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRGTLPW 975
+ H I+H D+K N+++ V K+ D G+++ + S V GT +
Sbjct: 130 NFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY--------ADMHCASIIGGIVNNT 1027
++PE G V + DVYS G V++E+LTG+ P+ A H +
Sbjct: 186 LSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--SA 241
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERP-SFSEISRRLRSMAAA 1071
+ + +++ A +P R + +E+ L +
Sbjct: 242 RHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 33/234 (14%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+ +++++ ELGSG + V + + G A K IK R D
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS--RRGVSRED 60
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-- 907
+E +L + HPNV++ + + + + + E + G L F D ++
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVAGGEL--F----DFLAEKESLT 112
Query: 908 -RLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+A G+ YLH I HFDLK EN+++ R+ +P KI D GL+
Sbjct: 113 EE-----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+ GT ++APE+++ + + + D++S G++ + LL+G P+
Sbjct: 168 IDFGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLG 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 28/263 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ +G G + V + G +VAIK I + P+ ++L +E ++ L+HP
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNHP 74
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
N+V + ++ L + E+ G + +L R + R K R I++ +
Sbjct: 75 NIVKLFEVIETEKTLYL--IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AV 127
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAP 978
+Y H K IVH DLK ENLL+ D + KI D G S + + G P+ AP
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFSNEFTVGGKLDAFC-GAPPYAAP 182
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDP 1038
EL GK + E +DV+S G++++ L++G P+ + + ++ R IP +
Sbjct: 183 ELFQGKKYDGPE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMST 239
Query: 1039 EWRSLMESCWASDPAERPSFSEI 1061
+ +L++ +P +R + +I
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQI 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 64/266 (24%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G+YG V A+K +K P+ + KE LL L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRK--RLIIAMDAAFG 918
NV+ ++ + + V E+ V G + +K+ +I G
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----G 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GTLPW 975
+EYLH + IVH D+K NLL+ + KI LG+++ R G+ +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
PE+ +G K+D++S G+ ++ + TG P+ + + I + IP
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--IPGD 235
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
C P L++ +PA+R S +I
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 42/273 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELG G + V + G + A K I R +EA + L HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHP 65
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM------DAAF 917
N+V + +++ + V + + G L F + I+A DA+
Sbjct: 66 NIVRLHDSIQE--ESFHYLVFDLVTGGEL--F--------ED----IVAREFYSEADASH 109
Query: 918 -------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ Y H IVH +LK ENLL+ + V K+ D GL+ + G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030
GT +++PE+L + ++ +D+++ G++++ LL G P+ D + I
Sbjct: 169 GTPGYLSPEVLKKDPY--SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 1031 QIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
P W PE +SL++S +P +R + +
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
D+ + +G G++G V + A K+I + + F
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVD----RFK 54
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E ++ SL HPN++ Y D + + V E G L F +R + ++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFED--NTDIYLVMELCTGGEL--F----ER-VVHKRVFR- 104
Query: 912 AMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
DAA M Y H N+ H DLK EN L P P+ K+ D GL+ +
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGK 163
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
+ GT +++P++L G + D +S G++M+ LL G P++ + ++ I
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLY---GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR 220
Query: 1025 NNTLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
T W + P+ SL+ P +R + +
Sbjct: 221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 64/272 (23%), Positives = 107/272 (39%), Gaps = 41/272 (15%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G G V R G A+K + S + +E + P++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQE--------VDHHWQASGGPHI 84
Query: 866 VSFYGIVRDGPDGSLAT--VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
V + + G + E M G L F R +R + +AA M
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGEL--F----SRIQERGDQAFTEREAAEIMRDIG 138
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++LH NI H D+K ENLL ++ + K+ D G +K Q + T ++
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YTPYYV 196
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L + + + D++S G++M+ LL G P+ +I G+ Q +
Sbjct: 197 APEVLGPEKY--DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-GFP 253
Query: 1037 DPEWRS-------LMESCWASDPAERPSFSEI 1061
+PEW L+ +DP ER + ++
Sbjct: 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 41/283 (14%)
Query: 794 LQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLI 847
+ TI E ELG G + V G + A I R
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN------TKKLSARDH 54
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+EA + L HPN+V + + + +G + + + G L F + + R
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGEL--F----EDIVAREY 106
Query: 908 ---RLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
DA+ + + H +VH +LK ENLL+ + V K+ D GL+
Sbjct: 107 YSEA-----DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLA 160
Query: 958 K-VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHC 1016
V+ + G GT +++PE+L + + +D+++ G++++ LL G P+ D
Sbjct: 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY--GKPVDLWACGVILYILLVGYPPFWDEDQ 218
Query: 1017 ASIIGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPS 1057
+ I P W PE + L+ +P++R +
Sbjct: 219 HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 66/297 (22%), Positives = 124/297 (41%), Gaps = 36/297 (12%)
Query: 782 PTIAEAEAIARGLQTI--KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKA 833
++ + + RG + + + + ELG G + V + G + A K I
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 834 SCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK 893
+ + + +EA + L HPN+V + +++ + V + + G L
Sbjct: 65 KKLSARDFQ------KLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGEL- 115
Query: 894 QFLQKKDRTIDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
F + I R+ A DA+ + Y H IVH +LK ENLL+ +
Sbjct: 116 -F----ED-IVAREFYSEA-DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168
Query: 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
V K+ D GL+ + G GT +++PE+L + ++ +D+++ G++++ LL
Sbjct: 169 AV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY--SKPVDIWACGVILYILLV 225
Query: 1007 GDEPYADMHCASIIGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
G P+ D + I P W PE +SL++S +P +R + +
Sbjct: 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G G + V R G A+K + + F P D +EA + L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHP 86
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA---MDAAFGM- 919
++V DG L V EFM L I +R A+ M
Sbjct: 87 HIVELLETYSS--DGMLYMVFEFMDGADL--C----FE-IVKRADAGFVYSEAVASHYMR 137
Query: 920 ------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGT 972
Y H NI+H D+K +L+ ++ PV K+G G++ + + LV+GG GT
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLVAGGRVGT 196
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
+MAPE++ + + + +DV+ G++++ LL+G P
Sbjct: 197 PHFMAPEVVKREPY--GKPVDVWGCGVILFILLSGCLP 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-28
Identities = 69/298 (23%), Positives = 116/298 (38%), Gaps = 36/298 (12%)
Query: 729 AEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAE 788
AE + + + + E V+ G+I TV + +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRG--KGTVSSNYDNYVFDIWK 141
Query: 789 AIARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSE 842
IK+D + + ELG+G +G V+ R G++ A K + S+
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESD 197
Query: 843 RERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+E KE +S L HP +V+ + D D + + EFM G L F ++
Sbjct: 198 KE----TVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGEL--F----EKV 245
Query: 903 IDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
D ++ +A G+ ++H N VH DLK EN++ + K+ D G
Sbjct: 246 ADEHNKMS-EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFG 302
Query: 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
L+ GT + APE+ GK V D++S G++ + LL+G P+
Sbjct: 303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 40/284 (14%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI------------------KASCFAGKPSERER 845
E+G G+YG V + A+K + G +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID- 904
I ++E +L L HPNVV ++ D + L V E + G + + K + D
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 905 -RRK-RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--K 960
R + +I G+EYLH + I+H D+K NLLV KI D G+S
Sbjct: 139 ARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEFKG 189
Query: 961 QQTLVSGGVRGTLPWMAPELLSGKSHMVT-EKIDVYSFGIVMWELLTGDEPYADMHCASI 1019
L+S V GT +MAPE LS + + + +DV++ G+ ++ + G P+ D +
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 1020 IGGIVNNTLRPQIPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
I + L P D + + L+ +P R EI
Sbjct: 249 HSKIKSQALE--FPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELGSG + V + + G + A K IK + R + +E +L + HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS--RRGVSREEIEREVNILREIRHP 68
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N+++ + I + + + E + G L F D ++ +A
Sbjct: 69 NIITLHDIFEN--KTDVVLILELVSGGEL--F----DFLAEKESLTED-----EATQFLK 115
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGT 972
G+ YLH K I HFDLK EN+++ ++ P K+ D G++ ++ GT
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GT 174
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
++APE+++ + + + D++S G++ + LL+G P+
Sbjct: 175 PEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLG 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-27
Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 38/276 (13%)
Query: 805 VRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+ G G +Y R G V +K + +G + E L+ +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAM----AMAERQFLAEVV 137
Query: 862 HPNVVSFYGIVRDGPDGSLAT---VTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HP++V + V V E+ V G SLK+ + + + + ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKG---QKLPVAEAIAYLLEILP 193
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH +V+ DLK EN+++ ++ K+ DLG G + GT + A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLGAVSRINSF---GYLYGTPGFQA 245
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++ T D+Y+ G + L + G+ + +
Sbjct: 246 PEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVD----GLPEDDPVLKTY---- 294
Query: 1038 PEWRSLMESCWASDPAERP-SFSEISRRLRSMAAAI 1072
+ L+ DP +R + E+S +L + +
Sbjct: 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 70/313 (22%), Positives = 119/313 (38%), Gaps = 46/313 (14%)
Query: 772 NDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEV----RELGSGTYGSVYHG--KWRGSD 825
+ + P + GLQ KN +++ + LG G G V K
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 826 VAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT-- 882
A+K ++ +E L + P++V + + G
Sbjct: 90 FALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-------EYLHGKNIVHFDLKCE 935
V E + G L F R DR + +A+ M +YLH NI H D+K E
Sbjct: 137 VMECLDGGEL--F----SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190
Query: 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVY 995
NLL + P + K+ D G +K T ++APE+L + + + D++
Sbjct: 191 NLLYTSKRPNAIL-KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY--DKSCDMW 247
Query: 996 SFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRS-------LMESCW 1048
S G++M+ LL G P+ H +I G+ Q + +PEW L+ +
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLL 306
Query: 1049 ASDPAERPSFSEI 1061
++P +R + +E
Sbjct: 307 KTEPTQRMTITEF 319
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 78/267 (29%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V K R + A+K I K S + + + +E LL L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLKKLDHP 81
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
N++ + I+ D S V E G L F D I +RKR DAA +
Sbjct: 82 NIMKLFEILED--SSSFYIVGELYTGGEL--F----DE-IIKRKRFS-EHDAARIIKQVF 131
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
Y+H NIVH DLK EN+L+ ++ + KI D GLS QQ GT ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L G EK DV+S G++++ LL+G P+ + I+ + +P W
Sbjct: 191 APEVLRGTY---DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247
Query: 1037 D--PEWRSLMESCWASDPAERPSFSEI 1061
+ + L+ P+ R + ++
Sbjct: 248 TISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 68/243 (27%), Positives = 100/243 (41%), Gaps = 35/243 (14%)
Query: 808 LGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G GTYG VY K + D A+K+I+ G R E LL L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACR-------EIALLRELKHP 78
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL--QKKDRTIDRRKRLIIAMDAAF---- 917
NV+S + D + + ++ L + + + + +L M +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQTLVSGGVR 970
G+ YLH ++H DLK N+LV P+R KI D+G ++ +K + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 971 GTLPWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
T W APELL G H ID+++ G + ELLT EP HC N
Sbjct: 198 -TF-WYRAPELLLGARHYTKA-IDIWAIGCIFAELLTS-EPI--FHCRQEDIKTSNPYHH 251
Query: 1030 PQI 1032
Q+
Sbjct: 252 DQL 254
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 59/268 (22%), Positives = 103/268 (38%), Gaps = 35/268 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIK-----RIKASCFAGKPSERERLIADFWKEALLLS 858
LG G +G+V+ G VAIK R+ +A W + +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW---KVGA 93
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGS-LKQFLQKKDR---TIDRRK-RLIIAM 913
HP V+ V E + L ++ +K R ++A
Sbjct: 94 GGGHPGVIRLLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+++ H + +VH D+K EN+L+ D +R K+ D G + + GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
+ PE +S + V+S GI++++++ GD P+ I+ + P
Sbjct: 203 VYSPPEWISRHQYHALP-ATVWSLGILLYDMVCGDIPFERDQ--EILEAEL------HFP 253
Query: 1034 SWCDPEWRSLMESCWASDPAERPSFSEI 1061
+ P+ +L+ C A P+ RPS EI
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 42/309 (13%), Positives = 91/309 (29%), Gaps = 56/309 (18%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSE----RERLIADFWKEAL---- 855
LG + + G + + + E L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 856 ------------LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
L+ ++ RD S + M +L+ F +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS 197
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+++ RL + + + LH +VH L+ ++++ D + V +
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGFEHL 253
Query: 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSH---------MVTEKIDVYSFGIVMWELLTGD 1008
+VS + + PEL + ++ ++T D ++ G+V++ + D
Sbjct: 254 VRDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 1009 EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS-----R 1063
P I + IP R+L+E +R +
Sbjct: 311 LPITKDAALGGSEWIFRS--CKNIPQPV----RALLEGFLRYPKEDRLLPLQAMETPEYE 364
Query: 1064 RLRSMAAAI 1072
+LR+ +A
Sbjct: 365 QLRTELSAA 373
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 51/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+K + + ELGSG +G V+ + G K I P ++
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----T 94
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
E +++ LHHP +++ + D + + EF+ G L F DR ++
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGEL--F----DRIAAEDYKM 146
Query: 910 IIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ G++++H +IVH D+K EN++ + KI D GL+
Sbjct: 147 S-EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLATKLNP 203
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+ T + APE++ + V D+++ G++ + LL+G P+A
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 35/280 (12%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
++++ R+LGSG +G V+ + R G + IK I K + +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN------KDRSQVP-MEQIE 68
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +L SL HPN++ + + D ++ V E G L +R + + R
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGEL--L----ERIVSAQARGKA 120
Query: 912 A--MDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
A M Y H +++VH DLK EN+L P P+ KI D GL+++ +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKS 179
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGG 1022
S GT +MAPE+ VT K D++S G+VM+ LLTG P+ +
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 1023 IVNNTLR-PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P+ L++ DP RPS +++
Sbjct: 237 ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 45/273 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
+D + + LG G++ +V + + AIK + K RER +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV------ 83
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA- 912
+S L HP V Y +D D L + NG L ++++K + R A
Sbjct: 84 ---MSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKV--------KQQ 962
+ +A EYLHGK I+H DLK EN+L+ +M +I D G +KV +
Sbjct: 139 IVSAL--EYLHGKGIIHRDLKPENILLNEDMH------IQITDFGTAKVLSPESKQARAN 190
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGG 1022
+ V GT +++PELL+ KS + D+++ G ++++L+ G P+ + I
Sbjct: 191 SFV-----GTAQYVSPELLTEKSA--CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 243
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
I+ P P+ R L+E D +R
Sbjct: 244 IIKLEYD--FPEKFFPKARDLVEKLLVLDATKR 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 53/238 (22%), Positives = 95/238 (39%), Gaps = 32/238 (13%)
Query: 791 ARGLQTIKNDDLEEV-----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSER 843
L ++ +ELG G + V + G + A K +K K
Sbjct: 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK------KRRRG 68
Query: 844 ERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+ A+ E +L P V++ + + + + + E+ G + F
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGGEI--F----SLC 120
Query: 903 IDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
+ ++ D G+ YLH NIVH DLK +N+L++ P + KI D G
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI-KIVDFG 179
Query: 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+S+ + GT ++APE+L+ +T D+++ GI+ + LLT P+
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 47/276 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK---EALLLSS 859
V+ LG G YG V R VA+K + + +R + E +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV----------DMKRAVDCPENIKKEICINKM 61
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L+H NVV FYG R+G E+ G L ++ + +R ++A
Sbjct: 62 LNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GT 972
G+ YLHG I H D+K ENLL+ D + + KI D GL+ V + + GT
Sbjct: 117 --GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGT 170
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS-----IIGGIVNNT 1027
LP++APELL + E +DV+S GIV+ +L G+ P+ +
Sbjct: 171 LPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--- 226
Query: 1028 LRPQIPSWC--DPEWRSLMESCWASDPAERPSFSEI 1061
+ W D +L+ +P+ R + +I
Sbjct: 227 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDI 259
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 43/218 (19%), Positives = 83/218 (38%), Gaps = 33/218 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+LG G +G V+ K +K K +++ KE +L+ H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQV----LVKKEISILNIARHR 61
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------ 917
N++ + L + EF+ + F +R L +
Sbjct: 62 NILHLHESFES--MEELVMIFEFISGLDI--F----ERINTSAFELN-EREIVSYVHQVC 112
Query: 918 -GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPW 975
+++LH NI HFD++ EN++ + + KI + G + ++K +
Sbjct: 113 EALQFLHSHNIGHFDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEY 169
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
APE+ V+ D++S G +++ LL+G P+
Sbjct: 170 YAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 55/264 (20%), Positives = 109/264 (41%), Gaps = 29/264 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LGSG +G V+ + +V +K IK + + E +LS + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGS-LKQFLQKKDRTID---RRK-RLIIAMDAAFG 918
N++ I + G V E +G L F+ + R + R +++
Sbjct: 90 NIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-----A 142
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+ YL K+I+H D+K EN+++ + K+ D G + +++ L GT+ + A
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCA 197
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE+L G + E ++++S G+ ++ L+ + P+ ++ + + P
Sbjct: 198 PEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPFCELE--ETVEAAI------HPPYLVS 248
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
E SL+ P R + ++
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKL 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 60/281 (21%), Positives = 106/281 (37%), Gaps = 58/281 (20%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
++G G+Y + + A+K I S E +LL HP
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---EE--------IEILLRYGQHP 76
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N+++ + D + VTE M G L D+ + ++ R +A+
Sbjct: 77 NIITLKDVYDD--GKYVYVVTELMKGGEL--L----DKILRQKFFSER-----EASAVLF 123
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLVSG 967
+EYLH + +VH DLK N+L +I D G +K + T
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-- 181
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027
T ++APE+L + + D++S G++++ +LTG P+A+ I+
Sbjct: 182 ---YTANFVAPEVLERQGY--DAACDIWSLGVLLYTMLTGYTPFAN-GPDDTPEEILARI 235
Query: 1028 LRPQIPSWCDPEWRS-------LMESCWASDPAERPSFSEI 1061
+ S W S L+ DP +R + + +
Sbjct: 236 GSGKF-SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 33/266 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
LGSG +GSVY G VAIK + K + E +LL +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEVVLLKKVSS 105
Query: 863 --PNVVSFYGIVRDGPDGSLATVTEFMVN-GSLKQFLQKKDR---TIDRRK-RLIIAMDA 915
V+ S + E L F+ ++ + R ++
Sbjct: 106 GFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--- 160
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
+ + H ++H D+K EN+L+ D R K+ D G + + T+ + GT +
Sbjct: 161 --AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVY 214
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035
PE + + V+S GI++++++ GD P+ II G V
Sbjct: 215 SPPEWIRYHRYHGRS-AAVWSLGILLYDMVCGDIPFEHDE--EIIRGQV------FFRQR 265
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
E + L+ C A P++RP+F EI
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-26
Identities = 42/307 (13%), Positives = 89/307 (28%), Gaps = 47/307 (15%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPS----ERERLIADFWKEA- 854
L LG + + G + + + + E L +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 855 ------------LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFM--VNGSLKQFLQ--- 897
+ P + D D + + + +L+ F +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 898 ---KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+++ RL + + + LH +VH L+ ++++ D + V +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGF 255
Query: 955 GLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSH---MVTEKIDVYSFGIVMWELLTGDE 1009
+ VS G A +L H ++T D ++ G+ ++ + D
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 1010 PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS-----RR 1064
P D I + IP R+L+E +R + +
Sbjct: 316 PNTDDAALGGSEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
Query: 1065 LRSMAAA 1071
LR+ +A
Sbjct: 370 LRTELSA 376
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 64/301 (21%), Positives = 115/301 (38%), Gaps = 69/301 (22%)
Query: 797 IKNDDLEEV-------RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLI 847
+K+ + + LG G++ K A+K I +R+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----------KRME 49
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
A+ KE L HPN+V + + D V E + G L F +R ++
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGEL--F----ERIKKKK 101
Query: 907 K---RLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
+A++ M ++H +VH DLK ENLL + + KI D G
Sbjct: 102 HFSET-----EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGF 155
Query: 957 SKVKQ------QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
+++K +T TL + APELL+ + E D++S G++++ +L+G P
Sbjct: 156 ARLKPPDNQPLKTPC-----FTLHYAAPELLNQNGY--DESCDLWSLGVILYTMLSGQVP 208
Query: 1011 YAD---MHCASIIGGIVNNTLRPQIPSWCDPEWRS-------LMESCWASDPAERPSFSE 1060
+ + I+ + S+ W++ L++ DP +R S
Sbjct: 209 FQSHDRSLTCTSAVEIMKKIKKGDF-SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267
Query: 1061 I 1061
+
Sbjct: 268 L 268
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 37/297 (12%)
Query: 728 GAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEA 787
+ +K ++ S + + A+ E + + + D + P +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD----IPAPPAPFDH 75
Query: 788 EAIARGLQTIKND-DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE 844
+ + + + + LG G +G V+ + G +A K IK ++E
Sbjct: 76 RIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKE 131
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
+ E +++ L H N++ Y + V E++ G L F DR ID
Sbjct: 132 ----EVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGEL--F----DRIID 179
Query: 905 RRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
L +D G+ ++H I+H DLK EN+L RD ++ KI D GL+
Sbjct: 180 ESYNLT-ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ--IKIIDFGLA 236
Query: 958 K-VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
+ K + + GT ++APE+++ V+ D++S G++ + LL+G P+
Sbjct: 237 RRYKPREKLKVNF-GTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 41/275 (14%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWK-EALLLSS 859
+ V+++GSG +G K VA+K I ER I + + E + S
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYI----------ERGAAIDENVQREIINHRS 72
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L HPN+V F ++ LA + E+ G L + + R + R + +++
Sbjct: 73 LRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--- 127
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-----TLVSGGVR 970
G+ Y H I H DLK EN L++ P KI D G SK + V
Sbjct: 128 --GVSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV----- 178
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030
GT ++APE+L + + + DV+S G+ ++ +L G P+ D + L
Sbjct: 179 GTPAYIAPEVLLRQEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237
Query: 1031 Q--IPS--WCDPEWRSLMESCWASDPAERPSFSEI 1061
+ IP PE L+ + +DPA R S EI
Sbjct: 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 41/270 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG GT+G V G+ + G VA+K + ++ +E L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
+++ Y ++ D V E++ G L ++ K R + RR + I++ +
Sbjct: 72 HIIKLYQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
+Y H +VH DLK EN+L+ D KI D GLS + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSD----GEFLRTSCGSPNY 176
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS----IIGGIVNNTLRPQ 1031
APE++SG+ + ++D++S G++++ LL G P+ D H + I GG+
Sbjct: 177 AAPEVISGRLY-AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------Y 229
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
IP + + +L+ DP +R + +I
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 63/266 (23%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWK 852
T + D + ++ LG+G++G V K + S A+K + K + E +
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLN---- 90
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E +L +++ P +V +D + +L V E++ G + L++ R + R A
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGV 969
EYLH ++++ DLK ENLL++ Q+ ++ D G +K + TL
Sbjct: 149 -QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWTLC---- 199
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
GT +APE++ K + + +D ++ G++++E+ G P+ I IV+ +R
Sbjct: 200 -GTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAER 1055
PS + + L+ + D +R
Sbjct: 257 --FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 49/277 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK---EALLLSS 859
V+ LG G YG V R VA+K + + +R + E +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV----------DMKRAVDCPENIKKEICINKM 61
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L+H NVV FYG R+G E+ G L ++ + +R ++A
Sbjct: 62 LNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GT 972
G+ YLHG I H D+K ENLL+ D + + KI D GL+ V + + GT
Sbjct: 117 --GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGT 170
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS------IIGGIVNN 1026
LP++APELL + E +DV+S GIV+ +L G+ P+ +
Sbjct: 171 LPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--- 226
Query: 1027 TLRPQIPSWC--DPEWRSLMESCWASDPAERPSFSEI 1061
+ W D +L+ +P+ R + +I
Sbjct: 227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDI 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 55/314 (17%), Positives = 106/314 (33%), Gaps = 34/314 (10%)
Query: 720 SVKRAALEGAEEVKAKVEESDDSVKPDTTTKE--APANEAELVNIHGEIEMDYDNDTVKT 777
S E +A+ E + + + + E ND
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 778 LKIEPTIAEAEAIARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRI 831
+ + +G G V R G + A+K +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 832 KASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATVTEFMVNG 890
+ + P + E + +E +L + HP++++ + V + M G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKG 185
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRD 943
L F D + + L + + +LH NIVH DLK EN+L+ D
Sbjct: 186 EL--F----DY-LTEKVALS-EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---D 234
Query: 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV----TEKIDVYSFGI 999
+ ++ D G S + + GT ++APE+L +++D+++ G+
Sbjct: 235 DNMQI-RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 1000 VMWELLTGDEPYAD 1013
+++ LL G P+
Sbjct: 294 ILFTLLAGSPPFWH 307
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 35/226 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSL-H 861
LG G V + + A+K I + E + L KE +L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF- 917
HPN++ + V + M G L F D ++ + +
Sbjct: 83 HPNIIQLKDTYET--NTFFFLVFDLMKKGEL--F----DYLTEKVTLSEK-----ETRKI 129
Query: 918 ------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
+ LH NIVH DLK EN+L+ D + K+ D G S V G
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLREVCG 185
Query: 972 TLPWMAPELLSGKSHMV----TEKIDVYSFGIVMWELLTGDEPYAD 1013
T ++APE++ + +++D++S G++M+ LL G P+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 65/299 (21%), Positives = 104/299 (34%), Gaps = 64/299 (21%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALL 856
+ E++ ++G G+YG V+ + R G VAIK+ S R E +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-------EIRM 55
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-RLIIAMDA 915
L L HPN+V+ + R L V E+ + ++ L + R + + I
Sbjct: 56 LKQLKHPNLVNLLEVFRR--KRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGV 969
+ + H N +H D+K EN+L+ V K+ D G V+
Sbjct: 113 Q-AVNFCHKHNCIHRDVKPENILITKHS----VIKLCDFGFARLLTGPSDYYDDEVA--- 164
Query: 970 RGTLPWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTGD-------------------- 1008
T W +PELL G + +DV++ G V ELL+G
Sbjct: 165 --TR-WYRSPELLVGDTQYGPP-VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220
Query: 1009 ----------EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPS 1057
I L + P+ L++ C DP ER +
Sbjct: 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI-SYPALGLLKGCLHMDPTERLT 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V VA+K I ++ + +E L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHP 69
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
+++ Y ++ D + V E+ G L ++ +K R + RR + II +
Sbjct: 70 HIIKLYDVITTPTD--IVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
EY H IVH DLK ENLL+ D V KI D GLS + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLSNIMTD----GNFLKTSCGSPNY 173
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS----IIGGIVNNTLRPQ 1031
APE+++GK + ++DV+S GIV++ +L G P+ D + + +
Sbjct: 174 AAPEVINGKLY-AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY------V 226
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+P + P +SL+ +DP +R + EI
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALL 856
E++ ++G GTYG+V+ K R VA+KR++ G PS R E L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICL 54
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMD 914
L L H N+V + ++ D L V EF + LK++ + +D K + +
Sbjct: 55 LKELKHKNIVRLHDVLHS--DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRG 971
G+ + H +N++H DLK +NLL+N + K+ + GL++ + + V
Sbjct: 112 K--GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVV-- 163
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
TL + P++L G T ID++S G + EL P
Sbjct: 164 TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 65/299 (21%), Positives = 110/299 (36%), Gaps = 70/299 (23%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE--RLIADFWKEALLLS 858
E + +G G+YG V + + G VAIK+ S + + + IA +E LL
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES------DDDKMVKKIA--MREIKLLK 79
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDAA 916
L H N+V+ + + V EF+ + ++ L+ +D + ++ + +
Sbjct: 80 QLRHENLVNLLEVCKK--KKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN- 135
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGVR 970
G+ + H NI+H D+K EN+LV+ V K+ D G + + V+
Sbjct: 136 -GIGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAAPGEVYDDEVA---- 186
Query: 971 GTLPWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY------------------ 1011
T W APELL G +DV++ G ++ E+ G EP
Sbjct: 187 -TR-WYRAPELLVGDVKYGKA-VDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLG 242
Query: 1012 -------------ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPS 1057
+ L + P L + C DP +RP
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL-SEVVIDLAKKCLHIDPDKRPF 300
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 52/285 (18%)
Query: 742 SVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDD 801
S +P TT+ + + G +++ D D K + T +G +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPG------QGPDRPQEVS 55
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-RLIADFWKEALLLS 858
+ + +G+G++G VY K G VAIK++ + + R E ++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNR-------ELQIMR 102
Query: 859 SLHHPNVVS----FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L H N+V FY + L V +++ ++ + R +
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV-------ARHYSRAKQTLP 154
Query: 915 AAF----------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQ 962
+ + Y+H I H D+K +NLL++ P V K+ D G +K V+ +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGE 211
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
VS + + APEL+ G + T IDV+S G V+ ELL G
Sbjct: 212 PNVSYIC--SRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLG 253
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLL 857
+ + ++G GTYG VY + G A+K+I+ G PS R E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-------EISIL 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
L H N+V Y ++ L V E + + LK+ L + ++ K ++ +
Sbjct: 55 KELKHSNIVKLYDVIHT--KKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ Y H + ++H DLK +NLL+N + KI D GL++ + V T
Sbjct: 112 --GIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIV--T 163
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L + AP++L G T ID++S G + E++ G
Sbjct: 164 LWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNG 197
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 26/265 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSE---RERLIADFWKE 853
D E +R +G G++G V + + A+K + K C +E I
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI------ 68
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ L HP +V+ + +D + + V + ++ G L+ LQ+ + +L I
Sbjct: 69 ---MQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC- 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ ++YL + I+H D+K +N+L+ D V I D ++ + + + GT
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILL---DEHGHV-HITDFNIAAMLPRETQITTMAGTK 178
Query: 974 PWMAPELLSGKSHMV-TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL--RP 1030
P+MAPE+ S + + +D +S G+ +ELL G PY + ++ IV+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY-HIRSSTSSKEIVHTFETTVV 237
Query: 1031 QIPSWCDPEWRSLMESCWASDPAER 1055
PS E SL++ +P +R
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 50/263 (19%)
Query: 768 MDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVR-----ELGSGTYGSVYHGKWR 822
N + +K+ P + I K + E+ +G+G++G V+ K
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 823 GSD-VAIKRIKASCFAGKPSERE-RLIADFWKEALLLSSLHHPNVVS----FYGIVRDGP 876
SD VAIK++ + + R E ++ + HPNVV FY
Sbjct: 63 ESDEVAIKKVL------QDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----------GMEYLHGKN 926
+ L V E++ ++ + +L M + Y+H
Sbjct: 110 EVFLNLVLEYV-PETVYRA-------SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGK 984
I H D+K +NLL++ P V K+ D G +K + + VS + + APEL+ G
Sbjct: 162 ICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGA 216
Query: 985 SHMVTEKIDVYSFGIVMWELLTG 1007
++ T ID++S G VM EL+ G
Sbjct: 217 TNY-TTNIDIWSTGCVMAELMQG 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 7e-23
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 28/262 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSERERLIADFWKEALL 856
D + +R LG+G++G V+ + R + A+K + K K + E E L+
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTND----ERLM 59
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS + HP ++ +G +D + + +++ G L L+K R + + A +
Sbjct: 60 LSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVC 116
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTL 973
+EYLH K+I++ DLK EN+L++ + KI D G +K TL GT
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYTLC-----GTP 167
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
++APE++S K + + ID +SFGI+++E+L G P+ D + I+N LR P
Sbjct: 168 DYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FP 223
Query: 1034 SWCDPEWRSLMESCWASDPAER 1055
+ + + + L+ D ++R
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQR 245
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLL 857
+ +++ ++G GTYG VY K G VA+KRI+ G PS R E LL
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EISLL 73
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
LHHPN+VS ++ + L V EFM LK+ L + + K + +
Sbjct: 74 KELHHPNIVSLIDVIHS--ERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ + H I+H DLK +NLL+N K+ D GL++ ++ V T
Sbjct: 131 --GVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEVV--T 182
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L + AP++L G T +D++S G + E++TG
Sbjct: 183 LWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITG 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 65/295 (22%), Positives = 107/295 (36%), Gaps = 67/295 (22%)
Query: 790 IARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSER 843
+ GLQ KN +++ + LG G G V + A+K ++
Sbjct: 4 VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------- 54
Query: 844 ERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT--VTEFMVNGSLKQFLQKKD 900
+E L + P++V + + G V E + G L F
Sbjct: 55 ----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--F----S 104
Query: 901 RTIDRRKRLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
R DR + +A+ M +YLH NI H D+K ENLL + P + K+ D
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTD 163
Query: 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD 1013
G A E K + D++S G++M+ LL G P+
Sbjct: 164 FGF--------------------AKETTGEKY---DKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRS-------LMESCWASDPAERPSFSEI 1061
H +I G+ Q + +PEW L+ + ++P +R + +E
Sbjct: 201 NHGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 73/306 (23%), Positives = 120/306 (39%), Gaps = 75/306 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-------RLIADF 850
D + +LG GTYG VY VAIKRI+ E E R
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIR----- 82
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
E LL L H N++ ++ + L + E+ LK++ +D+ +
Sbjct: 83 --EVSLLKELQHRNIIELKSVIHH--NHRLHLIFEYA-ENDLKKY-------MDKNPDVS 130
Query: 911 IAMDAAF------GMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGDLGLSKVKQ-- 961
+ + +F G+ + H + +H DLK +NLL+++ D + PV KIGD GL++
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 962 -QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY------AD- 1013
+ + TL + PE+L G H T +D++S + E+L P D
Sbjct: 191 IRQFTHEII--TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMK-TPLFPGDSEIDQ 246
Query: 1014 -MHCASIIG--------GIVN-------------NTLRPQIPSWCDPEWRSLMESCWASD 1051
++G G+ TL+ + + D E L+ + D
Sbjct: 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306
Query: 1052 PAERPS 1057
P +R S
Sbjct: 307 PVKRIS 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 77/275 (28%), Positives = 124/275 (45%), Gaps = 51/275 (18%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIK-----RIKASCFAGKPSERERLIADFWKEALLLS 858
LG GT+G V GK G VA+K +I++ GK RE L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQN---------LK 71
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMD 914
HP+++ Y ++ D + V E++ G L ++ K R + RR + I++
Sbjct: 72 LFRHPHIIKLYQVISTPSD--IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-- 127
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G++Y H +VH DLK EN+L+ D KI D GLS + G
Sbjct: 128 ---GVDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSD----GEFLRTSC 176
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS----IIGGIVNN 1026
G+ + APE++SG+ + E +D++S G++++ LL G P+ D H + I GI
Sbjct: 177 GSPNYAAPEVISGRLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-- 233
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P + +P SL++ DP +R + +I
Sbjct: 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 65/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ++ +LG GTY +VY GK + + VA+K I+ G P R E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLL 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
L H N+V+ + I+ + SL V E++ + LKQ+L I+ K + +
Sbjct: 55 KDLKHANIVTLHDIIHT--EKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ Y H + ++H DLK +NLL+N +R K+ D GL++ K +T + V T
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDNEVV--T 163
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L + P++L G S + +ID++ G + +E+ TG
Sbjct: 164 LWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATG 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+++ +LG+GTY +VY G + G VA+K +K G PS R E L+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLM 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N+V Y ++ + L V EFM + LK+++ + + L + + F
Sbjct: 58 KELKHENIVRLYDVIHT--ENKLTLVFEFM-DNDLKKYM-DSRTVGNTPRGLELNLVKYF 113
Query: 918 ------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGG 968
G+ + H I+H DLK +NLL+N +R K+GD GL++ T S
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
V TL + AP++L G T ID++S G ++ E++TG
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITG 205
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 7e-22
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 37/280 (13%)
Query: 790 IARGLQTIKNDDLEEVRELGSGTYGSVY---HGKWRGSDV--AIKRIKASCFAGKPSERE 844
+ RG + I+ + E +R LG G YG V+ + A+K +K + +
Sbjct: 7 VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66
Query: 845 RLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD 900
A E +L + HP +V +F G L + E++ G L L+++
Sbjct: 67 HTKA----ERNILEEVKHPFIVDLIYAFQ------TGGKLYLILEYLSGGELFMQLEREG 116
Query: 901 RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
++ +A + + + +LH K I++ DLK EN+++ + Q V K+ D GL K
Sbjct: 117 IFMEDTACFYLA-EISMALGHLHQKGIIYRDLKPENIML---NHQGHV-KLTDFGLCKES 171
Query: 961 QQTLVSGGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMH 1015
+ G GT+ +MAPE+L H +D +S G +M+++LTG P+ +
Sbjct: 172 ----IHDGTVTHTFCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPPFTGEN 225
Query: 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
I I+ L +P + E R L++ + A R
Sbjct: 226 RKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 36/222 (16%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864
LG G + V + A+K I+ R R+ ++E +L H N
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRV----FREVEMLYQCQGHRN 72
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR-----RKRLIIAMDAAFGM 919
V+ + + V E M GS+ R + ++ D A +
Sbjct: 73 VLELIEFFEE--EDRFYLVFEKMRGGSI--L----SHIHKRRHFNELEASVVVQDVASAL 124
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--------G 971
++LH K I H DLK EN+L + PV KI D L + + G
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 972 TLPWMAPELLSGKSHMVT---EKIDVYSFGIVMWELLTGDEP 1010
+ +MAPE++ S + ++ D++S G++++ LL+G P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 35/267 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + ++ LG GT+G V + + + A+K ++ K E + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVT----ESRVL 59
Query: 858 SSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ HP + +F L V E+ G L L ++ + R R A
Sbjct: 60 QNTRHPFLTALKYAFQ------THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA- 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--- 970
+ +EYLH +++V+ D+K ENL++ D + KI D GL K +S G
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGLCKEG----ISDGATMKT 164
Query: 971 --GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028
GT ++APE+L + +D + G+VM+E++ G P+ + + I+ +
Sbjct: 165 FCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAER 1055
R P PE +SL+ DP +R
Sbjct: 223 R--FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 73/319 (22%), Positives = 130/319 (40%), Gaps = 28/319 (8%)
Query: 745 PDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEE 804
P+ + A + + + + D + ++A+ + ++ E
Sbjct: 93 PEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 805 VRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ LG GT+G V K + + A+K +K K E + E +L + H
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLT----ENRVLQNSRH 207
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P + + + L V E+ G L L ++ + R R A + ++YL
Sbjct: 208 PFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYL 264
Query: 923 HG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWM 976
H KN+V+ DLK ENL++ D + KI D GL K + G GT ++
Sbjct: 265 HSEKNVVYRDLKLENLML---DKDGHI-KITDFGLCKEG----IKDGATMKTFCGTPEYL 316
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L + +D + G+VM+E++ G P+ + + I+ +R P
Sbjct: 317 APEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTL 372
Query: 1037 DPEWRSLMESCWASDPAER 1055
PE +SL+ DP +R
Sbjct: 373 GPEAKSLLSGLLKKDPKQR 391
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-21
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIK----ASCFAGKPSERERLIADFWKE 853
E++ LG G + +VY + + VAIK+IK + G R E
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-------E 62
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
LL L HPN++ G +++ V +FM L+ ++ D L +
Sbjct: 63 IKLLQELSHPNIIGLLDAF--GHKSNISLVFDFM-ETDLEVIIK------DNSLVLTPSH 113
Query: 914 DAAF------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
A+ G+EYLH I+H DLK NLL++ + V K+ D GL+K +
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAY 169
Query: 965 VSGGVRGTLPWM-APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
V T W APELL G + M +D+++ G ++ ELL
Sbjct: 170 THQVV--TR-WYRAPELLFG-ARMYGVGVDMWAVGCILAELLLR 209
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD + VR+LG G Y V+ V +K +K P +++++ +E +L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIK----REIKIL 84
Query: 858 SSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+L PN+++ IV+D + A V E + N KQ Q + D
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----------LTDYDIR 133
Query: 917 F-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
F ++Y H I+H D+K N++++ + ++ D GL++
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP 1010
+ + PELL M +D++S G ++ ++ EP
Sbjct: 191 VASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-21
Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 783 TIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFA 837
IA + G + E ++ LG G++G V+ G A+K +K +
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 838 GKPSER---ERLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNG 890
+ R ER I L ++HP +V +F +G L + +F+ G
Sbjct: 67 VRDRVRTKMERDI---------LVEVNHPFIVKLHYAFQ------TEGKLYLILDFLRGG 111
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
L L K+ + + +A + A +++LH I++ DLK EN+L+ D + + K
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILL---DEEGHI-K 166
Query: 951 IGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
+ D GLSK + + GT+ +MAPE+++ + H T+ D +SFG++M+E+L
Sbjct: 167 LTDFGLSKES----IDHEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEML 220
Query: 1006 TGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
TG P+ + I+ L +P + PE +SL+ + +PA R
Sbjct: 221 TGTLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 8e-21
Identities = 61/310 (19%), Positives = 121/310 (39%), Gaps = 26/310 (8%)
Query: 753 PANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGT 812
+E T + +K D + LG G+
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353
Query: 813 YGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870
+G V + +G+D A+K +K + E + + K L L P + +
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVE--KRVLALPG-KPPFLTQLHS 409
Query: 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930
+ L V E++ G L +Q+ R + A + A G+ +L K I++
Sbjct: 410 CFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYR 466
Query: 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKS 985
DLK +N+++ D + + KI D G+ K + GV GT ++APE+++ +
Sbjct: 467 DLKLDNVML---DSEGHI-KIADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 986 HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLME 1045
+ + +D ++FG++++E+L G P+ + I+ + + P E ++ +
Sbjct: 519 Y--GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICK 574
Query: 1046 SCWASDPAER 1055
P +R
Sbjct: 575 GLMTKHPGKR 584
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-21
Identities = 62/325 (19%), Positives = 132/325 (40%), Gaps = 51/325 (15%)
Query: 755 NEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYG 814
+ +I + + ++ E + ++ D + +R +G G+Y
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 815 SVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERLIADFWKEALLLSSLHHPNVV-- 866
V + + +D A++ + K + + E+ + + +HP +V
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV--------FEQASNHPFLVGL 118
Query: 867 --SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
F + L V E++ G L +Q++ + + R A + + + YLH
Sbjct: 119 HSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 171
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPE 979
+ I++ DLK +N+L+ D + + K+ D G+ K + G GT ++APE
Sbjct: 172 RGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG----LRPGDTTSTFCGTPNYIAPE 223
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGG---------IVNNTLRP 1030
+L G+ + +D ++ G++M+E++ G P+ + + I+ +R
Sbjct: 224 ILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280
Query: 1031 QIPSWCDPEWRSLMESCWASDPAER 1055
IP + S+++S DP ER
Sbjct: 281 -IPRSLSVKAASVLKSFLNKDPKER 304
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-21
Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 53/235 (22%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-------RLIADF 850
E++ ++G GT+G V+ + R G VA+K++ +E+E R
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALR----- 65
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKKDRTID 904
E +L L H NVV+ I R GS+ V +F + L L
Sbjct: 66 --EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 122
Query: 905 RR--KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
KR++ + G+ Y+H I+H D+K N+L+ + V K+ D GL+
Sbjct: 123 LSEIKRVMQMLLN--GLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLA----- 171
Query: 963 TLVSGGVRGTLPWM----------APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
S PELL G+ ID++ G +M E+ T
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWTR 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 64/270 (23%), Positives = 120/270 (44%), Gaps = 34/270 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSER---ERLIADF 850
+K +D + LG G++G V+ +++ ++ AIK + K E E+ +
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV--- 70
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + HP + + + +L V E++ G L +Q + R
Sbjct: 71 -----LSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY 123
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A + G+++LH K IV+ DLK +N+L+ D + KI D G+ K + G +
Sbjct: 124 AA-EIILGLQFLHSKGIVYRDLKLDNILL---DKDGHI-KIADFGMCKEN----MLGDAK 174
Query: 971 -----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025
GT ++APE+L G+ + +D +SFG++++E+L G P+ + I
Sbjct: 175 TNTFCGTPDYIAPEILLGQKY--NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
Query: 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
+ P W + E + L+ + +P +R
Sbjct: 233 DNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 63/317 (19%), Positives = 117/317 (36%), Gaps = 48/317 (15%)
Query: 766 IEMDYDNDTVKTLKIEPTIAE----AEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHG 819
+ + L + +A+ AE I L+ ++ DD E ++ +G G + V
Sbjct: 21 LLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVV 80
Query: 820 KWRGSD--VAIKRIKASCFAGKPSERERL-IADFWKEALLLSSLHHPNVVSFYGIVRDGP 876
K + + A+K + K +R ++ F +E +L + + + +D
Sbjct: 81 KMKQTGQVYAMKIMN------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-- 132
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935
+ L V E+ V G L L K I R +A + ++ +H VH D+K +
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLGYVHRDIKPD 191
Query: 936 NLLVNMRDPQRPVCKIGDLGLSK-------VKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988
N+L++ ++ D G V+ V GT +++PE+L
Sbjct: 192 NILLDRCGH----IRLADFGSCLKLRADGTVRSLVAV-----GTPDYLSPEILQAVGGGP 242
Query: 989 TEK-----IDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR---PQIPSWCDPEW 1040
D ++ G+ +E+ G P+ A G IV+ P + E
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 1041 RSLMES--CWASDPAER 1055
R ++ C P R
Sbjct: 303 RDFIQRLLC---PPETR 316
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 43/228 (18%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERE-------RLIAD 849
E V E+G G YG V+ K G VA+KR++ + E R +A
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGMPLSTIREVA- 63
Query: 850 FWKEALL--LSSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDR--- 901
+L L + HPNVV + + R + L V E + + L +L K
Sbjct: 64 -----VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGV 117
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
+ K ++ + G+++LH +VH DLK +N+LV K+ D GL+++
Sbjct: 118 PTETIKDMMFQLLR--GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYS 171
Query: 962 --QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L S V TL + APE+L S+ +D++S G + E+
Sbjct: 172 FQMALTSVVV--TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRR 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-20
Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 30/272 (11%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIAD--- 849
Q + + + R LG G +G V + R + A K+++ ++R+
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE----------KKRIKKRKGE 228
Query: 850 --FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI--DR 905
E +L ++ VVS +L V M G LK + + +
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286
Query: 906 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
R A + G+E LH + IV+ DLK EN+L+ +I DLGL+ +
Sbjct: 287 RAVFYAA-EICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLAVHVPEGQT 341
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025
G GT+ +MAPE++ + + T D ++ G +++E++ G P+ +
Sbjct: 342 IKGRVGTVGYMAPEVVKNERY--TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
Query: 1026 NTLR--PQIPSWCDPEWRSLMESCWASDPAER 1055
+ P+ RSL DPAER
Sbjct: 400 LVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-20
Identities = 58/271 (21%), Positives = 112/271 (41%), Gaps = 42/271 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSER---ERLIADFWKE 853
D + LG G++G V + +G+D A+K + K E E+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV------ 73
Query: 854 ALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
L P + F L V E++ G L +Q+ R +
Sbjct: 74 --LALPGKPPFLTQLHSCFQ------TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
A + A G+ +L K I++ DLK +N+++ D + + KI D G+ K + GV
Sbjct: 126 YAA-EIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIADFGMCKEN----IWDGV 176
Query: 970 R-----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
GT ++APE+++ + + + +D ++FG++++E+L G P+ + I+
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
+ + P E ++ + P +R
Sbjct: 235 EHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 62/291 (21%), Positives = 125/291 (42%), Gaps = 26/291 (8%)
Query: 769 DYDNDTVKTLK-IEPTIAEAEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHGKWRGSD 825
+ +N ++ K I + A+ ++ + +D E ++ +G G +G V K + +D
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99
Query: 826 --VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883
A+K + K +E F +E +L + + + + +D D +L V
Sbjct: 100 KVFAMKILNKWEML-KRAETAC----FREERDVLVNGDSKWITTLHYAFQD--DNNLYLV 152
Query: 884 TEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
++ V G L L K + + R +A + ++ +H + VH D+K +N+L+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLHYVHRDIKPDNILM--- 208
Query: 943 DPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGKSHMV---TEKIDVYSF 997
D + ++ D G ++ T+ S GT +++PE+L + D +S
Sbjct: 209 DMNGHI-RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 998 GIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD---PEWRSLME 1045
G+ M+E+L G+ P+ G I+N+ R Q P+ + L+
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIR 318
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-20
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 42/290 (14%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFA 837
E + + D+ E +R LG G++G V + + + A+K + K
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ 63
Query: 838 GKPSER---ERLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNG 890
E E+ I L + +HP + F L V EF+ G
Sbjct: 64 DDDVECTMTEKRI--------LSLARNHPFLTQLFCCFQ------TPDRLFFVMEFVNGG 109
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
L +QK R + R R A + + +LH K I++ DLK +N+L+ D + K
Sbjct: 110 DLMFHIQKSRRFDEARARFYAA-EIISALMFLHDKGIIYRDLKLDNVLL---DHEGHC-K 164
Query: 951 IGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005
+ D G+ K + GV GT ++APE+L + +D ++ G++++E+L
Sbjct: 165 LADFGMCKEG----ICNGVTTATFCGTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEML 218
Query: 1006 TGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
G P+ + + I+N+ + P+W + +++S +P R
Sbjct: 219 CGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERE----------RLI 847
E V E+G G YG+VY + S VA+K ++ P+ R +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR------VPNGGGGGGGLPISTVREV 62
Query: 848 ADFWKEALL--LSSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDR- 901
A LL L + HPNVV + R + + V E + + L+ +L K
Sbjct: 63 A------LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPP 115
Query: 902 --TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ K L+ G+++LH IVH DLK EN+LV K+ D GL+++
Sbjct: 116 GLPAETIKDLMRQFLR--GLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARI 169
Query: 960 KQ--QTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
L V TL + APE+L ++ +D++S G + E+
Sbjct: 170 YSYQMALTPVVV--TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRR 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 68/315 (21%), Positives = 130/315 (41%), Gaps = 32/315 (10%)
Query: 756 EAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGS 815
E D + + L ++ + A + + ++ E ++ LG+G YG
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHA-EKVGIENFELLKVLGTGAYGK 69
Query: 816 VY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFY 869
V+ G G A+K +K + K E E +L P +V+ +
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT----ERQVLEHIRQSPFLVTLH 125
Query: 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929
+ + L + +++ G L L +++R + ++ + + +E+LH I++
Sbjct: 126 YAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGIIY 182
Query: 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGK 984
D+K EN+L+ D V + D GLSK + + R GT+ +MAP+++ G
Sbjct: 183 RDIKLENILL---DSNGHV-VLTDFGLSK---EFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 985 SHMVTEKIDVYSFGIVMWELLTGDEPY----ADMHCASIIGGIVNNTLRPQIPSWCDPEW 1040
+ +D +S G++M+ELLTG P+ A I I+ + P
Sbjct: 236 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALA 293
Query: 1041 RSLMESCWASDPAER 1055
+ L++ DP +R
Sbjct: 294 KDLIQRLLMKDPKKR 308
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-19
Identities = 61/287 (21%), Positives = 123/287 (42%), Gaps = 51/287 (17%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERL 846
+ + D + +R +G G+Y V + + +D A+K + K + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 847 IADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+ + +HP +V F + L V E++ G L +Q++ +
Sbjct: 62 V--------FEQASNHPFLVGLHSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKL 107
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ R A + + + YLH + I++ DLK +N+L+ D + + K+ D G+ K
Sbjct: 108 PEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG-- 160
Query: 963 TLVSGGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA 1017
+ G GT ++APE+L G+ + +D ++ G++M+E++ G P+ + +
Sbjct: 161 --LRPGDTTSTFCGTPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSS 216
Query: 1018 SIIGG---------IVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
I+ +R IP + S+++S DP ER
Sbjct: 217 DNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 36/282 (12%), Positives = 70/282 (24%), Gaps = 66/282 (23%)
Query: 805 VRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ G W+ D VA+ + + L LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVDPQ-GVLPDDVLQE----TLSRTLRLS 86
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
+ P V +V V E++ GSL++ D + + A
Sbjct: 87 RIDKPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+ H + + V+ + G V P P
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVS------------------------IDGDVVLAYPATMP 177
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN---------TLR 1029
+ + D+ G ++ LL P + S + + +
Sbjct: 178 D--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
IP + ++ D R + S + ++ A
Sbjct: 230 RDIP----FQISAVAARSVQGDGGIRSA-STLLNLMQQATAV 266
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-19
Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 48/228 (21%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKP-SERE-RLIADFWKEALLLS 858
+ R G GT+G+V GK + G VAIK++ RE +++ L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQ-------DLA 74
Query: 859 SLHHPNVVSFYGIV-----RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
LHHPN+V RD D L V E++ +L + R +A
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRC-------CRNYYRRQVAP 126
Query: 914 DAAF----------GMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--V 959
+ LH N+ H D+K N+LVN K+ D G +K
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLS 183
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ V+ + + APEL+ G H T +D++S G + E++ G
Sbjct: 184 PSEPNVAYIC--SRYYRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLG 228
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 62/275 (22%), Positives = 113/275 (41%), Gaps = 38/275 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERL-IADFWKE 853
+K +D E V+ +G G +G V + + + A+K + K +R A FW+E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS------KFEMIKRSDSAFFWEE 119
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+++ + P VV + +D D L V E+M G L + D + +
Sbjct: 120 RDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 177
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-------VKQQTLVS 966
A + +H +H D+K +N+L++ + K+ D G V+ T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTAV- 230
Query: 967 GGVRGTLPWMAPELLSGKSHMV--TEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
GT +++PE+L + + D +S G+ ++E+L GD P+ I+
Sbjct: 231 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
Query: 1025 NNTLRPQIPSWCD--PEWRSLMES--CWASDPAER 1055
N+ P D E ++L+ + D R
Sbjct: 287 NHKNSLTFPDDNDISKEAKNLICAFLT---DREVR 318
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-19
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 29/273 (10%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWK 852
Q + D + R LG G +G V+ + + + A K++ + + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMV---- 234
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK----QFLQKKDRTIDRRKR 908
E +L+ +H +VS L V M G ++ + + R
Sbjct: 235 EKKILAKVHSRFIVSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVS 966
A G+E+LH +NI++ DLK EN+L++ +I DLGL+ QT
Sbjct: 293 FYTA-QIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRISDLGLAVELKAGQTKTK 347
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCAS---IIGG 1022
G GT +MAPELL G+ + +D ++ G+ ++E++ P A +
Sbjct: 348 GYA-GTPGFMAPELLLGEEY--DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 404
Query: 1023 IVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
++ + P P + E+ DP +R
Sbjct: 405 VLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-19
Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 42/274 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERLIADF 850
K D ++ +G G++G V + + +V A+K + K + K + ER +
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--- 91
Query: 851 WKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
LL ++ HP +V SF L V +++ G L LQ++ ++ R
Sbjct: 92 -----LLKNVKHPFLVGLHFSFQ------TADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
R A + A + YLH NIV+ DLK EN+L+ D Q + + D GL K +
Sbjct: 141 ARFYAA-EIASALGYLHSLNIVYRDLKPENILL---DSQGHI-VLTDFGLCKEN----IE 191
Query: 967 GGVR-----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG 1021
GT ++APE+L + + +D + G V++E+L G P+ + A +
Sbjct: 192 HNSTTSTFCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
Query: 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAER 1055
I+N L+ + R L+E D +R
Sbjct: 250 NILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 8e-19
Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 28/266 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSER----ERLIADFWKE 853
+D R +G G +G VY + + A+K + K E ER++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 244
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L+S+ P +V L+ + + M G L L + + R A
Sbjct: 245 --LVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA- 299
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ G+E++H + +V+ DLK N+L++ + +I DLGL+ + V GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKKPHASV-GTH 354
Query: 974 PWMAPE-LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS---IIGGIVNNTLR 1029
+MAPE L G ++ D +S G ++++LL G P+ I + +
Sbjct: 355 GYMAPEVLQKGVAY--DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAER 1055
+P PE RSL+E D R
Sbjct: 413 --LPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 35/223 (15%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSER-ERLIADFWKEAL--- 855
R + SG+YG+V + G VAIKR+ + G+ K L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSF--LCKRVLREI 80
Query: 856 -LLSSLHHPNVVSFYGIVRDGPDGSLAT---VTEFMVNGSLKQFLQKKDRTI-DRRKRLI 910
LL+ HHPN++ I + ++ VTE M L Q + + I + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 911 IAMDAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTL 964
+ + G+ LH +VH DL N+L+ I D L++
Sbjct: 140 M-----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADA 188
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APEL+ T+ +D++S G VM E+
Sbjct: 189 NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNR 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 39/226 (17%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+++ LG G G V VAIK+I P + + +E ++
Sbjct: 14 MDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIV---L-TDPQSVKHAL----REIKIIRR 64
Query: 860 LHHPNVVSFYGIVRDGPDGSLAT------------VTEFMVNGSLKQFLQKKDRTIDRRK 907
L H N+V + I+ V E+M L L++ + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHAR 123
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLV 965
+ + G++Y+H N++H DLK NL +N D KIGD GL+++
Sbjct: 124 LFMYQL--LRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLARIMDPHYS 176
Query: 966 SGGVR----GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
G T + +P LL + T+ ID+++ G + E+LTG
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 43/247 (17%), Positives = 81/247 (32%), Gaps = 60/247 (24%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG+G++G V G A+K++ + +E ++ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKN----RELDIMKVL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR-------------- 906
H N++ D + L +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 907 -------KRLIIAMDAAF-----------------GMEYLHGKNIVHFDLKCENLLVNMR 942
+++ + + + ++H I H D+K +NLLVN
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-- 175
Query: 943 DPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIV 1000
+ K+ D G +K + + V+ + + APEL+ G + T ID++S G V
Sbjct: 176 -SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEY-TPSIDLWSIGCV 231
Query: 1001 MWELLTG 1007
EL+ G
Sbjct: 232 FGELILG 238
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ +GSG G V + +VAIK++ +P + + ++E +L+ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKL------SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 863 PNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
N++ + P SL V E M + +L Q + + + +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVI-QMELDHERMSYLLYQM--L 137
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V C KI D GL++ + + T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ G E +D++S G +M E++ G
Sbjct: 192 YRAPEVILGMG--YKENVDIWSVGCIMGEMIKG 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ LG G YG V H G VAIK+I+ F KP R + +E +L
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEP--F-DKPLFALRTL----REIKILKH 65
Query: 860 LHHPNVVSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H N+++ + I R PD + E M L + + + + D + I
Sbjct: 66 FKHENIITIFNIQR--PDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQT- 121
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS-KVKQQTLVSGGVRG 971
++ LHG N++H DLK NLL+N C K+ D GL+ + + + G
Sbjct: 122 -LRAVKVLHGSNVIHRDLKPSNLLINSN------CDLKVCDFGLARIIDESAADNSEPTG 174
Query: 972 TLPWM----------APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
M APE++ S + +DV+S G ++ EL
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLR 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ +GSG YG+V G+ VAIK++ +P + E ++E LL + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKL------YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 863 PNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
NV+ + PD +L V FM L + ++ + DR + L+ M
Sbjct: 84 ENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 138
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+ Y+H I+H DLK NL VN C KI D GL++ + +G V T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-VTRW 190
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ T+ +D++S G +M E++TG
Sbjct: 191 YRAPEVILN-WMRYTQTVDIWSVGCIMAEMITG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMKCV 118
Query: 861 HHPNVVSFYGIVRDGPDGS----LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+H N++S + + V E M + +L Q + + + +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QMELDHERMSYLLYQMLC- 175
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V C KI D GL++ + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ G + E +D++S G +M E++
Sbjct: 229 YRAPEVILGMGY--KENVDIWSVGCIMGEMVRH 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+GSG YGSV K G VAIK++ +P + E ++E LLL +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL------SRPFQSEIFAKRAYRELLLLKHM 80
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H NV+ + P SL V FM L++ + + ++ + L+ M
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQYLVYQM- 135
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGT 972
G++Y+H +VH DLK NL VN C KI D GL++ + +G V T
Sbjct: 136 -LKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGYV-VT 186
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ + +D++S G +M E+LTG
Sbjct: 187 RWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ + +GSG YGSV G VA+K++ +P + ++E LL +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHM 85
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H NV+ + P SL VT M L ++ + T D + LI +
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI- 141
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGT 972
G++Y+H +I+H DLK NL VN C KI D GL++ + +G V T
Sbjct: 142 -LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ APE++ + +D++S G +M ELLTG
Sbjct: 193 RWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTG 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G G YG V + VAIK+I F + +R + +E +L
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FE-HQTYCQRTL----REIKILLRF 82
Query: 861 HHPNVVSFYGIVRDGPDGSLAT---VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
H N++ I+R + V + M L + L+ + + D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR----G 971
G++Y+H N++H DLK NLL+N C KI D GL++V G
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
T + APE++ S T+ ID++S G ++ E+L+
Sbjct: 194 TRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSN 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 57/249 (22%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+G G+YG VY + K +VAIK++ F + +R++ +E +L+ L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMF-EDLIDCKRIL----REITILNRL 82
Query: 861 HHPNVVSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ Y ++ PD L V E + LK+ + + + I+
Sbjct: 83 KSDYIIRLYDLII--PDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL---- 135
Query: 916 AF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS------------ 957
+ G ++H I+H DLK N L+N +D C K+ D GL+
Sbjct: 136 -YNLLLGENFIHESGIIHRDLKPANCLLN-QD-----CSVKVCDFGLARTINSEKDTNIV 188
Query: 958 -KVKQQTLVSGGVRGTLPWM----------APELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
+++ + + APEL+ T+ ID++S G + ELL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKSIDIWSTGCIFAELLN 247
Query: 1007 GDEPYADMH 1015
+ + +
Sbjct: 248 MLQSHINDP 256
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V++LG G YG V + G VA+K+I F ++ +R +E ++L+
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKI-FDAF-QNSTDAQRTF----REIMILTE 64
Query: 860 LH-HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L H N+V+ ++R D + V ++M L ++ ++ ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIK--V 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS------------KVKQQTL 964
++YLH ++H D+K N+L+N C K+ D GLS
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 965 VSGGVRGTLPWM----------APELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ P + APE+L G S T+ ID++S G ++ E+L G
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCG 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 58/256 (22%), Positives = 90/256 (35%), Gaps = 66/256 (25%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE----RLIADFWKEALL 856
E +G+G+YG V + VAIK+I + E R++ +E +
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRIL----REIAI 105
Query: 857 LSSLHHPNVVSFYGIVR---DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L+ L+H +VV IV L V E + K+ + + + ++
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-- 162
Query: 914 DAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSG 967
+ G++Y+H I+H DLK N LVN C K+ D GL++
Sbjct: 163 ---YNLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGN 213
Query: 968 GVRGTLPWM----------------------------APELLSGKSHMVTEKIDVYSFGI 999
P APEL+ TE IDV+S G
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGC 272
Query: 1000 VMWELLTGDEPYADMH 1015
+ ELL + H
Sbjct: 273 IFAELLNMIKENVAYH 288
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 7e-12
Identities = 37/255 (14%), Positives = 69/255 (27%), Gaps = 63/255 (24%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + L+ ++G G +G V+ + VAIK I ++ + E ++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 857 LSSLH---------HPNVVSFYG--IVRDGPDGSLAT----------------------- 882
L + V+ L
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 883 ---VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLL 938
V EF G + ++ K ++ K I + H DL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 939 VNMRDPQRPVCK----------------IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982
+ ++ I D LS+++ G V M +L +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE----RDGIVVFCDVSMDEDLFT 250
Query: 983 GKSHMVTEKIDVYSF 997
G + D+Y
Sbjct: 251 GDGDY---QFDIYRL 262
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
VR+LG G + +V+ K + VA+K ++ + +E E + + + +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLL----QRVNDADNTK 79
Query: 863 PNVVSFYGIVR-------DGPDGS-LATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAM 913
+ + I++ GP+G + V E + +L ++K + R I I+
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQ--RPVCKIGDLGLSKVKQQTLVSGGVR 970
G++Y+H + I+H D+K EN+L+ + D KI DLG + + +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008
T + +PE+L G D++S +++EL+TGD
Sbjct: 198 -TREYRSPEVLLGAPW--GCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 48/229 (20%), Positives = 92/229 (40%), Gaps = 35/229 (15%)
Query: 794 LQTIKNDDL----EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLI 847
+ +D + E ++ +G G++G V + VA+K ++ + +
Sbjct: 87 YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAA 141
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVR--DGPD--GSLATVTEFMVNGSLKQFLQK-KDRT 902
+E +L L + + ++ + + E + + +L + ++K K +
Sbjct: 142 ----EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG 196
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
A ++ LH I+H DLK EN+L+ R K+ D G S + Q
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK--QQGRSGIKVIDFGSSCYEHQ 254
Query: 963 T----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
+ S R APE++ G + ID++S G ++ ELLTG
Sbjct: 255 RVYTYIQSRFYR------APEVILGARY--GMPIDMWSLGCILAELLTG 295
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 23/169 (13%)
Query: 806 RELGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLI-----------ADFWKE 853
+G G +G +Y V +PS+ L + ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKV--EPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV----NGSLKQFLQKKDRTIDRRKRL 909
+ L + V ++G G FM+ L++ + + R+ L
Sbjct: 99 WIRTRKLKYLGVPKYWGS---GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+++ +EY+H VH D+K NLL+N ++P + + D GL+
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 54/280 (19%), Positives = 101/280 (36%), Gaps = 73/280 (26%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+R+LG G + +V+ VA+K +K++ + + E + +++ S +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL----KSVRNSDPND 97
Query: 863 PN---VVSFYGIVR-DGPDGS-LATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
PN VV + G +G+ + V E + L +++ K + + I
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDP------------------------------- 944
G++YLH K I+H D+K EN+L+++ +
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 945 --------------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTE 990
++ KI DLG + + T + + E+L G
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGSG--YNT 272
Query: 991 KIDVYSFGIVMWELLTGDEP----------YADMHCASII 1020
D++S + +EL TGD + H A II
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 41/292 (14%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R++GSG++G +Y G G +VAIK ++ +L E+ + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLH----IESKIYKMMQG 63
Query: 863 -PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+ + +G V E + G SL+ R + L++A +E
Sbjct: 64 GVGIPTIRWCGAEG--DYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV------SGGVRGT 972
Y+H KN +H D+K +N L+ + V I D GL+K +T + + GT
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 973 LPWMAPELLSGKSHMVTE---KIDVYSFGIVMWELLTGDEPYADMHCAS------IIGGI 1023
+ S +H+ E + D+ S G V+ G P+ + A+ I
Sbjct: 179 ARYA-----SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233
Query: 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
+T + E+ + + C + ++P +S + + R++
Sbjct: 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 91/679 (13%), Positives = 180/679 (26%), Gaps = 238/679 (35%)
Query: 132 NHYVDGDDRESERRYVDALNNMNDGNDFRK---LQH-PDSP--VISS--IDDI------- 176
+H++D + E + +Y D L+ D F + D P ++S ID I
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 177 ---------------HMAERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRY 221
M ++F + + Y L P +Q +++ Y
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEV-------LRINYKF--LMSPIKTEQRQPSMMTRMY 112
Query: 222 NEMEGPWSPAYYSPRHYGHHDPPRP---------LPEFPSSPSSARFRMP-FGEERVPEE 271
E Y + + ++ R L E + + + G+ V +
Sbjct: 113 IEQR---DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD 169
Query: 272 YARQHVNHHPTYEPQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLT 331
Y+ Q + + W+ N + ++ + E +
Sbjct: 170 VCLS-------YKVQCKMDFKIFWLNLKNCNSPET-----------------VLEMLQKL 205
Query: 332 YHRNQLHLDQPNIGNGLPQVPLSCAECRQNRENLVLNAEAKLPGMYPK-----DNDSRSV 386
+ Q+ + + + + L + L+ + Y N V
Sbjct: 206 LY--QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK------PYENCLLVLLN----V 253
Query: 387 YNESHCHERGWVLQHQLNPRIEEARTHMSGAGRL---NDHYLVDGPGMNIPPGHGNLVDG 443
N N + L + D
Sbjct: 254 QNA-------KAWNA-FNLS---CKI-------LLTTRFKQVTDFLSAATT--------- 286
Query: 444 HHVSPNHAHHRTGPEMGNELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP---- 499
H+S +H P+ L L + P T P
Sbjct: 287 THISLDHHSMTLTPDEVKSLL----LKY---LDCRPQDL--------PREVLTTNPRRLS 331
Query: 500 -----VSHGHATAQNLWRNVQNPIHVTPLEASGPVINGSITPAYLRGAVEGNPRIAV--- 551
+ G AT N W++V T +E+S +N + PA R + R++V
Sbjct: 332 IIAESIRDGLATWDN-WKHVNCDKLTTIIESS---LN-VLEPAEYRKMFD---RLSVFPP 383
Query: 552 GVDSPNS-----WIDPSQRVP----------------GFKGTATPPEYYYSQTQKMN--- 587
P W D + + T + P Y K+
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 588 ------------PQSYNQQNQLPDPV----------H--------QSDSFSALVQD---- 613
P++++ + +P + H + F + D
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 614 --KLVSSTTDCNLGLRVNNVSEAVRT-----DENCNLGQE----------KAANHVVKVE 656
K+ +T N + N + ++ +N + K +++ +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 657 ETDVKRSCLEQNMIPEKPI 675
TD+ R L M ++ I
Sbjct: 564 YTDLLRIAL---MAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 7e-07
Identities = 56/341 (16%), Positives = 107/341 (31%), Gaps = 96/341 (28%)
Query: 19 DDVPRVKFLCSF-LG-RILPRPQDGKL-RYVGGETR----IVSLPRDVTYEELMSRMREL 71
+V K +F L +IL + ++ ++ T + +T +E+ L
Sbjct: 251 LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK----SL 306
Query: 72 YEGAVVLKYQQ-PDEDLDA---LVSVV--NDDDVINMMEEYEKLGSGDGFTR-LRIFLFS 124
+ + Q P E L +S++ + D + + ++ + D T + L
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC-DKLTTIIESSLNV 365
Query: 125 HSDQDGSNHYVD--------------------GDDRESERRYVDALNNMNDGNDFRKL-- 162
+ + + V+ L+ L
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK-------YSLVE 418
Query: 163 QHPDSPVISSIDDIHMAERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRYN 222
+ P IS I I++ + + + +Y LH+ V H N P + +
Sbjct: 419 KQPKESTIS-IPSIYLELK----------VKLENEYALHRSIVDHYNI-----PKTFDSD 462
Query: 223 EMEGPWSPAY-YSPRHYGHH----DPPRPLPEFPSSPSSARF-----RMPFGEERVP--- 269
++ P+ Y YS H GHH + P + F RF R
Sbjct: 463 DLIPPYLDQYFYS--HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI 520
Query: 270 -------EEYARQHV-NHHPTYEPQ--------PQFSENLI 294
+ Y + ++ ++ P YE P+ ENLI
Sbjct: 521 LNTLQQLKFY-KPYICDNDPKYERLVNAILDFLPKIEENLI 560
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 80/573 (13%), Positives = 159/573 (27%), Gaps = 183/573 (31%)
Query: 449 NHAHHRTGPEMGNELFH--DPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYPVSHGHAT 506
+H HH E G + D ++ E+ V + D
Sbjct: 1 HHHHHHMDFETGEHQYQYKD----ILSVF-----EDAFVDNFDCKDVQDMP--------- 42
Query: 507 AQNLWRNVQNPIHVTPLEASGPVINGSITPAYLRGAVEGNPRIAV-----GVDSPN-SWI 560
+++ + + + S ++G++ L + V V N ++
Sbjct: 43 -----KSILSKEEIDHIIMSKDAVSGTL---RLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 561 -DPSQRVPGFKGTATPPEYYYSQTQKM--NPQSYNQQN-QLPDPVHQSDSFSALVQDKLV 616
P + + + Y Q ++ + Q + + N P + ++ L
Sbjct: 95 MSPIKTEQ--RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK-------LRQAL- 144
Query: 617 SSTTDCNLGLRVNN---------------VSEAVRTDENCNLGQEKAANHV--VKVEETD 659
L LR + + + Q K + + ++ +
Sbjct: 145 -------LELRPAKNVLIDGVLGSGKTWVALDVCLSYKV----QCKMDFKIFWLNLKNCN 193
Query: 660 VKRSCLE--QNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHN-----LS 712
+ LE Q ++ + I + S NI+ S + E +LL L
Sbjct: 194 SPETVLEMLQKLLYQ--IDPNWTSRSDHSSNIKLRIH---SIQAELRRLLKSKPYENCLL 248
Query: 713 ILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDN 772
+L V+ A A + K+ TT+ + I +D
Sbjct: 249 VLLN----VQNAKAWNAFNLSCKIL---------LTTRFKQVTDFLSAATTTHISLD--- 292
Query: 773 DTVKTLKIEPTIAEAEAI-ARGLQTIKNDDL-EEVRELGSGTYGSVYHGKWRGSDVAIKR 830
TL T E +++ + L + DL EV + +
Sbjct: 293 HHSMTL----TPDEVKSLLLKYL-DCRPQDLPREVL---------------TTNPRRLSI 332
Query: 831 IKASCFAGKPSERERLI-ADFWK-------EALLLSSLHH--PNVV-SFY---GIVRDG- 875
I S R+ L D WK ++ SSL+ P + +
Sbjct: 333 IAESI-------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 876 --PDGSLATV--------TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
P L+ + +VN K L +K K I +
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----PKESTI---------SIPS- 430
Query: 926 NIVHFDLKCENL--------LVNMRDPQRPVCK 950
++ +LK + +V+ + +
Sbjct: 431 --IYLELKVKLENEYALHRSIVDHYNIPKTFDS 461
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 2e-05
Identities = 71/424 (16%), Positives = 124/424 (29%), Gaps = 117/424 (27%)
Query: 702 EDSKLLAHNLSILPELIASVK------------RAALEGAEEVKAKVEESDDSVKPD--- 746
E + IL + ++ L EE+ + D
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILS-KEEIDHIIMSKDAVSGTLRLF 68
Query: 747 TTTKEAPANEAELVNIHGEIEMDYD--NDTVKTLKIEPT------IAEAEAIARGLQTIK 798
T + + + ++Y +KT + +P+ I + + + Q
Sbjct: 69 WTLLSKQEEMVQKF-VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 799 NDD------LEEVR----ELGSGTYGSVY----HGK-WRGSDVAIKRIKASCFAGKPSER 843
+ ++R EL + GK W DV + K
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK---- 183
Query: 844 ERLIADFW--------KEALL--LSSLHH---PNVVSFYGIVRDGPDGSLATVTEF-MVN 889
I FW E +L L L + PN S D S +
Sbjct: 184 ---I--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTS-------RSDHSSNIKLRIHSIQ 231
Query: 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
L++ L+ K L++ + + K F+L C+ +L+ R Q
Sbjct: 232 AELRRLLKSKPY----ENCLLV-LL-----NVQNAKAWNAFNLSCK-ILLTTRFKQ---- 276
Query: 950 KIGD-LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008
+ D L + +L P LL + + E+LT +
Sbjct: 277 -VTDFLSAATTTHISLDH-HSMTLTPDEVKSLLLKYLDCRPQDLPR--------EVLTTN 326
Query: 1009 EPYADMHCASIIGGIVNNTLRPQIPSWCDPEWR--------SLMESCWAS-DPAE-RPSF 1058
P SII +R + +W D W+ +++ES +PAE R F
Sbjct: 327 -PRR----LSIIAES----IRDGLATW-DN-WKHVNCDKLTTIIESSLNVLEPAEYRKMF 375
Query: 1059 SEIS 1062
+S
Sbjct: 376 DRLS 379
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 37/218 (16%)
Query: 805 VRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+G G++G V VAIK IK K + + E LL ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQ----IEVRLLELMNK 109
Query: 863 PNVVSFYGIVR--DGPD--GSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDA 915
+ Y IV L V E + + +L L+ + +++ ++ A
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQM 166
Query: 916 AFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGV 969
+ +L +I+H DLK EN+L+ +P+R KI D G S Q + S
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILL--CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFY 224
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG 1007
R +PE+L G + ID++S G ++ E+ TG
Sbjct: 225 R------SPEVLLGMPY--DLAIDMWSLGCILVEMHTG 254
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH- 861
R++GSG++G +Y G +VAIK ++ +L+ E+ + L
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLL----YESKIYRILQG 61
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+ + +G V + + G SL+ R + + L++A +E
Sbjct: 62 GTGIPNVRWFGVEG--DYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++H K+ +H D+K +N L+ + V I D GL+K
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 39/179 (21%), Positives = 58/179 (32%), Gaps = 46/179 (25%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERE-----RL----IADFWKEA 854
+++GSG +G +Y + A +K P E R+ W E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 855 LLLSSLHHPNVVSFYGIVRD-------------GPDGSLATVTEFMVNG--SLKQFLQKK 899
L L P G+ G L + NG LQ
Sbjct: 103 KQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERLGI--DLQKI--SGQNGTFKKSTVLQLG 157
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R +D +EY+H VH D+K NLL+ ++P + + D GLS
Sbjct: 158 IRMLDV-------------LEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 42/160 (26%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH- 862
+++G G +G + GK + VAIK S +L E L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQL----HLEYRFYKQLGSG 64
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+ Y G A V E + G SL+ DRT + L+IA+ MEY
Sbjct: 65 DGIPQVYYFGPCG--KYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIG---DLGLSK 958
+H KN+++ D+K EN L + P ++ D L+K
Sbjct: 121 VHSKNLIYRDVKPENFL--IGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 23/161 (14%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G++G ++ G VAIK S+ +L ++ LL
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGI 68
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMV----NGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
PNV F G +G +V SL+ L R + + A
Sbjct: 69 PNVYYF------GQEGLHN----VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLSK 958
++ +H K++V+ D+K +N L+ + + + + D G+ K
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 27/181 (14%), Positives = 50/181 (27%), Gaps = 47/181 (25%)
Query: 806 RELGSGTYGSVYHG----------KWRGSDVAIK--RIKASCFAGKPSERERLIADFWKE 853
G +Y + ++K F + + +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 854 ALLLSSLHHPNVVSFYG----------IVRD--GPDGSLATVTEFMVNG----SLKQFLQ 897
L S + + G +V G SL + V+ S + LQ
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR--SLQSA--LDVSPKHVLSERSVLQ 163
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
R +D +E+LH VH ++ EN+ V+ D + + G +
Sbjct: 164 VACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFA 208
Query: 958 K 958
Sbjct: 209 F 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 53/248 (21%)
Query: 794 LQTIKNDDLEE----VRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERL 846
L D L V LG G +G V K G VA+K +K E
Sbjct: 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAA 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVR--DGPD--GSLATVTEFMVNGSLKQFLQKKDR- 901
E +L L+ + S + V+ + + G + V E ++ S F+++
Sbjct: 59 R----SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFL 113
Query: 902 --TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN---------------MRDP 944
+D ++ +A + +LH + H DLK EN+L R
Sbjct: 114 PFRLDHIRK--MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 945 QRPVCKIGDLGLSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIV 1000
P K+ D G + + + + R APE++ ++ DV+S G +
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYR------APEVILALGW--SQPCDVWSIGCI 223
Query: 1001 MWELLTGD 1008
+ E G
Sbjct: 224 LIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 20/110 (18%), Positives = 39/110 (35%), Gaps = 27/110 (24%)
Query: 918 GMEYLHGKNIVHFDLKCENLLVN---------------MRDPQRPVCKIGDLGLSKVKQQ 962
+ +LH + H DLK EN+L + + ++ D G + +
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 963 T----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD 1008
+ + R PE++ + DV+S G +++E G
Sbjct: 195 HHTTIVATRHYR------PPEVILELGW--AQPCDVWSIGCILFEYYRGF 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1075 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-72 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 7e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 2e-72
Identities = 85/284 (29%), Positives = 139/284 (48%), Gaps = 22/284 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + + + +GSG++G+VY GKW G DVA+K + + + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN------VTAPTPQQLQAFKNEVGV 57
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L H N++ F G LA VT++ SL L + + K + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK---QQTLVSGGVRGTL 973
GM+YLH K+I+H DLK N+ ++ + KIGD GL+ VK + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 974 PWMAPELLSGKSH-MVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR--- 1029
WMAPE++ + + + DVY+FGIV++EL+TG PY++++ I +V
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 1030 -PQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072
++ S C + LM C ERP F +I + +A ++
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 1e-66
Identities = 86/274 (31%), Positives = 138/274 (50%), Gaps = 22/274 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ +L+ ++ +G G +G V G +RG+ VA+K IK + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----------NDATAQAFLAEASV 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDA 915
++ L H N+V G++ + G L VTE+M GSL +L+ + R+ + L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
MEYL G N VH DL N+LV+ + V K+ D GL+K T +G + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIPS 1034
APE L K + K DV+SFGI++WE+ + G PY + ++ + + P
Sbjct: 167 TAPEALREKKF--STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD 223
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
C P +M++CW D A RPSF ++ +L +
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-64
Identities = 83/274 (30%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWR DVAIK IK + +F +EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAK 51
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ +L H +V YG+ + +TE+M NG L +L++ ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
MEYL K +H DL N LVN + V K+ D GLS+ + S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032
W PE+L + K D+++FG++MWE+ + G PY + I LR
Sbjct: 166 RWSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
P + ++M SCW ERP+F + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 5e-64
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 20/276 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ + + DF +EA
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEAE 52
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HP +V YG+ + + V EFM +G L +L+ + L + +D
Sbjct: 53 VMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
GM YL ++H DL N LV + V K+ D G+++ Q S G + +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033
W +PE+ S + + K DV+SFG++MWE+ + + + S + ++ R P
Sbjct: 167 KWASPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224
Query: 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
+M CW P +RP+FS + R+L +A
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-63
Identities = 82/280 (29%), Positives = 124/280 (44%), Gaps = 24/280 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I DL + +LG G++G V G+W VA+K +K + + DF
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDFI 59
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E + SL H N++ YG+V P + VTE GSL L+K
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
A+ A GM YL K +H DL NLL+ RD + KIGD GL + ++
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 172
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
+ W APE L ++ + D + FG+ +WE+ T G EP+ ++ + I+ I
Sbjct: 173 HRKVPFAWCAPESLKTRTF--SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLR 1066
R P C + ++M CWA P +RP+F + L
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 8e-63
Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 21/267 (7%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ E+G G++ +VY G +VA ++ SER+R F +EA +L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQR----FKEEAEMLKG 64
Query: 860 LHHPNVVSFYGIVRDGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L HPN+V FY G + VTE M +G+LK +L++ + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILK 123
Query: 918 GMEYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLKC+N+ + KIGDLGL+ +K+ + + V GT +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEF 179
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP-QIPS 1034
MAPE+ K E +DVY+FG+ M E+ T + PY++ A+ I V + ++P
Sbjct: 180 MAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEI 1061
PE + ++E C + ER S ++
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 8e-63
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 24/273 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E + +G+G+YG + + G + K + S E E LL
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD------YGSMTEAEKQMLVSEVNLL 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMD 914
L HPN+V +Y + D + +L V E+ G L + K + +D L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 915 AAFGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGG 968
++ H G ++H DLK N+ ++ + K+GD GL++ + T +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKA 173
Query: 969 VRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028
GT +M+PE ++ S+ EK D++S G +++EL P+ + G I
Sbjct: 174 FVGTPYYMSPEQMNRMSY--NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK- 230
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
+IP E ++ RPS EI
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-62
Identities = 85/282 (30%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 797 IKNDDLEEV-RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFW 851
+K D+L ELG G +GSV G +R DVAIK +K + +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-------QGTEKADTEEMM 57
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EA ++ L +P +V G+ + L V E G L +FL K I +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
+ GM+YL KN VH DL N+L+ R KI D GLSK
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARS 170
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026
+ L W APE ++ + + + DV+S+G+ MWE L+ G +PY M ++ I
Sbjct: 171 AGKWPLKWYAPECINFRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
R + P C PE +LM CW +RP F + +R+R+
Sbjct: 229 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-62
Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 22/276 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V LG+G +G V+ G + + VA+K +K + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMD 914
L+ L H +V Y +V P + +TE+M NGSL FL+ + K L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM ++ +N +H DL+ N+LV+ CKI D GL+++ + G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
+ W APE ++ + T K DV+SFGI++ E++T + + R
Sbjct: 174 IKWTAPEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C E LM CW P +RP+F + L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 1e-61
Identities = 65/262 (24%), Positives = 111/262 (42%), Gaps = 18/262 (6%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++RE+G G++G+VY + VAIK++ S + D KE L L
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKL 72
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN + + G + + V E+ + + K + + + + A G+
Sbjct: 73 RHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
YLH N++H D+K N+L++ + K+GD G + + GT WMAPE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPA---NSFVGTPYWMAPEV 182
Query: 981 LSGKSHM-VTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCDPE 1039
+ K+DV+S GI EL P +M+ S + I N
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 1040 WRSLMESCWASDPAERPSFSEI 1061
+R+ ++SC P +RP+ +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-61
Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 21/269 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E + ELG G +G VY + + + A K I ++ E + D+ E +L
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--------TKSEEELEDYMVEIDIL 63
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+S HPN+V + +L + EF G++ + + +R + + ++
Sbjct: 64 ASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWM 976
+ YLH I+H DLK N+L K+ D G+S +T+ GT WM
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
Query: 977 APELLSG---KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQI 1032
APE++ K K DV+S GI + E+ + P+ +++ ++ I +
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEI 1061
PS ++ ++ C + R + S++
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-61
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + +
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKAN 55
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI ++ +T+ M G L ++++ I +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 965 VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV 1024
+ G + + WMA E + + + T + DV+S+G+ +WEL+T D AS I I+
Sbjct: 169 HAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226
Query: 1025 NNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069
R P C + +M CW D RP F E+ MA
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 68/264 (25%), Positives = 119/264 (45%), Gaps = 19/264 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E R LG G +G+VY + + S +A+K + + E+ + +E +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQ 60
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S L HPN++ YG D + + E+ G++ + LQK + D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 117
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ Y H K ++H D+K ENLL+ KI D G S + + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++ G+ H EK+D++S G++ +E L G P+ I + P +
Sbjct: 173 PEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVT 228
Query: 1038 PEWRSLMESCWASDPAERPSFSEI 1061
R L+ +P++RP E+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-60
Identities = 80/276 (28%), Positives = 124/276 (44%), Gaps = 27/276 (9%)
Query: 802 LEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
LE+ +ELGSG +G+V G ++ VA+K +K + L + EA ++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILK------NEANDPALKDELLAEANVM 62
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L +P +V GI S V E G L ++LQ+ R + + + + +
Sbjct: 63 QQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSM 118
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTL 973
GM+YL N VH DL N+L+ + KI D GLSK + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032
W APE ++ + K DV+SFG++MWE + G +PY M + + + R
Sbjct: 175 KWYAPECINYYKF--SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 231
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P+ C E LM CW D RP F+ + RLR+
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-60
Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 25/280 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K + + F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFL 56
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
A + + YL K VH D+ N+LV+ D K+GD GLS+ +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTL 1028
+ + WMAPE ++ + DV+ FG+ MWE+L G +P+ + +IG I N
Sbjct: 170 KLPIKWMAPESINFRRFT--SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 226
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
R +P C P SLM CWA DP+ RP F+E+ +L ++
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-59
Identities = 85/306 (27%), Positives = 128/306 (41%), Gaps = 49/306 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
++LE + LGSG +G V + G VA+K +K SERE
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREA---- 86
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR------- 901
E +++ L H N+V+ G G + + E+ G L +L+ K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 902 ---------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
+ L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HG 200
Query: 947 PVCKIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWE 1003
V KI D GL++ +V G R + WMAPE L + T K DV+S+GI++WE
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWE 258
Query: 1004 LLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEIS 1062
+ + G PY + + ++ N + P + E +M+SCWA D +RPSF ++
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 1063 RRLRSM 1068
L
Sbjct: 319 SFLGCQ 324
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-59
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 26/274 (9%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+G G +G VYHG +D A+K + ++ F E +++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------RITDIGEVSQFLTEGIIMKDF 85
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPNV+S GI +GS V +M +G L+ F++ + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-----QQTLVSGGVRGTLPW 975
+L K VH DL N +++ ++ K+ D GL++ G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDE-PYADMHCASIIGGIVNNTLRPQIPS 1034
MA E L + T K DV+SFG+++WEL+T PY D++ I ++ R P
Sbjct: 201 MALESLQTQKF--TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPE 257
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
+C +M CW RPSFSE+ R+ ++
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 5e-59
Identities = 94/303 (31%), Positives = 136/303 (44%), Gaps = 30/303 (9%)
Query: 780 IEP-TIAE-AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIK 832
I+P T + EA+ + I ++ + +G+G +G V G + VAIK +K
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL 892
E+ DF EA ++ HPNV+ G+V + +TEFM NGSL
Sbjct: 64 -------SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSL 114
Query: 893 KQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
FL++ D + + + A GM+YL N VH DL N+LVN VCK+
Sbjct: 115 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVS 170
Query: 953 DLGLSKV------KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
D GLS+ + G + + W APE + + DV+S+GIVMWE+++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT--SASDVWSYGIVMWEVMS 228
Query: 1007 -GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
G+ PY DM +I I + R P C LM CW D RP F +I L
Sbjct: 229 YGERPYWDMTNQDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 1066 RSM 1068
M
Sbjct: 288 DKM 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (513), Expect = 8e-59
Identities = 81/277 (29%), Positives = 132/277 (47%), Gaps = 22/277 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E + +F KEA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 64
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAM 913
++ + HPN+V G+ + +TEFM G+L +L++ +R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ--QTLVSGGVRG 971
+ MEYL KN +H DL N LV + K+ D GLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031
+ W APE L+ + K DV++FG+++WE+ T S + ++ R +
Sbjct: 179 PIKWTAPESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C + LM +CW +P++RPSF+EI + +M
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-58
Identities = 87/285 (30%), Positives = 131/285 (45%), Gaps = 25/285 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
I + + +G+G +G VY G + S VAIK +K E+ DF
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-------AGYTEKQRVDF 56
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
EA ++ H N++ G++ + +TE+M NG+L +FL++KD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVS 966
+ A GM+YL N VH DL N+LVN VCK+ D GLS+V + T +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026
G + + W APE +S + DV+SFGIVMWE++T E + +N+
Sbjct: 171 SGGKIPIRWTAPEAISYRKFT--SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
Query: 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071
R P C LM CW + A RP F++I L + A
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-58
Identities = 81/276 (29%), Positives = 121/276 (43%), Gaps = 22/276 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K + + F +EA
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF-LQKKDRTIDRRKRLIIAMD 914
++ L H +V Y +V + P + VTE+M GSL F + + + + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM Y+ N VH DL+ N+LV + VCK+ D GL+++ + G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI 1032
+ W APE T K DV+SFGI++ EL T + V R
Sbjct: 178 IKWTAPEAALYGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
P C LM CW +P ERP+F + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 4e-58
Identities = 84/303 (27%), Positives = 130/303 (42%), Gaps = 50/303 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWK 852
+++E VR++G G +G V+ + G VA+K +K + ADF +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-------EEASADMQADFQR 65
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----------- 901
EA L++ +PN+V G+ G + + E+M G L +FL+
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 902 ------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
+ ++L IA A GM YL + VH DL N LV + V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVV 179
Query: 950 KIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006
KI D GLS+ G + WM PE + + T + DV+++G+V+WE+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFS 237
Query: 1007 GDE-PYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRL 1065
PY M +I + + P C E +LM CW+ PA+RPSF I R L
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 1066 RSM 1068
+ M
Sbjct: 297 QRM 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-57
Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 22/267 (8%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++G G G+VY G +VAI+++ + ++E +I E L+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELII----NEILV 70
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ +PN+V++ L V E++ GSL + + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECL 126
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPW 975
+E+LH ++H D+K +N+L+ M K+ D G + + + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 976 MAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPS 1034
MAPE+++ K++ K+D++S GI+ E++ G+ PY + + + I N T Q P
Sbjct: 183 MAPEVVTRKAY--GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEI 1061
+R + C D +R S E+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-57
Identities = 89/293 (30%), Positives = 134/293 (45%), Gaps = 37/293 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWK 852
+ +D++ +G G +G V + + D AIKR+K + DF
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-------EYASKDDHRDFAG 59
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------- 900
E +L L HHPN+++ G G L E+ +G+L FL+K
Sbjct: 60 ELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 901 ----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
T+ ++ L A D A GM+YL K +H DL N+LV + V KI D GL
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGL 173
Query: 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMH 1015
S+ ++ + R + WMA E L+ + T DV+S+G+++WE+++ G PY M
Sbjct: 174 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 1016 CASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
CA + + R + P CD E LM CW P ERPSF++I L M
Sbjct: 232 CAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 198 bits (505), Expect = 5e-57
Identities = 55/271 (20%), Positives = 111/271 (40%), Gaps = 18/271 (6%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
Q D + + ELGSG +G V+ + G K I P ++ +
Sbjct: 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVK----N 75
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E +++ LHHP +++ + D + + EF+ G L + +D + + +
Sbjct: 76 EISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
A G++++H +IVH D+K EN++ + KI D GL+ + T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 973 LPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRP 1030
+ APE++ + D+++ G++ + LL+G P+A + +
Sbjct: 192 AEFAAPEIVDREPV--GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249
Query: 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
S PE + +++ +P +R + +
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-57
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 38/298 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ L + LG+G +G V G VA+K +K S +ERE
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREA---- 72
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E +LS L +H N+V+ G G +TE+ G L FL++K
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ +D L + A GM +L KN +H DL N+L+ +C
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDF 189
Query: 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP- 1010
G K +V G R + WMAPE + + T + DV+S+GI +WEL +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247
Query: 1011 YADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
Y M S ++ R P E +M++CW +DP +RP+F +I + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 77/315 (24%), Positives = 124/315 (39%), Gaps = 54/315 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ +G G +G V+ GKWRG +VA+K ER E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS------SREERSWF---REAEIYQTVM 53
Query: 860 LHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N++ F +G L V+++ +GSL +L + T++ + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALSTAS 111
Query: 918 GMEYLH--------GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQTL 964
G+ +LH I H DLK +N+LV C I DLGL S +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDI 167
Query: 965 VSGGVRGTLPWMAPELLSGKSHM----VTEKIDVYSFGIVMWELLTG----------DEP 1010
GT +MAPE+L +M ++ D+Y+ G+V WE+ P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 1011 YADMHCAS-----IIGGIVNNTLRPQIPSW-----CDPEWRSLMESCWASDPAERPSFSE 1060
Y D+ + + + LRP IP+ +M CW ++ A R +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 1061 ISRRLRSMAAAINVK 1075
I + L ++ +K
Sbjct: 288 IKKTLSQLSQQEGIK 302
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-56
Identities = 74/310 (23%), Positives = 123/310 (39%), Gaps = 62/310 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEA 854
+K+DD E++ ELG+G G V+ + S +A K I + + +E
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-------LEIKPAIRNQIIREL 55
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + P +V FYG DG ++ E M GSL Q L+K R I + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 915 AAFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYAD-------------------- 1013
+M+PE L G + + + D++S G+ + E+ G P
Sbjct: 168 SYMSPERLQGTHY--SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 1014 ----------------------MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASD 1051
M ++ IVN E++ + C +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 1052 PAERPSFSEI 1061
PAER ++
Sbjct: 286 PAERADLKQL 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 195 bits (496), Expect = 1e-55
Identities = 59/266 (22%), Positives = 108/266 (40%), Gaps = 18/266 (6%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + ELG+G +G V+ R G++ A K + P E ++ KE +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM------TPHESDK--ETVRKEIQTM 77
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S L HP +V+ + D D + + EFM G L + + + + + +
Sbjct: 78 SVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+ ++H N VH DLK EN++ + K+ D GL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSW 1035
PE+ GK D++S G++ + LL+G P+ + + + + + S
Sbjct: 194 PEVAEGKPV--GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
+ + + +DP R + +
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 21/268 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + V+ LG G YG V R ++ VA+K + + KE +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-------MKRAVDCPENIKKEICIN 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L+H NVV FYG R E+ G L + + D +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMA 114
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVRGTLP 974
G+ YLHG I H D+K ENLL++ RD KI D GL+ V + + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGD-EPYADMHCASIIGGIVNNTLRPQIP 1033
++APELL + E +DV+S GIV+ +L G+
Sbjct: 171 YVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 1034 SWCDPEWRSLMESCWASDPAERPSFSEI 1061
D +L+ +P+ R + +I
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 2e-55
Identities = 68/267 (25%), Positives = 109/267 (40%), Gaps = 17/267 (6%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
D + LG+G + V + + VAIK I GK E +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEIAV 60
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + HPN+V+ I G L + + + G L + +K R +
Sbjct: 61 LHKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVL 117
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH IVH DLK ENLL D + I D GLSK++ V GT ++
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW- 1035
APE+L+ K + ++ +D +S G++ + LL G P+ D + A + I+ P W
Sbjct: 177 APEVLAQKPY--SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 1036 -CDPEWRSLMESCWASDPAERPSFSEI 1061
+ + DP +R + +
Sbjct: 235 DISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-54
Identities = 50/266 (18%), Positives = 100/266 (37%), Gaps = 19/266 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ +LG G +G V+ S K +K K +++ KE +L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ H N++ + L + EF+ + + + ++ R+ +
Sbjct: 56 NIARHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+++LH NI HFD++ EN++ R KI + G ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN--TLRPQIPSW 1035
PE+ + D++S G +++ LL+G P+ II I+N T +
Sbjct: 172 PEVHQHDVV--STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 1036 CDPEWRSLMESCWASDPAERPSFSEI 1061
E ++ + R + SE
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-54
Identities = 65/267 (24%), Positives = 115/267 (43%), Gaps = 11/267 (4%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D + ELGSG + V + + G A K IK K S R D +E +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT--KSSRRGVSREDIEREVSI 66
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + HPNV++ + + + + + E + G L FL +K+ + +
Sbjct: 67 LKEIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-IL 123
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+ YLH I HFDLK EN+++ R+ +P KI D GL+ + GT ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI--VNNTLRPQIPS 1034
APE+++ + + D++S G++ + LL+G P+ + + VN + S
Sbjct: 184 APEIVNYEPL--GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEI 1061
+ + DP +R + +
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (475), Expect = 7e-54
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 17/272 (6%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALL 856
++ E LG G V + + A+K I + E + L KE +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 857 LSSLH-HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L + HPN++ + V + M G L +L +K T+ ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRAL 119
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
+ LH NIVH DLK EN+L++ K+ D G S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 976 MAPELLSGKSHM----VTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031
+APE++ + +++D++S G++M+ LL G P+ ++ I++ +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 1032 IPSWCD--PEWRSLMESCWASDPAERPSFSEI 1061
P W D + L+ P +R + E
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-54
Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
+ + +D + + LG G++ +V + + AIK ++ + +E + +
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTR 57
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E ++S L HP V Y +D D L + NG L ++++K + R A
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGV 969
+ +EYLHGK I+H DLK EN+L+N + +I D G +KV + + +
Sbjct: 116 -EIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
GT +++PELL+ KS + D+++ G ++++L+ G P+ + I I+ L
Sbjct: 171 VGTAQYVSPELLTEKSA--CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LE 226
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
P P+ R L+E D +R E+
Sbjct: 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-53
Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 37/299 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G D VA+K +K E+ +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-------SDATEKDL 62
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------- 899
+D E ++ + H N+++ G DG L + E+ G+L+++LQ +
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + A A GMEYL K +H DL N+LV + + +
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK-IADF 179
Query: 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPY 1011
G + R + WMAPE L + + T + DV+SFG+++WE+ T
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSP 237
Query: 1012 ADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAA 1070
+ ++ R PS C E +M CW + P++RP+F ++ L + A
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-53
Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 39/298 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L+ + LG G +G V G D VA+K +K + + A
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK------EGATHSEHRAL 63
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-------- 901
+ +L+ HH NVV+ G P G L + EF G+L +L+ K
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 902 -------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+ + + A GME+L + +H DL N+L++ ++ V KI D
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 178
Query: 955 GLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDE-P 1010
GL++ + G R L WMAPE + + + T + DV+SFG+++WE+ + P
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASP 236
Query: 1011 YADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
Y + + R + P + PE M CW +P++RP+FSE+ L ++
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-52
Identities = 61/264 (23%), Positives = 117/264 (44%), Gaps = 18/264 (6%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + LG G++G V+ +++ AIK +K + E + ++ +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD-VVLMDDDVECTMV---EKRVLS 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ HP + + + +L V E++ G L +Q + D + A +
Sbjct: 58 LAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL 114
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWM 976
G+++LH K IV+ DLK +N+L++ KI D G+ K + GT ++
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L G+ + +D +SFG++++E+L G P+ + I + P P W
Sbjct: 171 APEILLGQKY--NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWL 226
Query: 1037 DPEWRSLMESCWASDPAERPSFSE 1060
+ E + L+ + +P +R
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (453), Expect = 7e-51
Identities = 56/275 (20%), Positives = 112/275 (40%), Gaps = 15/275 (5%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D E LG G V+ + DVA+K ++A + F +EA
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-----ARDPSFYLRFRREAQN 60
Query: 857 LSSLHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++L+HP +V+ Y V E++ +L+ + + + ++ + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD 119
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A + + H I+H D+K N++++ + + + ++ + V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034
+++PE G S + DVYS G V++E+LTG+ P+ S+ V P
Sbjct: 180 YLSPEQARGDSV--DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 1035 W--CDPEWRSLMESCWASDPAERP-SFSEISRRLR 1066
+ +++ A +P R + +E+ L
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-50
Identities = 78/292 (26%), Positives = 118/292 (40%), Gaps = 36/292 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ + + RELG G++G VY G +G VAIK + + R +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-------EAASMRERIE 69
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-------- 901
F EA ++ + +VV G+V + E M G LK +L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 902 -TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV- 959
K + +A + A GM YL+ VH DL N +V + KIGD G+++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 183
Query: 960 --KQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDE-PYADMHC 1016
G + WM+PE L T DV+SFG+V+WE+ T E PY +
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 1017 ASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068
++ ++ P C LM CW +P RPSF EI ++
Sbjct: 242 EQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-48
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 30/284 (10%)
Query: 793 GLQTIKN---DDLEEVRE-LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
GLQ KN DD + + LG G G V + A+K ++ + RE
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVE 56
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKK-DRTI 903
+ + P++V + + L V E + G L +Q + D+
Sbjct: 57 L--------HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
R+ I ++YLH NI H D+K ENLL + P + K+ D G +K
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSH 167
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI 1023
T ++APE+L + + + D++S G++M+ LL G P+ H +I G+
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
Query: 1024 VNNTLRPQI------PSWCDPEWRSLMESCWASDPAERPSFSEI 1061
Q S E + L+ + ++P +R + +E
Sbjct: 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (442), Expect = 2e-48
Identities = 62/261 (23%), Positives = 103/261 (39%), Gaps = 14/261 (5%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D R +G G +G VY + G A+K + K + E L + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S+ P +V L+ + + M G L L + + R A
Sbjct: 62 STGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+E++H + +V+ DLK N+L++ + +I DLGL+ + GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-TLRPQIPSWC 1036
PE+L D +S G ++++LL G P+ T+ ++P
Sbjct: 174 PEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 1037 DPEWRSLMESCWASDPAERPS 1057
PE RSL+E D R
Sbjct: 233 SPELRSLLEGLLQRDVNRRLG 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (428), Expect = 4e-47
Identities = 68/265 (25%), Positives = 128/265 (48%), Gaps = 20/265 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +R LG+G++G V+ + R G A+K +K R + + E L+L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLML 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S + HP ++ +G +D + + +++ G L L+K R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+EYLH K+I++ DLK EN+L++ + KI D G +K + + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++S K + + ID +SFGI+++E+L G P+ D + I+N + P + +
Sbjct: 170 PEVVSTKPY--NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFN 225
Query: 1038 PEWRSLMESCWASDPAERPSFSEIS 1062
+ + L+ D ++R +
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNG 250
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 166 bits (421), Expect = 2e-46
Identities = 52/288 (18%), Positives = 104/288 (36%), Gaps = 31/288 (10%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G++G ++ G VAIK + S+ +L ++ LL
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDEYRTYKLLAGCTGI 63
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PNV F G +G + ++ SL+ L R + + A ++ +
Sbjct: 64 PNVYYF------GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVS--------GGVRGTL 973
H K++V+ D+K +N L+ + + + D G+ K + + + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 974 PWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI------IGGIVNNT 1027
+M+ G+ + + D+ + G V L G P+ + A+ IG +T
Sbjct: 178 RYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
++ + E+ M P + + + +N
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 56/267 (20%), Positives = 96/267 (35%), Gaps = 21/267 (7%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ LGSG +GSVY G VAIK ++ + E +L
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVL 60
Query: 857 LSSLH--HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L + V+ S + E + +
Sbjct: 61 LKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
+ + H ++H D+K EN+L+ D R K+ D G + + T+ + GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRV 174
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034
+ PE + + V+S GI++++++ GD P+ II G +
Sbjct: 175 YSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQ 225
Query: 1035 WCDPEWRSLMESCWASDPAERPSFSEI 1061
E + L+ C A P++RP+F EI
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-45
Identities = 52/287 (18%), Positives = 103/287 (35%), Gaps = 31/287 (10%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R++GSG++G +Y G G +VAIK + E+ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLEC----------VKTKHPQLHIESKIYKMMQG 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+ G +G + ++ SL+ R + L++A +EY+
Sbjct: 62 GVGIPTIRWC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--------VKQQTLVSGGVRGTLP 974
H KN +H D+K +N L+ + V I D GL+K + + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN------NTL 1028
+ + G + + D+ S G V+ G P+ + A+ +T
Sbjct: 179 YASINTHLGIEQ--SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075
+ E+ + + C + ++P +S + + R++
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 63/297 (21%), Positives = 109/297 (36%), Gaps = 46/297 (15%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ E V E+G G YG V+ + G VA+KR++ + E + +E
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVA 59
Query: 856 LLSSL---HHPNVVSFYGIVRDGP---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
+L L HPNVV + + + L V E + + + +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
+ G+++LH +VH DLK +N+LV K+ D GL+++ + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSV 175
Query: 970 RGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029
TL + APE+L S+ +D++S G + E+ + +G I++
Sbjct: 176 VVTLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 1030 PQIPSW-------------------------CDPEWRSLMESCWASDPAERPSFSEI 1061
P W D + L+ C +PA+R S
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-44
Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 19/261 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + ++ LG GT+G V + + G A+K ++ K +A E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVL 59
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ HP + + + L V E+ G L L ++ + R R A +
Sbjct: 60 QNTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVS 116
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWM 976
+EYLH +++V+ D+K ENL+++ + KI D GL K GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWC 1036
APE+L + +D + G+VM+E++ G P+ + + I+ + P
Sbjct: 173 APEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTL 228
Query: 1037 DPEWRSLMESCWASDPAERPS 1057
PE +SL+ DP +R
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLG 249
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-43
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 43/292 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
++ ++V ++G GTYG VY + + G VA+K+I+ +E E + + +E LL
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L+HPN+V ++ + L V EF+ K I
Sbjct: 56 KELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW-M 976
G+ + H ++H DLK +NLL+N K+ D GL++ + + W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW- 1035
APE+L G + + +D++S G + E++T + + I P W
Sbjct: 170 APEILLGCKYY-STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 1036 --------------------------CDPEWRSLMESCWASDPAERPSFSEI 1061
D + RSL+ DP +R S
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 7e-42
Identities = 56/265 (21%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + ++ LG+G++G V K + G+ A+K + + + + I E +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+++ P +V +D + L V E++ G + L++ R A
Sbjct: 96 QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVL 152
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
EYLH ++++ DLK ENLL++ + ++ D G +K + + + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037
PE++ K + + +D ++ G++++E+ G P+ I IV+ + + PS
Sbjct: 207 PEIILSKGY--NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFS 262
Query: 1038 PEWRSLMESCWASDPAERPSFSEIS 1062
+ + L+ + D +R +
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNG 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 63/271 (23%), Positives = 120/271 (44%), Gaps = 21/271 (7%)
Query: 800 DDLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ E ++ LG+G YG V+ G G A+K +K + K E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 855 LLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L + P +V+ + + + L + +++ G L L +++R + ++ +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG- 136
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRG 971
+ +E+LH I++ D+K EN+L++ + D GLSK V +T + G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGH----VVLTDFGLSKEFVADETERAYDFCG 192
Query: 972 TLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR-- 1029
T+ +MAP+++ G + +D +S G++M+ELLTG P+ + I L+
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
Query: 1030 PQIPSWCDPEWRSLMESCWASDPAERPSFSE 1060
P P + L++ DP +R
Sbjct: 253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (376), Expect = 1e-40
Identities = 57/290 (19%), Positives = 103/290 (35%), Gaps = 41/290 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ + ++G GTYG VY + G A+K+I+ E E + + +E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L H N+V Y ++ L ++ LK+ L + ++ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+ Y H + ++H DLK +NLL+N KI D GL++ + W
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 979 ELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW--- 1035
+ S + ID++S G + E++ G + + A + I P +W
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 1036 ------------------------CDPEWRSLMESCWASDPAERPSFSEI 1061
D L+ DP +R + +
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 64/305 (20%), Positives = 107/305 (35%), Gaps = 55/305 (18%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
E++ ++G GT+G V+ + R G VA+K++ +E+E +E +L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 63
Query: 858 SSLHHPNVVSFYGIVRDGP------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
L H NVV+ I R GS+ V +F + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----- 966
M G+ Y+H I+H D+K N+L+ + V K+ D GL++ S
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN 1026
TL + PELL G+ ID++ G +M E+ T + I
Sbjct: 179 TNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 1027 TLRPQIPSW------------------------------CDPEWRSLMESCWASDPAERP 1056
W DP L++ DPA+R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 1057 SFSEI 1061
+
Sbjct: 298 DSDDA 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 40/288 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ LG G + +VY + + ++ VAIK+IK + ++ + +E LL L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQEL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN++ +++ V +FM + + M G+E
Sbjct: 58 SHPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 114
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-GTLPWMAPE 979
YLH I+H DLK NLL++ + V K+ D GL+K + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 980 LLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW---- 1035
LL G M +D+++ G ++ ELL + I P W
Sbjct: 171 LLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1036 ----------------------CDPEWRSLMESCWASDPAERPSFSEI 1061
+ L++ + +P R + ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-40
Identities = 58/296 (19%), Positives = 102/296 (34%), Gaps = 51/296 (17%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G G YG V VAIK+I P E + +E +L
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-------PFEHQTYCQRTLREIKILLRF 63
Query: 861 HHPNVVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
H N++ I+R + ++ L + L K + + G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLP 974
++Y+H N++H DLK NLL+N KI D GL++V T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP---- 1030
+ APE++ T+ ID++S G ++ E+L+ + H + I+ P
Sbjct: 178 YRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 1031 -------------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
++ D + L++ +P +R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-39
Identities = 58/305 (19%), Positives = 102/305 (33%), Gaps = 51/305 (16%)
Query: 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+G + + + +G+G++G VY K G VAIK++ ++
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRF---- 59
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGS----LATVTEFMVNGSLKQFLQ--KKDRTI 903
+E ++ L H N+V + L V +++ + + +T+
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
+ + Y+H I H D+K +N + DP V K+ D G +K +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN---LLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 964 LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI 1023
+ + + APEL+ G T IDV+S G V+ ELL G + + I
Sbjct: 177 EPNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 1024 VNNTLRPQIPSW---------------------------CDPEWRSLMESCWASDPAERP 1056
+ P PE +L P R
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 1057 SFSEI 1061
+ E
Sbjct: 296 TPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 43/292 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
E++ ++G GTYG+V+ K R VA+KR++ + E + + +E LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N+V + ++ +L V EF K F + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+ + H +N++H DLK +NLL+N K+ + GL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 978 PELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNNTLRPQIPSW- 1035
P + + + + ID++S G + EL P + + I P W
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 1036 --------------------------CDPEWRSLMESCWASDPAERPSFSEI 1061
+ R L+++ +P +R S E
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (353), Expect = 5e-37
Identities = 54/307 (17%), Positives = 104/307 (33%), Gaps = 58/307 (18%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
++ DD + VR+LG G Y V+ V +K +K P ++++
Sbjct: 29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKK----IK 77
Query: 852 KEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +L PN+++ IV+D + A V E + N KQ Q +
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ ++Y H I+H D+K N+++ D + ++ D GL++
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
Query: 971 GTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEP-YADMHCASIIGGIVNNTLR 1029
+ + PELL +D++S G ++ ++ EP + + I
Sbjct: 191 ASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249
Query: 1030 PQIPSW-----------------------------------CDPEWRSLMESCWASDPAE 1054
+ + PE ++ D
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
Query: 1055 RPSFSEI 1061
R + E
Sbjct: 310 RLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-36
Identities = 65/294 (22%), Positives = 111/294 (37%), Gaps = 51/294 (17%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+++ +GSG YG+V G+ VAIK++ +P + E ++E LL +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHM 74
Query: 861 HHPNVVSFYGIVRDGPDGSLAT----VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H NV+ + T V FM G+ L K ++ + + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQML 131
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+ Y+H I+H DLK NL VN + KI D GL++ + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP------ 1030
APE++ T+ +D++S G +M E++TG + + I+ T P
Sbjct: 186 APEVILNWMRY-TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 1031 -----------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEI 1061
I + P +L+E D +R + E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 61/296 (20%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + + +GSG YGSV G VA+K++ +P + ++E LL
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLL 71
Query: 858 SSLHHPNVVSFYGIVRDG---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+ H NV+ + + + + ++ L ++ + T D + LI +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI- 130
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G++Y+H +I+H DLK NL VN KI D GL++ + T
Sbjct: 131 -LRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKILDFGLARHTDDEMTG--YVATRW 183
Query: 975 WMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034
+ APE++ H + +D++S G +M ELLTG + + I+ P
Sbjct: 184 YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 1035 W-----------------------------CDPEWRSLMESCWASDPAERPSFSEI 1061
+P L+E D +R + ++
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 7e-31
Identities = 53/305 (17%), Positives = 105/305 (34%), Gaps = 62/305 (20%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V +VAIK++ +P + + ++E +L+ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 861 HHPNVVSFYGIVRDGP----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+H N++S + + V E M + + +D + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQML 129
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 977 APELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW- 1035
APE++ G + E +D++S G +M E++ + ++ P
Sbjct: 186 APEVILGMGY--KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 1036 ---------------------------------------CDPEWRSLMESCWASDPAERP 1056
+ R L+ DPA+R
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 1057 SFSEI 1061
S +
Sbjct: 304 SVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (268), Expect = 1e-25
Identities = 56/320 (17%), Positives = 106/320 (33%), Gaps = 55/320 (17%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
+ K+ VR+LG G + +V+ K + VA+K ++ + +E E +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 853 EA--LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+A S+ +++ + V F V G L KK +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 911 --IAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
I+ G++Y+H + I+H D+K EN+L+ + D + +I L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS--------- 1018
T + +PE+L G D++S +++EL+TGD + S
Sbjct: 188 NSIQTREYRSPEVLLGAPW--GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 1019 ----IIGGIVNNTLR---------------------------------PQIPSWCDPEWR 1041
++G + + LR + E
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 1042 SLMESCWASDPAERPSFSEI 1061
+ DP +R +
Sbjct: 306 DFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 7e-15
Identities = 26/164 (15%), Positives = 45/164 (27%), Gaps = 30/164 (18%)
Query: 806 RELGSGTYGSVYHGK-WRGSDVAIKRIKAS----------CFAGKPSERERLIADFWKEA 854
+ +G G +V++ + + +K K G I E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L L V Y + A + E + L + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDEV--------LDM 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+ + + IVH DL N+LV+ I D S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.7 bits (124), Expect = 7e-09
Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 5/69 (7%)
Query: 42 KLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDDVI 100
K Y + + L D TY+EL S++ + L+ + D + D V
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTKLFDGSG---EEIKTDSQVS 71
Query: 101 NMMEEYEKL 109
N+++ K+
Sbjct: 72 NIIQAKLKI 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1075 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.32 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.16 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.12 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 97.02 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 96.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 86.6 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 86.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.01 Aligned_cols=264 Identities=33% Similarity=0.567 Sum_probs=222.6
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 31148890499997325938999999869325999820433489934689999999999999981899954356011124
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e 874 (1075)
|++..++|++.+.||+|+||+||+|++++ .||||+++...... ...+.|.+|+.+|++++|||||++++++.+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 13154518998898307885899999999-89999997346998------999999999999984799878645679715
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 99995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
..+++||||+++|+|.+++......+++..++.|+.||++||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 76 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~DF 148 (276)
T d1uwha_ 76 ---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDF 148 (276)
T ss_dssp ---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECCC
T ss_pred ---CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEEC----CCCCEEECCC
T ss_conf ---589999965899888999852357899999999999999998887509995161478997981----8997887500
Q ss_pred CCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-C
Q ss_conf 885123454---3247877888744720015887-8999235699999999999919999988785789976651458-9
Q 001449 955 GLSKVKQQT---LVSGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-R 1029 (1075)
Q Consensus 955 GLAk~~~~~---~~s~s~~GTp~YlAPEvL~g~~-~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l-~ 1029 (1075)
|+|+..... .......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+......+........ .
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 22133355677631256655743179999950568999953151635999999997889989989699999999658889
Q ss_pred C---CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 9---999989899999999962119999988999999999999970
Q 001449 1030 P---QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1030 ~---~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
+ .++..++.++.+||.+||..||.+|||+.++++.|+.+...+
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 8600036555499999999975889768929999999999999709
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=374.44 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=219.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||.||+|+++ |..||+|++.... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 94 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-- 94 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 657589889840768199999988999899999984524--------3169999999999986799799929999998--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
.+.+++|||||++|+|.+++.+....+++..++.|+.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+
T Consensus 95 ~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~ 172 (350)
T d1koaa2 95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGL 172 (350)
T ss_dssp TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCC--CCCEEEEEECCH
T ss_conf 999999998579988999997623789999999999999999999975697600015467364168--898699954521
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 512345432478778887447200158878999235699999999999919999988785789976651458999--999
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ--IPS 1034 (1075)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~--ip~ 1034 (1075)
|+............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+........ ...
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 250 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG
T ss_pred HEECCCCCCCCEECCCCCCCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 04425654320006862421889975899--8726765546599999985989989979999999998478898942235
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 898999999999621199999889999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
.++.++++||.+||..||.+|||+.++++.
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 899999999999756896679089998629
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=370.50 Aligned_cols=262 Identities=35% Similarity=0.608 Sum_probs=223.5
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CC---CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 33114889049999732593899999986--93---25999820433489934689999999999999981899954356
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1075)
Q Consensus 794 ~~ei~~~dYeilk~LGeGsfGtVYkak~k--Gt---~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkL 868 (1075)
.+++..++|++.+.||+|+||+||+|+++ +. .||+|.+.... .....+.|.+|+.+|++++|||||++
T Consensus 20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l 92 (299)
T d1jpaa_ 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHL 92 (299)
T ss_dssp SCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCCE
T ss_conf 62208004278569802788299999995799788999999978445-------98999999999999985799888618
Q ss_pred ECCCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCE
Q ss_conf 01112499995289996502884789873104667899999999999999999984991503578886575268999991
Q 001449 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1075)
Q Consensus 869 lgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~ 948 (1075)
++++.+ .+.+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 93 ~g~~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~ 166 (299)
T d1jpaa_ 93 EGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLV 166 (299)
T ss_dssp EEEECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCC
T ss_pred EEEEEE--CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCC
T ss_conf 999962--8877999972279853002104567999999999999999988988527983576150448988----9991
Q ss_pred EEEEECCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHH
Q ss_conf 99942588512345432------47877888744720015887899923569999999999991-999998878578997
Q 001449 949 CKIGDLGLSKVKQQTLV------SGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIG 1021 (1075)
Q Consensus 949 VKLiDFGLAk~~~~~~~------s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~ 1021 (1075)
+||+|||+|+....... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....+++.
T Consensus 167 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~ 244 (299)
T d1jpaa_ 167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244 (299)
T ss_dssp EEECCC-----------------------CGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 9988844315756777765365025666883003878883699--78612144535789999867999999999999999
Q ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 66514589999998989999999996211999998899999999999997
Q 001449 1022 GIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1022 ~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
.+... .+...+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 245 ~i~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 245 AIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHCC-CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99737-88999742269999999997587976892999999999998418
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.03 Aligned_cols=258 Identities=31% Similarity=0.512 Sum_probs=221.7
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCC-------CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEE
Q ss_conf 311488904999973259389999998693-------259998204334899346899999999999999818-999543
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGS-------DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~kGt-------~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL-~HPNIV 866 (1075)
|++..++|++.+.||+|+||+||+|++.+. .||+|.+..... ......+.+|+.++.++ +|||||
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHHCCCCCEE
T ss_conf 6577899397019830788199999985788554204999999663358-------789999999999999715899686
Q ss_pred EEECCCCCCCCCCEEEEEEEECCCCHHHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 5601112499995289996502884789873104----------------------667899999999999999999984
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------RTIDRRKRLIIAMDAAFGMEYLHG 924 (1075)
Q Consensus 867 kLlgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~----------------------k~Lse~~il~Ia~QIlsAL~yLHs 924 (1075)
++++++.+ .+.+++|||||++|+|.++|.... ..+++..++.|+.||+.||.|||+
T Consensus 105 ~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~ 182 (325)
T d1rjba_ 105 NLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182 (325)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 87788862--9958999972799959999986257775102210000122200125778999999999999999999973
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9915035788865752689999919994258851234543---2478778887447200158878999235699999999
Q 001449 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001 (1075)
Q Consensus 925 ~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVIL 1001 (1075)
++|+||||||+|||++ .++.+||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++
T Consensus 183 ~~IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 183 KSCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILL 256 (325)
T ss_dssp TTEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHH
T ss_pred CCEEECCCCHHCCCCC----CCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCC--CCCCEECCCHHHHH
T ss_conf 9905052703214434----59828985142222045778615623435787657838872799--99633030003999
Q ss_pred HHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 99991-9999988785789976651458999999898999999999621199999889999999999
Q 001449 1002 WELLT-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1002 yELLT-Gk~PF~~~~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Les 1067 (1075)
|||++ |..||.+......+..++....++..+..++.++++||.+||+.||++|||+.+|++.|..
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9998389999999898999999985699899887678999999999758896689399999999748
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.87 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=218.2
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 14889049999732593899999986--9325999820433489934689999999999999981899954356011124
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e 874 (1075)
+..++|++.+.||+|+||+||+|+++ ++.||+|++.+.... .......+.+|+.+++.++|||||++++++.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-----KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 6153769988985177858999999899949999998168856-----76899999999999985688888859999998
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 99995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
.+.+++|||||++|+|.+++.+.. .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 78 --~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DF 150 (263)
T d2j4za1 78 --ATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADF 150 (263)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEEC----CCCCEEECCC
T ss_conf --999899985047985898875048-999999999999999999999988946522023441466----8998711555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 88512345432478778887447200158878999235699999999999919999988785789976651458999999
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPS 1034 (1075)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip~ 1034 (1075)
|+|+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.. ..++.
T Consensus 151 G~a~~~~~~~~-~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~ 225 (263)
T d2j4za1 151 GWSVHAPSSRR-TTLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPD 225 (263)
T ss_dssp CSCSCCCCCCC-EETTEEGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCT
T ss_pred CEEEECCCCCC-CCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--CCCCC
T ss_conf 63354488852-3557887634999975899--8931440467599999832999988899999999997189--99986
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89899999999962119999988999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++.++++||.+||+.||.+|||+.++++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 68999999999976479768909999971
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=371.92 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=219.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||.||+|+++ +..||+|+++.... . ....+.+|+.+|++++|||||++++++.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-- 97 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------L--DKYTVKNEISIMNQLHHPKLINLHDAFED-- 97 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H--HHHHHHHHHHHHTTCCSTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH------H--HHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 4035998999317782999999989997999999887264------6--79999999999986799798919999998--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
+..+++|||||++|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+
T Consensus 98 ~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGl 175 (352)
T d1koba_ 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGL 175 (352)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTT
T ss_pred CCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCC--CCCEEEEEECCC
T ss_conf 999999998289980888898638998999999999999999999997792651314455311346--788489952563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC--CCCC
Q ss_conf 51234543247877888744720015887899923569999999999991999998878578997665145899--9999
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP--QIPS 1034 (1075)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~--~ip~ 1034 (1075)
|+............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+....... ....
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 253 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT
T ss_pred CEECCCCCCEEECCCCCCCCCHHHHCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 03437887201004764534899974799--8976333898999999996889989979999999998478898930024
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89899999999962119999988999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++.++.+||.+||..||.+|||+.++++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 79999999999975699668918999960
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.73 Aligned_cols=247 Identities=24% Similarity=0.419 Sum_probs=214.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|+++ |+.||+|+++...... .+.+.+|+.+|+.++|||||++++++.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 88 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLV-- 88 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHCCCCCEEEEEEEEEE--
T ss_conf 105388789812858299999998999899999984301727--------9999999999986799988058577988--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
.+.+++|||||++|+|.+++.+. .+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~ 162 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEEECCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEECCCHH
T ss_conf 99989999703798089886415--999999999999999999999987972267768886887----899686425156
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-CCCCCCC
Q ss_conf 512345-43247877888744720015887899923569999999999991999998878578997665145-8999999
Q 001449 957 SKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT-LRPQIPS 1034 (1075)
Q Consensus 957 Ak~~~~-~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~-l~~~ip~ 1034 (1075)
|+.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.... .....+.
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGG
T ss_pred HEEECCCCCCCCCCCCCCCCCCHHHHCCCC--CCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 413213666444444477736826644799--880120313729999980488998997999999999857999888855
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89899999999962119999988999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++.++++||.+||..||.+|||+.++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 37999999999986699668909999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.59 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=219.8
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 14889049999732593899999986--9325999820433489934689999999999999981899954356011124
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e 874 (1075)
+..++|++++.||+|+||.||+|+++ +..||+|++++...... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 844742898898317684999999989998999999815654497-----999999999999986799988778764035
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 99995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
...+++||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DF 149 (337)
T d1o6la_ 77 --HDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDF 149 (337)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCC
T ss_pred --CCCCCCCEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEEEEC
T ss_conf --642111000357986055553256-775999999999996521134315962246477784765----8998888205
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 88512345-43247877888744720015887899923569999999999991999998878578997665145899999
Q 001449 955 GLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 955 GLAk~~~~-~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip 1033 (1075)
|+|+.... .......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..++...+..... .++
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~--~~p 225 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFP 225 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCC
T ss_pred CCCCCCCCCCCCCCCCEECHHHHHHHHCCCCC--CCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCC
T ss_conf 65200356786205510088996666504898--88333102230678899878999999699999999852899--898
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 989899999999962119999988-----999999
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPS-----FSEISR 1063 (1075)
Q Consensus 1034 ~~lS~eLkdLIkkCLq~DP~kRPS-----a~EILq 1063 (1075)
..+++++++||.+||+.||.+|++ +.++++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 66899999999866638934422565234999972
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.52 Aligned_cols=257 Identities=32% Similarity=0.611 Sum_probs=221.9
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 14889049999732593899999986-93259998204334899346899999999999999818999543560111249
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 797 i~~~dYeilk~LGeGsfGtVYkak~k-Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~ 875 (1075)
++.++|++.+.||+|+||.||+|++. +..||||+++..... .+.|.+|+.++++++||||+++++++.+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLE- 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCCCCCCCEECC-
T ss_conf 896995888898208882999999889999999998788676---------8999999999996689975653524315-
Q ss_pred CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 99952899965028847898731046678999999999999999999849915035788865752689999919994258
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFG 955 (1075)
.+.+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 72 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 72 -QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred -CCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEEC----CCCCEEECCCC
T ss_conf -9933799983699918997520134788999999999999987765316431044315326666----88776865532
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 85123454--3247877888744720015887899923569999999999991-99999887857899766514589999
Q 001449 956 LSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 956 LAk~~~~~--~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~~~l~~~i 1032 (1075)
+++..... .......||+.|+|||++.+.. ++.++||||||+++|||++ |.+||......+++..+.. ..+...
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCC
T ss_pred HHEECCCCCCEEECCEECCCCCCCHHHHCCCC--CCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCC
T ss_conf 10023688733504300176667857860799--984033210599999998789888778999999999980-688899
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 998989999999996211999998899999999999997
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1033 p~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
+..++.++.+||.+||+.||.+|||+.++++.|+++...
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 543679999999997657976891999999999999857
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.72 Aligned_cols=261 Identities=30% Similarity=0.569 Sum_probs=220.8
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECC
Q ss_conf 33114889049999732593899999986--9325999820433489934689999999999999981899954356011
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 794 ~~ei~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv 871 (1075)
.|++..++|++.+.||+|+||+||+|+++ ++.||||+++..... .+.|.+|+.+|+.++|||||+++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH---------HHHHHHHHHHHHHCCCCCEECCCCC
T ss_conf 5174579939865982088808999999999969999997776103---------9999999999986799988267752
Q ss_pred CCCCCCCCEEEEEEEECCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEE
Q ss_conf 1249999528999650288478987310-466789999999999999999998499150357888657526899999199
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 872 ~~e~~e~~L~LVmEYleGGSL~dlLkk~-~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VK 950 (1075)
+.+ ...+++||||+++|+|.+++.+. ...+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 82 ~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~K 155 (287)
T d1opja_ 82 CTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVK 155 (287)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EEE--CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEE
T ss_conf 745--78547876314676067775303554157999999999999978889878930576045768998----999289
Q ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 9425885123454--32478778887447200158878999235699999999999919999988785789976651458
Q 001449 951 IGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL 1028 (1075)
Q Consensus 951 LiDFGLAk~~~~~--~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l 1028 (1075)
|+|||+|+..... .......|++.|+|||++.+.. ++.++|||||||++|||+++..||........+...+....
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~ 233 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 233 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 8324454653788722103556654666927872799--98104302178999999867998877425999999985588
Q ss_pred CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999998989999999996211999998899999999999997
Q 001449 1029 RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1029 ~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
++.++..++.++.+||.+||+.||.+|||+.++++.|+.+..+
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 8888743309999999997577976893999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=372.48 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=220.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.+.|++.+.||+|+||+||+|+++ ++.||+|++....... ....+.+|+.+|+.++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYES-- 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-------HHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 666699889940658399999999999899999981577312-------89999999999986799899919899998--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
++.+++|||||+||+|.+++...+ .+++..+..++.||+.||.|||+++|+||||||+|||+...+ .++.+||+|||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~ 156 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGL 156 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC--
T ss_pred CCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCC-CCCEEEEECCCE
T ss_conf 998889885268984888653036-788789999999999998752413055687046300110468-882499831543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 512345432478778887447200158878999235699999999999919999988785789976651458999--999
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ--IPS 1034 (1075)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~--ip~ 1034 (1075)
|+...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+.+...... ...
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ----------------CTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred EEECCCCCEEEEEEECCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 58725897044003284225918873799--9807873451599999985979999989999999986168777876666
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89899999999962119999988999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.+++++.+||.+||..||.+|||+.|+++
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 78999999999976089757918999862
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.02 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=218.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||.||+++++ |+.||+|++...... +...+.+.+|+.++++++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 33379967983088919999999999979999998746579------799999999999999778999824899999178
Q ss_pred CCCEEEEEEEECCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCCCCE
Q ss_conf 99528999650288478987310---466789999999999999999998499-----1503578886575268999991
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPV 948 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~---~k~Lse~~il~Ia~QIlsAL~yLHs~G-----IVHRDIKPeNILId~~~~~~g~ 948 (1075)
++.+++|||||++|+|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCC----CCCC
T ss_conf 998999995689993899998515457899999999999999999999997167788788586765425747----8885
Q ss_pred EEEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 999425885123454-3247877888744720015887899923569999999999991999998878578997665145
Q 001449 949 CKIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 949 VKLiDFGLAk~~~~~-~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~ 1027 (1075)
+||+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..++...+....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC
T ss_conf 79800100032245777556677882327999983999--9938988752789999801889989989999999997189
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 899999989899999999962119999988999999
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
. ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 231 ~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9-8897435999999999976799557918999972
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.12 Aligned_cols=248 Identities=26% Similarity=0.447 Sum_probs=215.7
Q ss_pred CEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCCC
Q ss_conf 9049999732593899999986--93259998204334899346899999999999999818999543560111249999
Q 001449 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 801 dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e~ 878 (1075)
.|+.++.||+|+||+||+|++. +..||||++..... ......+.+.+|+.+|+.++|||||++++++.+ .+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TT
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CC
T ss_conf 56762797018880999999989993999999844443-----588999999999999997789998238999998--99
Q ss_pred CEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCC
Q ss_conf 52899965028847898731046678999999999999999999849915035788865752689999919994258851
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk 958 (1075)
.+++|||||.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTCB
T ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEEC----CCCCEEEEECCCCC
T ss_conf 889999806999457899737-9999999999999999999999868976667884217987----99978984436533
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 234543247877888744720015887-8999235699999999999919999988785789976651458999999898
Q 001449 959 VKQQTLVSGGVRGTLPWMAPELLSGKS-HMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSWCD 1037 (1075)
Q Consensus 959 ~~~~~~~s~s~~GTp~YlAPEvL~g~~-~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip~~lS 1037 (1075)
..... ....||+.|+|||++.+.. ..|+.++|||||||++|||++|..||.+......+..+.........+..++
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 164 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred CCCCC---CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 46778---731347663688998346788867214545589999999878899999799999999982899988878889
Q ss_pred HHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 99999999962119999988999999
Q 001449 1038 PEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1038 ~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++++||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999999977379657918999971
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.68 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=215.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 89049999732593899999986--9325999820433489934689999999999999981899954356011124999
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e 877 (1075)
+.|++++.||+|+||.||+|+++ +..||+|++...... ..+.+.+|+.+|+.++|||||++++++.+ .
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~ 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------ELEDYMVEIDILASCDHPNIVKLLDAFYY--E 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------GGGGTHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHH--------HHHHHHHHHHHHHHCCCCCCCEEEEEEEE--C
T ss_conf 3759847993077819999999999939999998728999--------99999999999986799998849889800--9
Q ss_pred CCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCCC
Q ss_conf 95289996502884789873104667899999999999999999984991503578886575268999991999425885
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLA 957 (1075)
+.+++|||||++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~a 157 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVS 157 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEEC----CCCCEEEEECHHH
T ss_conf 958999962799818899986289999999999999999999999988988714070031487----8999899716123
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-CCCC
Q ss_conf 123454-324787788874472001588---78999235699999999999919999988785789976651458-9999
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGK---SHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL-RPQI 1032 (1075)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YlAPEvL~g~---~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l-~~~i 1032 (1075)
+..... .......||+.|+|||++... ...|+.++|||||||++|+|++|+.||.+.+..+.+..+..... ....
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred HCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 03577864100102562647999983202578888806657878999999820889999989999999997079987776
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 9989899999999962119999988999999
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1033 p~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
+..++.++++||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 5669999999999976699668919999962
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.10 Aligned_cols=261 Identities=31% Similarity=0.566 Sum_probs=221.0
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECC
Q ss_conf 033114889049999732593899999986-9325999820433489934689999999999999981899954356011
Q 001449 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 793 ~~~ei~~~dYeilk~LGeGsfGtVYkak~k-Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv 871 (1075)
+-|++..++|++.+.||+|+||.||+|+++ +..||||+++..... .+.|.+|+.++++++|||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 7700388993886798107982899999999999999998647688---------8999999999986799988578731
Q ss_pred CCCCCCCCEEEEEEEECCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEE
Q ss_conf 12499995289996502884789873104-66789999999999999999998499150357888657526899999199
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 872 ~~e~~e~~L~LVmEYleGGSL~dlLkk~~-k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VK 950 (1075)
+.+ +.+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 77 ~~~---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~K 149 (272)
T d1qpca_ 77 VTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCK 149 (272)
T ss_dssp ECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEE
T ss_pred ECC---CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEE----CCCCEE
T ss_conf 045---9769999957898288887514789887889999999999999999748954675642251562----024404
Q ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHCC
Q ss_conf 9425885123454--32478778887447200158878999235699999999999919-99998878578997665145
Q 001449 951 IGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCASIIGGIVNNT 1027 (1075)
Q Consensus 951 LiDFGLAk~~~~~--~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTG-k~PF~~~~~~eil~~Iv~~~ 1027 (1075)
|+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|||+|| .+||......+++..+. ..
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~ 226 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RG 226 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT
T ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-HC
T ss_conf 2341014773588644203567744445828983799--98245645257999999968988888889999999997-06
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 899999989899999999962119999988999999999999970
Q 001449 1028 LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1028 l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
.++..+..++.++.+||.+||+.||++|||+.++++.|++++.+.
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 888896557199999999975889768939999999861132137
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.81 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=222.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|+++ |+.||+|++++......... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG--VSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS--BCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 5677982798117895999999999998999999875663213406--899999999999986799899938899997--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
...+++|||||++|+|.+++.+.+ .+++..++.++.||+.||.|||+++|+||||||+|||++..+.....+||+|||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 998999998677864310010356-4215578999999999987666254221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC--CCC
Q ss_conf 512345432478778887447200158878999235699999999999919999988785789976651458999--999
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ--IPS 1034 (1075)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~--ip~ 1034 (1075)
|+............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+........ .+.
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCC
T ss_conf 21057776312247777430999981899--9976652214099999970889988999999999998168888701047
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89899999999962119999988999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++.++++||.+||..||.+|||+.++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 88999999999986389668919999961
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.13 Aligned_cols=259 Identities=32% Similarity=0.568 Sum_probs=220.5
Q ss_pred CCCCCEEEEEE-ECCCCCEEEEEEEEC----CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECC
Q ss_conf 14889049999-732593899999986----9325999820433489934689999999999999981899954356011
Q 001449 797 IKNDDLEEVRE-LGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (1075)
Q Consensus 797 i~~~dYeilk~-LGeGsfGtVYkak~k----Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv 871 (1075)
++.++|.+.+. ||+|+||.||+|.++ +..||||+++... .....+.|.+|+.+|++++|||||+++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 54447188784873060809999999608976899999988203-------97899999999999986799888068656
Q ss_pred CCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEE
Q ss_conf 12499995289996502884789873104667899999999999999999984991503578886575268999991999
Q 001449 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 872 ~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKL 951 (1075)
+.+ +.+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 78 ~~~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~Kl 150 (285)
T d1u59a_ 78 CQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKI 150 (285)
T ss_dssp EES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEE
T ss_pred ECC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC----CCCCEEE
T ss_conf 036---807999980789968997521256999999999999999987899868810576764660454----6885420
Q ss_pred EECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHC
Q ss_conf 425885123454----3247877888744720015887899923569999999999991-99999887857899766514
Q 001449 952 GDLGLSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 952 iDFGLAk~~~~~----~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~~ 1026 (1075)
+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+....++...+..
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~- 227 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 227 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-
T ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-
T ss_conf 33134211554343211356211374335868872799--995412322017899999389999999799999999981-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 5899999989899999999962119999988999999999999970
Q 001449 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1027 ~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
..++.++..++.++.+||.+||..||.+|||+.++++.|+.++..+
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 8999999767899999999975779768909999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.87 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=209.8
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCC
Q ss_conf 114889049999732593899999986--932599982043348993468999999999999998189995435601112
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (1075)
Q Consensus 796 ei~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~ 873 (1075)
++..++|++++.||+|+||+||+|+++ ++.||+|+++..... .....+.+|+.+|+.++|||||++++++.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------AIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-------THHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCH-------HHHHHHHHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 78756888978971277809999999899969999998754097-------89999999999998679999994999999
Q ss_pred CCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCCCCEEEEE
Q ss_conf 499995289996502884789873104667899999999999999999984-9915035788865752689999919994
Q 001449 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 874 e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs-~GIVHRDIKPeNILId~~~~~~g~VKLi 952 (1075)
+ .+.+++||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+
T Consensus 75 ~--~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~ 147 (322)
T d1s9ja_ 75 S--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLC 147 (322)
T ss_dssp C--SSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEEC
T ss_pred E--CCEEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC----CCCCEEEE
T ss_conf 8--999999997679986899874249-9999999999999999999999859997144577994687----89989995
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----------
Q ss_conf 258851234543247877888744720015887899923569999999999991999998878578997-----------
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIG----------- 1021 (1075)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~----------- 1021 (1075)
|||+|+...... ....+||+.|+|||++.+.. |+.++||||+||++|||++|+.||...+......
T Consensus 148 DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 148 DFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCCHHHHHHT-C---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred ECCCCCCCCCCC-CCCCCCCCCCCCCHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 487762567886-21113771411946875899--894888998999999999888998998878999999887517754
Q ss_pred -------------------------------HHHHCCCCCCCC-CCCCHHHHHHHHHHHHCCCCCCCCHHHHHH--HHHH
Q ss_conf -------------------------------665145899999-989899999999962119999988999999--9999
Q 001449 1022 -------------------------------GIVNNTLRPQIP-SWCDPEWRSLMESCWASDPAERPSFSEISR--RLRS 1067 (1075)
Q Consensus 1022 -------------------------------~Iv~~~l~~~ip-~~lS~eLkdLIkkCLq~DP~kRPSa~EILq--~Les 1067 (1075)
.+.. ...+.++ ..++.++.+||.+||..||.+|||+.|+++ +|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHT-SCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 57742123332211112223541347788766502-68766764448999999999986899467908999960986476
Q ss_pred H
Q ss_conf 9
Q 001449 1068 M 1068 (1075)
Q Consensus 1068 i 1068 (1075)
.
T Consensus 304 ~ 304 (322)
T d1s9ja_ 304 S 304 (322)
T ss_dssp H
T ss_pred C
T ss_conf 9
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.32 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=218.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 14889049999732593899999986--9325999820433489934689999999999999981899954356011124
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 797 i~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e 874 (1075)
...++|++++.||+|+||+||+|+++ ++.||||++...... .+.....+.+|+.++++++||||+++++++.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8998778988985087909999999899979999998657755-----77789999999999987688886179999998
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 99995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
++.+++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 80 --~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DF 152 (288)
T d1uu3a_ 80 --DEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDF 152 (288)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCC----CCCEEEECCC
T ss_conf --998899997048987777653159-999999999999999999762165088476774123668----8853886032
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 88512345---432478778887447200158878999235699999999999919999988785789976651458999
Q 001449 955 GLSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 955 GLAk~~~~---~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ 1031 (1075)
|+|+.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+...++..+.+... .
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~ 228 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--D 228 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--C
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCC--CCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--C
T ss_conf 1024225677643335556775525844002689--89666230456999998038899899599999999971899--9
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 999898999999999621199999889999999
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1032 ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
++..+++++++||.+||+.||.+|||+.|+++.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 985479999999999855797689197897377
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.35 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=208.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|+++ ++.||+|++...... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-- 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE-- 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-------HHHHHHHHHHHHHHHCCCCCEEEEEEEECC--
T ss_conf 74608998972174809999999999979999998456641-------279999999999985799888469654046--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
.+.+++||||+++|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~ 149 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 149 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC----CCCCEEECCCHH
T ss_conf 743679886458980899975379-999999999999999999999975983575468997887----899879832314
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHCCCCCCC
Q ss_conf 512345---432478778887447200158878999235699999999999919999988785789-9766514589999
Q 001449 957 SKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASI-IGGIVNNTLRPQI 1032 (1075)
Q Consensus 957 Ak~~~~---~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~ei-l~~Iv~~~l~~~i 1032 (1075)
|+.... .......+||+.|+|||++.+... ++.++|||||||++|+|++|+.||........ .............
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCCC-CCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 224046886531113255747428728618999-9971016173799999982997888898599999998638887886
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 9989899999999962119999988999999
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1033 p~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
...++.++.+||.+||+.||.+|||+.++++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 4469999999999976799668909999961
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.06 Aligned_cols=261 Identities=34% Similarity=0.605 Sum_probs=220.0
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECC------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 31148890499997325938999999869------325999820433489934689999999999999981899954356
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~kG------t~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkL 868 (1075)
.++..++|++.+.||+|+||.||+|++++ ..||||+++... .+.....|.+|+.++++++|||||++
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 85788996861598117790999999968998787999999988445-------96899999999999985689878323
Q ss_pred ECCCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCE
Q ss_conf 01112499995289996502884789873104667899999999999999999984991503578886575268999991
Q 001449 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (1075)
Q Consensus 869 lgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~ 948 (1075)
++++.+ ...+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 75 ~g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~ 148 (283)
T d1mqba_ 75 EGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLV 148 (283)
T ss_dssp EEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCC
T ss_pred EEEEEC--CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC----CCCE
T ss_conf 677833--8803899972135740222102345420899999999999854121212342576564427888----9984
Q ss_pred EEEEECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHH
Q ss_conf 999425885123454----32478778887447200158878999235699999999999919-9999887857899766
Q 001449 949 CKIGDLGLSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCASIIGGI 1023 (1075)
Q Consensus 949 VKLiDFGLAk~~~~~----~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTG-k~PF~~~~~~eil~~I 1023 (1075)
+||+|||+++..... .......||+.|+|||++.+.. ++.++||||||+++|||+++ .+||......+++. .
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~-~ 225 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-A 225 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-H
T ss_pred EEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH-H
T ss_conf 99845510300357876526742677773434888870499--99735563448989999967988655689999999-9
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 514589999998989999999996211999998899999999999997
Q 001449 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1024 v~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
+....++..+..++.++.+||.+||+.||++||++.++++.|+.+...
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 863578998504579999999997767976893999999999998669
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=360.83 Aligned_cols=248 Identities=27% Similarity=0.481 Sum_probs=217.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 4889049999732593899999986--93259998204334899346899999999999999818999543560111249
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~ 875 (1075)
..++|++++.||+|+||+||+|+++ |+.||+|++++.... .....+.+.+|+.+++.++|||||++++++.+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 75 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD- 75 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE-
T ss_conf 654708888972076808999999899979999998457754-----88999999999999986369675330356852-
Q ss_pred CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 99952899965028847898731046678999999999999999999849915035788865752689999919994258
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFG 955 (1075)
...+++||||+.|++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 76 -~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG 149 (316)
T d1fota_ 76 -AQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFG 149 (316)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCS
T ss_pred -CCEEEEEEEECCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEEC----CCCCEEEECCC
T ss_conf -880056765037863223432222-111007999999998765541247677055681050386----89988983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 85123454324787788874472001588789992356999999999999199999887857899766514589999998
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip~~ 1035 (1075)
+|+...... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+..... .++..
T Consensus 150 ~a~~~~~~~--~~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (316)
T d1fota_ 150 FAKYVPDVT--YTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPF 223 (316)
T ss_dssp SCEECSSCB--CCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTT
T ss_pred CCEEECCCC--CCCCCCCCCCCHHHHCCCC--CCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCC
T ss_conf 216712456--4345763435999983899--98043046533368999759899999699999999970898--89977
Q ss_pred CCHHHHHHHHHHHHCCCCCCC-----CHHHHHH
Q ss_conf 989999999996211999998-----8999999
Q 001449 1036 CDPEWRSLMESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1036 lS~eLkdLIkkCLq~DP~kRP-----Sa~EILq 1063 (1075)
++.++.++|.+||..||.+|+ ++.++++
T Consensus 224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 899999999999544997666431021999981
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.52 Aligned_cols=252 Identities=33% Similarity=0.589 Sum_probs=221.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 4889049999732593899999986-932599982043348993468999999999999998189995435601112499
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k-Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
+.++|++.+.||+|+||+||+|+++ +..||||+++..... .+.|.+|+.++++++||||+++++++.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-- 70 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTK-- 70 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEEEE--
T ss_conf 96997996898207883999999889989999998747577---------8999999999996689860158899850--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
.+.+++||||+++|+|.+++......+++..++.|+.||++||.|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred CCCEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEC----CCCCEEECCCHH
T ss_conf 7816999970489938886410246776899999999999999987546843466541358876----998479886144
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 51234543--247877888744720015887899923569999999999991-999998878578997665145899999
Q 001449 957 SKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 957 Ak~~~~~~--~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~~~l~~~ip 1033 (1075)
++...... ......+|+.|+|||++.+.. ++.++||||||+++|||++ |+.||......++...+.. ..+...+
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred HEECCCCCCEEECCCCCCCCCCCCHHHCCCC--CCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCCC
T ss_conf 2023578722524657887757807863799--885210336432467397559999889999999999980-7978996
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 9898999999999621199999889999999999
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISRRLRS 1067 (1075)
Q Consensus 1034 ~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Les 1067 (1075)
..++.++.+||.+||+.||.+|||+.++++.|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 5465999999999766897689399999987418
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=360.95 Aligned_cols=248 Identities=23% Similarity=0.415 Sum_probs=216.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 4889049999732593899999986--93259998204334899346899999999999999818999543560111249
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~ 875 (1075)
..++|++++.||+|+||.||+|+++ |+.||||++.+.... .......+.+|+.+|+.++|||||++++++.+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~- 112 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD- 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred CCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC-
T ss_conf 723708988961176808999999899989999998267745-----88999999999999997487727403444432-
Q ss_pred CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 99952899965028847898731046678999999999999999999849915035788865752689999919994258
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFG 955 (1075)
...+++||||+.+|+|.+++.+.+ .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 113 -~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG 186 (350)
T d1rdqe_ 113 -NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFG 186 (350)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCT
T ss_pred -CCCCCCCCCCCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCC----CCCCEEEEECE
T ss_conf -222232222334662266675158-989999999999999989999859986176799993607----78978861010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 85123454324787788874472001588789992356999999999999199999887857899766514589999998
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip~~ 1035 (1075)
+|+..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+..... .++..
T Consensus 187 ~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~ 260 (350)
T d1rdqe_ 187 FAKRVKGR--TWTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSH 260 (350)
T ss_dssp TCEECSSC--BCCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTT
T ss_pred EEEECCCC--CCCCCCCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC--CCCCC
T ss_conf 33322566--64336763567889971799--88533114500789999758899899599999999861798--89766
Q ss_pred CCHHHHHHHHHHHHCCCCCCC-----CHHHHHH
Q ss_conf 989999999996211999998-----8999999
Q 001449 1036 CDPEWRSLMESCWASDPAERP-----SFSEISR 1063 (1075)
Q Consensus 1036 lS~eLkdLIkkCLq~DP~kRP-----Sa~EILq 1063 (1075)
+++++.+||++||..||.+|+ ++.++++
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 899999999998340998606553454999971
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=359.76 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=207.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 4889049999732593899999986--93259998204334899346899999999999999818999543560111249
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~ 875 (1075)
..++|++++.||+|+||.||+|++. |..||+|++.+...... ...........++.+++.++|||||++++++.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~--~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~- 78 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 78 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHH--HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE-
T ss_conf 77768510188428890999999999997999999845875426--679999999999999850899858899999998-
Q ss_pred CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 99952899965028847898731046678999999999999999999849915035788865752689999919994258
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFG 955 (1075)
.+.+++||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFG 152 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLG 152 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCT
T ss_pred -CCEEEEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEEC----CCCCEEEEEEC
T ss_conf -998899999148983899987325-532789999999999999999977962204442216785----88967982201
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HHCCCCCCCCC
Q ss_conf 85123454324787788874472001588789992356999999999999199999887857899766-51458999999
Q 001449 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGI-VNNTLRPQIPS 1034 (1075)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~I-v~~~l~~~ip~ 1034 (1075)
+|+...... .....||+.|+|||++.... .++.++|||||||++|+|++|+.||............ ........++.
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHSTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred EEEECCCCC-CCCCCCCCCCCHHHHHHCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 023337886-43311345542168760389-9984410467789999998599988889989999999860468887887
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 89899999999962119999988-----999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPS-----FSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPS-----a~EILq 1063 (1075)
.+++++++||.+||..||.+||+ +.++++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 7899999999998566988808874357999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.40 Aligned_cols=261 Identities=31% Similarity=0.600 Sum_probs=223.5
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 3114889049999732593899999986-----93259998204334899346899999999999999818999543560
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~k-----Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLl 869 (1075)
+++..++|++.+.||+|+||.||+|++. +..||+|.++... .......|.+|+.+|++++||||++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 9768899698779930788299999993699644999999936566-------879999999999999868999985698
Q ss_pred CCCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEE
Q ss_conf 11124999952899965028847898731046678999999999999999999849915035788865752689999919
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 870 gv~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~V 949 (1075)
+++.+ +.+++||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++ ..+.+
T Consensus 75 ~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~ 147 (273)
T d1mp8a_ 75 GVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCV 147 (273)
T ss_dssp EEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEEC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEEC----CCCCE
T ss_conf 89953---747999984069807765422478999999999999998775230226744141026553206----78967
Q ss_pred EEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHC
Q ss_conf 99425885123454--3247877888744720015887899923569999999999991-99999887857899766514
Q 001449 950 KIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 950 KLiDFGLAk~~~~~--~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~~ 1026 (1075)
||+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|||++ |.+||......++...+...
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCC--CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
T ss_conf 87650342133677623305400583103266751699--8874524442478999982699998889999999999818
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 5899999989899999999962119999988999999999999970
Q 001449 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1027 ~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
....++..++.++.+||.+||..||.+|||+.+|++.|+.+..+.
T Consensus 226 -~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 226 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf -999898777999999999976879768929999999999997786
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.74 Aligned_cols=261 Identities=30% Similarity=0.571 Sum_probs=220.0
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CC----CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 33114889049999732593899999986--93----2599982043348993468999999999999998189995435
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1075)
Q Consensus 794 ~~ei~~~dYeilk~LGeGsfGtVYkak~k--Gt----~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVk 867 (1075)
++.++.++|++++.||+|+||+||+|++. ++ .||+|.++... .....+.|.+|+.++++++|||||+
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~ 75 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 75 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 243888999783198208992999999958998898999999965134-------9799999999999998679988815
Q ss_pred EECCCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 60111249999528999650288478987310466789999999999999999998499150357888657526899999
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (1075)
Q Consensus 868 Llgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g 947 (1075)
+++++.+ +..+++++++.+++|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++ .++
T Consensus 76 l~g~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~ 148 (317)
T d1xkka_ 76 LLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQ 148 (317)
T ss_dssp EEEEEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETT
T ss_pred EEEEEEC---CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEEC----CCC
T ss_conf 8999961---983699984268740101113345799999999999999999999876950476212031167----998
Q ss_pred EEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHH
Q ss_conf 19994258851234543---247877888744720015887899923569999999999991-99999887857899766
Q 001449 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGI 1023 (1075)
Q Consensus 948 ~VKLiDFGLAk~~~~~~---~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~I 1023 (1075)
.+||+|||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+....++...+
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred CEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 75860255222335444532236510586446708874699--9835654407999999997799999999989999999
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 514589999998989999999996211999998899999999999997
Q 001449 1024 VNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1024 v~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
....++..+..++.++.+||.+||..||.+|||+.++++.|..+...
T Consensus 227 -~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 227 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -75998999855689999999984789934691999999999998758
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.68 Aligned_cols=253 Identities=31% Similarity=0.536 Sum_probs=212.9
Q ss_pred EEEE-EEECCCCCEEEEEEEEC----CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 0499-99732593899999986----932599982043348993468999999999999998189995435601112499
Q 001449 802 LEEV-RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 802 Yeil-k~LGeGsfGtVYkak~k----Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
+.+. ++||+|+||.||+|.++ ++.||||+++.... .....+.|.+|+.+|++++|||||++++++..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-- 79 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 79 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred CEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC--
T ss_conf 7001878345878299999981697385999999880108------98999999999999986799898527777505--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
..+++||||+++|+|.+++.+.. .+++..++.|+.||+.||.|||+++|+||||||+|||++ ..+.+||+|||+
T Consensus 80 -~~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFGl 153 (277)
T d1xbba_ 80 -ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGL 153 (277)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCTT
T ss_pred -CCEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCC----CCCCCCCCCHHH
T ss_conf -97799997478896899975225-789999999999999997668747955677761131023----567512341345
Q ss_pred CCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 5123454----3247877888744720015887899923569999999999991-9999988785789976651458999
Q 001449 957 SKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQ 1031 (1075)
Q Consensus 957 Ak~~~~~----~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~~~l~~~ 1031 (1075)
++..... .......||+.|+|||++.+.. ++.++||||||+++|||++ |+.||.+....++...+.+ ..++.
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~ 230 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMG 230 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCC--CCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCC
T ss_conf 331343234432244567784203916653799--984344303403132896589999999899999999982-89999
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9998989999999996211999998899999999999997
Q 001449 1032 IPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1032 ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
++..++.++.+||.+||+.||.+|||+.++++.|+..+.+
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 9865679999999997588976890989999985288750
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.29 Aligned_cols=251 Identities=29% Similarity=0.506 Sum_probs=207.6
Q ss_pred CCCE-EEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 8890-49999732593899999986--93259998204334899346899999999999999818999543560111249
Q 001449 799 NDDL-EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 799 ~~dY-eilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~ 875 (1075)
..+| ++.++||+|+||+||+|+++ +..||+|++...... ....+.+.+|+.+|++++|||||++++++.+.
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 887788516970082849999999999959999998512279------89999999999999857999850699998403
Q ss_pred --CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCCCCEEEE
Q ss_conf --999528999650288478987310466789999999999999999998499--1503578886575268999991999
Q 001449 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 876 --~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~G--IVHRDIKPeNILId~~~~~~g~VKL 951 (1075)
....+++||||+++|+|.+++.+.. .+++..++.++.||++||.|||+++ |+||||||+|||++. .++.+||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~~~~~Kl 156 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKI 156 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEE
T ss_pred CCCCCEEEEEEECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEEC---CCCCEEE
T ss_conf 345888999995789894899975135-546999999999999999999978997996876743511667---9998898
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHHCCCCC
Q ss_conf 4258851234543247877888744720015887899923569999999999991999998878578-997665145899
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS-IIGGIVNNTLRP 1030 (1075)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~e-il~~Iv~~~l~~ 1030 (1075)
+|||+|+...... .....||+.|+|||++.+. ++.++|||||||++|||++|+.||.+..... +...+.......
T Consensus 157 ~DFGla~~~~~~~-~~~~~GT~~Y~aPE~~~~~---~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 157 GDLGLATLKRASF-AKAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232 (270)
T ss_dssp CCTTGGGGCCTTS-BEESCSSCCCCCGGGGGTC---CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EECCCCEECCCCC-CCCCCCCCCCCCHHHHCCC---CCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 0057654236876-6775538130089884789---99867110079999999878899987655999999997389986
Q ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 999989899999999962119999988999999
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1031 ~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++..+++++++||.+||..||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 567557899999999976379758929999967
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=355.27 Aligned_cols=259 Identities=23% Similarity=0.292 Sum_probs=224.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCH-HHHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCC
Q ss_conf 88904999973259389999998--69325999820433489934-68999999999999998189-9954356011124
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS-ERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~--kGt~VAIKvIk~~~~~~~~~-e~e~~i~~flrEi~ILkkL~-HPNIVkLlgv~~e 874 (1075)
.++|++++.||+|+||+||+|++ +++.||||++.+........ ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 99995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
.+.+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DF 154 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 154 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred --CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEEECCC
T ss_conf --760599997689866899998659-999999999999999999999875994323462548986----8998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 88512345432478778887447200158----87899923569999999999991999998878578997665145899
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSG----KSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YlAPEvL~g----~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~ 1030 (1075)
|+++............||+.|+|||++.+ ....++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred HHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 03167268872134524678889888605344567889923318565602310322888988999999999998189888
Q ss_pred CCC--CCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 999--9898999999999621199999889999999
Q 001449 1031 QIP--SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1031 ~ip--~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
..+ ..+|+++++||.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 985434689999999999765896689199999739
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.62 Aligned_cols=257 Identities=33% Similarity=0.623 Sum_probs=225.0
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCC
Q ss_conf 31148890499997325938999999869325999820433489934689999999999999981899954356011124
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e 874 (1075)
|+++.++|++.+.||+|+||.||+|+++++.||||+++.... .+.|.+|+.++++++||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT----------AQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHHH----------HHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 955789948857982079808999999990999999885777----------9999999999986789898549878872
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf 99995289996502884789873104-66789999999999999999998499150357888657526899999199942
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~-k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiD 953 (1075)
. .+.+++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 72 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~d 146 (262)
T d1byga_ 72 E-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECC
T ss_pred C-CCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEEC----CCCCEEECC
T ss_conf 3-89289999636999899998745788889999999999998523211337655366656760146----899776324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 58851234543247877888744720015887899923569999999999991-99999887857899766514589999
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVNNTLRPQI 1032 (1075)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~~~l~~~i 1032 (1075)
||+++...... ....++..|+|||++.+.. ++.++||||||+++|||++ |++||.......+...+.+ ..++.+
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~~~--~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCC
T ss_pred CCCCEECCCCC--CCCCCCCCCCCHHHHHCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCCC
T ss_conf 56003447877--6556664677817872798--885887775799999999789999999999999999980-899999
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 998989999999996211999998899999999999997
Q 001449 1033 PSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1033 p~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
+..+++++++||.+||..||.+|||+.++++.|+.+.+.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 765799999999997566976893999999999999867
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.76 Aligned_cols=250 Identities=19% Similarity=0.239 Sum_probs=217.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|.++ +..||+|+++... .. ...+.+|+.+|+.++|||||++++++.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~-- 72 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD---QVLVKKEISILNIARHRNILHLHESFES-- 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC------CC---HHHHHHHHHHHHHCCCCCCCEEEEEEEE--
T ss_conf 010588789831778399999998999699999975786------65---9999999999985799798909899988--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
.+.+++|||||.|++|.+++.+.+..+++..++.|+.||+.||.|||++||+||||||+|||++.+ ....+||+|||+
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~ 150 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEEEECCCCH
T ss_conf 998899995389980889987538999999999999999999999987699751355444344378--851899764411
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC--CC
Q ss_conf 5123454324787788874472001588789992356999999999999199999887857899766514589999--99
Q 001449 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQI--PS 1034 (1075)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~i--p~ 1034 (1075)
++............+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+.+..+.+....... ..
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHCCCCC--CCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCC
T ss_conf 10034677532122332223402104877--7840113027999999982899999989999999998389998802236
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89899999999962119999988999999
Q 001449 1035 WCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1035 ~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.++.++++||.+||..||.+|||+.++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 78999999999986699668909999963
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.65 Aligned_cols=263 Identities=29% Similarity=0.518 Sum_probs=218.9
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEE
Q ss_conf 3114889049999732593899999986-------93259998204334899346899999999999999818-999543
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~k-------Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL-~HPNIV 866 (1075)
|++..++|++.+.||+|+||.||+|++. ++.||+|+++.... ....+.+.+|..++.++ +|+||+
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~e~~~l~~~~~h~~iv 80 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVV 80 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCC-------CHHHHHHHHHHHHHHHHCCCCEEE
T ss_conf 2616799798449841678399999986777555783999999860017-------178999999999988614998499
Q ss_pred EEECCCCCCCCCCEEEEEEEECCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 5601112499995289996502884789873104---------------6678999999999999999999849915035
Q 001449 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (1075)
Q Consensus 867 kLlgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~---------------k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRD 931 (1075)
.+++++... ...+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++|+|||
T Consensus 81 ~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD 159 (299)
T d1ywna1 81 NLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 159 (299)
T ss_dssp CEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEECCC-CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 741154047-9757999984589929999985366666532220233214689999999999999999988737971786
Q ss_pred CCCCCEEECCCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-
Q ss_conf 78886575268999991999425885123454---32478778887447200158878999235699999999999919-
Q 001449 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG- 1007 (1075)
Q Consensus 932 IKPeNILId~~~~~~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTG- 1007 (1075)
|||+|||++ .++.+||+|||+|+..... .......||+.|+|||++.+.. ++.++|||||||++|||+++
T Consensus 160 lKp~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 160 LAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCGGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCCEEEC----CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCC--CCCCCCEEEHHHHHHHHHHCC
T ss_conf 773106577----99828984575200113566522247516672102036864688--996632213678999998688
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999887857899766514589999998989999999996211999998899999999999997
Q 001449 1008 DEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1008 k~PF~~~~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
..||.+......+...+....++.++..+++++++||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9999899989999999963898888865789999999997677966791999999999799867
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.85 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=205.5
Q ss_pred CCCEEEEE-EECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHH-HCCCCCEEEEECCCCC
Q ss_conf 88904999-9732593899999986--932599982043348993468999999999999998-1899954356011124
Q 001449 799 NDDLEEVR-ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS-SLHHPNVVSFYGIVRD 874 (1075)
Q Consensus 799 ~~dYeilk-~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILk-kL~HPNIVkLlgv~~e 874 (1075)
.++|+++. .||+|+||+||+|++. ++.||||+++.. ..+.+|+.++. .++|||||++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------------HHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 148798107965454869999998899989999998974-------------7799999999986699997829899950
Q ss_pred --CCCCCEEEEEEEECCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEE
Q ss_conf --99995289996502884789873104-667899999999999999999984991503578886575268999991999
Q 001449 875 --GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (1075)
Q Consensus 875 --~~e~~L~LVmEYleGGSL~dlLkk~~-k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKL 951 (1075)
..+..+++|||||+||+|.++|.+.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++..+ ..+.+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf 346897899999778998499999862787757999999999999999999976986444100220113555-5663113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC--
Q ss_conf 425885123454324787788874472001588789992356999999999999199999887857899766514589--
Q 001449 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR-- 1029 (1075)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~-- 1029 (1075)
+|||+|+............||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.........+......
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCC--CCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCC
T ss_conf 5455123336888643226775637927774898--88888887645167788658899889887788999999985388
Q ss_pred CCCC----CCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 9999----989899999999962119999988999999
Q 001449 1030 PQIP----SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 ~~ip----~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
..++ ..++.++.+||.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 88898543469999999999975699657909999970
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=353.81 Aligned_cols=259 Identities=32% Similarity=0.573 Sum_probs=220.9
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECC-------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 31148890499997325938999999869-------32599982043348993468999999999999998189995435
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~kG-------t~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVk 867 (1075)
.++..++|++++.||+|+||+||+|++++ +.||||+++... .......|.+|+.+|+.++||||++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 138988938867982078839999998887657788299999988210-------8579999999999999668997655
Q ss_pred EECCCCCCCCCCEEEEEEEECCCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 601112499995289996502884789873104-----------------------667899999999999999999984
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLHG 924 (1075)
Q Consensus 868 Llgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~-----------------------k~Lse~~il~Ia~QIlsAL~yLHs 924 (1075)
+++++.. ...++++|||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+
T Consensus 81 ~~~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 81 LLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEECC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 2466605--98038999815899299999852755421000011100121034678898999999999999998554135
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 991503578886575268999991999425885123454---32478778887447200158878999235699999999
Q 001449 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVM 1001 (1075)
Q Consensus 925 ~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVIL 1001 (1075)
++|+||||||+|||++ .++.+||+|||+|+..... .......+++.|+|||++.+.. ++.++|||||||++
T Consensus 159 ~~ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 159 RKFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVL 232 (301)
T ss_dssp TTCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHH
T ss_pred CCEEEEEECCCCEEEC----CCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCHHHHHCCCHHHH
T ss_conf 7868548840116898----99928983314421136776411157777676767989972688--98056302523629
Q ss_pred HHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf 999919-99998878578997665145899999989899999999962119999988999999999999
Q 001449 1002 WELLTG-DEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1002 yELLTG-k~PF~~~~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~ 1069 (1075)
|||+++ .+||.+.+..++...+.... .+.++..++.++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHCCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 999806899999989999999997399-78887325299999999974889657939999999999842
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.33 Aligned_cols=259 Identities=31% Similarity=0.567 Sum_probs=225.2
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC-----CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 1148890499997325938999999869-----32599982043348993468999999999999998189995435601
Q 001449 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 796 ei~~~dYeilk~LGeGsfGtVYkak~kG-----t~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlg 870 (1075)
.++.++|++++.||+|+||.||+|+++. ..||||+++...... +...+.|.+|+.+|++++||||+++++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCC-----HHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 886489199789803888399999998899907999999998355579-----899999999999998689999878987
Q ss_pred CCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEE
Q ss_conf 11249999528999650288478987310466789999999999999999998499150357888657526899999199
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 v~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VK 950 (1075)
++.+ ..+++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 79 ~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vk 151 (273)
T d1u46a_ 79 VVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 151 (273)
T ss_dssp EECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEEE---CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCC----CCCCEE
T ss_conf 7740---100114654238612544421268999999999999999999875217875205668881565----565433
Q ss_pred EEECCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHH
Q ss_conf 9425885123454----3247877888744720015887899923569999999999991-9999988785789976651
Q 001449 951 IGDLGLSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT-GDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 951 LiDFGLAk~~~~~----~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT-Gk~PF~~~~~~eil~~Iv~ 1025 (1075)
|+|||+++..... .......++..|+|||++.+.. ++.++||||||+++|||++ |..||.+.+..+....+.+
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 256115553035887526547632573107999983799--994215661489999999689999999699999999984
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 4589999998989999999996211999998899999999999
Q 001449 1026 NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSM 1068 (1075)
Q Consensus 1026 ~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi 1068 (1075)
...++..+..++.++.+||.+||..||++|||+.+|++.|++.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 7999998544539999999997688966792999999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.87 Aligned_cols=262 Identities=31% Similarity=0.560 Sum_probs=219.1
Q ss_pred HCCCCCCCCCEEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 3033114889049999732593899999986-932599982043348993468999999999999998189995435601
Q 001449 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 792 ~~~~ei~~~dYeilk~LGeGsfGtVYkak~k-Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlg 870 (1075)
.+-|++..++|++.+.||+|+||.||+|+++ +..||||+++..... .+.|.+|+.++++++|+|||++++
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g 79 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYA 79 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCEECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 75607477997984699307980999999999999999998804488---------899999999998666678868999
Q ss_pred CCCCCCCCCEEEEEEEECCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEE
Q ss_conf 11249999528999650288478987310-46678999999999999999999849915035788865752689999919
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 871 v~~e~~e~~L~LVmEYleGGSL~dlLkk~-~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~V 949 (1075)
++.+ +.+++||||+++|+|..++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 80 ~~~~---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~ 152 (285)
T d1fmka3 80 VVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVC 152 (285)
T ss_dssp EECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCE
T ss_pred EEEC---CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEEC----CCCCE
T ss_conf 9823---9759999944799435420000355305999999999999999987541143353123079998----99929
Q ss_pred EEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHC
Q ss_conf 99425885123454--32478778887447200158878999235699999999999919-9999887857899766514
Q 001449 950 KIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADMHCASIIGGIVNN 1026 (1075)
Q Consensus 950 KLiDFGLAk~~~~~--~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTG-k~PF~~~~~~eil~~Iv~~ 1026 (1075)
||+|||+++..... .......||+.|+|||++.... ++.++||||||+++|||++| .++|......+.+..+.+
T Consensus 153 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~- 229 (285)
T d1fmka3 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER- 229 (285)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-
T ss_pred EECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCC--CCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-
T ss_conf 98442555425688733524545566545808983799--891774132358999998689999988889999999982-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 5899999989899999999962119999988999999999999970
Q 001449 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1027 ~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
..+..++..++.++.+||.+||+.||++||++.+|++.|+..+...
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 6899998323799999999975669758919999999876662389
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=351.03 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=221.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC
Q ss_conf 4889049999732593899999986--93259998204334899346899999999999999818999543560111249
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~ 875 (1075)
..++|++.+.||+|+||.||+|++. ++.||+|+++..... .......+.+|+.+++.++||||+++++++...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC
T ss_conf 062069868996089929999999999989999998556646-----989999999999999856999887311435432
Q ss_pred CC--CCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf 99--9528999650288478987310466789999999999999999998499150357888657526899999199942
Q 001449 876 PD--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 876 ~e--~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiD 953 (1075)
.. ..+++||||++|++|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.++|+|
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d 154 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMD 154 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECC
T ss_pred CCCCCEEEEEEECCCCCEEHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCCEEEH
T ss_conf 688766999997788987101120358-999999999999999999999857952763467556657----543201003
Q ss_pred CCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 5885123454----324787788874472001588789992356999999999999199999887857899766514589
Q 001449 954 LGLSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR 1029 (1075)
Q Consensus 954 FGLAk~~~~~----~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~ 1029 (1075)
||.++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 232 (277)
T ss_dssp CTTCEECC----------------TTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 444322123544333346425762436999983999--996632026528999997697998996999999999846999
Q ss_pred C--CCCCCCCHHHHHHHHHHHHCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 9--99998989999999996211999998-89999999999999
Q 001449 1030 P--QIPSWCDPEWRSLMESCWASDPAERP-SFSEISRRLRSMAA 1070 (1075)
Q Consensus 1030 ~--~ip~~lS~eLkdLIkkCLq~DP~kRP-Sa~EILq~Lesi~s 1070 (1075)
+ .....+|.++.+||.+||..||.+|| |++++++.|..+.+
T Consensus 233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 97100347899999999998667976777399999999999758
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.83 Aligned_cols=248 Identities=25% Similarity=0.462 Sum_probs=212.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHH-HHCCCCCEEEEECCCCCCC
Q ss_conf 8904999973259389999998--693259998204334899346899999999999999-8189995435601112499
Q 001449 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~--kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~IL-kkL~HPNIVkLlgv~~e~~ 876 (1075)
++|++++.||+|+||+||+|++ +++.||+|++++..... ......+..|..++ +.++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-----~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-- 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-- 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCC-----HHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--
T ss_conf 97188658940878289999999999899999980555338-----48999999999999984799968789889704--
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
.+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||+
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG~ 149 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGM 149 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred CCCEEEEEEECCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC----CCCCEECCCCCH
T ss_conf 983167775037980899864047-899999999999999999999868934034765404444----899630155530
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 512345-4324787788874472001588789992356999999999999199999887857899766514589999998
Q 001449 957 SKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIPSW 1035 (1075)
Q Consensus 957 Ak~~~~-~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip~~ 1035 (1075)
++.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+...+...+.... +.++..
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRW 225 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCC
T ss_conf 232356653345457877768999982799--8832320112278989873889999989999999997189--989756
Q ss_pred CCHHHHHHHHHHHHCCCCCCCCHH-HHHH
Q ss_conf 989999999996211999998899-9999
Q 001449 1036 CDPEWRSLMESCWASDPAERPSFS-EISR 1063 (1075)
Q Consensus 1036 lS~eLkdLIkkCLq~DP~kRPSa~-EILq 1063 (1075)
++.++++||.+||..||.+||++. ++++
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 79999999999654489878388999980
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.00 Aligned_cols=261 Identities=30% Similarity=0.573 Sum_probs=222.8
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECC---------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 31148890499997325938999999869---------3259998204334899346899999999999999818-9995
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~kG---------t~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL-~HPN 864 (1075)
|.+..++|++.+.||+|+||.||+|+..+ ..||+|+++... .......+.+|...+.++ +|||
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCCCE
T ss_conf 72258996970098516782899999857875556675499999988112-------86889999999999998139996
Q ss_pred EEEEECCCCCCCCCCEEEEEEEECCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 435601112499995289996502884789873104---------------66789999999999999999998499150
Q 001449 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (1075)
Q Consensus 865 IVkLlgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~---------------k~Lse~~il~Ia~QIlsAL~yLHs~GIVH 929 (1075)
||++++++.+ +..+++||||+++|+|.++|.... ..+++..++.++.||+.||.|||+++|+|
T Consensus 81 Iv~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 81 IINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp BCCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEECCCCCCC--CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 9734652201--88689999736999099999860677643222334574346799999999999999998766379786
Q ss_pred CCCCCCCEEECCCCCCCCEEEEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 35788865752689999919994258851234543---247877888744720015887899923569999999999991
Q 001449 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLT 1006 (1075)
Q Consensus 930 RDIKPeNILId~~~~~~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLT 1006 (1075)
|||||+|||++ .++.+||+|||+++...... ......+++.|+|||++.+.. |+.++||||||+++|||++
T Consensus 159 rDiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 159 RDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp SCCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCEEEC----CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC--CCCHHHHHHHHHHHHHHCC
T ss_conf 30221022454----78976762211101135555543146678884663266751798--8825554775888887401
Q ss_pred -CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf -99999887857899766514589999998989999999996211999998899999999999997
Q 001449 1007 -GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAA 1071 (1075)
Q Consensus 1007 -Gk~PF~~~~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~se 1071 (1075)
|.+||.+.+...+...+ ....++..+..++.++.+||.+||+.||.+|||+.++++.|+.+.+-
T Consensus 233 ~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp TSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 798989999999999999-72888898743529999999997667976793999999999888604
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.00 Aligned_cols=262 Identities=34% Similarity=0.571 Sum_probs=223.7
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEEC--CC--CEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 3114889049999732593899999986--93--259998204334899346899999999999999818-999543560
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFY 869 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~k--Gt--~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL-~HPNIVkLl 869 (1075)
..++.++|++.+.||+|+||.||+|+++ +. .||||.++.... ....+.|.+|+.+|+.+ +|||||+++
T Consensus 5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~~~ 77 (309)
T d1fvra_ 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLL 77 (309)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 9668799688779820788289999998999699999999782338-------579999999999998622899883678
Q ss_pred CCCCCCCCCCEEEEEEEECCCCHHHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 111249999528999650288478987310---------------46678999999999999999999849915035788
Q 001449 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKC 934 (1075)
Q Consensus 870 gv~~e~~e~~L~LVmEYleGGSL~dlLkk~---------------~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKP 934 (1075)
+++.+ .+.+++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+++|+||||||
T Consensus 78 ~~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp 155 (309)
T d1fvra_ 78 GACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 155 (309)
T ss_dssp EEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEC--CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 88841--8736999980289869999864035555512310123457899999999999999998766308954555052
Q ss_pred CCEEECCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCC
Q ss_conf 8657526899999199942588512345432478778887447200158878999235699999999999919-999988
Q 001449 935 ENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYAD 1013 (1075)
Q Consensus 935 eNILId~~~~~~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTG-k~PF~~ 1013 (1075)
+|||++ ..+.+||+|||+++............||..|+|||.+.+.. ++.++||||||+++|||++| .+||.+
T Consensus 156 ~NIL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 156 RNILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp GGEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CEEEEC----CCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCC--CCCCCEEEHHHHHHHHHHHCCCCCCCC
T ss_conf 048986----88763874344322444223455301377555538752699--996221531388999998368999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 78578997665145899999989899999999962119999988999999999999970
Q 001449 1014 MHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1014 ~~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
.+..++...+.. ..++.++..+++++.+||.+||+.||++|||+.++++.|+++..+.
T Consensus 230 ~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 230 MTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 999999999982-6888887667899999999976789668949999999999998618
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.64 Aligned_cols=264 Identities=30% Similarity=0.510 Sum_probs=226.3
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCE
Q ss_conf 33114889049999732593899999986-------93259998204334899346899999999999999818-99954
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (1075)
Q Consensus 794 ~~ei~~~dYeilk~LGeGsfGtVYkak~k-------Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL-~HPNI 865 (1075)
.|++..++|++.+.||+|+||.||+|++. ++.||||+++... .......|.+|+.+++.+ +||||
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCE
T ss_conf 2637789969854982068829999998066447788699999987424-------877999999999998762699988
Q ss_pred EEEECCCCCCCCCCEEEEEEEECCCCHHHHHHHCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 35601112499995289996502884789873104-----------------6678999999999999999999849915
Q 001449 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------RTIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (1075)
Q Consensus 866 VkLlgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~-----------------k~Lse~~il~Ia~QIlsAL~yLHs~GIV 928 (1075)
|++++++.+ ...+++|||||++|+|.+++.+.. ..+++..++.|+.||+.||.|||+++++
T Consensus 90 v~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv 167 (311)
T d1t46a_ 90 VNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (311)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEEEEEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 789989831--997899997379987999998535665444445332223345889999999999999999988757926
Q ss_pred CCCCCCCCEEECCCCCCCCEEEEEECCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 0357888657526899999199942588512345---4324787788874472001588789992356999999999999
Q 001449 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELL 1005 (1075)
Q Consensus 929 HRDIKPeNILId~~~~~~g~VKLiDFGLAk~~~~---~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELL 1005 (1075)
||||||+|||++ ..+.+||+|||+++.... ........||+.|+|||++.+.. ++.++||||||+++|||+
T Consensus 168 HrDLKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 168 HRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELF 241 (311)
T ss_dssp CSCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCCC----CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCC--CCCCCCCCCHHHHHHHHH
T ss_conf 662410210000----25752102340102336788615862013596876778861799--997400102589999998
Q ss_pred C-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 1-999998878578997665145899999989899999999962119999988999999999999970
Q 001449 1006 T-GDEPYADMHCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1006 T-Gk~PF~~~~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
+ |.+||...+..+.+..++....++..+..++.++.+||.+||+.||.+|||+.++++.|++++.+.
T Consensus 242 t~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp TTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 58998877899899999998668988985436599999999975779657929999999998765349
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.61 Aligned_cols=256 Identities=28% Similarity=0.513 Sum_probs=211.6
Q ss_pred EEEEEEECCCCCEEEEEEEECC-----CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 0499997325938999999869-----32599982043348993468999999999999998189995435601112499
Q 001449 802 LEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 802 Yeilk~LGeGsfGtVYkak~kG-----t~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
+...++||+|+||+||+|++.. ..||||+++... .....+.|.+|+.+|++++||||+++++++...
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~- 100 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS- 100 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-
T ss_conf 526669813688099999997799879999999988436-------978999999999999867899986786789806-
Q ss_pred CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 99528999650288478987310466789999999999999999998499150357888657526899999199942588
Q 001449 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 877 e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
++.+++|||||++++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 101 ~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 101 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGL 176 (311)
T ss_dssp TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGG
T ss_pred CCCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEEC----CCCCEEEECCCC
T ss_conf 9943899987406741442101345404899999999988765200336762577668757677----999889910652
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHCCCCC
Q ss_conf 51234543-----24787788874472001588789992356999999999999199999887-8578997665145899
Q 001449 957 SKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADM-HCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 957 Ak~~~~~~-----~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~-~~~eil~~Iv~~~l~~ 1030 (1075)
++...... ......||+.|+|||.+.... ++.++||||||+++|||++|..||... ...+....+ ....++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~ 253 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRL 253 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCC
T ss_pred HHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HCCCCC
T ss_conf 3225566555310025655564556768874379--9974574661999999997899998889999999999-808988
Q ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 999989899999999962119999988999999999999970
Q 001449 1031 QIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAI 1072 (1075)
Q Consensus 1031 ~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seL 1072 (1075)
..+..++.++.+||.+||..||++||++.++++.|+.+.+..
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 996447599999999976889768939999999999999752
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.82 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=204.5
Q ss_pred EEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCCCCE
Q ss_conf 49999732593899999986--9325999820433489934689999999999999981899954356011124999952
Q 001449 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (1075)
Q Consensus 803 eilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e~~L 880 (1075)
+.++.||+|+||+||+|+++ ++.||||+++...... ..+.....+.+|+.+|+.++|||||++++++.+ ++.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCC
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCE
T ss_conf 95638512728299999999999699999984202124---567999999999999986799998689854225--8740
Q ss_pred EEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCCC
Q ss_conf 89996502884789873104667899999999999999999984991503578886575268999991999425885123
Q 001449 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 881 ~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~~ 960 (1075)
++||||+.++++..++. ....+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTT
T ss_pred EEHHHHHCCHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEEC----CCCCCCCCCCCCCCCC
T ss_conf 22045534507765541-266778999999999999999886316355035776258853----7784114657610005
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC---------
Q ss_conf 45-43247877888744720015887899923569999999999991999998878578997665145899---------
Q 001449 961 QQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP--------- 1030 (1075)
Q Consensus 961 ~~-~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~--------- 1030 (1075)
.. .......+||+.|+|||++.+.. .++.++|||||||++|||++|..||.+....+.+..+.+....+
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCCCCCCCCEECCHHHCCHHHHCCCC-CCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHH
T ss_conf 78755433020473336399972677-88805643630428999985969999999999999999851899725452100
Q ss_pred ------------C-----CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ------------9-----99989899999999962119999988999999
Q 001449 1031 ------------Q-----IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1031 ------------~-----ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
. +...++.++.+||.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 02134430347898867856568999999999976389456908999967
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.50 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=206.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 89049999732593899999986--9325999820433489934689999999999999981899954356011124999
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e 877 (1075)
++|++++.||+|+||+||+|++. ++.||+|+++..... +.....+.+|+.+|++++|||||++++++.+ .
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHT--E 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--C
T ss_conf 9977651772376809999999999979999998022257------5899999999999986799838874453322--4
Q ss_pred CCEEEEEEEECCCCHHHHH-HHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCC
Q ss_conf 9528999650288478987-310466789999999999999999998499150357888657526899999199942588
Q 001449 878 GSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (1075)
Q Consensus 878 ~~L~LVmEYleGGSL~dlL-kk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGL 956 (1075)
..+++||||+.+ ++.+++ ......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 74 NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGL 148 (298)
T ss_dssp TEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTH
T ss_pred CCEEEEEEECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEEC----CCCCCEECCCCC
T ss_conf 320378862377-445554420256888899999999999999986528899213571140113----467621035786
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC------
Q ss_conf 512345-4324787788874472001588789992356999999999999199999887857899766514589------
Q 001449 957 SKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR------ 1029 (1075)
Q Consensus 957 Ak~~~~-~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~------ 1029 (1075)
|+.... ........||+.|+|||++.... .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~-~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHHCCCSBCTTCCBCCCTTCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CEECCCCCCCCEEECCCCEEEEHHHHCCCC-CCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHC
T ss_conf 134368864100103652154112213665-7774221033331342796687998988999999999983289833314
Q ss_pred ----------CCC-----------CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf ----------999-----------99898999999999621199999889999999
Q 001449 1030 ----------PQI-----------PSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1030 ----------~~i-----------p~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
... ...++.++.+||.+||..||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44222421243454322220444166789999999999763995579189999678
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.45 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=206.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC---CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHH---HCCCCCEEEEECCC
Q ss_conf 889049999732593899999986---932599982043348993468999999999999998---18999543560111
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS---SLHHPNVVSFYGIV 872 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k---Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILk---kL~HPNIVkLlgv~ 872 (1075)
.++|++++.||+|+||+||+|++. ++.||||+++......... ..+.+|+.+|+ .++||||+++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHH------HHHHHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 5897988899215586999999988899899999980232451679------9999999999987425898802366322
Q ss_pred CC---CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEE
Q ss_conf 24---999952899965028847898731046678999999999999999999849915035788865752689999919
Q 001449 873 RD---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 873 ~e---~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~V 949 (1075)
.. .....++++|||+.++.+..........+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCE
T ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEC----CCCCE
T ss_conf 14666667469999974058714444430378999899999999999999999758898357986278985----89975
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-
Q ss_conf 9942588512345432478778887447200158878999235699999999999919999988785789976651458-
Q 001449 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL- 1028 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l- 1028 (1075)
||+|||+++............||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~--y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCC--CCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 421000101100234577765485114831001798--881110003289999998787998998989999999984079
Q ss_pred ------------------------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf ------------------------999999898999999999621199999889999999
Q 001449 1029 ------------------------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 ------------------------~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
...+...++..+.+||.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 961105321111033302234564544044589999999999874896679189999669
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.00 Aligned_cols=259 Identities=30% Similarity=0.512 Sum_probs=220.2
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 3114889049999732593899999986-------932599982043348993468999999999999998189995435
Q 001449 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (1075)
Q Consensus 795 ~ei~~~dYeilk~LGeGsfGtVYkak~k-------Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVk 867 (1075)
|++..++|++.+.||+|+||.||+|.++ ++.||||+++... .......|.+|+.++++++||||++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 042689918835982078818999998786447789689999987012-------8689999999999999769998841
Q ss_pred EECCCCCCCCCCEEEEEEEECCCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 601112499995289996502884789873104---------66789999999999999999998499150357888657
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLL 938 (1075)
Q Consensus 868 Llgv~~e~~e~~L~LVmEYleGGSL~dlLkk~~---------k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNIL 938 (1075)
+++++.. +..+++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 88 ~~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 88 LLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred EEEEEEC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEE
T ss_conf 2547842--88106777604899889998750332113444688799999999999999999876479654328677540
Q ss_pred ECCCCCCCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 5268999991999425885123454---32478778887447200158878999235699999999999919-9999887
Q 001449 939 VNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTG-DEPYADM 1014 (1075)
Q Consensus 939 Id~~~~~~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTG-k~PF~~~ 1014 (1075)
++ .++.+||+|||+|+..... .......+++.|+|||.+.+.. ++.++||||||+++|||+++ .+||.+.
T Consensus 166 ld----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 166 VA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp EC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EC----CCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 35----99649994245420235776303134023163237888873699--8833344437899999996899999998
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf 8578997665145899999989899999999962119999988999999999999
Q 001449 1015 HCASIIGGIVNNTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMA 1069 (1075)
Q Consensus 1015 ~~~eil~~Iv~~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~ 1069 (1075)
+..+.+..+.+.. .+.++..++..+.++|.+||+.+|.+|||+.++++.|++..
T Consensus 240 ~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 240 SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999999998088-88886335399999999975779658939999999978761
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.36 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=199.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC--
Q ss_conf 89049999732593899999986--93259998204334899346899999999999999818999543560111249--
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG-- 875 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~-- 875 (1075)
.+|+.+++||+|+||+||+|++. ++.||||+++..... +.+|+.+|+.++|+||+++++++...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------------~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------------CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------------HHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 7767516982176839999999999979999998816068------------9999999986689898738789974476
Q ss_pred --CCCCEEEEEEEECCCCHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCC-CEEE
Q ss_conf --9995289996502884789873--1046678999999999999999999849915035788865752689999-9199
Q 001449 876 --PDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR-PVCK 950 (1075)
Q Consensus 876 --~e~~L~LVmEYleGGSL~dlLk--k~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~-g~VK 950 (1075)
....+++||||+.++.+..+.. .....+++..++.|+.||+.||.|||++||+||||||+|||++ .+ ..+|
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~----~~~~~~k 163 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD----PDTAVLK 163 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTTCCEE
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEE----CCCCCEE
T ss_conf 577318999984168860788886310368999999999999999999999866876457886037873----5897116
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC---
Q ss_conf 94258851234543247877888744720015887899923569999999999991999998878578997665145---
Q 001449 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNT--- 1027 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~--- 1027 (1075)
|+|||+++............|++.|+|||.+.+.. .++.++||||+||++|||++|+.||......+.+..+.+..
T Consensus 164 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp ECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 73366054404776532002555556827764046-88821000246527785502879989879999999999974898
Q ss_pred ------------CC------------CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ------------89------------9999989899999999962119999988999999
Q 001449 1028 ------------LR------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 ------------l~------------~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
.. ......+++++.+||.+||..||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 177654306210110355445674444315689999999999976589557929999966
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=335.20 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=206.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCCC
Q ss_conf 89049999732593899999986-93259998204334899346899999999999999818999543560111249999
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~k-Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e~ 878 (1075)
++|+++++||+|+||+||+|+++ ++.||||+++...... .....+.+|+.+|++++||||+++++++.. .+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SS
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCH------HHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CC
T ss_conf 9963431872277818999996899999999981232685------899999999999986799868766012046--77
Q ss_pred CEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCC
Q ss_conf 52899965028847898731046678999999999999999999849915035788865752689999919994258851
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (1075)
Q Consensus 879 ~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk 958 (1075)
.+++++|++.++.+..+. .....+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred CEEEEEEEEHHHHHHHHH-HHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEEC----CCCCEEECCCCCCE
T ss_conf 315899740045678998-6047751445689999999999986057488267877505686----89978732366430
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC--------
Q ss_conf 23454-324787788874472001588789992356999999999999199999887857899766514589--------
Q 001449 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLR-------- 1029 (1075)
Q Consensus 959 ~~~~~-~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~-------- 1029 (1075)
..... .......+++.|+|||.+.+.. .++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ECCCCCCCCCEECCCCHHHHHHHHHCCC-CCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCC
T ss_conf 1146765410102431101378871788-888410021117589999779799898898999999998638997110421
Q ss_pred -------------------CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf -------------------9999989899999999962119999988999999
Q 001449 1030 -------------------PQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1030 -------------------~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
..+...++.++.+||++||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 23332214333335676466651258999999999986689668909999856
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.86 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=207.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC--
Q ss_conf 890499997325938999999869325999820433489934689999999999999981899954356011124999--
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD-- 877 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e-- 877 (1075)
.+|.+.+.||+|+||.||+|+++|..||||+++... ... ..+..|+..++.++||||+++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC-------HHH--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 689998898207881999999999899999987200-------467--99999999996279986832688998379860
Q ss_pred CCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCCCCEE
Q ss_conf 95289996502884789873104667899999999999999999984--------9915035788865752689999919
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG--------KNIVHFDLKCENLLVNMRDPQRPVC 949 (1075)
Q Consensus 878 ~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs--------~GIVHRDIKPeNILId~~~~~~g~V 949 (1075)
..+++||||+++|+|.+++++. .+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred EEEEEEEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC----CCCCE
T ss_conf 4899999646698989998658--99989999999999999999887665204689866153173135786----88776
Q ss_pred EEEECCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHCCCCCCCCC------
Q ss_conf 994258851234543-----2478778887447200158878----9992356999999999999199999887------
Q 001449 950 KIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSH----MVTEKIDVYSFGIVMWELLTGDEPYADM------ 1014 (1075)
Q Consensus 950 KLiDFGLAk~~~~~~-----~s~s~~GTp~YlAPEvL~g~~~----~yS~KsDIWSLGVILyELLTGk~PF~~~------ 1014 (1075)
||+|||+++...... ......||+.|+|||++.+... .++.++|||||||++|||++|..||...
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 88763866234677762001355250354767822105654546777675012201599999996289988766311241
Q ss_pred ---------CHHHHHHHHHHCCCCCCCCCC-----CCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf ---------857899766514589999998-----9899999999962119999988999999999999970899
Q 001449 1015 ---------HCASIIGGIVNNTLRPQIPSW-----CDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075 (1075)
Q Consensus 1015 ---------~~~eil~~Iv~~~l~~~ip~~-----lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seLnvK 1075 (1075)
..............++.++.. ....+.+|+.+||+.||.+|||+.++++.|+++..+.++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred HHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCC
T ss_conf 012255643099999987502468887765577689999999999976069858959999999999888865998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.06 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=206.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|+++ ++.||||+++.... .+...+.+.+|+.+|+.++|||||++++++....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 7718998898017781999999999998999999852225------9699999999999998668987547999863576
Q ss_pred ----CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEE
Q ss_conf ----9952899965028847898731046678999999999999999999849915035788865752689999919994
Q 001449 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 877 ----e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLi 952 (1075)
...+++||||+ +.+|..+++.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~~~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred CCCCCCEEEEEEECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCC----CCCCCCCC
T ss_conf 555541599998405-52189998740--226999999999999999998737876456685111121----00122113
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC----
Q ss_conf 2588512345432478778887447200158878999235699999999999919999988785789976651458----
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTL---- 1028 (1075)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l---- 1028 (1075)
|||+|+...... ....||+.|+|||++.+.. .++.++||||+||++|+|++|+.||.+.+....+..+.....
T Consensus 164 Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 164 DFGLARQADSEM--TGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCTTCEECCSSC--CSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCCEECCCCCC--CCCCCCCCCCCHHHHCCCC-CCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCH
T ss_conf 431022068763--1024553335889981787-8996501030038999999786998889768999999850378848
Q ss_pred -------------------------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf -------------------------999999898999999999621199999889999999
Q 001449 1029 -------------------------RPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1029 -------------------------~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
...+...+++++.+||.+||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8886530003443311578666556677556899999999999772995579299999639
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.75 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=202.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEECCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189--9954356011124
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIVRD 874 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~--HPNIVkLlgv~~e 874 (1075)
.++|++.+.||+|+||+||+|++. +..||+|++............ ....+.+|+.++++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~--~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP--NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT--TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 88379967984087839999999999979999998568844334556--7999999999999743589881279999830
Q ss_pred CCCCCEEEEEEEECC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf 999952899965028-8478987310466789999999999999999998499150357888657526899999199942
Q 001449 875 GPDGSLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYleG-GSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiD 953 (1075)
.+.+++||||+.+ +++.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++. +.+.+||+|
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~---~~~~vkl~D 154 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL---NRGELKLID 154 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred --CCEEEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC---CCCEEEECC
T ss_conf --9968999983368622899986158-9999999999999999999998779755667611147744---788489775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 58851234543247877888744720015887899923569999999999991999998878578997665145899999
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRPQIP 1033 (1075)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~~ip 1033 (1075)
||+|+...... .....||+.|+|||++.+... ++.++|||||||++|+|++|+.||.... .+.... ..++
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~--~~~~ 224 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ--VFFR 224 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC--CCCS
T ss_pred CCCCEECCCCC-CCCCCCCCCCCCHHHHCCCCC-CCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHCC--CCCC
T ss_conf 46535324445-566565877479999848997-8865332554034536756889988736------776154--4778
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 989899999999962119999988999999
Q 001449 1034 SWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1034 ~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
..+|.++++||.+||..||.+|||+.|+++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 779999999999976089758939999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=332.93 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=208.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE-CCCCCC
Q ss_conf 889049999732593899999986--93259998204334899346899999999999999818999543560-111249
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY-GIVRDG 875 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLl-gv~~e~ 875 (1075)
.++|++++.||+|+||.||+|++. ++.||||++...... ..+..|+.+++.++|++++..+ .++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~- 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE- 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----------HHHHHHHHHHHHCCCCCCCCEEEEEEEC-
T ss_conf 88899968985078809999999889989999997210058----------8899999999970389960179999951-
Q ss_pred CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECC
Q ss_conf 99952899965028847898731046678999999999999999999849915035788865752689999919994258
Q 001449 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (1075)
Q Consensus 876 ~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFG 955 (1075)
....++||||+ +++|.+.+......+++..++.++.|++.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus 75 -~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG 151 (299)
T d1ckia_ 75 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 151 (299)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCS
T ss_pred -CCEEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCC-CCCEEEEECCC
T ss_conf -98778999873-8713332443068876899999999999999999979944266787660643357-77615650467
Q ss_pred CCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---
Q ss_conf 851234543--------247877888744720015887899923569999999999991999998878578997665---
Q 001449 956 LSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIV--- 1024 (1075)
Q Consensus 956 LAk~~~~~~--------~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv--- 1024 (1075)
+|+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred CCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCC--CCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 51342554455410001357767873532999991899--8983218861778999984987665530577999999852
Q ss_pred HC---CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 14---589999998989999999996211999998899999999999997089
Q 001449 1025 NN---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINV 1074 (1075)
Q Consensus 1025 ~~---~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seLnv 1074 (1075)
.. .........+|.++.++|.+||+.+|.+||++.++.+.|++++.+.+.
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCC
T ss_conf 35678983575347889999999998439955791999999999999997699
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.15 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=201.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|+++ ++.||||++.+.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 898599789940648099999999999499999980310-------9589999999999999768989885888995056
Q ss_pred --CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf --995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 877 --DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 877 --e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
....+++++++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred CCCCCEEEEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC----CCCCEEECCC
T ss_conf 4554149999962598656644058--999999999999999999999978986777876437887----9997787545
Q ss_pred CCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 8851234543----247877888744720015887899923569999999999991999998878578997665145899
Q 001449 955 GLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP 1030 (1075)
Q Consensus 955 GLAk~~~~~~----~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~ 1030 (1075)
|+++...... .....+||+.|+|||++.... .++.++||||+||++|+|++|+.||..................+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC-SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred CCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCC-CCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 70565047776410101102652000387860478-88741010046701337766979978888899999876520699
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf -----------------------------9999898999999999621199999889999999
Q 001449 1031 -----------------------------QIPSWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1031 -----------------------------~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
.....++.++++||.+||..||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 756642343322220244677557787778378999999999999764895679089998619
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=328.33 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=201.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCC
Q ss_conf 4889049999732593899999986--932599982043348993468999999999999998189-9954356011124
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~-HPNIVkLlgv~~e 874 (1075)
..++|+++++||+|+||+||+|++. ++.||||+++... .+.+.+|+.+|+.+. ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 9867189789831748199999988999799999988899-----------99999999999851579987679999981
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEEC
Q ss_conf 99995289996502884789873104667899999999999999999984991503578886575268999991999425
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDF 954 (1075)
.....+++||||+.+++|..+.+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++..+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCG
T ss_pred CCCCCEEEEEEECCCCCHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEECCC
T ss_conf 68771268886317985899746----8999999999999999998876433443456441237748---9983664156
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHH--------
Q ss_conf 8851234543247877888744720015887899923569999999999991999998878578-9976651--------
Q 001449 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCAS-IIGGIVN-------- 1025 (1075)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~e-il~~Iv~-------- 1025 (1075)
|+|+............+|+.|+|||++.+.. .++.++||||+||++|+|++|+.||....... ....+..
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHH
T ss_conf 5426646887444322486424761026888-888452323354555876048899988760189999999987884155
Q ss_pred ---------------------------CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ---------------------------45899999989899999999962119999988999999
Q 001449 1026 ---------------------------NTLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1026 ---------------------------~~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
..........+++++.+||++||..||.+|+|+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 55542254447430000033343311211552112448999999999986699568908999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=325.59 Aligned_cols=263 Identities=17% Similarity=0.232 Sum_probs=213.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEECCCCC
Q ss_conf 4889049999732593899999986--9325999820433489934689999999999999981899-954356011124
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGIVRD 874 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~H-PNIVkLlgv~~e 874 (1075)
..++|++++.||+|+||+||+|++. ++.||+|++...... ..+.+|+..++.+.| +|++.+++++.+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----------HHHHHHHHHHHHHCCCCCCCEEEEEEEC
T ss_conf 898069979984178829999999889979999997502582----------9999999999996489998779999601
Q ss_pred CCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CCCCEEEEEE
Q ss_conf 999952899965028847898731046678999999999999999999849915035788865752689-9999199942
Q 001449 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGD 953 (1075)
Q Consensus 875 ~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~-~~~g~VKLiD 953 (1075)
....++||||+ +++|.+++...+..+++..++.++.|++.||.|||++||+||||||+|||++... ...+.+||+|
T Consensus 73 --~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 --GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred --CCCCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECC
T ss_conf --88117999964-888799997520311068999999999999999997796626677131523475434479568723
Q ss_pred CCCCCCCCCC--------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH
Q ss_conf 5885123454--------324787788874472001588789992356999999999999199999887857---89976
Q 001449 954 LGLSKVKQQT--------LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA---SIIGG 1022 (1075)
Q Consensus 954 FGLAk~~~~~--------~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~---eil~~ 1022 (1075)
||+|+..... .......||+.|+|||++.+.. ++.++||||||+++|||++|..||.+.... .....
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred CCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 6605771467665411102467627751026798964888--88699989831999999869876788530219999999
Q ss_pred HHHC---CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 6514---5899999989899999999962119999988999999999999970899
Q 001449 1023 IVNN---TLRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISRRLRSMAAAINVK 1075 (1075)
Q Consensus 1023 Iv~~---~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~Lesi~seLnvK 1075 (1075)
+... .....+...+|.++.+++..|+..+|++||+++.+.+.|++++.+.+.+
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
T ss_conf 97056799958965799899999999984399300859999999999999975999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.82 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=202.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCC
Q ss_conf 889049999732593899999986--932599982043348993468999999999999998189995435601112499
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~ 876 (1075)
.++|++++.||+|+||+||+|+++ ++.||||++........ ...++.+|+.+|+.++|+||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHH------HHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 2798899997227482999999989997999999842224637------8999999999999835999660676540246
Q ss_pred ------CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEE
Q ss_conf ------99528999650288478987310466789999999999999999998499150357888657526899999199
Q 001449 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 877 ------e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VK 950 (1075)
...+++||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEE
T ss_pred CCCCCCCCEEEEEEECCCCCCCC-HHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEEC----CCCCEE
T ss_conf 54444576389998535787410-1222034433089999999999999885229988567672220366----899687
Q ss_pred EEECCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9425885123454-----32478778887447200158878999235699999999999919999988785789976651
Q 001449 951 IGDLGLSKVKQQT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVN 1025 (1075)
Q Consensus 951 LiDFGLAk~~~~~-----~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~ 1025 (1075)
|+|||+++..... ......+||+.|+|||++.+... ++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCC-CCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 63135002235544432113566024978742899707999-89178700678646617448799899899999999998
Q ss_pred CCCCC--CCC----------------------------CCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 45899--999----------------------------9898999999999621199999889999999
Q 001449 1026 NTLRP--QIP----------------------------SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1026 ~~l~~--~ip----------------------------~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
..... ... ...+.++.+||.+||+.||++|+|+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 418998255344320344433201334455503340444599899999999873896589099999749
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.66 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=210.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE-----CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEEC
Q ss_conf 1488904999973259389999998-----69325999820433489934689999999999999981899-95435601
Q 001449 797 IKNDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYG 870 (1075)
Q Consensus 797 i~~~dYeilk~LGeGsfGtVYkak~-----kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~H-PNIVkLlg 870 (1075)
+..++|++++.||+|+||+||+|++ +|+.||+|+++......+.. ..+.+.+|+.++++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~----~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----TTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHH----HHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 45102599989832878399999987658879489999983677210168----99999999999986467983999620
Q ss_pred CCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEE
Q ss_conf 11249999528999650288478987310466789999999999999999998499150357888657526899999199
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 v~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VK 950 (1075)
++.+ ...++++|||+.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 97 ~~~~--~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vk 169 (322)
T d1vzoa_ 97 AFQT--ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVV 169 (322)
T ss_dssp EEEE--TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEE
T ss_pred EECC--CCCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEEC----CCCCEE
T ss_conf 0024--873001231234117999987304-543788888899999999885149989654773201246----999888
Q ss_pred EEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC--
Q ss_conf 942588512345--4324787788874472001588789992356999999999999199999887857899766514--
Q 001449 951 IGDLGLSKVKQQ--TLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNN-- 1026 (1075)
Q Consensus 951 LiDFGLAk~~~~--~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~-- 1026 (1075)
|+|||+++.... ........|++.|++||.+.+....++.++|||||||+||+|++|+.||...........+...
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 74132022203444432212223333310687605776887132517777999999768999888877779999998335
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 5899999989899999999962119999988-----999999
Q 001449 1027 TLRPQIPSWCDPEWRSLMESCWASDPAERPS-----FSEISR 1063 (1075)
Q Consensus 1027 ~l~~~ip~~lS~eLkdLIkkCLq~DP~kRPS-----a~EILq 1063 (1075)
...+.++..++.++.+||.+||..||.+|+| ++|+++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 689988654799999999997445898819997450999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.19 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=204.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC-
Q ss_conf 889049999732593899999986--93259998204334899346899999999999999818999543560111249-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~- 875 (1075)
.++|++++.||+|+||+||+|++. ++.||||+++.... .......+.+|+.+|+.++|+|||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9871888898317883999999999997999999882002------8689999999999998668987425999996346
Q ss_pred --CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEE
Q ss_conf --999528999650288478987310466789999999999999999998499150357888657526899999199942
Q 001449 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (1075)
Q Consensus 876 --~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiD 953 (1075)
++...+++++|+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~~~~~kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECC
T ss_pred CCCCCCEEEEEEEECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCCCCCC
T ss_conf 45668649999962588623200224--530999999999999999999738876516677633455----432200132
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC---
Q ss_conf 58851234543247877888744720015887899923569999999999991999998878578997665145899---
Q 001449 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP--- 1030 (1075)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~--- 1030 (1075)
||++....... ....|++.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 165 fg~a~~~~~~~--~~~~g~~~y~apE~~~~~~-~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 165 FGLARHTDDEM--TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp C----CCTGGG--SSSCHHHHTSCHHHHTTCS-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCHHCCCCCCC--CCCCCCCCCCCCHHHCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 10001257544--4434543555835533775-67855124320589999976889978898899999999730799757
Q ss_pred ------------------C--------CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ------------------9--------99989899999999962119999988999999
Q 001449 1031 ------------------Q--------IPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1031 ------------------~--------ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
. ....++.++++||.+||..||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 73200102445444303557875556626789999999999977588345938999855
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.98 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=203.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCC-
Q ss_conf 889049999732593899999986--93259998204334899346899999999999999818999543560111249-
Q 001449 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (1075)
Q Consensus 799 ~~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~- 875 (1075)
.++|+++++||+|+||+||+|.++ ++.||||+++..... ......+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 37759988962175859999999999989999998823369------799999999999998648987648998970256
Q ss_pred ---CCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEE
Q ss_conf ---99952899965028847898731046678999999999999999999849915035788865752689999919994
Q 001449 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (1075)
Q Consensus 876 ---~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLi 952 (1075)
....+|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|++
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~ 161 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred CCCCCCEEEEEEECCCH-HHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC----CCCCEEEE
T ss_conf 43457626999841446-7787650---3899999999999999999886522112456776321136----54431320
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC--
Q ss_conf 258851234543247877888744720015887899923569999999999991999998878578997665145899--
Q 001449 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCASIIGGIVNNTLRP-- 1030 (1075)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~eil~~Iv~~~l~~-- 1030 (1075)
|||+++............+|+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+.+.......+......+
T Consensus 162 df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~--~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCCC---------------CCTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 102321146665533221465555813314777--787743335662578986598998889778899999972058987
Q ss_pred ------------------C--------------CC------CCCCHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf ------------------9--------------99------9898999999999621199999889999999
Q 001449 1031 ------------------Q--------------IP------SWCDPEWRSLMESCWASDPAERPSFSEISRR 1064 (1075)
Q Consensus 1031 ------------------~--------------ip------~~lS~eLkdLIkkCLq~DP~kRPSa~EILq~ 1064 (1075)
. .+ ...+.++.+||++||..||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.02 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=203.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCC
Q ss_conf 89049999732593899999986--9325999820433489934689999999999999981899954356011124999
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlgv~~e~~e 877 (1075)
++|+++++||+|+||+||+|++. ++.||||+++..... +.....+.+|+.+|+.++|+||+++++++.+ .
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 73 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--C
T ss_conf 9978626971286819999999999969999998032178------6899999999999985675788821354444--4
Q ss_pred CCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEEEEECCCC
Q ss_conf 95289996502884789873104667899999999999999999984991503578886575268999991999425885
Q 001449 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (1075)
Q Consensus 878 ~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLA 957 (1075)
..++++++++.+++|..++... +.+++..++.++.|++.||+|||+++|+||||||+|||++ ..+.+||+|||.+
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~a 148 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCC----CCCCEEEEECCHH
T ss_conf 3115886302332221121235-6540367899999999998774339986001467612113----3782665204601
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHHCC--------
Q ss_conf 123454-3247877888744720015887899923569999999999991999998-878578997665145--------
Q 001449 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYA-DMHCASIIGGIVNNT-------- 1027 (1075)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~-~~~~~eil~~Iv~~~-------- 1027 (1075)
+..... .......++..|+|||++.+.. .++.++|||||||++|||++|+.||. +.+..+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred HCCCCCCCCCEEECCCCCHHHHHHHCCCC-CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 10468875100103443101466750698-88804440265418899851899998899999999999861189973551
Q ss_pred -------------------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf -------------------899999989899999999962119999988999999
Q 001449 1028 -------------------LRPQIPSWCDPEWRSLMESCWASDPAERPSFSEISR 1063 (1075)
Q Consensus 1028 -------------------l~~~ip~~lS~eLkdLIkkCLq~DP~kRPSa~EILq 1063 (1075)
........++..+.+||++||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 3443222113344454431043306568999999999986499668909999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-41 Score=284.11 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=187.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----------CCC
Q ss_conf 488904999973259389999998--6932599982043348993468999999999999998189-----------995
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----------HPN 864 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~--kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~-----------HPN 864 (1075)
...+|+++++||+|+||+||+|++ +|+.||||+++... .....+.+|+.+++.+. |+|
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---------CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCC
T ss_conf 4785799899750778189999999999799999983431---------3368999999999984014555554227676
Q ss_pred EEEEECCCCCCCCCCEEEEEEEECCCCHHHH--HHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECC
Q ss_conf 4356011124999952899965028847898--73104667899999999999999999984-99150357888657526
Q 001449 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQF--LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNM 941 (1075)
Q Consensus 865 IVkLlgv~~e~~e~~L~LVmEYleGGSL~dl--Lkk~~k~Lse~~il~Ia~QIlsAL~yLHs-~GIVHRDIKPeNILId~ 941 (1075)
|+++++++........+++++++..+..... .......+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred EEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC
T ss_conf 47899876312565202343200035420000012234678689999999999999888764058646567705705630
Q ss_pred CC--CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH--
Q ss_conf 89--99991999425885123454324787788874472001588789992356999999999999199999887857--
Q 001449 942 RD--PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKIDVYSFGIVMWELLTGDEPYADMHCA-- 1017 (1075)
Q Consensus 942 ~~--~~~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YlAPEvL~g~~~~yS~KsDIWSLGVILyELLTGk~PF~~~~~~-- 1017 (1075)
.+ .....++++|||.+...... .....||+.|+|||++.+.. ++.++||||+||++++|++|+.||......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCCCCCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCCCCC--CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 576564430567531442123445--42236652105713214667--77643201237899999878899898755432
Q ss_pred ----HHHHHHHHC----------------------CC------------------CCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf ----899766514----------------------58------------------9999998989999999996211999
Q 001449 1018 ----SIIGGIVNN----------------------TL------------------RPQIPSWCDPEWRSLMESCWASDPA 1053 (1075)
Q Consensus 1018 ----eil~~Iv~~----------------------~l------------------~~~ip~~lS~eLkdLIkkCLq~DP~ 1053 (1075)
..+...... .. ........+.++.+||.+||..||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHH
T ss_conf 10268999999983799878862453220001320122024323577644421000156743589999999998779945
Q ss_pred CCCCHHHHHHH
Q ss_conf 99889999999
Q 001449 1054 ERPSFSEISRR 1064 (1075)
Q Consensus 1054 kRPSa~EILq~ 1064 (1075)
+|||+.|+++.
T Consensus 318 ~Rpta~e~L~H 328 (362)
T d1q8ya_ 318 KRADAGGLVNH 328 (362)
T ss_dssp TCBCHHHHHTC
T ss_pred HCCCHHHHHCC
T ss_conf 79089999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=3.4e-23 Score=165.99 Aligned_cols=172 Identities=16% Similarity=0.022 Sum_probs=120.4
Q ss_pred EEEEEEECCCCCEEEEEEEE-CCCCEEEEEEECCCCCC----------CCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEC
Q ss_conf 04999973259389999998-69325999820433489----------93468999999999999998189995435601
Q 001449 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAG----------KPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (1075)
Q Consensus 802 Yeilk~LGeGsfGtVYkak~-kGt~VAIKvIk~~~~~~----------~~~e~e~~i~~flrEi~ILkkL~HPNIVkLlg 870 (1075)
+.+.+.||+|+||+||+|++ +|..||||+++...... ...........+.+|...+..+.+.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred CCCCCCCCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCEEE
Q ss_conf 11249999528999650288478987310466789999999999999999998499150357888657526899999199
Q 001449 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (1075)
Q Consensus 871 v~~e~~e~~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs~GIVHRDIKPeNILId~~~~~~g~VK 950 (1075)
+.. .+++|||+.+..+.+ ++......++.|++.+|.+||++||+||||||+|||++ + ..++
T Consensus 82 ~~~------~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~-~~~~ 142 (191)
T d1zara2 82 WEG------NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E-EGIW 142 (191)
T ss_dssp EET------TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T-TEEE
T ss_pred ECC------CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEE----C-CCEE
T ss_conf 628------889999504565420--------01578999999999999998268889836890361142----8-9899
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 942588512345432478778887447------2001588789992356999999999
Q 001449 951 IGDLGLSKVKQQTLVSGGVRGTLPWMA------PELLSGKSHMVTEKIDVYSFGIVMW 1002 (1075)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YlA------PEvL~g~~~~yS~KsDIWSLGVILy 1002 (1075)
|+|||+|......... .|.. .+.+. +. |+.++|+||+.--+.
T Consensus 143 liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~-r~--y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR-------EILERDVRNIITYFS-RT--YRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHH-HH--HCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCH-------HHHHHHHHHHHHHHC-CC--CCCCCCHHHHHHHHH
T ss_conf 9877884308998709-------999877999999975-78--998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=7.4e-07 Score=59.55 Aligned_cols=140 Identities=17% Similarity=0.069 Sum_probs=85.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEECCCCCCCCC
Q ss_conf 89049999732593899999986932599982043348993468999999999999998189-99543560111249999
Q 001449 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (1075)
Q Consensus 800 ~dYeilk~LGeGsfGtVYkak~kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~-HPNIVkLlgv~~e~~e~ 878 (1075)
..|+..+..+.++.+.||+....+..+++|+......... ..+.+|...+..+. +--+.+++.+... .+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~--------~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFERH--DG 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEEEE--TT
T ss_pred HCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCH--------HHHHHHHHHHHHHHCCCCCCCEEEEEEC--CC
T ss_conf 3527997678998771899990898699998488765325--------5699999999987606998728999750--89
Q ss_pred CEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q ss_conf 5289996502884789873104667899999999999999999984----------------------------------
Q 001449 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG---------------------------------- 924 (1075)
Q Consensus 879 ~L~LVmEYleGGSL~dlLkk~~k~Lse~~il~Ia~QIlsAL~yLHs---------------------------------- 924 (1075)
..++||++++|.++.+..... .. ...++.++...+..||+
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred CEEEEEEECCCCCCCCCCCCC---CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 649999860433435433440---26---999999899999998556842143576446565557789987765555430
Q ss_pred -------------------------CCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCC
Q ss_conf -------------------------99150357888657526899999199942588512
Q 001449 925 -------------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 925 -------------------------~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~ 959 (1075)
..++|+|+.+.|||++ +...+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEEC----CCCEEEEEECHHCCC
T ss_conf 33232005799999999844986781789860047642364----996599960231441
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.24 E-value=3.2e-06 Score=55.40 Aligned_cols=77 Identities=19% Similarity=0.217 Sum_probs=60.4
Q ss_pred CCCCCCCCCCEEEEEEECCCEEECCCCCCCEEEECCCEEEEECCCCCCHHHHHHHHHHHHCC-CEEEEEECCCCCCCCEE
Q ss_conf 98888999991799940298220389999703325931689756888958999999988089-36998518999978255
Q 001449 13 STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALV 91 (1075)
Q Consensus 13 ~~~~~~~~~~~vk~~csygG~i~pr~~d~~l~Y~gg~tri~~v~r~~~~~~l~~kl~~~~~~-~~~~kyqlp~edld~Li 91 (1075)
+..++..+...||.-+.|+ +|++++.|+.+++|.+|+.++.+.+.. .+.|||+ .|| +-+|
T Consensus 2 ~~~s~~~~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--Ded-gd~v 62 (85)
T d1ip9a_ 2 AMGSSTSGLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--LFD-GSGE 62 (85)
T ss_dssp CCSCCCCCCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--CSS-SCCS
T ss_pred CCCCCCCCCCCEEEEEEEC----------------CCEEEEEECCCCCHHHHHHHHHHHHCCCCEEEEEE--CCC-CCEE
T ss_conf 8887889998799999989----------------92999993799889999999999858783689999--689-9978
Q ss_pred ECCCHHHHHHHHHHHHH
Q ss_conf 11581669999999965
Q 001449 92 SVVNDDDVINMMEEYEK 108 (1075)
Q Consensus 92 sv~~dedl~~m~~eydr 108 (1075)
+++||+||..+|++..+
T Consensus 63 ~i~sD~Dl~~ai~~~~k 79 (85)
T d1ip9a_ 63 EIKTDSQVSNIIQAKLK 79 (85)
T ss_dssp CCCSHHHHHHHHHTTCC
T ss_pred EEECHHHHHHHHHHCCC
T ss_conf 98378999999972282
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=0.00011 Score=45.42 Aligned_cols=136 Identities=16% Similarity=0.109 Sum_probs=73.0
Q ss_pred EECCCC-CEEEEEEEEC-CCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEECCCCCCCCCCEEE
Q ss_conf 973259-3899999986-932599982043348993468999999999999998189--995435601112499995289
Q 001449 807 ELGSGT-YGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIVRDGPDGSLAT 882 (1075)
Q Consensus 807 ~LGeGs-fGtVYkak~k-Gt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~--HPNIVkLlgv~~e~~e~~L~L 882 (1075)
.+..|. .+.||+...+ +..+++|........ .+..|...++.+. .-.+.+++.+..+ .+..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH-----------HHHHHHHHHHHHHHCCCCCCCEEEECCC--CCCEEE
T ss_conf 767865477589999389878999958966776-----------8999999999998659998861322245--661599
Q ss_pred EEEEECCCCHHHH-------H-------HH------CCCCC--CHHHHHHHHH--------------------HHHHHHH
Q ss_conf 9965028847898-------7-------31------04667--8999999999--------------------9999999
Q 001449 883 VTEFMVNGSLKQF-------L-------QK------KDRTI--DRRKRLIIAM--------------------DAAFGME 920 (1075)
Q Consensus 883 VmEYleGGSL~dl-------L-------kk------~~k~L--se~~il~Ia~--------------------QIlsAL~ 920 (1075)
||++++|.++.+. + .+ ....+ .......-.. .....+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 98744135543221268999999999999873688544887554124688999999875411011340112137999999
Q ss_pred HHHHC-------CCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 99849-------9150357888657526899999199942588512
Q 001449 921 YLHGK-------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 921 yLHs~-------GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~ 959 (1075)
.+... .++|+|+.+.|||++ ....+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~----~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEE----CCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773----796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=0.0012 Score=38.70 Aligned_cols=81 Identities=20% Similarity=0.141 Sum_probs=45.1
Q ss_pred EEEEECCCCCEEEEEEEEC--CCCEEEEEEECCCC-CCC--CHHHHHHHHHHHHHHHHHHHCC--C-CCEEEEECCCCCC
Q ss_conf 9999732593899999986--93259998204334-899--3468999999999999998189--9-9543560111249
Q 001449 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCF-AGK--PSERERLIADFWKEALLLSSLH--H-PNVVSFYGIVRDG 875 (1075)
Q Consensus 804 ilk~LGeGsfGtVYkak~k--Gt~VAIKvIk~~~~-~~~--~~e~e~~i~~flrEi~ILkkL~--H-PNIVkLlgv~~e~ 875 (1075)
..+.||.|....||++... +..+++|....... .++ .... .+...|...|+.+. . ..+++++.+ +
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~----~R~~~E~~~L~~~~~~~p~~vP~v~~~--d- 102 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTI----DRARIESSALIRQGEHVPHLVPRVFYS--D- 102 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCT----THHHHHHHHHHHHHTTCGGGSCCEEEE--E-
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCH----HHHHHHHHHHHHHHHHCCCCCCEEEEE--C-
T ss_conf 699807985276899995799848999617713034677788877----899999999998650579885528998--5-
Q ss_pred CCCCEEEEEEEECCCCH
Q ss_conf 99952899965028847
Q 001449 876 PDGSLATVTEFMVNGSL 892 (1075)
Q Consensus 876 ~e~~L~LVmEYleGGSL 892 (1075)
....++|||++.+..+
T Consensus 103 -~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 103 -TEMAVTVMEDLSHLKI 118 (392)
T ss_dssp -TTTTEEEECCCTTSEE
T ss_pred -CCCCEEEEECCCCCCC
T ss_conf -9887798713577653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.32 E-value=0.00081 Score=39.73 Aligned_cols=152 Identities=13% Similarity=0.035 Sum_probs=78.2
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCEEEE
Q ss_conf 33114889049999732593899999986932599982043348993468999999999999998189-----9954356
Q 001449 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----HPNVVSF 868 (1075)
Q Consensus 794 ~~ei~~~dYeilk~LGeGsfGtVYkak~kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~-----HPNIVkL 868 (1075)
+..+....+...+.|..|.-.+.|+.+.++..+++|++.... .. ..+..|..++..+. .|..+..
T Consensus 12 l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~~---------~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 12 LTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EK---------NDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC----C---------CHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCC-CH---------HHHHHHHHHHHHHHHCCCCCCCCCEE
T ss_conf 986799985685237888526738999789728999807899-98---------89999999987543025554556410
Q ss_pred E-CCCCCCCCCCEEEEEEEECCCCHHH-----------HH---HHC--------CC------------------CCCHHH
Q ss_conf 0-1112499995289996502884789-----------87---310--------46------------------678999
Q 001449 869 Y-GIVRDGPDGSLATVTEFMVNGSLKQ-----------FL---QKK--------DR------------------TIDRRK 907 (1075)
Q Consensus 869 l-gv~~e~~e~~L~LVmEYleGGSL~d-----------lL---kk~--------~k------------------~Lse~~ 907 (1075)
. +............++.++.+..... .+ ... .. ......
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHH
T ss_conf 48976213412550245311465533320467888889987645444320245310111012002456777765311412
Q ss_pred HHHHHHHHHHHHHHHHH----CCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 99999999999999984----99150357888657526899999199942588512
Q 001449 908 RLIIAMDAAFGMEYLHG----KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (1075)
Q Consensus 908 il~Ia~QIlsAL~yLHs----~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~ 959 (1075)
....+..+...+..... .|+||+|+.++||+++ .+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~----~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCC----CCCCEEEECCCCCCC
T ss_conf 7999999987642048554545033378636564020----454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.16 E-value=0.0017 Score=37.68 Aligned_cols=79 Identities=14% Similarity=0.309 Sum_probs=45.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECC---------CCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC-EEE
Q ss_conf 48890499997325938999999869---------32599982043348993468999999999999998189995-435
Q 001449 798 KNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVS 867 (1075)
Q Consensus 798 ~~~dYeilk~LGeGsfGtVYkak~kG---------t~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~HPN-IVk 867 (1075)
..++++ ++.|..|-.-.+|++.... ..+.+++.-.. . .. ....+|..+++.+.-.+ ..+
T Consensus 41 ~~~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~-~~-----idr~~E~~i~~~ls~~gl~Pk 109 (395)
T d1nw1a_ 41 PLEHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----E-TE-----SHLVAESVIFTLLSERHLGPK 109 (395)
T ss_dssp CGGGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----C-CH-----HHHHHHHHHHHHHHHTTSSSC
T ss_pred CCCCEE-EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC----C-HH-----HHHHHHHHHHHHHHHCCCCCE
T ss_conf 930169-999178533434899968877544578981799965996----1-16-----589999999999975799980
Q ss_pred EECCCCCCCCCCEEEEEEEECCCCHH
Q ss_conf 60111249999528999650288478
Q 001449 868 FYGIVRDGPDGSLATVTEFMVNGSLK 893 (1075)
Q Consensus 868 Llgv~~e~~e~~L~LVmEYleGGSL~ 893 (1075)
+++++.. ++|+||++|.+|.
T Consensus 110 ll~~~~~------g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 110 LYGIFSG------GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEEETT------EEEECCCCEEECC
T ss_pred EEEECCC------CEEEEEECCCCCC
T ss_conf 8998189------5699973455488
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=0.0029 Score=36.17 Aligned_cols=70 Identities=26% Similarity=0.480 Sum_probs=60.0
Q ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHCCCCCCCCCEEEEEE
Q ss_conf 59316897568889589999999880893699851899997825511581669999999965079999860799980
Q 001449 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (1075)
Q Consensus 47 gg~tri~~v~r~~~~~~l~~kl~~~~~~~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~flf 123 (1075)
-||-||+.++|.++|.+|..|+.+.+|..+.+-|- .-..+|..+|.+||+.-++..||- +.-++ ||+.|-
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~----n~El~IPl~~Q~DLDkAvellDrs-~~~ks--LrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM----NNELSILLKNQDDLDKAIDILDRS-SSMKS--LRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE----CSSCEEECCSHHHHHHHHHHHHHC-SSCCS--EEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE----CCEEEEECCCHHHHHHHHHHHCCC-CCCCE--EEEEEE
T ss_conf 37068995278842999999999985983646775----671788525677789999987169-66330--699973
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.02 E-value=0.0031 Score=35.94 Aligned_cols=71 Identities=25% Similarity=0.431 Sum_probs=60.4
Q ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHCCCCCCCCCEEEEEEC
Q ss_conf 593168975688895899999998808936998518999978255115816699999999650799998607999801
Q 001449 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFS 124 (1075)
Q Consensus 47 gg~tri~~v~r~~~~~~l~~kl~~~~~~~~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~flf~ 124 (1075)
-||-||+.++|.++|.+|..|+.+.+|..+.+-|- + -.-+|..+|.+||+.-++..||- +.-++ ||+.|.-
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n--~EL~IPl~~Q~DLDkAvellDrs-~~~ks--LrilL~~ 80 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--N--NELVIPLTTQDDLDKAVELLDRS-IHMKS--LKILLVI 80 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--E--TTEEEECCCHHHHHHHHHHHHHC-SSCCS--EEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE--C--CEEEEECCCHHHHHHHHHHHCCC-CCCCC--EEEEEEE
T ss_conf 37068995278843899999999985984668885--6--76888625677789999987169-66342--6899995
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.78 E-value=0.0074 Score=33.48 Aligned_cols=80 Identities=19% Similarity=0.312 Sum_probs=56.3
Q ss_pred CEEEEEEECCCEEECCCCCCCEEEECCCEEEEECCCCCCHHHHHHHHHHHHCCC-EEEEEECCCCCCCCEEECCCHHHHH
Q ss_conf 917999402982203899997033259316897568889589999999880893-6998518999978255115816699
Q 001449 22 PRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA-VVLKYQQPDEDLDALVSVVNDDDVI 100 (1075)
Q Consensus 22 ~~vk~~csygG~i~pr~~d~~l~Y~gg~tri~~v~r~~~~~~l~~kl~~~~~~~-~~~kyqlp~edld~Lisv~~dedl~ 100 (1075)
|.|.+-.+|||.+. | =.++.+++.+|.+|..++...++-. +.|||. . |-+-.|.++||+||+
T Consensus 3 p~vtvKvtf~~dt~-R-------------F~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~--D-dd~e~v~l~~d~dl~ 65 (85)
T d2bkfa1 3 PQVTLNVTFKNEIQ-S-------------FLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--D-EENEEVSINSQGEYE 65 (85)
T ss_dssp CCEEEEEEETTEEE-E-------------EEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--C-TTSCEEEECSHHHHH
T ss_pred CCEEEEEEECCCEE-E-------------EEECCCCCCCHHHHHHHHHHHCCCCCCEEEEE--C-CCCCEEEEECHHHHH
T ss_conf 60899999878458-9-------------99648877769999999998669664138987--5-999989980688899
Q ss_pred HHHHHHHHCCCCCCCCCEEEEEE
Q ss_conf 99999965079999860799980
Q 001449 101 NMMEEYEKLGSGDGFTRLRIFLF 123 (1075)
Q Consensus 101 ~m~~eydr~~~~~~~~r~r~flf 123 (1075)
.-++-.-+ ....+|++++
T Consensus 66 E~~~~a~~-----~~~~irl~v~ 83 (85)
T d2bkfa1 66 EALKMAVK-----QGNQLQMQVH 83 (85)
T ss_dssp HHHHHHHH-----TTTEEEEEEE
T ss_pred HHHHHHHC-----CCCEEEEEEE
T ss_conf 99999866-----8988999996
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.018 Score=31.01 Aligned_cols=135 Identities=14% Similarity=0.051 Sum_probs=67.2
Q ss_pred CCCEEEEEEEE-CCCCEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCEEEEECCCCCCCCCCEEEEE
Q ss_conf 59389999998-6932599982043348993468999999999999998189-----99543560111249999528999
Q 001449 811 GTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----HPNVVSFYGIVRDGPDGSLATVT 884 (1075)
Q Consensus 811 GsfGtVYkak~-kGt~VAIKvIk~~~~~~~~~e~e~~i~~flrEi~ILkkL~-----HPNIVkLlgv~~e~~e~~L~LVm 884 (1075)
+.-..||+++. +|..+++|+.+..... .+.+..|...+..|. .+..+..-+-......+..+.++
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEE
T ss_conf 6120269998389997999984787788---------9999999999999985599878752068980566534799998
Q ss_pred EEECCCCHH----HHHH----------H----C----CCCCCHH----------------------HHHHHHHHHHHHHH
Q ss_conf 650288478----9873----------1----0----4667899----------------------99999999999999
Q 001449 885 EFMVNGSLK----QFLQ----------K----K----DRTIDRR----------------------KRLIIAMDAAFGME 920 (1075)
Q Consensus 885 EYleGGSL~----dlLk----------k----~----~k~Lse~----------------------~il~Ia~QIlsAL~ 920 (1075)
+++.|..+. +.+. . . ...++.. ....++.+++..+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 65277688999999999989999998863035786556778978876656899987476998898999999999999999
Q ss_pred HHH----HCCCCCCCCCCCCEEECCCCCCCCEEEEEECCCCCCC
Q ss_conf 998----4991503578886575268999991999425885123
Q 001449 921 YLH----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (1075)
Q Consensus 921 yLH----s~GIVHRDIKPeNILId~~~~~~g~VKLiDFGLAk~~ 960 (1075)
.+- ..+++|+|+.+.|||++ ++ ..++||+.+...
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~----~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWR----DG--PMFVDLDDARNG 221 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES----SS--EEECCCTTCCEE
T ss_pred HHCCCCCCCEEECCCCCCCCEEEE----CC--CEEEECHHCCCC
T ss_conf 845456871202478880428783----89--358865201468
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.60 E-value=0.68 Score=20.70 Aligned_cols=71 Identities=21% Similarity=0.337 Sum_probs=54.7
Q ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCC----EEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHCCCCCCCCCEEEEE
Q ss_conf 59316897568889589999999880893----69985189999782551158166999999996507999986079998
Q 001449 47 GGETRIVSLPRDVTYEELMSRMRELYEGA----VVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFL 122 (1075)
Q Consensus 47 gg~tri~~v~r~~~~~~l~~kl~~~~~~~----~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~~~~~~~~r~r~fl 122 (1075)
+|+--|..++-+++|.+|...+.++|+.. +++|.- +|+-| =++++++..|+.-+-.|... +-+-|-+-+
T Consensus 9 ~G~i~it~~~~~it~e~l~~evr~~C~f~~~q~fT~KWi--DeEGD-PCTISSQmEL~EA~RLye~n----~dseL~iHV 81 (83)
T d1wmha_ 9 RGDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEEGD-PCTVSSQLELEEAFRLYELN----KDSELLIHV 81 (83)
T ss_dssp TTEEEEEEECTTCCHHHHHHHHHHHTTCCTTCCCEEEEE--CTTSC-EEECCSHHHHHHHHHHHHHT----TCSCEEEEE
T ss_pred CCEEEEEECCCCCCHHHHHHHHHHHHCCCCCCCEEEEEE--CCCCC-CEEEECHHHHHHHHHHHHCC----CCCCEEEEE
T ss_conf 675999943887559999999999848986796778877--47999-50655488799999999705----776469984
Q ss_pred EC
Q ss_conf 01
Q 001449 123 FS 124 (1075)
Q Consensus 123 f~ 124 (1075)
||
T Consensus 82 FP 83 (83)
T d1wmha_ 82 FP 83 (83)
T ss_dssp EC
T ss_pred CC
T ss_conf 69
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.25 E-value=0.71 Score=20.58 Aligned_cols=54 Identities=20% Similarity=0.418 Sum_probs=42.8
Q ss_pred EECCCCCCHHHHHHHHHHHHCCC--EEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHC
Q ss_conf 97568889589999999880893--6998518999978255115816699999999650
Q 001449 53 VSLPRDVTYEELMSRMRELYEGA--VVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKL 109 (1075)
Q Consensus 53 ~~v~r~~~~~~l~~kl~~~~~~~--~~~kyqlp~edld~Lisv~~dedl~~m~~eydr~ 109 (1075)
|.-++-++|.++...++....-. -.+.|- .||-|. |+|.+||+|..|+.=|.-.
T Consensus 30 V~~~~~l~F~dvL~~i~q~~p~at~taFEYE--DEdGDR-ITVRSDEEl~AMisyy~~~ 85 (105)
T d2npta1 30 VHSGPQLLFRDVLDVIGQVLPEATTTAFEYE--DEDGDR-ITVRSDEEMKAMLSYYYST 85 (105)
T ss_dssp ECC--CCCHHHHHHHHHHHSTTSCCSEEEEE--CTTSCE-EEECSHHHHHHHHHHHHHH
T ss_pred ECCCCEEEHHHHHHHHHHHCCCCCCCCEEEC--CCCCCE-EEECCHHHHHHHHHHHHHH
T ss_conf 3488643399999999986634454210302--565887-6872679999999999999
|